data_2i9y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2i9y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.310000000000002 115.341 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 75.25 108.462 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.140000000000001 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.439999999999998 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.535 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.509999999999998 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.535 ' N ' HD21 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.140000000000001 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.239999999999995 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 72.200000000000003 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.150000000000006 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.209999999999994 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.420000000000002 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 71.439999999999998 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.200000000000003 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.409999999999997 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.099999999999994 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.540000000000006 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.439999999999998 108.769 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 73.420000000000002 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 75.010000000000005 111.488 -178.947 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 111.843 0.312 . . . . 73.129999999999995 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.120000000000005 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.210000000000001 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 54.43 110.662 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.349999999999994 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.409999999999997 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.129999999999995 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.549999999999997 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.129999999999995 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.329999999999998 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 62.140000000000001 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 37.25 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.120000000000005 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.230000000000004 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 86' ' ' LYS . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.129999999999995 108.132 -176.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.100000000000001 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.439999999999998 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.420000000000002 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.319999999999993 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.200000000000003 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.310000000000002 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.340000000000003 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.230000000000004 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 74.239999999999995 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.409999999999997 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.010000000000005 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.209999999999994 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.219999999999999 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.150000000000006 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.409999999999997 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.319999999999993 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 37.25 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 73.0 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 72.040000000000006 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.019999999999996 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.040000000000006 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 63.439999999999998 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.450000000000003 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 74.200000000000003 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.310000000000002 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.340000000000003 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.109999999999999 109.716 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.430000000000007 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.109999999999999 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.530000000000001 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 70.319999999999993 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.479 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm . . . . . 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 64.450000000000003 112.037 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.329999999999998 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.479 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 64.25 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.209999999999994 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.049999999999997 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.531 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.299999999999997 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.430000000000007 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 74.409999999999997 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.319999999999993 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.5 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.219999999999999 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.209999999999994 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 73.219999999999999 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.461 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.229999999999997 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.420000000000002 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 75.340000000000003 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.120000000000005 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.209999999999994 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.049999999999997 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 74.030000000000001 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 118' ' ' PHE . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.200000000000003 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.540000000000006 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.577 ' HA ' HE21 ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 74.120000000000005 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.531 ' SG ' HD22 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.200000000000003 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.130000000000003 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.129999999999995 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.433 ' HB3' HG12 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.209999999999994 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.549999999999997 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.340000000000003 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.540000000000006 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.120000000000005 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.310000000000002 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 74.349999999999994 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.010000000000005 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 110.044 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 91.1 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.219999999999999 117.173 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.420000000000002 107.271 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.319999999999993 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.109999999999999 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.552 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 74.140000000000001 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.552 ' N ' HD21 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.549999999999997 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 74.109999999999999 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.039999999999999 110.377 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.420000000000002 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.010000000000005 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.299999999999997 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 72.420000000000002 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.120000000000005 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.310000000000002 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.399999999999999 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.129999999999995 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.030000000000001 111.28 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 75.140000000000001 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.5 m170 . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 60.420000000000002 110.706 176.156 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.240000000000002 108.93 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.409999999999997 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.109999999999999 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 63.530000000000001 109.204 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.399999999999999 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 71.219999999999999 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.310000000000002 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.519999999999996 108.345 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.439999999999998 108.554 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 74.140000000000001 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.310000000000002 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.491 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 75.310000000000002 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.530000000000001 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.450000000000003 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.549999999999997 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.129999999999995 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.299999999999997 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.310000000000002 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.439999999999998 108.353 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.200000000000003 106.88 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.519999999999996 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.510000000000005 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.430000000000007 108.623 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.450000000000003 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.430000000000007 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.299999999999997 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.415 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.120000000000005 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 65.040000000000006 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.409999999999997 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.476 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.450000000000003 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.229999999999997 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.240000000000002 110.951 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' O ' HD13 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.120000000000005 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.109999999999999 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.445 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.219999999999999 109.245 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.520000000000003 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.120000000000005 112.884 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.120000000000005 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.019999999999996 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.049999999999997 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.329999999999998 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 70.400000000000006 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.200000000000003 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.209999999999994 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.210000000000001 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.150000000000006 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.529 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 74.510000000000005 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.519999999999996 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.310000000000002 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.230000000000004 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HA ' ' OG ' ' A' ' 133' ' ' SER . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.130000000000003 113.83 -176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.477 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.129999999999995 110.668 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 133' ' ' SER . . . . . . . . 0 N--CA 1.437 -1.276 0 CA-C-O 121.313 0.396 . . . . 37.200000000000003 112.758 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.477 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.310000000000002 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.409999999999997 110.385 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.209999999999994 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.519999999999996 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.439 ' CH2' ' HA ' ' A' ' 158' ' ' CYS . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 75.25 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.310000000000002 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.439999999999998 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.409999999999997 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 73.200000000000003 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.230000000000004 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.150000000000006 111.509 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.329999999999998 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.469 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.409999999999997 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.329999999999998 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.140000000000001 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 73.120000000000005 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.240000000000002 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 74.140000000000001 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.319999999999993 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.310000000000002 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.319999999999993 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 71.510000000000005 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.229999999999997 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.329999999999998 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.439 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.530000000000001 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.409999999999997 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.399999999999999 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.340000000000003 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.219999999999999 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.219999999999999 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.129999999999995 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.430000000000007 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.420000000000002 111.277 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.994 1.109 . . . . 62.539999999999999 113.994 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.519999999999996 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.100000000000001 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.310000000000002 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.219999999999999 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.200000000000003 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.530000000000001 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 75.450000000000003 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.319999999999993 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.239999999999995 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.209999999999994 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.200000000000003 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.509999999999998 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.030000000000001 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 75.099999999999994 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.530000000000001 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.329999999999998 107.764 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 7.0 t60 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.420000000000002 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 . . . . . 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 71.319999999999993 113.803 -179.331 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.387 -0.598 . . . . 63.329999999999998 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.219999999999999 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.430000000000007 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.239999999999995 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.310000000000002 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.310000000000002 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.329999999999998 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.109999999999999 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.340000000000003 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.120000000000005 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.019999999999996 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 72.120000000000005 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.409999999999997 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.310000000000002 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 50.340000000000003 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.439999999999998 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.409999999999997 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 63.140000000000001 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.030000000000001 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.120000000000005 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.140000000000001 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.140000000000001 107.961 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.109999999999999 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.510000000000005 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.420000000000002 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.120000000000005 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.299999999999997 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.616 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.239999999999995 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.340000000000003 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.430000000000007 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.4 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.030000000000001 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.409999999999997 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.010000000000005 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.43 HG11 ' CE ' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.109999999999999 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 107' ' ' ILE . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 73.450000000000003 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 72.530000000000001 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.530000000000001 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.474 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.299999999999997 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.310000000000002 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 74.120000000000005 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.150000000000006 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.310000000000002 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.54 ' CG ' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.230000000000004 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.472 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.140000000000001 107.597 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 73.400000000000006 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.210000000000001 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.040000000000006 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.510000000000005 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.430000000000007 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.540000000000006 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.439999999999998 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.239999999999995 112.424 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.399999999999999 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.544 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.020000000000003 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 71.409999999999997 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 55.200000000000003 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.210000000000001 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.049999999999997 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.420000000000002 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.425 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.439999999999998 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.299999999999997 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.54 HG12 ' CG ' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.549999999999997 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.443 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.299999999999997 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.299999999999997 111.469 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.310000000000002 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.229999999999997 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.209999999999994 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.150000000000006 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.340000000000003 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 74.400000000000006 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 61.240000000000002 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.310000000000002 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.349999999999994 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.140000000000001 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.601 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 74.530000000000001 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.430000000000007 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.310000000000002 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 63.409999999999997 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.601 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.349999999999994 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.310000000000002 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 62.450000000000003 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.409999999999997 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.329999999999998 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.568 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.420000000000002 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 73.209999999999994 111.113 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 86.9 mt . . . . . 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.040000000000006 110.749 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 113.18 0.808 . . . . 75.430000000000007 113.18 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.310000000000002 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.439999999999998 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.129999999999995 110.404 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.319999999999993 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.329999999999998 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 50.130000000000003 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.409999999999997 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.530000000000001 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.140000000000001 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.574 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.420000000000002 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB2' HD12 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.430000000000007 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.150000000000006 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.219999999999999 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.409999999999997 106.953 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 65.299999999999997 113.954 -179.791 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.476 0.179 . . . . 64.310000000000002 110.739 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.420000000000002 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.349999999999994 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.530000000000001 111.347 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.319999999999993 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.140000000000001 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.439999999999998 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.420000000000002 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 77' ' ' TRP . 0.9 OUTLIER -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.329999999999998 108.748 176.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.140000000000001 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.150000000000006 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.549999999999997 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.200000000000003 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 36.759999999999998 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.230000000000004 108.97 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.119999999999997 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 75.340000000000003 107.432 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.349999999999994 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.049999999999997 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.409999999999997 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.439999999999998 108.193 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.030000000000001 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.530000000000001 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.540000000000006 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.140000000000001 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.140000000000001 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.140000000000001 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.119999999999997 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.438 HG12 HG21 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.549999999999997 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.431 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 74.099999999999994 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.420000000000002 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.019999999999996 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.019999999999996 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.310000000000002 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.532 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.019999999999996 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.409999999999997 109.847 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.666 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.109999999999999 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.400000000000006 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.049999999999997 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.439999999999998 110.726 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.405 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 64.030000000000001 108.038 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.533 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.340000000000003 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.099999999999994 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.149999999999999 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.200000000000003 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.140000000000001 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.019999999999996 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.239999999999995 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.310000000000002 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.200000000000003 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.541 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.420000000000002 111.928 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.019999999999996 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.340000000000003 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.541 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 64.230000000000004 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.319999999999993 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.400000000000006 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.229999999999997 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.140000000000001 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 112.598 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.319999999999993 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.459 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 75.040000000000006 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.140000000000001 105.511 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.409999999999997 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.340000000000003 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 70.25 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.439999999999998 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 53.409999999999997 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.310000000000002 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.219999999999999 112.134 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.120000000000005 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.510000000000005 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.299999999999997 110.235 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.200000000000003 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.349999999999994 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.109999999999999 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 74.219999999999999 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.329999999999998 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.109999999999999 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.120000000000005 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.329999999999998 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.120000000000005 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.439999999999998 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 61.310000000000002 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.634 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.400000000000006 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.349999999999994 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 63.109999999999999 110.505 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.519999999999996 115.799 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.420000000000002 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.030000000000001 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.140000000000001 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.562 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.109999999999999 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.562 ' N ' HD21 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.340000000000003 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.430000000000007 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.009999999999998 109.519 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 75.319999999999993 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.239999999999995 113.24 178.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.474 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.219999999999999 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 45.149999999999999 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 72.549999999999997 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.420000000000002 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 63.32 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 38' ' ' LYS . 12.5 m-70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 109.778 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.337 -0.616 . . . . 70.129999999999995 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 72.340000000000003 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.239999999999995 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.130000000000003 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.140000000000001 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 64.230000000000004 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.239999999999995 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' HG21 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.400000000000006 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.409999999999997 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 65.299999999999997 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.239999999999995 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.230000000000004 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.109999999999999 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.439999999999998 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.010000000000005 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.481 HG21 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 75.239999999999995 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 63.109999999999999 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.140000000000001 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.109999999999999 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.129999999999995 108.406 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.509999999999998 110.397 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.109999999999999 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.430000000000007 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.209999999999994 108.997 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.409999999999997 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.209999999999994 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.319999999999993 110.658 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.674 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.450000000000003 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.209999999999994 109.323 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 74.319999999999993 111.567 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.120000000000005 110.951 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 65.010000000000005 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.129999999999995 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.340000000000003 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.475 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.530000000000001 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.420000000000002 113.933 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.349999999999994 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.230000000000004 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.533 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.219999999999999 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.329999999999998 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.540000000000006 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.533 ' O ' ' HE1' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.409999999999997 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.521 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.010000000000005 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.150000000000006 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 75.310000000000002 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.329999999999998 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.674 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.540000000000006 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.418 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.140000000000001 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.418 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.399999999999999 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.575 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.519999999999996 110.899 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 111.777 -0.529 . . . . 74.299999999999997 111.777 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.409999999999997 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.200000000000003 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 64.439999999999998 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 81.5 m-70 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.140000000000001 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 74.439999999999998 106.284 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.439999999999998 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.219999999999999 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.349999999999994 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.329999999999998 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.450000000000003 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.129999999999995 105.726 168.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.400000000000006 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.230000000000004 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.230000000000004 112.237 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.239999999999995 109.762 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.509999999999998 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 63.210000000000001 112.891 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.120000000000005 111.512 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.329999999999998 112.252 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.200000000000003 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.229999999999997 110.161 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.340000000000003 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.140000000000001 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 73.230000000000004 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.209999999999994 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.019999999999996 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.230000000000004 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.010000000000005 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.109999999999999 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.019999999999996 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 75.450000000000003 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.450000000000003 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 73.109999999999999 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.400000000000006 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.129999999999995 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 87.6 mt . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.209999999999994 110.331 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 111.077 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.239999999999995 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.420000000000002 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.530000000000001 110.954 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.319999999999993 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.350000000000001 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.540000000000006 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.219999999999999 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.450000000000003 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.588 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.299999999999997 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.450000000000003 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.140000000000001 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 43.240000000000002 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.030000000000001 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.420000000000002 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 74.310000000000002 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 73.439999999999998 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 5.2 t60 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.209999999999994 108.51 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.409999999999997 110.631 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.245 0.828 0 CA-C-O 120.476 0.179 . . . . 74.040000000000006 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.049999999999997 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.200000000000003 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.109999999999999 110.664 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 62.520000000000003 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.340000000000003 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.400000000000006 111.591 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.438 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 11.8 m120 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.200000000000003 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.319999999999993 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.040000000000006 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.439999999999998 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.310000000000002 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.020000000000003 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.430000000000007 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.299999999999997 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.419 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.310000000000002 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.420000000000002 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.439999999999998 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 73.439999999999998 109.144 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.150000000000006 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.310000000000002 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.129999999999995 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.109999999999999 104.739 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.349999999999994 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.422 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.109999999999999 111.808 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.010000000000005 112.777 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.540000000000006 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.129999999999995 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.540000000000006 111.592 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 74.120000000000005 110.724 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.450000000000003 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.099999999999994 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.140000000000001 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.230000000000004 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.240000000000002 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.319999999999993 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.049999999999997 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 75.099999999999994 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.502 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.239999999999995 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.349999999999994 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.129999999999995 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.310000000000002 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HG3' ' OE1' ' A' ' 142' ' ' GLU . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.439999999999998 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.472 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.120000000000005 108.127 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 72.420000000000002 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.349999999999994 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 72.140000000000001 109.901 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.099999999999994 109.74 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.329999999999998 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.019999999999996 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.099999999999994 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.519999999999996 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.63 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.099999999999994 112.155 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 C--O 1.226 -0.346 0 N-CA-C 115.006 0.762 . . . . 73.140000000000001 115.006 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.040000000000006 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.63 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 73.239999999999995 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.310000000000002 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.340000000000003 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 73.319999999999993 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.400000000000006 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.109999999999999 110.345 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.310000000000002 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.445 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.299999999999997 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.219999999999999 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.439999999999998 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.475 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.239999999999995 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.510000000000005 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.239999999999995 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.019999999999996 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 72.450000000000003 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 75.439999999999998 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.430000000000007 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.219999999999999 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 74.030000000000001 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.219999999999999 112.512 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.129999999999995 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 65.140000000000001 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.010000000000005 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.240000000000002 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.299999999999997 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 70.040000000000006 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.240000000000002 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.483 ' HB2' ' NZ ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.530000000000001 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.349999999999994 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 75.450000000000003 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.049999999999997 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.200000000000003 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.310000000000002 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt . . . . . 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.130000000000003 110.297 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.461 0.088 0 N-CA-C 113.762 1.023 . . . . 73.209999999999994 113.762 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.129999999999995 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 37.670000000000002 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.009999999999998 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.577 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 71.510000000000005 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' HD21 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.030000000000001 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.150000000000006 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.420000000000002 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.547 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.409999999999997 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.120000000000005 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.439999999999998 113.288 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.030000000000001 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 73.230000000000004 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.040000000000006 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.539999999999999 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.340000000000003 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 6.1 t60 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 75.519999999999996 109.221 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.140000000000001 113.053 -178.191 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 111.489 0.181 . . . . 75.219999999999999 111.489 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.109999999999999 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.119999999999997 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.140000000000001 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.409999999999997 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.010000000000005 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.019999999999996 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.439999999999998 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.030000000000001 107.842 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.420000000000002 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.400000000000006 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.549999999999997 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.439999999999998 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.439999999999998 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 61.149999999999999 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.340000000000003 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 86' ' ' LYS . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.299999999999997 110.259 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 72.230000000000004 108.979 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.129999999999995 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.030000000000001 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.319999999999993 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.109999999999999 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.340000000000003 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.049999999999997 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.409999999999997 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.209999999999994 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.530000000000001 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.350000000000001 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 75.420000000000002 112.554 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.230000000000004 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 62.25 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.150000000000006 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.340000000000003 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.450000000000003 108.723 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.430000000000007 106.487 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 74.310000000000002 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.420000000000002 111.481 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.230000000000004 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.439999999999998 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.420000000000002 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.540000000000006 109.793 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.099999999999994 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.129999999999995 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.530000000000001 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.340000000000003 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 74.329999999999998 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.540000000000006 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.509999999999998 110.484 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.239999999999995 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.200000000000003 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.229999999999997 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.450000000000003 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.439999999999998 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 73.019999999999996 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.109999999999999 109.147 178.278 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.310000000000002 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.340000000000003 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.109999999999999 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.299999999999997 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 73.549999999999997 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 75.0 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.200000000000003 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 74.310000000000002 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.140000000000001 113.211 -171.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.239999999999995 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.646 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.420000000000002 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.420000000000002 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.200000000000003 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.200000000000003 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.430000000000007 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.119999999999997 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 75.25 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 61.350000000000001 114.309 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 64.329999999999998 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 64.519999999999996 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.424 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 70.450000000000003 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.540000000000006 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 75.409999999999997 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.239999999999995 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.129999999999995 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 73.450000000000003 110.647 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.540000000000006 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.439999999999998 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.210000000000001 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.409999999999997 111.565 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.547 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.439999999999998 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.319999999999993 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 72.129999999999995 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.400000000000006 110.747 -179.065 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 64.510000000000005 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.399999999999999 109.862 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.240000000000002 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.349999999999994 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.109999999999999 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.519999999999996 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.030000000000001 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.430000000000007 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.119999999999997 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.430000000000007 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.140000000000001 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.530000000000001 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 75.209999999999994 112.045 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.439999999999998 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.200000000000003 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.140000000000001 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 75.230000000000004 113.564 175.749 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 120.615 0.245 . . . . 73.230000000000004 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.540000000000006 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.049999999999997 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.240000000000002 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.319999999999993 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.010000000000005 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 63.43 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.340000000000003 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.349999999999994 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 72.430000000000007 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.140000000000001 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.487 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.510000000000005 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.450000000000003 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.030000000000001 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.049999999999997 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.430000000000007 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.109999999999999 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 63.329999999999998 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.530000000000001 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HE2' ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.219999999999999 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.129999999999995 107.931 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.450000000000003 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.329999999999998 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.120000000000005 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.540000000000006 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.140000000000001 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.140000000000001 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.430000000000007 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.400000000000006 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 74.030000000000001 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.040000000000006 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 75.040000000000006 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 74.239999999999995 110.767 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 70.230000000000004 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.219999999999999 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.530000000000001 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.019999999999996 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.010000000000005 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.239999999999995 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.129999999999995 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.519999999999996 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.530000000000001 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.539999999999999 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.435 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.310000000000002 106.592 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.210000000000001 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.230000000000004 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 64.200000000000003 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.349999999999994 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.439999999999998 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 72.519999999999996 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 71.019999999999996 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.400000000000006 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.009999999999998 111.461 -179.294 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 111.634 -0.586 . . . . 52.210000000000001 111.634 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.239999999999995 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.425 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.319999999999993 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.310000000000002 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.219999999999999 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 74.129999999999995 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 72.109999999999999 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.229999999999997 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.239999999999995 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.219999999999999 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.540000000000006 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.413 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.430000000000007 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.209999999999994 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.496 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.519999999999996 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.140000000000001 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.400000000000006 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.219999999999999 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 64.319999999999993 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 73.040000000000006 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.140000000000001 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.129999999999995 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.010000000000005 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.405 ' CD1' ' HH ' ' A' ' 115' ' ' TYR . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.540000000000006 110.965 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.209999999999994 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 74.400000000000006 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.319999999999993 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.140000000000001 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.329999999999998 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 70.340000000000003 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.51 ' CB ' HG12 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 61.399999999999999 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.230000000000004 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.219999999999999 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.519999999999996 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.319999999999993 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.209999999999994 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 65.239999999999995 109.349 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.310000000000002 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.340000000000003 110.167 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.045 . . . . 72.409999999999997 113.823 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.140000000000001 106.918 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.040000000000006 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.109999999999999 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.219999999999999 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.540000000000006 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 63.350000000000001 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.400000000000006 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.319999999999993 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 71.140000000000001 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.020000000000003 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.239999999999995 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 74.120000000000005 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.119999999999997 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.549999999999997 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.44 ' NZ ' ' HB3' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.219999999999999 108.452 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 72.239999999999995 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 . . . . . 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.200000000000003 114.347 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.817 0.303 . . . . 73.349999999999994 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.140000000000001 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.400000000000006 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.219999999999999 109.001 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.409999999999997 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.319999999999993 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 74.200000000000003 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.349999999999994 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.349999999999994 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.319999999999993 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.540000000000006 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.340000000000003 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.329999999999998 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.519999999999996 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 75.230000000000004 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 52.530000000000001 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 75.120000000000005 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.130000000000003 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.517 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.400000000000006 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.209999999999994 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.45 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.239999999999995 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.129999999999995 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.219999999999999 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.45 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.230000000000004 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.439999999999998 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.210000000000001 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.019999999999996 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.319999999999993 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.510000000000005 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.219999999999999 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 75.150000000000006 110.543 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.439999999999998 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.299999999999997 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.530000000000001 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.039999999999999 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.400000000000006 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.129999999999995 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.010000000000005 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 74.219999999999999 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.450000000000003 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.129999999999995 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.329999999999998 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.430000000000007 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.329999999999998 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.310000000000002 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.030000000000001 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.109999999999999 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 64.319999999999993 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.040000000000006 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.2 tttm . . . . . 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.230000000000004 111.309 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 111.099 -0.8 . . . . 73.409999999999997 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.030000000000001 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.019999999999996 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 74.439999999999998 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.219999999999999 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.239999999999995 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.540000000000006 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.229999999999997 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 75.209999999999994 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.519999999999996 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 74.409999999999997 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.439999999999998 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 75.209999999999994 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.020000000000003 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.239999999999995 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.239999999999995 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.109999999999999 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.209999999999994 111.192 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 110.827 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.530000000000001 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 0.0 OUTLIER -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.150000000000006 112.004 176.816 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.349999999999994 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.439999999999998 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.010000000000005 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.509999999999998 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.418 ' CB ' HG12 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.310000000000002 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.009999999999998 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.409999999999997 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.340000000000003 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.230000000000004 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.409999999999997 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.239999999999995 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 60.43 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.039999999999999 109.311 178.47 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.278 0.561 . . . . 64.299999999999997 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 73.109999999999999 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.409 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.030000000000001 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.120000000000005 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.239999999999995 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.200000000000003 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.109999999999999 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.329999999999998 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.030000000000001 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.409999999999997 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.491 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.230000000000004 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.310000000000002 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.140000000000001 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.042 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.405 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.119999999999997 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.329999999999998 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.310000000000002 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.559 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 4.7 t60 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.400000000000006 109.812 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.49 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 32.8 m-70 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 71.430000000000007 113.51 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 110.397 -0.223 . . . . 65.099999999999994 110.397 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.310000000000002 108.67 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.040000000000006 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.219999999999999 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.430000000000007 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.530000000000001 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.140000000000001 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.140000000000001 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 71.129999999999995 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.409999999999997 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.409999999999997 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.310000000000002 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 65.420000000000002 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.530000000000001 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.487 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.109999999999999 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.340000000000003 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' HD12 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.329999999999998 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.329999999999998 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.239999999999995 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.539999999999999 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 74.430000000000007 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.420000000000002 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.340000000000003 111.465 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.549999999999997 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.329999999999998 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . 0.559 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.519999999999996 111.848 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.562 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.340000000000003 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.239999999999995 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.329999999999998 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.129999999999995 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.049999999999997 109.735 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 73.25 110.072 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.329999999999998 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 72.349999999999994 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.409999999999997 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.439999999999998 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.568 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.299999999999997 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.530000000000001 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.433 ' H ' HD21 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.439999999999998 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.540000000000006 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 73.409999999999997 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 75.219999999999999 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.349999999999994 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.109999999999999 108.712 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.510000000000005 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.230000000000004 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.130000000000003 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.209999999999994 109.074 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.310000000000002 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.240000000000002 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.209999999999994 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.200000000000003 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 72.540000000000006 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.476 ' CD ' HG13 ' A' ' 134' ' ' ILE . 86.6 tttt . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.109999999999999 111.754 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.420000000000002 109.254 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.476 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.140000000000001 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.240000000000002 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.239999999999995 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 74.549999999999997 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 64.209999999999994 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.349999999999994 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.530000000000001 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.510000000000005 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.209999999999994 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.409 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 75.120000000000005 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 74.010000000000005 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.310000000000002 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.329999999999998 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.430000000000007 110.791 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.530000000000001 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.467 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.400000000000006 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.219999999999999 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 74.200000000000003 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 118' ' ' PHE . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.219999999999999 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 75.140000000000001 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.140000000000001 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.420000000000002 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 75.099999999999994 111.967 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.299999999999997 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 54.140000000000001 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 72.140000000000001 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.439999999999998 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.491 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.140000000000001 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.439999999999998 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 62.399999999999999 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.420000000000002 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 110.691 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.132 0.79 . . . . 74.230000000000004 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.120000000000005 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.120000000000005 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.219999999999999 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.400000000000006 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD21 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.219999999999999 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.219999999999999 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.299999999999997 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.109999999999999 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 43.450000000000003 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 64.209999999999994 111.614 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.329999999999998 108.345 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.450000000000003 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.530000000000001 110.535 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 72.25 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.140000000000001 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 64.400000000000006 110.909 176.855 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.479 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m . . . . . 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 54.549999999999997 110.699 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 74.409999999999997 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.340000000000003 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.120000000000005 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.310000000000002 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.519999999999996 110.378 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 70.319999999999993 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.039999999999999 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.658 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.219999999999999 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 37.509999999999998 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.478 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.430000000000007 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.129999999999995 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.420000000000002 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.140000000000001 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.510000000000005 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.658 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.140000000000001 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.039999999999999 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.510000000000005 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.329999999999998 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.310000000000002 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.329999999999998 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.240000000000002 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.140000000000001 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 74.120000000000005 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.150000000000006 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 64.219999999999999 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.340000000000003 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.420000000000002 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.697 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.400000000000006 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.240000000000002 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.109999999999999 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 72.129999999999995 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 73.319999999999993 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.299999999999997 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.319999999999993 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.409999999999997 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.329999999999998 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.109999999999999 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.510000000000005 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.200000000000003 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.319999999999993 112.073 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.350000000000001 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 75.400000000000006 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.530000000000001 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 74.430000000000007 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.541 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.239999999999995 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 75.120000000000005 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.541 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 55.409999999999997 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 72.0 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 73.040000000000006 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.219999999999999 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 71.219999999999999 108.467 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.439999999999998 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.099999999999994 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.409999999999997 109.035 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.140000000000001 111.413 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 60.130000000000003 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.239999999999995 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.340000000000003 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.400000000000006 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.219999999999999 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 73.049999999999997 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.210000000000001 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 74.010000000000005 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.439999999999998 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.200000000000003 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.209999999999994 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.340000000000003 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.409999999999997 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.209999999999994 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 63.520000000000003 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.430000000000007 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.340000000000003 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 74.120000000000005 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.329999999999998 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.510000000000005 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 73.319999999999993 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 52.340000000000003 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 64.439999999999998 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.519999999999996 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 75.319999999999993 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.430000000000007 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.530000000000001 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.099999999999994 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 61.240000000000002 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.514 ' CB ' HG12 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.109999999999999 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.109999999999999 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.239999999999995 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.409999999999997 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.319999999999993 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.109999999999999 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 72.549999999999997 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 85.3 mt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.603 0.594 . . . . 75.319999999999993 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 64.030000000000001 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.099999999999994 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.450000000000003 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.129999999999995 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 61.409999999999997 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 64.230000000000004 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.140000000000001 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.310000000000002 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.340000000000003 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.239999999999995 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 72.400000000000006 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.219999999999999 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 61.229999999999997 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.319999999999993 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 73.019999999999996 112.396 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.109999999999999 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.299999999999997 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 38.3 m-70 . . . . . 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.120000000000005 111.277 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.916 0.339 . . . . 72.299999999999997 111.916 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.030000000000001 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.329999999999998 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 64.439999999999998 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 70.430000000000007 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.120000000000005 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.450000000000003 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.439999999999998 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.200000000000003 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 73.310000000000002 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.140000000000001 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.539999999999999 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.219999999999999 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.239999999999995 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.129999999999995 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.319999999999993 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.400000000000006 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.299999999999997 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.219999999999999 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.399999999999999 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.030000000000001 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 75.010000000000005 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.319999999999993 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 71.019999999999996 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.510000000000005 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.150000000000006 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.420000000000002 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.109999999999999 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.049999999999997 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.319999999999993 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 74.519999999999996 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.120000000000005 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 73.430000000000007 110.609 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.349999999999994 108.54 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 54.439999999999998 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 74.129999999999995 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 74.340000000000003 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.219999999999999 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.430000000000007 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.120000000000005 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.109999999999999 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.435 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.230000000000004 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.540000000000006 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.400000000000006 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.120000000000005 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.329999999999998 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 73.230000000000004 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 74.129999999999995 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.310000000000002 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 75.540000000000006 109.991 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.340000000000003 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.420000000000002 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 73.349999999999994 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.409999999999997 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.520000000000003 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 63.3 tttm . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.230000000000004 110.556 -178.899 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.021 0 CA-C-O 120.771 0.095 . . . . 63.219999999999999 112.973 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 61.109999999999999 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.511 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 72.420000000000002 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.400000000000006 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 74.439999999999998 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.230000000000004 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 74.129999999999995 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.150000000000006 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.530000000000001 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 73.540000000000006 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.508 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.439999999999998 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 71.120000000000005 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.340000000000003 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.129999999999995 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.329999999999998 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.329999999999998 111.053 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.219999999999999 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 54.409999999999997 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.530000000000001 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 72.120000000000005 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.010000000000005 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.408 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 64.420000000000002 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.299999999999997 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 65.010000000000005 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.219999999999999 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.439999999999998 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.419 ' HA ' HG23 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.310000000000002 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 75.310000000000002 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.329999999999998 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.319999999999993 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.400000000000006 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.209999999999994 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.239999999999995 110.828 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.510000000000005 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.100000000000001 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.340000000000003 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 71.0 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.219999999999999 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.019999999999996 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 50.32 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.400000000000006 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 75.400000000000006 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HG3' HD12 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.430000000000007 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.400000000000006 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.430000000000007 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.420000000000002 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 62.130000000000003 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.439999999999998 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 . . . . . 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.209999999999994 110.257 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 111.34 0.126 . . . . 72.299999999999997 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.399999999999999 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.219999999999999 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.509999999999998 111.962 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.019999999999996 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 72.239999999999995 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.239999999999995 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.530000000000001 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 72.329999999999998 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 62.130000000000003 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.540000000000006 108.383 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.420000000000002 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.200000000000003 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.329999999999998 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.109999999999999 108.446 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.519999999999996 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.329999999999998 108.187 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.510000000000005 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.219999999999999 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.450000000000003 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.040000000000006 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.452 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.329999999999998 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.409999999999997 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.450000000000003 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 74.310000000000002 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.100000000000001 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.409999999999997 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.230000000000004 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.340000000000003 111.205 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 74.329999999999998 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.409999999999997 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.430000000000007 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 74.0 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.510000000000005 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.409999999999997 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.430000000000007 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.540000000000006 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.109999999999999 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.130000000000003 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.019999999999996 110.988 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.019999999999996 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.299999999999997 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.030000000000001 108.919 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.57 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.140000000000001 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 72.420000000000002 107.563 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.641 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 74.030000000000001 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.129999999999995 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 50.219999999999999 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.109999999999999 108.581 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 63.450000000000003 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.150000000000006 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 65.409999999999997 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.403 ' CD ' HG13 ' A' ' 134' ' ' ILE . 86.2 tttt . . . . . 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.039999999999999 109.358 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 62.310000000000002 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 63.039999999999999 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.109999999999999 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 62.539999999999999 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.310000000000002 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.219999999999999 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.109999999999999 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.329999999999998 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.329999999999998 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.010000000000005 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.219999999999999 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.57 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.530000000000001 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.219999999999999 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.219999999999999 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.150000000000006 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.340000000000003 110.174 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.230000000000004 109.844 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 72.420000000000002 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.519999999999996 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 73.540000000000006 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.230000000000004 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.430000000000007 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.509999999999998 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.400000000000006 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.340000000000003 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.099999999999994 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.140000000000001 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.219999999999999 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 74.040000000000006 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.329999999999998 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.421 ' O ' HD11 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.420000000000002 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.140000000000001 110.486 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.140000000000001 109.279 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.319999999999993 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.400000000000006 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt . . . . . 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.120000000000005 111.637 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 115.201 1.556 . . . . 71.319999999999993 115.201 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.310000000000002 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.400000000000006 112.887 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.239999999999995 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.409999999999997 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.319999999999993 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.200000000000003 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.439999999999998 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.200000000000003 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 74.239999999999995 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.450000000000003 109.699 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.329999999999998 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.150000000000006 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.239999999999995 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.510000000000005 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 73.329999999999998 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.319999999999993 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 . . . . . 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 75.030000000000001 111.229 -174.12 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.858 0.361 . . . . 72.340000000000003 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.129999999999995 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.129999999999995 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.420000000000002 109.955 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.219999999999999 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.009999999999998 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 74.510000000000005 108.468 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 72.299999999999997 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . 0.447 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.519999999999996 109.987 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.340000000000003 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.239999999999995 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.019999999999996 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.129999999999995 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.129999999999995 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.439999999999998 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.310000000000002 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.210000000000001 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' HD12 ' A' ' 107' ' ' ILE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.129999999999995 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.319999999999993 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.530000000000001 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 65.230000000000004 109.3 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.520000000000003 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.319999999999993 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.439999999999998 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.540000000000006 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.439999999999998 112.362 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.209999999999994 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.040000000000006 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.219999999999999 111.941 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.319999999999993 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.010000000000005 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.504 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.200000000000003 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 64.340000000000003 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.450000000000003 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.030000000000001 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.310000000000002 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.230000000000004 112.006 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 62.049999999999997 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.109999999999999 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.504 ' O ' ' HE1' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 75.109999999999999 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.520000000000003 111.105 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.420000000000002 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.504 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 74.140000000000001 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 71.310000000000002 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.411 ' CG2' HD13 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.329999999999998 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 64.049999999999997 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.310000000000002 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.310000000000002 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 127' ' ' LYS . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.549999999999997 114.094 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.509999999999998 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.462 ' H ' ' C ' ' A' ' 125' ' ' THR . 88.0 tttt . . . . . 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.120000000000005 112.156 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.229999999999997 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.219999999999999 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.476 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 37.060000000000002 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.509999999999998 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 71.219999999999999 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.430000000000007 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.519999999999996 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 158' ' ' CYS . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.109999999999999 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.409999999999997 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.450000000000003 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.613 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.530000000000001 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 70.519999999999996 107.193 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 70.319999999999993 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.299999999999997 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.400000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.613 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.510000000000005 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.150000000000006 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.465 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.230000000000004 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.319999999999993 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.240000000000002 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.450000000000003 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.409999999999997 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 74.209999999999994 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.402 ' SG ' HD22 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 65.310000000000002 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.329999999999998 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 37.060000000000002 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.477 ' CB ' HG12 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.439999999999998 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.230000000000004 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.219999999999999 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.430000000000007 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.530000000000001 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 75.200000000000003 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.230000000000004 110.434 -177.525 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 121.279 0.562 . . . . 62.109999999999999 112.307 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.210000000000001 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.530000000000001 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.149999999999999 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.329999999999998 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.319999999999993 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.239999999999995 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.349999999999994 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.299999999999997 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.140000000000001 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.120000000000005 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 75.230000000000004 111.92 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.349999999999994 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.350000000000001 111.022 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.209999999999994 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.420000000000002 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.439999999999998 111.812 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.430000000000007 111.987 -177.651 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.432 0.158 . . . . 72.439999999999998 110.91 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.229999999999997 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.219999999999999 110.803 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.299999999999997 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.310000000000002 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 63.509999999999998 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 75.530000000000001 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.329999999999998 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.5 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 72.209999999999994 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.509999999999998 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.399999999999999 110.737 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.219999999999999 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 109.9 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 73.530000000000001 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.019999999999996 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.530000000000001 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.43 HG23 HG22 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.510000000000005 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.130000000000003 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.430000000000007 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.439999999999998 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 72.209999999999994 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.526 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 61.299999999999997 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.140000000000001 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 110.811 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 72.099999999999994 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.120000000000005 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.230000000000004 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 70.430000000000007 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.310000000000002 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.130000000000003 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.120000000000005 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.540000000000006 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.520000000000003 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.540000000000006 111.443 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.109999999999999 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.140000000000001 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.48 ' O ' ' HE1' ' A' ' 112' ' ' MET . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.129999999999995 105.653 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.43 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.430000000000007 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.519999999999996 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 72.329999999999998 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.439999999999998 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.109999999999999 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.030000000000001 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.340000000000003 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.319999999999993 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.400000000000006 112.842 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.319999999999993 111.121 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.568 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.329999999999998 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 70.349999999999994 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 90.0 m-70 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 74.349999999999994 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.340000000000003 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.099999999999994 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 70.140000000000001 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.409999999999997 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.040000000000006 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.329999999999998 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.349999999999994 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.426 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.209999999999994 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.350000000000001 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.349999999999994 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 62.229999999999997 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.210000000000001 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.607 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.200000000000003 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.349999999999994 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 75.430000000000007 108.887 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.140000000000001 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.458 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.349999999999994 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 50.530000000000001 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 15.1 mm100 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 74.409999999999997 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 74.530000000000001 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.140000000000001 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 73.140000000000001 111.5 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.540000000000006 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 70.239999999999995 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.010000000000005 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.030000000000001 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.200000000000003 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.150000000000006 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.554 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.009999999999998 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 63.450000000000003 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt . . . . . 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.409999999999997 110.996 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 61.530000000000001 114.796 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.540000000000006 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.229999999999997 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.039999999999999 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 74.230000000000004 108.564 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.340000000000003 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.109999999999999 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.230000000000004 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.310000000000002 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.209999999999994 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.219999999999999 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.420000000000002 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 62.140000000000001 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.229999999999997 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.140000000000001 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.129999999999995 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.540000000000006 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 74.200000000000003 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 . . . . . 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.310000000000002 113.831 -177.445 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.161 -1.052 . . . . 73.150000000000006 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.109999999999999 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.549999999999997 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' THR . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.340000000000003 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.420000000000002 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.540000000000006 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.572 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 73.409999999999997 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.329999999999998 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.109999999999999 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.340000000000003 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.510000000000005 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.239999999999995 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.340000000000003 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.200000000000003 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.209999999999994 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 75.5 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 62.140000000000001 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.219999999999999 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.572 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.239999999999995 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.030000000000001 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.340000000000003 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.299999999999997 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.400000000000006 109.893 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.420000000000002 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.109999999999999 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.601 ' HB3' HE21 ' A' ' 123' ' ' GLN . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.319999999999993 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.420000000000002 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.310000000000002 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.310000000000002 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.329999999999998 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.420000000000002 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.209999999999994 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.405 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.299999999999997 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.099999999999994 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 109' ' ' GLY 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 71.409999999999997 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.430000000000007 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.049999999999997 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 72.439999999999998 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 117' ' ' SER . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.520000000000003 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.329999999999998 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.456 ' O ' ' HE1' ' A' ' 112' ' ' MET . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 72.230000000000004 108.901 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.58 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 70.040000000000006 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.457 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.209999999999994 106.449 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 74.319999999999993 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.129999999999995 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.209999999999994 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 71.120000000000005 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 72.319999999999993 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.601 HE21 ' HB3' ' A' ' 99' ' ' LYS . 57.5 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.549999999999997 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.209999999999994 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 74.329999999999998 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.219999999999999 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.55 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt . . . . . 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.310000000000002 111.458 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.040000000000006 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 70.430000000000007 110.913 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.55 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.239999999999995 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.129999999999995 108.639 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.129999999999995 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.329999999999998 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.450000000000003 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.129999999999995 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.230000000000004 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.120000000000005 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.420000000000002 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.229999999999997 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.58 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 73.430000000000007 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.200000000000003 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 72.219999999999999 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 74.409999999999997 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.130000000000003 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.319999999999993 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.129999999999995 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.310000000000002 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.439999999999998 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 61.43 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 74.340000000000003 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 73.319999999999993 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 72.420000000000002 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.420000000000002 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.439999999999998 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 72.140000000000001 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 62.539999999999999 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.239999999999995 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 71.239999999999995 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.319999999999993 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.400000000000006 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.040000000000006 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.516 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.319999999999993 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.230000000000004 110.636 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 73.299999999999997 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.340000000000003 109.745 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HB2' ' HH ' ' A' ' 141' ' ' TYR . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.120000000000005 110.5 169.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 70.519999999999996 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.420000000000002 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.129999999999995 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.420000000000002 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB2' HD12 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.219999999999999 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.430000000000007 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.512 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.319999999999993 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 109.776 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.109999999999999 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.019999999999996 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.109999999999999 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.049999999999997 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.544 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 22.5 m-70 . . . . . 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 110.977 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 110.607 -0.146 . . . . 74.150000000000006 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.120000000000005 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.109999999999999 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.406 ' HB3' HD12 ' A' ' 92' ' ' ILE . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.420000000000002 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.229999999999997 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.430000000000007 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.239999999999995 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.329999999999998 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.329999999999998 109.383 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.519999999999996 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 64.340000000000003 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.519999999999996 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.140000000000001 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.209999999999994 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.120000000000005 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.439999999999998 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 73.329999999999998 109.256 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.450000000000003 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.109999999999999 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 74.430000000000007 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.430000000000007 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.310000000000002 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 75.450000000000003 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.230000000000004 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.310000000000002 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.209999999999994 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.439999999999998 111.117 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 51.0 t30 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.239999999999995 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.239999999999995 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.439999999999998 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.400000000000006 110.383 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.319999999999993 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.140000000000001 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 73.120000000000005 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.130000000000003 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.507 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.230000000000004 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.240000000000002 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.519999999999996 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.476 ' O ' ' HE1' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.109999999999999 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.530000000000001 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.426 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.129999999999995 107.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.531 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 74.109999999999999 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.209999999999994 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.219999999999999 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.530000000000001 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 137' ' ' TRP . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.200000000000003 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.510000000000005 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.553 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 75.019999999999996 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.510000000000005 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.329999999999998 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.541 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.230000000000004 109.963 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 133' ' ' SER . . . . . . . . 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.099999999999994 109.954 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.530000000000001 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.541 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.209999999999994 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.230000000000004 108.971 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.514 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.200000000000003 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.120000000000005 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 73.25 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.400000000000006 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.595 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 72.099999999999994 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.409999999999997 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.420000000000002 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.254 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.109999999999999 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.310000000000002 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.439999999999998 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . 0.436 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 74.219999999999999 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.019999999999996 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.540000000000006 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 71.310000000000002 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.109999999999999 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.540000000000006 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 74.230000000000004 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.584 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 73.200000000000003 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.522 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.519999999999996 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.458 ' CB ' HG12 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.340000000000003 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.319999999999993 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.530000000000001 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.530000000000001 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.421 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.319999999999993 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.229999999999997 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.420000000000002 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 74.140000000000001 110.273 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt . . . . . 0 C--O 1.237 0.427 0 N-CA-C 112.777 0.658 . . . . 75.540000000000006 112.777 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.310000000000002 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 39.030000000000001 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.310000000000002 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.546 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.409999999999997 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.546 ' N ' HD21 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.209999999999994 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.140000000000001 109.623 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.340000000000003 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 75.109999999999999 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 60.329999999999998 112.0 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.430000000000007 109.517 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 110.226 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 74.5 110.148 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.239999999999995 108.533 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.319999999999993 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 21.1 m-70 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.499 0.19 . . . . 72.430000000000007 110.856 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.450000000000003 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.310000000000002 110.83 -175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 74.329999999999998 109.883 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 75.329999999999998 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.340000000000003 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.430000000000007 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.140000000000001 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.519999999999996 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 73.519999999999996 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.010000000000005 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.340000000000003 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.149999999999999 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.097 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 63.109999999999999 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 109.816 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . 0.489 ' HB ' ' HZ2' ' A' ' 89' ' ' LYS . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.409999999999997 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 64.420000000000002 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.239999999999995 105.624 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.329999999999998 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.409999999999997 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.040000000000006 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.329999999999998 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.030000000000001 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HB3' ' NE2' ' A' ' 123' ' ' GLN . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.487 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.420000000000002 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.530000000000001 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.420000000000002 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.430000000000007 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.129999999999995 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.209999999999994 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.439999999999998 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.450000000000003 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.430000000000007 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.509999999999998 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.404 HD13 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.329999999999998 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.688 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 75.299999999999997 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.439999999999998 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.420000000000002 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 72.209999999999994 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.420000000000002 110.399 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.119999999999997 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.209999999999994 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.409999999999997 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.200000000000003 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.230000000000004 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.552 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.040000000000006 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.487 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 74.019999999999996 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.319999999999993 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.010000000000005 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.459 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.400000000000006 110.158 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.150000000000006 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.409999999999997 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.530000000000001 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 74.019999999999996 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 91.6 m-70 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.439999999999998 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 71.239999999999995 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.239999999999995 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 73.25 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.530000000000001 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 72.209999999999994 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.130000000000003 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.420000000000002 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.129999999999995 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.239999999999995 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.109999999999999 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.519999999999996 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.582 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 73.129999999999995 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 73.019999999999996 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.519999999999996 112.038 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 74.230000000000004 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.439999999999998 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.409999999999997 109.569 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.510000000000005 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.399999999999999 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.530000000000001 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.420000000000002 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.150000000000006 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.019999999999996 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.426 ' HB3' HG12 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 63.130000000000003 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 75.400000000000006 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.239999999999995 109.482 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.099999999999994 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.219999999999999 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.340000000000003 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 111.623 176.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 60.119999999999997 110.203 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 112.737 0.643 . . . . 53.219999999999999 112.737 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 71.200000000000003 108.082 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.219999999999999 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.430000000000007 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.340000000000003 107.177 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.530000000000001 108.303 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.519999999999996 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 65.409999999999997 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.510000000000005 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.299999999999997 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.200000000000003 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.430000000000007 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.540000000000006 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.340000000000003 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.219999999999999 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.150000000000006 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.329999999999998 110.699 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.120000000000005 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 111.984 -174.446 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.731 -0.47 . . . . 74.549999999999997 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 74.519999999999996 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.109999999999999 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.200000000000003 110.882 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.510000000000005 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.219999999999999 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 72.510000000000005 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.349999999999994 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 73.420000000000002 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.530000000000001 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 74.420000000000002 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.329999999999998 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.430000000000007 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.010000000000005 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.230000000000004 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.409999999999997 109.353 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.510000000000005 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.219999999999999 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.209999999999994 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 71.530000000000001 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.299999999999997 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 50.439999999999998 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.439999999999998 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.010000000000005 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 74.219999999999999 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 64.239999999999995 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.219999999999999 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.049999999999997 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.239999999999995 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.450000000000003 109.561 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.040000000000006 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.420000000000002 114.056 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.209999999999994 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 38.530000000000001 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.340000000000003 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.219999999999999 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.467 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 65.109999999999999 110.548 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.540000000000006 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.349999999999994 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . 0.454 ' CE2' HD23 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.439999999999998 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 72.209999999999994 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.59 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.120000000000005 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.019999999999996 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.59 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.109999999999999 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.149999999999999 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.010000000000005 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 64.430000000000007 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 52.030000000000001 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.010000000000005 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.420000000000002 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 73.099999999999994 109.198 179.847 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.519999999999996 111.275 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.030000000000001 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 62.25 109.763 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.430000000000007 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.319999999999993 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.239999999999995 109.716 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.439999999999998 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.51 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.230000000000004 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.230000000000004 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.140000000000001 114.197 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.219999999999999 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.230000000000004 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.439999999999998 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.219999999999999 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.140000000000001 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.420000000000002 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.310000000000002 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.109999999999999 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.420000000000002 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.420000000000002 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.219999999999999 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . 0.454 HD23 ' CE2' ' A' ' 115' ' ' TYR . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.229999999999997 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.409999999999997 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.439999999999998 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 53.119999999999997 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.400000000000006 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.319999999999993 110.477 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 55.0 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.340000000000003 111.933 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.420000000000002 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.319999999999993 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.420000000000002 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 63.420000000000002 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.540000000000006 110.372 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 112.612 0.597 . . . . 74.400000000000006 112.612 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.540000000000006 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.549999999999997 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.140000000000001 110.568 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 74.319999999999993 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 73.150000000000006 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 65.530000000000001 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.129999999999995 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 43.5 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.230000000000004 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.329999999999998 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 73.530000000000001 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.010000000000005 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.299999999999997 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.340000000000003 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.310000000000002 111.412 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.109999999999999 112.703 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 74.209999999999994 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 23.8 t-80 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.319999999999993 110.638 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 54.2 m-70 . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 74.319999999999993 112.679 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.453 0.168 . . . . 74.450000000000003 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.129999999999995 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.439999999999998 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.540000000000006 110.373 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.319999999999993 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.239999999999995 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.349999999999994 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.329999999999998 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.310000000000002 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.310000000000002 108.667 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.430000000000007 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 75.010000000000005 107.498 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.329999999999998 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.409999999999997 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.140000000000001 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.310000000000002 107.851 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.140000000000001 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.230000000000004 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.540000000000006 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.209999999999994 107.089 171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 74.549999999999997 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.239999999999995 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.530000000000001 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.229999999999997 110.724 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.230000000000004 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.129999999999995 111.499 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . 0.608 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.420000000000002 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . 0.442 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.519999999999996 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.340000000000003 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.140000000000001 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.409999999999997 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 72.400000000000006 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.519999999999996 111.496 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.150000000000006 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.150000000000006 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 71.439999999999998 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.120000000000005 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.400000000000006 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.319999999999993 111.832 176.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 72.140000000000001 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.310000000000002 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.409999999999997 106.939 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' PHE . . . . . 0.516 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.230000000000004 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . 0.516 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.129999999999995 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.420000000000002 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.239999999999995 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 55.1 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.340000000000003 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' VAL . . . . . 0.442 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.530000000000001 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.310000000000002 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.140000000000001 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HB3' ' HZ1' ' A' ' 127' ' ' LYS . 7.1 mtpm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.340000000000003 109.798 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 112.462 -0.255 . . . . 52.310000000000002 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.409 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.420000000000002 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.519999999999996 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 72.439999999999998 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.409999999999997 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 65.239999999999995 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.349999999999994 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.129999999999995 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TYR . . . . . 0.414 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.239999999999995 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 75.219999999999999 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.230000000000004 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.310000000000002 106.494 170.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.340000000000003 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 74.5 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.310000000000002 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 74.030000000000001 110.192 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.329999999999998 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.319999999999993 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.439999999999998 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.010000000000005 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.409999999999997 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.129999999999995 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' LEU . . . . . 0.612 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 74.310000000000002 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.420000000000002 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 73.109999999999999 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.230000000000004 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.240000000000002 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 73.140000000000001 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 75.230000000000004 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.010000000000005 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.530000000000001 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.019999999999996 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.430000000000007 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.099999999999994 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 74.450000000000003 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.319999999999993 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt . . . . . 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 74.409999999999997 110.116 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 110.429 -0.211 . . . . 44.399999999999999 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 63.07 -178.21 0.15 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.094 0.871 . . . . 74.099999999999994 109.864 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.402 ' HB2' ' HZ3' ' A' ' 143' ' ' LYS . . . -75.11 95.24 3.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.819 -1.178 . . . . 61.310000000000002 107.819 171.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -69.39 -35.54 75.89 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.893 -0.594 . . . . 65.219999999999999 111.087 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.464 ' C ' ' H ' ' A' ' 23' ' ' VAL . 7.3 m -89.74 -5.58 56.85 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.07 -0.715 . . . . 73.329999999999998 109.07 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt 62.04 -22.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.310000000000002 115.341 -173.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.464 ' H ' ' C ' ' A' ' 21' ' ' SER . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 75.25 108.462 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.140000000000001 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.439999999999998 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.535 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.509999999999998 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.535 ' N ' HD21 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.140000000000001 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.239999999999995 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 72.200000000000003 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG12 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.150000000000006 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.209999999999994 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.420000000000002 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 71.439999999999998 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.525 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.200000000000003 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.409999999999997 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.099999999999994 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.540000000000006 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.608 ' O ' ' HG2' ' A' ' 42' ' ' MET . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.439999999999998 108.769 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 73.420000000000002 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.16 -30.1 66.11 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 75.010000000000005 111.488 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 27.6 ptm -64.75 -22.3 66.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.87 0.367 . . . . 52.409999999999997 111.37 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.3 0.29 33.5 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.402 -0.363 . . . . 73.319999999999993 111.321 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.91 167.64 9.93 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 108.005 -1.109 . . . . 74.340000000000003 108.005 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.54 49.48 3.89 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 114.925 0.73 . . . . 75.230000000000004 114.925 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HD2' ' C ' ' A' ' 46' ' ' LYS . 3.0 tmmm? -170.96 90.04 0.47 Allowed Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 108.73 -0.841 . . . . 74.109999999999999 108.73 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.439 ' HD3' ' HG3' ' A' ' 65' ' ' GLU . 60.0 Cg_endo -102.59 5.54 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.243 2.629 . . . . 61.140000000000001 112.109 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 t60 73.05 96.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.306 1.442 . . . . 62.119999999999997 111.917 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -177.37 113.21 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.096 -1.446 . . . . 72.230000000000004 107.096 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.99 139.7 50.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 110.912 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -85.6 80.44 9.03 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.253 -1.017 . . . . 74.310000000000002 108.253 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -101.68 154.6 18.74 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.277 -0.874 . . . . 73.439999999999998 109.831 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.48 18.29 5.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.58 1.152 . . . . 62.32 109.188 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.7 t -115.3 100.04 53.12 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.187 -0.915 . . . . 51.039999999999999 110.947 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -92.41 9.04 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.575 2.183 . . . . 65.430000000000007 109.944 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.41 47.69 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.135 -0.939 . . . . 44.100000000000001 110.946 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -74.2 116.63 15.08 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.134 0.492 . . . . 72.099999999999994 110.438 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.4 mt -92.5 114.72 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.719 -0.673 . . . . 74.439999999999998 110.697 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -164.34 17.28 0.06 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.956 -1.02 . . . . 72.129999999999995 108.784 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.88 175.47 33.58 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 109.241 -1.544 . . . . 45.530000000000001 109.241 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.06 120.45 29.42 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.961 -1.126 . . . . 73.420000000000002 107.961 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.3 138.0 56.73 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.558 0.536 . . . . 74.200000000000003 109.782 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.38 94.86 1.67 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.472 0.653 . . . . 72.519999999999996 111.27 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -99.0 -172.37 2.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.267 -0.879 . . . . 73.209999999999994 112.453 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . 0.468 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 1.2 mp0 -38.32 139.9 0.34 Allowed 'General case' 0 C--O 1.243 0.758 0 C-N-CA 126.608 1.963 . . . . 73.540000000000006 111.981 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.27 121.52 26.56 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.438 -0.801 . . . . 72.319999999999993 113.618 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.48 19.85 3.63 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.489 -0.93 . . . . 75.25 108.489 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.729 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 3.3 t-105 -86.86 -1.93 58.19 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.813 -1.085 . . . . 72.5 109.063 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 7.88 57.09 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.041 -0.6 . . . . 63.409999999999997 113.74 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m 69.74 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.491 0.716 . . . . 73.129999999999995 111.843 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.120000000000005 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.210000000000001 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.729 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 54.43 110.662 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.349999999999994 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.409999999999997 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.129999999999995 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.549999999999997 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.129999999999995 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.329999999999998 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 62.140000000000001 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 37.25 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.120000000000005 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.230000000000004 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.442 ' HZ2' ' HB3' ' A' ' 86' ' ' LYS . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.129999999999995 108.132 -176.331 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.100000000000001 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.439999999999998 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.420000000000002 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.319999999999993 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.200000000000003 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.310000000000002 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.340000000000003 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.230000000000004 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 74.239999999999995 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.409999999999997 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.010000000000005 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.209999999999994 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.485 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.219999999999999 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.150000000000006 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.44 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.409999999999997 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.319999999999993 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.408 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.433 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 37.25 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 73.0 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 72.040000000000006 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.019999999999996 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.433 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.401 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.040000000000006 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 63.439999999999998 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.450000000000003 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.437 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.44 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 74.200000000000003 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.310000000000002 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.340000000000003 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.109999999999999 109.716 -176.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.505 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.430000000000007 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.109999999999999 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.530000000000001 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.434 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 70.319999999999993 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.434 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.479 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm -135.56 -59.13 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 64.450000000000003 112.037 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.2 Cg_endo -65.56 -30.07 52.07 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.006 1.137 . . . . 74.340000000000003 110.94 174.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.85 143.2 4.4 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.906 -0.664 . . . . 72.400000000000006 113.156 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.95 -124.32 33.75 Favored Glycine 0 C--O 1.243 0.693 0 O-C-N 123.827 0.369 . . . . 61.329999999999998 113.513 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.1 -17.15 22.26 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.934 2.422 . . . . 72.430000000000007 111.779 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.39 106.62 1.4 Allowed Glycine 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.329999999999998 111.117 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.479 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.505 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 64.25 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.209999999999994 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.049999999999997 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.531 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.299999999999997 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.430000000000007 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 74.409999999999997 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.319999999999993 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.5 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.219999999999999 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.209999999999994 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 73.219999999999999 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.461 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.229999999999997 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.420000000000002 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 75.340000000000003 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.5 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.120000000000005 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.209999999999994 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.409 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.049999999999997 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 74.030000000000001 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.413 HD12 ' CZ ' ' A' ' 118' ' ' PHE . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.200000000000003 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.540000000000006 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.577 ' HA ' HE21 ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 74.120000000000005 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.531 ' SG ' HD22 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.200000000000003 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.404 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.130000000000003 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.129999999999995 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.433 ' HB3' HG12 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.209999999999994 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.549999999999997 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.340000000000003 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.540000000000006 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.55 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.120000000000005 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.310000000000002 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 74.349999999999994 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.010000000000005 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.55 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt -71.84 -33.12 68.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 110.044 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.99 61.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.442 -0.799 . . . . 52.32 111.717 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.84 160.23 18.96 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.327 0.585 . . . . 51.109999999999999 112.038 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.427 -1.583 0 CA-C-N 114.772 -1.104 . . . . 70.129999999999995 110.272 178.972 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 111.744 0.276 . . . . 72.019999999999996 111.744 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.34 -77.49 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.267 1.027 . . . . 70.120000000000005 110.66 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.14 103.23 14.6 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 106.848 -1.538 . . . . 75.239999999999995 106.848 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -58.47 -28.67 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.834 0.454 . . . . 70.140000000000001 112.18 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.44 ' C ' ' H ' ' A' ' 23' ' ' VAL . 24.2 p -76.86 -20.08 56.71 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 112.596 0.591 . . . . 64.530000000000001 112.596 -178.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.288 91.1 mt 55.46 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.219999999999999 117.173 -176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.44 ' H ' ' C ' ' A' ' 21' ' ' SER . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.420000000000002 107.271 171.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.319999999999993 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.109999999999999 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.552 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 74.140000000000001 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.552 ' N ' HD21 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.549999999999997 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 74.109999999999999 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.039999999999999 110.377 -179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.420000000000002 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.010000000000005 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.299999999999997 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 72.420000000000002 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.120000000000005 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.310000000000002 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.399999999999999 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.129999999999995 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.555 ' HE3' ' OE2' ' A' ' 173' ' ' GLU . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.030000000000001 111.28 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.415 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 75.140000000000001 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.443 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 19.5 m170 -61.5 -30.23 70.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 60.420000000000002 110.706 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.443 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 95.6 mmm -72.29 -31.35 65.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.483 ' CE2' ' HA ' ' A' ' 100' ' ' ASN . 82.6 m-85 -71.62 -27.07 62.85 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 120.6 -0.44 . . . . 73.450000000000003 110.781 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.29 -55.83 5.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.329 -1.36 . . . . 63.200000000000003 107.329 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.15 100.96 0.35 Allowed Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 114.923 -1.035 . . . . 71.450000000000003 112.738 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.443 ' HE2' ' HB3' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -99.38 106.26 38.17 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 106.689 -1.597 . . . . 72.019999999999996 106.689 173.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.44 106.92 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.504 2.136 . . . . 64.140000000000001 112.443 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.98 85.19 7.36 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.946 0.879 . . . . 72.349999999999994 109.571 174.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -122.49 99.93 6.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.509 -1.223 . . . . 70.420000000000002 111.013 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -169.33 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 122.375 1.083 . . . . 72.129999999999995 111.6 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.2 m -139.17 14.69 2.62 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.031 -0.986 . . . . 72.230000000000004 108.454 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -127.39 175.74 7.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.365 -1.289 . . . . 72.439999999999998 107.885 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -52.39 11.15 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.123 -1.066 . . . . 72.219999999999999 108.123 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -127.42 98.69 28.6 Favored Pre-proline 0 N--CA 1.417 -2.077 0 N-CA-C 107.422 -1.325 . . . . 74.439999999999998 107.422 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.02 141.63 8.39 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.965 1.776 . . . . 72.540000000000006 112.356 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.66 141.25 16.44 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.406 -1.477 . . . . 44.5 109.406 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.07 86.22 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.973 0.909 . . . . 74.349999999999994 111.549 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -73.67 -50.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.652 -1.24 . . . . 72.140000000000001 107.652 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.55 72.41 10.29 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.08 64.37 3.34 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.627 -0.715 . . . . 37.200000000000003 111.487 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.4 p -92.61 79.91 4.82 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.983 0.896 . . . . 64.209999999999994 112.03 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.98 -40.75 5.37 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.953 -1.129 . . . . 74.239999999999995 107.953 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.49 168.95 9.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.471 -1.307 . . . . 74.409999999999997 107.471 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -148.08 -148.71 0.27 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.897 -1.89 . . . . 75.239999999999995 105.897 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 148.19 48.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-N 119.269 0.94 . . . . 62.119999999999997 111.816 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.02 -91.53 1.51 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.045 -1.222 . . . . 51.32 110.045 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.62 -56.74 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.858 0.463 . . . . 73.349999999999994 110.129 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -73.13 -17.36 61.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.911 -0.586 . . . . 72.340000000000003 111.924 -174.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 12.54 83.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.658 -0.782 . . . . 53.039999999999999 113.719 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -148.52 166.07 29.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.240000000000002 108.93 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.409999999999997 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.403 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.109999999999999 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 63.530000000000001 109.204 177.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.399999999999999 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 71.219999999999999 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.310000000000002 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.519999999999996 108.345 -177.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.439999999999998 108.554 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 74.140000000000001 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.310000000000002 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.491 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 75.310000000000002 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.530000000000001 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.450000000000003 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.549999999999997 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.129999999999995 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.491 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.299999999999997 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.310000000000002 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.439999999999998 108.353 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.200000000000003 106.88 -174.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.519999999999996 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.510000000000005 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.430000000000007 108.623 173.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.450000000000003 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.430000000000007 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.493 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.299999999999997 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.415 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.120000000000005 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 65.040000000000006 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.409999999999997 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.483 ' HA ' ' CE2' ' A' ' 43' ' ' PHE . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.450000000000003 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.229999999999997 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.240000000000002 110.951 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' O ' HD13 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.120000000000005 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.109999999999999 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.445 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.219999999999999 109.245 174.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.489 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.520000000000003 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.120000000000005 112.884 -175.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.120000000000005 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.019999999999996 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.049999999999997 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.566 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.329999999999998 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 70.400000000000006 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.568 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.200000000000003 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.209999999999994 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.210000000000001 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.529 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.239999999999995 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.422 HD13 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.150000000000006 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.529 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 74.510000000000005 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.519999999999996 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.310000000000002 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.230000000000004 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.406 ' HA ' ' OG ' ' A' ' 133' ' ' SER . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.130000000000003 113.83 -176.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.477 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt -84.65 146.42 46.71 Favored Pre-proline 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.129999999999995 110.668 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.299 1.999 . . . . 72.030000000000001 111.406 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.59 51.61 0.77 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.671 -0.776 . . . . 43.210000000000001 111.67 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -154.87 143.46 9.98 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.224 -0.988 . . . . 71.140000000000001 110.934 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -65.17 -25.8 57.67 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.773 2.315 . . . . 75.049999999999997 111.565 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.42 ' C ' ' HG ' ' A' ' 133' ' ' SER . . . -79.55 -165.94 31.55 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.821 -0.627 . . . . 37.200000000000003 112.758 -178.69 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.477 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.310000000000002 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.409999999999997 110.385 176.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.209999999999994 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.519999999999996 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.439 ' CH2' ' HA ' ' A' ' 158' ' ' CYS . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 75.25 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.310000000000002 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.439999999999998 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.409999999999997 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 73.200000000000003 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.230000000000004 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.150000000000006 111.509 178.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.329999999999998 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.469 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.409999999999997 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.329999999999998 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.140000000000001 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.469 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 73.120000000000005 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.240000000000002 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 74.140000000000001 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.319999999999993 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.310000000000002 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.319999999999993 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 71.510000000000005 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.414 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.229999999999997 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.329999999999998 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.439 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.530000000000001 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.409999999999997 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.399999999999999 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.340000000000003 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.449 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.219999999999999 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.219999999999999 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.463 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.449 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.129999999999995 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.430000000000007 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -75.17 -18.69 60.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.420000000000002 111.277 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.19 -168.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.512 -0.767 . . . . 74.430000000000007 109.775 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.6 152.93 42.96 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.133 0.492 . . . . 74.120000000000005 112.174 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.555 ' OE2' ' HE3' ' A' ' 38' ' ' LYS . 8.6 pt-20 . . . . . 0 C--N 1.307 -1.252 0 CA-C-N 115.232 -0.894 . . . . 72.239999999999995 109.399 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.547 ' HA ' ' HB2' ' A' ' 146' ' ' GLU . 42.9 m . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.32 1.057 . . . . 54.409999999999997 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.75 21.76 1.98 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.557 -1.656 . . . . 51.219999999999999 110.341 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.25 113.24 7.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.717 -0.674 . . . . 71.329999999999998 109.539 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -72.3 -27.75 62.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.696 -0.683 . . . . 65.010000000000005 111.667 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.7 m -56.56 -44.09 80.6 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 113.854 1.057 . . . . 72.0 113.854 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.499 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt 65.61 -40.2 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.514 1.125 . . . . 62.539999999999999 113.994 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.519999999999996 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.100000000000001 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.425 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.310000000000002 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.219999999999999 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.200000000000003 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.530000000000001 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 75.450000000000003 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.319999999999993 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.239999999999995 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.209999999999994 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.200000000000003 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.509999999999998 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.030000000000001 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 75.099999999999994 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.530000000000001 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' MET . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.329999999999998 107.764 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 7.0 t60 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.420000000000002 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -76.67 -40.9 47.55 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 71.319999999999993 113.803 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.42 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 26.7 ptm -53.56 -34.64 59.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.579 1.326 . . . . 74.129999999999995 114.579 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -84.92 -21.53 29.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.019 -0.672 . . . . 75.219999999999999 112.344 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.72 22.59 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.94 -0.475 . . . . 64.319999999999993 111.533 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.63 46.36 1.08 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.147 -0.781 . . . . 64.109999999999999 111.147 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' C ' ' H ' ' A' ' 48' ' ' HIS . 0.0 OUTLIER 64.75 111.54 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 124.578 1.151 . . . . 73.140000000000001 112.953 179.836 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.28 22.53 0.81 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.823 2.349 . . . . 74.450000000000003 111.324 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' H ' ' C ' ' A' ' 46' ' ' LYS . 44.5 t-80 -66.11 143.68 57.16 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.213 1.005 . . . . 75.420000000000002 110.422 -179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -132.16 143.55 50.05 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.383 -0.969 . . . . 64.439999999999998 108.383 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.58 134.31 39.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.305 -0.998 . . . . 73.209999999999994 108.305 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.2 m -107.5 96.99 6.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.014 0.435 . . . . 75.099999999999994 111.656 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -142.4 175.86 9.45 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.026 -1.101 . . . . 63.43 108.026 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.72 27.65 16.97 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.419 0.688 . . . . 73.040000000000006 111.237 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.8 m 67.61 93.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.798 0.839 . . . . 72.340000000000003 111.074 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -50.72 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.971 2.448 . . . . 74.219999999999999 114.284 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.8 -161.5 15.03 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.296 -1.122 . . . . 55.100000000000001 110.296 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.45 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.145 0.978 . . . . 63.329999999999998 110.922 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -90.03 89.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 113.927 1.084 . . . . 75.239999999999995 113.927 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 62.49 -168.49 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.344 -0.844 . . . . 74.349999999999994 112.198 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.58 -17.06 2.86 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.236 -0.438 . . . . 60.219999999999999 112.31 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.4 m 69.72 -42.66 0.51 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.833 1.253 . . . . 62.200000000000003 112.93 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.68 139.64 53.49 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 122.741 0.416 . . . . 71.299999999999997 110.652 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 tp -128.65 88.82 2.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.342 0.591 . . . . 73.530000000000001 110.107 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -149.94 101.93 3.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.297 -0.865 . . . . 71.299999999999997 109.055 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.63 -66.79 0.81 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.213 -0.662 . . . . 60.340000000000003 109.213 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.79 15.89 2.63 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.099 -1.048 . . . . 75.540000000000006 113.657 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.28 161.54 39.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.307 -0.957 . . . . 70.519999999999996 112.07 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -105.83 -10.9 16.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 108.828 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 -12.34 68.59 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.359 -0.837 . . . . 64.140000000000001 112.32 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.441 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m -118.8 150.1 40.39 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.387 -0.598 . . . . 63.329999999999998 109.387 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.219999999999999 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.430000000000007 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.441 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.239999999999995 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.310000000000002 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.310000000000002 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.426 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.329999999999998 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.109999999999999 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.340000000000003 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.120000000000005 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.019999999999996 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 72.120000000000005 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.409999999999997 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.310000000000002 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 50.340000000000003 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.439999999999998 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.409999999999997 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 63.140000000000001 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.426 ' HG2' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.030000000000001 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.120000000000005 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.140000000000001 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.140000000000001 107.961 173.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.109999999999999 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.510000000000005 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.420000000000002 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.452 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.120000000000005 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.299999999999997 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.616 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.239999999999995 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.340000000000003 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.430000000000007 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.4 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.030000000000001 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.492 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.409999999999997 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.431 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.010000000000005 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.43 HG11 ' CE ' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.109999999999999 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.446 HG21 HD13 ' A' ' 107' ' ' ILE . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 73.450000000000003 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.474 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 72.530000000000001 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.530000000000001 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.474 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.299999999999997 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.310000000000002 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.522 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 74.120000000000005 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.150000000000006 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.52 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.310000000000002 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.54 ' CG ' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.230000000000004 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.472 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.140000000000001 107.597 -178.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.467 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 73.400000000000006 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.210000000000001 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.467 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.040000000000006 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.510000000000005 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.430000000000007 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.540000000000006 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.439999999999998 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.544 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm -129.03 -53.97 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.239999999999995 112.424 -173.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.459 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 34.6 Cg_exo -64.23 -49.01 4.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.406 1.404 . . . . 74.329999999999998 111.533 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.42 -121.66 1.02 Allowed Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.309 -0.716 . . . . 73.209999999999994 111.309 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.1 -81.69 0.89 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.572 -1.011 . . . . 63.420000000000002 110.572 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.66 95.88 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.108 1.872 . . . . 65.200000000000003 110.886 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.492 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 134.32 116.83 1.7 Allowed Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.399999999999999 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.544 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.020000000000003 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 71.409999999999997 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 55.200000000000003 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.210000000000001 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.049999999999997 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.420000000000002 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.425 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.439999999999998 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.299999999999997 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.54 HG12 ' CG ' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.549999999999997 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.443 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.299999999999997 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.547 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.299999999999997 111.469 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.310000000000002 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.443 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.229999999999997 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.209999999999994 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.150000000000006 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.340000000000003 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 74.400000000000006 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.544 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 61.240000000000002 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.310000000000002 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.349999999999994 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.140000000000001 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.601 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 74.530000000000001 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.496 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.430000000000007 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.310000000000002 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 63.409999999999997 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.601 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.349999999999994 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.568 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.310000000000002 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 62.450000000000003 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.421 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.409999999999997 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.329999999999998 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.568 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.420000000000002 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.404 HD21 ' SD ' ' A' ' 42' ' ' MET . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 73.209999999999994 111.113 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.421 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 86.9 mt -74.29 -25.66 59.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.040000000000006 110.749 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 105.79 8.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.624 -1.25 . . . . 73.239999999999995 107.624 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.5 151.62 42.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.592 0.71 . . . . 72.540000000000006 112.602 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 114.878 -1.055 . . . . 74.129999999999995 108.804 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.3 m . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.281 0.563 . . . . 73.349999999999994 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -116.03 174.19 6.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.696 -0.684 . . . . 73.019999999999996 109.483 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.09 131.36 4.44 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.701 0.286 . . . . 72.450000000000003 110.332 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.5 p -62.06 -29.02 70.01 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.64 0.733 . . . . 72.400000000000006 109.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -76.39 -5.92 49.39 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.925 -1.034 . . . . 73.010000000000005 112.229 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt 63.23 12.88 6.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 75.430000000000007 113.18 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.310000000000002 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.439999999999998 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.129999999999995 110.404 174.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.319999999999993 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.329999999999998 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 50.130000000000003 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.409999999999997 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.530000000000001 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.488 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.140000000000001 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.574 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.420000000000002 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.518 ' HB2' HD12 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.430000000000007 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.413 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.461 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.150000000000006 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.219999999999999 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.523 ' O ' ' HG2' ' A' ' 42' ' ' MET . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.409999999999997 106.953 174.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.461 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -77.08 -32.34 56.64 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 65.299999999999997 113.954 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.523 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 23.3 ptt? -62.35 -28.51 69.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 120.497 -0.481 . . . . 74.430000000000007 111.548 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.28 -20.1 65.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.299 0.571 . . . . 70.0 110.815 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.43 14.34 32.26 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 116.011 -0.54 . . . . 72.319999999999993 112.429 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.67 -49.0 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 118.108 -1.996 . . . . 55.100000000000001 114.804 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.0 mptp? -69.68 141.36 90.16 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 116.86 0.33 . . . . 73.409999999999997 111.347 -178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.92 165.68 25.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.117 1.878 . . . . 71.409999999999997 110.607 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.412 ' HE2' ' CD ' ' A' ' 90' ' ' GLU . 57.1 t60 -87.46 -9.28 55.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.434 0.635 . . . . 53.539999999999999 110.464 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -136.57 151.17 49.08 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.484 1.114 . . . . 75.209999999999994 108.827 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -53.35 122.89 3.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.279 0.561 . . . . 73.439999999999998 110.325 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 t -105.3 106.81 17.48 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.89 -0.595 . . . . 61.409999999999997 110.61 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' HE3' ' OG ' ' A' ' 54' ' ' SER . 38.5 ttpt -168.2 147.02 4.5 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.195 -1.039 . . . . 65.109999999999999 108.195 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.72 82.48 6.71 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.571 0.7 . . . . 71.230000000000004 111.744 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.503 ' OG ' ' HE3' ' A' ' 52' ' ' LYS . 58.9 m -138.24 135.78 18.74 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 115.3 -0.864 . . . . 74.430000000000007 109.27 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 149.15 68.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 123.134 2.556 . . . . 61.310000000000002 112.909 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 -35.42 0.12 Allowed Glycine 0 C--N 1.302 -1.359 0 N-CA-C 108.744 -1.742 . . . . 61.140000000000001 108.744 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -143.63 -177.75 5.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.441 . . . . 72.400000000000006 107.108 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.417 HG13 ' HG3' ' A' ' 59' ' ' GLN . 37.1 pt -53.75 -34.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.392 0.886 . . . . 74.049999999999997 113.392 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.417 ' HG3' HG13 ' A' ' 58' ' ' ILE . 95.3 mt-30 -101.93 -35.31 9.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 111.16 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.45 -66.16 3.85 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 109.499 -1.44 . . . . 36.759999999999998 109.499 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 50.7 t -107.8 147.18 31.21 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.154 -1.795 . . . . 65.329999999999998 106.154 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -72.41 98.89 2.33 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.198 0.523 . . . . 55.049999999999997 109.616 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.38 132.71 49.41 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.547 -0.751 . . . . 74.219999999999999 109.6 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 66.93 89.86 0.1 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 122.0 0.905 . . . . 70.310000000000002 110.857 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.64 145.41 30.36 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.902 -1.045 . . . . 54.43 110.664 -177.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.48 -27.3 1.82 Allowed Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.661 -0.78 . . . . 74.340000000000003 112.019 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 70.77 149.49 0.09 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.823 0.849 . . . . 73.25 112.073 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.5 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 40.6 m95 -107.5 15.66 24.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.85 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.31 14.56 38.19 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.17 -1.014 . . . . 62.100000000000001 110.746 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m 72.52 -68.77 0.21 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.91 1.284 . . . . 64.310000000000002 110.739 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.420000000000002 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.349999999999994 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.5 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.530000000000001 111.347 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.319999999999993 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.453 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.140000000000001 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.439999999999998 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.523 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.420000000000002 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.476 HD21 ' C ' ' A' ' 77' ' ' TRP . 0.9 OUTLIER -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.329999999999998 108.748 176.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.140000000000001 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.150000000000006 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.549999999999997 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.200000000000003 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 36.759999999999998 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.230000000000004 108.97 -179.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.119999999999997 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.436 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.523 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 75.340000000000003 107.432 -179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.349999999999994 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.049999999999997 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.424 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.409999999999997 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.439999999999998 108.193 174.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.030000000000001 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.530000000000001 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.438 HG21 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.540000000000006 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.479 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.140000000000001 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.140000000000001 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.413 ' ND2' ' HB2' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.140000000000001 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.479 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.119999999999997 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.438 HG12 HG21 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.549999999999997 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.431 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 74.099999999999994 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.424 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.420000000000002 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.463 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.019999999999996 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.532 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.019999999999996 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.310000000000002 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.532 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.019999999999996 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.409999999999997 109.847 177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.666 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.109999999999999 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.400000000000006 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.447 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.049999999999997 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.666 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.439999999999998 110.726 179.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.405 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 64.030000000000001 108.038 175.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.533 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.340000000000003 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.099999999999994 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.533 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.149999999999999 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.200000000000003 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.140000000000001 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.019999999999996 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.239999999999995 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.310000000000002 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.200000000000003 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.541 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm -86.44 -55.59 0.37 Allowed Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.420000000000002 111.928 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 13.0 Cg_exo -73.21 -56.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.193 1.262 . . . . 73.400000000000006 110.499 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.98 108.67 0.23 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.369 -0.92 . . . . 70.510000000000005 112.848 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.71 -117.2 8.26 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 123.998 0.469 . . . . 60.32 114.084 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.66 111.41 0.95 Allowed 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 123.08 2.52 . . . . 75.319999999999993 110.766 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.574 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 107.82 68.59 0.66 Allowed Glycine 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.019999999999996 109.212 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.340000000000003 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.541 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 64.230000000000004 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.319999999999993 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 73.329999999999998 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.400000000000006 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.229999999999997 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.140000000000001 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 112.598 -172.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.319999999999993 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.459 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 75.040000000000006 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.140000000000001 105.511 169.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.409999999999997 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.340000000000003 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 70.25 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.447 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.439999999999998 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 53.409999999999997 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.310000000000002 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.219999999999999 112.134 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.120000000000005 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.510000000000005 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.299999999999997 110.235 178.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.200000000000003 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.349999999999994 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.109999999999999 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 74.219999999999999 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 63.219999999999999 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.438 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.329999999999998 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.109999999999999 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.405 ' HA ' HG23 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.120000000000005 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.634 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.329999999999998 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.405 HG23 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.120000000000005 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.407 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.439999999999998 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 61.310000000000002 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.634 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.400000000000006 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.349999999999994 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.518 HD12 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -75.58 -40.83 56.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 63.109999999999999 110.505 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.8 30.63 18.37 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.051 1.341 . . . . 72.140000000000001 111.112 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.27 149.59 50.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.894 -1.048 . . . . 74.340000000000003 110.162 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 108.664 -0.865 . . . . 75.310000000000002 108.664 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.818 -0.808 . . . . 73.230000000000004 108.818 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -164.65 168.63 17.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.673 -1.232 . . . . 63.109999999999999 107.673 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.34 103.56 11.19 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.159 -0.682 . . . . 64.519999999999996 109.159 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 p -72.68 -43.08 63.56 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.162 0.506 . . . . 65.140000000000001 111.106 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -80.32 -22.89 41.03 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.421 -0.809 . . . . 71.409999999999997 109.645 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.443 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt 63.58 -20.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.519999999999996 115.799 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.420000000000002 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.030000000000001 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.140000000000001 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.562 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.109999999999999 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.562 ' N ' HD21 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.340000000000003 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.430000000000007 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.009999999999998 109.519 177.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 75.319999999999993 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.239999999999995 113.24 178.25 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.474 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.219999999999999 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.408 ' HB2' HD12 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 45.149999999999999 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 72.549999999999997 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.458 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.420000000000002 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.458 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 63.32 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.446 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.458 ' CD2' ' HA ' ' A' ' 38' ' ' LYS . 12.5 m-70 -68.03 -42.44 80.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 109.778 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.487 ' HE2' ' HA ' ' A' ' 42' ' ' MET . 14.3 mmt -74.91 -41.02 60.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 75.030000000000001 112.385 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.42 5.76 49.52 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.376 0.88 . . . . 73.329999999999998 113.376 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.14 95.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 43.219999999999999 110.477 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.435 ' O ' ' HD3' ' A' ' 46' ' ' LYS . . . 104.21 -15.16 51.16 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.46 -0.656 . . . . 43.229999999999997 111.46 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.435 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 74.7 mmtt -135.02 157.24 77.43 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 108.289 -1.004 . . . . 71.129999999999995 108.289 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.91 113.84 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.079 1.852 . . . . 72.299999999999997 108.395 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -94.27 141.54 28.44 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.145 -0.622 . . . . 63.520000000000003 109.626 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -54.3 112.68 1.03 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.767 0.667 . . . . 70.530000000000001 109.684 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.87 -27.93 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.517 0.562 . . . . 74.430000000000007 112.517 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 m 66.2 31.35 8.71 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.777 0.673 . . . . 64.040000000000006 110.838 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.18 -168.17 0.2 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.12 0.968 . . . . 74.310000000000002 111.55 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 76.56 -46.08 0.51 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.325 1.45 . . . . 42.409999999999997 112.232 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 p -154.39 144.52 15.66 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.603 -0.518 . . . . 64.519999999999996 109.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.1 174.51 12.3 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 122.279 1.986 . . . . 75.049999999999997 111.3 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.53 63.44 0.53 Allowed Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 111.259 -0.736 . . . . 53.229999999999997 111.259 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.53 158.32 28.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.237 -0.653 . . . . 62.009999999999998 109.237 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.2 mt 76.47 99.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 108.127 -1.064 . . . . 74.219999999999999 108.127 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -66.48 129.49 40.03 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.314 0.857 . . . . 54.009999999999998 113.314 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.22 57.45 0.43 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 109.532 -1.427 . . . . 51.119999999999997 109.532 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.61 159.71 19.14 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.416 -0.392 . . . . 73.219999999999999 110.781 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -63.54 135.75 57.06 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.394 1.078 . . . . 63.039999999999999 113.688 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.401 HD13 ' N ' ' A' ' 63' ' ' LEU . 3.2 mp -105.61 -168.85 1.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.261 -2.126 . . . . 62.340000000000003 105.261 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -88.47 131.99 34.66 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.465 -1.294 . . . . 60.020000000000003 107.705 171.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.77 159.17 29.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 120.506 0.194 . . . . 70.510000000000005 111.196 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.4 119.31 16.71 Favored Glycine 0 N--CA 1.44 -1.092 0 O-C-N 123.905 0.753 . . . . 75.209999999999994 111.697 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.48 2.26 2.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.176 0.806 . . . . 75.099999999999994 113.176 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -82.6 -2.12 52.88 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.621 -0.718 . . . . 74.219999999999999 109.23 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.78 39.35 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.35 -0.929 . . . . 50.340000000000003 111.456 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m 74.79 -64.8 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.022 0.929 . . . . 70.129999999999995 109.337 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 72.340000000000003 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.239999999999995 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.130000000000003 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.140000000000001 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 64.230000000000004 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.239999999999995 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.481 ' OD1' HG21 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.400000000000006 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.409999999999997 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 65.299999999999997 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.239999999999995 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.230000000000004 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.109999999999999 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.439999999999998 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.010000000000005 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.481 HG21 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 75.239999999999995 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 63.109999999999999 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.475 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.140000000000001 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.109999999999999 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.129999999999995 108.406 178.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.509999999999998 110.397 178.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.109999999999999 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.430000000000007 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.209999999999994 108.997 179.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.409999999999997 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.209999999999994 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.319999999999993 110.658 178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.674 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.450000000000003 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.209999999999994 109.323 -177.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 74.319999999999993 111.567 177.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.120000000000005 110.951 176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 65.010000000000005 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.454 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.418 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.129999999999995 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.447 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.340000000000003 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.475 ' CB ' ' HG2' ' A' ' 89' ' ' LYS . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.530000000000001 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.420000000000002 113.933 -179.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.454 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.349999999999994 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.230000000000004 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.533 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.219999999999999 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.329999999999998 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.540000000000006 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.533 ' O ' ' HE1' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.409999999999997 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.521 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.010000000000005 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.150000000000006 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.521 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 75.310000000000002 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.329999999999998 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.674 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.540000000000006 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.418 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.140000000000001 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.418 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.399999999999999 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.575 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt -77.84 151.46 79.46 Favored Pre-proline 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.519999999999996 110.899 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.21 100.36 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.381 2.054 . . . . 72.409999999999997 110.099 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.4 -28.02 3.88 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.835 -0.906 . . . . 45.229999999999997 110.835 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 127.88 -89.38 0.33 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.312 -0.947 . . . . 44.340000000000003 113.92 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.494 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 9.9 Cg_endo -46.66 114.32 0.88 Allowed 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 124.542 3.495 . . . . 71.430000000000007 115.232 -173.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.16 -172.26 26.51 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.41 -0.814 . . . . 74.299999999999997 111.777 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.469 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.409999999999997 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.575 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.200000000000003 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 64.439999999999998 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.452 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 81.5 m-70 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.140000000000001 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 74.439999999999998 106.284 177.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.439999999999998 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.219999999999999 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.349999999999994 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.329999999999998 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.443 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.450000000000003 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.129999999999995 105.726 168.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.400000000000006 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.230000000000004 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.230000000000004 112.237 -175.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.239999999999995 109.762 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.509999999999998 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 63.210000000000001 112.891 -178.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.120000000000005 111.512 177.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.329999999999998 112.252 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.200000000000003 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.229999999999997 110.161 -179.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.525 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.340000000000003 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.140000000000001 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 73.230000000000004 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.209999999999994 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.525 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.019999999999996 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.230000000000004 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.010000000000005 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.109999999999999 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.019999999999996 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 75.450000000000003 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.474 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.450000000000003 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 73.109999999999999 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.400000000000006 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.129999999999995 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 87.6 mt -82.51 -41.29 19.88 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.209999999999994 110.331 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 46.33 72.6 0.22 Allowed 'General case' 0 C--O 1.251 1.151 0 C-N-CA 125.102 1.361 . . . . 64.120000000000005 113.808 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.52 -158.46 0.88 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.898 -1.501 . . . . 63.130000000000003 107.447 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--N 1.298 -1.651 0 O-C-N 123.187 0.304 . . . . 74.310000000000002 111.014 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.106 0.479 . . . . 62.219999999999999 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -134.68 173.16 11.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.738 -0.838 . . . . 72.439999999999998 108.738 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.39 -14.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.856 1.263 . . . . 42.130000000000003 113.436 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -72.18 -32.08 66.51 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.118 0.567 . . . . 55.210000000000001 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 m -84.27 -5.5 59.27 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.992 -0.549 . . . . 64.439999999999998 110.907 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.5 mt -80.71 19.03 0.87 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 111.077 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.239999999999995 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.420000000000002 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.530000000000001 110.954 -178.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.319999999999993 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.350000000000001 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.540000000000006 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.219999999999999 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.433 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.450000000000003 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.588 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.299999999999997 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.404 ' HB2' HD12 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.450000000000003 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.140000000000001 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 43.240000000000002 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.030000000000001 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.420000000000002 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.414 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 74.310000000000002 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 73.439999999999998 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.422 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 5.2 t60 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.209999999999994 108.51 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.414 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 -63.43 -35.2 79.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.409999999999997 110.631 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.19 -23.63 60.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.182 0.515 . . . . 74.109999999999999 111.508 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.44 3.36 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.156 -0.475 . . . . 70.420000000000002 110.788 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.75 -50.83 2.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.733 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.21 -146.37 6.43 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.509 -0.636 . . . . 73.329999999999998 111.509 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 9.8 mptt -108.21 156.21 38.84 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.348 -0.612 . . . . 63.219999999999999 109.348 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.44 118.96 6.0 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.182 1.921 . . . . 73.439999999999998 109.033 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -116.37 127.1 54.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.819 -0.808 . . . . 72.109999999999999 108.819 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -92.07 163.89 13.8 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.427 0.528 . . . . 71.010000000000005 112.427 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.78 128.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.285 -0.87 . . . . 52.509999999999998 110.309 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -164.12 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.901 -0.407 . . . . 75.510000000000005 109.901 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 70.34 145.69 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.123 0.969 . . . . 72.420000000000002 111.115 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 73.33 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.073 0.939 . . . . 61.350000000000001 111.411 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -138.65 164.7 38.01 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 106.632 -1.618 . . . . 73.049999999999997 106.632 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.11 152.62 74.67 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 121.634 1.556 . . . . 74.120000000000005 110.967 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.1 -135.3 4.92 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.965 -0.636 . . . . 54.020000000000003 111.968 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.09 104.93 11.91 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 110.805 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 pt -140.18 174.05 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.32 -0.992 . . . . 61.049999999999997 108.32 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -84.28 147.32 27.29 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.907 -0.775 . . . . 61.210000000000001 108.907 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.8 113.38 3.09 Favored Glycine 0 C--N 1.298 -1.552 0 C-N-CA 120.372 -0.918 . . . . 65.519999999999996 110.86 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.1 t -94.11 153.83 17.92 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.903 0.382 . . . . 70.349999999999994 110.215 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -100.82 -10.85 20.35 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.26 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.19 92.83 2.08 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.198 0.523 . . . . 73.230000000000004 110.512 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -85.51 114.33 22.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.555 0.693 . . . . 62.25 111.806 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.32 169.85 10.06 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.174 -0.921 . . . . 75.310000000000002 109.365 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.13 59.89 4.83 Favored Glycine 0 C--N 1.314 -0.658 0 C-N-CA 120.971 -0.633 . . . . 62.049999999999997 112.333 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -83.78 158.42 21.73 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 122.557 0.343 . . . . 62.5 110.504 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -98.59 -17.13 18.81 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.814 -0.439 . . . . 75.420000000000002 109.814 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.26 -10.8 67.52 Favored Glycine 0 C--O 1.243 0.689 0 CA-C-N 115.852 -0.613 . . . . 37.159999999999997 113.687 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p -140.19 170.45 15.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 122.915 0.486 . . . . 74.040000000000006 111.085 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.049999999999997 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.200000000000003 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.109999999999999 110.664 179.139 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 62.520000000000003 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.340000000000003 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.400000000000006 111.591 -178.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.438 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 11.8 m120 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.200000000000003 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.319999999999993 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.040000000000006 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.439999999999998 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.310000000000002 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.020000000000003 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.430000000000007 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.486 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.299999999999997 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.419 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.462 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.310000000000002 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.438 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.420000000000002 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.439999999999998 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 73.439999999999998 109.144 179.554 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.150000000000006 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.310000000000002 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.129999999999995 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.109999999999999 104.739 172.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.349999999999994 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.422 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.109999999999999 111.808 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.010000000000005 112.777 -175.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.540000000000006 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.129999999999995 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.540000000000006 111.592 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 74.120000000000005 110.724 176.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.450000000000003 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.099999999999994 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.140000000000001 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.438 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.230000000000004 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.407 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.240000000000002 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.407 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.319999999999993 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.049999999999997 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 75.099999999999994 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.502 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.239999999999995 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.349999999999994 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.129999999999995 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.503 ' CE1' ' HB2' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.310000000000002 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HG3' ' OE1' ' A' ' 142' ' ' GLU . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.439999999999998 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.472 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.120000000000005 108.127 174.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 72.420000000000002 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.349999999999994 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 72.140000000000001 109.901 -179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.099999999999994 109.74 177.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.329999999999998 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.019999999999996 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.099999999999994 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.519999999999996 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.63 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -64.3 141.08 98.09 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.099999999999994 112.155 -176.098 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo -69.03 -24.33 33.12 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.242 1.962 . . . . 61.509999999999998 109.957 175.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.16 150.63 15.89 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 108.618 -1.793 . . . . 72.299999999999997 108.618 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.9 -170.02 13.22 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.31 -0.948 . . . . 75.129999999999995 111.73 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -96.43 166.74 1.14 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.022 2.482 . . . . 71.400000000000006 113.508 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.588 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . 55.67 -103.73 0.25 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.352 -0.84 . . . . 73.140000000000001 115.006 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.040000000000006 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.63 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 73.239999999999995 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.310000000000002 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.340000000000003 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 73.319999999999993 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.400000000000006 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.109999999999999 110.345 -175.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.310000000000002 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 75.040000000000006 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.445 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.299999999999997 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.412 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.219999999999999 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.428 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.439999999999998 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.475 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.239999999999995 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.510000000000005 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.239999999999995 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.475 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.019999999999996 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.503 ' HB2' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 72.450000000000003 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 75.439999999999998 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.430000000000007 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.219999999999999 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 74.030000000000001 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.219999999999999 112.512 -179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.432 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.129999999999995 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.45 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 65.140000000000001 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.010000000000005 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.240000000000002 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.462 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.299999999999997 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.422 ' O ' HG23 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 70.040000000000006 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.240000000000002 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.483 ' HB2' ' NZ ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.530000000000001 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.349999999999994 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.506 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 75.450000000000003 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.049999999999997 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.200000000000003 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.506 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.310000000000002 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.404 HD12 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt -68.31 -43.03 78.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.130000000000003 110.297 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 38.24 86.93 0.01 OUTLIER 'General case' 0 C--O 1.246 0.908 0 C-N-CA 126.016 1.726 . . . . 55.109999999999999 115.056 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -100.82 137.72 38.83 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.573 0.702 . . . . 62.009999999999998 110.493 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.273 -2.726 0 CA-C-N 114.955 -1.02 . . . . 73.150000000000006 108.625 -177.829 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 108.113 -1.069 . . . . 61.299999999999997 108.113 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -94.87 179.45 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.901 -1.045 . . . . 65.219999999999999 110.566 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.44 33.21 11.32 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.296 0.998 . . . . 70.319999999999993 108.767 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -59.2 -28.34 66.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.282 -1.326 . . . . 71.310000000000002 112.132 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 t -75.93 -15.46 60.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.96 -0.296 . . . . 65.450000000000003 110.457 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt 56.69 15.38 2.14 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.472 1.509 . . . . 73.209999999999994 113.762 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.129999999999995 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.431 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 37.670000000000002 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.009999999999998 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.577 HD21 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 71.510000000000005 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' N ' HD21 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.030000000000001 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.150000000000006 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.420000000000002 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.547 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.409999999999997 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.120000000000005 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.439999999999998 113.288 -176.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.030000000000001 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 73.230000000000004 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.040000000000006 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.539999999999999 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.340000000000003 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.408 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 6.1 t60 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 75.519999999999996 109.221 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -63.24 -44.46 95.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.140000000000001 113.053 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -67.87 -31.84 71.93 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.728 -0.389 . . . . 75.450000000000003 111.491 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.07 -23.44 61.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.229 0.537 . . . . 73.409999999999997 110.139 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.53 11.51 19.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.981 -0.554 . . . . 53.100000000000001 111.036 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.94 -151.7 6.6 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.587 -0.605 . . . . 71.230000000000004 111.587 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 155.82 60.42 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.851 -0.796 . . . . 71.519999999999996 108.851 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.71 145.65 29.33 Favored 'Trans proline' 0 C--O 1.257 1.436 0 N-CA-C 108.621 -1.338 . . . . 73.040000000000006 108.621 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.87 -49.65 64.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 63.23 -80.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.435 1.094 . . . . 51.32 112.048 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.149 0.58 . . . . 74.530000000000001 110.001 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -103.06 115.86 31.4 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.957 -1.497 . . . . 71.439999999999998 106.957 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 49.7 mtmt -121.88 176.37 5.8 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.005 -176.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.52 90.96 6.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.728 -0.841 . . . . 55.109999999999999 108.728 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -131.98 104.3 14.06 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 108.003 -1.11 . . . . 72.319999999999993 108.003 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.4 -36.66 65.33 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.988 2.458 . . . . 74.409999999999997 112.005 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.23 -139.14 10.6 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.712 -0.955 . . . . 64.040000000000006 110.712 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 t30 61.03 28.93 18.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.956 0.884 . . . . 75.510000000000005 109.247 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -73.6 112.33 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.487 -0.779 . . . . 64.430000000000007 110.419 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 71.77 -62.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.583 1.153 . . . . 62.210000000000001 113.108 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.6 104.11 0.85 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.072 -1.211 . . . . 61.130000000000003 110.072 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.89 -18.64 60.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.223 0.535 . . . . 73.239999999999995 111.034 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.52 0.25 57.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.709 -0.678 . . . . 63.5 112.346 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 pp -114.59 145.22 42.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.413 -0.515 . . . . 74.010000000000005 111.253 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -146.18 -29.48 0.4 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.579 -0.282 . . . . 74.120000000000005 110.695 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 80.54 118.85 0.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 125.592 1.557 . . . . 75.439999999999998 109.076 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.74 9.08 63.07 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.132 -1.587 . . . . 44.329999999999998 109.132 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.17 -45.25 5.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.328 -0.436 . . . . 72.140000000000001 110.643 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -106.39 -5.39 19.03 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.243 1.02 . . . . 73.319999999999993 109.173 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 -14.29 59.03 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 117.316 1.686 . . . . 72.409999999999997 117.316 168.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m 60.42 -75.94 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.402 1.101 . . . . 75.219999999999999 111.489 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.109999999999999 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.119999999999997 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.140000000000001 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.409999999999997 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.010000000000005 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.599 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.019999999999996 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.439999999999998 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.3 t-20 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.030000000000001 107.842 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.420000000000002 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.400000000000006 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.549999999999997 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.439999999999998 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.439999999999998 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 61.149999999999999 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.340000000000003 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.578 ' HB3' ' HZ1' ' A' ' 86' ' ' LYS . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.299999999999997 110.259 -175.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 72.230000000000004 108.979 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.129999999999995 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.599 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.030000000000001 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.319999999999993 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.109999999999999 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.340000000000003 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.049999999999997 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.409999999999997 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.209999999999994 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.44 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.530000000000001 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.350000000000001 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 75.420000000000002 112.554 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.230000000000004 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.44 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 62.25 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.150000000000006 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.340000000000003 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.450000000000003 108.723 178.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.430000000000007 106.487 176.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 74.310000000000002 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.420000000000002 111.481 -176.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.230000000000004 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.439999999999998 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.420000000000002 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.540000000000006 109.793 -177.18 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.099999999999994 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.129999999999995 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.407 ' CE2' HD13 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.530000000000001 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.340000000000003 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 74.329999999999998 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.576 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.540000000000006 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.509999999999998 110.484 175.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.576 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.239999999999995 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.200000000000003 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.229999999999997 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.450000000000003 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.439999999999998 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 73.019999999999996 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -63.22 114.08 11.59 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.109999999999999 109.147 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.25 -22.35 32.43 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.497 2.798 . . . . 74.510000000000005 114.168 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.04 25.53 11.38 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.968 -1.11 . . . . 73.329999999999998 114.183 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.71 19.43 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 119.239 -1.458 . . . . 74.120000000000005 113.684 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.9 154.96 53.55 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.82 2.347 . . . . 72.209999999999994 112.859 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.09 -177.13 24.05 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.310000000000002 110.407 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.340000000000003 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.109999999999999 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.299999999999997 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 73.549999999999997 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 75.0 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.200000000000003 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 74.310000000000002 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.140000000000001 113.211 -171.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.239999999999995 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.646 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.420000000000002 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.420000000000002 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.646 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.200000000000003 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.200000000000003 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.430000000000007 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.119999999999997 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 75.25 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 61.350000000000001 114.309 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 64.329999999999998 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 64.519999999999996 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.424 ' H ' HD21 ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 70.450000000000003 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.540000000000006 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 75.409999999999997 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.239999999999995 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.129999999999995 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 73.450000000000003 110.647 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.540000000000006 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.439999999999998 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.210000000000001 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.409999999999997 111.565 -175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.547 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.439999999999998 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.319999999999993 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 72.129999999999995 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 90.6 mt -80.72 -39.7 26.6 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.400000000000006 110.747 -179.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 60.61 73.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.48 -1.236 . . . . 44.149999999999999 111.432 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.47 157.2 45.23 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.527 -1.67 . . . . 75.319999999999993 108.648 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 106.41 -1.7 . . . . 70.329999999999998 106.41 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.558 1.26 0 N-CA-C 114.337 1.236 . . . . 72.420000000000002 114.337 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.95 164.66 25.0 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.045 0.757 . . . . 72.239999999999995 113.045 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.53 51.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.216 -0.902 . . . . 71.239999999999995 111.643 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -66.19 -27.94 68.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.484 -0.78 . . . . 73.219999999999999 111.581 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.491 ' C ' ' H ' ' A' ' 23' ' ' VAL . 28.0 m -65.08 -3.92 4.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.459 1.281 . . . . 44.020000000000003 114.459 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.24 32.94 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.345 0.658 . . . . 64.510000000000005 112.171 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 21' ' ' SER . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.399999999999999 109.862 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.240000000000002 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.349999999999994 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.503 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.109999999999999 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.515 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.519999999999996 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.030000000000001 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.430000000000007 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.51 HG12 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.119999999999997 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.425 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.45 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.430000000000007 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.140000000000001 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.530000000000001 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 75.209999999999994 112.045 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.439999999999998 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.200000000000003 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.552 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.140000000000001 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -78.17 -29.21 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 75.230000000000004 113.564 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.49 ' HE1' ' HA ' ' A' ' 42' ' ' MET . 16.9 mmt -54.02 -24.06 15.67 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 116.756 2.132 . . . . 75.239999999999995 116.756 -169.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.6 -18.0 18.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.547 -0.861 . . . . 74.409999999999997 110.974 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.43 106.06 3.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.599 -0.728 . . . . 52.119999999999997 110.411 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.82 69.06 1.86 Allowed Glycine 0 C--N 1.296 -1.686 0 CA-C-N 114.529 -1.214 . . . . 53.409999999999997 112.094 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -92.12 150.94 41.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.034 -0.728 . . . . 74.329999999999998 109.034 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.87 115.29 1.76 Allowed 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.151 2.567 . . . . 37.93 112.601 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -77.21 104.19 7.57 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.517 -0.919 . . . . 65.200000000000003 108.517 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -54.53 170.55 0.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.821 1.786 . . . . 74.349999999999994 115.821 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t 80.43 92.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.025 1.33 . . . . 51.340000000000003 108.701 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t -130.73 159.48 37.14 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.651 -1.158 . . . . 63.219999999999999 109.023 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -135.75 149.89 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.436 -0.579 . . . . 74.099999999999994 109.436 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 95.45 0.07 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.253 0.549 . . . . 70.439999999999998 110.895 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 p -169.89 175.2 1.6 Allowed Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.171 -1.418 . . . . 73.129999999999995 107.171 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.88 111.87 1.03 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.032 1.822 . . . . 75.200000000000003 110.537 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.17 61.31 0.45 Allowed Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 110.615 -0.994 . . . . 53.229999999999997 110.615 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -76.25 139.37 41.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.666 -0.494 . . . . 72.430000000000007 109.666 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.8 mm 69.89 -56.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.901 1.28 . . . . 74.409999999999997 111.679 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.77 93.22 6.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.049 -1.093 . . . . 70.0 108.049 174.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.99 -80.1 0.39 Allowed Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.332 -0.707 . . . . 42.310000000000002 111.332 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -170.82 135.21 1.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.139 0.495 . . . . 72.140000000000001 110.837 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.71 137.54 26.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.774 -1.195 . . . . 72.329999999999998 107.774 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 tt -160.3 118.94 2.65 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.332 -1.729 . . . . 74.439999999999998 106.332 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -108.51 -20.15 13.2 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.525 -0.47 . . . . 73.209999999999994 111.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 66.67 109.5 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 61.439999999999998 112.282 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.46 -32.05 5.18 Favored Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 110.54 -1.024 . . . . 72.129999999999995 110.54 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.19 102.29 12.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.387 -0.968 . . . . 74.030000000000001 108.387 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -94.43 -16.17 23.64 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.789 -0.365 . . . . 75.310000000000002 110.606 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.65 12.59 84.3 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 112.224 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p -134.18 164.12 28.08 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.51 0.324 . . . . 73.230000000000004 110.341 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.540000000000006 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.049999999999997 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.240000000000002 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.319999999999993 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.010000000000005 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 63.43 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.340000000000003 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.349999999999994 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 72.430000000000007 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.140000000000001 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.487 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.510000000000005 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.450000000000003 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.030000000000001 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.049999999999997 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.430000000000007 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.487 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.109999999999999 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 63.329999999999998 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.530000000000001 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.463 ' HE2' ' N ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.219999999999999 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.129999999999995 107.931 175.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.450000000000003 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.329999999999998 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.120000000000005 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.449 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.540000000000006 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.140000000000001 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.140000000000001 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.430000000000007 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.400000000000006 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 74.030000000000001 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.040000000000006 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 75.040000000000006 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 74.239999999999995 110.767 -177.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.467 HG11 ' HE3' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 70.230000000000004 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.418 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.219999999999999 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.530000000000001 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.019999999999996 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.010000000000005 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.485 HD12 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.239999999999995 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.129999999999995 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.519999999999996 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.541 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.530000000000001 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.539999999999999 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.435 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.310000000000002 106.592 173.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.489 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.210000000000001 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.489 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.230000000000004 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 64.200000000000003 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.349999999999994 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.453 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.439999999999998 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 72.519999999999996 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 71.019999999999996 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.400000000000006 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -98.25 125.77 42.25 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.009999999999998 111.461 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -64.09 115.21 3.0 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.475 2.117 . . . . 72.120000000000005 109.501 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.37 -34.91 1.94 Allowed Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.53 -1.028 . . . . 72.319999999999993 110.53 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.44 -91.01 0.33 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.381 -0.914 . . . . 62.43 112.977 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.39 140.17 39.72 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.813 2.342 . . . . 75.329999999999998 113.106 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.79 -177.68 40.4 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.514 -0.766 . . . . 52.210000000000001 111.634 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.239999999999995 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.425 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.319999999999993 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.310000000000002 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.219999999999999 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.515 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 74.129999999999995 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 72.109999999999999 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.49 HD22 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.229999999999997 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.239999999999995 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.219999999999999 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.540000000000006 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.413 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.430000000000007 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.209999999999994 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.496 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.519999999999996 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.413 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.140000000000001 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.400000000000006 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.496 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.219999999999999 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 64.319999999999993 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 73.040000000000006 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.140000000000001 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.129999999999995 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.010000000000005 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.405 ' CD1' ' HH ' ' A' ' 115' ' ' TYR . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.540000000000006 110.965 173.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.209999999999994 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 74.400000000000006 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.319999999999993 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.49 ' SG ' HD22 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.140000000000001 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.329999999999998 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.45 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 70.340000000000003 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.51 ' CB ' HG12 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 61.399999999999999 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.230000000000004 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.219999999999999 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.411 ' O ' HD12 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.519999999999996 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.45 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.319999999999993 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.209999999999994 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.424 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 65.239999999999995 109.349 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.310000000000002 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.1 -35.13 79.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.340000000000003 110.167 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.78 -41.32 60.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.287 -0.869 . . . . 63.119999999999997 112.055 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.424 ' HG2' ' O ' ' A' ' 168' ' ' HIS . 23.5 mm-40 -69.7 170.89 9.99 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.596 0.712 . . . . 74.109999999999999 112.767 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.658 -1.156 . . . . 75.319999999999993 110.275 -177.769 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.31 -1.367 . . . . 62.039999999999999 107.31 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.427 ' HB2' ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -101.67 159.22 15.5 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.951 -0.389 . . . . 42.140000000000001 109.951 -178.662 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.68 105.04 15.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.258 -1.386 . . . . 65.230000000000004 107.258 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.4 p -60.68 -40.1 90.9 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.307 0.575 . . . . 63.200000000000003 111.123 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.421 ' C ' ' H ' ' A' ' 23' ' ' VAL . 18.7 m -89.15 -3.6 58.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.589 -0.732 . . . . 62.43 110.63 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt 68.85 -23.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.292 . . . . 72.409999999999997 113.823 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.421 ' H ' ' C ' ' A' ' 21' ' ' SER . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.140000000000001 106.918 170.658 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.040000000000006 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.414 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.109999999999999 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.219999999999999 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.540000000000006 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 63.350000000000001 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.418 HG12 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.400000000000006 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.527 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.319999999999993 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 71.140000000000001 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.020000000000003 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.239999999999995 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 74.120000000000005 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.119999999999997 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.549999999999997 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.44 ' HB3' ' NZ ' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . 0.539 ' O ' ' HG3' ' A' ' 42' ' ' MET . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.219999999999999 108.452 177.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 72.239999999999995 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -75.93 -28.93 58.17 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.200000000000003 114.347 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.539 ' HG3' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -53.13 -21.36 4.81 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.059 1.503 . . . . 75.340000000000003 115.059 -173.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.492 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 99.0 m-85 -65.92 -31.67 72.73 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 109.26 -0.644 . . . . 74.109999999999999 109.26 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.91 -47.17 4.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.28 -0.637 . . . . 72.239999999999995 109.28 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.56 -119.29 4.02 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.264 -1.135 . . . . 75.450000000000003 110.264 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 31.1 mmtp -100.73 160.84 25.68 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.761 -0.829 . . . . 74.140000000000001 108.761 175.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -41.61 -44.83 6.38 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 124.155 3.237 . . . . 72.340000000000003 112.989 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.53 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . 39.4 t60 -147.64 -46.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.474 -0.33 . . . . 65.030000000000001 110.555 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 13.0 t60 68.8 114.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.266 1.027 . . . . 75.219999999999999 111.38 -177.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.74 148.32 22.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.393 -0.595 . . . . 75.299999999999997 109.393 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -95.6 112.59 24.28 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.288 -1.004 . . . . 75.120000000000005 108.288 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 72.52 159.17 0.21 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.976 0.91 . . . . 62.350000000000001 109.843 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 84.69 6.56 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.715 -0.846 . . . . 63.200000000000003 108.715 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -160.87 172.73 5.48 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 106.627 -1.619 . . . . 74.420000000000002 106.627 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.31 109.67 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.839 1.692 . . . . 71.420000000000002 110.179 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.58 -56.58 14.32 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 115.62 -0.718 . . . . 72.450000000000003 112.709 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 69.34 -70.44 0.14 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.08 0.952 . . . . 73.409999999999997 109.634 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.3 mt -74.61 117.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.464 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 11.7 pt20 -92.81 152.06 19.66 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.715 -0.675 . . . . 55.240000000000002 111.061 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.15 5.27 81.41 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.979 -0.848 . . . . 72.430000000000007 110.979 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.53 ' SG ' ' HA ' ' A' ' 48' ' ' HIS . 39.6 m -76.78 83.57 3.38 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.625 -0.88 . . . . 62.310000000000002 108.625 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.54 -32.68 54.07 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.287 -0.87 . . . . 62.43 110.956 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.492 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 48.0 tp 62.93 83.84 0.15 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 108.689 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -91.01 95.95 10.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.687 -1.142 . . . . 74.519999999999996 110.185 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -110.39 154.01 24.16 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.501 -0.772 . . . . 71.099999999999994 109.278 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.64 134.85 28.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 109.829 -1.308 . . . . 55.210000000000001 109.829 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -62.65 -17.94 61.37 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.936 1.087 . . . . 64.519999999999996 113.936 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.48 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 87.6 m95 -102.13 18.11 21.63 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.551 -0.46 . . . . 74.099999999999994 110.753 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.16 41.28 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.846 -0.693 . . . . 62.219999999999999 112.855 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m 72.47 -71.79 0.13 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.807 0.843 . . . . 73.349999999999994 111.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.140000000000001 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.400000000000006 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.48 ' HA ' ' HB2' ' A' ' 68' ' ' TRP . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.219999999999999 109.001 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.517 HG22 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.409999999999997 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.319999999999993 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 74.200000000000003 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.349999999999994 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.349999999999994 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.319999999999993 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.540000000000006 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.340000000000003 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.329999999999998 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.519999999999996 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 75.230000000000004 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 52.530000000000001 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 75.120000000000005 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.130000000000003 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.517 ' O ' HG22 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.400000000000006 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.209999999999994 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.45 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.239999999999995 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.129999999999995 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.219999999999999 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.45 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.230000000000004 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.412 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.439999999999998 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.210000000000001 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.019999999999996 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.319999999999993 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.510000000000005 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.219999999999999 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 75.150000000000006 110.543 -179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.439999999999998 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.299999999999997 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.478 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.530000000000001 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.039999999999999 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.400000000000006 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.129999999999995 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.010000000000005 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 74.219999999999999 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.450000000000003 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.129999999999995 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.329999999999998 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.479 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.430000000000007 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.479 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.329999999999998 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.310000000000002 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.030000000000001 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.109999999999999 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 64.319999999999993 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.040000000000006 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.496 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.2 tttm -119.2 -57.06 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.230000000000004 111.309 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.489 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 11.5 Cg_exo -76.58 -55.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.24 1.294 . . . . 73.519999999999996 109.829 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.03 142.13 6.75 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 116.017 -0.538 . . . . 63.420000000000002 112.369 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 132' ' ' GLY . . . 68.49 -121.24 12.56 Favored Glycine 0 N--CA 1.45 -0.416 0 O-C-N 123.701 0.294 . . . . 74.310000000000002 112.736 177.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.85 39.48 0.81 Allowed 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.524 2.816 . . . . 71.319999999999993 111.627 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.446 ' H ' ' C ' ' A' ' 130' ' ' GLY . . . -163.13 113.67 0.57 Allowed Glycine 0 C--N 1.274 -2.889 0 CA-C-N 114.893 -1.049 . . . . 73.409999999999997 111.099 179.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.030000000000001 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.527 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.019999999999996 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 74.439999999999998 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.219999999999999 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.239999999999995 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.414 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.540000000000006 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.229999999999997 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 75.209999999999994 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.519999999999996 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 74.409999999999997 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.517 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.439999999999998 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 75.209999999999994 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.020000000000003 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.239999999999995 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.239999999999995 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.109999999999999 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.209999999999994 111.192 -177.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 73.540000000000006 110.827 179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.427 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.530000000000001 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.636 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 0.0 OUTLIER -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.150000000000006 112.004 176.816 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.349999999999994 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.427 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.439999999999998 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.010000000000005 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.636 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.509999999999998 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.418 ' CB ' HG12 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.310000000000002 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.009999999999998 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.431 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.409999999999997 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.340000000000003 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.230000000000004 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.409999999999997 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.239999999999995 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 60.43 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.15 -43.24 71.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.039999999999999 109.311 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 36.18 76.49 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.758 1.623 . . . . 54.549999999999997 114.197 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.39 148.38 52.2 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.267 -0.878 . . . . 74.340000000000003 109.06 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 119.054 -0.498 . . . . 74.209999999999994 110.27 -173.266 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 CA--C 1.557 1.233 0 CA-C-O 120.91 0.386 . . . . 61.100000000000001 111.726 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.92 90.31 1.93 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.645 0.736 . . . . 65.409999999999997 111.83 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 178.35 25.88 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 126.811 2.044 . . . . 65.420000000000002 105.849 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 m -57.01 -48.7 77.85 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.22 -1.355 . . . . 62.310000000000002 112.799 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -85.99 -28.89 23.93 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 111.78 0.289 . . . . 74.129999999999995 111.78 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt 65.4 5.04 2.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.328 1.051 . . . . 64.299999999999997 112.365 -172.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 73.109999999999999 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.409 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.030000000000001 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.555 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.120000000000005 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.239999999999995 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.200000000000003 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.109999999999999 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.329999999999998 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.030000000000001 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.409999999999997 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.491 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.230000000000004 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.310000000000002 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.140000000000001 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.427 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.042 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.405 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.119999999999997 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.329999999999998 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.310000000000002 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.559 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 4.7 t60 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.400000000000006 109.812 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.49 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 32.8 m-70 -66.13 -44.29 84.68 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 71.430000000000007 113.51 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.29 -23.91 67.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.571 0.952 . . . . 74.219999999999999 113.571 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.408 ' C ' ' H ' ' A' ' 45' ' ' GLY . 43.7 t80 -101.36 5.26 42.16 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.128 -1.029 . . . . 72.409999999999997 110.888 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.6 22.21 0.47 Allowed 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.447 -0.783 . . . . 74.329999999999998 111.013 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 43' ' ' PHE . . . 160.87 -143.48 8.99 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.214 -1.554 . . . . 75.109999999999999 109.214 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -146.56 146.83 28.45 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.347 -0.983 . . . . 74.030000000000001 108.347 178.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.96 172.53 16.18 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.185 1.923 . . . . 74.420000000000002 111.904 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -82.78 97.3 8.53 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.704 0.764 . . . . 70.439999999999998 109.117 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -113.29 119.91 39.34 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.94 -1.027 . . . . 75.099999999999994 109.563 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.16 140.88 15.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.636 -0.876 . . . . 73.319999999999993 108.636 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 64' ' ' HIS . 14.6 t -140.94 -176.72 4.78 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.869 -1.53 . . . . 72.540000000000006 106.869 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -70.79 123.52 22.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.058 -0.657 . . . . 73.219999999999999 111.502 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 109.29 6.32 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.698 -1.137 . . . . 61.229999999999997 111.327 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.0 m -149.34 83.14 6.64 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.331 -0.395 . . . . 61.030000000000001 110.171 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.48 148.53 42.91 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.416 2.077 . . . . 72.340000000000003 110.776 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.33 -175.72 38.96 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.181 -0.768 . . . . 73.519999999999996 111.181 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -84.07 103.09 13.01 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.783 -0.451 . . . . 63.43 109.783 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.457 ' O ' HG22 ' A' ' 58' ' ' ILE . 42.0 mm 64.44 23.17 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-O 122.406 1.098 . . . . 65.010000000000005 110.606 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -165.62 179.66 5.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.557 -0.747 . . . . 60.399999999999999 109.193 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.62 -163.85 29.05 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.053 -1.07 . . . . 53.119999999999997 112.104 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.7 t -147.01 152.04 37.94 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.412 -0.959 . . . . 73.510000000000005 108.412 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -78.2 -50.68 11.47 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.206 -0.664 . . . . 74.140000000000001 109.206 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.91 111.18 21.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.808 -0.812 . . . . 74.109999999999999 108.808 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.487 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 15.0 t60 -63.72 -41.0 98.13 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.56 -1.274 . . . . 71.439999999999998 107.56 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -144.88 148.38 33.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.366 1.466 . . . . 74.319999999999993 107.225 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -159.58 28.2 Favored Glycine 0 C--N 1.319 -0.406 0 C-N-CA 119.984 -1.103 . . . . 75.540000000000006 112.917 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.89 129.73 34.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.284 0.634 . . . . 72.450000000000003 109.906 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -93.34 -17.11 23.94 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.721 -0.792 . . . . 73.409999999999997 110.38 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.39 12.59 83.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.432 0.933 . . . . 55.049999999999997 115.432 170.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -144.7 -177.91 5.74 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 117.866 0.833 . . . . 65.099999999999994 110.397 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.310000000000002 108.67 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.040000000000006 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.445 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.219999999999999 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.404 HG22 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.583 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.430000000000007 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.530000000000001 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.140000000000001 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.140000000000001 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 71.129999999999995 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 74.129999999999995 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.409999999999997 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.409999999999997 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.310000000000002 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.487 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 65.420000000000002 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.530000000000001 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.487 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.109999999999999 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.340000000000003 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.441 ' HB3' HD12 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.329999999999998 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.583 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.329999999999998 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.239999999999995 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.445 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.539999999999999 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 74.430000000000007 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.420000000000002 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.340000000000003 111.465 179.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.562 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.549999999999997 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.329999999999998 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . 0.559 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.519999999999996 111.848 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.562 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.340000000000003 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.468 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.239999999999995 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.329999999999998 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.129999999999995 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.049999999999997 109.735 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 73.25 110.072 179.716 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.476 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.329999999999998 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 72.349999999999994 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.441 HD12 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.409999999999997 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.439999999999998 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.568 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.299999999999997 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.530000000000001 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.433 ' H ' HD21 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.439999999999998 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.601 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.540000000000006 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 73.409999999999997 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.601 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 75.219999999999999 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.349999999999994 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.109999999999999 108.712 174.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.518 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.510000000000005 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.230000000000004 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.506 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.130000000000003 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.209999999999994 109.074 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.310000000000002 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.240000000000002 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.209999999999994 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.200000000000003 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 72.540000000000006 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.476 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.6 tttt -147.01 -60.29 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.109999999999999 111.754 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.476 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 61.3 Cg_endo -92.02 6.89 3.31 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.4 1.4 . . . . 73.450000000000003 110.75 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 147.84 -166.83 28.82 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 37.75 109.181 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.39 -75.28 0.94 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.597 -0.601 . . . . 51.039999999999999 111.597 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.427 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 9.8 Cg_endo -54.43 129.23 33.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.035 2.49 . . . . 64.239999999999995 110.615 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.31 73.03 1.26 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.420000000000002 109.254 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.476 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.140000000000001 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.240000000000002 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.239999999999995 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 74.549999999999997 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 64.209999999999994 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.405 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.349999999999994 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.530000000000001 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.510000000000005 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.209999999999994 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.409 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 75.120000000000005 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 74.010000000000005 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.310000000000002 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.329999999999998 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.430000000000007 110.791 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.530000000000001 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.467 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.400000000000006 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.427 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.219999999999999 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 74.200000000000003 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.518 HD12 ' CE1' ' A' ' 118' ' ' PHE . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.219999999999999 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 75.140000000000001 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.436 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.140000000000001 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.420000000000002 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 75.099999999999994 111.967 -175.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.436 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.299999999999997 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 54.140000000000001 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.499 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 72.140000000000001 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.439999999999998 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 75.439999999999998 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.491 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.140000000000001 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.43 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.439999999999998 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 62.399999999999999 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.420000000000002 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.11 -25.79 31.63 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 110.691 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -19.04 65.02 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.161 -0.927 . . . . 73.340000000000003 112.017 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -121.77 162.09 21.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.763 0.316 . . . . 72.340000000000003 110.593 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.624 -1.251 . . . . 74.540000000000006 107.624 176.206 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.573 1.833 0 CA-C-O 121.581 0.705 . . . . 73.329999999999998 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.07 121.02 17.49 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 121.358 -0.838 . . . . 74.010000000000005 109.222 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.05 142.04 18.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 110.375 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -72.57 -36.87 68.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.722 0.638 . . . . 62.25 112.722 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.6 p -86.37 -22.35 26.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.856 -0.338 . . . . 72.349999999999994 111.69 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt 66.88 -4.66 0.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.568 1.147 . . . . 74.230000000000004 113.132 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.120000000000005 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.120000000000005 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.219999999999999 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.42 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.400000000000006 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.42 ' N ' HD21 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.219999999999999 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.219999999999999 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.514 HG12 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.45 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.299999999999997 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.444 ' HB2' HD12 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.109999999999999 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 43.450000000000003 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 64.209999999999994 111.614 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.329999999999998 108.345 173.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.450000000000003 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.530000000000001 110.535 -178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 72.25 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.140000000000001 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -62.58 -29.54 70.67 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 64.400000000000006 110.909 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.16 -26.63 60.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.579 -0.282 . . . . 73.519999999999996 111.738 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -82.85 -32.21 27.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.562 0.696 . . . . 73.430000000000007 109.595 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.39 28.49 3.68 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.346 -0.983 . . . . 71.409999999999997 108.346 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.41 48.46 2.88 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.101 -0.954 . . . . 42.130000000000003 114.116 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.04 95.89 31.72 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 107.716 -1.216 . . . . 75.200000000000003 107.716 170.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 176.79 6.38 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 123.018 2.478 . . . . 74.129999999999995 113.21 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -79.96 150.64 30.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.328 -0.99 . . . . 74.409999999999997 108.328 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -130.86 109.46 10.58 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.768 -0.827 . . . . 62.219999999999999 108.768 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.33 149.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.149 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.448 ' OG ' ' HB2' ' A' ' 54' ' ' SER . 47.8 t -140.96 90.51 2.33 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.019 0.438 . . . . 73.439999999999998 111.377 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.59 -40.19 17.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.853 -1.166 . . . . 75.329999999999998 107.853 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.54 85.81 1.52 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 42.409999999999997 107.988 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.448 ' HB2' ' OG ' ' A' ' 51' ' ' SER . 46.9 m -152.58 102.4 2.72 Favored Pre-proline 0 N--CA 1.435 -1.203 0 CA-C-N 116.052 -0.522 . . . . 41.43 112.222 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.09 -22.41 22.72 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.124 1.883 . . . . 74.310000000000002 109.689 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.34 71.88 0.04 OUTLIER Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.746 -1.741 . . . . 71.219999999999999 108.746 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -93.16 92.0 7.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 113.422 0.897 . . . . 73.430000000000007 113.422 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 42.6 mm -122.95 123.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.11 -1.811 . . . . 72.530000000000001 106.11 174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.454 ' HG3' ' SG ' ' A' ' 61' ' ' CYS . 10.9 pt20 -82.66 -5.78 59.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.3 0.481 . . . . 73.310000000000002 112.3 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.13 74.54 0.75 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 121.155 -0.545 . . . . 73.329999999999998 112.636 176.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.454 ' SG ' ' HG3' ' A' ' 59' ' ' GLN . 61.9 m -104.54 -1.78 26.1 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.711 0.767 . . . . 73.230000000000004 109.297 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.73 135.95 33.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.202 -0.908 . . . . 74.349999999999994 112.156 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -133.85 -60.29 0.83 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.901 -1.888 . . . . 70.329999999999998 105.901 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -148.87 115.84 6.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.004 -1.48 . . . . 74.140000000000001 107.004 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.66 -6.07 47.22 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.755 0.788 . . . . 72.5 109.933 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.88 -130.92 3.07 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 109.013 -1.635 . . . . 60.119999999999997 109.013 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.17 -171.77 3.65 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.863 -1.162 . . . . 72.430000000000007 107.863 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -77.54 -17.31 58.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 112.251 0.463 . . . . 74.530000000000001 112.251 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.54 13.93 82.95 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.694 -0.765 . . . . 75.439999999999998 112.137 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.479 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m -126.85 143.09 51.37 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 54.549999999999997 110.699 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 74.409999999999997 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.340000000000003 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.479 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.120000000000005 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.310000000000002 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.519999999999996 110.378 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 70.319999999999993 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.039999999999999 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.658 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.219999999999999 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.5 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 37.509999999999998 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.478 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.430000000000007 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.129999999999995 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.420000000000002 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.140000000000001 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.510000000000005 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.658 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.140000000000001 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.039999999999999 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.510000000000005 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.417 ' O ' HG22 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.329999999999998 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.310000000000002 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.329999999999998 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.240000000000002 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.140000000000001 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.408 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 74.120000000000005 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.401 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.150000000000006 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 64.219999999999999 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.340000000000003 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.420000000000002 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.697 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.400000000000006 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' A' ' 95' ' ' VAL . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.240000000000002 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.109999999999999 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.415 HG22 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 72.129999999999995 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 73.319999999999993 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.299999999999997 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.319999999999993 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.409999999999997 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.47 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.329999999999998 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.109999999999999 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.510000000000005 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.200000000000003 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.498 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.319999999999993 112.073 -179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.350000000000001 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.465 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 75.400000000000006 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.465 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.463 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.530000000000001 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 74.430000000000007 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.541 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.239999999999995 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 75.120000000000005 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.541 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 55.409999999999997 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 72.0 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 73.040000000000006 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.697 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.219999999999999 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 71.219999999999999 108.467 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.439999999999998 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.099999999999994 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.442 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt -86.82 167.14 23.37 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.409999999999997 109.035 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.78 112.31 0.87 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.134 1.889 . . . . 75.230000000000004 110.248 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.16 -55.41 0.71 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.786 -0.926 . . . . 71.510000000000005 110.786 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 126.53 -64.46 0.58 Allowed Glycine 0 CA--C 1.539 1.57 0 C-N-CA 120.061 -1.066 . . . . 74.209999999999994 114.85 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.31 -53.72 5.8 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 123.354 2.702 . . . . 72.109999999999999 114.061 -176.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.442 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . -81.52 165.48 46.41 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.140000000000001 111.413 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 60.130000000000003 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.45 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.239999999999995 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.340000000000003 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.400000000000006 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.219999999999999 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 73.049999999999997 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.210000000000001 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 74.010000000000005 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.439999999999998 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.200000000000003 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.209999999999994 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.463 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.340000000000003 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.409999999999997 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.209999999999994 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 63.520000000000003 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.430000000000007 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.340000000000003 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 74.120000000000005 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.329999999999998 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.510000000000005 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 73.319999999999993 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 52.340000000000003 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.639 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 64.439999999999998 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.519999999999996 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 75.319999999999993 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.471 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.430000000000007 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.639 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.530000000000001 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.099999999999994 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 61.240000000000002 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.514 ' CB ' HG12 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.109999999999999 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.109999999999999 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.239999999999995 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.409999999999997 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.476 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.319999999999993 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.471 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.109999999999999 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 72.549999999999997 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.476 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 85.3 mt -68.99 -41.27 78.09 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.63 15.93 9.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.048 -1.433 . . . . 64.409999999999997 110.863 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.27 149.65 21.33 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.255 -1.339 . . . . 72.040000000000006 108.151 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.277 -2.575 0 CA-C-O 118.078 -0.963 . . . . 74.329999999999998 109.35 -175.796 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 73.409999999999997 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.47 127.54 32.54 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.474 -0.785 . . . . 72.329999999999998 112.222 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.52 96.45 2.27 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.269 -1.011 . . . . 37.0 108.269 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -61.57 -48.37 81.26 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.748 -0.66 . . . . 71.239999999999995 112.582 -174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.6 t -90.86 -5.81 55.05 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.733 -0.387 . . . . 71.329999999999998 110.848 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt 57.27 27.49 13.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.457 0.703 . . . . 75.319999999999993 112.603 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 64.030000000000001 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.099999999999994 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.438 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.450000000000003 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.129999999999995 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 61.409999999999997 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 64.230000000000004 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.140000000000001 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.310000000000002 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.511 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.340000000000003 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.239999999999995 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.616 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 72.400000000000006 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.219999999999999 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 61.229999999999997 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.319999999999993 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.436 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 73.019999999999996 112.396 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.109999999999999 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.299999999999997 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.436 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 38.3 m-70 -59.16 -38.19 79.14 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.120000000000005 111.277 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 81.7 mtp -59.86 -26.55 65.94 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.1 0.778 . . . . 72.25 113.1 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -101.59 -31.96 10.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.167 -0.613 . . . . 72.439999999999998 111.25 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.49 -37.29 28.15 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.113 0.412 . . . . 73.109999999999999 112.113 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.0 80.54 0.13 Allowed Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 108.697 -1.761 . . . . 75.219999999999999 108.697 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 132.52 5.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 114.026 1.121 . . . . 73.140000000000001 114.026 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.38 3.8 7.49 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 123.565 2.844 . . . . 74.150000000000006 110.726 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -134.8 93.55 3.04 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.853 -1.067 . . . . 72.099999999999994 108.365 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -95.64 150.93 19.81 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.56 -0.456 . . . . 70.439999999999998 109.914 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -98.1 96.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.45 1.119 . . . . 72.439999999999998 111.511 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 27.0 m -143.99 96.39 2.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.438 -1.255 . . . . 74.120000000000005 107.759 178.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -134.85 -59.19 0.8 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.105 -0.498 . . . . 73.230000000000004 110.852 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.66 115.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.462 1.101 . . . . 64.530000000000001 111.712 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 21.2 p -62.92 133.71 95.4 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.398 -0.819 . . . . 75.140000000000001 112.237 -177.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_exo -57.53 119.8 7.29 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.472 2.114 . . . . 75.099999999999994 111.27 176.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.27 48.46 1.32 Allowed Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.013 -1.235 . . . . 72.409999999999997 110.013 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -146.27 160.11 42.44 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.15 -1.426 . . . . 55.109999999999999 107.15 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.53 -31.22 52.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.568 -0.901 . . . . 71.219999999999999 108.568 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 71.66 96.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.423 1.489 . . . . 73.549999999999997 112.089 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -57.71 0.28 Allowed Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.45 -1.06 . . . . 53.109999999999999 110.45 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 28.0 t 60.59 28.65 18.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.584 1.183 . . . . 73.129999999999995 108.126 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.33 -28.76 57.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.073 -1.421 . . . . 73.540000000000006 110.926 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.21 111.13 9.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.882 -0.599 . . . . 71.140000000000001 109.566 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -73.91 123.47 24.31 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.893 -0.594 . . . . 73.109999999999999 110.273 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.33 158.37 43.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.045 -0.724 . . . . 73.329999999999998 109.045 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 -14.12 17.88 Favored Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.251 -1.14 . . . . 63.43 110.251 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -178.09 151.32 0.65 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.528 -1.286 . . . . 75.439999999999998 107.528 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -106.06 -16.73 14.54 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.687 -0.486 . . . . 75.420000000000002 109.687 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -5.89 81.31 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.793 -0.64 . . . . 44.509999999999998 113.642 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -115.79 144.35 44.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 111.916 0.339 . . . . 72.299999999999997 111.916 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.030000000000001 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.329999999999998 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 64.439999999999998 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.452 HG22 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 70.430000000000007 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.120000000000005 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.450000000000003 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.439999999999998 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.200000000000003 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 73.310000000000002 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.140000000000001 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.539999999999999 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.219999999999999 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.239999999999995 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.129999999999995 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.319999999999993 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.400000000000006 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.299999999999997 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.219999999999999 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.399999999999999 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' HG22 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.030000000000001 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 75.010000000000005 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.319999999999993 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 71.019999999999996 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.510000000000005 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.437 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.150000000000006 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.420000000000002 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.109999999999999 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.049999999999997 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.43 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.319999999999993 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.437 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 74.519999999999996 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.120000000000005 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 73.430000000000007 110.609 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.349999999999994 108.54 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 54.439999999999998 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 74.129999999999995 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.5 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 74.340000000000003 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.219999999999999 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.430000000000007 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.120000000000005 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.109999999999999 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.435 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.230000000000004 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.540000000000006 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.400000000000006 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.120000000000005 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.427 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.329999999999998 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.427 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 73.230000000000004 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 74.129999999999995 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.310000000000002 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 75.540000000000006 109.991 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.340000000000003 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.420000000000002 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.43 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 73.349999999999994 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.409999999999997 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.520000000000003 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.532 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 63.3 tttm -99.49 -67.45 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.230000000000004 110.556 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 31.1 Cg_exo -63.69 -39.66 33.56 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 120.818 1.328 . . . . 54.420000000000002 110.014 170.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.48 135.99 8.99 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.673 -0.694 . . . . 63.32 111.422 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.01 -110.58 3.15 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.363 -0.695 . . . . 45.340000000000003 111.363 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -81.57 29.47 0.54 Allowed 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.362 2.708 . . . . 72.409999999999997 112.205 178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.471 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . -152.0 106.59 0.31 Allowed Glycine 0 C--N 1.286 -2.226 0 CA-C-N 115.48 -0.782 . . . . 63.219999999999999 112.973 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 61.109999999999999 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.511 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 72.420000000000002 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.400000000000006 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 74.439999999999998 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.230000000000004 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 74.129999999999995 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.150000000000006 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.530000000000001 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 73.540000000000006 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.508 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.439999999999998 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.427 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 71.120000000000005 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.340000000000003 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.129999999999995 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.329999999999998 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.329999999999998 111.053 -174.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.508 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.219999999999999 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 54.409999999999997 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.530000000000001 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 72.120000000000005 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.010000000000005 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.408 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.588 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.43 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 64.420000000000002 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.299999999999997 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 65.010000000000005 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.219999999999999 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.439999999999998 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.449 ' O ' HG23 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.419 ' HA ' HG23 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.310000000000002 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 75.310000000000002 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HD12 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.329999999999998 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.319999999999993 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.528 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.400000000000006 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.593 HD12 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.209999999999994 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.437 HD12 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt -84.15 -19.39 34.24 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.239999999999995 110.828 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.6 -45.14 17.8 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.07 -0.968 . . . . 72.209999999999994 111.615 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -109.1 168.56 9.28 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.495 0.554 . . . . 72.109999999999999 112.495 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 115.438 -0.801 . . . . 74.209999999999994 109.7 -177.709 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 111.403 0.149 . . . . 73.140000000000001 111.403 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.22 145.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.076 0.951 . . . . 73.519999999999996 111.352 -175.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.89 138.59 10.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.231 -0.655 . . . . 73.140000000000001 109.231 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 p -60.79 -28.37 68.7 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.882 0.473 . . . . 51.399999999999999 111.895 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 m -72.74 -4.7 33.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 113.086 0.773 . . . . 75.530000000000001 113.086 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -70.93 -4.43 24.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 64.129999999999995 110.932 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.510000000000005 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.100000000000001 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.340000000000003 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 71.0 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.219999999999999 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.019999999999996 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 50.32 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.47 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.400000000000006 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 75.400000000000006 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.436 ' HG3' HD12 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.430000000000007 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.426 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.400000000000006 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 74.439999999999998 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.430000000000007 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.420000000000002 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 62.130000000000003 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.439999999999998 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.523 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 -64.14 -30.44 71.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.209999999999994 110.257 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.461 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 93.8 mmm -59.74 -24.35 63.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.486 0.715 . . . . 71.140000000000001 112.684 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.34 -28.63 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 72.25 110.868 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.47 97.55 9.52 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.458 -0.571 . . . . 64.200000000000003 109.458 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.85 -170.76 23.6 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.888 -0.885 . . . . 45.549999999999997 110.888 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.62 150.98 40.28 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 110.238 -0.282 . . . . 73.439999999999998 110.238 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.11 163.14 14.9 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.056 2.504 . . . . 73.409999999999997 112.596 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -77.44 109.77 11.65 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 116.064 -0.516 . . . . 73.010000000000005 111.63 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -65.57 128.36 35.6 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.675 -1.148 . . . . 55.439999999999998 108.026 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.28 134.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.162 -0.681 . . . . 72.5 109.162 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 t -89.04 104.49 17.03 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.706 0.765 . . . . 75.430000000000007 109.531 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -129.24 149.49 51.01 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.909 -1.041 . . . . 73.430000000000007 108.391 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.92 -67.12 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.549 -1.278 . . . . 62.229999999999997 107.549 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 79.6 p 56.61 145.69 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.011 1.724 . . . . 71.329999999999998 114.344 178.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 12.6 Cg_exo -71.38 100.75 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.609 1.539 . . . . 73.099999999999994 109.459 173.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.67 164.82 19.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.516 -0.849 . . . . 43.399999999999999 112.158 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.6 100.37 11.91 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.41 0.624 . . . . 74.230000000000004 109.872 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.2 mt 70.96 98.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 114.72 -1.127 . . . . 73.230000000000004 109.35 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -53.66 121.37 7.69 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.111 -0.95 . . . . 73.219999999999999 112.06 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.24 -102.13 0.23 Allowed Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 108.728 -1.749 . . . . 63.299999999999997 108.728 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.6 t -154.34 136.48 14.76 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.722 -0.473 . . . . 75.200000000000003 109.722 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.3 147.47 30.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.128 -1.804 . . . . 60.399999999999999 106.128 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.53 69.48 4.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.478 0.656 . . . . 71.540000000000006 110.251 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -98.03 101.93 13.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.142 -1.058 . . . . 71.420000000000002 108.142 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -108.23 144.78 35.22 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.108 -0.496 . . . . 75.349999999999994 111.19 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.42 19.5 50.62 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 109.223 -1.551 . . . . 54.350000000000001 109.223 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.77 128.8 37.74 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.455 -0.873 . . . . 74.400000000000006 109.163 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.454 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.6 m95 -107.44 10.07 29.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.22 -0.445 . . . . 72.129999999999995 111.082 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.68 51.92 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.476 -1.345 . . . . 74.340000000000003 111.195 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m 76.48 -68.21 0.19 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.495 1.118 . . . . 72.299999999999997 111.34 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.399999999999999 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.41 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.219999999999999 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.454 ' OG ' ' HB2' ' A' ' 68' ' ' TRP . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.509999999999998 111.962 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.019999999999996 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 72.239999999999995 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.475 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.239999999999995 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.530000000000001 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 72.329999999999998 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 62.130000000000003 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.540000000000006 108.383 175.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.420000000000002 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.200000000000003 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.329999999999998 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.109999999999999 108.446 -178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.475 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.519999999999996 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.329999999999998 108.187 177.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.495 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.510000000000005 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.219999999999999 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . 0.452 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.450000000000003 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.040000000000006 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.452 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.329999999999998 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.409999999999997 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.450000000000003 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.475 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 74.310000000000002 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.100000000000001 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.409999999999997 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.230000000000004 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.340000000000003 111.205 -178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 74.329999999999998 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.409999999999997 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.430000000000007 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 74.0 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.510000000000005 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.443 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.409999999999997 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.526 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.495 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.430000000000007 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.546 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.540000000000006 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.109999999999999 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.443 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.130000000000003 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.544 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.019999999999996 110.988 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.546 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.019999999999996 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.299999999999997 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.030000000000001 108.919 -177.202 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.57 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.140000000000001 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.436 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 72.420000000000002 107.563 179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.641 -179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 74.030000000000001 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.129999999999995 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.445 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 50.219999999999999 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.109999999999999 108.581 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 63.450000000000003 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.150000000000006 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 65.409999999999997 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.515 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.2 tttt -164.48 -67.13 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.039999999999999 109.358 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.526 ' HD2' ' O ' ' A' ' 132' ' ' GLY . 32.5 Cg_exo -65.87 -55.43 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 120.647 1.267 . . . . 74.349999999999994 110.812 170.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.36 110.86 2.17 Favored Glycine 0 CA--C 1.507 -0.451 0 C-N-CA 120.316 -0.945 . . . . 71.230000000000004 112.915 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.78 -114.51 3.84 Favored Glycine 0 CA--C 1.499 -0.915 0 N-CA-C 110.328 -1.109 . . . . 37.049999999999997 110.328 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.09 91.13 0.38 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.891 1.727 . . . . 75.340000000000003 109.272 171.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.526 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 136.02 92.5 0.36 Allowed Glycine 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 -176.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 62.310000000000002 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.47 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 63.039999999999999 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.109999999999999 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.445 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 62.539999999999999 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.310000000000002 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.219999999999999 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.419 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.109999999999999 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.329999999999998 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.329999999999998 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.010000000000005 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.219999999999999 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.57 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.530000000000001 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.219999999999999 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.219999999999999 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.150000000000006 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.340000000000003 110.174 -179.106 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.230000000000004 109.844 -178.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 72.420000000000002 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.519999999999996 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 73.540000000000006 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.230000000000004 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.567 ' O ' HG22 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.430000000000007 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.509999999999998 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.400000000000006 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.419 ' SG ' HD22 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.340000000000003 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.567 HG22 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.099999999999994 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.140000000000001 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.219999999999999 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 74.040000000000006 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.329999999999998 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.421 ' O ' HD11 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.420000000000002 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.140000000000001 110.486 176.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.488 ' OE2' ' HA ' ' A' ' 171' ' ' ALA . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.140000000000001 109.279 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.319999999999993 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.400000000000006 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.436 HD12 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt -83.73 -40.91 18.24 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.120000000000005 111.637 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . 0.488 ' HA ' ' OE2' ' A' ' 167' ' ' GLU . . . 52.8 78.26 0.14 Allowed 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.906 1.282 . . . . 75.25 111.013 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.07 160.56 15.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.003 -0.999 . . . . 74.209999999999994 112.563 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.707 -1.22 . . . . 74.400000000000006 107.707 -179.175 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 121.259 0.552 . . . . 75.040000000000006 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.69 159.89 41.37 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.668 -0.696 . . . . 74.219999999999999 109.334 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.65 99.49 1.87 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.036 0.446 . . . . 51.420000000000002 109.817 -176.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 m -71.21 -26.65 63.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.587 -0.733 . . . . 72.519999999999996 111.455 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.8 m -66.72 -12.68 59.53 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.249 -0.432 . . . . 71.299999999999997 110.594 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt 62.88 -34.43 0.12 Allowed 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 126.169 1.788 . . . . 71.319999999999993 115.201 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.310000000000002 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.400000000000006 112.887 -178.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.239999999999995 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.409999999999997 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.319999999999993 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.200000000000003 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.477 HG12 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.439999999999998 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.476 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.200000000000003 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 74.239999999999995 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.450000000000003 109.699 -178.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.329999999999998 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.150000000000006 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.239999999999995 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.510000000000005 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.402 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 73.329999999999998 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.319999999999993 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -62.24 -32.35 73.02 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 75.030000000000001 111.229 -174.12 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.518 ' HE2' ' HA ' ' A' ' 42' ' ' MET . 3.0 mmt -71.67 -35.02 70.18 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.938 0.718 . . . . 74.129999999999995 112.938 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.35 -32.89 7.27 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.311 -0.956 . . . . 64.319999999999993 113.542 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.67 95.49 0.04 OUTLIER 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 110.582 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.32 -145.77 8.7 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.192 -1.163 . . . . 72.129999999999995 110.192 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HE3' ' O ' ' A' ' 48' ' ' HIS . 0.1 OUTLIER -79.13 152.03 76.23 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.029 -0.73 . . . . 74.150000000000006 109.029 176.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.28 -42.94 7.75 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.381 3.388 . . . . 72.549999999999997 114.451 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.449 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 53.0 t-80 -78.84 93.91 5.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.34 0.59 . . . . 74.319999999999993 109.552 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -98.64 129.48 45.14 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.187 -0.915 . . . . 54.420000000000002 108.745 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -82.42 102.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.45 -1.315 . . . . 71.5 107.45 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.2 m -82.65 -177.25 6.64 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.591 -0.731 . . . . 72.530000000000001 110.744 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.61 150.27 48.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.672 -0.24 . . . . 75.129999999999995 110.746 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.37 -31.42 69.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.622 -0.881 . . . . 70.219999999999999 108.622 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 m -62.6 137.61 96.48 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 114.455 -1.248 . . . . 51.229999999999997 108.841 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.02 -29.36 64.57 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.021 2.481 . . . . 61.140000000000001 112.234 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.37 50.55 2.18 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.656 -0.783 . . . . 73.349999999999994 111.33 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -79.63 82.62 5.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.321 0.581 . . . . 72.200000000000003 110.377 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 46.7 mm -128.25 127.69 67.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.931 -1.137 . . . . 70.430000000000007 107.931 178.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -69.19 106.22 2.77 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.685 -0.487 . . . . 62.149999999999999 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.26 71.34 1.23 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.683 -0.77 . . . . 63.329999999999998 111.648 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 80.6 m -89.22 97.37 11.16 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 51.25 108.351 176.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -85.47 81.57 8.65 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.508 0.671 . . . . 74.129999999999995 109.447 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.27 -63.45 1.29 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.206 -0.906 . . . . 72.400000000000006 109.811 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -84.21 -37.08 22.27 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.167 -0.679 . . . . 75.420000000000002 109.167 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -84.21 -17.19 40.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.571 -0.74 . . . . 63.240000000000002 110.531 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.46 64.29 3.23 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.274 -0.73 . . . . 72.040000000000006 111.274 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -134.32 117.43 16.38 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.466 0.65 . . . . 71.310000000000002 112.006 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -104.42 14.72 29.6 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.907 -1.042 . . . . 74.439999999999998 109.329 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.82 12.35 66.54 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 71.409999999999997 111.286 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m 71.86 -74.37 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.383 1.073 . . . . 72.340000000000003 110.091 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.129999999999995 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.129999999999995 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.420000000000002 109.955 179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.219999999999999 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.009999999999998 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 74.510000000000005 108.468 178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 72.299999999999997 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.447 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.519999999999996 109.987 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.340000000000003 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.239999999999995 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.019999999999996 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.129999999999995 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.129999999999995 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.439999999999998 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . 0.411 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.310000000000002 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.210000000000001 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.415 ' HB3' HD12 ' A' ' 107' ' ' ILE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.129999999999995 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.319999999999993 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.530000000000001 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 65.230000000000004 109.3 -178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.520000000000003 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.319999999999993 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.439999999999998 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.540000000000006 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.439999999999998 112.362 -176.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.209999999999994 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.414 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.040000000000006 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.219999999999999 111.941 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.319999999999993 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . 0.457 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.010000000000005 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.504 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.200000000000003 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.415 HD12 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 64.340000000000003 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.450000000000003 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.030000000000001 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.310000000000002 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.230000000000004 112.006 -178.248 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.504 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 62.049999999999997 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.109999999999999 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.504 ' O ' ' HE1' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 75.109999999999999 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.520000000000003 111.105 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.420000000000002 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.504 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 74.140000000000001 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 71.310000000000002 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.457 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.411 ' CG2' HD13 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.329999999999998 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 64.049999999999997 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.310000000000002 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.310000000000002 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.462 ' C ' ' H ' ' A' ' 127' ' ' LYS . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.549999999999997 114.094 -177.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.509999999999998 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.493 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 88.0 tttt -53.43 -53.66 54.04 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.120000000000005 112.156 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.493 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -83.54 -12.44 8.92 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 121.979 1.786 . . . . 71.439999999999998 111.944 174.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 137.85 -150.54 20.91 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.961 -0.856 . . . . 72.540000000000006 110.961 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.94 -72.07 1.04 Allowed Glycine 0 C--O 1.239 0.424 0 N-CA-C 109.964 -1.254 . . . . 62.210000000000001 109.964 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.19 113.23 2.78 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.319 2.012 . . . . 75.230000000000004 109.04 171.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.447 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 106.5 114.64 3.93 Favored Glycine 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.229999999999997 109.54 -173.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.219999999999999 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.476 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 37.060000000000002 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.509999999999998 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 71.219999999999999 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.442 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.430000000000007 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.519999999999996 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.402 HD22 ' SG ' ' A' ' 158' ' ' CYS . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.109999999999999 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.452 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.409999999999997 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.450000000000003 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.613 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.530000000000001 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 70.519999999999996 107.193 170.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 70.319999999999993 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.299999999999997 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.400000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.613 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.510000000000005 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.438 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.150000000000006 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.465 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.230000000000004 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.515 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.319999999999993 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.240000000000002 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.450000000000003 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.409999999999997 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 74.209999999999994 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.402 ' SG ' HD22 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 65.310000000000002 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 74.409999999999997 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.426 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.329999999999998 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 37.060000000000002 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.477 ' CB ' HG12 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.439999999999998 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.230000000000004 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.219999999999999 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.430000000000007 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.530000000000001 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 75.200000000000003 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 86.9 mt -69.64 -43.2 73.12 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.230000000000004 110.434 -177.525 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 54.6 23.08 4.39 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.861 1.264 . . . . 53.039999999999999 112.401 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.68 149.95 24.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.373 0.606 . . . . 75.420000000000002 111.848 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.163 -1.421 . . . . 70.099999999999994 107.163 175.835 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 121.448 0.642 . . . . 74.319999999999993 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 175.47 159.16 0.23 Allowed 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 126.085 1.754 . . . . 71.540000000000006 109.061 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.39 109.84 2.2 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.826 -0.805 . . . . 38.009999999999998 108.826 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -64.81 -42.77 94.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.747 0.647 . . . . 71.239999999999995 112.747 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 p -89.32 -39.04 13.73 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.728 0.64 . . . . 62.100000000000001 112.728 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt 62.57 15.29 7.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.528 0.731 . . . . 62.109999999999999 112.307 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.210000000000001 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.530000000000001 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.149999999999999 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.329999999999998 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.319999999999993 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.239999999999995 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.349999999999994 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.473 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.299999999999997 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.140000000000001 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.120000000000005 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.454 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 75.230000000000004 111.92 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.532 ' HB2' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.349999999999994 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.350000000000001 111.022 176.781 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.209999999999994 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.420000000000002 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 13.6 t-80 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.439999999999998 111.812 178.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.434 ' HB2' ' OXT' ' A' ' 173' ' ' GLU . 87.0 m-70 -76.72 -50.64 13.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.430000000000007 111.987 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -29.63 67.97 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.251 1.204 . . . . 73.219999999999999 114.251 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.09 -0.644 . . . . 71.450000000000003 110.229 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.57 -43.6 31.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.209 -0.45 . . . . 42.450000000000003 111.043 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.2 33.54 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.877 -0.889 . . . . 43.119999999999997 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.0 100.06 47.76 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 112.641 0.608 . . . . 71.400000000000006 112.641 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.58 150.05 24.38 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.19 1.927 . . . . 71.140000000000001 108.189 171.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -68.43 -32.15 71.98 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.958 -0.697 . . . . 74.420000000000002 109.457 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -145.96 161.52 39.87 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 108.235 -1.024 . . . . 70.420000000000002 108.235 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.447 ' HB ' ' CE1' ' A' ' 168' ' ' HIS . 34.6 m -70.52 162.88 3.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.53 0.519 . . . . 71.239999999999995 110.065 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . 0.502 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 26.7 p -59.58 144.93 46.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.838 0.681 . . . . 65.239999999999995 112.838 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 63.47 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.079 1.352 . . . . 71.239999999999995 110.962 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.79 -64.37 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.445 1.498 . . . . 63.409999999999997 112.107 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.4 m -88.14 151.01 48.51 Favored Pre-proline 0 N--CA 1.413 -2.315 0 C-N-CA 123.939 0.895 . . . . 74.230000000000004 109.398 -179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -79.01 -149.18 0.04 OUTLIER 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.235 1.956 . . . . 74.349999999999994 107.731 169.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 51.09 4.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.035 -1.078 . . . . 61.439999999999998 110.723 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -143.47 147.26 34.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.736 -1.579 . . . . 74.329999999999998 106.736 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.3 mt -84.76 113.71 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.317 0.58 . . . . 73.540000000000006 111.322 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -117.37 159.95 21.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.551 -0.75 . . . . 71.430000000000007 109.845 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.23 -165.48 11.81 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.634 -1.387 . . . . 54.240000000000002 109.634 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.9 m 69.42 162.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.788 0.835 . . . . 64.230000000000004 111.638 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.74 155.44 25.61 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 122.187 -0.321 . . . . 55.25 110.181 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.3 102.34 13.3 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.576 -0.898 . . . . 63.310000000000002 108.576 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -89.45 -15.49 33.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.051 -0.522 . . . . 75.329999999999998 110.637 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.5 90.73 2.75 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.249 0.547 . . . . 74.519999999999996 110.107 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.06 -161.46 21.7 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-N 115.046 -0.979 . . . . 61.32 110.918 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.36 93.17 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.337 1.065 . . . . 64.430000000000007 112.022 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -104.52 -16.25 15.11 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.579 -1.191 . . . . 72.519999999999996 109.44 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -12.51 32.36 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.764 -0.653 . . . . 74.319999999999993 114.338 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -119.3 179.51 4.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 123.06 0.544 . . . . 72.439999999999998 110.91 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.43 HG22 HG23 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.229999999999997 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.219999999999999 110.803 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.299999999999997 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.310000000000002 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 63.509999999999998 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m120 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 75.530000000000001 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.329999999999998 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.5 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 72.209999999999994 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.509999999999998 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.399999999999999 110.737 177.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.219999999999999 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 109.9 -174.733 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.456 ' HB3' HD12 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 73.530000000000001 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.019999999999996 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.530000000000001 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.43 HG23 HG22 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.510000000000005 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.130000000000003 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.526 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.430000000000007 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.439999999999998 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 72.209999999999994 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.526 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.532 ' ND2' ' HB2' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 61.299999999999997 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.140000000000001 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 64.409999999999997 110.811 177.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 72.099999999999994 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.120000000000005 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.230000000000004 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.527 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 70.430000000000007 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.310000000000002 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.130000000000003 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.120000000000005 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.540000000000006 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.520000000000003 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.48 ' HE1' ' O ' ' A' ' 115' ' ' TYR . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.540000000000006 111.443 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.109999999999999 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.607 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.140000000000001 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.48 ' O ' ' HE1' ' A' ' 112' ' ' MET . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.129999999999995 105.653 179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.43 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.430000000000007 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.55 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.519999999999996 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.55 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 72.329999999999998 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.439999999999998 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.417 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.109999999999999 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.030000000000001 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.340000000000003 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.319999999999993 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.568 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt -89.32 -54.22 0.32 Allowed Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.400000000000006 112.842 -175.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.457 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 3.4 Cg_exo -79.96 -24.55 5.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 121.334 1.356 . . . . 74.150000000000006 110.633 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.75 19.63 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.422 -1.471 . . . . 70.420000000000002 109.422 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.5 -77.04 0.79 Allowed Glycine 0 C--N 1.309 -0.939 0 C-N-CA 121.261 -0.495 . . . . 55.420000000000002 112.411 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . 0.454 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 18.4 Cg_endo -60.83 129.68 29.99 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.759 2.306 . . . . 73.439999999999998 110.825 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.72 84.42 0.39 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.319999999999993 111.121 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 70.230000000000004 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.568 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.329999999999998 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 70.349999999999994 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.417 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 90.0 m-70 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 74.349999999999994 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.340000000000003 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.099999999999994 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 70.140000000000001 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.409999999999997 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.040000000000006 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.329999999999998 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.581 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.349999999999994 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.426 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.209999999999994 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.581 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.350000000000001 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.349999999999994 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 62.229999999999997 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.568 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.210000000000001 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.607 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.200000000000003 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.349999999999994 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 75.430000000000007 108.887 175.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.140000000000001 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.458 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.349999999999994 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 50.530000000000001 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.599 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 15.1 mm100 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 74.409999999999997 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 74.530000000000001 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.140000000000001 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 73.140000000000001 111.5 -179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.599 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.540000000000006 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.455 ' O ' HG23 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 70.239999999999995 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.010000000000005 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.030000000000001 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.200000000000003 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.455 HG23 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.150000000000006 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.554 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.009999999999998 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.447 ' CE1' ' HB ' ' A' ' 50' ' ' VAL . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 63.450000000000003 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt -67.4 -20.21 65.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.409999999999997 110.996 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.62 -20.8 24.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.792 0.664 . . . . 74.239999999999995 112.792 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 7.5 pt-20 -118.76 -177.31 3.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.221 0.822 . . . . 64.129999999999995 113.221 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . 0.434 ' OXT' ' HB2' ' A' ' 41' ' ' HIS . 10.1 pt-20 . . . . . 0 C--O 1.263 1.775 0 C-N-CA 124.661 1.184 . . . . 73.230000000000004 114.123 -176.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.172 -1.788 . . . . 72.150000000000006 106.172 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.61 143.62 24.14 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.628 0.728 . . . . 75.420000000000002 111.673 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.46 94.63 9.46 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 73.200000000000003 112.024 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 p -72.65 -39.31 67.27 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.799 . . . . 75.109999999999999 110.792 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -85.5 -10.81 55.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.557 -0.747 . . . . 71.409999999999997 110.532 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt 62.47 -40.47 0.16 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 61.530000000000001 114.796 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.431 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.540000000000006 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.229999999999997 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.039999999999999 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 74.230000000000004 108.564 168.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.340000000000003 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.109999999999999 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.230000000000004 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.527 HG12 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.310000000000002 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.209999999999994 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.219999999999999 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.420000000000002 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 62.140000000000001 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.229999999999997 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.140000000000001 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.129999999999995 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.516 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.540000000000006 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 74.200000000000003 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -66.2 -35.51 80.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.310000000000002 113.831 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -73.38 -26.06 60.83 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 118.808 -1.157 . . . . 74.299999999999997 112.443 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -86.66 -31.73 20.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.146 -0.622 . . . . 63.43 110.813 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.56 75.76 2.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.494 0.664 . . . . 72.420000000000002 109.912 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.74 -159.45 24.55 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.846 -1.301 . . . . 62.219999999999999 109.846 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -102.84 134.15 20.0 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 117.175 0.487 . . . . 74.310000000000002 110.379 -179.308 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_exo -68.66 -20.73 40.17 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.616 2.211 . . . . 65.140000000000001 111.353 177.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -102.18 144.29 30.92 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.051 -0.722 . . . . 72.299999999999997 109.051 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -116.12 146.34 42.32 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 112.198 0.444 . . . . 62.310000000000002 112.198 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 t 64.01 82.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 O-C-N 125.209 1.568 . . . . 74.209999999999994 110.083 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -79.64 -19.93 47.97 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.799 -1.091 . . . . 71.510000000000005 110.79 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -147.31 -66.68 0.26 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.493 -0.929 . . . . 73.25 108.493 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.84 169.8 19.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.825 -0.625 . . . . 73.120000000000005 110.575 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -161.69 172.68 5.36 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.518 -1.66 . . . . 72.450000000000003 106.518 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.99 119.04 5.64 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.238 1.959 . . . . 74.439999999999998 110.976 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.25 -49.16 2.96 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 110.095 -1.202 . . . . 74.209999999999994 110.095 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 61.0 t30 69.76 85.89 0.13 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.665 1.586 . . . . 63.200000000000003 113.049 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.92 106.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.035 -1.468 . . . . 71.329999999999998 107.035 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -76.06 -31.01 58.6 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.751 -0.659 . . . . 63.140000000000001 110.011 -177.19 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 -53.11 4.55 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.734 -0.946 . . . . 63.439999999999998 110.734 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.8 t 67.38 86.17 0.13 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.926 1.29 . . . . 75.430000000000007 110.876 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.19 -63.64 1.38 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.255 -0.884 . . . . 62.210000000000001 109.002 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 tp 52.83 73.18 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.526 1.142 . . . . 75.219999999999999 111.658 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.28 166.34 19.64 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.184 -1.043 . . . . 73.140000000000001 108.184 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.97 92.0 7.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.799 0.809 . . . . 71.030000000000001 112.202 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.53 -110.35 3.11 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.763 -1.735 . . . . 74.319999999999993 108.763 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.88 134.8 34.18 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.6 -0.519 . . . . 73.409999999999997 109.6 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -74.52 -13.87 60.74 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.997 -0.547 . . . . 74.25 111.842 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.71 12.53 82.72 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.916 -0.659 . . . . 73.109999999999999 112.887 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m -156.66 142.76 18.07 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.161 -1.052 . . . . 73.150000000000006 108.161 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.409 HG22 HG23 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.109999999999999 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.549999999999997 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.486 ' HB2' ' O ' ' A' ' 70' ' ' THR . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.340000000000003 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.420000000000002 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.540000000000006 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.572 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 73.409999999999997 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.329999999999998 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.109999999999999 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.340000000000003 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.510000000000005 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.239999999999995 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.340000000000003 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.200000000000003 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.209999999999994 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 75.5 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 62.140000000000001 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.482 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.219999999999999 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.572 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.239999999999995 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.030000000000001 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.456 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.340000000000003 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.299999999999997 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.400000000000006 109.893 178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.499 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.420000000000002 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.109999999999999 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.601 ' HB3' HE21 ' A' ' 123' ' ' GLN . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.319999999999993 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.420000000000002 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.415 HD22 ' C ' ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.310000000000002 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.310000000000002 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.329999999999998 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.420000000000002 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.475 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.209999999999994 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.405 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.299999999999997 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.099999999999994 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.459 ' CD ' ' H ' ' A' ' 109' ' ' GLY 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 71.409999999999997 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.430000000000007 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.458 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.049999999999997 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.405 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 72.439999999999998 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.457 ' HE2' ' HA ' ' A' ' 117' ' ' SER . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.520000000000003 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.329999999999998 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.456 ' O ' ' HE1' ' A' ' 112' ' ' MET . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 72.230000000000004 108.901 -178.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.58 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 70.040000000000006 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.457 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.209999999999994 106.449 177.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 74.319999999999993 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.129999999999995 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.209999999999994 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 71.120000000000005 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 72.319999999999993 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.601 HE21 ' HB3' ' A' ' 99' ' ' LYS . 57.5 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.549999999999997 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.209999999999994 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.468 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 74.329999999999998 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.468 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.219999999999999 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.55 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt -142.77 -51.37 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.310000000000002 111.458 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.434 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 48.5 Cg_exo -61.13 -35.98 83.55 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 121.614 1.543 . . . . 73.129999999999995 111.282 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.92 -112.28 0.51 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.855 -0.898 . . . . 73.219999999999999 110.855 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.47 -77.52 0.52 Allowed Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.996 -0.842 . . . . 63.439999999999998 110.996 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.51 164.61 28.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.328 2.019 . . . . 75.420000000000002 110.696 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.417 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 88.82 103.24 1.0 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.040000000000006 110.762 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 70.430000000000007 110.913 -178.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.55 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.239999999999995 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.129999999999995 108.639 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.129999999999995 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.329999999999998 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.450000000000003 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.129999999999995 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.230000000000004 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.120000000000005 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.431 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.420000000000002 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.229999999999997 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.58 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 73.430000000000007 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.200000000000003 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.456 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 72.219999999999999 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 74.409999999999997 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.130000000000003 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.319999999999993 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.129999999999995 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.310000000000002 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.439999999999998 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.537 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 61.43 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.51 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 74.340000000000003 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 73.319999999999993 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.534 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 72.420000000000002 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.420000000000002 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.51 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.439999999999998 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 72.140000000000001 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.527 ' CB ' HG12 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 62.539999999999999 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.515 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.239999999999995 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 71.239999999999995 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.319999999999993 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.403 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.400000000000006 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.040000000000006 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.516 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.319999999999993 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -68.95 -21.87 64.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.230000000000004 110.636 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.93 -165.4 1.22 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.508 -1.293 . . . . 71.129999999999995 107.508 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 -169.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 114.054 1.131 . . . . 73.329999999999998 114.054 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 118.855 -0.593 . . . . 72.420000000000002 110.357 -178.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 107.42 -1.326 . . . . 74.530000000000001 107.42 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.93 164.87 25.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.993 0.425 . . . . 74.329999999999998 111.511 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -120.21 35.24 4.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.83 -0.433 . . . . 72.319999999999993 109.83 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 t -54.95 -45.04 74.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.423 0.689 . . . . 72.319999999999993 111.788 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -89.55 -7.4 54.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.866 -0.42 . . . . 74.420000000000002 109.866 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.459 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt 65.43 -64.13 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.647 1.579 . . . . 75.329999999999998 111.925 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.568 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 73.299999999999997 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.595 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.340000000000003 109.745 175.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.446 ' HB2' ' HH ' ' A' ' 141' ' ' TYR . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.120000000000005 110.5 169.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 70.519999999999996 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.420000000000002 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.458 HG12 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.129999999999995 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.421 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.420000000000002 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.401 ' HB2' HD12 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.219999999999999 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.430000000000007 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.512 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.319999999999993 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 109.776 175.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.109999999999999 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.512 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.019999999999996 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.109999999999999 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.049999999999997 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.544 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 22.5 m-70 -76.14 -37.79 57.57 Favored 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 110.977 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 mmt -74.42 -23.78 59.0 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.49 0.552 . . . . 72.519999999999996 112.49 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.4 -31.96 26.39 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.739 -0.384 . . . . 75.329999999999998 110.623 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.67 -67.64 0.84 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.812 0.339 . . . . 72.129999999999995 111.276 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.55 75.23 1.69 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.789 -0.924 . . . . 64.120000000000005 110.789 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.36 139.98 96.51 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 123.361 0.664 . . . . 64.329999999999998 110.49 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.79 -173.95 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.286 1.991 . . . . 73.219999999999999 111.397 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.56 -32.44 66.05 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.457 -0.942 . . . . 72.450000000000003 108.457 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 65.07 105.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 72.319999999999993 111.246 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.89 137.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 51.310000000000002 109.758 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t -74.23 97.59 3.0 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.421 0.629 . . . . 53.25 109.608 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.39 -62.13 1.67 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.045 -0.98 . . . . 73.239999999999995 108.805 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -179.14 103.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.105 1.362 . . . . 71.450000000000003 108.202 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.2 p -118.72 111.48 37.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 120.667 0.27 . . . . 64.010000000000005 110.967 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.16 -15.8 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.58 2.186 . . . . 60.210000000000001 112.531 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.543 ' C ' ' HB3' ' A' ' 62' ' ' ASP . . . 83.84 -54.88 4.99 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 121.368 -0.444 . . . . 61.420000000000002 112.957 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 16.8 m120 -141.48 120.55 12.88 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.745 -0.835 . . . . 61.100000000000001 108.745 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.482 HG13 ' H ' ' A' ' 59' ' ' GLN . 27.2 pt -107.92 -60.29 2.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.61 -0.436 . . . . 73.340000000000003 111.384 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.482 ' H ' HG13 ' A' ' 58' ' ' ILE . 54.9 mt-30 -145.03 93.3 2.37 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.211 -1.403 . . . . 75.409999999999997 107.211 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.66 -55.96 0.89 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 108.773 -1.731 . . . . 42.109999999999999 108.773 -175.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 t -169.66 -169.29 0.89 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.19 -1.411 . . . . 74.140000000000001 107.19 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.543 ' HB3' ' C ' ' A' ' 56' ' ' GLY . 11.7 t70 -156.01 -48.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.262 1.025 . . . . 70.329999999999998 109.233 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.26 110.68 12.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.998 -1.853 . . . . 74.140000000000001 105.998 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -75.94 107.01 7.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.595 0.591 . . . . 74.319999999999993 112.595 -172.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -26.25 10.97 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.754 -0.657 . . . . 75.239999999999995 110.133 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.42 37.62 4.23 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.27 -1.132 . . . . 62.100000000000001 110.27 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.39 -35.12 60.0 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.416 1.086 . . . . 70.310000000000002 112.678 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.49 ' CB ' ' HA ' ' A' ' 73' ' ' SER . 26.6 m-90 -92.01 14.25 16.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.664 -0.698 . . . . 73.519999999999996 112.149 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.22 12.51 73.32 Favored Glycine 0 C--O 1.246 0.867 0 C-N-CA 120.225 -0.988 . . . . 65.030000000000001 111.739 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m 72.59 -72.72 0.11 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.04 0.936 . . . . 74.150000000000006 110.607 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.120000000000005 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.109999999999999 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.49 ' HA ' ' CB ' ' A' ' 68' ' ' TRP . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.420000000000002 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.451 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.229999999999997 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.430000000000007 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.239999999999995 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.329999999999998 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.329999999999998 109.383 -178.482 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.519999999999996 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 64.340000000000003 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.519999999999996 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.140000000000001 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.209999999999994 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.120000000000005 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.439999999999998 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 73.329999999999998 109.256 -178.266 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.450000000000003 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.109999999999999 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 74.430000000000007 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.406 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.430000000000007 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . 0.418 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.310000000000002 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 75.450000000000003 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.429 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.230000000000004 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.310000000000002 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.209999999999994 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.439999999999998 111.117 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.557 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 51.0 t30 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.429 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.239999999999995 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.428 HG22 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.239999999999995 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.439999999999998 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.400000000000006 110.383 177.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.457 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.319999999999993 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.140000000000001 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 73.120000000000005 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.130000000000003 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.507 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.230000000000004 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.240000000000002 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.519999999999996 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.476 ' O ' ' HE1' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.109999999999999 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.530000000000001 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.426 ' CA ' ' HE2' ' A' ' 112' ' ' MET . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.129999999999995 107.0 175.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.531 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 74.109999999999999 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.209999999999994 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.531 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.219999999999999 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.530000000000001 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.455 HG21 ' HA ' ' A' ' 137' ' ' TRP . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.200000000000003 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.510000000000005 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.553 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 75.019999999999996 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.510000000000005 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.329999999999998 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.541 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt -82.85 142.48 45.15 Favored Pre-proline 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.230000000000004 109.963 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 127' ' ' LYS . 31.6 Cg_exo -61.62 -46.69 13.37 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.07 2.513 . . . . 62.140000000000001 112.747 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.82 84.44 0.3 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 120.568 -0.825 . . . . 64.329999999999998 111.78 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.12 146.44 4.93 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.993 -0.622 . . . . 52.439999999999998 111.982 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 118.93 5.92 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.998 2.465 . . . . 72.209999999999994 111.845 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . 0.428 ' C ' ' HG ' ' A' ' 133' ' ' SER . . . 152.71 -164.3 30.68 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.099999999999994 109.954 -179.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.472 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.530000000000001 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.541 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.209999999999994 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.230000000000004 108.971 178.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.514 ' O ' ' HG3' ' A' ' 27' ' ' GLU . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.200000000000003 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.120000000000005 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 73.25 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.400000000000006 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.595 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 72.099999999999994 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.568 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.409999999999997 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.420000000000002 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.254 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.109999999999999 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.310000000000002 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.439999999999998 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . 0.436 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 74.219999999999999 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.443 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.019999999999996 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . 0.436 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.540000000000006 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 74.400000000000006 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.443 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 71.310000000000002 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . 0.522 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.109999999999999 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.540000000000006 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.404 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 74.230000000000004 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.584 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 73.200000000000003 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.522 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.519999999999996 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.458 ' CB ' HG12 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.340000000000003 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.584 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.319999999999993 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.530000000000001 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.412 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.530000000000001 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.421 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.319999999999993 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . 0.574 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.229999999999997 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.420000000000002 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.401 HD12 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt -81.17 -41.55 22.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 74.140000000000001 110.273 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.68 15.27 4.59 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.892 1.277 . . . . 63.210000000000001 114.441 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.09 166.72 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.787 1.235 . . . . 64.420000000000002 114.223 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 114.968 -1.014 . . . . 64.120000000000005 108.485 174.211 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 114.708 1.373 . . . . 61.030000000000001 114.708 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -143.96 177.34 8.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.845 -1.909 . . . . 61.340000000000003 105.845 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.2 145.44 46.27 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.062 -0.718 . . . . 74.430000000000007 109.062 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -62.52 -28.8 70.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.139 0.495 . . . . 72.310000000000002 111.083 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.7 p -88.91 -5.26 58.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.879 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt 60.33 20.98 10.5 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.054 0.942 . . . . 75.540000000000006 112.777 -175.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.310000000000002 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 39.030000000000001 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.310000000000002 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.546 HD21 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.409999999999997 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.546 ' N ' HD21 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.209999999999994 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.140000000000001 109.623 177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.426 HG12 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.340000000000003 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 75.109999999999999 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 60.329999999999998 112.0 -179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.430000000000007 109.517 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.448 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 110.226 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 74.5 110.148 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.239999999999995 108.533 178.81 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.319999999999993 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.448 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 21.1 m-70 -70.25 -50.78 36.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.531 ' SD ' HD13 ' A' ' 169' ' ' LEU . 24.7 ptm -74.57 -22.9 58.75 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.376 0.88 . . . . 62.109999999999999 113.376 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -76.41 -24.47 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.328 0.585 . . . . 71.409999999999997 109.66 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.11 -16.32 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.575 0.702 . . . . 70.519999999999996 109.696 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.38 73.01 0.27 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.579 -1.408 . . . . 75.439999999999998 109.579 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.519 ' HE2' ' OG1' ' A' ' 70' ' ' THR . 58.8 mttp -68.46 143.85 95.83 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.418 -0.391 . . . . 64.319999999999993 110.763 -176.203 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.91 117.1 3.63 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.734 2.29 . . . . 54.030000000000001 111.454 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -91.15 81.42 5.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.448 -0.575 . . . . 74.140000000000001 109.448 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 55.48 89.14 0.04 OUTLIER 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.82 1.248 . . . . 73.530000000000001 112.071 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.11 156.8 38.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.91 -0.586 . . . . 70.209999999999994 110.016 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -160.6 93.96 1.03 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.306 -0.627 . . . . 65.150000000000006 109.306 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -178.73 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.178 0.991 . . . . 73.219999999999999 108.485 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.98 92.94 8.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.441 -0.799 . . . . 74.019999999999996 109.956 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 p -177.47 163.42 1.4 Allowed Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.01 -1.107 . . . . 72.109999999999999 108.01 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.62 135.94 71.75 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.16 1.906 . . . . 62.299999999999997 110.012 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.9 65.4 3.53 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.127 -0.559 . . . . 52.149999999999999 113.614 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -126.8 99.39 5.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.373 -0.973 . . . . 64.450000000000003 108.373 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.78 120.45 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 115.732 -0.667 . . . . 71.049999999999997 109.649 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -82.46 133.76 35.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.998 -0.546 . . . . 73.239999999999995 110.068 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.92 167.47 21.83 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.532 -0.842 . . . . 74.409999999999997 111.27 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.2 t 71.07 -66.67 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.038 0.935 . . . . 74.209999999999994 112.501 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -124.85 100.41 6.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.006 0.431 . . . . 72.040000000000006 110.185 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.51 99.67 8.39 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.763 -1.94 . . . . 63.009999999999998 105.763 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -91.06 131.79 36.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.505 -0.924 . . . . 71.120000000000005 108.505 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -146.68 -90.51 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.63 -0.507 . . . . 73.340000000000003 109.63 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.26 -136.66 5.5 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 124.008 0.817 . . . . 72.450000000000003 112.411 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.95 110.17 22.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.867 -1.901 . . . . 73.230000000000004 105.867 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.588 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 1.2 t90 -88.32 -17.24 31.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.599 -0.519 . . . . 73.219999999999999 109.599 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.0 4.81 58.61 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.16 -0.543 . . . . 74.319999999999993 112.922 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.519 ' OG1' ' HE2' ' A' ' 46' ' ' LYS . 50.7 m 67.68 -76.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.859 0.863 . . . . 72.430000000000007 110.856 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.521 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.450000000000003 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.310000000000002 110.83 -175.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 74.329999999999998 109.883 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 75.329999999999998 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.340000000000003 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.430000000000007 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.140000000000001 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.519999999999996 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 73.519999999999996 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.010000000000005 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.340000000000003 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.149999999999999 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.097 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 63.109999999999999 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 109.816 -176.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . 0.489 ' HB ' ' HZ2' ' A' ' 89' ' ' LYS . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.409999999999997 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.566 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 64.420000000000002 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.239999999999995 105.624 177.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.521 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.329999999999998 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.409999999999997 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.040000000000006 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.503 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.329999999999998 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.030000000000001 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.552 ' HB3' ' NE2' ' A' ' 123' ' ' GLN . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.487 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.420000000000002 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.442 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.530000000000001 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.420000000000002 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.430000000000007 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.129999999999995 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.209999999999994 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.404 HG11 HD13 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.439999999999998 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.453 ' H ' HD12 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.450000000000003 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.430000000000007 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.509999999999998 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . 0.455 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.404 HD13 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.329999999999998 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.688 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 75.299999999999997 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.439999999999998 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.582 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.420000000000002 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.688 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 72.209999999999994 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.420000000000002 110.399 179.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.119999999999997 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.209999999999994 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.409999999999997 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.200000000000003 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.230000000000004 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.476 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.552 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.040000000000006 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.487 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 74.019999999999996 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.319999999999993 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.010000000000005 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.459 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt -78.14 142.01 63.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.400000000000006 110.158 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.47 100.92 1.3 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.209 1.939 . . . . 70.400000000000006 111.17 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.06 52.91 29.42 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.325 -0.71 . . . . 75.430000000000007 111.325 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.51 137.31 4.58 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.636 -0.792 . . . . 51.530000000000001 111.871 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.28 113.13 3.51 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.546 2.164 . . . . 53.509999999999998 111.332 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.48 -159.98 23.82 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.150000000000006 110.469 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.409999999999997 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.459 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.530000000000001 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 74.019999999999996 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.476 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 91.6 m-70 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.439999999999998 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 71.239999999999995 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . 0.413 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.239999999999995 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 73.25 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.530000000000001 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 72.209999999999994 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.130000000000003 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.420000000000002 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.412 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.129999999999995 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.239999999999995 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.109999999999999 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.519999999999996 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.47 ' CG1' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.582 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 73.129999999999995 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 73.019999999999996 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.519999999999996 112.038 174.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 74.230000000000004 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.439999999999998 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.409999999999997 109.569 176.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.510000000000005 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.399999999999999 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.530000000000001 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.487 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.420000000000002 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.150000000000006 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.019999999999996 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.426 ' HB3' HG12 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 63.130000000000003 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 75.400000000000006 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.239999999999995 109.482 -176.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.099999999999994 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.219999999999999 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.340000000000003 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.531 HD13 ' SD ' ' A' ' 42' ' ' MET . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 111.623 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt -77.53 -21.56 52.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 60.119999999999997 110.203 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.07 108.12 17.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.174 -1.046 . . . . 61.109999999999999 108.174 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.49 155.84 19.82 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.719 -0.792 . . . . 70.109999999999999 110.96 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.318 -0.855 . . . . 73.049999999999997 109.897 -178.87 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 63.020000000000003 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.79 -5.62 59.22 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.168 -0.923 . . . . 75.540000000000006 109.689 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.13 8.01 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.645 -1.161 . . . . 52.509999999999998 108.363 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -66.08 -28.7 69.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.989 -0.551 . . . . 64.540000000000006 111.802 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 50.4 m -87.79 -3.94 58.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.517 -0.31 . . . . 64.299999999999997 111.714 179.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt 62.81 18.55 10.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.638 0.775 . . . . 53.219999999999999 112.737 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 71.200000000000003 108.082 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.219999999999999 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.430000000000007 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.340000000000003 107.177 178.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.530000000000001 108.303 -179.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.519999999999996 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 65.409999999999997 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.510000000000005 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.299999999999997 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.492 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.200000000000003 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . 0.441 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.430000000000007 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.505 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.540000000000006 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.340000000000003 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.219999999999999 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.150000000000006 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.329999999999998 110.699 175.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.120000000000005 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -76.26 -43.37 42.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 111.984 -174.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.4 mmm -74.53 -31.87 62.29 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.713 1.005 . . . . 74.340000000000003 113.713 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -77.8 -32.12 52.18 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.033 -0.667 . . . . 75.430000000000007 110.612 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.32 -27.72 22.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.219 0.533 . . . . 43.25 110.708 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.02 21.15 17.01 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.618 -0.719 . . . . 74.409999999999997 113.428 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.459 ' HD3' ' C ' ' A' ' 46' ' ' LYS . 6.6 tmtm? -83.67 121.16 76.18 Favored Pre-proline 0 N--CA 1.427 -1.588 0 N-CA-C 107.581 -1.266 . . . . 74.409999999999997 107.581 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.89 104.33 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.147 1.898 . . . . 64.349999999999994 110.069 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -86.44 120.97 28.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.075 0.464 . . . . 72.430000000000007 110.793 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -160.08 -44.59 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.574 -0.739 . . . . 74.329999999999998 110.796 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.2 t 69.61 87.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.982 -1.118 . . . . 75.209999999999994 107.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.5 p -67.25 -68.31 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.691 -1.14 . . . . 71.519999999999996 113.162 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.486 ' HE2' ' O ' ' A' ' 54' ' ' SER . 57.7 mtpt 65.68 172.86 0.22 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.665 0.786 . . . . 74.120000000000005 112.166 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.48 -32.43 48.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.337 -0.986 . . . . 74.239999999999995 108.337 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.486 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 45.7 p -139.27 129.87 14.65 Favored Pre-proline 0 N--CA 1.425 -1.703 0 N-CA-C 107.317 -1.364 . . . . 61.299999999999997 107.317 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.93 -54.32 5.61 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 123.397 2.731 . . . . 62.539999999999999 113.385 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.61 84.25 0.07 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.746 -1.341 . . . . 64.319999999999993 109.746 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -92.35 87.94 6.22 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.114 0.483 . . . . 73.329999999999998 112.272 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.68 -174.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 125.222 1.409 . . . . 72.209999999999994 108.289 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -55.88 -56.81 16.15 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.094 0.473 . . . . 62.109999999999999 111.303 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.5 82.97 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.39 -0.91 . . . . 71.310000000000002 111.674 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.4 t -143.5 118.4 9.97 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.834 -1.173 . . . . 72.209999999999994 107.834 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.13 104.59 5.72 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.76 0.791 . . . . 73.010000000000005 111.453 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.1 tt -87.97 131.38 34.64 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 105.416 -2.068 . . . . 60.32 105.416 175.015 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -83.9 94.06 8.16 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.023 0.916 . . . . 53.240000000000002 113.017 -174.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -98.34 102.56 14.34 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.64 -1.618 . . . . 74.530000000000001 107.772 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.57 166.1 39.39 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 110.61 -0.996 . . . . 63.310000000000002 110.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.35 134.94 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.8 0.333 . . . . 63.039999999999999 111.319 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.45 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 20.7 m0 -87.48 -16.01 35.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.606 -0.725 . . . . 64.329999999999998 110.52 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.08 12.24 81.26 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 121.307 -0.473 . . . . 43.520000000000003 113.438 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -157.01 179.73 9.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.731 -0.47 . . . . 74.549999999999997 109.731 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 74.519999999999996 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.109999999999999 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.45 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.200000000000003 110.882 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.510000000000005 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.219999999999999 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 72.510000000000005 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.349999999999994 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 73.420000000000002 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.530000000000001 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 74.420000000000002 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.329999999999998 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.430000000000007 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.010000000000005 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.230000000000004 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.409999999999997 109.353 -176.208 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.510000000000005 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.219999999999999 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.209999999999994 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 71.530000000000001 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.299999999999997 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 50.439999999999998 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.439999999999998 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.010000000000005 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 74.219999999999999 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 64.239999999999995 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.558 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.219999999999999 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.456 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.049999999999997 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.239999999999995 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.450000000000003 109.561 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.040000000000006 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.448 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.420000000000002 114.056 -175.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.209999999999994 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.537 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 38.530000000000001 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.340000000000003 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.439 ' HB2' HG23 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.219999999999999 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.467 ' HE1' ' HA ' ' A' ' 112' ' ' MET . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 65.109999999999999 110.548 -178.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.537 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.540000000000006 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.423 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.349999999999994 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . 0.454 ' CE2' HD23 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.439999999999998 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . 0.424 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 72.209999999999994 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.59 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.120000000000005 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.019999999999996 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.59 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.109999999999999 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.149999999999999 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.010000000000005 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.558 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 64.430000000000007 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 52.030000000000001 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.010000000000005 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.420000000000002 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 22.4 ptmt -94.04 163.34 23.94 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 73.099999999999994 109.198 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 110.41 0.74 Allowed 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.405 2.07 . . . . 63.020000000000003 111.299 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 143.92 -158.37 27.37 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.038 -1.225 . . . . 70.129999999999995 110.038 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.58 -76.58 1.25 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.527 -0.844 . . . . 53.25 111.445 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -84.59 153.15 11.84 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.406 2.071 . . . . 74.540000000000006 110.948 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 107.55 148.62 14.51 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.519999999999996 111.275 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.030000000000001 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 62.25 109.763 175.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.430000000000007 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.319999999999993 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.239999999999995 109.716 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.439999999999998 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.51 HD22 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.230000000000004 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.230000000000004 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.140000000000001 114.197 -174.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.219999999999999 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.230000000000004 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . 0.424 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.439999999999998 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.446 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.219999999999999 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.140000000000001 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.411 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.420000000000002 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.310000000000002 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.109999999999999 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.420000000000002 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.420000000000002 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.219999999999999 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . 0.454 HD23 ' CE2' ' A' ' 115' ' ' TYR . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.229999999999997 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.464 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.409999999999997 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.439999999999998 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.51 ' SG ' HD22 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 53.119999999999997 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.400000000000006 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.465 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.319999999999993 110.477 176.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 55.0 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HB3' ' HZ3' ' A' ' 163' ' ' LYS . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.340000000000003 111.933 179.914 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.465 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.420000000000002 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.574 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.319999999999993 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.492 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.420000000000002 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 63.420000000000002 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.21 -19.15 37.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.540000000000006 110.372 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.69 -162.82 0.45 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.99 -1.004 . . . . 38.530000000000001 110.507 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.58 179.33 4.64 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.411 -0.813 . . . . 74.25 110.016 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.255 1.387 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.851 177.66 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.43 0.633 . . . . 71.540000000000006 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -106.82 -14.92 14.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.636 -0.711 . . . . 74.400000000000006 112.208 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.52 21.68 1.84 Allowed 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.045 -0.979 . . . . 71.340000000000003 109.44 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 t -72.48 -27.85 62.54 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.607 -0.724 . . . . 73.340000000000003 109.515 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.5 m -79.58 -22.99 43.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.829 -0.623 . . . . 61.119999999999997 111.311 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt 58.16 17.62 4.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.838 0.855 . . . . 74.400000000000006 112.612 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.540000000000006 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.549999999999997 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.140000000000001 110.568 173.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 74.319999999999993 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 73.150000000000006 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 65.530000000000001 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.129999999999995 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.481 HG12 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 43.5 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.230000000000004 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.434 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.329999999999998 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 73.530000000000001 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.010000000000005 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.299999999999997 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.340000000000003 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.486 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.310000000000002 111.412 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 42' ' ' MET . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.109999999999999 112.703 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 74.209999999999994 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 23.8 t-80 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.319999999999993 110.638 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' HIS . . . . . 0.486 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 54.2 m-70 -77.15 -53.11 8.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 74.319999999999993 112.679 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . 0.452 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 3.4 ppp? -72.03 -23.93 61.46 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.081 1.141 . . . . 54.219999999999999 114.081 -170.19 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' CZ ' HG23 ' A' ' 95' ' ' VAL . 80.2 t80 -69.25 -31.48 70.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.486 -0.485 . . . . 74.219999999999999 109.949 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.51 -34.1 35.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.809 -0.632 . . . . 75.319999999999993 109.928 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' MET . . . 167.63 173.04 35.38 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.607 -0.997 . . . . 50.329999999999998 110.607 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.05 122.57 87.15 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.915 0.357 . . . . 64.239999999999995 110.188 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PRO . . . . . 0.402 ' HG3' ' HB3' ' A' ' 41' ' ' HIS . 17.1 Cg_exo -68.09 -63.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.751 1.634 . . . . 54.399999999999999 110.348 177.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.49 179.92 4.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.377 -0.971 . . . . 73.109999999999999 108.377 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -136.93 141.61 42.67 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 123.407 0.442 . . . . 73.400000000000006 111.177 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.9 131.27 63.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.553 -0.748 . . . . 75.349999999999994 110.091 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -105.79 94.32 5.13 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.889 -0.725 . . . . 74.099999999999994 112.122 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.31 125.32 34.42 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.175 -1.417 . . . . 72.040000000000006 107.175 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . 57.95 -160.34 0.25 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.239 -1.023 . . . . 73.439999999999998 108.239 -172.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -98.63 104.79 26.39 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.301 -1.0 . . . . 70.099999999999994 108.301 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 8.0 Cg_exo -72.28 132.94 20.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.515 2.143 . . . . 71.129999999999995 111.681 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.18 126.78 29.02 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.39 -0.823 . . . . 73.310000000000002 112.853 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -91.71 102.48 15.1 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.107 -0.701 . . . . 75.310000000000002 109.107 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.434 HG13 ' HG ' ' A' ' 61' ' ' CYS . 31.4 pt -87.8 172.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.419 -0.809 . . . . 55.509999999999998 111.06 -178.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.81 151.06 28.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.908 -1.042 . . . . 74.019999999999996 109.707 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.53 -4.7 54.28 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.585 -0.817 . . . . 44.299999999999997 113.128 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . 0.434 ' HG ' HG13 ' A' ' 58' ' ' ILE . 77.8 m -94.03 -21.08 19.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.298 0.571 . . . . 64.109999999999999 109.581 177.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.06 149.18 24.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.797 -1.186 . . . . 73.540000000000006 107.797 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.69 118.22 30.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 112.577 0.584 . . . . 70.430000000000007 112.577 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -78.97 -30.52 44.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.503 -0.771 . . . . 75.219999999999999 109.833 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.61 164.61 16.91 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.825 -0.805 . . . . 62.439999999999998 108.825 -175.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.63 -118.35 0.86 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.996 -0.842 . . . . 75.329999999999998 110.996 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 67.41 15.22 9.85 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.955 0.902 . . . . 73.150000000000006 111.405 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' TRP . . . . . 0.436 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 92.1 m95 -85.33 -0.45 54.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 73.239999999999995 111.24 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.88 49.81 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 119.212 -1.47 . . . . 65.409999999999997 109.873 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m 75.77 -60.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.547 1.139 . . . . 74.450000000000003 110.889 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.129999999999995 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.439999999999998 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.436 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.540000000000006 110.373 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.319999999999993 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.239999999999995 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.405 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.349999999999994 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.329999999999998 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.310000000000002 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.310000000000002 108.667 -178.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.430000000000007 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 75.010000000000005 107.498 -177.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.329999999999998 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.409999999999997 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.140000000000001 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.310000000000002 107.851 -175.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.140000000000001 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.584 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.230000000000004 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' O ' HG22 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.540000000000006 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.209999999999994 107.089 171.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 74.549999999999997 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.239999999999995 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.530000000000001 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.438 HG23 ' CZ ' ' A' ' 43' ' ' PHE . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.229999999999997 110.724 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.230000000000004 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.129999999999995 111.499 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.608 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.420000000000002 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . 0.442 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.519999999999996 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LEU . . . . . 0.443 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.340000000000003 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.140000000000001 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.409999999999997 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 72.400000000000006 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.519999999999996 111.496 -176.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.150000000000006 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.150000000000006 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 71.439999999999998 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.120000000000005 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' MET . . . . . 0.434 ' HE2' ' HA ' ' A' ' 117' ' ' SER . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.400000000000006 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.404 ' HD3' ' C ' ' A' ' 113' ' ' LYS . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.319999999999993 111.832 176.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 72.140000000000001 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.310000000000002 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' SER . . . . . 0.434 ' HA ' ' HE2' ' A' ' 112' ' ' MET . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.409999999999997 106.939 175.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' PHE . . . . . 0.516 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.230000000000004 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.516 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.129999999999995 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.420000000000002 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.239999999999995 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . 0.409 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 55.1 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.340000000000003 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' VAL . . . . . 0.442 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.530000000000001 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.310000000000002 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.140000000000001 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . 0.472 ' HB3' ' HZ1' ' A' ' 127' ' ' LYS . 7.1 mtpm? -72.06 148.58 91.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.340000000000003 109.798 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.29 110.1 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.484 2.123 . . . . 64.310000000000002 110.449 176.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.94 -53.65 0.8 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.025 -1.23 . . . . 65.109999999999999 110.025 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.99 -79.59 0.2 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.728 -0.748 . . . . 55.009999999999998 113.102 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.53 125.31 17.41 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.134 3.223 . . . . 73.420000000000002 114.078 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.95 175.67 49.24 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.548 -0.751 . . . . 52.310000000000002 112.462 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.409 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.420000000000002 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . 0.507 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.519999999999996 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 72.439999999999998 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.409999999999997 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 65.239999999999995 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.349999999999994 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.129999999999995 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TYR . . . . . 0.414 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.239999999999995 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 75.219999999999999 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.230000000000004 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.310000000000002 106.494 170.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.340000000000003 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 74.5 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.310000000000002 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 74.030000000000001 110.192 -179.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.329999999999998 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.319999999999993 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.439999999999998 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.010000000000005 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.409999999999997 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.129999999999995 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' LEU . . . . . 0.612 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 74.310000000000002 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.420000000000002 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.340000000000003 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . 0.612 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 73.109999999999999 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.230000000000004 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.240000000000002 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 73.140000000000001 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.556 ' O ' HG23 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 75.230000000000004 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.010000000000005 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.530000000000001 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.556 HG23 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.019999999999996 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASP . . . . . 0.434 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.430000000000007 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.099999999999994 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 74.450000000000003 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.319999999999993 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt -65.47 -43.98 88.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 74.409999999999997 110.116 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 50.69 -74.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.255 1.822 . . . . 74.319999999999993 114.538 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.35 171.35 13.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.977 -0.749 . . . . 75.450000000000003 108.977 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 106.747 -1.575 . . . . 72.519999999999996 106.747 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.310000000000002 115.341 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 74.430000000000007 108.462 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.140000000000001 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.439999999999998 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.509999999999998 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.140000000000001 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.239999999999995 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 70.310000000000002 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.150000000000006 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.209999999999994 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.420000000000002 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 42.219999999999999 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.200000000000003 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.409999999999997 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.099999999999994 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.540000000000006 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.439999999999998 108.769 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 61.409999999999997 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 72.010000000000005 111.488 -178.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 111.843 0.312 . . . . 73.129999999999995 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.120000000000005 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.210000000000001 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 43.439999999999998 110.662 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.349999999999994 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.409999999999997 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.129999999999995 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.549999999999997 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.129999999999995 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.329999999999998 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 61.210000000000001 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 34.439999999999998 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.120000000000005 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.230000000000004 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.129999999999995 108.132 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.100000000000001 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.439999999999998 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.420000000000002 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.319999999999993 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.200000000000003 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.310000000000002 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.340000000000003 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.230000000000004 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 61.439999999999998 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.409999999999997 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.010000000000005 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.209999999999994 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.219999999999999 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.150000000000006 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.150000000000006 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.319999999999993 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 32.210000000000001 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 72.450000000000003 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 64.450000000000003 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.019999999999996 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.040000000000006 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 62.439999999999998 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.450000000000003 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 73.25 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.310000000000002 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.340000000000003 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.456 HG22 HD11 ' A' ' 101' ' ' LEU . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.109999999999999 109.716 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.430000000000007 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.109999999999999 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.530000000000001 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 54.509999999999998 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.516 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm . . . . . 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 53.039999999999999 112.037 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.329999999999998 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 31' ' ' GLU . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 62.149999999999999 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.209999999999994 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.049999999999997 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.542 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.299999999999997 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.430000000000007 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 71.310000000000002 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.319999999999993 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.219999999999999 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.209999999999994 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 55.340000000000003 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.229999999999997 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.420000000000002 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 44.149999999999999 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.120000000000005 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.209999999999994 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.049999999999997 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 65.109999999999999 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.200000000000003 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.540000000000006 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 21.5 mm-40 -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 70.329999999999998 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.542 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.200000000000003 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.130000000000003 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.129999999999995 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.488 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.209999999999994 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.549999999999997 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.340000000000003 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.540000000000006 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.555 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.120000000000005 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.310000000000002 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 62.43 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.010000000000005 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 110.044 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 143' ' ' LYS 0.288 91.1 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.219999999999999 117.173 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.420000000000002 107.271 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.319999999999993 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.109999999999999 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 72.109999999999999 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' HD23 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.549999999999997 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 63.450000000000003 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.039999999999999 110.377 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.420000000000002 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.010000000000005 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.299999999999997 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 71.530000000000001 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.120000000000005 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.310000000000002 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.399999999999999 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.129999999999995 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.030000000000001 111.28 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 70.430000000000007 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.5 m170 . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 53.009999999999998 110.706 176.156 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.240000000000002 108.93 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.409999999999997 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.109999999999999 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 92' ' ' ILE . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 62.229999999999997 109.204 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.399999999999999 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 45.039999999999999 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.310000000000002 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.519999999999996 108.345 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.439999999999998 108.554 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 72.25 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.310000000000002 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.517 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 73.549999999999997 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.530000000000001 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.450000000000003 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.549999999999997 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.129999999999995 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.299999999999997 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.310000000000002 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' TRP . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.439999999999998 108.353 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 108' ' ' GLU . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.200000000000003 106.88 -174.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.519999999999996 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.510000000000005 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 73' ' ' SER . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.430000000000007 108.623 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.450000000000003 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.430000000000007 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.299999999999997 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.120000000000005 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 55.329999999999998 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.409999999999997 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.450000000000003 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.229999999999997 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.240000000000002 110.951 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.120000000000005 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.109999999999999 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.219999999999999 109.245 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.520000000000003 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' A' ' 89' ' ' LYS . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.120000000000005 112.884 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.120000000000005 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.019999999999996 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.049999999999997 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.329999999999998 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.200000000000003 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.209999999999994 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.130000000000003 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.230000000000004 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.150000000000006 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 71.209999999999994 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.219999999999999 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.310000000000002 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.230000000000004 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.130000000000003 113.83 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.129999999999995 110.668 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.276 0 CA-C-O 121.313 0.396 . . . . 25.109999999999999 112.758 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.310000000000002 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.409999999999997 110.385 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.109999999999999 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.519999999999996 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 74.450000000000003 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.310000000000002 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.439999999999998 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.409999999999997 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 53.420000000000002 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.230000000000004 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.150000000000006 111.509 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.329999999999998 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.409999999999997 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.329999999999998 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.140000000000001 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 61.200000000000003 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.240000000000002 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 73.430000000000007 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.319999999999993 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.310000000000002 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.319999999999993 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 44.210000000000001 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.229999999999997 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.329999999999998 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.451 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.530000000000001 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.409999999999997 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.310000000000002 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.340000000000003 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.219999999999999 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.219999999999999 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.129999999999995 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.430000000000007 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.420000000000002 111.277 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.994 1.109 . . . . 62.539999999999999 113.994 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.519999999999996 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.100000000000001 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.310000000000002 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.219999999999999 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.200000000000003 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.530000000000001 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 72.329999999999998 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.319999999999993 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.498 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.239999999999995 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' HD11 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.209999999999994 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.200000000000003 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.509999999999998 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.030000000000001 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 73.329999999999998 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.530000000000001 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.329999999999998 107.764 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 98' ' ' ASP . 41.5 t-80 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.420000000000002 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.8 m80 . . . . . 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 70.200000000000003 113.803 -179.331 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.387 -0.598 . . . . 63.329999999999998 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.219999999999999 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.430000000000007 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.239999999999995 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.149999999999999 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.310000000000002 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.329999999999998 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.109999999999999 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.340000000000003 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.120000000000005 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.019999999999996 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 70.430000000000007 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.409999999999997 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.310000000000002 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 34.409999999999997 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.439999999999998 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.409999999999997 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 33.219999999999999 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.030000000000001 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.120000000000005 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.140000000000001 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 73' ' ' SER . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.129999999999995 107.961 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.109999999999999 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.510000000000005 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.420000000000002 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.120000000000005 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.299999999999997 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASP . . . . . 0.414 ' HA ' ' NE2' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.239999999999995 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.340000000000003 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.430000000000007 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.42 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.030000000000001 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.409999999999997 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.010000000000005 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.552 HG11 ' HE1' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.109999999999999 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 108' ' ' GLU . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 64.450000000000003 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 71.129999999999995 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.530000000000001 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.469 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.299999999999997 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.310000000000002 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.552 ' HE1' HG11 ' A' ' 106' ' ' VAL . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 63.210000000000001 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.150000000000006 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.140000000000001 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.614 ' HG3' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.230000000000004 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.140000000000001 107.597 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 64.099999999999994 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.210000000000001 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 120' ' ' LEU . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.040000000000006 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.510000000000005 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.430000000000007 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.540000000000006 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.439999999999998 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.239999999999995 112.424 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.399999999999999 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.636 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.020000000000003 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 64.129999999999995 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 54.509999999999998 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.210000000000001 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.049999999999997 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.420000000000002 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.439999999999998 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.299999999999997 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.614 HG12 ' HG3' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.549999999999997 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.299999999999997 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.299999999999997 111.469 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.310000000000002 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.229999999999997 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.209999999999994 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.150000000000006 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.340000000000003 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 54.439999999999998 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 43.009999999999998 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.310000000000002 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.349999999999994 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.140000000000001 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 73.430000000000007 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.430000000000007 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.310000000000002 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 51.219999999999999 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.606 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.349999999999994 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.310000000000002 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 44.310000000000002 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.409999999999997 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.329999999999998 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.588 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.420000000000002 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 53.25 111.113 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.040000000000006 110.749 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 113.18 0.808 . . . . 75.430000000000007 113.18 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.310000000000002 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.439999999999998 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.129999999999995 110.404 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.319999999999993 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.329999999999998 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 34.109999999999999 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.409999999999997 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.530000000000001 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.140000000000001 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.420000000000002 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.430000000000007 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.150000000000006 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.219999999999999 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.409999999999997 106.953 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 63.009999999999998 113.954 -179.791 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.476 0.179 . . . . 64.310000000000002 110.739 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.420000000000002 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.349999999999994 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.530000000000001 111.347 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.319999999999993 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.140000000000001 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.439999999999998 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.420000000000002 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.329999999999998 108.748 176.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.140000000000001 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.150000000000006 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.549999999999997 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.200000000000003 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 34.240000000000002 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.230000000000004 108.97 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.119999999999997 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 62.509999999999998 107.432 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.349999999999994 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.049999999999997 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.409999999999997 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.409 ' CG2' HG23 ' A' ' 95' ' ' VAL . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.439999999999998 108.193 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.030000000000001 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.530000000000001 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.540000000000006 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.140000000000001 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.140000000000001 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.140000000000001 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.119999999999997 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.549999999999997 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 63.100000000000001 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.420000000000002 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.019999999999996 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.019999999999996 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.310000000000002 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.683 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.019999999999996 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 106' ' ' VAL . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.409999999999997 109.847 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.109999999999999 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.400000000000006 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.049999999999997 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.439999999999998 110.726 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 51.329999999999998 108.038 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.340000000000003 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.099999999999994 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.149999999999999 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.200000000000003 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.140000000000001 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.019999999999996 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.239999999999995 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.310000000000002 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.200000000000003 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.420000000000002 111.928 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.019999999999996 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.340000000000003 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.581 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 61.409999999999997 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.319999999999993 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 65.299999999999997 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.400000000000006 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.229999999999997 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.140000000000001 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.4 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 112.598 -172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.319999999999993 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.54 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 71.109999999999999 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 116' ' ' LYS . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.040000000000006 105.511 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.409999999999997 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.340000000000003 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 62.32 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.439999999999998 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 32.420000000000002 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.310000000000002 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HA ' HD12 ' A' ' 154' ' ' LEU . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.219999999999999 112.134 175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.120000000000005 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.510000000000005 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.299999999999997 110.235 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.200000000000003 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.349999999999994 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.109999999999999 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 52.030000000000001 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 52.119999999999997 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.329999999999998 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.109999999999999 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.120000000000005 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.329999999999998 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.120000000000005 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.439999999999998 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 44.119999999999997 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.657 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.400000000000006 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.349999999999994 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 51.329999999999998 110.505 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.430000000000007 115.799 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.420000000000002 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.030000000000001 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.140000000000001 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.109999999999999 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.340000000000003 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.430000000000007 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.009999999999998 109.519 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 53.420000000000002 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.239999999999995 113.24 178.25 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.219999999999999 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 43.310000000000002 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 61.219999999999999 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.420000000000002 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 55.020000000000003 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 12.5 m-70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 109.778 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.337 -0.616 . . . . 70.129999999999995 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 65.299999999999997 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.239999999999995 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.130000000000003 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.140000000000001 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 45.200000000000003 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.239999999999995 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' OD1' HG22 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.400000000000006 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.409999999999997 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 64.200000000000003 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.239999999999995 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.230000000000004 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.109999999999999 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.439999999999998 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.010000000000005 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 70.319999999999993 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 51.109999999999999 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.140000000000001 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.109999999999999 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 102' ' ' ILE . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.129999999999995 108.406 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.509999999999998 110.397 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.109999999999999 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.430000000000007 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.209999999999994 108.997 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.409999999999997 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.209999999999994 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.319999999999993 110.658 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.683 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.450000000000003 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.209999999999994 109.323 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 92' ' ' ILE . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 72.400000000000006 111.567 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.120000000000005 110.951 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 64.219999999999999 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 118' ' ' PHE . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.129999999999995 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.556 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.340000000000003 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.519999999999996 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 112' ' ' MET . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.420000000000002 113.933 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.349999999999994 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.230000000000004 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.219999999999999 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.329999999999998 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.540000000000006 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.409999999999997 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.543 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.010000000000005 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.150000000000006 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.543 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 63.329999999999998 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.329999999999998 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.683 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.540000000000006 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.140000000000001 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.399999999999999 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.519999999999996 110.899 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 111.777 -0.529 . . . . 74.299999999999997 111.777 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.409999999999997 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.200000000000003 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 44.32 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 77.0 m80 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.140000000000001 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 71.099999999999994 106.284 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.439999999999998 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.219999999999999 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.349999999999994 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.329999999999998 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.450000000000003 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 148' ' ' VAL . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.129999999999995 105.726 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.400000000000006 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.230000000000004 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.230000000000004 112.237 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.239999999999995 109.762 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.509999999999998 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 55.25 112.891 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 154' ' ' LEU . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.120000000000005 111.512 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.329999999999998 112.252 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.200000000000003 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 151' ' ' PRO . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.229999999999997 110.161 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.340000000000003 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.140000000000001 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 63.009999999999998 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.209999999999994 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.019999999999996 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.230000000000004 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.010000000000005 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.109999999999999 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.019999999999996 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 74.120000000000005 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.450000000000003 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 63.509999999999998 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.400000000000006 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.129999999999995 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 33' ' ' LYS . 87.6 mt . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.209999999999994 110.331 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 82.5 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 111.077 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.239999999999995 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.420000000000002 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.530000000000001 110.954 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.319999999999993 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.350000000000001 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.540000000000006 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.019999999999996 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.450000000000003 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.299999999999997 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.450000000000003 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.140000000000001 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 34.530000000000001 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.030000000000001 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.420000000000002 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 65.129999999999995 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 65.019999999999996 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.209999999999994 108.51 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.409999999999997 110.631 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.245 0.828 0 CA-C-O 120.476 0.179 . . . . 74.040000000000006 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.049999999999997 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.200000000000003 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.485 ' HB3' HD12 ' A' ' 92' ' ' ILE . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.109999999999999 110.664 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 61.539999999999999 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.340000000000003 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.400000000000006 111.591 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.442 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 74.0 m-20 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.200000000000003 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.319999999999993 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.040000000000006 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.439999999999998 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.310000000000002 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.020000000000003 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.430000000000007 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.299999999999997 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.310000000000002 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.420000000000002 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.439999999999998 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 73' ' ' SER . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 71.430000000000007 109.144 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.150000000000006 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.310000000000002 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.129999999999995 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.109999999999999 104.739 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.349999999999994 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.109999999999999 111.808 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.010000000000005 112.777 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.540000000000006 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.129999999999995 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.540000000000006 111.592 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 70.299999999999997 110.724 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.450000000000003 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.099999999999994 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.140000000000001 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.230000000000004 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.240000000000002 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.319999999999993 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.049999999999997 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 74.209999999999994 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.427 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.239999999999995 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.349999999999994 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.129999999999995 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.496 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.310000000000002 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' ILE . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.439999999999998 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.120000000000005 108.127 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 52.399999999999999 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.349999999999994 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 71.010000000000005 109.901 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 102' ' ' ILE . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.099999999999994 109.74 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.329999999999998 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.019999999999996 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.099999999999994 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.519999999999996 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.66 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.099999999999994 112.155 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 C--O 1.226 -0.346 0 N-CA-C 115.006 0.762 . . . . 73.140000000000001 115.006 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.040000000000006 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 64.340000000000003 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.310000000000002 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.340000000000003 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 72.230000000000004 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.400000000000006 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 154' ' ' LEU . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.109999999999999 110.345 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.310000000000002 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.299999999999997 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.219999999999999 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.439999999999998 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.239999999999995 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.510000000000005 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.239999999999995 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.019999999999996 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 62.200000000000003 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.430000000000007 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.219999999999999 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 73.120000000000005 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 139' ' ' LEU . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.219999999999999 112.512 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.129999999999995 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 64.530000000000001 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.010000000000005 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.240000000000002 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.299999999999997 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 43.350000000000001 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.240000000000002 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.530000000000001 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.349999999999994 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 62.119999999999997 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.049999999999997 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.200000000000003 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.310000000000002 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt . . . . . 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.130000000000003 110.297 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.461 0.088 0 N-CA-C 113.762 1.023 . . . . 73.209999999999994 113.762 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.129999999999995 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 35.340000000000003 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.009999999999998 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 63.420000000000002 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.030000000000001 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.150000000000006 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.420000000000002 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.409999999999997 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.120000000000005 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.439999999999998 113.288 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.030000000000001 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 60.530000000000001 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.040000000000006 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.539999999999999 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.200000000000003 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 72.219999999999999 109.221 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.140000000000001 113.053 -178.191 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 111.489 0.181 . . . . 75.219999999999999 111.489 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.109999999999999 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.119999999999997 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.140000000000001 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.409999999999997 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.010000000000005 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.019999999999996 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.439999999999998 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.030000000000001 107.842 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.420000000000002 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.400000000000006 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.549999999999997 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.439999999999998 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.439999999999998 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 51.119999999999997 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.229999999999997 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.299999999999997 110.259 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 44.109999999999999 108.979 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.129999999999995 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.030000000000001 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.319999999999993 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.109999999999999 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.340000000000003 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.049999999999997 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.409999999999997 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.209999999999994 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.530000000000001 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.350000000000001 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 74.530000000000001 112.554 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.230000000000004 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 41.350000000000001 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.150000000000006 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.340000000000003 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.450000000000003 108.723 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 119' ' ' LEU . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.430000000000007 106.487 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 72.040000000000006 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.420000000000002 111.481 -176.738 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.230000000000004 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.439999999999998 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.420000000000002 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.401 ' HE2' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.540000000000006 109.793 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.099999999999994 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.129999999999995 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.530000000000001 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.340000000000003 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 72.030000000000001 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.540000000000006 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' HG2' ' A' ' 105' ' ' ARG . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.509999999999998 110.484 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.239999999999995 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.200000000000003 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.229999999999997 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.450000000000003 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.439999999999998 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 63.030000000000001 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.109999999999999 109.147 178.278 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.310000000000002 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.340000000000003 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.109999999999999 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.299999999999997 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 72.230000000000004 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 73.25 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.200000000000003 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 52.450000000000003 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.478 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.140000000000001 113.211 -171.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.239999999999995 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.655 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.420000000000002 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.420000000000002 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.655 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.200000000000003 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.200000000000003 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.430000000000007 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.119999999999997 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' A' ' 154' ' ' LEU . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 60.310000000000002 114.309 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 55.299999999999997 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 51.210000000000001 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.495 ' H ' HD22 ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 65.25 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.540000000000006 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 63.409999999999997 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.239999999999995 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.129999999999995 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 165' ' ' ILE . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 64.329999999999998 110.647 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.540000000000006 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.439999999999998 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.210000000000001 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.409999999999997 111.565 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.549 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.439999999999998 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.319999999999993 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 53.130000000000003 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 34' ' ' ALA . 90.6 mt . . . . . 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.400000000000006 110.747 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 64.510000000000005 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.25 109.862 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.240000000000002 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.349999999999994 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.109999999999999 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.519999999999996 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.030000000000001 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.430000000000007 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.119999999999997 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.430000000000007 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.140000000000001 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.530000000000001 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 41.310000000000002 112.045 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.439999999999998 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.200000000000003 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.140000000000001 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 72.209999999999994 113.564 175.749 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 120.615 0.245 . . . . 73.230000000000004 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.540000000000006 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.049999999999997 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.240000000000002 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.319999999999993 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.010000000000005 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 61.200000000000003 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.340000000000003 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.349999999999994 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 54.340000000000003 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.140000000000001 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.498 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.510000000000005 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.450000000000003 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.030000000000001 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.049999999999997 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.430000000000007 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.109999999999999 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 62.43 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.530000000000001 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.519 ' H ' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.219999999999999 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 105' ' ' ARG . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.129999999999995 107.931 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.450000000000003 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.329999999999998 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.120000000000005 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.540000000000006 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.140000000000001 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.140000000000001 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.430000000000007 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.400000000000006 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 51.229999999999997 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.040000000000006 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 73.349999999999994 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 91' ' ' ARG . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 62.149999999999999 110.767 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.402 HG11 ' HE1' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 64.239999999999995 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.219999999999999 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.530000000000001 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.019999999999996 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.010000000000005 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.239999999999995 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.129999999999995 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.519999999999996 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.209999999999994 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.539999999999999 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.310000000000002 106.592 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.210000000000001 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.515 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.230000000000004 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 61.25 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.349999999999994 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.439999999999998 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 61.240000000000002 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 63.420000000000002 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.400000000000006 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.009999999999998 111.461 -179.294 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 111.634 -0.586 . . . . 52.210000000000001 111.634 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.239999999999995 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.319999999999993 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.310000000000002 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.219999999999999 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 64.310000000000002 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 61.43 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.229999999999997 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.239999999999995 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.219999999999999 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.540000000000006 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.430000000000007 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.209999999999994 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.519999999999996 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.140000000000001 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.400000000000006 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.219999999999999 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 52.409999999999997 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 53.299999999999997 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.140000000000001 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.129999999999995 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.010000000000005 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.540000000000006 110.965 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.209999999999994 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 62.049999999999997 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.319999999999993 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.140000000000001 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.329999999999998 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 63.25 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.505 ' CB ' HG11 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 43.299999999999997 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.230000000000004 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.219999999999999 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.519999999999996 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.319999999999993 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.209999999999994 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 62.530000000000001 109.349 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.310000000000002 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.340000000000003 110.167 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.045 . . . . 72.409999999999997 113.823 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.140000000000001 106.918 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.040000000000006 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.109999999999999 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.219999999999999 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.540000000000006 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 61.009999999999998 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.400000000000006 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.319999999999993 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 62.009999999999998 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.020000000000003 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.239999999999995 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 65.209999999999994 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.119999999999997 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.549999999999997 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' NZ ' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.219999999999999 108.452 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 64.230000000000004 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.8 m80 . . . . . 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.200000000000003 114.347 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.817 0.303 . . . . 54.329999999999998 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.140000000000001 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.400000000000006 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.219999999999999 109.001 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.409999999999997 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.319999999999993 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 71.409999999999997 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.349999999999994 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.349999999999994 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.319999999999993 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.540000000000006 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.340000000000003 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.329999999999998 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.519999999999996 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 64.540000000000006 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 50.030000000000001 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 64.049999999999997 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.130000000000003 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.400000000000006 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.209999999999994 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.239999999999995 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.129999999999995 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.219999999999999 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.230000000000004 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.439999999999998 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.210000000000001 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.019999999999996 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.319999999999993 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.510000000000005 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.219999999999999 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' HD21 ' A' ' 119' ' ' LEU . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 52.329999999999998 110.543 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.439999999999998 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.010000000000005 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.530000000000001 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.039999999999999 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.400000000000006 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.129999999999995 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.010000000000005 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.450000000000003 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.129999999999995 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.329999999999998 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.495 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.430000000000007 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 103' ' ' THR . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 120' ' ' LEU . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.329999999999998 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.310000000000002 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.030000000000001 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.109999999999999 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 62.020000000000003 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.040000000000006 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.2 tttm . . . . . 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.230000000000004 111.309 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 111.099 -0.8 . . . . 73.409999999999997 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.030000000000001 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.534 HG13 ' HD3' ' A' ' 127' ' ' LYS . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.019999999999996 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 54.439999999999998 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.219999999999999 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.239999999999995 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.540000000000006 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.229999999999997 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.523 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 72.439999999999998 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.519999999999996 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 72.219999999999999 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.523 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.439999999999998 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 64.239999999999995 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.020000000000003 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.239999999999995 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.239999999999995 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.109999999999999 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' THR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 156' ' ' GLN . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.209999999999994 111.192 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.827 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.530000000000001 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 1.1 pp0? -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.150000000000006 112.004 176.816 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.349999999999994 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.439999999999998 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.010000000000005 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.509999999999998 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.310000000000002 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.009999999999998 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.409999999999997 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.340000000000003 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.230000000000004 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.409999999999997 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.239999999999995 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 54.200000000000003 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.039999999999999 109.311 178.47 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.278 0.561 . . . . 64.299999999999997 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 71.510000000000005 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.030000000000001 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.120000000000005 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.239999999999995 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.200000000000003 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.109999999999999 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.329999999999998 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.030000000000001 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.409999999999997 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.230000000000004 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.310000000000002 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.140000000000001 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.042 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.119999999999997 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.329999999999998 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.310000000000002 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.400000000000006 109.812 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.3 m80 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 64.450000000000003 113.51 -177.475 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 110.397 -0.223 . . . . 51.119999999999997 110.397 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 95' ' ' VAL . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.310000000000002 108.67 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.040000000000006 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.219999999999999 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.409999999999997 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.530000000000001 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.140000000000001 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.140000000000001 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 62.450000000000003 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 72.400000000000006 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.409999999999997 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.409999999999997 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.310000000000002 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 63.219999999999999 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.530000000000001 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.109999999999999 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.340000000000003 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.329999999999998 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.329999999999998 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.239999999999995 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.539999999999999 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 51.119999999999997 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.420000000000002 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.340000000000003 111.465 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.549999999999997 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.329999999999998 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.519999999999996 111.848 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.627 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.340000000000003 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.239999999999995 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.329999999999998 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.129999999999995 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.049999999999997 109.735 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 64.109999999999999 110.072 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.329999999999998 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 71.540000000000006 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.409999999999997 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.439999999999998 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.577 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.299999999999997 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.530000000000001 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.439999999999998 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.540000000000006 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 64.25 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 74.420000000000002 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.349999999999994 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.109999999999999 108.712 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.510000000000005 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.230000000000004 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.130000000000003 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.209999999999994 109.074 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.310000000000002 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.240000000000002 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.209999999999994 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.200000000000003 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 62.299999999999997 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' CD ' HG13 ' A' ' 134' ' ' ILE . 86.6 tttt . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.109999999999999 111.754 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.420000000000002 109.254 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.505 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.140000000000001 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.229999999999997 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.239999999999995 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 73.25 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 63.299999999999997 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.349999999999994 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.530000000000001 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.510000000000005 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.209999999999994 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.478 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 72.129999999999995 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 65.510000000000005 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.310000000000002 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.329999999999998 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.430000000000007 110.791 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.530000000000001 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.400000000000006 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.219999999999999 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 61.210000000000001 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.219999999999999 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 74.319999999999993 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.140000000000001 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.420000000000002 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 156' ' ' GLN . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 73.010000000000005 111.967 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.299999999999997 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 52.200000000000003 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 71.239999999999995 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.439999999999998 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 73.5 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.140000000000001 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.439999999999998 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 55.43 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.420000000000002 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 110.691 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.132 0.79 . . . . 74.230000000000004 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.120000000000005 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.120000000000005 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.219999999999999 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.400000000000006 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.219999999999999 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.219999999999999 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.299999999999997 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.109999999999999 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 41.32 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 63.43 111.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.329999999999998 108.345 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.450000000000003 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.530000000000001 110.535 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 62.539999999999999 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.140000000000001 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 55.439999999999998 110.909 176.855 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.507 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m . . . . . 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 53.420000000000002 110.699 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 63.030000000000001 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.340000000000003 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.120000000000005 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.310000000000002 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.519999999999996 110.378 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 60.229999999999997 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.039999999999999 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.7 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.219999999999999 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 34.109999999999999 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.430000000000007 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.129999999999995 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.420000000000002 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.140000000000001 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.510000000000005 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.140000000000001 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.039999999999999 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.510000000000005 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.329999999999998 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.310000000000002 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.329999999999998 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.240000000000002 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.140000000000001 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 73.109999999999999 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.150000000000006 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 61.299999999999997 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.340000000000003 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.420000000000002 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.712 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.400000000000006 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.240000000000002 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.109999999999999 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 54.149999999999999 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 64.340000000000003 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.299999999999997 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.319999999999993 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.409999999999997 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.329999999999998 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.109999999999999 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.510000000000005 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.200000000000003 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.319999999999993 112.073 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.350000000000001 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 72.540000000000006 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.530000000000001 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 64.230000000000004 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.568 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.239999999999995 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 64.540000000000006 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 45.240000000000002 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 60.149999999999999 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.219999999999999 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 36' ' ' ALA . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 70.109999999999999 108.467 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.439999999999998 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.099999999999994 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.409999999999997 109.035 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.140000000000001 111.413 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 51.409999999999997 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.239999999999995 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.340000000000003 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.400000000000006 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.219999999999999 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 71.420000000000002 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.210000000000001 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 71.299999999999997 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.439999999999998 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.200000000000003 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.209999999999994 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.340000000000003 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.329999999999998 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.209999999999994 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 54.149999999999999 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.430000000000007 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.340000000000003 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 72.439999999999998 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.329999999999998 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.510000000000005 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 64.140000000000001 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 50.329999999999998 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 54.240000000000002 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.519999999999996 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 62.030000000000001 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.430000000000007 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.530000000000001 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.099999999999994 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 55.25 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.517 ' CB ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.109999999999999 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.109999999999999 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.239999999999995 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.409999999999997 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.319999999999993 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.109999999999999 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 53.5 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 33' ' ' LYS . 85.3 mt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.603 0.594 . . . . 61.32 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 63.229999999999997 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.099999999999994 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.450000000000003 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.129999999999995 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 51.509999999999998 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 53.25 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.140000000000001 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.310000000000002 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.340000000000003 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.239999999999995 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 61.020000000000003 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.219999999999999 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 54.420000000000002 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.319999999999993 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 72.200000000000003 112.396 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.109999999999999 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.299999999999997 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.7 m80 . . . . . 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.120000000000005 111.277 177.656 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.916 0.339 . . . . 72.299999999999997 111.916 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.030000000000001 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.329999999999998 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 61.43 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 61.109999999999999 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.120000000000005 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.450000000000003 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.439999999999998 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.200000000000003 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 63.439999999999998 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.140000000000001 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.539999999999999 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.219999999999999 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.239999999999995 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.129999999999995 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.319999999999993 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.400000000000006 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.299999999999997 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.219999999999999 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.399999999999999 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.030000000000001 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 70.439999999999998 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.319999999999993 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 60.240000000000002 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.510000000000005 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.150000000000006 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.420000000000002 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.109999999999999 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.049999999999997 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.438 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.319999999999993 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 65.019999999999996 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.120000000000005 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 55.240000000000002 110.609 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.349999999999994 108.54 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 53.409999999999997 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 72.230000000000004 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 65.010000000000005 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.219999999999999 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.430000000000007 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.120000000000005 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.109999999999999 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.438 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.230000000000004 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.540000000000006 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.400000000000006 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.120000000000005 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.329999999999998 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 64.200000000000003 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.581 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.310000000000002 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 65.040000000000006 109.991 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.340000000000003 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.420000000000002 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 51.119999999999997 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.409999999999997 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.520000000000003 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.427 ' CD ' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.230000000000004 110.556 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.021 0 CA-C-O 120.771 0.095 . . . . 63.219999999999999 112.973 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 41.340000000000003 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 64.310000000000002 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.400000000000006 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 63.409999999999997 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.230000000000004 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 73.329999999999998 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.150000000000006 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.530000000000001 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 63.43 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.439999999999998 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 62.409999999999997 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.340000000000003 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.129999999999995 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.329999999999998 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.329999999999998 111.053 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.219999999999999 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 52.420000000000002 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.530000000000001 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 64.25 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.010000000000005 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 61.5 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.299999999999997 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 62.030000000000001 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.219999999999999 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.439999999999998 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.310000000000002 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 61.240000000000002 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.603 ' O ' HD13 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.329999999999998 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.319999999999993 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.400000000000006 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.209999999999994 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.239999999999995 110.828 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 53.219999999999999 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.510000000000005 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.100000000000001 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.340000000000003 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 53.149999999999999 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.219999999999999 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.019999999999996 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 42.210000000000001 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.400000000000006 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 73.439999999999998 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.430000000000007 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.400000000000006 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 63.130000000000003 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.430000000000007 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.420000000000002 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 44.420000000000002 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.439999999999998 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 . . . . . 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.209999999999994 110.257 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 111.34 0.126 . . . . 60.549999999999997 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.399999999999999 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.219999999999999 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.509999999999998 111.962 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.019999999999996 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 64.329999999999998 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.525 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.239999999999995 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.530000000000001 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 63.200000000000003 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 53.219999999999999 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.408 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.540000000000006 108.383 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.420000000000002 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.200000000000003 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.329999999999998 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.109999999999999 108.446 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.519999999999996 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.329999999999998 108.187 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.510000000000005 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.219999999999999 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.450000000000003 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.040000000000006 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.329999999999998 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.409999999999997 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.450000000000003 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 62.409999999999997 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.100000000000001 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.409999999999997 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.230000000000004 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.340000000000003 111.205 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 71.5 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.409999999999997 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.430000000000007 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 63.140000000000001 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.510000000000005 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.409999999999997 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.74 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.430000000000007 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.540000000000006 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.109999999999999 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.130000000000003 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.019999999999996 110.988 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.019999999999996 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.299999999999997 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.42 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.030000000000001 108.919 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.596 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.140000000000001 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 71.420000000000002 107.563 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 154' ' ' LEU . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.641 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 71.120000000000005 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.129999999999995 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 41.119999999999997 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.109999999999999 108.581 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 55.409999999999997 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.150000000000006 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 52.409999999999997 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.459 ' HD3' HG13 ' A' ' 134' ' ' ILE . 86.2 tttt . . . . . 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.039999999999999 109.358 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 51.549999999999997 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 62.030000000000001 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.109999999999999 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 54.329999999999998 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.310000000000002 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.219999999999999 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.429 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.109999999999999 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.329999999999998 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.329999999999998 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.010000000000005 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.219999999999999 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.596 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.530000000000001 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.219999999999999 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.219999999999999 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.150000000000006 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 144' ' ' ILE . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.340000000000003 110.174 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.230000000000004 109.844 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 62.420000000000002 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.519999999999996 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 62.439999999999998 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.230000000000004 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.430000000000007 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.509999999999998 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.400000000000006 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.429 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.340000000000003 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.099999999999994 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.140000000000001 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.219999999999999 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 61.310000000000002 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.329999999999998 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.429 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.420000000000002 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.140000000000001 110.486 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.140000000000001 109.279 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.319999999999993 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.400000000000006 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt . . . . . 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.120000000000005 111.637 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 115.201 1.556 . . . . 71.319999999999993 115.201 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.200000000000003 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.400000000000006 112.887 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.239999999999995 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.409999999999997 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.319999999999993 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.200000000000003 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG11 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.439999999999998 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.200000000000003 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 71.310000000000002 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' HD11 ' A' ' 170' ' ' LEU . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.450000000000003 109.699 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.240000000000002 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.150000000000006 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.239999999999995 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.510000000000005 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 54.520000000000003 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.319999999999993 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.3 m80 . . . . . 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 74.299999999999997 111.229 -174.12 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.858 0.361 . . . . 72.340000000000003 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.129999999999995 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.129999999999995 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.420000000000002 109.955 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.219999999999999 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.009999999999998 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 89' ' ' LYS . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 70.140000000000001 108.468 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 62.310000000000002 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.519999999999996 109.987 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.340000000000003 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.239999999999995 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.019999999999996 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.129999999999995 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.129999999999995 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.439999999999998 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.310000000000002 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.210000000000001 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.429 ' HA ' ' HD1' ' A' ' 76' ' ' PHE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.129999999999995 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.319999999999993 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 73' ' ' SER . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.530000000000001 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' ILE . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 53.119999999999997 109.3 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.520000000000003 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.319999999999993 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.439999999999998 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.540000000000006 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.299999999999997 112.362 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.209999999999994 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD11 ' CG2' ' A' ' 121' ' ' THR . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.040000000000006 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.219999999999999 111.941 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.319999999999993 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.010000000000005 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.200000000000003 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 44.140000000000001 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.450000000000003 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.030000000000001 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.310000000000002 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.230000000000004 112.006 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 61.109999999999999 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.109999999999999 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 74.439999999999998 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' HG12 ' A' ' 144' ' ' ILE . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.520000000000003 111.105 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.420000000000002 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 71.340000000000003 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 65.209999999999994 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.329999999999998 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 62.130000000000003 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.310000000000002 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.310000000000002 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.549999999999997 114.094 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.509999999999998 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.0 tttt . . . . . 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.120000000000005 112.156 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.229999999999997 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.219999999999999 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.545 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 34.340000000000003 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.509999999999998 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 54.32 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.299999999999997 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.140000000000001 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 137' ' ' TRP . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.109999999999999 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.409999999999997 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.450000000000003 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.629 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.450000000000003 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 116' ' ' LYS . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 65.439999999999998 107.193 170.817 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 61.210000000000001 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.299999999999997 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.400000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.629 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.510000000000005 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.150000000000006 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.612 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.230000000000004 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.319999999999993 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.240000000000002 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.450000000000003 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.409999999999997 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 71.239999999999995 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.405 ' SG ' HD21 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 62.450000000000003 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 60.439999999999998 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.329999999999998 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 23.329999999999998 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.439999999999998 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.230000000000004 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.219999999999999 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.430000000000007 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.530000000000001 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.230000000000004 110.434 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 121.279 0.562 . . . . 62.109999999999999 112.307 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.210000000000001 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.530000000000001 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.149999999999999 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.329999999999998 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.319999999999993 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.239999999999995 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.349999999999994 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.299999999999997 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.557 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.140000000000001 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.120000000000005 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 73.349999999999994 111.92 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.349999999999994 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.350000000000001 111.022 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.209999999999994 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.25 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 57.4 t60 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.439999999999998 111.812 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.430000000000007 111.987 -177.651 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.432 0.158 . . . . 72.439999999999998 110.91 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.229999999999997 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 92' ' ' ILE . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.219999999999999 110.803 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.299999999999997 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.310000000000002 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 62.299999999999997 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 73.219999999999999 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.329999999999998 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.140000000000001 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 71.129999999999995 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.509999999999998 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.399999999999999 110.737 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.219999999999999 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 109.9 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HB3' HD11 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 70.340000000000003 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.019999999999996 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.530000000000001 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.496 HG22 HG23 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.510000000000005 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.130000000000003 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.430000000000007 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.439999999999998 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 71.129999999999995 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 60.200000000000003 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.140000000000001 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 122' ' ' ILE . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 45.32 110.811 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 65.519999999999996 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.120000000000005 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.230000000000004 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 65.340000000000003 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.310000000000002 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.130000000000003 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.120000000000005 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.540000000000006 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.520000000000003 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.540000000000006 111.443 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.109999999999999 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.140000000000001 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.129999999999995 105.653 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.219999999999999 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.430000000000007 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.310000000000002 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 63.149999999999999 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.439999999999998 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 102' ' ' ILE . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.109999999999999 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.030000000000001 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.340000000000003 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.319999999999993 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.400000000000006 112.842 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.319999999999993 111.121 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 65.439999999999998 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.329999999999998 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 65.409999999999997 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 77.0 m80 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 60.549999999999997 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.340000000000003 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.099999999999994 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 55.43 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.409999999999997 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.040000000000006 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.329999999999998 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.349999999999994 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.439 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.209999999999994 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.350000000000001 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.349999999999994 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 61.009999999999998 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.585 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.210000000000001 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.200000000000003 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.349999999999994 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 152' ' ' GLU . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 72.230000000000004 108.887 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.140000000000001 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.474 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.349999999999994 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 44.549999999999997 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 86.6 mm-40 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 71.099999999999994 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 50.009999999999998 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.140000000000001 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 155' ' ' LEU . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 63.240000000000002 111.5 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.540000000000006 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 64.519999999999996 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.010000000000005 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.030000000000001 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.200000000000003 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.150000000000006 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.557 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.009999999999998 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 55.43 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt . . . . . 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.409999999999997 110.996 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 51.399999999999999 114.796 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.540000000000006 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.229999999999997 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.039999999999999 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 155' ' ' LEU . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 63.32 108.564 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.340000000000003 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.109999999999999 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.230000000000004 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.310000000000002 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.209999999999994 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.219999999999999 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.420000000000002 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 54.32 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.229999999999997 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.140000000000001 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.129999999999995 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.540000000000006 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 45.130000000000003 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 . . . . . 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.310000000000002 113.831 -177.445 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.161 -1.052 . . . . 73.150000000000006 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG23 HG22 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.109999999999999 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.549999999999997 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.518 ' HB3' HD12 ' A' ' 92' ' ' ILE . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.340000000000003 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.420000000000002 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.540000000000006 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.585 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 72.030000000000001 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.329999999999998 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.109999999999999 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.340000000000003 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.510000000000005 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.239999999999995 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.340000000000003 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.200000000000003 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.209999999999994 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 74.319999999999993 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 53.340000000000003 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.219999999999999 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.239999999999995 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.030000000000001 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.340000000000003 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.299999999999997 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 71' ' ' VAL . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.400000000000006 109.893 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.656 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.420000000000002 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.109999999999999 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.656 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.319999999999993 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.420000000000002 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.310000000000002 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.310000000000002 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.329999999999998 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.420000000000002 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.209999999999994 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.299999999999997 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.656 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.099999999999994 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 89' ' ' LYS 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 70.430000000000007 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.430000000000007 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.463 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.049999999999997 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 55.5 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.520000000000003 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.329999999999998 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 64.239999999999995 108.901 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.605 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 65.319999999999993 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.209999999999994 106.449 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 64.420000000000002 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.129999999999995 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.209999999999994 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 65.239999999999995 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 62.240000000000002 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 10.1 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.549999999999997 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.209999999999994 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.467 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 64.450000000000003 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.219999999999999 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.579 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt . . . . . 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.310000000000002 111.458 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.040000000000006 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 53.25 110.913 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.579 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.239999999999995 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 30' ' ' VAL . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.129999999999995 108.639 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.129999999999995 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.329999999999998 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.450000000000003 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.129999999999995 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.230000000000004 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.120000000000005 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.420000000000002 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.229999999999997 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.605 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 60.130000000000003 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.200000000000003 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 53.020000000000003 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 73.540000000000006 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.130000000000003 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.319999999999993 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.129999999999995 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.109999999999999 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.439999999999998 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 42.100000000000001 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 64.510000000000005 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 60.049999999999997 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 61.130000000000003 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.420000000000002 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.439999999999998 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 65.519999999999996 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.537 ' CB ' HG11 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 51.240000000000002 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.239999999999995 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 65.319999999999993 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.319999999999993 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.411 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.400000000000006 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.040000000000006 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.525 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.319999999999993 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.230000000000004 110.636 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 111.925 0.343 . . . . 75.329999999999998 111.925 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 51.299999999999997 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.340000000000003 109.745 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.120000000000005 110.5 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 62.340000000000003 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.420000000000002 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.129999999999995 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.420000000000002 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.219999999999999 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.430000000000007 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.319999999999993 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 109.776 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD2' ' CE1' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.109999999999999 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.019999999999996 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.109999999999999 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.049999999999997 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' HIS . . . . . 0.427 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 33.2 m80 . . . . . 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 110.977 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 110.607 -0.146 . . . . 74.150000000000006 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.120000000000005 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.109999999999999 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB3' HD12 ' A' ' 92' ' ' ILE . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.420000000000002 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.229999999999997 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.430000000000007 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.239999999999995 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.329999999999998 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.329999999999998 109.383 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.519999999999996 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 42.329999999999998 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.519999999999996 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.140000000000001 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.209999999999994 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.120000000000005 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.439999999999998 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 52.219999999999999 109.256 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.450000000000003 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.109999999999999 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 62.409999999999997 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.430000000000007 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.310000000000002 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 73.349999999999994 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.230000000000004 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.310000000000002 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.209999999999994 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.439999999999998 111.117 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.576 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 2.2 t-20 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.239999999999995 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.239999999999995 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.439999999999998 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.400000000000006 110.383 177.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.319999999999993 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.140000000000001 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 72.349999999999994 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.130000000000003 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.230000000000004 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.240000000000002 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.519999999999996 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.109999999999999 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.530000000000001 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.129999999999995 107.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 73.010000000000005 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.209999999999994 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.219999999999999 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.530000000000001 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 102' ' ' ILE . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.200000000000003 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.510000000000005 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 72.549999999999997 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.510000000000005 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.329999999999998 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.230000000000004 109.963 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.099999999999994 109.954 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.530000000000001 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.209999999999994 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.230000000000004 108.971 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.517 ' HA ' HG22 ' A' ' 122' ' ' ILE . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.200000000000003 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.120000000000005 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 72.329999999999998 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.400000000000006 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 71.430000000000007 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.409999999999997 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.420000000000002 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.254 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.109999999999999 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.310000000000002 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.439999999999998 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 72.219999999999999 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.019999999999996 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.540000000000006 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 60.130000000000003 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.109999999999999 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.540000000000006 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 73.430000000000007 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 155' ' ' LEU . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 72.209999999999994 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.519999999999996 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.433 ' CB ' HG11 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.340000000000003 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.319999999999993 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.530000000000001 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.530000000000001 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.209999999999994 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.229999999999997 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.420000000000002 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 73.540000000000006 110.273 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt . . . . . 0 C--O 1.237 0.427 0 N-CA-C 112.777 0.658 . . . . 75.540000000000006 112.777 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.310000000000002 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 21.399999999999999 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.310000000000002 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.409999999999997 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.209999999999994 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 134' ' ' ILE . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.140000000000001 109.623 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.340000000000003 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 34' ' ' ALA . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 61.240000000000002 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 32' ' ' ILE . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 45.130000000000003 112.0 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.430000000000007 109.517 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 110.226 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 73.129999999999995 110.148 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 169' ' ' LEU . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.239999999999995 108.533 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.319999999999993 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 36.3 m80 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.499 0.19 . . . . 72.430000000000007 110.856 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.450000000000003 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.310000000000002 110.83 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 60.340000000000003 109.883 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 71.129999999999995 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.340000000000003 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.430000000000007 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.140000000000001 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.519999999999996 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 71.239999999999995 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.010000000000005 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.340000000000003 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.149999999999999 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.097 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 60.420000000000002 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 109.816 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.409999999999997 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 62.420000000000002 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.239999999999995 105.624 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.329999999999998 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.409999999999997 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.040000000000006 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.329999999999998 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.030000000000001 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.628 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.420000000000002 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.239999999999995 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.420000000000002 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.430000000000007 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.129999999999995 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.120000000000005 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.439999999999998 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.450000000000003 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.728 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.430000000000007 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.509999999999998 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.329999999999998 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.678 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 70.299999999999997 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.439999999999998 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.420000000000002 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 71.25 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB3' HG12 ' A' ' 144' ' ' ILE . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.420000000000002 110.399 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.119999999999997 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.209999999999994 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.409999999999997 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.200000000000003 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.219999999999999 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.040000000000006 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 65.310000000000002 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.319999999999993 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.010000000000005 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.400000000000006 110.158 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.150000000000006 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.409999999999997 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 29' ' ' ASP . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.530000000000001 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 62.240000000000002 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 76.6 m80 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.439999999999998 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 63.539999999999999 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.239999999999995 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.530000000000001 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 63.32 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.130000000000003 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.420000000000002 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.129999999999995 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.239999999999995 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.109999999999999 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.519999999999996 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.579 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 71.439999999999998 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 65.349999999999994 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.519999999999996 112.038 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 72.549999999999997 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.439999999999998 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.409999999999997 109.569 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.510000000000005 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.399999999999999 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.530000000000001 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.420000000000002 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.150000000000006 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.019999999999996 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 61.219999999999999 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 70.349999999999994 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.239999999999995 109.482 -176.891 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.099999999999994 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.219999999999999 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.329999999999998 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 39' ' ' PHE . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 111.623 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 50.020000000000003 110.203 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 112.737 0.643 . . . . 53.219999999999999 112.737 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 61.240000000000002 108.082 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.219999999999999 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.430000000000007 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.340000000000003 107.177 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.530000000000001 108.303 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.519999999999996 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 62.140000000000001 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.510000000000005 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.299999999999997 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.200000000000003 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.430000000000007 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.612 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.540000000000006 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.340000000000003 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.219999999999999 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.150000000000006 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HA ' HD22 ' A' ' 169' ' ' LEU . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.329999999999998 110.699 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.120000000000005 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 111.984 -174.446 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.731 -0.47 . . . . 74.549999999999997 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 73.030000000000001 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.109999999999999 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.200000000000003 110.882 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.510000000000005 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.219999999999999 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 71.140000000000001 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.349999999999994 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 63.210000000000001 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.530000000000001 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 73.109999999999999 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.329999999999998 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.430000000000007 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.010000000000005 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.230000000000004 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.409999999999997 109.353 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.510000000000005 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.219999999999999 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.209999999999994 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 60.020000000000003 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.299999999999997 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 35.130000000000003 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.439999999999998 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.010000000000005 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 65.299999999999997 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 62.340000000000003 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.219999999999999 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.049999999999997 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.239999999999995 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.450000000000003 109.561 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.040000000000006 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 111' ' ' LEU . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.420000000000002 114.056 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.019999999999996 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 33.409999999999997 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.340000000000003 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.219999999999999 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 64.319999999999993 110.548 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.540000000000006 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.349999999999994 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TYR . . . . . 0.476 ' CE2' HD21 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.439999999999998 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 63.329999999999998 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.120000000000005 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.019999999999996 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.604 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.109999999999999 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.149999999999999 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.010000000000005 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 54.020000000000003 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 35.450000000000003 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.010000000000005 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.420000000000002 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 134' ' ' ILE . 22.4 ptmt . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 70.230000000000004 109.198 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.519999999999996 111.275 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.030000000000001 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 127' ' ' LYS . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 61.109999999999999 109.763 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.430000000000007 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.319999999999993 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.404 ' HH2' ' HB ' ' A' ' 161' ' ' VAL . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.239999999999995 109.716 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.439999999999998 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.230000000000004 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.140000000000001 114.197 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.219999999999999 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.230000000000004 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.439999999999998 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.219999999999999 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.140000000000001 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.420000000000002 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.310000000000002 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.109999999999999 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.420000000000002 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.420000000000002 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.219999999999999 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 118' ' ' PHE . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.229999999999997 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.409999999999997 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.439999999999998 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.516 ' SG ' HD21 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 20.239999999999998 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.400000000000006 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HB ' ' HH2' ' A' ' 137' ' ' TRP . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.319999999999993 110.477 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 51.149999999999999 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.340000000000003 111.933 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.420000000000002 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.319999999999993 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.493 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.420000000000002 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 62.409999999999997 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.540000000000006 110.372 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 112.612 0.597 . . . . 74.400000000000006 112.612 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.540000000000006 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.549999999999997 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.140000000000001 110.568 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 63.310000000000002 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 64.150000000000006 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 52.109999999999999 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.129999999999995 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 34.329999999999998 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.230000000000004 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.439 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.329999999999998 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 72.519999999999996 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.010000000000005 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.299999999999997 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.340000000000003 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.310000000000002 111.412 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.109999999999999 112.703 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.319999999999993 110.638 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 75.1 m80 . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 73.140000000000001 112.679 178.993 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.453 0.168 . . . . 74.450000000000003 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.129999999999995 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.439999999999998 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.540000000000006 110.373 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.319999999999993 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.239999999999995 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.349999999999994 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.329999999999998 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.310000000000002 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.310000000000002 108.667 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.430000000000007 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.403 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 74.400000000000006 107.498 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.329999999999998 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.409999999999997 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.140000000000001 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 79' ' ' TYR . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.310000000000002 107.851 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.140000000000001 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.230000000000004 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.540000000000006 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 91' ' ' ARG . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.209999999999994 107.089 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 44.420000000000002 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.239999999999995 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.530000000000001 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.229999999999997 110.724 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.230000000000004 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.129999999999995 111.499 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.420000000000002 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.519999999999996 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.340000000000003 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.140000000000001 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.409999999999997 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 53.509999999999998 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.519 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.519999999999996 111.496 -176.242 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.150000000000006 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 52.5 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.120000000000005 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' MET . . . . . 0.565 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.400000000000006 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.319999999999993 111.832 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 63.240000000000002 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.310000000000002 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.409999999999997 106.939 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.129999999999995 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.129999999999995 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.420000000000002 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.239999999999995 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 10.0 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.340000000000003 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.530000000000001 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.310000000000002 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.140000000000001 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . 0.42 ' HG3' ' CA ' ' A' ' 133' ' ' SER . 7.1 mtpm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.340000000000003 109.798 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 112.462 -0.255 . . . . 52.310000000000002 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.42 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.420000000000002 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.519999999999996 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 42.409999999999997 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.130000000000003 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 63.420000000000002 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.349999999999994 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.129999999999995 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.239999999999995 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 62.32 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.230000000000004 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 148' ' ' VAL . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.310000000000002 106.494 170.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.340000000000003 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.310000000000002 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' HB ' ' A' ' 144' ' ' ILE . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 65.010000000000005 110.192 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.329999999999998 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.319999999999993 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.439999999999998 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.010000000000005 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.409999999999997 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.129999999999995 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' LEU . . . . . 0.602 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 71.349999999999994 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.420000000000002 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.329999999999998 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 51.020000000000003 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.230000000000004 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.240000000000002 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 62.329999999999998 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 60.130000000000003 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.010000000000005 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.530000000000001 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.019999999999996 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.430000000000007 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.099999999999994 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 62.399999999999999 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.319999999999993 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt . . . . . 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 61.149999999999999 110.116 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 110.429 -0.211 . . . . 44.399999999999999 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 63.07 -178.21 0.15 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.094 0.871 . . . . 74.099999999999994 109.864 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 95.24 3.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.819 -1.178 . . . . 61.310000000000002 107.819 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -69.39 -35.54 75.89 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.893 -0.594 . . . . 60.32 111.087 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 23' ' ' VAL . 7.3 m -89.74 -5.58 56.85 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.07 -0.715 . . . . 73.329999999999998 109.07 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt 62.04 -22.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.310000000000002 115.341 -173.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 21' ' ' SER . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 74.430000000000007 108.462 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.140000000000001 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.439999999999998 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.509999999999998 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.140000000000001 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.239999999999995 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 70.310000000000002 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.150000000000006 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.209999999999994 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.420000000000002 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 42.219999999999999 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.200000000000003 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.409999999999997 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.099999999999994 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.540000000000006 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.604 ' O ' ' HG2' ' A' ' 42' ' ' MET . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.439999999999998 108.769 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 61.409999999999997 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -58.16 -30.1 66.11 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 72.010000000000005 111.488 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 27.6 ptm -64.75 -22.3 66.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.87 0.367 . . . . 52.409999999999997 111.37 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.3 0.29 33.5 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.402 -0.363 . . . . 72.549999999999997 111.321 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.91 167.64 9.93 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 108.005 -1.109 . . . . 74.340000000000003 108.005 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.54 49.48 3.89 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 114.925 0.73 . . . . 75.230000000000004 114.925 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 46' ' ' LYS . 3.0 tmmm? -170.96 90.04 0.47 Allowed Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 108.73 -0.841 . . . . 74.109999999999999 108.73 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 65' ' ' GLU . 60.0 Cg_endo -102.59 5.54 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.243 2.629 . . . . 61.140000000000001 112.109 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 t60 73.05 96.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.306 1.442 . . . . 62.119999999999997 111.917 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -177.37 113.21 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.096 -1.446 . . . . 72.230000000000004 107.096 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.99 139.7 50.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.135 0.493 . . . . 73.340000000000003 110.912 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -85.6 80.44 9.03 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.253 -1.017 . . . . 74.310000000000002 108.253 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -101.68 154.6 18.74 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.277 -0.874 . . . . 73.439999999999998 109.831 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.48 18.29 5.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.58 1.152 . . . . 53.340000000000003 109.188 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.7 t -115.3 100.04 53.12 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.187 -0.915 . . . . 43.109999999999999 110.947 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -92.41 9.04 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.575 2.183 . . . . 65.430000000000007 109.944 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.41 47.69 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.135 -0.939 . . . . 44.100000000000001 110.946 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -74.2 116.63 15.08 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.134 0.492 . . . . 72.099999999999994 110.438 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.4 mt -92.5 114.72 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.719 -0.673 . . . . 73.209999999999994 110.697 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -164.34 17.28 0.06 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.956 -1.02 . . . . 72.129999999999995 108.784 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.88 175.47 33.58 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 109.241 -1.544 . . . . 45.530000000000001 109.241 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.06 120.45 29.42 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.961 -1.126 . . . . 73.420000000000002 107.961 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.3 138.0 56.73 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.558 0.536 . . . . 74.200000000000003 109.782 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.38 94.86 1.67 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.472 0.653 . . . . 72.519999999999996 111.27 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -99.0 -172.37 2.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.267 -0.879 . . . . 73.209999999999994 112.453 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 1.2 mp0 -38.32 139.9 0.34 Allowed 'General case' 0 C--O 1.243 0.758 0 C-N-CA 126.608 1.963 . . . . 73.540000000000006 111.981 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.27 121.52 26.56 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.438 -0.801 . . . . 72.319999999999993 113.618 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.48 19.85 3.63 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.489 -0.93 . . . . 75.25 108.489 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.739 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 3.3 t-105 -86.86 -1.93 58.19 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.813 -1.085 . . . . 72.5 109.063 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 7.88 57.09 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.041 -0.6 . . . . 63.409999999999997 113.74 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m 69.74 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.491 0.716 . . . . 73.129999999999995 111.843 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.120000000000005 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.210000000000001 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.739 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 43.439999999999998 110.662 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.409999999999997 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.349999999999994 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.409999999999997 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.129999999999995 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.549999999999997 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.129999999999995 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.329999999999998 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 61.210000000000001 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 34.439999999999998 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.120000000000005 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.230000000000004 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.129999999999995 108.132 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.100000000000001 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.439999999999998 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.420000000000002 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.319999999999993 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.200000000000003 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.310000000000002 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.340000000000003 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.230000000000004 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 61.439999999999998 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.409999999999997 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.010000000000005 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.209999999999994 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.219999999999999 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.219999999999999 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.150000000000006 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.310000000000002 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.150000000000006 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.319999999999993 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.040000000000006 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 32.210000000000001 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 72.450000000000003 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 64.450000000000003 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.019999999999996 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.450000000000003 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.040000000000006 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 62.439999999999998 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.450000000000003 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 73.25 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.310000000000002 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.340000000000003 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.456 HG22 HD11 ' A' ' 101' ' ' LEU . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.109999999999999 109.716 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.430000000000007 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.109999999999999 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.530000000000001 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 54.509999999999998 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.420000000000002 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.516 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm -135.56 -59.13 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 53.039999999999999 112.037 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 127' ' ' LYS . 27.2 Cg_endo -65.56 -30.07 52.07 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.006 1.137 . . . . 61.32 110.94 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.85 143.2 4.4 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.906 -0.664 . . . . 72.400000000000006 113.156 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.95 -124.32 33.75 Favored Glycine 0 C--O 1.243 0.693 0 O-C-N 123.827 0.369 . . . . 61.329999999999998 113.513 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.1 -17.15 22.26 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.934 2.422 . . . . 72.430000000000007 111.779 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.39 106.62 1.4 Allowed Glycine 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.329999999999998 111.117 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.109999999999999 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 31' ' ' GLU . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.340000000000003 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 62.149999999999999 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.209999999999994 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.049999999999997 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.542 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.299999999999997 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.430000000000007 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 71.310000000000002 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.319999999999993 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.219999999999999 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.209999999999994 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 55.340000000000003 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.229999999999997 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.420000000000002 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 44.149999999999999 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.120000000000005 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.209999999999994 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.049999999999997 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.420000000000002 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 65.109999999999999 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.200000000000003 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.540000000000006 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.421 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 21.5 mm-40 -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 70.329999999999998 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.542 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.340000000000003 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.200000000000003 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.130000000000003 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.129999999999995 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.488 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.209999999999994 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.549999999999997 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.340000000000003 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.540000000000006 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.555 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.120000000000005 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.310000000000002 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 62.43 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.010000000000005 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt -71.84 -33.12 68.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.140000000000001 110.044 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.99 61.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.442 -0.799 . . . . 52.32 111.717 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.84 160.23 18.96 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.327 0.585 . . . . 51.109999999999999 112.038 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.427 -1.583 0 CA-C-N 114.772 -1.104 . . . . 70.129999999999995 110.272 178.972 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 111.744 0.276 . . . . 72.019999999999996 111.744 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.34 -77.49 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.267 1.027 . . . . 64.109999999999999 110.66 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.14 103.23 14.6 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 106.848 -1.538 . . . . 75.239999999999995 106.848 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -58.47 -28.67 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.834 0.454 . . . . 70.140000000000001 112.18 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 p -76.86 -20.08 56.71 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 112.596 0.591 . . . . 64.530000000000001 112.596 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 143' ' ' LYS 0.288 91.1 mt 55.46 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.219999999999999 117.173 -176.167 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.420000000000002 107.271 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.319999999999993 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.109999999999999 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 72.109999999999999 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' HD23 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.549999999999997 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 63.450000000000003 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.039999999999999 110.377 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.420000000000002 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.010000000000005 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.299999999999997 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 71.530000000000001 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.120000000000005 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.310000000000002 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.399999999999999 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.129999999999995 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HE3' ' OE2' ' A' ' 173' ' ' GLU . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.030000000000001 111.28 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.519999999999996 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 70.430000000000007 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.47 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 19.5 m170 -61.5 -30.23 70.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 53.009999999999998 110.706 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 95.6 mmm -72.29 -31.35 65.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.335 -0.393 . . . . 72.239999999999995 111.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 100' ' ' ASN . 82.6 m-85 -71.62 -27.07 62.85 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 120.6 -0.44 . . . . 73.450000000000003 110.781 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.29 -55.83 5.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.329 -1.36 . . . . 63.200000000000003 107.329 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.15 100.96 0.35 Allowed Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 114.923 -1.035 . . . . 71.450000000000003 112.738 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -99.38 106.26 38.17 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 106.689 -1.597 . . . . 72.019999999999996 106.689 173.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.44 106.92 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.504 2.136 . . . . 54.310000000000002 112.443 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.98 85.19 7.36 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.946 0.879 . . . . 72.219999999999999 109.571 174.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -122.49 99.93 6.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.509 -1.223 . . . . 70.420000000000002 111.013 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -169.33 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 122.375 1.083 . . . . 72.129999999999995 111.6 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.2 m -139.17 14.69 2.62 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.031 -0.986 . . . . 72.230000000000004 108.454 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -127.39 175.74 7.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.365 -1.289 . . . . 72.439999999999998 107.885 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -52.39 11.15 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.123 -1.066 . . . . 72.219999999999999 108.123 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -127.42 98.69 28.6 Favored Pre-proline 0 N--CA 1.417 -2.077 0 N-CA-C 107.422 -1.325 . . . . 74.439999999999998 107.422 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.02 141.63 8.39 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.965 1.776 . . . . 72.540000000000006 112.356 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.66 141.25 16.44 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.406 -1.477 . . . . 44.5 109.406 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.07 86.22 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.973 0.909 . . . . 74.349999999999994 111.549 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -73.67 -50.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.652 -1.24 . . . . 72.140000000000001 107.652 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.55 72.41 10.29 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.825 -1.176 . . . . 74.129999999999995 107.825 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.08 64.37 3.34 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.627 -0.715 . . . . 32.130000000000003 111.487 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.4 p -92.61 79.91 4.82 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.983 0.896 . . . . 61.450000000000003 112.03 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.98 -40.75 5.37 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.953 -1.129 . . . . 74.239999999999995 107.953 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.49 168.95 9.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.471 -1.307 . . . . 74.239999999999995 107.471 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -148.08 -148.71 0.27 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.897 -1.89 . . . . 74.140000000000001 105.897 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 148.19 48.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-N 119.269 0.94 . . . . 62.119999999999997 111.816 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.02 -91.53 1.51 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.045 -1.222 . . . . 51.32 110.045 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.62 -56.74 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.858 0.463 . . . . 73.349999999999994 110.129 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -73.13 -17.36 61.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.911 -0.586 . . . . 72.340000000000003 111.924 -174.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 12.54 83.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.658 -0.782 . . . . 53.039999999999999 113.719 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -148.52 166.07 29.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.240000000000002 108.93 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.409999999999997 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.109999999999999 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 92' ' ' ILE . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 62.229999999999997 109.204 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.399999999999999 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 45.039999999999999 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.310000000000002 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.519999999999996 108.345 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.7 m-20 -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.439999999999998 108.554 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 72.25 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.310000000000002 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.517 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 73.549999999999997 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.530000000000001 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.450000000000003 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.549999999999997 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.129999999999995 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.299999999999997 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.310000000000002 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' TRP . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.439999999999998 108.353 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 108' ' ' GLU . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.200000000000003 106.88 -174.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.519999999999996 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.510000000000005 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 73' ' ' SER . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.430000000000007 108.623 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.450000000000003 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.430000000000007 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.299999999999997 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.120000000000005 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 55.329999999999998 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.409999999999997 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.450000000000003 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.229999999999997 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.030000000000001 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.240000000000002 110.951 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.120000000000005 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.109999999999999 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.219999999999999 109.245 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.655 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.520000000000003 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' A' ' 89' ' ' LYS . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.120000000000005 112.884 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.120000000000005 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.019999999999996 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.049999999999997 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.420000000000002 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.329999999999998 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 64.439999999999998 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.200000000000003 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.209999999999994 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.130000000000003 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.230000000000004 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.150000000000006 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 71.209999999999994 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.219999999999999 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.310000000000002 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.439999999999998 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.230000000000004 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.130000000000003 113.83 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt -84.65 146.42 46.71 Favored Pre-proline 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.129999999999995 110.668 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.299 1.999 . . . . 72.030000000000001 111.406 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.59 51.61 0.77 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.671 -0.776 . . . . 43.210000000000001 111.67 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 131' ' ' PRO . . . -154.87 143.46 9.98 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.224 -0.988 . . . . 71.140000000000001 110.934 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 130' ' ' GLY . 23.9 Cg_exo -65.17 -25.8 57.67 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.773 2.315 . . . . 75.049999999999997 111.565 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.55 -165.94 31.55 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.821 -0.627 . . . . 25.109999999999999 112.758 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.310000000000002 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.409999999999997 110.385 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.109999999999999 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 77.9 m80 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.519999999999996 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 74.450000000000003 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.310000000000002 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.439999999999998 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.409999999999997 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 53.420000000000002 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.230000000000004 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.150000000000006 111.509 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.329999999999998 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.409999999999997 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.329999999999998 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.140000000000001 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 61.200000000000003 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.240000000000002 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 73.430000000000007 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.319999999999993 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.310000000000002 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.319999999999993 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 44.210000000000001 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.509999999999998 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.229999999999997 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.329999999999998 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.451 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.240000000000002 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.530000000000001 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.409999999999997 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.310000000000002 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.340000000000003 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.219999999999999 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.420000000000002 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.219999999999999 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.230000000000004 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.129999999999995 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.439999999999998 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.430000000000007 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -75.17 -18.69 60.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.420000000000002 111.277 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.19 -168.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.512 -0.767 . . . . 74.430000000000007 109.775 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.6 152.93 42.96 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.133 0.492 . . . . 74.120000000000005 112.174 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' HE3' ' A' ' 38' ' ' LYS . 8.6 pt-20 . . . . . 0 C--N 1.307 -1.252 0 CA-C-N 115.232 -0.894 . . . . 72.239999999999995 109.399 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' HB2' ' A' ' 146' ' ' GLU . 42.9 m . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.32 1.057 . . . . 54.409999999999997 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.75 21.76 1.98 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.557 -1.656 . . . . 51.219999999999999 110.341 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.25 113.24 7.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.717 -0.674 . . . . 71.329999999999998 109.539 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -72.3 -27.75 62.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.696 -0.683 . . . . 65.010000000000005 111.667 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.7 m -56.56 -44.09 80.6 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 113.854 1.057 . . . . 72.0 113.854 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt 65.61 -40.2 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.514 1.125 . . . . 62.539999999999999 113.994 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.519999999999996 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.100000000000001 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.310000000000002 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.219999999999999 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.439999999999998 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.200000000000003 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.530000000000001 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 72.329999999999998 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.319999999999993 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.498 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.239999999999995 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' HD11 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.209999999999994 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.200000000000003 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.509999999999998 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.030000000000001 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 73.329999999999998 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.530000000000001 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 42' ' ' MET . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.329999999999998 107.764 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.414 ' NE2' ' HA ' ' A' ' 98' ' ' ASP . 41.5 t-80 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.420000000000002 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 8.8 m80 -76.67 -40.9 47.55 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 70.200000000000003 113.803 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 26.7 ptm -53.56 -34.64 59.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.579 1.326 . . . . 74.129999999999995 114.579 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -84.92 -21.53 29.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.019 -0.672 . . . . 75.219999999999999 112.344 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.72 22.59 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.94 -0.475 . . . . 64.319999999999993 111.533 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.63 46.36 1.08 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.147 -0.781 . . . . 64.109999999999999 111.147 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.75 111.54 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 124.578 1.151 . . . . 73.140000000000001 112.953 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.28 22.53 0.81 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.823 2.349 . . . . 74.450000000000003 111.324 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -66.11 143.68 57.16 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.213 1.005 . . . . 74.129999999999995 110.422 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -132.16 143.55 50.05 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.383 -0.969 . . . . 60.520000000000003 108.383 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.58 134.31 39.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.305 -0.998 . . . . 73.209999999999994 108.305 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.2 m -107.5 96.99 6.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.014 0.435 . . . . 75.099999999999994 111.656 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -142.4 175.86 9.45 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.026 -1.101 . . . . 63.43 108.026 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.72 27.65 16.97 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.419 0.688 . . . . 73.040000000000006 111.237 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.8 m 67.61 93.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.798 0.839 . . . . 72.340000000000003 111.074 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -50.72 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.971 2.448 . . . . 74.219999999999999 114.284 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.8 -161.5 15.03 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.296 -1.122 . . . . 55.100000000000001 110.296 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.45 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.145 0.978 . . . . 63.329999999999998 110.922 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -90.03 89.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 113.927 1.084 . . . . 75.239999999999995 113.927 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 62.49 -168.49 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.344 -0.844 . . . . 74.349999999999994 112.198 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.58 -17.06 2.86 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.236 -0.438 . . . . 60.219999999999999 112.31 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.4 m 69.72 -42.66 0.51 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.833 1.253 . . . . 62.200000000000003 112.93 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.68 139.64 53.49 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 122.741 0.416 . . . . 71.299999999999997 110.652 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 tp -128.65 88.82 2.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.342 0.591 . . . . 62.229999999999997 110.107 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -149.94 101.93 3.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.297 -0.865 . . . . 63.130000000000003 109.055 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.63 -66.79 0.81 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.213 -0.662 . . . . 60.340000000000003 109.213 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.79 15.89 2.63 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.099 -1.048 . . . . 75.540000000000006 113.657 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.28 161.54 39.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.307 -0.957 . . . . 70.519999999999996 112.07 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -105.83 -10.9 16.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.72 -1.127 . . . . 74.409999999999997 108.828 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 -12.34 68.59 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.359 -0.837 . . . . 64.140000000000001 112.32 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m -118.8 150.1 40.39 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.387 -0.598 . . . . 63.329999999999998 109.387 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.219999999999999 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.430000000000007 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.239999999999995 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.149999999999999 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.310000000000002 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.329999999999998 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.109999999999999 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.340000000000003 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.120000000000005 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.019999999999996 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 70.430000000000007 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.409999999999997 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.310000000000002 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 34.409999999999997 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.439999999999998 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.409999999999997 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 33.219999999999999 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.030000000000001 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.120000000000005 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.140000000000001 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 73' ' ' SER . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.129999999999995 107.961 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.109999999999999 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.510000000000005 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.420000000000002 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.120000000000005 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.299999999999997 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASP . . . . . 0.414 ' HA ' ' NE2' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.239999999999995 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.040000000000006 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.340000000000003 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.430000000000007 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.030000000000001 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.409999999999997 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.010000000000005 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.552 HG11 ' HE1' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.109999999999999 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 108' ' ' GLU . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 64.450000000000003 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 71.129999999999995 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.530000000000001 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.469 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.299999999999997 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.310000000000002 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.552 ' HE1' HG11 ' A' ' 106' ' ' VAL . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 63.210000000000001 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.150000000000006 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.129999999999995 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.140000000000001 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.614 ' HG3' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.230000000000004 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.140000000000001 107.597 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 64.099999999999994 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.210000000000001 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.5 HD23 ' H ' ' A' ' 120' ' ' LEU . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.040000000000006 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.510000000000005 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.430000000000007 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.310000000000002 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.540000000000006 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.439999999999998 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm -129.03 -53.97 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.239999999999995 112.424 -173.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 34.6 Cg_exo -64.23 -49.01 4.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.406 1.404 . . . . 74.329999999999998 111.533 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.42 -121.66 1.02 Allowed Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.309 -0.716 . . . . 73.209999999999994 111.309 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.1 -81.69 0.89 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.572 -1.011 . . . . 63.420000000000002 110.572 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.66 95.88 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.108 1.872 . . . . 65.200000000000003 110.886 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 134.32 116.83 1.7 Allowed Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.399999999999999 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.636 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.020000000000003 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 64.129999999999995 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 54.509999999999998 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.210000000000001 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.049999999999997 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.420000000000002 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.129999999999995 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.439999999999998 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.409999999999997 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.299999999999997 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.614 HG12 ' HG3' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.549999999999997 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.299999999999997 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.76 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.299999999999997 111.469 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.310000000000002 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.229999999999997 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.209999999999994 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.150000000000006 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.340000000000003 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 54.439999999999998 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 43.009999999999998 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.310000000000002 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.349999999999994 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.140000000000001 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 73.430000000000007 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.430000000000007 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.310000000000002 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 51.219999999999999 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.606 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.349999999999994 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.310000000000002 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 44.310000000000002 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.409999999999997 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.329999999999998 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.588 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.420000000000002 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.423 HD21 ' SD ' ' A' ' 42' ' ' MET . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 53.25 111.113 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -74.29 -25.66 59.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.040000000000006 110.749 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 105.79 8.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.624 -1.25 . . . . 73.239999999999995 107.624 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.5 151.62 42.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.592 0.71 . . . . 72.540000000000006 112.602 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 114.878 -1.055 . . . . 62.020000000000003 108.804 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.3 m . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.281 0.563 . . . . 73.349999999999994 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -116.03 174.19 6.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.696 -0.684 . . . . 73.019999999999996 109.483 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.09 131.36 4.44 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.701 0.286 . . . . 72.450000000000003 110.332 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.5 p -62.06 -29.02 70.01 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.64 0.733 . . . . 72.400000000000006 109.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -76.39 -5.92 49.39 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.925 -1.034 . . . . 63.219999999999999 112.229 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt 63.23 12.88 6.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 75.430000000000007 113.18 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.310000000000002 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.439999999999998 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.129999999999995 110.404 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.319999999999993 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.329999999999998 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 34.109999999999999 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.409999999999997 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.530000000000001 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.140000000000001 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.420000000000002 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.430000000000007 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.430000000000007 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.450000000000003 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.150000000000006 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.219999999999999 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 42' ' ' MET . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.409999999999997 106.953 174.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -77.08 -32.34 56.64 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 63.009999999999998 113.954 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 23.3 ptt? -62.35 -28.51 69.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 120.497 -0.481 . . . . 74.430000000000007 111.548 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.28 -20.1 65.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.299 0.571 . . . . 64.420000000000002 110.815 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.43 14.34 32.26 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 116.011 -0.54 . . . . 72.209999999999994 112.429 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.67 -49.0 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 118.108 -1.996 . . . . 55.100000000000001 114.804 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 42' ' ' MET . 4.0 mptp? -69.68 141.36 90.16 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 116.86 0.33 . . . . 73.409999999999997 111.347 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.92 165.68 25.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.117 1.878 . . . . 71.409999999999997 110.607 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.425 ' HB3' HG11 ' A' ' 75' ' ' VAL . 57.1 t60 -87.46 -9.28 55.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.434 0.635 . . . . 53.539999999999999 110.464 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -136.57 151.17 49.08 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.484 1.114 . . . . 72.340000000000003 108.827 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -53.35 122.89 3.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.279 0.561 . . . . 73.439999999999998 110.325 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 t -105.3 106.81 17.48 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.89 -0.595 . . . . 61.409999999999997 110.61 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 54' ' ' SER . 38.5 ttpt -168.2 147.02 4.5 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.195 -1.039 . . . . 65.109999999999999 108.195 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.72 82.48 6.71 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.571 0.7 . . . . 71.230000000000004 111.744 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 52' ' ' LYS . 58.9 m -138.24 135.78 18.74 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 115.3 -0.864 . . . . 74.430000000000007 109.27 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 149.15 68.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 123.134 2.556 . . . . 61.310000000000002 112.909 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 -35.42 0.12 Allowed Glycine 0 C--N 1.302 -1.359 0 N-CA-C 108.744 -1.742 . . . . 61.140000000000001 108.744 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -143.63 -177.75 5.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.441 . . . . 72.400000000000006 107.108 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG13 ' HG3' ' A' ' 59' ' ' GLN . 37.1 pt -53.75 -34.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.392 0.886 . . . . 74.049999999999997 113.392 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 58' ' ' ILE . 95.3 mt-30 -101.93 -35.31 9.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 74.040000000000006 111.16 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.45 -66.16 3.85 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 109.499 -1.44 . . . . 34.539999999999999 109.499 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 50.7 t -107.8 147.18 31.21 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.154 -1.795 . . . . 65.329999999999998 106.154 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -72.41 98.89 2.33 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.198 0.523 . . . . 55.049999999999997 109.616 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.38 132.71 49.41 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.547 -0.751 . . . . 74.219999999999999 109.6 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 66.93 89.86 0.1 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 122.0 0.905 . . . . 70.310000000000002 110.857 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -104.64 145.41 30.36 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.902 -1.045 . . . . 54.43 110.664 -177.452 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.48 -27.3 1.82 Allowed Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.661 -0.78 . . . . 74.340000000000003 112.019 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 70.77 149.49 0.09 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.823 0.849 . . . . 73.25 112.073 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 40.6 m95 -107.5 15.66 24.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.198 -0.455 . . . . 75.120000000000005 110.85 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.31 14.56 38.19 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.17 -1.014 . . . . 62.100000000000001 110.746 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m 72.52 -68.77 0.21 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.91 1.284 . . . . 64.310000000000002 110.739 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.420000000000002 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.349999999999994 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.530000000000001 111.347 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.319999999999993 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.140000000000001 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.439999999999998 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.420000000000002 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.501 HD22 ' C ' ' A' ' 77' ' ' TRP . 0.9 OUTLIER -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.329999999999998 108.748 176.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.140000000000001 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.150000000000006 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.549 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.549999999999997 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.200000000000003 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 34.240000000000002 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.230000000000004 108.97 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.119999999999997 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.530000000000001 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 62.509999999999998 107.432 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.349999999999994 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.049999999999997 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.409999999999997 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.409 ' CG2' HG23 ' A' ' 95' ' ' VAL . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.439999999999998 108.193 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.030000000000001 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.530000000000001 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.540000000000006 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.540000000000006 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.140000000000001 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.319999999999993 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.140000000000001 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.140000000000001 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.119999999999997 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.549999999999997 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 63.100000000000001 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.420000000000002 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.019999999999996 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.019999999999996 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.019999999999996 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.310000000000002 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.683 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.019999999999996 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 106' ' ' VAL . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.409999999999997 109.847 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.109999999999999 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.400000000000006 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.049999999999997 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.439999999999998 110.726 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 51.329999999999998 108.038 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.340000000000003 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.099999999999994 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.149999999999999 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.200000000000003 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.140000000000001 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.019999999999996 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.239999999999995 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.310000000000002 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.200000000000003 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm -86.44 -55.59 0.37 Allowed Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.420000000000002 111.928 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 13.0 Cg_exo -73.21 -56.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.193 1.262 . . . . 71.140000000000001 110.499 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.98 108.67 0.23 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.369 -0.92 . . . . 70.510000000000005 112.848 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.71 -117.2 8.26 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 123.998 0.469 . . . . 60.32 114.084 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.66 111.41 0.95 Allowed 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 123.08 2.52 . . . . 75.319999999999993 110.766 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 107.82 68.59 0.66 Allowed Glycine 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.019999999999996 109.212 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.340000000000003 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.581 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 61.409999999999997 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.319999999999993 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 65.299999999999997 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.400000000000006 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.229999999999997 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.140000000000001 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.4 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.549999999999997 112.598 -172.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.319999999999993 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.54 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 71.109999999999999 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 116' ' ' LYS . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.040000000000006 105.511 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.409999999999997 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.340000000000003 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 62.32 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.439999999999998 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 32.420000000000002 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.310000000000002 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HA ' HD12 ' A' ' 154' ' ' LEU . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.219999999999999 112.134 175.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.120000000000005 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.510000000000005 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.299999999999997 110.235 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.200000000000003 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.349999999999994 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.109999999999999 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 52.030000000000001 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 52.119999999999997 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.329999999999998 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.109999999999999 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.120000000000005 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.329999999999998 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.120000000000005 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.439999999999998 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 44.119999999999997 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.657 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.400000000000006 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.349999999999994 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -75.58 -40.83 56.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 51.329999999999998 110.505 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.8 30.63 18.37 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.051 1.341 . . . . 72.140000000000001 111.112 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.27 149.59 50.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.894 -1.048 . . . . 74.340000000000003 110.162 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 108.664 -0.865 . . . . 75.310000000000002 108.664 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.818 -0.808 . . . . 54.32 108.818 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -164.65 168.63 17.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.673 -1.232 . . . . 63.109999999999999 107.673 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.34 103.56 11.19 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.159 -0.682 . . . . 64.519999999999996 109.159 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 p -72.68 -43.08 63.56 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.162 0.506 . . . . 65.140000000000001 111.106 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -80.32 -22.89 41.03 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.421 -0.809 . . . . 71.409999999999997 109.645 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt 63.58 -20.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.430000000000007 115.799 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.420000000000002 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.030000000000001 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.140000000000001 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.109999999999999 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.340000000000003 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.430000000000007 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.009999999999998 109.519 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 53.420000000000002 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.239999999999995 113.24 178.25 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.219999999999999 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 43.310000000000002 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.219999999999999 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 61.219999999999999 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.420000000000002 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 55.020000000000003 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.400000000000006 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.299999999999997 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 12.5 m-70 -68.03 -42.44 80.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 109.778 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.3 mmt -74.91 -41.02 60.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 75.030000000000001 112.385 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.42 5.76 49.52 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.376 0.88 . . . . 73.329999999999998 113.376 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.14 95.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 43.219999999999999 110.477 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 46' ' ' LYS . . . 104.21 -15.16 51.16 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.46 -0.656 . . . . 43.229999999999997 111.46 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 74.7 mmtt -135.02 157.24 77.43 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 108.289 -1.004 . . . . 63.039999999999999 108.289 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.91 113.84 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.079 1.852 . . . . 72.299999999999997 108.395 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -94.27 141.54 28.44 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.145 -0.622 . . . . 63.520000000000003 109.626 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -54.3 112.68 1.03 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.767 0.667 . . . . 70.530000000000001 109.684 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.87 -27.93 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.517 0.562 . . . . 74.430000000000007 112.517 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 m 66.2 31.35 8.71 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.777 0.673 . . . . 64.040000000000006 110.838 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.18 -168.17 0.2 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.12 0.968 . . . . 74.310000000000002 111.55 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 76.56 -46.08 0.51 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.325 1.45 . . . . 42.409999999999997 112.232 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 p -154.39 144.52 15.66 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.603 -0.518 . . . . 64.519999999999996 109.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.1 174.51 12.3 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 122.279 1.986 . . . . 75.049999999999997 111.3 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.53 63.44 0.53 Allowed Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 111.259 -0.736 . . . . 53.229999999999997 111.259 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.53 158.32 28.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.237 -0.653 . . . . 62.009999999999998 109.237 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.2 mt 76.47 99.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 108.127 -1.064 . . . . 74.219999999999999 108.127 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -66.48 129.49 40.03 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.314 0.857 . . . . 54.009999999999998 113.314 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.22 57.45 0.43 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 109.532 -1.427 . . . . 51.119999999999997 109.532 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.61 159.71 19.14 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.416 -0.392 . . . . 73.219999999999999 110.781 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -63.54 135.75 57.06 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.394 1.078 . . . . 63.039999999999999 113.688 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.405 HD12 ' N ' ' A' ' 63' ' ' LEU . 3.2 mp -105.61 -168.85 1.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.261 -2.126 . . . . 62.340000000000003 105.261 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -88.47 131.99 34.66 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.465 -1.294 . . . . 60.020000000000003 107.705 171.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.77 159.17 29.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 120.506 0.194 . . . . 70.510000000000005 111.196 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.4 119.31 16.71 Favored Glycine 0 N--CA 1.44 -1.092 0 O-C-N 123.905 0.753 . . . . 75.209999999999994 111.697 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.48 2.26 2.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.176 0.806 . . . . 75.099999999999994 113.176 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -82.6 -2.12 52.88 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.621 -0.718 . . . . 74.219999999999999 109.23 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.78 39.35 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.35 -0.929 . . . . 50.340000000000003 111.456 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m 74.79 -64.8 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.022 0.929 . . . . 70.129999999999995 109.337 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 65.299999999999997 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.239999999999995 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.130000000000003 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.140000000000001 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 45.200000000000003 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.239999999999995 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.239999999999995 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' OD1' HG22 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.400000000000006 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.409999999999997 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 64.200000000000003 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.0 t-80 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.100000000000001 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.239999999999995 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.230000000000004 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.109999999999999 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.439999999999998 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.010000000000005 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 70.319999999999993 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 51.109999999999999 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.120000000000005 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.140000000000001 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.109999999999999 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 102' ' ' ILE . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.129999999999995 108.406 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.509999999999998 110.397 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.109999999999999 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.430000000000007 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.209999999999994 108.997 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.409999999999997 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.209999999999994 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.319999999999993 110.658 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.683 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.450000000000003 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.209999999999994 109.323 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 92' ' ' ILE . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 72.400000000000006 111.567 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.120000000000005 110.951 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 64.219999999999999 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 118' ' ' PHE . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.129999999999995 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.556 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.340000000000003 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.519999999999996 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 112' ' ' MET . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.420000000000002 113.933 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.349999999999994 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.230000000000004 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.219999999999999 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.329999999999998 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.540000000000006 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.409999999999997 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.543 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.010000000000005 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.150000000000006 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.543 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 63.329999999999998 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.430000000000007 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.329999999999998 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.683 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.540000000000006 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.140000000000001 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.399999999999999 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt -77.84 151.46 79.46 Favored Pre-proline 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.519999999999996 110.899 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.21 100.36 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.381 2.054 . . . . 72.040000000000006 110.099 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.4 -28.02 3.88 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.835 -0.906 . . . . 45.229999999999997 110.835 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 127.88 -89.38 0.33 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.312 -0.947 . . . . 44.340000000000003 113.92 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 9.9 Cg_endo -46.66 114.32 0.88 Allowed 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 124.542 3.495 . . . . 71.430000000000007 115.232 -173.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.16 -172.26 26.51 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.41 -0.814 . . . . 74.299999999999997 111.777 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.409999999999997 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.200000000000003 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 44.32 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 77.0 m80 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.400000000000006 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.140000000000001 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 71.099999999999994 106.284 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.439999999999998 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.219999999999999 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.349999999999994 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.329999999999998 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.450000000000003 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 148' ' ' VAL . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.129999999999995 105.726 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.400000000000006 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.230000000000004 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.432 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.230000000000004 112.237 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.239999999999995 109.762 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.509999999999998 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 55.25 112.891 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 154' ' ' LEU . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.120000000000005 111.512 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.329999999999998 112.252 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.200000000000003 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 151' ' ' PRO . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.229999999999997 110.161 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.340000000000003 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.140000000000001 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 63.009999999999998 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.209999999999994 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.019999999999996 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.230000000000004 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.120000000000005 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.010000000000005 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.109999999999999 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.019999999999996 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 74.120000000000005 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.450000000000003 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 63.509999999999998 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.400000000000006 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.129999999999995 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 33' ' ' LYS . 87.6 mt -82.51 -41.29 19.88 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.209999999999994 110.331 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 46.33 72.6 0.22 Allowed 'General case' 0 C--O 1.251 1.151 0 C-N-CA 125.102 1.361 . . . . 64.120000000000005 113.808 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.52 -158.46 0.88 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.898 -1.501 . . . . 63.130000000000003 107.447 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--N 1.298 -1.651 0 O-C-N 123.187 0.304 . . . . 63.240000000000002 111.014 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.106 0.479 . . . . 62.219999999999999 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -134.68 173.16 11.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.738 -0.838 . . . . 55.219999999999999 108.738 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.39 -14.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.856 1.263 . . . . 42.130000000000003 113.436 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -72.18 -32.08 66.51 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.118 0.567 . . . . 55.210000000000001 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 m -84.27 -5.5 59.27 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.992 -0.549 . . . . 64.439999999999998 110.907 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 82.5 mt -80.71 19.03 0.87 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.319999999999993 111.077 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.239999999999995 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.420000000000002 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.530000000000001 110.954 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.319999999999993 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.350000000000001 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.540000000000006 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.019999999999996 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.450000000000003 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.299999999999997 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.450000000000003 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.140000000000001 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 34.530000000000001 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.030000000000001 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.420000000000002 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 65.129999999999995 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 65.019999999999996 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 27.1 t-80 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.209999999999994 108.51 176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 -63.43 -35.2 79.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.409999999999997 110.631 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.19 -23.63 60.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.182 0.515 . . . . 72.109999999999999 111.508 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.44 3.36 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.156 -0.475 . . . . 63.109999999999999 110.788 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.75 -50.83 2.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.045 -0.525 . . . . 72.239999999999995 110.733 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.21 -146.37 6.43 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.509 -0.636 . . . . 73.329999999999998 111.509 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' HD2' ' N ' ' A' ' 46' ' ' LYS . 9.8 mptt -108.21 156.21 38.84 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.348 -0.612 . . . . 63.219999999999999 109.348 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.44 118.96 6.0 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.182 1.921 . . . . 73.439999999999998 109.033 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -116.37 127.1 54.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.819 -0.808 . . . . 72.109999999999999 108.819 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -92.07 163.89 13.8 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.427 0.528 . . . . 71.010000000000005 112.427 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.78 128.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.285 -0.87 . . . . 52.509999999999998 110.309 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -164.12 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.901 -0.407 . . . . 75.510000000000005 109.901 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 70.34 145.69 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.123 0.969 . . . . 64.420000000000002 111.115 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 73.33 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.073 0.939 . . . . 61.350000000000001 111.411 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -138.65 164.7 38.01 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 106.632 -1.618 . . . . 73.049999999999997 106.632 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.11 152.62 74.67 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 121.634 1.556 . . . . 74.120000000000005 110.967 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.1 -135.3 4.92 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.965 -0.636 . . . . 54.020000000000003 111.968 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.09 104.93 11.91 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.074 0.464 . . . . 74.340000000000003 110.805 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 pt -140.18 174.05 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.32 -0.992 . . . . 61.049999999999997 108.32 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -84.28 147.32 27.29 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.907 -0.775 . . . . 61.210000000000001 108.907 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.8 113.38 3.09 Favored Glycine 0 C--N 1.298 -1.552 0 C-N-CA 120.372 -0.918 . . . . 65.519999999999996 110.86 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.1 t -94.11 153.83 17.92 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.903 0.382 . . . . 70.349999999999994 110.215 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -100.82 -10.85 20.35 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.992 0.425 . . . . 63.539999999999999 111.26 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.19 92.83 2.08 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.198 0.523 . . . . 73.230000000000004 110.512 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -85.51 114.33 22.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.555 0.693 . . . . 62.25 111.806 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.32 169.85 10.06 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.174 -0.921 . . . . 75.310000000000002 109.365 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.13 59.89 4.83 Favored Glycine 0 C--N 1.314 -0.658 0 C-N-CA 120.971 -0.633 . . . . 62.049999999999997 112.333 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -83.78 158.42 21.73 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 122.557 0.343 . . . . 62.5 110.504 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -98.59 -17.13 18.81 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.814 -0.439 . . . . 75.010000000000005 109.814 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.26 -10.8 67.52 Favored Glycine 0 C--O 1.243 0.689 0 CA-C-N 115.852 -0.613 . . . . 32.140000000000001 113.687 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p -140.19 170.45 15.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 122.915 0.486 . . . . 74.040000000000006 111.085 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.049999999999997 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.200000000000003 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.485 ' HB3' HD12 ' A' ' 92' ' ' ILE . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.109999999999999 110.664 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 61.539999999999999 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.340000000000003 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.400000000000006 111.591 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.442 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.540000000000006 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 74.0 m-20 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.200000000000003 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.319999999999993 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.040000000000006 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 61.7 t-80 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.439999999999998 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.310000000000002 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.020000000000003 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.430000000000007 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.299999999999997 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.209999999999994 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.310000000000002 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.420000000000002 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.439999999999998 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 73' ' ' SER . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 71.430000000000007 109.144 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.150000000000006 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.310000000000002 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.129999999999995 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.109999999999999 104.739 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.349999999999994 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.109999999999999 111.808 -178.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.010000000000005 112.777 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.540000000000006 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.129999999999995 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.540000000000006 111.592 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 70.299999999999997 110.724 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.450000000000003 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.099999999999994 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.140000000000001 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.594 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.230000000000004 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.240000000000002 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.319999999999993 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.049999999999997 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 74.209999999999994 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.427 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.239999999999995 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.349999999999994 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.129999999999995 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.496 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.310000000000002 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' ILE . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.439999999999998 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.120000000000005 108.127 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 52.399999999999999 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.349999999999994 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 71.010000000000005 109.901 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 102' ' ' ILE . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.099999999999994 109.74 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.329999999999998 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.019999999999996 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.099999999999994 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.519999999999996 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.66 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -64.3 141.08 98.09 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.099999999999994 112.155 -176.098 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 127' ' ' LYS . 18.6 Cg_exo -69.03 -24.33 33.12 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.242 1.962 . . . . 61.509999999999998 109.957 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.16 150.63 15.89 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 108.618 -1.793 . . . . 72.299999999999997 108.618 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.9 -170.02 13.22 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.31 -0.948 . . . . 75.129999999999995 111.73 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -96.43 166.74 1.14 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.022 2.482 . . . . 71.400000000000006 113.508 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . 55.67 -103.73 0.25 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.352 -0.84 . . . . 73.140000000000001 115.006 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.040000000000006 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 64.340000000000003 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.310000000000002 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.340000000000003 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 72.230000000000004 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.400000000000006 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 154' ' ' LEU . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.109999999999999 110.345 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.310000000000002 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 74.340000000000003 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.299999999999997 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.219999999999999 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.439999999999998 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.239999999999995 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.510000000000005 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.239999999999995 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.019999999999996 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 65.209999999999994 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 62.200000000000003 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.430000000000007 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.219999999999999 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 73.120000000000005 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 139' ' ' LEU . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.219999999999999 112.512 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.129999999999995 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 64.530000000000001 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.010000000000005 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.240000000000002 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.209999999999994 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.299999999999997 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 43.350000000000001 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.240000000000002 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.496 ' HD3' ' H ' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.530000000000001 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.349999999999994 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 62.119999999999997 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.319999999999993 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.049999999999997 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.200000000000003 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.310000000000002 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt -68.31 -43.03 78.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.130000000000003 110.297 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 38.24 86.93 0.01 OUTLIER 'General case' 0 C--O 1.246 0.908 0 C-N-CA 126.016 1.726 . . . . 55.109999999999999 115.056 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -100.82 137.72 38.83 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.573 0.702 . . . . 62.009999999999998 110.493 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.273 -2.726 0 CA-C-N 114.955 -1.02 . . . . 73.150000000000006 108.625 -177.829 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 108.113 -1.069 . . . . 61.299999999999997 108.113 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -94.87 179.45 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.901 -1.045 . . . . 65.219999999999999 110.566 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.44 33.21 11.32 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.296 0.998 . . . . 70.319999999999993 108.767 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -59.2 -28.34 66.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.282 -1.326 . . . . 62.310000000000002 112.132 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 t -75.93 -15.46 60.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.96 -0.296 . . . . 65.450000000000003 110.457 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt 56.69 15.38 2.14 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.472 1.509 . . . . 73.209999999999994 113.762 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.129999999999995 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 35.340000000000003 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.009999999999998 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 63.420000000000002 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.030000000000001 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.150000000000006 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.420000000000002 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.409999999999997 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.120000000000005 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.439999999999998 113.288 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.030000000000001 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 60.530000000000001 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.040000000000006 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.539999999999999 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.200000000000003 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 34.2 t-80 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 72.219999999999999 109.221 177.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -63.24 -44.46 95.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.140000000000001 113.053 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -67.87 -31.84 71.93 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.728 -0.389 . . . . 75.450000000000003 111.491 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.07 -23.44 61.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.229 0.537 . . . . 72.0 110.139 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.53 11.51 19.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.981 -0.554 . . . . 53.100000000000001 111.036 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.94 -151.7 6.6 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.587 -0.605 . . . . 71.230000000000004 111.587 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 155.82 60.42 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.851 -0.796 . . . . 65.299999999999997 108.851 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.71 145.65 29.33 Favored 'Trans proline' 0 C--O 1.257 1.436 0 N-CA-C 108.621 -1.338 . . . . 73.040000000000006 108.621 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.87 -49.65 64.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.915 -0.772 . . . . 75.209999999999994 108.915 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 63.23 -80.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.435 1.094 . . . . 51.32 112.048 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.149 0.58 . . . . 74.530000000000001 110.001 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -103.06 115.86 31.4 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.957 -1.497 . . . . 62.420000000000002 106.957 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 49.7 mtmt -121.88 176.37 5.8 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.833 0.349 . . . . 74.349999999999994 111.005 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.52 90.96 6.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.728 -0.841 . . . . 30.219999999999999 108.728 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -131.98 104.3 14.06 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 108.003 -1.11 . . . . 72.319999999999993 108.003 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.4 -36.66 65.33 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.988 2.458 . . . . 74.409999999999997 112.005 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.23 -139.14 10.6 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.712 -0.955 . . . . 64.040000000000006 110.712 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 t30 61.03 28.93 18.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.956 0.884 . . . . 75.510000000000005 109.247 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -73.6 112.33 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.487 -0.779 . . . . 64.430000000000007 110.419 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 71.77 -62.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.583 1.153 . . . . 53.439999999999998 113.108 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.6 104.11 0.85 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.072 -1.211 . . . . 61.130000000000003 110.072 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.89 -18.64 60.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.223 0.535 . . . . 72.439999999999998 111.034 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.52 0.25 57.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.709 -0.678 . . . . 63.5 112.346 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 pp -114.59 145.22 42.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.413 -0.515 . . . . 74.010000000000005 111.253 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -146.18 -29.48 0.4 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.579 -0.282 . . . . 64.230000000000004 110.695 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 80.54 118.85 0.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 125.592 1.557 . . . . 75.439999999999998 109.076 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.74 9.08 63.07 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.132 -1.587 . . . . 44.329999999999998 109.132 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.17 -45.25 5.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.328 -0.436 . . . . 72.140000000000001 110.643 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -106.39 -5.39 19.03 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.243 1.02 . . . . 73.319999999999993 109.173 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 -14.29 59.03 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 117.316 1.686 . . . . 72.409999999999997 117.316 168.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m 60.42 -75.94 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.402 1.101 . . . . 75.219999999999999 111.489 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.109999999999999 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.119999999999997 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.140000000000001 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.409999999999997 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.010000000000005 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.019999999999996 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.439999999999998 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 4.6 t30 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.030000000000001 107.842 175.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.420000000000002 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.400000000000006 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.549999999999997 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.439999999999998 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.439999999999998 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 51.119999999999997 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.229999999999997 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.299999999999997 110.259 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 44.109999999999999 108.979 -177.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.129999999999995 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.030000000000001 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.319999999999993 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.109999999999999 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.340000000000003 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.049999999999997 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.409999999999997 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.209999999999994 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.530000000000001 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.350000000000001 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 74.530000000000001 112.554 -179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.230000000000004 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.120000000000005 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 41.350000000000001 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.150000000000006 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.340000000000003 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.450000000000003 108.723 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 119' ' ' LEU . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.430000000000007 106.487 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 72.040000000000006 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.432 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.420000000000002 111.481 -176.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.230000000000004 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.439999999999998 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.420000000000002 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.401 ' HE2' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.540000000000006 109.793 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.099999999999994 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.129999999999995 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.530000000000001 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.340000000000003 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 72.030000000000001 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.540000000000006 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' HG2' ' A' ' 105' ' ' ARG . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.509999999999998 110.484 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.239999999999995 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.200000000000003 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.229999999999997 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.450000000000003 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.420000000000002 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.439999999999998 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 63.030000000000001 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -63.22 114.08 11.59 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.109999999999999 109.147 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.25 -22.35 32.43 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.497 2.798 . . . . 74.510000000000005 114.168 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.04 25.53 11.38 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.968 -1.11 . . . . 73.329999999999998 114.183 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.71 19.43 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 119.239 -1.458 . . . . 74.120000000000005 113.684 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.9 154.96 53.55 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.82 2.347 . . . . 71.140000000000001 112.859 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.09 -177.13 24.05 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.310000000000002 110.407 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.340000000000003 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.109999999999999 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.299999999999997 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 72.230000000000004 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 73.25 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.200000000000003 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 52.450000000000003 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.319999999999993 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.478 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.140000000000001 113.211 -171.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.239999999999995 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.655 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.140000000000001 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.420000000000002 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.420000000000002 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.655 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.200000000000003 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.200000000000003 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.430000000000007 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.119999999999997 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 71.239999999999995 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' A' ' 154' ' ' LEU . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 60.310000000000002 114.309 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 55.299999999999997 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 51.210000000000001 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.495 ' H ' HD22 ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 65.25 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.540000000000006 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.420000000000002 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 63.409999999999997 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.239999999999995 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.129999999999995 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 165' ' ' ILE . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 64.329999999999998 110.647 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.540000000000006 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.439999999999998 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.210000000000001 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.409999999999997 111.565 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.549 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.439999999999998 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.129999999999995 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.319999999999993 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 53.130000000000003 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 34' ' ' ALA . 90.6 mt -80.72 -39.7 26.6 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.400000000000006 110.747 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 60.61 73.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.48 -1.236 . . . . 44.149999999999999 111.432 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.47 157.2 45.23 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.527 -1.67 . . . . 75.319999999999993 108.648 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 106.41 -1.7 . . . . 70.329999999999998 106.41 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.558 1.26 0 N-CA-C 114.337 1.236 . . . . 71.099999999999994 114.337 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.95 164.66 25.0 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.045 0.757 . . . . 72.239999999999995 113.045 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.53 51.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.216 -0.902 . . . . 71.239999999999995 111.643 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -66.19 -27.94 68.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.484 -0.78 . . . . 73.219999999999999 111.581 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 23' ' ' VAL . 28.0 m -65.08 -3.92 4.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.459 1.281 . . . . 44.020000000000003 114.459 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.24 32.94 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.345 0.658 . . . . 64.510000000000005 112.171 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 21' ' ' SER . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.25 109.862 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.240000000000002 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.349999999999994 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.109999999999999 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.519999999999996 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.030000000000001 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.430000000000007 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.119999999999997 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.409999999999997 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.430000000000007 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.140000000000001 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.530000000000001 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 41.310000000000002 112.045 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.439999999999998 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.200000000000003 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.140000000000001 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -78.17 -29.21 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 72.209999999999994 113.564 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.9 mmt -54.02 -24.06 15.67 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 116.756 2.132 . . . . 75.239999999999995 116.756 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.6 -18.0 18.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.547 -0.861 . . . . 74.409999999999997 110.974 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.43 106.06 3.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.599 -0.728 . . . . 52.119999999999997 110.411 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.82 69.06 1.86 Allowed Glycine 0 C--N 1.296 -1.686 0 CA-C-N 114.529 -1.214 . . . . 53.409999999999997 112.094 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -92.12 150.94 41.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.034 -0.728 . . . . 74.329999999999998 109.034 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.87 115.29 1.76 Allowed 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.151 2.567 . . . . 35.140000000000001 112.601 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -77.21 104.19 7.57 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.517 -0.919 . . . . 62.299999999999997 108.517 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -54.53 170.55 0.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.821 1.786 . . . . 74.349999999999994 115.821 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t 80.43 92.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.025 1.33 . . . . 51.340000000000003 108.701 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t -130.73 159.48 37.14 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.651 -1.158 . . . . 63.219999999999999 109.023 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -135.75 149.89 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.436 -0.579 . . . . 74.099999999999994 109.436 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 95.45 0.07 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.253 0.549 . . . . 70.439999999999998 110.895 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 p -169.89 175.2 1.6 Allowed Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.171 -1.418 . . . . 73.129999999999995 107.171 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.88 111.87 1.03 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.032 1.822 . . . . 75.200000000000003 110.537 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.17 61.31 0.45 Allowed Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 110.615 -0.994 . . . . 53.229999999999997 110.615 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -76.25 139.37 41.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.666 -0.494 . . . . 72.430000000000007 109.666 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.8 mm 69.89 -56.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.901 1.28 . . . . 74.409999999999997 111.679 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.77 93.22 6.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.049 -1.093 . . . . 70.0 108.049 174.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.99 -80.1 0.39 Allowed Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.332 -0.707 . . . . 42.310000000000002 111.332 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -170.82 135.21 1.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.139 0.495 . . . . 72.140000000000001 110.837 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.71 137.54 26.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.774 -1.195 . . . . 72.329999999999998 107.774 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 tt -160.3 118.94 2.65 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.332 -1.729 . . . . 74.439999999999998 106.332 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -108.51 -20.15 13.2 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.525 -0.47 . . . . 73.209999999999994 111.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 66.67 109.5 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 61.439999999999998 112.282 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.46 -32.05 5.18 Favored Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 110.54 -1.024 . . . . 72.129999999999995 110.54 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.19 102.29 12.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.387 -0.968 . . . . 74.030000000000001 108.387 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -94.43 -16.17 23.64 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.789 -0.365 . . . . 74.420000000000002 110.606 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.65 12.59 84.3 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.182 -0.463 . . . . 74.120000000000005 112.224 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p -134.18 164.12 28.08 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.51 0.324 . . . . 73.230000000000004 110.341 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.540000000000006 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.049999999999997 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.240000000000002 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.319999999999993 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.010000000000005 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 61.200000000000003 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.340000000000003 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 36.4 m-80 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.349999999999994 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 54.340000000000003 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.140000000000001 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.498 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.510000000000005 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.450000000000003 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.030000000000001 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.049999999999997 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.430000000000007 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.109999999999999 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 62.43 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.530000000000001 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.519 ' H ' ' HE2' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.519999999999996 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.219999999999999 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 105' ' ' ARG . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.129999999999995 107.931 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.450000000000003 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.239999999999995 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.329999999999998 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.120000000000005 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.540000000000006 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.140000000000001 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.140000000000001 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.430000000000007 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.400000000000006 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 51.229999999999997 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.040000000000006 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.340000000000003 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 73.349999999999994 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 91' ' ' ARG . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 62.149999999999999 110.767 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.402 HG11 ' HE1' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 64.239999999999995 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.219999999999999 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.530000000000001 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.019999999999996 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.010000000000005 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.239999999999995 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.319999999999993 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.129999999999995 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.519999999999996 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.209999999999994 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.539999999999999 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.310000000000002 106.592 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.210000000000001 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.515 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.230000000000004 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 61.25 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.349999999999994 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.439999999999998 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 61.240000000000002 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 63.420000000000002 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.400000000000006 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -98.25 125.77 42.25 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.009999999999998 111.461 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -64.09 115.21 3.0 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.475 2.117 . . . . 72.120000000000005 109.501 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.37 -34.91 1.94 Allowed Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.53 -1.028 . . . . 72.319999999999993 110.53 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.44 -91.01 0.33 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.381 -0.914 . . . . 62.43 112.977 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.39 140.17 39.72 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.813 2.342 . . . . 74.019999999999996 113.106 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.79 -177.68 40.4 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.514 -0.766 . . . . 52.210000000000001 111.634 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.239999999999995 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.319999999999993 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.310000000000002 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.219999999999999 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 64.310000000000002 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 61.43 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.229999999999997 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.239999999999995 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.219999999999999 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.540000000000006 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.430000000000007 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.209999999999994 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.519999999999996 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.140000000000001 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.400000000000006 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.219999999999999 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 52.409999999999997 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 53.299999999999997 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.140000000000001 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.129999999999995 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.010000000000005 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.540000000000006 110.965 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.209999999999994 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 62.049999999999997 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.319999999999993 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.140000000000001 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.329999999999998 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 63.25 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.409999999999997 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.505 ' CB ' HG11 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 43.299999999999997 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.230000000000004 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.219999999999999 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.519999999999996 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.319999999999993 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.209999999999994 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 62.530000000000001 109.349 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.310000000000002 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.1 -35.13 79.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.340000000000003 110.167 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.78 -41.32 60.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.287 -0.869 . . . . 63.119999999999997 112.055 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 168' ' ' HIS . 23.5 mm-40 -69.7 170.89 9.99 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.596 0.712 . . . . 74.109999999999999 112.767 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.658 -1.156 . . . . 75.319999999999993 110.275 -177.769 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.31 -1.367 . . . . 62.039999999999999 107.31 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -101.67 159.22 15.5 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.951 -0.389 . . . . 42.140000000000001 109.951 -178.662 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.68 105.04 15.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.258 -1.386 . . . . 65.230000000000004 107.258 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.4 p -60.68 -40.1 90.9 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.307 0.575 . . . . 63.200000000000003 111.123 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -89.15 -3.6 58.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.589 -0.732 . . . . 62.43 110.63 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt 68.85 -23.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.292 . . . . 72.409999999999997 113.823 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.140000000000001 106.918 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.040000000000006 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.109999999999999 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.219999999999999 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.540000000000006 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.340000000000003 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 61.009999999999998 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.400000000000006 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.319999999999993 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 62.009999999999998 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.020000000000003 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.239999999999995 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 65.209999999999994 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.119999999999997 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.549999999999997 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' HB3' ' NZ ' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.209999999999994 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 42' ' ' MET . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.219999999999999 108.452 177.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 64.230000000000004 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 59.8 m80 -75.93 -28.93 58.17 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.200000000000003 114.347 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -53.13 -21.36 4.81 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.059 1.503 . . . . 75.340000000000003 115.059 -173.422 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 99.0 m-85 -65.92 -31.67 72.73 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 109.26 -0.644 . . . . 63.030000000000001 109.26 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.91 -47.17 4.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.28 -0.637 . . . . 52.409999999999997 109.28 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.56 -119.29 4.02 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.264 -1.135 . . . . 75.450000000000003 110.264 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 31.1 mmtp -100.73 160.84 25.68 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.761 -0.829 . . . . 74.140000000000001 108.761 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -41.61 -44.83 6.38 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 124.155 3.237 . . . . 72.340000000000003 112.989 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.519 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . 39.4 t60 -147.64 -46.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.474 -0.33 . . . . 65.030000000000001 110.555 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 13.0 t60 68.8 114.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.266 1.027 . . . . 75.219999999999999 111.38 -177.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.74 148.32 22.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.393 -0.595 . . . . 75.299999999999997 109.393 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -95.6 112.59 24.28 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.288 -1.004 . . . . 73.120000000000005 108.288 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 72.52 159.17 0.21 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.976 0.91 . . . . 62.350000000000001 109.843 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 84.69 6.56 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.715 -0.846 . . . . 63.200000000000003 108.715 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -160.87 172.73 5.48 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 106.627 -1.619 . . . . 74.420000000000002 106.627 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.31 109.67 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.839 1.692 . . . . 71.420000000000002 110.179 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.58 -56.58 14.32 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 115.62 -0.718 . . . . 72.450000000000003 112.709 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 69.34 -70.44 0.14 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.08 0.952 . . . . 73.409999999999997 109.634 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.3 mt -74.61 117.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.561 -1.274 . . . . 73.239999999999995 107.561 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 11.7 pt20 -92.81 152.06 19.66 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.715 -0.675 . . . . 55.240000000000002 111.061 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.15 5.27 81.41 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.979 -0.848 . . . . 72.430000000000007 110.979 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 48' ' ' HIS . 39.6 m -76.78 83.57 3.38 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.625 -0.88 . . . . 51.43 108.625 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.54 -32.68 54.07 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.287 -0.87 . . . . 62.43 110.956 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 48.0 tp 62.93 83.84 0.15 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.872 -1.058 . . . . 73.329999999999998 108.689 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -91.01 95.95 10.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.687 -1.142 . . . . 74.519999999999996 110.185 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -110.39 154.01 24.16 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.501 -0.772 . . . . 71.099999999999994 109.278 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.64 134.85 28.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 109.829 -1.308 . . . . 55.210000000000001 109.829 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -62.65 -17.94 61.37 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.936 1.087 . . . . 64.519999999999996 113.936 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.544 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 87.6 m95 -102.13 18.11 21.63 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.551 -0.46 . . . . 74.099999999999994 110.753 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.16 41.28 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.846 -0.693 . . . . 62.219999999999999 112.855 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m 72.47 -71.79 0.13 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.807 0.843 . . . . 54.329999999999998 111.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.140000000000001 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.400000000000006 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 68' ' ' TRP . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.219999999999999 109.001 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.409999999999997 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.319999999999993 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 71.409999999999997 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.349999999999994 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.349999999999994 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.319999999999993 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.540000000000006 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.340000000000003 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.329999999999998 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.519999999999996 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 64.540000000000006 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 50.030000000000001 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 64.049999999999997 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.130000000000003 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.400000000000006 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.209999999999994 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.239999999999995 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.129999999999995 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.219999999999999 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.230000000000004 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.439999999999998 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.210000000000001 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.019999999999996 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.319999999999993 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.510000000000005 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.219999999999999 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' HD21 ' A' ' 119' ' ' LEU . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 52.329999999999998 110.543 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.439999999999998 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.010000000000005 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.530000000000001 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.525 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.039999999999999 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.400000000000006 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.129999999999995 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.329999999999998 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.010000000000005 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 63.439999999999998 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.450000000000003 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.129999999999995 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.439999999999998 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.329999999999998 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.495 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.430000000000007 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 103' ' ' THR . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.409999999999997 109.006 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.505 HD23 ' H ' ' A' ' 120' ' ' LEU . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.329999999999998 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.310000000000002 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.030000000000001 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.109999999999999 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.129999999999995 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 62.020000000000003 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.040000000000006 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 63.2 tttm -119.2 -57.06 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.230000000000004 111.309 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 11.5 Cg_exo -76.58 -55.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.24 1.294 . . . . 73.519999999999996 109.829 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.03 142.13 6.75 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 116.017 -0.538 . . . . 63.420000000000002 112.369 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.49 -121.24 12.56 Favored Glycine 0 N--CA 1.45 -0.416 0 O-C-N 123.701 0.294 . . . . 74.310000000000002 112.736 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.85 39.48 0.81 Allowed 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.524 2.816 . . . . 63.039999999999999 111.627 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -163.13 113.67 0.57 Allowed Glycine 0 C--N 1.274 -2.889 0 CA-C-N 114.893 -1.049 . . . . 73.409999999999997 111.099 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.030000000000001 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.534 HG13 ' HD3' ' A' ' 127' ' ' LYS . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.019999999999996 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 54.439999999999998 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.219999999999999 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.430000000000007 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.239999999999995 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.219999999999999 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.540000000000006 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.140000000000001 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.229999999999997 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.523 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 72.439999999999998 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.519999999999996 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 72.219999999999999 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.523 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.439999999999998 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 64.239999999999995 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.020000000000003 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.239999999999995 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.239999999999995 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.109999999999999 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.230000000000004 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' THR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 156' ' ' GLN . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.209999999999994 111.192 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 71.120000000000005 110.827 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.530000000000001 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 1.1 pp0? -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.150000000000006 112.004 176.816 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.349999999999994 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.439999999999998 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.010000000000005 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.509999999999998 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.310000000000002 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.009999999999998 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.409999999999997 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.340000000000003 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.230000000000004 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.409999999999997 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.239999999999995 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 54.200000000000003 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.15 -43.24 71.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.039999999999999 109.311 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 36.18 76.49 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.758 1.623 . . . . 54.549999999999997 114.197 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.39 148.38 52.2 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.267 -0.878 . . . . 51.039999999999999 109.06 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 119.054 -0.498 . . . . 74.209999999999994 110.27 -173.266 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 CA--C 1.557 1.233 0 CA-C-O 120.91 0.386 . . . . 61.100000000000001 111.726 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.92 90.31 1.93 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.645 0.736 . . . . 65.409999999999997 111.83 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 178.35 25.88 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 126.811 2.044 . . . . 65.420000000000002 105.849 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 m -57.01 -48.7 77.85 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.22 -1.355 . . . . 62.310000000000002 112.799 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -85.99 -28.89 23.93 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 111.78 0.289 . . . . 71.109999999999999 111.78 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt 65.4 5.04 2.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.328 1.051 . . . . 64.299999999999997 112.365 -172.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 71.510000000000005 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.030000000000001 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.120000000000005 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.239999999999995 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.200000000000003 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.109999999999999 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.329999999999998 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.030000000000001 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.409999999999997 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.230000000000004 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.310000000000002 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.140000000000001 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.310000000000002 111.042 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.119999999999997 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.329999999999998 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.310000000000002 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 25.6 t-80 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.400000000000006 109.812 178.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 58.3 m80 -66.13 -44.29 84.68 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 64.450000000000003 113.51 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.29 -23.91 67.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.571 0.952 . . . . 74.219999999999999 113.571 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 45' ' ' GLY . 43.7 t80 -101.36 5.26 42.16 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.128 -1.029 . . . . 72.409999999999997 110.888 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.6 22.21 0.47 Allowed 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.447 -0.783 . . . . 74.329999999999998 111.013 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 43' ' ' PHE . . . 160.87 -143.48 8.99 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.214 -1.554 . . . . 75.109999999999999 109.214 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -146.56 146.83 28.45 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.347 -0.983 . . . . 74.030000000000001 108.347 178.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.96 172.53 16.18 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.185 1.923 . . . . 71.239999999999995 111.904 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -82.78 97.3 8.53 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.704 0.764 . . . . 51.310000000000002 109.117 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -113.29 119.91 39.34 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.94 -1.027 . . . . 75.099999999999994 109.563 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.16 140.88 15.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.636 -0.876 . . . . 73.319999999999993 108.636 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 64' ' ' HIS . 14.6 t -140.94 -176.72 4.78 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.869 -1.53 . . . . 64.549999999999997 106.869 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -70.79 123.52 22.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.058 -0.657 . . . . 73.219999999999999 111.502 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 109.29 6.32 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.698 -1.137 . . . . 61.229999999999997 111.327 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.0 m -149.34 83.14 6.64 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.331 -0.395 . . . . 61.030000000000001 110.171 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.48 148.53 42.91 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.416 2.077 . . . . 72.340000000000003 110.776 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.33 -175.72 38.96 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.181 -0.768 . . . . 73.519999999999996 111.181 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -84.07 103.09 13.01 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.783 -0.451 . . . . 63.43 109.783 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 58' ' ' ILE . 42.0 mm 64.44 23.17 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-O 122.406 1.098 . . . . 65.010000000000005 110.606 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -165.62 179.66 5.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.557 -0.747 . . . . 60.399999999999999 109.193 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.62 -163.85 29.05 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.053 -1.07 . . . . 53.119999999999997 112.104 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.7 t -147.01 152.04 37.94 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.412 -0.959 . . . . 73.510000000000005 108.412 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -78.2 -50.68 11.47 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.206 -0.664 . . . . 74.140000000000001 109.206 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.91 111.18 21.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.808 -0.812 . . . . 74.109999999999999 108.808 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 64.7 t-80 -63.72 -41.0 98.13 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.56 -1.274 . . . . 71.439999999999998 107.56 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -144.88 148.38 33.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.366 1.466 . . . . 74.319999999999993 107.225 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -159.58 28.2 Favored Glycine 0 C--N 1.319 -0.406 0 C-N-CA 119.984 -1.103 . . . . 75.540000000000006 112.917 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.89 129.73 34.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.284 0.634 . . . . 72.450000000000003 109.906 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -93.34 -17.11 23.94 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.721 -0.792 . . . . 73.409999999999997 110.38 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.39 12.59 83.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.432 0.933 . . . . 55.049999999999997 115.432 170.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -144.7 -177.91 5.74 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 117.866 0.833 . . . . 51.119999999999997 110.397 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 95' ' ' VAL . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.310000000000002 108.67 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.040000000000006 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.219999999999999 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.409999999999997 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.530000000000001 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.140000000000001 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 35.1 m-80 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.140000000000001 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 62.450000000000003 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 72.400000000000006 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.409999999999997 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.409999999999997 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.310000000000002 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 63.219999999999999 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.530000000000001 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.030000000000001 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.109999999999999 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.340000000000003 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.329999999999998 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.329999999999998 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.239999999999995 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.539999999999999 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 51.119999999999997 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.420000000000002 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.340000000000003 111.465 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.549999999999997 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.329999999999998 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.519999999999996 111.848 -174.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.627 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.340000000000003 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.239999999999995 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.329999999999998 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.129999999999995 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.049999999999997 109.735 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 64.109999999999999 110.072 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.329999999999998 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 71.540000000000006 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.409999999999997 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.439999999999998 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.577 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.299999999999997 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.530000000000001 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.439999999999998 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.540000000000006 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 64.25 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 74.420000000000002 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.349999999999994 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.109999999999999 108.712 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.510000000000005 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.230000000000004 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.130000000000003 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.209999999999994 109.074 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.310000000000002 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.240000000000002 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.209999999999994 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.200000000000003 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 62.299999999999997 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.59 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.6 tttt -147.01 -60.29 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.109999999999999 111.754 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 61.3 Cg_endo -92.02 6.89 3.31 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.4 1.4 . . . . 73.450000000000003 110.75 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 147.84 -166.83 28.82 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 31.23 109.181 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.39 -75.28 0.94 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.597 -0.601 . . . . 51.039999999999999 111.597 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 9.8 Cg_endo -54.43 129.23 33.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.035 2.49 . . . . 64.239999999999995 110.615 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.31 73.03 1.26 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.420000000000002 109.254 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.310000000000002 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.505 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.140000000000001 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.229999999999997 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.239999999999995 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 73.25 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 63.299999999999997 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.349999999999994 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.530000000000001 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.510000000000005 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.209999999999994 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.478 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.140000000000001 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 72.129999999999995 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 65.510000000000005 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.310000000000002 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.329999999999998 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.340000000000003 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.430000000000007 110.791 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.530000000000001 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.400000000000006 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.219999999999999 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 61.210000000000001 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.219999999999999 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 74.319999999999993 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.140000000000001 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.310000000000002 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.420000000000002 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 156' ' ' GLN . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 73.010000000000005 111.967 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.299999999999997 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.430000000000007 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 52.200000000000003 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 71.239999999999995 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.439999999999998 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 73.5 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.140000000000001 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.439999999999998 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 55.43 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.420000000000002 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.11 -25.79 31.63 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.319999999999993 110.691 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -19.04 65.02 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.161 -0.927 . . . . 73.340000000000003 112.017 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -121.77 162.09 21.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.763 0.316 . . . . 72.340000000000003 110.593 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.624 -1.251 . . . . 74.540000000000006 107.624 176.206 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.573 1.833 0 CA-C-O 121.581 0.705 . . . . 73.010000000000005 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.07 121.02 17.49 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 121.358 -0.838 . . . . 74.010000000000005 109.222 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.05 142.04 18.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 116.107 -0.497 . . . . 72.340000000000003 110.375 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -72.57 -36.87 68.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.722 0.638 . . . . 60.450000000000003 112.722 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.6 p -86.37 -22.35 26.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.856 -0.338 . . . . 72.349999999999994 111.69 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt 66.88 -4.66 0.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.568 1.147 . . . . 74.230000000000004 113.132 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.120000000000005 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.120000000000005 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.219999999999999 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.400000000000006 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.299999999999997 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.219999999999999 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.219999999999999 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.129999999999995 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.299999999999997 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.109999999999999 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.109999999999999 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 41.32 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 63.43 111.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.329999999999998 108.345 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.450000000000003 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.530000000000001 110.535 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 62.539999999999999 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.140000000000001 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -62.58 -29.54 70.67 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 55.439999999999998 110.909 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.16 -26.63 60.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.579 -0.282 . . . . 73.519999999999996 111.738 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -82.85 -32.21 27.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.562 0.696 . . . . 73.430000000000007 109.595 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.39 28.49 3.68 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.346 -0.983 . . . . 71.409999999999997 108.346 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.41 48.46 2.88 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.101 -0.954 . . . . 42.130000000000003 114.116 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.04 95.89 31.72 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 107.716 -1.216 . . . . 75.200000000000003 107.716 170.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 176.79 6.38 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 123.018 2.478 . . . . 74.129999999999995 113.21 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -79.96 150.64 30.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.328 -0.99 . . . . 72.0 108.328 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -130.86 109.46 10.58 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.768 -0.827 . . . . 53.149999999999999 108.768 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.33 149.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 120.818 0.342 . . . . 74.430000000000007 111.149 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 54' ' ' SER . 47.8 t -140.96 90.51 2.33 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.019 0.438 . . . . 73.439999999999998 111.377 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.59 -40.19 17.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.853 -1.166 . . . . 75.329999999999998 107.853 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.54 85.81 1.52 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 42.409999999999997 107.988 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.452 ' HB2' ' OG ' ' A' ' 51' ' ' SER . 46.9 m -152.58 102.4 2.72 Favored Pre-proline 0 N--CA 1.435 -1.203 0 CA-C-N 116.052 -0.522 . . . . 41.43 112.222 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.09 -22.41 22.72 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.124 1.883 . . . . 73.540000000000006 109.689 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.34 71.88 0.04 OUTLIER Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.746 -1.741 . . . . 71.219999999999999 108.746 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -93.16 92.0 7.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 113.422 0.897 . . . . 73.430000000000007 113.422 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 60' ' ' GLY . 42.6 mm -122.95 123.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.11 -1.811 . . . . 64.439999999999998 106.11 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.468 ' HG3' ' SG ' ' A' ' 61' ' ' CYS . 10.9 pt20 -82.66 -5.78 59.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.3 0.481 . . . . 73.310000000000002 112.3 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 58' ' ' ILE . . . 72.13 74.54 0.75 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 121.155 -0.545 . . . . 73.329999999999998 112.636 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.468 ' SG ' ' HG3' ' A' ' 59' ' ' GLN . 61.9 m -104.54 -1.78 26.1 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.711 0.767 . . . . 73.230000000000004 109.297 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.73 135.95 33.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.202 -0.908 . . . . 72.450000000000003 112.156 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -133.85 -60.29 0.83 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.901 -1.888 . . . . 70.329999999999998 105.901 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -148.87 115.84 6.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.004 -1.48 . . . . 74.140000000000001 107.004 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.66 -6.07 47.22 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.755 0.788 . . . . 72.5 109.933 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.88 -130.92 3.07 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 109.013 -1.635 . . . . 60.119999999999997 109.013 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.17 -171.77 3.65 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.863 -1.162 . . . . 72.430000000000007 107.863 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -77.54 -17.31 58.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 112.251 0.463 . . . . 74.299999999999997 112.251 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.54 13.93 82.95 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.694 -0.765 . . . . 75.439999999999998 112.137 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.507 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m -126.85 143.09 51.37 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 53.420000000000002 110.699 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 63.030000000000001 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.340000000000003 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.120000000000005 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.310000000000002 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.519999999999996 110.378 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 60.229999999999997 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.039999999999999 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.7 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.219999999999999 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 34.109999999999999 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.430000000000007 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.129999999999995 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.420000000000002 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.140000000000001 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.510000000000005 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.140000000000001 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.219999999999999 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.039999999999999 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.510000000000005 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.329999999999998 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.310000000000002 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.329999999999998 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.240000000000002 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.140000000000001 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 73.109999999999999 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.150000000000006 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 61.299999999999997 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.340000000000003 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.420000000000002 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.712 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.400000000000006 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.240000000000002 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.109999999999999 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 54.149999999999999 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 64.340000000000003 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.299999999999997 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.319999999999993 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.409999999999997 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.329999999999998 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.109999999999999 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.510000000000005 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.200000000000003 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.319999999999993 112.073 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.350000000000001 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 72.540000000000006 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.530000000000001 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 64.230000000000004 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.568 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.239999999999995 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 64.540000000000006 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 45.240000000000002 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 60.149999999999999 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 72.450000000000003 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.219999999999999 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 36' ' ' ALA . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 70.109999999999999 108.467 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.439999999999998 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.099999999999994 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt -86.82 167.14 23.37 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.409999999999997 109.035 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.78 112.31 0.87 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.134 1.889 . . . . 75.230000000000004 110.248 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.16 -55.41 0.71 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.786 -0.926 . . . . 71.510000000000005 110.786 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 126.53 -64.46 0.58 Allowed Glycine 0 CA--C 1.539 1.57 0 C-N-CA 120.061 -1.066 . . . . 74.209999999999994 114.85 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.31 -53.72 5.8 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 123.354 2.702 . . . . 72.109999999999999 114.061 -176.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . -81.52 165.48 46.41 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.140000000000001 111.413 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 51.409999999999997 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.239999999999995 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.340000000000003 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.400000000000006 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.219999999999999 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 71.420000000000002 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.210000000000001 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 71.299999999999997 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.439999999999998 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.200000000000003 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.209999999999994 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.340000000000003 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.329999999999998 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.209999999999994 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 54.149999999999999 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.430000000000007 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.340000000000003 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 72.439999999999998 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.329999999999998 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.510000000000005 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 64.140000000000001 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 50.329999999999998 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 54.240000000000002 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.519999999999996 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 62.030000000000001 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.430000000000007 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.530000000000001 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.099999999999994 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 55.25 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.517 ' CB ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.109999999999999 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.109999999999999 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.239999999999995 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.409999999999997 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.319999999999993 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.200000000000003 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.109999999999999 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 53.5 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 33' ' ' LYS . 85.3 mt -68.99 -41.27 78.09 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.63 15.93 9.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.048 -1.433 . . . . 64.409999999999997 110.863 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.27 149.65 21.33 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.255 -1.339 . . . . 54.049999999999997 108.151 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.277 -2.575 0 CA-C-O 118.078 -0.963 . . . . 74.329999999999998 109.35 -175.796 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 61.509999999999998 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.47 127.54 32.54 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.474 -0.785 . . . . 72.329999999999998 112.222 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.52 96.45 2.27 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.269 -1.011 . . . . 35.450000000000003 108.269 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -61.57 -48.37 81.26 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.748 -0.66 . . . . 71.239999999999995 112.582 -174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.6 t -90.86 -5.81 55.05 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.733 -0.387 . . . . 71.329999999999998 110.848 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt 57.27 27.49 13.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.457 0.703 . . . . 61.32 112.603 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 63.229999999999997 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.099999999999994 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.450000000000003 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.129999999999995 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 51.509999999999998 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 53.25 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.140000000000001 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.310000000000002 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.340000000000003 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.239999999999995 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 61.020000000000003 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.219999999999999 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 54.420000000000002 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.319999999999993 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 72.200000000000003 112.396 178.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.230000000000004 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.109999999999999 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.299999999999997 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 56.7 m80 -59.16 -38.19 79.14 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.120000000000005 111.277 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 81.7 mtp -59.86 -26.55 65.94 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.1 0.778 . . . . 70.239999999999995 113.1 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -101.59 -31.96 10.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.167 -0.613 . . . . 72.439999999999998 111.25 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.49 -37.29 28.15 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.113 0.412 . . . . 73.109999999999999 112.113 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.0 80.54 0.13 Allowed Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 108.697 -1.761 . . . . 75.219999999999999 108.697 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 132.52 5.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 114.026 1.121 . . . . 73.140000000000001 114.026 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.38 3.8 7.49 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 123.565 2.844 . . . . 74.150000000000006 110.726 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -134.8 93.55 3.04 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.853 -1.067 . . . . 72.099999999999994 108.365 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -95.64 150.93 19.81 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.56 -0.456 . . . . 51.130000000000003 109.914 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -98.1 96.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.45 1.119 . . . . 70.230000000000004 111.511 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.411 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . 27.0 m -143.99 96.39 2.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.438 -1.255 . . . . 72.010000000000005 107.759 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -134.85 -59.19 0.8 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.105 -0.498 . . . . 73.230000000000004 110.852 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.66 115.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.462 1.101 . . . . 62.109999999999999 111.712 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 21.2 p -62.92 133.71 95.4 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.398 -0.819 . . . . 74.530000000000001 112.237 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 50.5 Cg_exo -57.53 119.8 7.29 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.472 2.114 . . . . 72.439999999999998 111.27 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.27 48.46 1.32 Allowed Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.013 -1.235 . . . . 72.409999999999997 110.013 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -146.27 160.11 42.44 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.15 -1.426 . . . . 55.109999999999999 107.15 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.53 -31.22 52.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.568 -0.901 . . . . 71.219999999999999 108.568 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 71.66 96.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.423 1.489 . . . . 73.549999999999997 112.089 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -57.71 0.28 Allowed Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.45 -1.06 . . . . 53.109999999999999 110.45 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 51' ' ' SER . 28.0 t 60.59 28.65 18.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.584 1.183 . . . . 73.129999999999995 108.126 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.33 -28.76 57.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.073 -1.421 . . . . 73.540000000000006 110.926 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.21 111.13 9.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.882 -0.599 . . . . 71.140000000000001 109.566 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -73.91 123.47 24.31 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.893 -0.594 . . . . 71.400000000000006 110.273 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.33 158.37 43.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.045 -0.724 . . . . 73.329999999999998 109.045 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 -14.12 17.88 Favored Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.251 -1.14 . . . . 63.43 110.251 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -178.09 151.32 0.65 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.528 -1.286 . . . . 75.439999999999998 107.528 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -106.06 -16.73 14.54 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.687 -0.486 . . . . 75.420000000000002 109.687 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -5.89 81.31 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.793 -0.64 . . . . 44.509999999999998 113.642 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -115.79 144.35 44.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 111.916 0.339 . . . . 72.299999999999997 111.916 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.030000000000001 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.329999999999998 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 61.43 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 61.109999999999999 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.120000000000005 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.450000000000003 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.439999999999998 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.200000000000003 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 63.439999999999998 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.140000000000001 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.539999999999999 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.219999999999999 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.239999999999995 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.129999999999995 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.319999999999993 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.400000000000006 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.299999999999997 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.219999999999999 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.399999999999999 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.030000000000001 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 70.439999999999998 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.319999999999993 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 60.240000000000002 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.510000000000005 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.150000000000006 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.420000000000002 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.109999999999999 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.049999999999997 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.438 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.319999999999993 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 65.019999999999996 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.120000000000005 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 55.240000000000002 110.609 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.349999999999994 108.54 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 53.409999999999997 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 72.230000000000004 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.673 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 65.010000000000005 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.219999999999999 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.430000000000007 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.120000000000005 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.109999999999999 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.438 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.230000000000004 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.540000000000006 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.400000000000006 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.120000000000005 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.329999999999998 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 64.200000000000003 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 73.209999999999994 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.581 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.310000000000002 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 65.040000000000006 109.991 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.340000000000003 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.420000000000002 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 51.119999999999997 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.409999999999997 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.520000000000003 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.67 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 63.3 tttm -99.49 -67.45 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.230000000000004 110.556 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 31.1 Cg_exo -63.69 -39.66 33.56 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 120.818 1.328 . . . . 54.420000000000002 110.014 170.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.48 135.99 8.99 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.673 -0.694 . . . . 63.32 111.422 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.01 -110.58 3.15 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.363 -0.695 . . . . 45.340000000000003 111.363 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 97.8 Cg_endo -81.57 29.47 0.54 Allowed 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.362 2.708 . . . . 72.409999999999997 112.205 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . -152.0 106.59 0.31 Allowed Glycine 0 C--N 1.286 -2.226 0 CA-C-N 115.48 -0.782 . . . . 63.219999999999999 112.973 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 41.340000000000003 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 64.310000000000002 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.400000000000006 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 63.409999999999997 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.230000000000004 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 73.329999999999998 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.150000000000006 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.530000000000001 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 63.43 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.540000000000006 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.439999999999998 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 62.409999999999997 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.340000000000003 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.129999999999995 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.329999999999998 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.329999999999998 111.053 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.219999999999999 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 52.420000000000002 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.530000000000001 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 64.25 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.010000000000005 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.420000000000002 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 61.5 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.299999999999997 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 62.030000000000001 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.219999999999999 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.439999999999998 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.150000000000006 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.340000000000003 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.310000000000002 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 61.240000000000002 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.603 ' O ' HD13 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.329999999999998 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.319999999999993 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.519999999999996 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.400000000000006 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.209999999999994 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt -84.15 -19.39 34.24 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.239999999999995 110.828 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.6 -45.14 17.8 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.07 -0.968 . . . . 60.210000000000001 111.615 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -109.1 168.56 9.28 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.495 0.554 . . . . 72.109999999999999 112.495 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 115.438 -0.801 . . . . 74.209999999999994 109.7 -177.709 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 111.403 0.149 . . . . 71.140000000000001 111.403 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.22 145.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.076 0.951 . . . . 71.109999999999999 111.352 -175.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.89 138.59 10.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.231 -0.655 . . . . 73.140000000000001 109.231 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 p -60.79 -28.37 68.7 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.882 0.473 . . . . 44.149999999999999 111.895 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 m -72.74 -4.7 33.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 113.086 0.773 . . . . 74.049999999999997 113.086 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -70.93 -4.43 24.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 53.219999999999999 110.932 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.510000000000005 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.100000000000001 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.340000000000003 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 53.149999999999999 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.219999999999999 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.019999999999996 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 42.210000000000001 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.400000000000006 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 73.439999999999998 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.430000000000007 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.400000000000006 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 63.130000000000003 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.430000000000007 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.420000000000002 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 44.420000000000002 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.439999999999998 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 -64.14 -30.44 71.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.209999999999994 110.257 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 93.8 mmm -59.74 -24.35 63.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.486 0.715 . . . . 71.140000000000001 112.684 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.34 -28.63 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 72.25 110.868 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.47 97.55 9.52 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.458 -0.571 . . . . 54.210000000000001 109.458 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.85 -170.76 23.6 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.888 -0.885 . . . . 45.549999999999997 110.888 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.62 150.98 40.28 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 110.238 -0.282 . . . . 73.439999999999998 110.238 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.11 163.14 14.9 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.056 2.504 . . . . 73.409999999999997 112.596 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -77.44 109.77 11.65 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 116.064 -0.516 . . . . 73.010000000000005 111.63 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -65.57 128.36 35.6 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.675 -1.148 . . . . 55.439999999999998 108.026 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.28 134.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.162 -0.681 . . . . 72.5 109.162 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 t -89.04 104.49 17.03 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.706 0.765 . . . . 75.430000000000007 109.531 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -129.24 149.49 51.01 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.909 -1.041 . . . . 73.430000000000007 108.391 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.92 -67.12 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.549 -1.278 . . . . 62.229999999999997 107.549 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 79.6 p 56.61 145.69 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.011 1.724 . . . . 71.329999999999998 114.344 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 12.6 Cg_exo -71.38 100.75 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.609 1.539 . . . . 73.099999999999994 109.459 173.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.67 164.82 19.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.516 -0.849 . . . . 43.399999999999999 112.158 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.6 100.37 11.91 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.41 0.624 . . . . 74.230000000000004 109.872 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.2 mt 70.96 98.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 114.72 -1.127 . . . . 73.230000000000004 109.35 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -53.66 121.37 7.69 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.111 -0.95 . . . . 73.219999999999999 112.06 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.24 -102.13 0.23 Allowed Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 108.728 -1.749 . . . . 63.299999999999997 108.728 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.6 t -154.34 136.48 14.76 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.722 -0.473 . . . . 75.200000000000003 109.722 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.3 147.47 30.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.128 -1.804 . . . . 60.399999999999999 106.128 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.53 69.48 4.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.478 0.656 . . . . 71.540000000000006 110.251 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -98.03 101.93 13.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.142 -1.058 . . . . 70.219999999999999 108.142 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -108.23 144.78 35.22 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.108 -0.496 . . . . 75.349999999999994 111.19 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.42 19.5 50.62 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 109.223 -1.551 . . . . 54.350000000000001 109.223 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.77 128.8 37.74 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.455 -0.873 . . . . 74.400000000000006 109.163 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.6 m95 -107.44 10.07 29.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.22 -0.445 . . . . 72.129999999999995 111.082 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.68 51.92 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.476 -1.345 . . . . 74.340000000000003 111.195 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m 76.48 -68.21 0.19 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.495 1.118 . . . . 60.549999999999997 111.34 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.399999999999999 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.219999999999999 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 68' ' ' TRP . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.509999999999998 111.962 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.019999999999996 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.439999999999998 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 64.329999999999998 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.525 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.239999999999995 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.530000000000001 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 63.200000000000003 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 53.219999999999999 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.408 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.540000000000006 108.383 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.420000000000002 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.200000000000003 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.329999999999998 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.109999999999999 108.446 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.519999999999996 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.329999999999998 108.187 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.510000000000005 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.219999999999999 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.450000000000003 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.040000000000006 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.329999999999998 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.409999999999997 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.450000000000003 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 62.409999999999997 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.100000000000001 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.409999999999997 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.230000000000004 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.340000000000003 111.205 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 71.5 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.409999999999997 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.430000000000007 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 63.140000000000001 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.510000000000005 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.409999999999997 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.74 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.239999999999995 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.430000000000007 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.540000000000006 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.109999999999999 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.130000000000003 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.019999999999996 110.988 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.019999999999996 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.299999999999997 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.42 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.030000000000001 108.919 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.596 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.140000000000001 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 71.420000000000002 107.563 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 154' ' ' LEU . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.420000000000002 110.641 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 71.120000000000005 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.129999999999995 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 41.119999999999997 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.109999999999999 108.581 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 55.409999999999997 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.150000000000006 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 52.409999999999997 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.656 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.2 tttt -164.48 -67.13 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.039999999999999 109.358 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 32.5 Cg_exo -65.87 -55.43 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 120.647 1.267 . . . . 72.409999999999997 110.812 170.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.36 110.86 2.17 Favored Glycine 0 CA--C 1.507 -0.451 0 C-N-CA 120.316 -0.945 . . . . 71.230000000000004 112.915 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.78 -114.51 3.84 Favored Glycine 0 CA--C 1.499 -0.915 0 N-CA-C 110.328 -1.109 . . . . 35.039999999999999 110.328 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.09 91.13 0.38 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.891 1.727 . . . . 75.340000000000003 109.272 171.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.526 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 136.02 92.5 0.36 Allowed Glycine 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 -176.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 51.549999999999997 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 62.030000000000001 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.109999999999999 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 54.329999999999998 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.310000000000002 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.219999999999999 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.429 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.109999999999999 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.329999999999998 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.329999999999998 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.010000000000005 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.219999999999999 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.596 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.530000000000001 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.219999999999999 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.219999999999999 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.150000000000006 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 144' ' ' ILE . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.340000000000003 110.174 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.230000000000004 109.844 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 62.420000000000002 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.519999999999996 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 62.439999999999998 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.230000000000004 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.430000000000007 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 82.7 mm-40 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.509999999999998 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.400000000000006 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.429 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.340000000000003 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.099999999999994 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.140000000000001 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.219999999999999 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 61.310000000000002 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.329999999999998 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.429 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.420000000000002 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.140000000000001 110.486 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 171' ' ' ALA . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.140000000000001 109.279 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.319999999999993 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.400000000000006 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt -83.73 -40.91 18.24 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.120000000000005 111.637 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' OE2' ' A' ' 167' ' ' GLU . . . 52.8 78.26 0.14 Allowed 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.906 1.282 . . . . 75.25 111.013 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.07 160.56 15.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.003 -0.999 . . . . 74.209999999999994 112.563 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.707 -1.22 . . . . 74.400000000000006 107.707 -179.175 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 121.259 0.552 . . . . 75.040000000000006 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.69 159.89 41.37 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.668 -0.696 . . . . 74.219999999999999 109.334 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.65 99.49 1.87 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.036 0.446 . . . . 41.009999999999998 109.817 -176.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 m -71.21 -26.65 63.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.587 -0.733 . . . . 72.519999999999996 111.455 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.8 m -66.72 -12.68 59.53 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.249 -0.432 . . . . 71.299999999999997 110.594 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt 62.88 -34.43 0.12 Allowed 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 126.169 1.788 . . . . 71.319999999999993 115.201 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.200000000000003 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.400000000000006 112.887 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.239999999999995 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.409999999999997 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.319999999999993 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.200000000000003 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG11 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.439999999999998 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.200000000000003 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 71.310000000000002 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' HD11 ' A' ' 170' ' ' LEU . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.450000000000003 109.699 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.240000000000002 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.150000000000006 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.239999999999995 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.510000000000005 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 54.520000000000003 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.319999999999993 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 39.3 m80 -62.24 -32.35 73.02 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 74.299999999999997 111.229 -174.12 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.418 ' CE ' ' HA ' ' A' ' 42' ' ' MET . 3.0 mmt -71.67 -35.02 70.18 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.938 0.718 . . . . 74.129999999999995 112.938 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.35 -32.89 7.27 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.311 -0.956 . . . . 64.319999999999993 113.542 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.67 95.49 0.04 OUTLIER 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.882 0.372 . . . . 70.439999999999998 110.582 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.32 -145.77 8.7 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.192 -1.163 . . . . 72.129999999999995 110.192 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -79.13 152.03 76.23 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.029 -0.73 . . . . 72.439999999999998 109.029 176.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.28 -42.94 7.75 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.381 3.388 . . . . 72.549999999999997 114.451 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.451 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 53.0 t-80 -78.84 93.91 5.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.34 0.59 . . . . 74.319999999999993 109.552 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -98.64 129.48 45.14 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.187 -0.915 . . . . 54.420000000000002 108.745 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -82.42 102.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.45 -1.315 . . . . 71.5 107.45 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.2 m -82.65 -177.25 6.64 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.591 -0.731 . . . . 72.530000000000001 110.744 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.61 150.27 48.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.672 -0.24 . . . . 75.129999999999995 110.746 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.37 -31.42 69.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.622 -0.881 . . . . 70.219999999999999 108.622 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 m -62.6 137.61 96.48 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 114.455 -1.248 . . . . 51.229999999999997 108.841 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.02 -29.36 64.57 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.021 2.481 . . . . 61.140000000000001 112.234 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.37 50.55 2.18 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.656 -0.783 . . . . 73.349999999999994 111.33 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -79.63 82.62 5.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.321 0.581 . . . . 72.200000000000003 110.377 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.7 mm -128.25 127.69 67.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.931 -1.137 . . . . 70.430000000000007 107.931 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -69.19 106.22 2.77 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.685 -0.487 . . . . 62.149999999999999 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.26 71.34 1.23 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.683 -0.77 . . . . 63.329999999999998 111.648 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 58' ' ' ILE . 80.6 m -89.22 97.37 11.16 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 50.009999999999998 108.351 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -85.47 81.57 8.65 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.508 0.671 . . . . 74.129999999999995 109.447 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.27 -63.45 1.29 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.206 -0.906 . . . . 72.400000000000006 109.811 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -84.21 -37.08 22.27 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.167 -0.679 . . . . 75.420000000000002 109.167 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -84.21 -17.19 40.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.571 -0.74 . . . . 63.240000000000002 110.531 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.46 64.29 3.23 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.274 -0.73 . . . . 72.040000000000006 111.274 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -134.32 117.43 16.38 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.466 0.65 . . . . 71.310000000000002 112.006 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -104.42 14.72 29.6 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.907 -1.042 . . . . 63.549999999999997 109.329 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.82 12.35 66.54 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 71.409999999999997 111.286 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m 71.86 -74.37 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.383 1.073 . . . . 72.340000000000003 110.091 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.129999999999995 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.129999999999995 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.420000000000002 109.955 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.219999999999999 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.009999999999998 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 89' ' ' LYS . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 70.140000000000001 108.468 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 62.310000000000002 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.519999999999996 109.987 179.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.340000000000003 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.239999999999995 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.239999999999995 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.019999999999996 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.129999999999995 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.129999999999995 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.439999999999998 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.310000000000002 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.210000000000001 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.329999999999998 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.429 ' HA ' ' HD1' ' A' ' 76' ' ' PHE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.129999999999995 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.310000000000002 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.319999999999993 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 73' ' ' SER . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.530000000000001 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' ILE . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 53.119999999999997 109.3 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.520000000000003 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.319999999999993 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.439999999999998 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.540000000000006 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.299999999999997 112.362 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.209999999999994 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD11 ' CG2' ' A' ' 121' ' ' THR . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.040000000000006 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.219999999999999 111.941 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.319999999999993 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.010000000000005 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.200000000000003 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 44.140000000000001 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.450000000000003 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.030000000000001 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.310000000000002 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.230000000000004 112.006 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.099999999999994 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 61.109999999999999 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.109999999999999 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 74.439999999999998 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' HG12 ' A' ' 144' ' ' ILE . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.520000000000003 111.105 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.420000000000002 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 71.340000000000003 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 65.209999999999994 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.329999999999998 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 62.130000000000003 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.310000000000002 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.310000000000002 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.549999999999997 114.094 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.509999999999998 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 88.0 tttt -53.43 -53.66 54.04 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.120000000000005 112.156 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -83.54 -12.44 8.92 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 121.979 1.786 . . . . 71.439999999999998 111.944 174.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 137.85 -150.54 20.91 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.961 -0.856 . . . . 72.540000000000006 110.961 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.94 -72.07 1.04 Allowed Glycine 0 C--O 1.239 0.424 0 N-CA-C 109.964 -1.254 . . . . 62.210000000000001 109.964 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.19 113.23 2.78 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.319 2.012 . . . . 75.230000000000004 109.04 171.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 106.5 114.64 3.93 Favored Glycine 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.229999999999997 109.54 -173.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.219999999999999 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.545 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 34.340000000000003 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.509999999999998 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 54.32 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.299999999999997 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.140000000000001 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 137' ' ' TRP . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.109999999999999 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.409999999999997 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.219999999999999 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.450000000000003 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.629 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.450000000000003 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 116' ' ' LYS . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 65.439999999999998 107.193 170.817 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 61.210000000000001 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.299999999999997 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.400000000000006 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.629 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.510000000000005 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.150000000000006 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.612 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.230000000000004 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.319999999999993 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.240000000000002 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.450000000000003 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.519999999999996 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.409999999999997 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 71.239999999999995 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.405 ' SG ' HD21 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 62.450000000000003 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 60.439999999999998 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.329999999999998 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 23.329999999999998 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.439999999999998 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.230000000000004 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.219999999999999 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.430000000000007 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.420000000000002 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.530000000000001 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 74.430000000000007 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.239999999999995 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -69.64 -43.2 73.12 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.230000000000004 110.434 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 54.6 23.08 4.39 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.861 1.264 . . . . 40.329999999999998 112.401 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.68 149.95 24.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.373 0.606 . . . . 75.420000000000002 111.848 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.163 -1.421 . . . . 64.510000000000005 107.163 175.835 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 121.448 0.642 . . . . 74.319999999999993 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 175.47 159.16 0.23 Allowed 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 126.085 1.754 . . . . 71.540000000000006 109.061 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.39 109.84 2.2 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.826 -0.805 . . . . 34.450000000000003 108.826 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -64.81 -42.77 94.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.747 0.647 . . . . 71.239999999999995 112.747 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 p -89.32 -39.04 13.73 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.728 0.64 . . . . 61.130000000000003 112.728 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt 62.57 15.29 7.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.528 0.731 . . . . 62.109999999999999 112.307 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.210000000000001 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.530000000000001 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.149999999999999 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.329999999999998 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.319999999999993 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.239999999999995 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.439999999999998 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.349999999999994 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.299999999999997 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.557 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.140000000000001 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.120000000000005 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 73.349999999999994 111.92 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.349999999999994 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.350000000000001 111.022 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.209999999999994 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.25 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 57.4 t60 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.439999999999998 111.812 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HB2' ' OXT' ' A' ' 173' ' ' GLU . 87.0 m-70 -76.72 -50.64 13.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.430000000000007 111.987 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -29.63 67.97 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.251 1.204 . . . . 73.219999999999999 114.251 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.09 -0.644 . . . . 71.450000000000003 110.229 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.57 -43.6 31.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.209 -0.45 . . . . 42.450000000000003 111.043 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.2 33.54 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.877 -0.889 . . . . 43.119999999999997 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.0 100.06 47.76 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 112.641 0.608 . . . . 71.400000000000006 112.641 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.58 150.05 24.38 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.19 1.927 . . . . 71.140000000000001 108.189 171.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -68.43 -32.15 71.98 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.958 -0.697 . . . . 70.230000000000004 109.457 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -145.96 161.52 39.87 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 108.235 -1.024 . . . . 70.420000000000002 108.235 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 168' ' ' HIS . 34.6 m -70.52 162.88 3.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.53 0.519 . . . . 60.409999999999997 110.065 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 26.7 p -59.58 144.93 46.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.838 0.681 . . . . 65.239999999999995 112.838 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 63.47 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.079 1.352 . . . . 65.209999999999994 110.962 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.79 -64.37 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.445 1.498 . . . . 32.299999999999997 112.107 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 15.4 m -88.14 151.01 48.51 Favored Pre-proline 0 N--CA 1.413 -2.315 0 C-N-CA 123.939 0.895 . . . . 74.230000000000004 109.398 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 5.6 Cg_exo -79.01 -149.18 0.04 OUTLIER 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.235 1.956 . . . . 74.349999999999994 107.731 169.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 51.09 4.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.035 -1.078 . . . . 61.439999999999998 110.723 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -143.47 147.26 34.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.736 -1.579 . . . . 74.329999999999998 106.736 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.3 mt -84.76 113.71 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.317 0.58 . . . . 73.540000000000006 111.322 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -117.37 159.95 21.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.551 -0.75 . . . . 71.430000000000007 109.845 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.23 -165.48 11.81 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.634 -1.387 . . . . 54.240000000000002 109.634 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.9 m 69.42 162.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.788 0.835 . . . . 64.230000000000004 111.638 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.74 155.44 25.61 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 122.187 -0.321 . . . . 55.25 110.181 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.3 102.34 13.3 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.576 -0.898 . . . . 63.310000000000002 108.576 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -89.45 -15.49 33.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.051 -0.522 . . . . 75.329999999999998 110.637 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.5 90.73 2.75 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.249 0.547 . . . . 74.519999999999996 110.107 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.06 -161.46 21.7 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-N 115.046 -0.979 . . . . 61.32 110.918 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.36 93.17 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.337 1.065 . . . . 64.430000000000007 112.022 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -104.52 -16.25 15.11 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.579 -1.191 . . . . 61.200000000000003 109.44 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -12.51 32.36 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.764 -0.653 . . . . 74.319999999999993 114.338 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -119.3 179.51 4.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 123.06 0.544 . . . . 72.439999999999998 110.91 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.140000000000001 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.229999999999997 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 92' ' ' ILE . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.219999999999999 110.803 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.299999999999997 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.310000000000002 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 62.299999999999997 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.230000000000004 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.7 m-80 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.329999999999998 108.775 -178.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 73.219999999999999 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.329999999999998 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.140000000000001 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 71.129999999999995 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.509999999999998 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.399999999999999 110.737 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.219999999999999 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.329999999999998 109.9 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.030000000000001 109.131 -175.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HB3' HD11 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 70.340000000000003 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.019999999999996 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.530000000000001 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.496 HG22 HG23 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.510000000000005 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.130000000000003 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.430000000000007 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.430000000000007 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.439999999999998 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 71.129999999999995 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.530000000000001 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 60.200000000000003 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.140000000000001 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 122' ' ' ILE . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 45.32 110.811 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 65.519999999999996 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.120000000000005 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.230000000000004 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 65.340000000000003 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.310000000000002 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.130000000000003 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.120000000000005 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.540000000000006 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.520000000000003 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.540000000000006 111.443 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.109999999999999 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.140000000000001 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.129999999999995 105.653 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.219999999999999 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.430000000000007 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.129999999999995 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.310000000000002 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 63.149999999999999 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.439999999999998 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 102' ' ' ILE . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.109999999999999 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.030000000000001 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.340000000000003 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.319999999999993 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt -89.32 -54.22 0.32 Allowed Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.400000000000006 112.842 -175.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.497 ' HD3' HG12 ' A' ' 134' ' ' ILE . 3.4 Cg_exo -79.96 -24.55 5.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 121.334 1.356 . . . . 74.150000000000006 110.633 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.75 19.63 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.422 -1.471 . . . . 70.420000000000002 109.422 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.5 -77.04 0.79 Allowed Glycine 0 C--N 1.309 -0.939 0 C-N-CA 121.261 -0.495 . . . . 55.420000000000002 112.411 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' PRO . . . . . 0.458 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 18.4 Cg_endo -60.83 129.68 29.99 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.759 2.306 . . . . 73.439999999999998 110.825 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.72 84.42 0.39 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.319999999999993 111.121 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 65.439999999999998 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.329999999999998 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 65.409999999999997 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 77.0 m80 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 60.549999999999997 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.340000000000003 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.099999999999994 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 55.43 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.409999999999997 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.040000000000006 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.329999999999998 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.349999999999994 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.439 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.209999999999994 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.350000000000001 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.349999999999994 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 61.009999999999998 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.585 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.210000000000001 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.200000000000003 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.430000000000007 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.349999999999994 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 152' ' ' GLU . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 72.230000000000004 108.887 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.140000000000001 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.474 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.349999999999994 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 44.549999999999997 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 86.6 mm-40 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 71.099999999999994 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 50.009999999999998 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.140000000000001 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 155' ' ' LEU . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 63.240000000000002 111.5 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.540000000000006 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 64.519999999999996 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.010000000000005 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.030000000000001 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.200000000000003 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.150000000000006 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.557 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.100000000000001 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.009999999999998 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.467 ' CE1' ' HB ' ' A' ' 50' ' ' VAL . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 55.43 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt -67.4 -20.21 65.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.409999999999997 110.996 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.62 -20.8 24.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.792 0.664 . . . . 74.239999999999995 112.792 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 7.5 pt-20 -118.76 -177.31 3.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.221 0.822 . . . . 64.129999999999995 113.221 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLU . . . . . 0.457 ' OXT' ' HB2' ' A' ' 41' ' ' HIS . 10.1 pt-20 . . . . . 0 C--O 1.263 1.775 0 C-N-CA 124.661 1.184 . . . . 73.230000000000004 114.123 -176.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.172 -1.788 . . . . 61.399999999999999 106.172 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.61 143.62 24.14 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.628 0.728 . . . . 75.420000000000002 111.673 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.46 94.63 9.46 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 73.200000000000003 112.024 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 p -72.65 -39.31 67.27 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.799 . . . . 75.109999999999999 110.792 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -85.5 -10.81 55.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.557 -0.747 . . . . 71.409999999999997 110.532 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt 62.47 -40.47 0.16 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 51.399999999999999 114.796 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.540000000000006 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.229999999999997 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.039999999999999 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 155' ' ' LEU . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 63.32 108.564 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.340000000000003 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.109999999999999 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.230000000000004 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.310000000000002 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.209999999999994 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.219999999999999 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.420000000000002 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 54.32 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.229999999999997 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.140000000000001 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.129999999999995 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.540000000000006 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 45.130000000000003 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -66.2 -35.51 80.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.310000000000002 113.831 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -73.38 -26.06 60.83 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 118.808 -1.157 . . . . 74.299999999999997 112.443 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -86.66 -31.73 20.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.146 -0.622 . . . . 63.43 110.813 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.56 75.76 2.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.494 0.664 . . . . 72.420000000000002 109.912 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.74 -159.45 24.55 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.846 -1.301 . . . . 62.219999999999999 109.846 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -102.84 134.15 20.0 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 117.175 0.487 . . . . 74.310000000000002 110.379 -179.308 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 18.1 Cg_exo -68.66 -20.73 40.17 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.616 2.211 . . . . 65.140000000000001 111.353 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -102.18 144.29 30.92 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.051 -0.722 . . . . 72.299999999999997 109.051 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -116.12 146.34 42.32 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 112.198 0.444 . . . . 62.310000000000002 112.198 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 t 64.01 82.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 O-C-N 125.209 1.568 . . . . 74.209999999999994 110.083 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -79.64 -19.93 47.97 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.799 -1.091 . . . . 71.510000000000005 110.79 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -147.31 -66.68 0.26 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.493 -0.929 . . . . 73.25 108.493 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.84 169.8 19.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.825 -0.625 . . . . 73.120000000000005 110.575 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -161.69 172.68 5.36 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.518 -1.66 . . . . 72.450000000000003 106.518 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.99 119.04 5.64 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.238 1.959 . . . . 74.439999999999998 110.976 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.25 -49.16 2.96 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 110.095 -1.202 . . . . 74.209999999999994 110.095 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 61.0 t30 69.76 85.89 0.13 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.665 1.586 . . . . 63.200000000000003 113.049 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.92 106.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.035 -1.468 . . . . 71.329999999999998 107.035 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -76.06 -31.01 58.6 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.751 -0.659 . . . . 63.0 110.011 -177.19 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 -53.11 4.55 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.734 -0.946 . . . . 63.439999999999998 110.734 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.8 t 67.38 86.17 0.13 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.926 1.29 . . . . 75.430000000000007 110.876 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.19 -63.64 1.38 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.255 -0.884 . . . . 62.210000000000001 109.002 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 tp 52.83 73.18 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.526 1.142 . . . . 75.219999999999999 111.658 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.28 166.34 19.64 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.184 -1.043 . . . . 73.140000000000001 108.184 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.97 92.0 7.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.799 0.809 . . . . 71.030000000000001 112.202 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.53 -110.35 3.11 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.763 -1.735 . . . . 74.319999999999993 108.763 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.88 134.8 34.18 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.6 -0.519 . . . . 73.409999999999997 109.6 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -74.52 -13.87 60.74 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.997 -0.547 . . . . 74.25 111.842 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.71 12.53 82.72 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.916 -0.659 . . . . 73.109999999999999 112.887 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m -156.66 142.76 18.07 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.161 -1.052 . . . . 73.150000000000006 108.161 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG23 HG22 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.109999999999999 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.549999999999997 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.518 ' HB3' HD12 ' A' ' 92' ' ' ILE . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.340000000000003 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.420000000000002 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.540000000000006 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.585 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 72.030000000000001 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.329999999999998 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.109999999999999 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.340000000000003 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.510000000000005 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.239999999999995 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.340000000000003 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.200000000000003 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.209999999999994 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.109999999999999 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.310000000000002 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 74.319999999999993 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 53.340000000000003 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.219999999999999 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.239999999999995 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.030000000000001 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.230000000000004 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.340000000000003 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.299999999999997 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 71' ' ' VAL . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.400000000000006 109.893 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.656 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.420000000000002 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.109999999999999 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.209999999999994 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.656 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.319999999999993 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.420000000000002 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.417 ' C ' HD23 ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.310000000000002 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.310000000000002 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.329999999999998 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.420000000000002 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.209999999999994 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.299999999999997 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.656 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.099999999999994 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 89' ' ' LYS 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 70.430000000000007 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.430000000000007 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.463 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.049999999999997 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 55.5 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.520000000000003 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.329999999999998 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.519999999999996 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 64.239999999999995 108.901 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.605 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 65.319999999999993 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.209999999999994 106.449 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 64.420000000000002 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.129999999999995 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.209999999999994 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 65.239999999999995 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 62.240000000000002 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.451 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 10.1 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.549999999999997 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.209999999999994 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.467 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 64.450000000000003 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.219999999999999 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.579 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt -142.77 -51.37 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.310000000000002 111.458 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 48.5 Cg_exo -61.13 -35.98 83.55 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 121.614 1.543 . . . . 73.129999999999995 111.282 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.92 -112.28 0.51 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.855 -0.898 . . . . 73.219999999999999 110.855 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.47 -77.52 0.52 Allowed Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.996 -0.842 . . . . 63.439999999999998 110.996 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.51 164.61 28.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.328 2.019 . . . . 74.25 110.696 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 88.82 103.24 1.0 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.040000000000006 110.762 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 53.25 110.913 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.579 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.239999999999995 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 30' ' ' VAL . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.129999999999995 108.639 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.129999999999995 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.329999999999998 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.450000000000003 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.129999999999995 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.230000000000004 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.120000000000005 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.420000000000002 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.229999999999997 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.605 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 60.130000000000003 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.200000000000003 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.536 ' H ' ' CD ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 53.020000000000003 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 73.540000000000006 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.130000000000003 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.409999999999997 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.319999999999993 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.129999999999995 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.109999999999999 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.439999999999998 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 42.100000000000001 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 64.510000000000005 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 60.049999999999997 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 61.130000000000003 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.420000000000002 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.439999999999998 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 65.519999999999996 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.537 ' CB ' HG11 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 51.240000000000002 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.239999999999995 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 65.319999999999993 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.319999999999993 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.411 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.120000000000005 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.400000000000006 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.040000000000006 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.525 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.319999999999993 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -68.95 -21.87 64.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.230000000000004 110.636 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.93 -165.4 1.22 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.508 -1.293 . . . . 71.129999999999995 107.508 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 -169.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 114.054 1.131 . . . . 73.329999999999998 114.054 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 118.855 -0.593 . . . . 72.420000000000002 110.357 -178.513 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 107.42 -1.326 . . . . 52.049999999999997 107.42 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.93 164.87 25.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.993 0.425 . . . . 74.329999999999998 111.511 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 146' ' ' GLU . . . -120.21 35.24 4.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.83 -0.433 . . . . 72.319999999999993 109.83 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 t -54.95 -45.04 74.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.423 0.689 . . . . 72.319999999999993 111.788 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -89.55 -7.4 54.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.866 -0.42 . . . . 74.420000000000002 109.866 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt 65.43 -64.13 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.647 1.579 . . . . 75.329999999999998 111.925 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 51.299999999999997 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.340000000000003 109.745 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.120000000000005 110.5 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 62.340000000000003 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.420000000000002 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.129999999999995 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.420000000000002 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.219999999999999 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.430000000000007 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.319999999999993 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.140000000000001 109.776 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.427 ' OD2' ' CE1' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.109999999999999 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.019999999999996 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.109999999999999 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.049999999999997 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.427 ' CE1' ' OD2' ' A' ' 37' ' ' ASP . 33.2 m80 -76.14 -37.79 57.57 Favored 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.319999999999993 110.977 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 mmt -74.42 -23.78 59.0 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.49 0.552 . . . . 72.519999999999996 112.49 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.4 -31.96 26.39 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.739 -0.384 . . . . 75.329999999999998 110.623 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.67 -67.64 0.84 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.812 0.339 . . . . 72.129999999999995 111.276 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.55 75.23 1.69 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.789 -0.924 . . . . 64.120000000000005 110.789 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.36 139.98 96.51 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 123.361 0.664 . . . . 64.329999999999998 110.49 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.79 -173.95 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.286 1.991 . . . . 73.219999999999999 111.397 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.56 -32.44 66.05 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.457 -0.942 . . . . 63.420000000000002 108.457 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 34.8 t-80 65.07 105.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 72.319999999999993 111.246 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.89 137.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 51.310000000000002 109.758 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t -74.23 97.59 3.0 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.421 0.629 . . . . 53.25 109.608 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.39 -62.13 1.67 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.045 -0.98 . . . . 73.239999999999995 108.805 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -179.14 103.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.105 1.362 . . . . 71.450000000000003 108.202 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.2 p -118.72 111.48 37.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 120.667 0.27 . . . . 64.010000000000005 110.967 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.16 -15.8 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.58 2.186 . . . . 60.210000000000001 112.531 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' C ' ' HB3' ' A' ' 62' ' ' ASP . . . 83.84 -54.88 4.99 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 121.368 -0.444 . . . . 61.420000000000002 112.957 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -141.48 120.55 12.88 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.745 -0.835 . . . . 52.130000000000003 108.745 179.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG13 ' H ' ' A' ' 59' ' ' GLN . 27.2 pt -107.92 -60.29 2.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.61 -0.436 . . . . 73.340000000000003 111.384 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' H ' HG13 ' A' ' 58' ' ' ILE . 54.9 mt-30 -145.03 93.3 2.37 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.211 -1.403 . . . . 75.409999999999997 107.211 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.66 -55.96 0.89 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 108.773 -1.731 . . . . 42.109999999999999 108.773 -175.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 t -169.66 -169.29 0.89 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.19 -1.411 . . . . 74.140000000000001 107.19 177.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' C ' ' A' ' 56' ' ' GLY . 11.7 t70 -156.01 -48.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.262 1.025 . . . . 51.340000000000003 109.233 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.26 110.68 12.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.998 -1.853 . . . . 74.140000000000001 105.998 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -75.94 107.01 7.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.595 0.591 . . . . 74.319999999999993 112.595 -172.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -26.25 10.97 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.754 -0.657 . . . . 75.239999999999995 110.133 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.42 37.62 4.23 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.27 -1.132 . . . . 62.100000000000001 110.27 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.39 -35.12 60.0 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.416 1.086 . . . . 70.310000000000002 112.678 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.496 ' CB ' ' HA ' ' A' ' 73' ' ' SER . 26.6 m-90 -92.01 14.25 16.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.664 -0.698 . . . . 73.400000000000006 112.149 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.22 12.51 73.32 Favored Glycine 0 C--O 1.246 0.867 0 C-N-CA 120.225 -0.988 . . . . 65.030000000000001 111.739 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m 72.59 -72.72 0.11 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.04 0.936 . . . . 74.150000000000006 110.607 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.120000000000005 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.109999999999999 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 68' ' ' TRP . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.420000000000002 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.530000000000001 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.229999999999997 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.430000000000007 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.239999999999995 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.329999999999998 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.329999999999998 109.383 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.519999999999996 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 42.329999999999998 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.519999999999996 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.140000000000001 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.209999999999994 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.120000000000005 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.439999999999998 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 52.219999999999999 109.256 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.450000000000003 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.109999999999999 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 62.409999999999997 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.430000000000007 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.329999999999998 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.310000000000002 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 73.349999999999994 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.230000000000004 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.310000000000002 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.209999999999994 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.439999999999998 111.117 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.576 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 2.2 t-20 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.239999999999995 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.030000000000001 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.239999999999995 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.340000000000003 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.439999999999998 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.44 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.400000000000006 110.383 177.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.319999999999993 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.140000000000001 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 72.349999999999994 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.130000000000003 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.230000000000004 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.240000000000002 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.519999999999996 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.109999999999999 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.530000000000001 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.129999999999995 107.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 73.010000000000005 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.209999999999994 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.219999999999999 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.530000000000001 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 102' ' ' ILE . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.200000000000003 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.510000000000005 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 135' ' ' VAL . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 72.549999999999997 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.510000000000005 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.329999999999998 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt -82.85 142.48 45.15 Favored Pre-proline 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.230000000000004 109.963 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 127' ' ' LYS . 31.6 Cg_exo -61.62 -46.69 13.37 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.07 2.513 . . . . 62.140000000000001 112.747 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.82 84.44 0.3 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 120.568 -0.825 . . . . 64.329999999999998 111.78 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.12 146.44 4.93 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.993 -0.622 . . . . 52.439999999999998 111.982 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 118.93 5.92 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.998 2.465 . . . . 72.209999999999994 111.845 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 152.71 -164.3 30.68 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.099999999999994 109.954 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.530000000000001 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.209999999999994 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.230000000000004 108.971 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.517 ' HA ' HG22 ' A' ' 122' ' ' ILE . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.200000000000003 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.120000000000005 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 72.329999999999998 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.400000000000006 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 71.430000000000007 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.230000000000004 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.409999999999997 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.420000000000002 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 19' ' ' ALA . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.310000000000002 111.254 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.109999999999999 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.310000000000002 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.439999999999998 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 72.219999999999999 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.019999999999996 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.540000000000006 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 71.120000000000005 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 60.130000000000003 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.310000000000002 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.109999999999999 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.540000000000006 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 73.430000000000007 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 155' ' ' LEU . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 72.209999999999994 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.519999999999996 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.433 ' CB ' HG11 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.340000000000003 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.319999999999993 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.530000000000001 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.530000000000001 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.209999999999994 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.229999999999997 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.420000000000002 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt -81.17 -41.55 22.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 73.540000000000006 110.273 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.68 15.27 4.59 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.892 1.277 . . . . 63.210000000000001 114.441 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.09 166.72 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.787 1.235 . . . . 64.420000000000002 114.223 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 114.968 -1.014 . . . . 64.120000000000005 108.485 174.211 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 114.708 1.373 . . . . 61.030000000000001 114.708 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -143.96 177.34 8.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.845 -1.909 . . . . 61.340000000000003 105.845 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.2 145.44 46.27 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.062 -0.718 . . . . 74.430000000000007 109.062 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -62.52 -28.8 70.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.139 0.495 . . . . 72.310000000000002 111.083 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.7 p -88.91 -5.26 58.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.214 -0.448 . . . . 72.319999999999993 110.879 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt 60.33 20.98 10.5 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.054 0.942 . . . . 75.540000000000006 112.777 -175.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.310000000000002 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 21.399999999999999 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.310000000000002 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.409999999999997 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.209999999999994 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.540000000000006 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 134' ' ' ILE . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.140000000000001 109.623 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.219999999999999 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.340000000000003 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 34' ' ' ALA . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 61.240000000000002 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 32' ' ' ILE . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 45.130000000000003 112.0 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.430000000000007 109.517 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.409999999999997 110.226 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 73.129999999999995 110.148 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 169' ' ' LEU . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.239999999999995 108.533 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.319999999999993 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -70.25 -50.78 36.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.532 ' SD ' HD13 ' A' ' 169' ' ' LEU . 24.7 ptm -74.57 -22.9 58.75 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.376 0.88 . . . . 62.109999999999999 113.376 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -76.41 -24.47 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.328 0.585 . . . . 71.239999999999995 109.66 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.11 -16.32 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.575 0.702 . . . . 45.030000000000001 109.696 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.38 73.01 0.27 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.579 -1.408 . . . . 75.439999999999998 109.579 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HE2' ' OG1' ' A' ' 70' ' ' THR . 58.8 mttp -68.46 143.85 95.83 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.418 -0.391 . . . . 64.040000000000006 110.763 -176.203 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.91 117.1 3.63 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.734 2.29 . . . . 54.030000000000001 111.454 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -91.15 81.42 5.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.448 -0.575 . . . . 74.140000000000001 109.448 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 55.48 89.14 0.04 OUTLIER 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.82 1.248 . . . . 73.099999999999994 112.071 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.11 156.8 38.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.91 -0.586 . . . . 70.209999999999994 110.016 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -160.6 93.96 1.03 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.306 -0.627 . . . . 65.150000000000006 109.306 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -178.73 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.178 0.991 . . . . 73.219999999999999 108.485 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.98 92.94 8.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.441 -0.799 . . . . 74.019999999999996 109.956 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 p -177.47 163.42 1.4 Allowed Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.01 -1.107 . . . . 71.230000000000004 108.01 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.62 135.94 71.75 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.16 1.906 . . . . 62.299999999999997 110.012 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.9 65.4 3.53 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.127 -0.559 . . . . 52.149999999999999 113.614 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -126.8 99.39 5.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.373 -0.973 . . . . 64.450000000000003 108.373 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.78 120.45 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 115.732 -0.667 . . . . 71.049999999999997 109.649 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -82.46 133.76 35.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.998 -0.546 . . . . 73.239999999999995 110.068 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.92 167.47 21.83 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.532 -0.842 . . . . 74.409999999999997 111.27 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.2 t 71.07 -66.67 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.038 0.935 . . . . 74.209999999999994 112.501 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -124.85 100.41 6.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.006 0.431 . . . . 72.040000000000006 110.185 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.51 99.67 8.39 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.763 -1.94 . . . . 50.020000000000003 105.763 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -91.06 131.79 36.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.505 -0.924 . . . . 70.219999999999999 108.505 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -146.68 -90.51 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.63 -0.507 . . . . 73.019999999999996 109.63 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.26 -136.66 5.5 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 124.008 0.817 . . . . 72.450000000000003 112.411 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.95 110.17 22.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.867 -1.901 . . . . 73.230000000000004 105.867 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 1.2 t90 -88.32 -17.24 31.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.599 -0.519 . . . . 72.0 109.599 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.0 4.81 58.61 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.16 -0.543 . . . . 74.319999999999993 112.922 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' HE2' ' A' ' 46' ' ' LYS . 50.7 m 67.68 -76.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.859 0.863 . . . . 72.430000000000007 110.856 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.450000000000003 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.310000000000002 110.83 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.598 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 60.340000000000003 109.883 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 71.129999999999995 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.340000000000003 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.430000000000007 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.140000000000001 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.519999999999996 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 71.239999999999995 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.010000000000005 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.340000000000003 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.149999999999999 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.540000000000006 111.097 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 60.420000000000002 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.439999999999998 109.816 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.409999999999997 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.310000000000002 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 62.420000000000002 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.239999999999995 105.624 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.329999999999998 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.310000000000002 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.409999999999997 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.040000000000006 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.329999999999998 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.030000000000001 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.239999999999995 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.628 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.420000000000002 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.239999999999995 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.420000000000002 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.430000000000007 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.129999999999995 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.120000000000005 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.439999999999998 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.631 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.450000000000003 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.728 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.430000000000007 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.509999999999998 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.329999999999998 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.329999999999998 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.678 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 70.299999999999997 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.439999999999998 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.420000000000002 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 71.25 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB3' HG12 ' A' ' 144' ' ' ILE . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.420000000000002 110.399 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.119999999999997 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.209999999999994 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.409999999999997 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.200000000000003 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.219999999999999 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.409999999999997 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.040000000000006 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 65.310000000000002 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.319999999999993 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.010000000000005 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt -78.14 142.01 63.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.400000000000006 110.158 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.47 100.92 1.3 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.209 1.939 . . . . 70.400000000000006 111.17 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.06 52.91 29.42 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.325 -0.71 . . . . 75.430000000000007 111.325 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.51 137.31 4.58 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.636 -0.792 . . . . 51.530000000000001 111.871 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.28 113.13 3.51 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.546 2.164 . . . . 53.509999999999998 111.332 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.48 -159.98 23.82 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.150000000000006 110.469 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.409999999999997 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 29' ' ' ASP . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.530000000000001 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 62.240000000000002 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 76.6 m80 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.439999999999998 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 63.539999999999999 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.239999999999995 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.530000000000001 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 63.32 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.130000000000003 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.420000000000002 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.129999999999995 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.239999999999995 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.109999999999999 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.519999999999996 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.579 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 71.439999999999998 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 65.349999999999994 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.519999999999996 112.038 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 72.549999999999997 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.439999999999998 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.409999999999997 109.569 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.510000000000005 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 71.0 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.399999999999999 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.530000000000001 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.420000000000002 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.150000000000006 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.019999999999996 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.409999999999997 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 61.219999999999999 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.340000000000003 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 70.349999999999994 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.239999999999995 109.482 -176.891 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.099999999999994 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.219999999999999 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.329999999999998 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.532 HD13 ' SD ' ' A' ' 42' ' ' MET . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.219999999999999 111.623 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt -77.53 -21.56 52.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 50.020000000000003 110.203 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.07 108.12 17.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.174 -1.046 . . . . 61.109999999999999 108.174 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.49 155.84 19.82 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.719 -0.792 . . . . 70.109999999999999 110.96 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.318 -0.855 . . . . 73.049999999999997 109.897 -178.87 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 63.020000000000003 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.79 -5.62 59.22 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.168 -0.923 . . . . 75.540000000000006 109.689 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.13 8.01 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.645 -1.161 . . . . 52.509999999999998 108.363 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -66.08 -28.7 69.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.989 -0.551 . . . . 43.119999999999997 111.802 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 23' ' ' VAL . 50.4 m -87.79 -3.94 58.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.517 -0.31 . . . . 60.119999999999997 111.714 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt 62.81 18.55 10.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.638 0.775 . . . . 53.219999999999999 112.737 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 21' ' ' SER . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 61.240000000000002 108.082 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.219999999999999 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.430000000000007 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.340000000000003 107.177 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.530000000000001 108.303 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.519999999999996 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 62.140000000000001 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.510000000000005 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.299999999999997 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.200000000000003 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.430000000000007 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.420000000000002 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.612 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.540000000000006 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.340000000000003 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.219999999999999 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.150000000000006 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HA ' HD22 ' A' ' 169' ' ' LEU . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.329999999999998 110.699 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 74.2 m80 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.120000000000005 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -76.26 -43.37 42.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.510000000000005 111.984 -174.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.4 mmm -74.53 -31.87 62.29 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.713 1.005 . . . . 74.340000000000003 113.713 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -77.8 -32.12 52.18 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.033 -0.667 . . . . 74.230000000000004 110.612 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.32 -27.72 22.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.219 0.533 . . . . 43.25 110.708 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.02 21.15 17.01 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.618 -0.719 . . . . 74.409999999999997 113.428 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' HD3' ' C ' ' A' ' 46' ' ' LYS . 6.6 tmtm? -83.67 121.16 76.18 Favored Pre-proline 0 N--CA 1.427 -1.588 0 N-CA-C 107.581 -1.266 . . . . 74.409999999999997 107.581 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.89 104.33 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.147 1.898 . . . . 64.349999999999994 110.069 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -86.44 120.97 28.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.075 0.464 . . . . 72.430000000000007 110.793 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -160.08 -44.59 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.574 -0.739 . . . . 71.409999999999997 110.796 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.2 t 69.61 87.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.982 -1.118 . . . . 75.209999999999994 107.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.5 p -67.25 -68.31 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.691 -1.14 . . . . 64.099999999999994 113.162 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 54' ' ' SER . 57.7 mtpt 65.68 172.86 0.22 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.665 0.786 . . . . 74.120000000000005 112.166 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.48 -32.43 48.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.337 -0.986 . . . . 43.409999999999997 108.337 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 45.7 p -139.27 129.87 14.65 Favored Pre-proline 0 N--CA 1.425 -1.703 0 N-CA-C 107.317 -1.364 . . . . 61.299999999999997 107.317 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.93 -54.32 5.61 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 123.397 2.731 . . . . 62.539999999999999 113.385 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.61 84.25 0.07 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.746 -1.341 . . . . 64.319999999999993 109.746 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -92.35 87.94 6.22 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.114 0.483 . . . . 73.329999999999998 112.272 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.68 -174.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 125.222 1.409 . . . . 72.209999999999994 108.289 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -55.88 -56.81 16.15 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.094 0.473 . . . . 62.109999999999999 111.303 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.5 82.97 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.39 -0.91 . . . . 71.310000000000002 111.674 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.4 t -143.5 118.4 9.97 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.834 -1.173 . . . . 72.209999999999994 107.834 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.13 104.59 5.72 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.76 0.791 . . . . 73.010000000000005 111.453 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 64' ' ' HIS . 5.1 tt -87.97 131.38 34.64 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 105.416 -2.068 . . . . 60.32 105.416 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.402 ' N ' HD23 ' A' ' 63' ' ' LEU . 33.9 m-70 -83.9 94.06 8.16 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.023 0.916 . . . . 53.240000000000002 113.017 -174.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -98.34 102.56 14.34 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.64 -1.618 . . . . 74.530000000000001 107.772 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.57 166.1 39.39 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 110.61 -0.996 . . . . 63.310000000000002 110.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.35 134.94 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.8 0.333 . . . . 63.039999999999999 111.319 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 20.7 m0 -87.48 -16.01 35.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.606 -0.725 . . . . 64.329999999999998 110.52 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.08 12.24 81.26 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 121.307 -0.473 . . . . 43.520000000000003 113.438 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -157.01 179.73 9.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.731 -0.47 . . . . 74.549999999999997 109.731 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 73.030000000000001 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.109999999999999 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.200000000000003 110.882 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.510000000000005 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.219999999999999 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 71.140000000000001 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.349999999999994 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 63.210000000000001 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.530000000000001 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 73.109999999999999 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.329999999999998 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.430000000000007 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.109999999999999 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.010000000000005 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.230000000000004 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.409999999999997 109.353 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.510000000000005 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.219999999999999 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.209999999999994 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 60.020000000000003 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.299999999999997 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 35.130000000000003 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.439999999999998 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.010000000000005 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 65.299999999999997 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.299999999999997 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 62.340000000000003 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.219999999999999 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.049999999999997 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.239999999999995 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.209999999999994 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.450000000000003 109.561 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.040000000000006 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 111' ' ' LEU . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.439999999999998 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.495 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.420000000000002 114.056 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.019999999999996 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 33.409999999999997 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.340000000000003 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.219999999999999 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 64.319999999999993 110.548 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.540000000000006 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.349999999999994 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TYR . . . . . 0.476 ' CE2' HD21 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.439999999999998 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.219999999999999 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 63.329999999999998 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.120000000000005 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.019999999999996 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.604 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.109999999999999 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.149999999999999 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.010000000000005 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 54.020000000000003 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 35.450000000000003 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.010000000000005 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.420000000000002 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 134' ' ' ILE . 22.4 ptmt -94.04 163.34 23.94 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 70.230000000000004 109.198 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 110.41 0.74 Allowed 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.405 2.07 . . . . 41.109999999999999 111.299 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 143.92 -158.37 27.37 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.038 -1.225 . . . . 70.129999999999995 110.038 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.58 -76.58 1.25 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.527 -0.844 . . . . 53.25 111.445 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -84.59 153.15 11.84 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.406 2.071 . . . . 74.540000000000006 110.948 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 107.55 148.62 14.51 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.519999999999996 111.275 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.030000000000001 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 127' ' ' LYS . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 61.109999999999999 109.763 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.430000000000007 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.319999999999993 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.404 ' HH2' ' HB ' ' A' ' 161' ' ' VAL . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.239999999999995 109.716 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.439999999999998 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.109999999999999 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.230000000000004 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.140000000000001 114.197 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.219999999999999 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.230000000000004 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.439999999999998 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.219999999999999 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.140000000000001 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.497 ' H ' ' CD ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.420000000000002 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.310000000000002 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.109999999999999 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.420000000000002 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.420000000000002 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.219999999999999 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 118' ' ' PHE . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.229999999999997 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.340000000000003 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.409999999999997 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.439999999999998 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.516 ' SG ' HD21 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 20.239999999999998 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.400000000000006 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.200000000000003 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HB ' ' HH2' ' A' ' 137' ' ' TRP . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.319999999999993 110.477 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 51.149999999999999 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.340000000000003 111.933 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.420000000000002 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.319999999999993 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.493 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.420000000000002 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.450000000000003 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 62.409999999999997 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.530000000000001 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.21 -19.15 37.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.540000000000006 110.372 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.69 -162.82 0.45 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.99 -1.004 . . . . 23.43 110.507 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.58 179.33 4.64 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.411 -0.813 . . . . 74.25 110.016 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.255 1.387 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.851 177.66 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.43 0.633 . . . . 54.409999999999997 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -106.82 -14.92 14.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.636 -0.711 . . . . 74.400000000000006 112.208 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.52 21.68 1.84 Allowed 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.045 -0.979 . . . . 71.340000000000003 109.44 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 t -72.48 -27.85 62.54 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.607 -0.724 . . . . 73.340000000000003 109.515 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.5 m -79.58 -22.99 43.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.829 -0.623 . . . . 61.119999999999997 111.311 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt 58.16 17.62 4.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.838 0.855 . . . . 74.400000000000006 112.612 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.540000000000006 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.549999999999997 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.140000000000001 110.568 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 63.310000000000002 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 64.150000000000006 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 52.109999999999999 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.129999999999995 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 34.329999999999998 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.230000000000004 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.439 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.329999999999998 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 72.519999999999996 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.010000000000005 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.299999999999997 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.340000000000003 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.310000000000002 111.412 178.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.109999999999999 112.703 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 73.129999999999995 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 81.4 t60 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.319999999999993 110.638 -179.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' HIS . . . . . 0.45 ' HB3' ' HG3' ' A' ' 47' ' ' PRO . 75.1 m80 -77.15 -53.11 8.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 73.140000000000001 112.679 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 3.4 ppp? -72.03 -23.93 61.46 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.081 1.141 . . . . 54.219999999999999 114.081 -170.19 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' CZ ' HG21 ' A' ' 95' ' ' VAL . 80.2 t80 -69.25 -31.48 70.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.486 -0.485 . . . . 74.219999999999999 109.949 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.51 -34.1 35.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.809 -0.632 . . . . 75.319999999999993 109.928 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' MET . . . 167.63 173.04 35.38 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.607 -0.997 . . . . 50.329999999999998 110.607 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.05 122.57 87.15 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.915 0.357 . . . . 64.239999999999995 110.188 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 41' ' ' HIS . 17.1 Cg_exo -68.09 -63.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.751 1.634 . . . . 54.399999999999999 110.348 177.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.49 179.92 4.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.377 -0.971 . . . . 73.109999999999999 108.377 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 79.2 m-70 -136.93 141.61 42.67 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 123.407 0.442 . . . . 73.400000000000006 111.177 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.9 131.27 63.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.553 -0.748 . . . . 75.349999999999994 110.091 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -105.79 94.32 5.13 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.889 -0.725 . . . . 74.099999999999994 112.122 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.31 125.32 34.42 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.175 -1.417 . . . . 63.520000000000003 107.175 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . 57.95 -160.34 0.25 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.239 -1.023 . . . . 73.439999999999998 108.239 -172.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -98.63 104.79 26.39 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.301 -1.0 . . . . 64.530000000000001 108.301 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 8.0 Cg_exo -72.28 132.94 20.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.515 2.143 . . . . 71.129999999999995 111.681 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.18 126.78 29.02 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.39 -0.823 . . . . 73.310000000000002 112.853 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -91.71 102.48 15.1 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.107 -0.701 . . . . 75.310000000000002 109.107 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.8 172.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.419 -0.809 . . . . 55.509999999999998 111.06 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.81 151.06 28.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.908 -1.042 . . . . 74.019999999999996 109.707 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.53 -4.7 54.28 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.585 -0.817 . . . . 44.299999999999997 113.128 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.8 m -94.03 -21.08 19.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.298 0.571 . . . . 64.109999999999999 109.581 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.06 149.18 24.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.797 -1.186 . . . . 73.540000000000006 107.797 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.69 118.22 30.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 112.577 0.584 . . . . 70.430000000000007 112.577 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -78.97 -30.52 44.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.503 -0.771 . . . . 75.219999999999999 109.833 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.61 164.61 16.91 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.825 -0.805 . . . . 62.439999999999998 108.825 -175.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.63 -118.35 0.86 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.996 -0.842 . . . . 75.329999999999998 110.996 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 67.41 15.22 9.85 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.955 0.902 . . . . 73.150000000000006 111.405 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 92.1 m95 -85.33 -0.45 54.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 65.409999999999997 111.24 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.88 49.81 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 119.212 -1.47 . . . . 65.409999999999997 109.873 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m 75.77 -60.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.547 1.139 . . . . 74.450000000000003 110.889 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.129999999999995 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.439999999999998 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.540000000000006 110.373 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.319999999999993 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.239999999999995 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.349999999999994 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.329999999999998 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.310000000000002 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.310000000000002 108.667 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.430000000000007 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.403 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 74.400000000000006 107.498 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.329999999999998 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.409999999999997 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.140000000000001 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 79' ' ' TYR . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.310000000000002 107.851 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.140000000000001 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.230000000000004 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.540000000000006 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 91' ' ' ARG . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.209999999999994 107.089 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 44.420000000000002 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.239999999999995 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.530000000000001 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.449 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.229999999999997 110.724 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.230000000000004 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.129999999999995 111.499 179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.420000000000002 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.519999999999996 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.340000000000003 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.140000000000001 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.409999999999997 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 53.509999999999998 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.219999999999999 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.519 ' H ' HD13 ' A' ' 107' ' ' ILE . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.519999999999996 111.496 -176.242 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.109999999999999 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.150000000000006 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 52.5 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.120000000000005 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' MET . . . . . 0.565 ' HA ' ' HE3' ' A' ' 112' ' ' MET . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.400000000000006 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.319999999999993 111.832 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 63.240000000000002 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.310000000000002 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.409999999999997 106.939 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.129999999999995 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.129999999999995 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.420000000000002 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.239999999999995 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 10.0 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.340000000000003 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.530000000000001 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.310000000000002 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.140000000000001 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' HG3' ' CA ' ' A' ' 133' ' ' SER . 7.1 mtpm? -72.06 148.58 91.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.340000000000003 109.798 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.29 110.1 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.484 2.123 . . . . 64.310000000000002 110.449 176.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.94 -53.65 0.8 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.025 -1.23 . . . . 65.109999999999999 110.025 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.99 -79.59 0.2 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.728 -0.748 . . . . 55.009999999999998 113.102 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.53 125.31 17.41 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.134 3.223 . . . . 73.420000000000002 114.078 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.95 175.67 49.24 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.548 -0.751 . . . . 52.310000000000002 112.462 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.42 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.420000000000002 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.519999999999996 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 42.409999999999997 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.130000000000003 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 63.420000000000002 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.349999999999994 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.129999999999995 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.239999999999995 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 62.32 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.230000000000004 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 148' ' ' VAL . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.310000000000002 106.494 170.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.340000000000003 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 73.439999999999998 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.310000000000002 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' HB ' ' A' ' 144' ' ' ILE . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 65.010000000000005 110.192 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.329999999999998 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.319999999999993 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.439999999999998 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.010000000000005 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.409999999999997 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.129999999999995 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' LEU . . . . . 0.602 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 71.349999999999994 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.420000000000002 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.329999999999998 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 51.020000000000003 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.230000000000004 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.240000000000002 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 62.329999999999998 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 60.130000000000003 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.010000000000005 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.530000000000001 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.019999999999996 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.430000000000007 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.099999999999994 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 62.399999999999999 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.319999999999993 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt -65.47 -43.98 88.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 61.149999999999999 110.116 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 50.69 -74.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.255 1.822 . . . . 74.219999999999999 114.538 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.35 171.35 13.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.977 -0.749 . . . . 75.450000000000003 108.977 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 106.747 -1.575 . . . . 72.519999999999996 106.747 -177.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt . . . . . 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.31 115.341 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 74.43 108.462 172.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.14 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.44 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.51 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.14 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.24 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 70.31 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.15 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.21 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.42 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 42.22 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.41 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.2 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.41 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.1 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.54 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.44 108.769 173.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 61.41 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 . . . . . 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 72.01 111.488 -178.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m . . . . . 0 CA--C 1.551 1.011 0 N-CA-C 111.843 0.312 . . . . 73.13 111.843 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.12 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.21 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 43.44 110.662 -179.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.41 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.35 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.41 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.13 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.55 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.13 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.33 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 61.21 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 34.44 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.12 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.23 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.13 108.132 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.1 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.44 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.42 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.32 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.2 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.31 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.34 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.23 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 61.44 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.41 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.01 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.21 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.22 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.22 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.15 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.31 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.15 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.32 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.04 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 32.21 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 72.45 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 64.45 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.02 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.45 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.04 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 62.44 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.45 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 73.25 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.31 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.34 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.456 HG22 HD11 ' A' ' 101' ' ' LEU . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.11 109.716 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.43 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.11 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.53 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 54.51 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.42 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.516 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm . . . . . 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 53.04 112.037 -178.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.33 111.117 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.11 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 31' ' ' GLU . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.34 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 62.15 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.21 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.05 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.542 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.3 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.43 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 71.31 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.32 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.22 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.21 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 55.34 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.23 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.42 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 44.15 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.12 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.21 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.05 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.42 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 65.11 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.2 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.54 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 70.33 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.542 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.34 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.2 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.13 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.13 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.488 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.21 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.55 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.34 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.54 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.555 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.12 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.31 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 62.43 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.01 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt . . . . . 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.14 110.044 177.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 143' ' ' LYS 0.288 91.1 mt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.22 117.173 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.42 107.271 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.32 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.11 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 72.11 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' HD23 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.55 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 63.45 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.04 110.377 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.42 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.01 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.3 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 71.53 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.12 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.31 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.4 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.13 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.03 111.28 -178.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.52 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 70.43 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 19.5 m170 . . . . . 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 53.01 110.706 176.156 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t . . . . . 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.24 108.93 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.41 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.11 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 92' ' ' ILE . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 62.23 109.204 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.4 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 45.04 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.31 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.52 108.345 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.44 108.554 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 72.25 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.31 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.517 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 73.55 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.53 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.45 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.55 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.13 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.3 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.31 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' TRP . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.44 108.353 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 108' ' ' GLU . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.2 106.88 -174.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.52 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.51 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 73' ' ' SER . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.43 108.623 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.45 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.43 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.3 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.12 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 55.33 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.41 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.45 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.23 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.03 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.24 110.951 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.12 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.11 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.22 109.245 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.52 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' A' ' 89' ' ' LYS . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.12 112.884 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.12 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.02 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.05 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.42 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.33 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 64.44 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.2 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.21 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.13 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.23 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 71.21 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.22 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.31 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.44 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.23 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.13 113.83 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.13 110.668 177.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.276 0 CA-C-O 121.313 0.396 . . . . 25.11 112.758 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.31 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.41 110.385 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.11 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.52 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 74.45 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.31 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.44 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.41 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 53.42 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.23 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.15 111.509 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.33 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.41 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.33 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.14 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 61.2 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.24 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 73.43 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.32 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.31 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.32 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 44.21 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.51 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.23 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.33 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.451 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.24 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.53 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.41 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.31 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.34 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.22 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.42 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.22 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.23 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.13 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.43 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.42 111.277 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt . . . . . 0 N--CA 1.479 0.979 0 N-CA-C 113.994 1.109 . . . . 62.54 113.994 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.52 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.1 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.31 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.22 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.2 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.53 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 72.33 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.32 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.498 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.24 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' HD11 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.21 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.2 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.51 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.03 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 73.33 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.53 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.33 107.764 176.605 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 7.0 t60 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.42 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 . . . . . 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 70.2 113.803 -179.331 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m . . . . . 0 N--CA 1.439 -1.012 0 N-CA-C 109.387 -0.598 . . . . 63.33 109.387 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.22 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.43 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.24 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.15 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.31 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.33 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.11 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.34 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.12 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.02 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 70.43 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.41 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.31 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 34.41 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.44 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.41 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 33.22 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.03 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.12 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.14 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 73' ' ' SER . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.13 107.961 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.11 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.51 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.42 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.12 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.3 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.614 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.24 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.04 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.34 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.43 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.42 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.03 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.41 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.01 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.552 HG11 ' HE1' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.11 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 108' ' ' GLU . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 64.45 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 71.13 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.53 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.469 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.3 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.31 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.552 ' HE1' HG11 ' A' ' 106' ' ' VAL . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 63.21 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.15 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.13 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.14 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.614 ' HG3' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.23 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.14 107.597 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 64.1 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.21 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 120' ' ' LEU . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.04 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.51 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.43 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.54 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.44 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm . . . . . 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.24 112.424 -173.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.4 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.636 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.02 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 64.13 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 54.51 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.21 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.05 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.42 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.13 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.44 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.3 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.614 HG12 ' HG3' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.55 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.3 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.3 111.469 -173.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.31 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.23 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.21 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.15 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.34 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 54.44 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 43.01 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.31 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.35 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.14 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 73.43 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.43 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.31 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 51.22 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.606 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.35 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.31 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 44.31 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.41 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.33 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.588 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.42 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 53.25 111.113 176.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.04 110.749 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt . . . . . 0 N--CA 1.481 1.102 0 N-CA-C 113.18 0.808 . . . . 75.43 113.18 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.31 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.44 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.13 110.404 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.32 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.33 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 34.11 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.41 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.53 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.582 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.42 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.43 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.43 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.45 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.15 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.22 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.41 106.953 174.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 . . . . . 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 63.01 113.954 -179.791 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m . . . . . 0 CA--C 1.537 0.449 0 CA-C-O 120.476 0.179 . . . . 64.31 110.739 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.42 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.35 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.53 111.347 -178.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.32 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.14 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.44 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.42 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.501 HD22 ' C ' ' A' ' 77' ' ' TRP . 0.9 OUTLIER -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.33 108.748 176.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.14 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.15 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.549 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.55 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.2 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 34.24 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.23 108.97 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.12 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.53 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 62.51 107.432 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.35 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.05 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.41 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.409 ' CG2' HG23 ' A' ' 95' ' ' VAL . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.44 108.193 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.03 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.53 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.54 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.54 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.14 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.32 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.14 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.434 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.14 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.12 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.55 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 63.1 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.42 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.02 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.02 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.02 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.31 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.683 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.02 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 106' ' ' VAL . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.41 109.847 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.11 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.4 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.05 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.44 110.726 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 51.33 108.038 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.34 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.1 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.15 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.2 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.14 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.02 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.24 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.31 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.2 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm . . . . . 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.42 111.928 -175.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.02 109.212 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.34 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.581 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 61.41 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.32 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 65.3 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.4 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.23 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.14 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.4 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.55 112.598 -172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.32 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.54 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 71.11 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 116' ' ' LYS . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.04 105.511 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.41 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.34 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 62.32 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.44 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 32.42 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.31 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HA ' HD12 ' A' ' 154' ' ' LEU . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.22 112.134 175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.12 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.51 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.3 110.235 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.2 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.35 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.11 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 52.03 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.33 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.11 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.12 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.33 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.12 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.44 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 44.12 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.657 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.4 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.35 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 51.33 110.505 179.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.466 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt . . . . . 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.43 115.799 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.42 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.03 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.14 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.11 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.34 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.43 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.01 109.519 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 53.42 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.24 113.24 178.25 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.22 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 43.31 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.22 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 61.22 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.42 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 55.02 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.4 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.3 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 12.5 m-70 . . . . . 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.1 109.778 -178.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m . . . . . 0 CA--C 1.535 0.381 0 N-CA-C 109.337 -0.616 . . . . 70.13 109.337 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 65.3 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.24 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.13 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.14 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 45.2 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.24 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.24 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.477 ' OD1' HG22 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.4 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.41 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 64.2 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.1 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.24 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.23 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.11 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.44 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.01 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 70.32 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 51.11 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.12 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.14 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.11 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 102' ' ' ILE . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.13 108.406 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.51 110.397 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.11 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.43 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.21 108.997 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.41 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.21 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.32 110.658 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.683 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.45 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.21 109.323 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 92' ' ' ILE . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 72.4 111.567 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.12 110.951 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 64.22 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 118' ' ' PHE . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.13 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.34 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.52 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 112' ' ' MET . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.42 113.933 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.35 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.23 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.22 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.33 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.54 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.41 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.543 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.01 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.15 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.543 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 63.33 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.43 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.33 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.683 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.54 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.14 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.4 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt . . . . . 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.52 110.899 177.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.288 0 N-CA-C 111.777 -0.529 . . . . 74.3 111.777 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.41 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.2 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 44.32 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 81.5 m-70 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.4 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.14 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 71.1 106.284 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.44 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.22 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.35 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.33 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.45 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 148' ' ' VAL . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.13 105.726 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.4 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.23 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.23 112.237 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.24 109.762 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.51 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 55.25 112.891 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 154' ' ' LEU . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.12 111.512 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.33 112.252 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.2 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 151' ' ' PRO . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.23 110.161 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.34 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.14 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 63.01 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.21 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.02 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.23 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.01 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.11 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.02 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 74.12 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.45 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 63.51 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.4 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.13 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 33' ' ' LYS . 87.6 mt . . . . . 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.21 110.331 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 82.5 mt . . . . . 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.32 111.077 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.24 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.42 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.53 110.954 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.32 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.35 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.54 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.02 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.45 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.3 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.45 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.14 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 34.53 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.03 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.42 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 65.13 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 65.02 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 5.2 t60 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.21 108.51 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 . . . . . 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.41 110.631 -177.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p . . . . . 0 C--O 1.245 0.828 0 CA-C-O 120.476 0.179 . . . . 74.04 111.085 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.05 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.2 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.485 ' HB3' HD12 ' A' ' 92' ' ' ILE . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.11 110.664 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 61.54 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.34 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.4 111.591 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.442 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.54 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 11.8 m120 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.2 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.32 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.04 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.44 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.31 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.02 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.43 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.3 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.31 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.42 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.44 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 73' ' ' SER . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 71.43 109.144 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.15 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.31 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.13 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.11 104.739 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.35 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.11 111.808 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.01 112.777 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.54 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.13 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.54 111.592 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 70.3 110.724 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.45 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.1 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.14 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.23 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.24 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.32 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.05 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 74.21 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.427 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.24 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.35 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.13 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.496 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.31 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' ILE . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.44 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.12 108.127 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 52.4 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.35 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.901 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 102' ' ' ILE . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.1 109.74 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.02 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.1 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.52 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.66 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.1 112.155 -176.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . . . . . . 0 C--O 1.226 -0.346 0 N-CA-C 115.006 0.762 . . . . 73.14 115.006 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.04 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 64.34 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.31 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.34 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 72.23 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.4 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 154' ' ' LEU . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.11 110.345 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.31 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 74.34 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.3 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.22 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.44 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.24 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.51 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.24 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.02 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 65.21 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 62.2 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.43 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.22 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 73.12 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 139' ' ' LEU . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.22 112.512 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.13 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 64.53 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.01 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.24 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.21 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.3 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 43.35 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.24 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.496 ' H ' ' HD3' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.53 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.35 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 62.12 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.32 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.05 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.2 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.31 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt . . . . . 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.13 110.297 -179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt . . . . . 0 N--CA 1.461 0.088 0 N-CA-C 113.762 1.023 . . . . 73.21 113.762 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 35.34 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.01 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 63.42 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.03 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.15 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.42 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.41 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.12 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.44 113.288 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.03 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 60.53 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.04 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.54 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.2 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 6.1 t60 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 72.22 109.221 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 . . . . . 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.14 113.053 -178.191 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m . . . . . 0 CA--C 1.569 1.675 0 N-CA-C 111.489 0.181 . . . . 75.22 111.489 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.11 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.12 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.14 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.41 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.01 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.02 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.44 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.435 HD22 HG22 ' A' ' 87' ' ' VAL . 26.3 t-20 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.03 107.842 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.42 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.4 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.55 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.44 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.44 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 51.12 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.23 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.3 110.259 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 HD22 ' A' ' 78' ' ' ASN . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 44.11 108.979 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.13 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.03 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.32 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.11 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.34 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.05 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.41 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.21 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.53 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.35 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 74.53 112.554 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.23 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.12 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 41.35 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.15 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.34 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.45 108.723 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 119' ' ' LEU . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.43 106.487 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 72.04 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.42 111.481 -176.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.23 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.44 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.401 ' HE2' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.54 109.793 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.1 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.13 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.53 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.34 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 72.03 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.54 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' HG2' ' A' ' 105' ' ' ARG . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.51 110.484 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.24 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.2 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.23 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.45 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.42 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.44 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 63.03 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt . . . . . 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.11 109.147 178.278 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.31 110.407 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.34 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.11 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.3 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 72.23 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 73.25 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.2 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 52.45 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.32 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.478 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.14 113.211 -171.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.24 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.655 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.14 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.42 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.42 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.655 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.2 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.2 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.43 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.12 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 71.24 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' A' ' 154' ' ' LEU . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 60.31 114.309 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 55.3 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 51.21 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 65.25 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.54 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 63.41 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.24 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.13 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 165' ' ' ILE . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 64.33 110.647 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.54 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.44 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.21 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.41 111.565 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.549 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.44 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.13 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.32 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 53.13 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 34' ' ' ALA . 90.6 mt . . . . . 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.4 110.747 -179.065 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt . . . . . 0 N--CA 1.494 1.726 0 CA-C-O 121.2 0.524 . . . . 64.51 112.171 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.25 109.862 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.24 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.35 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.11 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.52 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.03 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.43 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.12 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.43 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.14 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.53 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 41.31 112.045 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.44 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.2 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.14 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 . . . . . 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 72.21 113.564 175.749 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p . . . . . 0 N--CA 1.435 -1.195 0 CA-C-O 120.615 0.245 . . . . 73.23 110.341 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.54 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.05 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.24 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.32 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.01 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 61.2 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.34 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.35 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 54.34 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.14 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.498 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.51 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.45 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.03 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.05 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.43 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.11 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 62.43 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.53 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.519 ' HE2' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.22 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 105' ' ' ARG . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.13 107.931 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.45 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.24 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.33 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.12 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.54 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.14 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.14 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.43 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.4 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 51.23 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.04 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.34 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 73.35 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 91' ' ' ARG . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 62.15 110.767 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.402 HG11 ' HE1' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 64.24 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.22 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.53 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.02 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.01 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.24 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.32 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.13 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.52 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.21 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.54 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.31 106.592 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.21 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.515 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.23 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 61.25 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.35 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.44 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 61.24 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 63.42 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.4 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt . . . . . 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.01 111.461 -179.294 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.356 0 N-CA-C 111.634 -0.586 . . . . 52.21 111.634 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.24 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.32 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.31 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.22 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 64.31 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 61.43 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.23 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.24 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.22 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.54 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.43 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.21 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.52 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.14 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.4 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.22 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 52.41 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 53.3 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.14 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.13 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.01 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.54 110.965 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.21 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 62.05 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.32 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.14 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.33 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 63.25 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.505 ' CB ' HG11 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 43.3 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.23 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.22 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.52 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.32 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.21 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 62.53 109.349 175.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.31 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt . . . . . 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.34 110.167 177.527 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt . . . . . 0 N--CA 1.477 0.904 0 N-CA-C 113.823 1.045 . . . . 72.41 113.823 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.14 106.918 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.04 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.11 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.22 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.54 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.34 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 61.01 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.4 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.32 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 62.01 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.02 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.24 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 65.21 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.12 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.55 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.21 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.22 108.452 177.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 64.23 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 . . . . . 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.2 114.347 179.976 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m . . . . . 0 CA--C 1.543 0.686 0 N-CA-C 111.817 0.303 . . . . 54.33 111.817 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.14 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.4 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.22 109.001 -177.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.41 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.32 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 71.41 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.35 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.35 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.32 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.54 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.34 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.33 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.52 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 64.54 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 50.03 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 64.05 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.13 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.4 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.21 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.24 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.13 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.22 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.23 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.44 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.21 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.02 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.32 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.51 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.22 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' HD21 ' A' ' 119' ' ' LEU . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 52.33 110.543 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.44 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.01 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.53 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.04 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.4 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.13 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.01 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 63.44 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.45 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.13 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.44 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.33 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.495 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.43 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 103' ' ' THR . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.41 109.006 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 120' ' ' LEU . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.33 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.03 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.11 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 62.02 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.04 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.534 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.2 tttm . . . . . 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.23 111.309 -177.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.448 0 N-CA-C 111.099 -0.8 . . . . 73.41 111.099 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.03 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.534 HG13 ' HD3' ' A' ' 127' ' ' LYS . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.02 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 54.44 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.22 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.43 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.24 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.22 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.54 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.14 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.23 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.523 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 72.44 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.52 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 72.22 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.523 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.44 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 64.24 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.02 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.24 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.24 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.11 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.23 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 156' ' ' GLN . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.21 111.192 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.827 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.53 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 0.0 OUTLIER -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.15 112.004 176.816 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.35 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.44 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.01 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.51 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.31 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.01 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.41 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.34 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.23 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.41 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.24 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 54.2 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt . . . . . 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.04 109.311 178.47 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt . . . . . 0 N--CA 1.483 1.21 0 CA-C-O 121.278 0.561 . . . . 64.3 112.365 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 71.51 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.03 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.12 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.24 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.2 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.11 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.33 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.03 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.41 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.23 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.31 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.14 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.31 111.042 -177.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.12 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.33 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.31 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 4.7 t60 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.4 109.812 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.49 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 32.8 m-70 . . . . . 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 64.45 113.51 -177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t . . . . . 0 N--CA 1.445 -0.698 0 N-CA-C 110.397 -0.223 . . . . 51.12 110.397 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 95' ' ' VAL . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.31 108.67 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.04 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.22 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.41 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.53 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.14 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.14 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 62.45 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 72.4 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.41 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.41 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.31 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 63.22 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.53 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.03 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.11 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.34 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.33 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.33 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.24 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.54 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 51.12 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.42 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.34 111.465 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.55 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.33 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . 0.565 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.52 111.848 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.627 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.34 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.24 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.33 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.13 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.05 109.735 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 64.11 110.072 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.33 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 71.54 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.41 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.44 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.577 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.3 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.53 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.44 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.54 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 64.25 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 74.42 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.35 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.11 108.712 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.51 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.23 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.13 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.21 109.074 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.31 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.24 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.21 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.2 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 62.3 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.505 ' CD ' HG13 ' A' ' 134' ' ' ILE . 86.6 tttt . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.11 111.754 -177.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.42 109.254 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.31 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.505 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.14 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.23 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.24 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 73.25 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 63.3 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.35 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.53 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.51 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.21 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.478 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.14 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 72.13 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 65.51 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.31 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.33 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.34 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.43 110.791 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.53 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.4 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.22 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 61.21 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.22 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 74.32 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.14 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.42 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 156' ' ' GLN . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 73.01 111.967 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.3 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 52.2 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 71.24 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.44 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 73.5 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.14 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.44 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 55.43 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.42 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt . . . . . 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.32 110.691 -179.999 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt . . . . . 0 N--CA 1.477 0.877 0 N-CA-C 113.132 0.79 . . . . 74.23 113.132 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.12 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.12 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.22 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.4 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.22 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.22 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.508 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.3 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.11 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.11 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 41.32 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 63.43 111.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.33 108.345 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.45 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.53 110.535 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 62.54 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.14 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 . . . . . 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 55.44 110.909 176.855 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.507 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m . . . . . 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 53.42 110.699 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 63.03 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.34 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.12 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.31 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.52 110.378 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 60.23 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.04 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.7 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.22 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 34.11 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.43 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.13 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.42 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.14 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.51 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.14 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.22 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.04 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.51 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.33 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.31 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.33 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.24 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.14 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 73.11 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.15 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 61.3 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.34 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.42 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.712 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.4 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.24 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.11 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 54.15 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 64.34 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.3 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.32 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.41 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.33 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.11 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.51 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.2 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.32 112.073 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.35 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 72.54 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.53 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 64.23 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.568 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.24 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 64.54 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 45.24 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 60.15 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 72.45 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.22 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 36' ' ' ALA . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 70.11 108.467 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.44 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.1 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt . . . . . 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.41 109.035 -178.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . . . . . . 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.14 111.413 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 51.41 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.24 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.34 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.4 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.22 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 71.42 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.21 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 71.3 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.44 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.2 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.21 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.34 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.33 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.21 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 54.15 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.43 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.34 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 72.44 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.33 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.51 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 64.14 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 50.33 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 54.24 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.52 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 62.03 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.43 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.53 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.1 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 55.25 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.517 ' CB ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.11 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.11 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.24 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.41 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.32 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.2 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.11 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 53.5 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 33' ' ' LYS . 85.3 mt . . . . . 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt . . . . . 0 N--CA 1.476 0.837 0 N-CA-C 112.603 0.594 . . . . 61.32 112.603 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 63.23 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.1 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.45 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.13 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 51.51 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 53.25 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.14 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.31 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.34 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 61.02 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.22 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 54.42 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.32 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 72.2 112.396 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.23 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.11 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.3 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 38.3 m-70 . . . . . 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.12 111.277 177.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 111.916 0.339 . . . . 72.3 111.916 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.03 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.33 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 61.43 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 61.11 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.12 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.45 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.44 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.2 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 63.44 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.14 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.54 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.22 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.24 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.13 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.32 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.4 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.3 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.22 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.4 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.03 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 70.44 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.32 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 60.24 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.51 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.15 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.42 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.11 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.05 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.438 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.32 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 65.02 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.12 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 55.24 110.609 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.35 108.54 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 53.41 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 72.23 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 65.01 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.22 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.43 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.12 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.11 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.438 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.23 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.54 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.4 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.12 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.33 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 64.2 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 73.21 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.581 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.31 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 65.04 109.991 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.34 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.42 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 51.12 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.41 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.52 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.427 ' CD ' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm . . . . . 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.23 110.556 -178.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.426 -2.021 0 CA-C-O 120.771 0.095 . . . . 63.22 112.973 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 41.34 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 64.31 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.4 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 63.41 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.23 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 73.33 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.15 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.53 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 63.43 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.44 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 62.41 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.34 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.13 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.33 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.33 111.053 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.22 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 52.42 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.53 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 64.25 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.01 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.42 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 61.5 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.3 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 62.03 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.22 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.44 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.34 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.31 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 61.24 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.603 ' O ' HD13 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.33 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.32 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.52 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.4 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.21 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt . . . . . 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.24 110.828 178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 53.22 110.932 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.51 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.1 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.34 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 53.15 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.22 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.02 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 42.21 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.4 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 73.44 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.43 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.4 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 63.13 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.43 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.42 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 44.42 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.44 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 . . . . . 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.21 110.257 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m . . . . . 0 CA--C 1.541 0.606 0 N-CA-C 111.34 0.126 . . . . 60.55 111.34 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.4 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.22 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.51 111.962 -178.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.02 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.44 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 64.33 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.525 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.24 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.53 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 63.2 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 53.22 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.408 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.54 108.383 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.42 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.2 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.33 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.11 108.446 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.52 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.33 108.187 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.51 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.22 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.45 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.04 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.33 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.41 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.45 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 62.41 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.1 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.41 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.23 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.34 111.205 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 71.5 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.41 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 63.14 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.51 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.41 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.24 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.43 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.54 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.11 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.13 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.02 110.988 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.02 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.3 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.42 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.03 108.919 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.596 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.14 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 71.42 107.563 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 154' ' ' LEU . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.42 110.641 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 71.12 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.13 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 41.12 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.11 108.581 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 55.41 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.15 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 52.41 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.459 ' HD3' HG13 ' A' ' 134' ' ' ILE . 86.2 tttt . . . . . 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.04 109.358 176.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 51.55 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 62.03 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.11 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 54.33 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.31 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.22 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.429 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.11 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.33 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.33 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.01 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.22 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.596 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.53 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.22 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.22 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.15 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 144' ' ' ILE . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.34 110.174 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.23 109.844 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 62.42 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.52 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 62.44 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.23 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.43 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.51 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.4 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.429 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.34 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.1 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.14 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.22 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 61.31 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.33 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.429 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.42 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.14 110.486 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.14 109.279 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.32 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.4 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt . . . . . 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.12 111.637 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt . . . . . 0 C--O 1.212 -0.883 0 N-CA-C 115.201 1.556 . . . . 71.32 115.201 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.2 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.4 112.887 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.24 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.41 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.32 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.2 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.487 HG11 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.44 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.2 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 71.31 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' HD11 ' A' ' 170' ' ' LEU . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.45 109.699 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.24 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.15 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.24 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.51 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 54.52 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.32 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 . . . . . 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 74.3 111.229 -174.12 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m . . . . . 0 CA--C 1.547 0.849 0 CA-C-O 120.858 0.361 . . . . 72.34 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.13 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.13 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.42 109.955 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.22 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.01 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 89' ' ' LYS . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 70.14 108.468 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 62.31 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.52 109.987 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.34 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.24 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.24 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.02 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.13 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.13 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.44 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.31 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.21 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.33 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.429 ' HA ' ' HD1' ' A' ' 76' ' ' PHE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.13 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.31 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.32 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 73' ' ' SER . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.53 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' ILE . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 53.12 109.3 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.52 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.32 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.44 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.54 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.3 112.362 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.21 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.464 HD11 ' CG2' ' A' ' 121' ' ' THR . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.04 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.22 111.941 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.32 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.2 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 44.14 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.45 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.03 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.31 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.23 112.006 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.1 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 61.11 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.11 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 74.44 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' HG12 ' A' ' 144' ' ' ILE . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.52 111.105 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.42 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 71.34 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 65.21 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.33 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 62.13 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.31 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.31 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.55 114.094 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.51 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.428 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.0 tttt . . . . . 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.12 112.156 -177.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.23 109.54 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.22 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.545 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 34.34 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.51 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 54.32 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.3 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.14 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 137' ' ' TRP . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.11 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.41 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.22 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.45 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.629 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.45 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 116' ' ' LYS . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 65.44 107.193 170.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 61.21 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.3 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.4 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.629 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.51 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.15 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.612 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.23 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.32 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.24 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.45 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.52 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.41 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 71.24 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.405 ' SG ' HD21 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 62.45 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 60.44 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.33 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 23.33 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.44 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.23 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.22 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.43 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.42 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.53 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.24 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt . . . . . 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.23 110.434 -177.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt . . . . . 0 N--CA 1.472 0.674 0 CA-C-O 121.279 0.562 . . . . 62.11 112.307 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.21 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.53 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.15 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.33 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.32 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.24 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.35 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.3 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.557 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.14 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.12 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 73.35 111.92 -179.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.35 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.35 111.022 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.21 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.25 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 13.6 t-80 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.44 111.812 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 . . . . . 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.43 111.987 -177.651 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p . . . . . 0 N--CA 1.44 -0.931 0 CA-C-O 120.432 0.158 . . . . 72.44 110.91 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.14 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.23 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 92' ' ' ILE . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.22 110.803 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.3 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.31 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 62.3 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . 0.404 ' ND2' HG22 ' A' ' 87' ' ' VAL . 15.8 m120 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 73.22 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.33 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.14 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 71.13 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.51 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.4 110.737 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.22 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.33 109.9 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.404 HG22 ' ND2' ' A' ' 78' ' ' ASN . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.03 109.131 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HB3' HD11 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 70.34 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.02 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.53 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.496 HG22 HG23 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.51 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.13 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.43 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.43 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.44 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 71.13 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.53 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 60.2 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.14 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 122' ' ' ILE . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 45.32 110.811 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 65.52 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.12 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.23 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 65.34 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.31 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.13 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.12 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.54 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.52 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.54 111.443 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.11 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.14 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.13 105.653 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.22 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.43 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.13 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.31 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 63.15 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.44 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 102' ' ' ILE . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.11 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.03 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.34 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.32 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt . . . . . 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.4 112.842 -175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.32 111.121 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 65.44 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.33 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 65.41 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 90.0 m-70 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 60.55 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.34 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.1 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 55.43 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.41 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.04 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.33 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.35 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.439 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.21 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.35 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.35 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 61.01 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.585 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.21 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.2 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.43 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.35 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 152' ' ' GLU . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 72.23 108.887 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.14 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.474 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.35 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 44.55 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 15.1 mm100 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 71.1 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 50.01 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.14 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 155' ' ' LEU . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 63.24 111.5 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.54 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 64.52 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.01 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.03 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.2 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.15 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.557 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.1 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.01 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 55.43 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt . . . . . 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.41 110.996 178.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt . . . . . 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 51.4 114.796 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.54 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.23 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.04 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 155' ' ' LEU . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 63.32 108.564 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.34 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.23 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.31 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.21 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.22 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 54.32 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.23 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.14 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.13 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.54 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 45.13 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 . . . . . 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.31 113.831 -177.445 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m . . . . . 0 N--CA 1.44 -0.943 0 N-CA-C 108.161 -1.052 . . . . 73.15 108.161 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.469 HG23 HG22 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.11 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.55 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.518 ' HB3' HD12 ' A' ' 92' ' ' ILE . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.34 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.42 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.54 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.585 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 72.03 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.33 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.11 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.34 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.51 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.24 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.34 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.2 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.21 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.11 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.31 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 74.32 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 53.34 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.22 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.24 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.03 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.23 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.34 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.3 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 71' ' ' VAL . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.4 109.893 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.656 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.42 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.11 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.21 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.727 ' HB3' HE21 ' A' ' 123' ' ' GLN . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.32 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.42 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.31 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.31 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.33 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.42 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.21 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.3 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.656 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.1 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 89' ' ' LYS 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 70.43 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.43 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.463 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.05 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 55.5 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.52 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.33 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.52 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 64.24 108.901 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.605 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 65.32 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.21 106.449 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 64.42 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.21 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 65.24 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 62.24 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.727 HE21 ' HB3' ' A' ' 99' ' ' LYS . 57.5 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.55 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.21 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.467 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 64.45 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.22 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.579 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt . . . . . 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.31 111.458 178.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.04 110.762 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 53.25 110.913 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.579 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.24 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 30' ' ' VAL . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.13 108.639 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.13 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.33 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.45 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.13 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.23 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.12 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.42 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.23 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.605 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 60.13 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.2 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 53.02 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 73.54 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.13 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.41 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.32 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.13 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.11 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.44 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 42.1 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 64.51 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 60.05 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 61.13 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.42 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.44 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 65.52 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.537 ' CB ' HG11 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 51.24 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.24 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 65.32 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.32 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.411 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.12 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.4 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.04 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.525 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.32 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt . . . . . 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.23 110.636 175.755 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt . . . . . 0 C--O 1.239 0.52 0 N-CA-C 111.925 0.343 . . . . 75.33 111.925 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 51.3 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.34 109.745 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.12 110.5 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 62.34 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.42 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.13 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.42 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.22 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.43 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.32 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.14 109.776 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.11 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.02 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.11 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.05 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.544 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 22.5 m-70 . . . . . 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.32 110.977 -178.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m . . . . . 0 CA--C 1.553 1.092 0 N-CA-C 110.607 -0.146 . . . . 74.15 110.607 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.12 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.11 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB3' HD12 ' A' ' 92' ' ' ILE . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.42 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.53 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.23 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.43 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.33 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.33 109.383 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.52 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 42.33 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.52 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.14 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.21 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.12 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.44 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 52.22 109.256 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.45 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.11 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 62.41 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.43 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.33 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.31 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 73.35 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.23 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.31 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.21 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.44 111.117 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.576 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 51.0 t30 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.24 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.03 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.24 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.34 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.44 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.4 110.383 177.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.32 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.14 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 72.35 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.13 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.23 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.24 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.52 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.11 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.53 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.13 107.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 73.01 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.21 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.22 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.53 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 102' ' ' ILE . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.2 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.51 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.57 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.51 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.33 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt . . . . . 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.23 109.963 176.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.1 109.954 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.53 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.21 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.23 108.971 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.517 ' HA ' HG22 ' A' ' 122' ' ' ILE . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.2 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.12 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 72.33 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.4 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 71.43 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.23 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.41 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.42 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.31 111.254 -178.614 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.11 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.31 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.44 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 72.22 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.02 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.54 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 71.12 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 60.13 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.31 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.11 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.54 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 73.43 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 155' ' ' LEU . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 72.21 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.52 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.433 ' CB ' HG11 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.34 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.32 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.53 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.53 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.21 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.23 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.42 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt . . . . . 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 73.54 110.273 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt . . . . . 0 C--O 1.237 0.427 0 N-CA-C 112.777 0.658 . . . . 75.54 112.777 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.31 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 21.4 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.31 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.41 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.21 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.54 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 134' ' ' ILE . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.14 109.623 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.22 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.34 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 34' ' ' ALA . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 61.24 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 32' ' ' ILE . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 45.13 112.0 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.43 109.517 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.41 110.226 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 73.13 110.148 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 169' ' ' LEU . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.24 108.533 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.32 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 21.1 m-70 . . . . . 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 50.7 m . . . . . 0 CA--C 1.545 0.762 0 CA-C-O 120.499 0.19 . . . . 72.43 110.856 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.45 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.31 110.83 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 60.34 109.883 178.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 71.13 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.34 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.43 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.14 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.52 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 71.24 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.01 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.34 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.15 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.54 111.097 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 60.42 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.44 109.816 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.41 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.31 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 62.42 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.24 105.624 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.33 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.31 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.41 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.04 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.33 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.03 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.24 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.628 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.42 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.24 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.42 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.43 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.13 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.12 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.44 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.45 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.728 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.43 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.51 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.33 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.33 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.678 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 70.3 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.44 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.42 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 71.25 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB3' HG12 ' A' ' 144' ' ' ILE . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.42 110.399 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.12 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.21 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.41 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.2 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.22 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.41 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.04 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 65.31 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.32 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.01 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt . . . . . 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.4 110.158 -179.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.15 110.469 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.41 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 29' ' ' ASP . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.53 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 62.24 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 91.6 m-70 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 63.54 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.24 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.53 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 63.32 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.13 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.42 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.13 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.24 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.11 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.52 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.579 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 71.44 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 65.35 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.52 112.038 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 72.55 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.44 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.41 109.569 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.51 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.4 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.53 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.42 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.15 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.02 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.41 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 61.22 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.34 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 70.35 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.24 109.482 -176.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.1 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.22 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.33 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.437 HD11 ' HA ' ' A' ' 39' ' ' PHE . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.22 111.623 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt . . . . . 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 50.02 110.203 179.82 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt . . . . . 0 N--CA 1.474 0.753 0 N-CA-C 112.737 0.643 . . . . 53.22 112.737 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 61.24 108.082 176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.22 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.34 107.177 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.53 108.303 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.52 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 62.14 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.51 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.3 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.2 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.43 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.42 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.612 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.54 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.34 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.22 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.15 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HA ' HD22 ' A' ' 169' ' ' LEU . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.33 110.699 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.12 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 . . . . . 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.51 111.984 -174.446 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.435 -1.2 0 N-CA-C 109.731 -0.47 . . . . 74.55 109.731 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.11 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.2 110.882 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.51 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.22 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 71.14 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.35 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 63.21 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.53 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 73.11 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.33 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.43 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.01 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.23 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.41 109.353 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.51 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.22 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.21 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 60.02 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.3 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 35.13 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.44 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.01 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 65.3 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.3 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 62.34 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.22 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.05 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.24 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.21 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.45 109.561 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.04 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 111' ' ' LEU . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.495 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.42 114.056 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.02 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 33.41 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.34 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.22 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 64.32 110.548 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.54 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.35 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . 0.476 ' CE2' HD21 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.44 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.22 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 63.33 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.604 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.12 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.02 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.604 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.11 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.15 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.01 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 54.02 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 35.45 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.01 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.42 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 134' ' ' ILE . 22.4 ptmt . . . . . 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 70.23 109.198 179.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.52 111.275 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.03 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 127' ' ' LYS . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 61.11 109.763 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.43 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.32 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.404 ' HH2' ' HB ' ' A' ' 161' ' ' VAL . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.24 109.716 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.44 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.11 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.23 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.14 114.197 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.22 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.23 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.44 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.22 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.14 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.42 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.31 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.11 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.42 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.42 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.22 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 118' ' ' PHE . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.23 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.34 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.41 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.44 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.516 ' SG ' HD21 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 20.24 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.4 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.2 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HB ' ' HH2' ' A' ' 137' ' ' TRP . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.32 110.477 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 51.15 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.34 111.933 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.42 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.32 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.493 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.42 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.45 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 62.41 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.53 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt . . . . . 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.54 110.372 178.271 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 112.612 0.597 . . . . 74.4 112.612 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.54 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.55 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.14 110.568 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 63.31 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 64.15 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 52.11 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.13 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 34.33 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.23 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.439 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.33 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 72.52 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.01 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.3 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.34 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.31 111.412 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.11 112.703 -175.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 23.8 t-80 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.32 110.638 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 54.2 m-70 . . . . . 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 73.14 112.679 178.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m . . . . . 0 N--CA 1.446 -0.657 0 CA-C-O 120.453 0.168 . . . . 74.45 110.889 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.13 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.44 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.54 110.373 -178.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.32 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.24 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.35 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.33 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.31 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.43 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.403 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 74.4 107.498 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.33 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.41 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.14 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 79' ' ' TYR . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.31 107.851 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.14 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.23 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.54 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 91' ' ' ARG . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.21 107.089 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 44.42 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.24 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.53 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.23 110.724 178.395 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.23 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.13 111.499 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . 0.69 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.42 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.52 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.34 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.14 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.41 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 53.51 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.22 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.52 111.496 -176.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.11 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.15 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 52.5 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.12 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' MET . . . . . 0.565 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.4 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.32 111.832 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 63.24 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.31 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.41 106.939 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.13 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.13 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.42 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.24 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 55.1 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.34 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.53 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.31 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.14 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . 0.42 ' HG3' ' CA ' ' A' ' 133' ' ' SER . 7.1 mtpm? . . . . . 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.34 109.798 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -1.03 0 N-CA-C 112.462 -0.255 . . . . 52.31 112.462 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.42 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.42 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.52 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 42.41 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.13 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 63.42 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.35 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.13 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.24 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 62.32 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.23 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 148' ' ' VAL . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.31 106.494 170.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.34 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 73.44 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.31 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' HB ' ' A' ' 144' ' ' ILE . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 65.01 110.192 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.33 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.32 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.44 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.01 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.41 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.13 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' LEU . . . . . 0.602 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 71.35 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.42 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 51.02 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.23 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.24 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 62.33 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 60.13 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.01 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.53 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.02 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.43 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.1 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 62.4 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.32 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt . . . . . 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 61.15 110.116 -178.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.429 -1.509 0 N-CA-C 110.429 -0.211 . . . . 44.4 110.429 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 63.07 -178.21 0.15 Allowed 'General case' 0 C--O 1.248 1.01 0 O-C-N 124.094 0.871 . . . . 74.1 109.864 -178.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.11 95.24 3.04 Favored 'General case' 0 N--CA 1.424 -1.773 0 N-CA-C 107.819 -1.178 . . . . 61.31 107.819 171.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.9 m -69.39 -35.54 75.89 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.893 -0.594 . . . . 60.32 111.087 -176.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 23' ' ' VAL . 7.3 m -89.74 -5.58 56.85 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.07 -0.715 . . . . 73.33 109.07 178.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . 0.287 77.9 mt 62.04 -22.67 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 N-CA-C 115.341 1.608 . . . . 73.31 115.341 -173.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.42 ' H ' ' C ' ' A' ' 21' ' ' SER . 8.5 p -77.46 123.97 35.04 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.295 0 N-CA-C 108.462 -0.94 . . . . 74.43 108.462 172.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.66 156.76 15.53 Favored Glycine 0 N--CA 1.402 -3.617 0 N-CA-C 109.313 -1.515 . . . . 54.14 109.313 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.5 ptmt -148.05 155.17 41.18 Favored 'General case' 0 C--N 1.259 -3.348 0 N-CA-C 109.352 -0.61 . . . . 53.44 109.352 -178.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.547 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.6 tt -148.09 138.0 22.54 Favored 'General case' 0 C--N 1.278 -2.51 0 N-CA-C 106.026 -1.842 . . . . 54.51 106.026 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.547 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.3 mt-10 -130.05 132.54 46.24 Favored 'General case' 0 C--N 1.282 -2.328 0 N-CA-C 109.044 -0.725 . . . . 75.14 109.044 -178.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.2 t -140.33 159.74 41.51 Favored 'General case' 0 C--N 1.288 -2.074 0 N-CA-C 107.771 -1.196 . . . . 71.24 107.771 -178.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -130.07 121.96 27.42 Favored 'General case' 0 C--N 1.291 -1.976 0 N-CA-C 108.152 -1.055 . . . . 70.31 108.152 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.488 HG11 ' HB3' ' A' ' 162' ' ' SER . 96.4 t -107.49 141.56 22.42 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.922 0 N-CA-C 108.294 -1.002 . . . . 75.15 108.294 -179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 134' ' ' ILE . 24.4 mt-10 -97.25 140.44 31.72 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.695 -0.854 . . . . 71.21 108.695 -179.098 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 33.6 pt -128.03 161.65 35.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 109.801 -0.444 . . . . 73.42 109.801 179.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -97.17 -23.6 16.12 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.774 -1.195 . . . . 42.22 107.774 179.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -61.94 136.99 58.2 Favored 'General case' 0 N--CA 1.432 -1.365 0 CA-C-N 114.72 -1.127 . . . . 74.41 110.724 177.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.536 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 29.5 t -67.82 137.79 55.62 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.011 -0.995 . . . . 62.2 109.825 -178.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.35 -35.09 76.48 Favored 'General case' 0 CA--C 1.511 -0.54 0 N-CA-C 109.635 -0.506 . . . . 71.41 109.635 176.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -66.29 -37.47 85.52 Favored 'General case' 0 CA--C 1.508 -0.655 0 CA-C-N 115.373 -0.831 . . . . 74.1 110.016 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 82.5 tttt -76.03 -28.47 57.74 Favored 'General case' 0 C--N 1.306 -1.286 0 CA-C-N 115.082 -0.963 . . . . 75.54 109.937 -178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.604 ' O ' ' HG2' ' A' ' 42' ' ' MET . 59.6 t80 -74.18 -49.72 22.38 Favored 'General case' 0 C--O 1.207 -1.161 0 N-CA-C 108.769 -0.826 . . . . 74.44 108.769 173.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -53.95 -28.99 40.72 Favored 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 124.45 1.1 . . . . 61.41 110.122 178.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 66.5 t-80 -58.16 -30.1 66.11 Favored 'General case' 0 C--N 1.306 -1.284 0 C-N-CA 125.402 1.481 . . . . 72.01 111.488 -178.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.604 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 27.6 ptm -64.75 -22.3 66.95 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-O 120.87 0.367 . . . . 52.41 111.37 -178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -80.3 0.29 33.5 Favored 'General case' 0 C--O 1.239 0.523 0 CA-C-N 116.402 -0.363 . . . . 72.55 111.321 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.91 167.64 9.93 Favored 'General case' 0 N--CA 1.408 -2.532 0 N-CA-C 108.005 -1.109 . . . . 74.34 108.005 177.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -87.54 49.48 3.89 Favored Glycine 0 C--N 1.272 -2.993 0 N-CA-C 114.925 0.73 . . . . 75.23 114.925 -174.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.426 ' HD2' ' C ' ' A' ' 46' ' ' LYS . 3.0 tmmm? -170.96 90.04 0.47 Allowed Pre-proline 0 N--CA 1.437 -1.097 0 N-CA-C 108.73 -0.841 . . . . 74.11 108.73 176.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.492 ' HD3' ' HG3' ' A' ' 65' ' ' GLU . 60.0 Cg_endo -102.59 5.54 0.44 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 123.243 2.629 . . . . 61.14 112.109 175.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.4 t60 73.05 96.5 0.07 Allowed 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.306 1.442 . . . . 62.12 111.917 -176.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -177.37 113.21 0.09 Allowed 'General case' 0 C--N 1.308 -1.22 0 N-CA-C 107.096 -1.446 . . . . 72.23 107.096 176.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.1 p -125.99 139.7 50.73 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 CA-C-O 121.135 0.493 . . . . 73.34 110.912 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 49.1 m -85.6 80.44 9.03 Favored 'General case' 0 N--CA 1.428 -1.526 0 N-CA-C 108.253 -1.017 . . . . 74.31 108.253 175.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -101.68 154.6 18.74 Favored 'General case' 0 N--CA 1.429 -1.516 0 CA-C-N 115.277 -0.874 . . . . 73.44 109.831 -175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 71.48 18.29 5.5 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.58 1.152 . . . . 53.34 109.188 -174.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.7 t -115.3 100.04 53.12 Favored Pre-proline 0 N--CA 1.424 -1.745 0 CA-C-N 115.187 -0.915 . . . . 43.11 110.947 -177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -92.41 9.04 2.71 Favored 'Trans proline' 0 N--CA 1.447 -1.249 0 C-N-CA 122.575 2.183 . . . . 65.43 109.944 172.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 147.41 47.69 0.03 OUTLIER Glycine 0 N--CA 1.433 -1.517 0 CA-C-N 115.135 -0.939 . . . . 44.1 110.946 -178.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -74.2 116.63 15.08 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.134 0.492 . . . . 72.1 110.438 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.4 mt -92.5 114.72 29.92 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.607 0 CA-C-N 115.719 -0.673 . . . . 73.21 110.697 -178.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -164.34 17.28 0.06 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.956 -1.02 . . . . 72.13 108.784 178.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 97.88 175.47 33.58 Favored Glycine 0 N--CA 1.431 -1.691 0 N-CA-C 109.241 -1.544 . . . . 45.53 109.241 -172.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 43.1 t -88.06 120.45 29.42 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 107.961 -1.126 . . . . 73.42 107.961 178.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -58.3 138.0 56.73 Favored 'General case' 0 C--O 1.241 0.64 0 O-C-N 123.558 0.536 . . . . 74.2 109.782 -179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.38 94.86 1.67 Allowed 'General case' 0 C--O 1.242 0.659 0 CA-C-O 121.472 0.653 . . . . 72.52 111.27 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -99.0 -172.37 2.27 Favored 'General case' 0 C--N 1.306 -1.305 0 CA-C-N 115.267 -0.879 . . . . 73.21 112.453 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.542 ' CD ' ' H ' ' A' ' 65' ' ' GLU . 1.2 mp0 -38.32 139.9 0.34 Allowed 'General case' 0 C--O 1.243 0.758 0 C-N-CA 126.608 1.963 . . . . 73.54 111.981 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -61.27 121.52 26.56 Favored Glycine 0 N--CA 1.435 -1.389 0 CA-C-N 115.438 -0.801 . . . . 72.32 113.618 -175.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.48 19.85 3.63 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.489 -0.93 . . . . 75.25 108.489 176.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.739 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 3.3 t-105 -86.86 -1.93 58.19 Favored 'General case' 0 CA--C 1.551 0.989 0 CA-C-N 114.813 -1.085 . . . . 72.5 109.063 -175.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.07 7.88 57.09 Favored Glycine 0 C--O 1.237 0.342 0 C-N-CA 121.041 -0.6 . . . . 63.41 113.74 176.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 46.6 m 69.74 -78.93 0.04 OUTLIER 'General case' 0 CA--C 1.551 1.011 0 C-N-CA 123.491 0.716 . . . . 73.13 111.843 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.8 t -72.54 129.94 35.65 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 O-C-N 121.789 -0.569 . . . . 75.12 109.796 179.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 89.96 -0.67 79.5 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.529 -0.844 . . . . 40.21 111.287 -178.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.739 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 42.2 t -66.29 131.67 46.65 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-O 121.008 0.432 . . . . 43.44 110.662 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.2 mt -118.7 115.85 49.34 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.312 0 N-CA-C 107.758 -1.201 . . . . 72.5 107.758 175.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 14.3 p -132.85 160.45 42.61 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.648 0 N-CA-C 106.64 -1.615 . . . . 71.41 106.64 -177.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -126.11 133.53 51.61 Favored 'General case' 0 N--CA 1.413 -2.297 0 C-N-CA 120.414 -0.514 . . . . 74.35 110.214 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 50.0 t-105 -107.37 120.55 42.47 Favored 'General case' 0 N--CA 1.416 -2.154 0 N-CA-C 107.003 -1.481 . . . . 75.41 107.003 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 46.9 t-20 -123.49 131.97 53.79 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 108.654 -0.869 . . . . 64.13 108.654 -175.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -154.28 161.59 41.69 Favored 'General case' 0 C--N 1.29 -1.992 0 CA-C-N 115.923 -0.58 . . . . 73.55 109.574 -177.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 66.8 t -105.68 127.49 60.57 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.148 0 N-CA-C 107.255 -1.387 . . . . 71.13 107.255 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 41.2 t60 -135.79 113.01 10.51 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.009 -1.108 . . . . 65.33 108.009 -177.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 64.13 28.91 14.16 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.29 1.036 . . . . 61.21 111.72 -177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.45 -11.24 71.97 Favored Glycine 0 C--N 1.313 -0.721 0 C-N-CA 120.644 -0.789 . . . . 34.44 113.219 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -95.28 145.4 25.11 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-O 120.895 0.379 . . . . 65.12 110.694 177.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.71 116.46 24.83 Favored 'General case' 0 C--N 1.294 -1.828 0 N-CA-C 107.499 -1.297 . . . . 72.23 107.499 176.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -113.38 135.83 53.44 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 108.132 -1.062 . . . . 74.13 108.132 -176.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 55.9 t -134.03 136.18 53.91 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.249 0 N-CA-C 108.703 -0.851 . . . . 60.1 108.703 -177.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.17 127.44 54.2 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.185 -0.672 . . . . 63.44 109.185 176.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -103.25 119.87 39.68 Favored 'General case' 0 N--CA 1.418 -2.029 0 N-CA-C 107.55 -1.278 . . . . 75.42 107.55 177.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -146.41 159.14 43.77 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 115.505 -0.771 . . . . 71.5 111.662 -169.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 23.6 ttt180 -136.63 131.5 33.77 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-N 114.885 -1.052 . . . . 74.32 108.223 173.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 40.4 mt -72.59 122.65 25.61 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 C-N-CA 120.06 -0.656 . . . . 74.2 109.634 176.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -96.33 -41.64 8.54 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.575 -0.898 . . . . 75.31 108.575 -177.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.57 146.55 18.22 Favored 'General case' 0 C--O 1.238 0.481 0 CA-C-N 116.647 -0.252 . . . . 52.34 110.48 -178.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 53.3 t -141.42 126.36 17.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.755 0.422 . . . . 75.23 111.427 179.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.582 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 42.6 mm-40 -100.74 110.13 59.75 Favored Pre-proline 0 CA--C 1.497 -1.058 0 N-CA-C 108.444 -0.947 . . . . 61.44 108.444 174.171 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -71.1 -34.1 10.73 Favored 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 121.403 1.402 . . . . 75.41 111.918 177.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -80.15 -37.51 33.33 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 120.952 0.406 . . . . 73.25 111.506 -177.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -92.89 -5.73 50.24 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.035 -0.53 . . . . 74.01 111.347 -177.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 66.0 t30 53.22 73.0 0.39 Allowed 'General case' 0 N--CA 1.481 1.094 0 C-N-CA 124.601 1.16 . . . . 72.21 110.279 -174.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.582 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 46.0 tp -130.77 139.21 50.21 Favored 'General case' 0 C--N 1.309 -1.182 0 CA-C-N 115.709 -0.678 . . . . 72.22 109.627 -176.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -139.03 122.35 18.75 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 CA-C-O 121.793 0.806 . . . . 61.22 110.727 175.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 24.4 m -99.56 121.71 41.58 Favored 'General case' 0 C--N 1.296 -1.728 0 CA-C-N 114.974 -1.012 . . . . 65.5 110.501 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.3 m-85 -103.15 135.56 44.58 Favored 'General case' 0 CA--C 1.51 -0.594 0 N-CA-C 109.734 -0.469 . . . . 73.15 109.734 179.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 62.6 ttt180 -109.19 136.16 49.13 Favored 'General case' 0 C--N 1.291 -1.955 0 N-CA-C 108.397 -0.964 . . . . 63.31 108.397 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.559 HG11 ' HB3' ' A' ' 118' ' ' PHE . 13.2 p -78.3 135.09 26.8 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.354 0 N-CA-C 108.549 -0.908 . . . . 71.15 108.549 176.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 24.1 pt -117.44 -29.37 2.01 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 116.382 -0.372 . . . . 72.32 110.551 178.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 112' ' ' MET . 8.5 tp10 -51.72 132.33 31.02 Favored 'General case' 0 C--O 1.238 0.448 0 CA-C-N 115.465 -0.789 . . . . 71.04 111.727 175.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -77.3 -23.84 67.29 Favored Glycine 0 N--CA 1.433 -1.544 0 CA-C-N 114.856 -1.066 . . . . 32.21 112.081 -175.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -58.37 -47.96 82.15 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.243 0.544 . . . . 72.45 111.081 177.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.3 mt -72.61 -24.53 61.09 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.259 0.552 . . . . 64.45 110.473 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.54 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.2 mmt -70.49 -11.31 60.84 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 115.724 -0.671 . . . . 64.02 110.417 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 34.1 mmtp -84.26 -6.16 59.36 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.969 0.414 . . . . 74.45 110.986 -178.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.466 ' HA ' HG12 ' A' ' 148' ' ' VAL . 47.7 mt-10 -122.25 -32.6 3.63 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 121.404 0.621 . . . . 74.04 110.263 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 112' ' ' MET . 22.7 m-85 -127.64 126.88 42.8 Favored 'General case' 0 CA--C 1.49 -1.338 0 N-CA-C 106.602 -1.629 . . . . 62.44 106.602 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -80.19 -4.88 54.86 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-O 121.334 0.588 . . . . 71.45 111.504 -177.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 32.9 p -169.26 130.58 1.14 Allowed 'General case' 0 N--CA 1.428 -1.552 0 C-N-CA 124.812 1.245 . . . . 71.0 108.986 173.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.559 ' HB3' HG11 ' A' ' 106' ' ' VAL . 11.2 t80 -138.71 124.13 19.4 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.058 -0.719 . . . . 73.25 109.058 -179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.0 tp -129.44 129.44 44.65 Favored 'General case' 0 C--N 1.287 -2.146 0 N-CA-C 107.798 -1.186 . . . . 75.31 107.798 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -130.02 125.63 35.77 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.399 0.619 . . . . 64.34 109.73 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.456 HG22 HD11 ' A' ' 101' ' ' LEU . 16.3 m -116.76 134.23 55.05 Favored 'General case' 0 C--N 1.278 -2.527 0 CA-C-N 115.902 -0.59 . . . . 75.11 109.716 -176.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 43.0 pt -120.81 144.14 30.69 Favored 'Isoleucine or valine' 0 C--O 1.245 0.854 0 C-N-CA 120.527 -0.469 . . . . 71.43 110.661 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -135.03 120.27 18.91 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.422 -0.955 . . . . 73.11 108.422 177.183 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 52.5 t -106.44 111.12 34.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 N-CA-C 108.989 -0.745 . . . . 72.53 108.989 -178.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.422 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 4.9 t -139.3 154.72 72.18 Favored Pre-proline 0 C--N 1.294 -1.837 0 N-CA-C 108.318 -0.993 . . . . 54.51 108.318 -179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.422 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 20.6 Cg_endo -59.46 136.05 68.98 Favored 'Trans proline' 0 C--O 1.236 0.382 0 C-N-CA 122.698 2.265 . . . . 71.42 109.598 173.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.516 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.3 tttm -135.56 -59.13 0.02 OUTLIER Pre-proline 0 C--N 1.292 -1.897 0 C-N-CA 119.842 -0.743 . . . . 53.04 112.037 -178.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.421 ' HD2' ' H ' ' A' ' 127' ' ' LYS . 27.2 Cg_endo -65.56 -30.07 52.07 Favored 'Trans proline' 0 C--N 1.373 1.868 0 C-N-CA 121.006 1.137 . . . . 61.32 110.94 174.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 138.85 143.2 4.4 Favored Glycine 0 N--CA 1.441 -1.02 0 C-N-CA 120.906 -0.664 . . . . 72.4 113.156 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 61.95 -124.32 33.75 Favored Glycine 0 C--O 1.243 0.693 0 O-C-N 123.827 0.369 . . . . 61.33 113.513 176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -74.1 -17.15 22.26 Favored 'Trans proline' 0 C--O 1.239 0.535 0 C-N-CA 122.934 2.422 . . . . 72.43 111.779 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.39 106.62 1.4 Allowed Glycine 0 N--CA 1.437 -1.255 0 N-CA-C 111.117 -0.793 . . . . 72.33 111.117 179.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 16.9 m -118.2 146.04 44.53 Favored 'General case' 0 N--CA 1.41 -2.434 0 CA-C-O 121.265 0.555 . . . . 74.11 110.701 -175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.58 HD12 ' HG2' ' A' ' 31' ' ' GLU . 45.4 mm -119.06 136.55 55.91 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 108.567 -0.901 . . . . 61.25 108.567 179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.3 p -100.6 116.3 43.77 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.094 0 CA-C-O 121.599 0.714 . . . . 64.34 109.606 177.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.498 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 94.1 m-70 -89.48 117.51 28.45 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 115.24 -0.891 . . . . 62.15 108.762 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -99.6 121.86 41.81 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 109.124 -0.695 . . . . 73.21 109.124 176.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.2 t60 -118.32 110.5 17.57 Favored 'General case' 0 C--N 1.285 -2.209 0 N-CA-C 107.697 -1.223 . . . . 73.05 107.697 177.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.542 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.7 mp -115.64 135.65 53.85 Favored 'General case' 0 C--N 1.307 -1.269 0 N-CA-C 110.061 -0.348 . . . . 62.3 110.061 -176.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.11 129.15 29.31 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.844 -0.799 . . . . 74.43 108.844 177.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -149.46 139.53 22.08 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 113.052 0.76 . . . . 71.31 113.052 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -94.72 114.95 26.93 Favored 'General case' 0 C--N 1.293 -1.854 0 CA-C-N 115.406 -0.815 . . . . 74.32 109.023 -177.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.514 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 1.5 mptm? -65.44 134.0 52.51 Favored 'General case' 0 CA--C 1.499 -1.011 0 CA-C-N 116.264 -0.425 . . . . 71.22 110.768 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 62.2 mt -71.45 -38.72 69.5 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 106.64 -1.615 . . . . 71.21 106.64 170.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.1 t -166.52 169.57 13.64 Favored 'General case' 0 N--CA 1.429 -1.513 0 N-CA-C 105.789 -1.93 . . . . 55.34 105.789 172.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.474 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 5.5 mm-40 -67.68 -55.77 11.93 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 114.967 1.469 . . . . 63.23 114.967 -173.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -63.6 -20.56 65.76 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-O 122.228 1.014 . . . . 60.42 109.623 -179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 114' ' ' GLU . 65.8 t -78.06 -32.41 17.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 114.306 -1.316 . . . . 44.15 110.563 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.514 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -93.15 141.82 27.99 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.263 -0.426 . . . . 71.12 110.256 -179.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -135.51 89.51 22.19 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.853 -0.158 . . . . 72.21 110.682 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.502 ' HA ' HD23 ' A' ' 154' ' ' LEU . 96.9 Cg_exo -46.56 -25.97 3.92 Favored 'Trans proline' 0 N--CA 1.5 1.883 0 C-N-CA 124.32 3.347 . . . . 72.05 114.405 -178.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -52.41 -45.3 65.83 Favored 'General case' 0 C--O 1.245 0.845 0 C-N-CA 124.443 1.097 . . . . 74.42 111.866 177.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.2 p -66.33 -31.26 71.94 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-N 115.275 -0.875 . . . . 65.11 112.51 -171.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.502 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.6 mm? -72.98 -39.68 65.9 Favored 'General case' 0 N--CA 1.437 -1.096 0 C-N-CA 121.025 -0.27 . . . . 71.2 110.514 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 68.8 mt -64.42 -41.37 96.64 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 121.125 -0.23 . . . . 65.54 111.612 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.664 HE21 ' HA ' ' A' ' 156' ' ' GLN . 0.0 OUTLIER -61.41 -42.03 98.09 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.28 -0.418 . . . . 62.43 110.203 176.606 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -62.2 -42.4 99.26 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.934 0.397 . . . . 70.33 110.071 178.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.542 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.5 m -64.35 -48.22 76.36 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 116.029 -0.532 . . . . 73.34 112.142 -179.316 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.6 p -66.29 -40.4 86.73 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 120.838 0.352 . . . . 62.2 111.869 -175.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 9.3 mm-40 -68.14 -29.39 68.28 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 116.22 -0.445 . . . . 62.13 111.559 -177.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 88.9 t -77.34 -43.95 30.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 CA-C-N 116.38 -0.373 . . . . 71.13 110.115 175.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.488 ' HB3' HG11 ' A' ' 30' ' ' VAL . 55.5 m -53.74 -51.16 64.24 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 123.02 0.528 . . . . 74.21 112.269 -178.083 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -65.6 -33.59 76.26 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 116.157 -0.474 . . . . 74.55 111.516 -178.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -73.64 -50.08 22.85 Favored 'General case' 0 CA--C 1.49 -1.333 0 C-N-CA 120.649 -0.42 . . . . 71.34 111.064 -177.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -64.66 -39.02 84.18 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.614 0 CA-C-N 116.061 -0.518 . . . . 74.54 110.765 -175.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.555 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 22.7 t70 -61.41 -52.81 63.02 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 115.456 -0.793 . . . . 74.12 110.949 177.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -69.99 -31.81 69.69 Favored 'General case' 0 CA--C 1.503 -0.829 0 N-CA-C 112.639 0.607 . . . . 75.31 112.639 -177.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.1 t60 -64.78 -37.04 86.25 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 109.925 -0.398 . . . . 62.43 109.925 178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 94.7 mt -76.14 -32.45 59.11 Favored 'General case' 0 C--N 1.318 -0.774 0 C-N-CA 120.72 -0.392 . . . . 74.01 110.923 178.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.555 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 84.2 mt -71.84 -33.12 68.19 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.181 0.515 . . . . 73.14 110.044 177.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.99 61.84 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.442 -0.799 . . . . 52.32 111.717 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -113.84 160.23 18.96 Favored 'General case' 0 N--CA 1.425 -1.694 0 CA-C-O 121.327 0.585 . . . . 51.11 112.038 -179.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 . . . . . 0 N--CA 1.427 -1.583 0 CA-C-N 114.772 -1.104 . . . . 70.13 110.272 178.972 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.8 m . . . . . 0 N--CA 1.437 -1.082 0 N-CA-C 111.744 0.276 . . . . 72.02 111.744 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 64.34 -77.49 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.817 0 C-N-CA 124.267 1.027 . . . . 64.11 110.66 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.14 103.23 14.6 Favored 'General case' 0 C--N 1.265 -3.075 0 N-CA-C 106.848 -1.538 . . . . 75.24 106.848 174.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 32.9 t -58.47 -28.67 65.56 Favored 'General case' 0 C--N 1.323 -0.553 0 C-N-CA 122.834 0.454 . . . . 70.14 112.18 -173.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.2 p -76.86 -20.08 56.71 Favored 'General case' 0 N--CA 1.436 -1.157 0 N-CA-C 112.596 0.591 . . . . 64.53 112.596 -178.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.421 ' O ' ' HD3' ' A' ' 143' ' ' LYS 0.288 91.1 mt 55.46 -15.65 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 117.173 2.286 . . . . 52.22 117.173 -176.167 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -75.93 118.32 21.94 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.301 0 N-CA-C 107.271 -1.381 . . . . 75.42 107.271 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.11 135.7 12.29 Favored Glycine 1 N--CA 1.392 -4.252 0 CA-C-N 114.621 -1.172 . . . . 64.32 110.515 -176.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.3 ptmt -140.8 142.7 34.64 Favored 'General case' 1 C--N 1.24 -4.191 0 N-CA-C 108.409 -0.959 . . . . 61.11 108.409 178.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.55 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -142.89 138.27 30.1 Favored 'General case' 0 C--N 1.27 -2.879 0 N-CA-C 107.03 -1.47 . . . . 72.11 107.03 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.55 ' N ' HD23 ' A' ' 26' ' ' LEU . 34.0 tt0 -132.84 123.44 26.08 Favored 'General case' 0 C--N 1.285 -2.23 0 N-CA-C 108.423 -0.955 . . . . 74.55 108.423 -179.115 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.0 t -131.17 166.38 21.25 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 109.282 -0.636 . . . . 63.45 109.282 -176.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.432 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.4 p-10 -131.07 126.22 35.27 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-O 121.152 0.501 . . . . 50.04 110.377 -179.749 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 83.4 t -119.34 132.27 69.63 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 N-CA-C 108.55 -0.908 . . . . 63.42 108.55 177.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -92.83 139.9 30.06 Favored 'General case' 0 C--N 1.291 -1.96 0 N-CA-C 113.107 0.78 . . . . 75.01 113.107 177.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 30.1 pt -113.0 158.76 13.26 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 CA-C-N 114.992 -1.004 . . . . 75.3 108.325 177.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 52.6 mttp -82.04 -16.57 49.73 Favored 'General case' 0 C--N 1.3 -1.556 0 CA-C-O 120.861 0.363 . . . . 71.53 110.847 -177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.44 152.87 20.78 Favored 'General case' 0 C--N 1.306 -1.292 0 CA-C-N 115.905 -0.589 . . . . 74.12 111.753 -177.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -76.97 145.61 38.0 Favored 'General case' 0 N--CA 1.431 -1.417 0 CA-C-N 115.356 -0.838 . . . . 70.31 110.054 178.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -60.35 -24.9 65.43 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-O 121.316 0.579 . . . . 55.4 110.135 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -54.86 -44.41 73.99 Favored 'General case' 0 CA--C 1.511 -0.533 0 CA-C-N 114.984 -1.007 . . . . 70.13 110.191 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.564 ' HE3' ' OE2' ' A' ' 173' ' ' GLU . 47.1 mtpt -71.05 -33.16 70.01 Favored 'General case' 0 CA--C 1.501 -0.923 0 C-N-CA 120.168 -0.613 . . . . 74.03 111.28 -178.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -67.97 -37.1 81.11 Favored 'General case' 0 C--N 1.313 -1.005 0 N-CA-C 108.546 -0.909 . . . . 74.52 108.546 179.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.413 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 34.0 t-80 -64.9 -38.62 91.59 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-N 115.602 -0.726 . . . . 70.43 109.401 174.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.47 ' HB3' ' HE2' ' A' ' 46' ' ' LYS . 19.5 m170 -61.5 -30.23 70.48 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 115.552 -0.749 . . . . 53.01 110.706 176.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.451 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 95.6 mmm -72.29 -31.35 65.65 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.335 -0.393 . . . . 72.24 111.823 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.496 ' CE2' ' HA ' ' A' ' 100' ' ' ASN . 82.6 m-85 -71.62 -27.07 62.85 Favored 'General case' 0 CA--C 1.503 -0.857 0 C-N-CA 120.6 -0.44 . . . . 73.45 110.781 176.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -73.29 -55.83 5.88 Favored 'General case' 0 N--CA 1.435 -1.208 0 N-CA-C 107.329 -1.36 . . . . 63.2 107.329 172.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 81.15 100.96 0.35 Allowed Glycine 0 N--CA 1.423 -2.208 0 CA-C-N 114.923 -1.035 . . . . 71.45 112.738 177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.47 ' HE2' ' HB3' ' A' ' 41' ' ' HIS . 0.0 OUTLIER -99.38 106.26 38.17 Favored Pre-proline 0 C--N 1.307 -1.279 0 N-CA-C 106.689 -1.597 . . . . 72.02 106.689 173.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -56.44 106.92 0.23 Allowed 'Trans proline' 0 N--CA 1.451 -0.982 0 C-N-CA 122.504 2.136 . . . . 54.31 112.443 -176.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -83.98 85.19 7.36 Favored 'General case' 0 N--CA 1.434 -1.242 0 CA-C-O 121.946 0.879 . . . . 72.22 109.571 174.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -122.49 99.93 6.67 Favored 'General case' 0 N--CA 1.433 -1.303 0 CA-C-N 114.509 -1.223 . . . . 70.42 111.013 -172.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.2 p -169.33 100.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 122.375 1.083 . . . . 72.13 111.6 175.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.2 m -139.17 14.69 2.62 Favored 'General case' 0 C--N 1.299 -1.597 0 CA-C-N 115.031 -0.986 . . . . 72.23 108.454 177.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -127.39 175.74 7.98 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-N 114.365 -1.289 . . . . 72.44 107.885 -178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.07 -52.39 11.15 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.123 -1.066 . . . . 72.22 108.123 176.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 47.4 t -127.42 98.69 28.6 Favored Pre-proline 0 N--CA 1.417 -2.077 0 N-CA-C 107.422 -1.325 . . . . 74.44 107.422 177.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -85.02 141.63 8.39 Favored 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 121.965 1.776 . . . . 72.54 112.356 -179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.66 141.25 16.44 Favored Glycine 0 N--CA 1.431 -1.682 0 N-CA-C 109.406 -1.477 . . . . 44.5 109.406 175.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.07 86.22 0.11 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 123.973 0.909 . . . . 74.35 111.549 -176.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.1 mt -73.67 -50.21 31.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 N-CA-C 107.652 -1.24 . . . . 72.14 107.652 177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -83.55 72.41 10.29 Favored 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 107.825 -1.176 . . . . 74.13 107.825 172.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -89.08 64.37 3.34 Favored Glycine 0 N--CA 1.434 -1.497 0 CA-C-N 115.627 -0.715 . . . . 32.13 111.487 -178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 13.4 p -92.61 79.91 4.82 Favored 'General case' 0 N--CA 1.426 -1.659 0 CA-C-O 121.983 0.896 . . . . 61.45 112.03 -179.713 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -106.98 -40.75 5.37 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 107.953 -1.129 . . . . 74.24 107.953 174.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.1 mp -101.49 168.95 9.18 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 107.471 -1.307 . . . . 74.24 107.471 167.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 1.5 t-80 -148.08 -148.71 0.27 Allowed 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 105.897 -1.89 . . . . 74.14 105.897 -176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.9 148.19 48.07 Favored 'General case' 0 C--O 1.252 1.211 0 CA-C-N 119.269 0.94 . . . . 62.12 111.816 -179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 82.02 -91.53 1.51 Allowed Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.045 -1.222 . . . . 51.32 110.045 -177.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 18.1 t70 -169.62 -56.74 0.02 OUTLIER 'General case' 0 CA--C 1.492 -1.262 0 C-N-CA 122.858 0.463 . . . . 73.35 110.129 178.662 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -73.13 -17.36 61.4 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.911 -0.586 . . . . 72.34 111.924 -174.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.68 12.54 83.73 Favored Glycine 0 C--O 1.239 0.422 0 C-N-CA 120.658 -0.782 . . . . 53.04 113.719 174.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.8 t -148.52 166.07 29.33 Favored 'General case' 0 N--CA 1.426 -1.641 0 N-CA-C 108.93 -0.767 . . . . 54.24 108.93 -175.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 70.6 t -65.78 137.12 25.52 Favored 'Isoleucine or valine' 0 C--O 1.242 0.685 0 N-CA-C 109.19 -0.671 . . . . 64.41 109.19 178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.421 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 101.42 -0.91 53.51 Favored Glycine 0 N--CA 1.432 -1.581 0 C-N-CA 120.212 -0.994 . . . . 44.11 110.99 -175.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 92' ' ' ILE . 37.2 t -62.01 135.12 57.4 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 109.204 -0.665 . . . . 62.23 109.204 177.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 87.8 mt -128.15 119.77 51.76 Favored 'Isoleucine or valine' 0 C--O 1.26 1.615 0 CA-C-N 115.731 -0.668 . . . . 62.4 109.357 178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 22.8 m -130.66 156.73 42.8 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 116.039 -0.528 . . . . 45.04 109.879 177.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -113.28 129.35 56.55 Favored 'General case' 0 N--CA 1.402 -2.871 0 CA-C-O 122.042 0.925 . . . . 72.31 111.129 177.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.411 ' HB3' ' HB3' ' A' ' 88' ' ' ALA . 28.5 t90 -107.02 120.98 43.55 Favored 'General case' 0 N--CA 1.393 -3.31 0 CA-C-N 114.32 -1.309 . . . . 64.52 108.345 -177.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.412 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -104.59 131.84 51.53 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 108.554 -0.906 . . . . 72.44 108.554 179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -144.77 157.01 44.34 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 108.945 -0.761 . . . . 72.25 108.945 -179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 68.5 t -105.14 123.81 59.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.971 0 CA-C-O 121.304 0.573 . . . . 73.31 109.681 -177.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.517 ' HB3' ' CG ' ' A' ' 86' ' ' LYS . 70.0 t60 -137.21 120.02 16.3 Favored 'General case' 0 C--N 1.296 -1.752 0 CA-C-N 115.12 -0.945 . . . . 73.55 109.173 -179.715 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 62.79 28.37 16.44 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 125.391 1.476 . . . . 73.53 111.359 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.71 -12.17 62.19 Favored Glycine 0 C--N 1.307 -1.069 0 C-N-CA 121.0 -0.619 . . . . 75.45 113.543 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -95.55 150.98 19.73 Favored 'General case' 0 CA--C 1.492 -1.279 0 CA-C-N 117.373 0.587 . . . . 64.55 109.797 177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.33 116.22 24.36 Favored 'General case' 0 N--CA 1.426 -1.662 0 N-CA-C 108.13 -1.063 . . . . 74.13 108.13 176.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.517 ' CG ' ' HB3' ' A' ' 81' ' ' HIS . 10.5 mmpt? -98.1 151.17 20.66 Favored 'General case' 0 C--N 1.284 -2.269 0 N-CA-C 106.781 -1.563 . . . . 73.3 106.781 -179.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.1 t -129.4 134.53 63.52 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 N-CA-C 108.675 -0.861 . . . . 73.31 108.675 178.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.411 ' HB3' ' HB3' ' A' ' 77' ' ' TRP . . . -106.2 138.09 42.99 Favored 'General case' 0 C--N 1.294 -1.816 0 N-CA-C 108.353 -0.98 . . . . 64.44 108.353 -178.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.451 ' HG3' ' HB3' ' A' ' 108' ' ' GLU . 39.4 mmtm -110.68 125.78 53.82 Favored 'General case' 0 N--CA 1.432 -1.366 0 N-CA-C 106.88 -1.526 . . . . 60.2 106.88 -174.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -151.41 154.17 36.12 Favored 'General case' 0 N--CA 1.429 -1.49 0 C-N-CA 120.44 -0.504 . . . . 73.52 111.651 -173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.511 ' HD3' ' OE2' ' A' ' 93' ' ' GLU . 70.3 ttt-85 -138.26 141.09 39.89 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 106.565 -1.642 . . . . 74.51 106.565 172.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.41 HD12 ' HB3' ' A' ' 73' ' ' SER . 55.1 mt -76.63 120.97 27.84 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 C-N-CA 118.94 -1.104 . . . . 73.43 108.623 173.54 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.511 ' OE2' ' HD3' ' A' ' 91' ' ' ARG . 31.4 mm-40 -99.79 -41.98 7.03 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-O 121.413 0.625 . . . . 62.45 110.02 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -150.45 144.08 25.18 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.295 -1.002 . . . . 54.43 108.295 -177.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.18 123.34 3.93 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 CA-C-O 121.553 0.692 . . . . 75.43 110.258 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.566 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 46.3 mm-40 -117.32 108.22 43.99 Favored Pre-proline 0 C--N 1.297 -1.704 0 N-CA-C 108.496 -0.928 . . . . 73.3 108.496 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.413 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 38.0 Cg_exo -60.73 -47.53 13.16 Favored 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 121.863 1.708 . . . . 74.12 112.253 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 29.0 m-20 -80.98 -15.92 54.89 Favored 'General case' 0 CA--C 1.49 -1.332 0 N-CA-C 114.102 1.149 . . . . 55.33 114.102 -177.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.443 ' HD2' ' HG3' ' A' ' 96' ' ' GLU . 96.2 mttt -99.02 -9.51 23.84 Favored 'General case' 0 C--N 1.294 -1.808 0 C-N-CA 119.819 -0.753 . . . . 72.41 111.3 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.497 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 88.4 m-20 60.22 44.19 12.98 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 109.421 -0.585 . . . . 70.45 109.421 -177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.566 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.8 tp -118.3 134.78 54.74 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 115.236 -0.893 . . . . 41.23 109.544 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.5 tp -146.66 122.1 2.85 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.441 0 CA-C-O 121.618 0.723 . . . . 70.03 110.299 177.237 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.424 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 56.9 m -99.47 129.11 45.63 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-N 114.938 -1.028 . . . . 63.24 110.951 178.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.415 ' O ' HD12 ' A' ' 119' ' ' LEU . 82.1 m-85 -111.34 149.16 31.53 Favored 'General case' 0 C--O 1.236 0.366 0 C-N-CA 124.152 0.981 . . . . 71.12 109.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.3 ttt180 -133.51 144.61 49.51 Favored 'General case' 0 C--N 1.311 -1.084 0 C-N-CA 122.877 0.471 . . . . 73.11 110.039 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.5 p -78.71 126.62 38.85 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.91 0 N-CA-C 109.245 -0.65 . . . . 65.22 109.245 174.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.655 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -117.19 -24.46 3.44 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 C-N-CA 120.265 -0.574 . . . . 63.52 112.336 -179.538 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.451 ' HB3' ' HG3' ' A' ' 89' ' ' LYS . 11.3 tp10 -75.06 -80.62 0.08 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.884 0.698 . . . . 74.12 112.884 -175.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 163.25 -26.72 0.22 Allowed Glycine 0 C--O 1.213 -1.173 0 C-N-CA 118.708 -1.71 . . . . 65.12 114.087 -178.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -47.81 -48.88 30.4 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 112.917 0.71 . . . . 74.02 112.917 179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.4 mt -74.17 -23.56 59.26 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.182 0.515 . . . . 74.05 111.284 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.558 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 4.0 mmt -74.62 -6.73 50.29 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 115.973 -0.558 . . . . 74.42 111.241 -178.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.659 ' HE2' ' HA ' ' A' ' 113' ' ' LYS . 9.8 mmpt? -85.16 -8.9 58.39 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 121.174 0.511 . . . . 74.33 109.92 178.073 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -123.22 -31.25 3.6 Favored 'General case' 0 C--N 1.308 -1.222 0 CA-C-N 115.694 -0.684 . . . . 64.44 110.998 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.558 ' O ' ' HA ' ' A' ' 112' ' ' MET . 58.5 m-85 -124.8 143.98 50.52 Favored 'General case' 0 CA--C 1.489 -1.376 0 N-CA-C 107.011 -1.477 . . . . 70.2 107.011 177.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -90.82 -0.63 57.77 Favored 'General case' 0 C--N 1.292 -1.905 0 C-N-CA 119.387 -0.925 . . . . 71.21 112.363 -178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 78.7 p -165.87 144.94 6.12 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 107.757 -1.201 . . . . 52.13 107.757 170.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 120' ' ' LEU . 90.2 t80 -151.06 116.46 5.38 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.173 0.511 . . . . 74.23 110.143 -178.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.415 HD12 ' O ' ' A' ' 104' ' ' PHE . 52.7 tp -132.85 129.64 38.72 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.256 -1.016 . . . . 73.15 108.256 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.553 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.1 pt? -133.31 139.39 46.85 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 120.515 -0.474 . . . . 71.21 110.615 -178.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 37.5 m -126.52 136.09 52.14 Favored 'General case' 0 C--N 1.281 -2.412 0 N-CA-C 109.566 -0.531 . . . . 65.22 109.566 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 41.5 pt -120.53 145.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.872 0 N-CA-C 109.69 -0.485 . . . . 72.25 109.69 177.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.0 tt0 -143.87 130.82 20.46 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 109.487 -0.56 . . . . 64.31 109.487 178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 68.9 t -95.14 120.24 44.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-O 121.455 0.645 . . . . 74.44 110.723 -177.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 62.5 m -121.01 128.2 25.86 Favored Pre-proline 0 N--CA 1.428 -1.547 0 CA-C-N 115.004 -0.998 . . . . 73.23 108.827 -178.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -58.98 154.44 44.84 Favored 'Trans proline' 0 N--CA 1.483 0.864 0 C-N-CA 123.5 2.8 . . . . 52.13 113.83 -176.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.505 ' HG3' ' HA ' ' A' ' 133' ' ' SER . 57.4 mtpt -84.65 146.42 46.71 Favored Pre-proline 0 CA--C 1.509 -0.615 0 CA-C-N 116.255 -0.43 . . . . 72.13 110.668 177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_exo -59.76 -58.16 0.66 Allowed 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.299 1.999 . . . . 72.03 111.406 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.59 51.61 0.77 Allowed Glycine 0 N--CA 1.433 -1.541 0 C-N-CA 120.671 -0.776 . . . . 43.21 111.67 -179.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 131' ' ' PRO . . . -154.87 143.46 9.98 Favored Glycine 0 N--CA 1.427 -1.905 0 C-N-CA 120.224 -0.988 . . . . 71.14 110.934 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 130' ' ' GLY . 23.9 Cg_exo -65.17 -25.8 57.67 Favored 'Trans proline' 0 C--N 1.349 0.559 0 C-N-CA 122.773 2.315 . . . . 75.05 111.565 178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -79.55 -165.94 31.55 Favored Glycine 0 N--CA 1.437 -1.276 0 CA-C-N 115.821 -0.627 . . . . 25.11 112.758 -178.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.505 ' HA ' ' HG3' ' A' ' 127' ' ' LYS . 62.5 m -150.22 158.4 44.12 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.428 -0.454 . . . . 70.31 110.701 -179.146 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.432 ' CG2' ' HB2' ' A' ' 29' ' ' ASP . 1.7 mp -99.94 128.87 51.39 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-O 121.072 0.463 . . . . 73.41 110.385 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.7 p -93.25 119.61 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.245 0 N-CA-C 107.811 -1.181 . . . . 73.11 107.811 173.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -89.54 111.8 22.82 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.126 -0.943 . . . . 75.52 109.392 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.472 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 54.3 m95 -93.26 121.43 34.62 Favored 'General case' 0 N--CA 1.427 -1.575 0 N-CA-C 108.809 -0.812 . . . . 74.45 108.809 177.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -118.19 111.07 18.35 Favored 'General case' 0 C--N 1.285 -2.213 0 N-CA-C 107.263 -1.384 . . . . 75.31 107.263 178.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.4 mp -115.78 130.67 56.94 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 109.585 -0.524 . . . . 73.44 109.585 -176.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -130.66 128.08 40.21 Favored 'General case' 0 C--N 1.309 -1.191 0 N-CA-C 109.379 -0.6 . . . . 74.41 109.379 176.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -151.2 158.02 43.4 Favored 'General case' 0 C--N 1.292 -1.903 0 CA-C-N 115.691 -0.686 . . . . 53.42 112.098 -174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -110.14 120.97 44.15 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 108.776 -0.824 . . . . 75.23 108.776 -178.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.7 mptm? -65.51 135.52 55.24 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 120.515 0.198 . . . . 65.15 111.509 178.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 64.9 mt -74.51 -38.89 47.05 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.012 0 N-CA-C 105.801 -1.926 . . . . 73.33 105.801 168.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.482 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 27.7 t -169.93 169.58 8.13 Favored 'General case' 0 N--CA 1.427 -1.595 0 N-CA-C 105.546 -2.02 . . . . 74.41 105.546 175.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -69.58 -55.92 8.77 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 113.598 0.962 . . . . 54.33 113.598 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.27 -19.56 61.86 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.638 0.732 . . . . 74.14 110.472 178.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.482 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 58.7 t -85.66 -18.27 9.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 CA-C-N 115.053 -0.976 . . . . 61.2 110.755 -177.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -104.2 142.05 35.2 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 122.074 -0.391 . . . . 63.24 110.365 -178.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 65.3 m-70 -132.4 87.63 42.0 Favored Pre-proline 0 C--N 1.315 -0.906 0 N-CA-C 111.687 0.255 . . . . 73.43 111.687 176.805 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -63.3 -13.68 37.38 Favored 'Trans proline' 0 N--CA 1.485 1.016 0 C-N-CA 122.356 2.037 . . . . 70.32 111.142 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 25.9 mt-10 -56.85 -46.62 81.64 Favored 'General case' 0 CA--C 1.511 -0.543 0 C-N-CA 125.238 1.415 . . . . 60.31 109.89 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 66.4 p -80.17 -29.65 38.77 Favored 'General case' 0 N--CA 1.417 -2.11 0 CA-C-N 113.933 -1.485 . . . . 73.32 110.578 -172.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.6 mt -61.89 -40.21 94.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.726 -0.67 . . . . 44.21 109.662 177.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 159' ' ' VAL . 75.7 mt -65.78 -36.87 84.76 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.18 -0.464 . . . . 62.51 111.226 177.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.445 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 37.2 mt-30 -68.07 -35.94 79.02 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 116.303 -0.408 . . . . 60.23 110.47 177.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -60.18 -39.06 85.14 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.635 -0.505 . . . . 72.33 109.635 176.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.451 ' HA ' ' CH2' ' A' ' 137' ' ' TRP . 62.3 m -61.14 -46.17 91.66 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.615 -0.72 . . . . 62.24 109.842 177.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.424 HG23 ' O ' ' A' ' 155' ' ' LEU . 61.6 t -60.14 -44.38 95.08 Favored 'Isoleucine or valine' 0 C--O 1.241 0.607 0 CA-C-N 115.849 -0.614 . . . . 62.53 111.208 -179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 8.9 mm-40 -64.34 -32.04 73.49 Favored 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 112.301 0.482 . . . . 75.41 112.301 -177.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 62.7 t -75.7 -41.15 40.61 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.191 0 N-CA-C 108.922 -0.77 . . . . 61.31 108.922 175.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 53.1 m -54.12 -40.66 67.53 Favored 'General case' 0 N--CA 1.446 -0.632 0 N-CA-C 114.526 1.306 . . . . 74.34 114.526 -176.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.501 ' HD2' ' H ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -69.24 -39.98 78.18 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 118.1 -1.44 . . . . 72.22 112.208 -178.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -70.09 -48.02 59.45 Favored 'General case' 0 CA--C 1.516 -0.343 0 CA-C-O 120.904 0.383 . . . . 74.42 110.523 -176.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -63.85 -37.57 80.07 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 CA-C-N 115.876 -0.602 . . . . 61.22 109.707 -176.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.467 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 23.0 t70 -60.46 -51.82 67.85 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 115.717 -0.674 . . . . 74.23 111.738 178.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 10.2 pt-20 -74.02 -32.02 63.18 Favored 'General case' 0 C--O 1.243 0.737 0 CA-C-O 120.845 0.355 . . . . 74.13 111.805 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 8.8 t60 -67.08 -34.57 77.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.149 -0.478 . . . . 73.44 110.136 -176.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 75.7 mt -76.21 -24.84 54.65 Favored 'General case' 0 C--O 1.215 -0.726 0 C-N-CA 120.607 -0.437 . . . . 74.43 111.46 177.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -75.17 -18.69 60.13 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.28 0.562 . . . . 65.42 111.277 179.179 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.19 -168.32 1.62 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.512 -0.767 . . . . 74.43 109.775 176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -65.6 152.93 42.96 Favored 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.133 0.492 . . . . 74.12 112.174 -178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.564 ' OE2' ' HE3' ' A' ' 38' ' ' LYS . 8.6 pt-20 . . . . . 0 C--N 1.307 -1.252 0 CA-C-N 115.232 -0.894 . . . . 72.24 109.399 178.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.76 ' HA ' ' HB2' ' A' ' 146' ' ' GLU . 42.9 m . . . . . 0 N--CA 1.445 -0.689 0 CA-C-O 122.32 1.057 . . . . 54.41 110.573 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -142.75 21.76 1.98 Allowed 'General case' 0 C--N 1.31 -1.111 0 CA-C-N 113.557 -1.656 . . . . 51.22 110.341 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -141.25 113.24 7.86 Favored 'General case' 0 N--CA 1.431 -1.412 0 CA-C-N 115.717 -0.674 . . . . 71.33 109.539 -178.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 17.3 m -72.3 -27.75 62.66 Favored 'General case' 0 C--N 1.306 -1.324 0 CA-C-N 115.696 -0.683 . . . . 65.01 111.667 -178.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.7 m -56.56 -44.09 80.6 Favored 'General case' 0 C--O 1.241 0.627 0 N-CA-C 113.854 1.057 . . . . 72.0 113.854 -174.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.517 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 80.1 mt 65.61 -40.2 0.31 Allowed 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.514 1.125 . . . . 62.54 113.994 -174.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.6 t -73.52 131.29 35.14 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 N-CA-C 108.878 -0.786 . . . . 70.52 108.878 175.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -148.76 174.56 28.37 Favored Glycine 0 N--CA 1.425 -2.074 0 C-N-CA 120.406 -0.902 . . . . 63.1 112.643 -177.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 43.5 mtpt -137.5 157.31 46.82 Favored 'General case' 0 C--N 1.288 -2.099 0 C-N-CA 123.593 0.757 . . . . 64.31 111.081 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.2 tp -140.78 128.9 22.14 Favored 'General case' 0 N--CA 1.405 -2.682 0 N-CA-C 107.478 -1.304 . . . . 55.22 107.478 168.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -133.74 130.24 37.79 Favored 'General case' 0 C--N 1.271 -2.807 0 N-CA-C 109.401 -0.592 . . . . 73.44 109.401 -175.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.0 t -146.51 162.9 37.34 Favored 'General case' 0 C--N 1.291 -1.95 0 N-CA-C 108.132 -1.062 . . . . 74.2 108.132 -178.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -130.98 134.43 46.71 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 108.855 -0.794 . . . . 75.53 108.855 176.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 59.0 t -116.64 144.23 24.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 N-CA-C 108.182 -1.044 . . . . 72.33 108.182 -179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 132.83 41.03 Favored 'General case' 0 N--CA 1.42 -1.937 0 N-CA-C 108.739 -0.837 . . . . 73.32 108.739 -179.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.498 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.7 pt -113.98 148.66 16.67 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.037 0 N-CA-C 107.743 -1.206 . . . . 75.24 107.743 174.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.439 ' HB2' HD11 ' A' ' 170' ' ' LEU . 73.8 mmtt -86.17 -7.2 58.74 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.592 0.71 . . . . 64.21 109.843 -177.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.31 155.58 23.52 Favored 'General case' 0 N--CA 1.421 -1.894 0 CA-C-N 114.971 -1.013 . . . . 73.2 109.978 178.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.7 t -84.82 146.32 27.4 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 109.743 -0.466 . . . . 54.51 109.743 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.72 -28.12 65.53 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 115.79 -0.641 . . . . 73.03 110.029 177.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.62 -35.86 77.2 Favored 'General case' 0 C--O 1.209 -1.047 0 CA-C-N 115.692 -0.686 . . . . 73.33 111.828 178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -73.41 -30.95 63.57 Favored 'General case' 0 C--N 1.32 -0.712 0 C-N-CA 118.848 -1.141 . . . . 74.53 112.016 -178.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.438 ' O ' ' HG2' ' A' ' 42' ' ' MET . 61.5 t80 -70.85 -39.61 72.83 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 107.764 -1.199 . . . . 65.33 107.764 176.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.614 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 7.0 t60 -60.18 -41.71 93.47 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.403 -1.271 . . . . 74.42 109.512 176.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -76.67 -40.9 47.55 Favored 'General case' 0 C--O 1.202 -1.395 0 N-CA-C 113.803 1.038 . . . . 70.2 113.803 -179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.438 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 26.7 ptm -53.56 -34.64 59.04 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 114.579 1.326 . . . . 74.13 114.579 -171.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -84.92 -21.53 29.62 Favored 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 120.019 -0.672 . . . . 75.22 112.344 -175.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -133.72 22.59 3.93 Favored 'General case' 0 C--N 1.316 -0.856 0 O-C-N 121.94 -0.475 . . . . 64.32 111.533 -174.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -130.63 46.36 1.08 Allowed Glycine 0 N--CA 1.437 -1.269 0 N-CA-C 111.147 -0.781 . . . . 64.11 111.147 -178.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 64.75 111.54 0.03 OUTLIER Pre-proline 0 N--CA 1.466 0.35 0 C-N-CA 124.578 1.151 . . . . 73.14 112.953 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -81.28 22.53 0.81 Allowed 'Trans proline' 0 CA--C 1.546 1.086 0 C-N-CA 122.823 2.349 . . . . 74.45 111.324 177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 44.5 t-80 -66.11 143.68 57.16 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 124.213 1.005 . . . . 74.13 110.422 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -132.16 143.55 50.05 Favored 'General case' 0 N--CA 1.434 -1.233 0 N-CA-C 108.383 -0.969 . . . . 60.52 108.383 173.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 11.7 p -99.58 134.31 39.31 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 N-CA-C 108.305 -0.998 . . . . 73.21 108.305 176.229 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 37.2 m -107.5 96.99 6.79 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.014 0.435 . . . . 75.1 111.656 -176.823 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -142.4 175.86 9.45 Favored 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 108.026 -1.101 . . . . 63.43 108.026 178.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.72 27.65 16.97 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.419 0.688 . . . . 73.04 111.237 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 67.8 m 67.61 93.88 0.05 OUTLIER Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.798 0.839 . . . . 72.34 111.074 -176.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -78.4 -50.72 0.08 OUTLIER 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 122.971 2.448 . . . . 74.22 114.284 -175.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.8 -161.5 15.03 Favored Glycine 0 N--CA 1.433 -1.557 0 N-CA-C 110.296 -1.122 . . . . 55.1 110.296 -176.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.8 t30 62.45 96.05 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.145 0.978 . . . . 63.33 110.922 -179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 29.4 pt -90.03 89.19 3.03 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.144 0 N-CA-C 113.927 1.084 . . . . 75.24 113.927 -174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 98.0 mt-30 62.49 -168.49 0.19 Allowed 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 115.344 -0.844 . . . . 74.35 112.198 177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 140.58 -17.06 2.86 Favored Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 116.236 -0.438 . . . . 60.22 112.31 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.4 m 69.72 -42.66 0.51 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 124.833 1.253 . . . . 62.2 112.93 -178.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -69.68 139.64 53.49 Favored 'General case' 0 C--N 1.318 -0.802 0 C-N-CA 122.741 0.416 . . . . 71.3 110.652 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 55.3 tp -128.65 88.82 2.79 Favored 'General case' 0 C--N 1.307 -1.276 0 CA-C-O 121.342 0.591 . . . . 62.23 110.107 179.118 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -149.94 101.93 3.08 Favored 'General case' 0 C--N 1.306 -1.29 0 CA-C-N 115.297 -0.865 . . . . 63.13 109.055 178.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -78.63 -66.79 0.81 Allowed 'General case' 0 C--N 1.31 -1.131 0 N-CA-C 109.213 -0.662 . . . . 60.34 109.213 176.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -141.79 15.89 2.63 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.099 -1.048 . . . . 75.54 113.657 -179.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.28 161.54 39.16 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 119.307 -0.957 . . . . 70.52 112.07 -178.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 38.0 m95 -105.83 -10.9 16.45 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 114.72 -1.127 . . . . 74.41 108.828 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 90.45 -12.34 68.59 Favored Glycine 0 CA--C 1.518 0.263 0 CA-C-N 115.359 -0.837 . . . . 64.14 112.32 -178.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.462 ' O ' ' HB2' ' A' ' 73' ' ' SER . 30.7 m -118.8 150.1 40.39 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 109.387 -0.598 . . . . 63.33 109.387 -176.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 38.3 t -68.64 140.12 19.48 Favored 'Isoleucine or valine' 0 C--O 1.239 0.547 0 N-CA-C 107.557 -1.275 . . . . 64.22 107.557 176.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 103.32 0.98 47.48 Favored Glycine 0 N--CA 1.439 -1.154 0 N-CA-C 109.466 -1.454 . . . . 71.43 109.466 -173.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.462 ' HB2' ' O ' ' A' ' 70' ' ' THR . 37.7 t -60.22 138.86 57.84 Favored 'General case' 0 N--CA 1.438 -1.04 0 C-N-CA 124.795 1.238 . . . . 72.24 110.458 179.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.0 mt -130.92 115.67 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.041 0 N-CA-C 108.297 -1.001 . . . . 52.15 108.297 175.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.5 p -133.0 154.12 39.07 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.943 0 N-CA-C 109.183 -0.673 . . . . 74.31 109.183 -178.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 20.2 m-85 -114.42 121.68 44.31 Favored 'General case' 0 N--CA 1.42 -1.94 0 C-N-CA 119.865 -0.734 . . . . 72.33 109.3 179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 22.4 t-105 -113.01 145.72 40.36 Favored 'General case' 0 N--CA 1.414 -2.249 0 N-CA-C 107.706 -1.22 . . . . 73.11 107.706 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 -102.88 131.69 49.61 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-O 120.844 0.354 . . . . 61.34 110.504 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -126.32 152.93 45.56 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.637 -1.245 . . . . 75.12 107.637 179.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.3 t -106.24 118.36 53.73 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 C-N-CA 120.24 -0.584 . . . . 70.02 109.683 -176.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -127.17 111.31 13.84 Favored 'General case' 0 N--CA 1.425 -1.681 0 CA-C-N 115.258 -0.883 . . . . 70.43 109.269 -178.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 64.43 30.88 12.94 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 124.096 0.958 . . . . 64.41 111.899 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 92.02 -12.73 68.77 Favored Glycine 0 C--N 1.302 -1.339 0 CA-C-N 115.294 -0.867 . . . . 41.32 114.576 178.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -94.84 142.88 26.96 Favored 'General case' 0 CA--C 1.488 -1.416 0 CA-C-N 118.264 1.032 . . . . 74.31 109.999 174.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.22 114.36 26.89 Favored 'General case' 0 N--CA 1.421 -1.883 0 N-CA-C 106.248 -1.76 . . . . 34.41 106.248 173.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 36.4 mtpt -110.34 168.9 9.11 Favored 'General case' 0 C--N 1.285 -2.234 0 N-CA-C 106.962 -1.496 . . . . 75.44 106.962 -174.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 44.7 t -114.63 138.88 43.31 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 C-N-CA 120.533 -0.467 . . . . 75.41 109.932 -175.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.04 121.87 45.7 Favored 'General case' 0 N--CA 1.422 -1.87 0 N-CA-C 107.368 -1.345 . . . . 33.22 107.368 176.363 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.45 ' HB2' ' HB3' ' A' ' 108' ' ' GLU . 97.1 mttt -109.02 123.43 49.13 Favored 'General case' 0 N--CA 1.42 -1.967 0 N-CA-C 108.469 -0.937 . . . . 70.03 108.469 -177.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.73 164.52 29.97 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.546 -0.752 . . . . 75.12 112.164 -166.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 8.1 tpt180 -137.67 122.99 19.43 Favored 'General case' 0 C--N 1.286 -2.161 0 CA-C-N 114.614 -1.176 . . . . 72.14 108.992 176.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.402 HD12 ' HB3' ' A' ' 73' ' ' SER . 53.9 mt -78.87 122.2 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.073 0 N-CA-C 107.961 -1.126 . . . . 72.13 107.961 173.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -102.57 -24.0 13.83 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-O 121.569 0.7 . . . . 63.11 109.142 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -163.45 142.36 8.16 Favored 'General case' 0 CA--C 1.501 -0.936 0 N-CA-C 108.677 -0.86 . . . . 74.51 108.677 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.3 p -146.81 123.32 3.18 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 CA-C-O 121.191 0.52 . . . . 64.42 110.113 178.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.465 ' CB ' ' HB2' ' A' ' 99' ' ' LYS . 7.3 mm-40 -113.29 107.59 53.51 Favored Pre-proline 0 C--N 1.299 -1.62 0 N-CA-C 108.98 -0.748 . . . . 71.12 108.98 -178.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_exo -62.69 -42.66 24.66 Favored 'Trans proline' 0 CA--C 1.531 0.365 0 C-N-CA 122.652 2.235 . . . . 71.3 112.109 179.212 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.614 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 2.0 m-20 -79.91 -34.64 38.81 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 113.771 1.026 . . . . 75.24 113.771 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.465 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 91.9 mttt -85.62 -8.83 58.02 Favored 'General case' 0 C--N 1.31 -1.114 0 N-CA-C 112.107 0.41 . . . . 74.04 112.107 -177.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.9 m-20 62.32 38.56 13.07 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 123.722 0.639 . . . . 62.34 109.602 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.436 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.7 tp -118.37 139.76 50.87 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 115.781 -0.645 . . . . 72.25 110.202 -173.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.4 tt -149.82 124.78 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.309 -1.175 0 CA-C-O 121.817 0.818 . . . . 74.43 111.165 176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 ' CG2' HD21 ' A' ' 119' ' ' LEU . 53.3 m -99.33 123.41 43.59 Favored 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.847 -1.07 . . . . 74.03 111.062 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 119' ' ' LEU . 91.4 m-85 -109.34 134.8 51.36 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 123.079 0.552 . . . . 71.41 110.584 179.244 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.464 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 19.2 ttm180 -109.13 148.65 30.53 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 108.821 -0.807 . . . . 70.01 108.821 175.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.552 HG11 ' HE1' ' A' ' 112' ' ' MET . 11.9 p -73.55 144.38 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.877 0 N-CA-C 109.459 -0.571 . . . . 74.11 109.459 174.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.425 HG13 ' N ' ' A' ' 108' ' ' GLU . 31.8 pt -137.37 -40.21 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 O-C-N 122.249 -0.282 . . . . 64.45 111.74 178.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.469 ' OE2' ' HB2' ' A' ' 110' ' ' ASP 0.345 0.0 OUTLIER -49.76 -65.94 0.48 Allowed 'General case' 0 CA--C 1.539 0.54 0 N-CA-C 118.61 2.819 . . . . 71.13 118.61 -173.78 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 133.15 -28.09 3.36 Favored Glycine 0 C--N 1.295 -1.739 0 C-N-CA 120.314 -0.946 . . . . 74.53 111.766 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.469 ' HB2' ' OE2' ' A' ' 108' ' ' GLU . 6.1 m-20 -68.03 -43.16 79.41 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.891 0.377 . . . . 75.3 110.789 -179.596 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 96.1 mt -68.47 -24.82 64.74 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.719 0.771 . . . . 73.31 109.629 177.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.552 ' HE1' HG11 ' A' ' 106' ' ' VAL . 7.9 mmt -78.25 -5.84 53.16 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.02 -0.991 . . . . 63.21 111.434 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -81.81 -19.32 41.41 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-O 121.352 0.596 . . . . 74.15 109.432 177.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -113.18 -25.3 8.96 Favored 'General case' 0 C--N 1.309 -1.174 0 CA-C-N 115.434 -0.803 . . . . 73.13 110.461 -177.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.514 ' O ' ' HA ' ' A' ' 112' ' ' MET . 71.2 m-85 -132.61 146.99 52.33 Favored 'General case' 0 C--O 1.206 -1.236 0 N-CA-C 109.017 -0.734 . . . . 72.14 109.017 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.614 ' HG3' HG12 ' A' ' 144' ' ' ILE . 6.3 mtpm? -84.19 -18.31 37.06 Favored 'General case' 0 C--N 1.305 -1.327 0 CA-C-O 121.744 0.783 . . . . 74.23 109.603 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.8 t -158.01 143.05 16.61 Favored 'General case' 0 N--CA 1.425 -1.723 0 N-CA-C 107.597 -1.26 . . . . 51.14 107.597 -178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.483 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.4 t80 -156.85 115.38 3.3 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-O 121.11 0.481 . . . . 64.1 110.023 -178.353 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 104' ' ' PHE . 8.4 tt -141.3 131.87 25.47 Favored 'General case' 0 N--CA 1.423 -1.809 0 N-CA-C 108.679 -0.859 . . . . 62.21 108.679 178.052 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.5 ' H ' HD23 ' A' ' 120' ' ' LEU . 1.9 pt? -129.3 135.65 49.03 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.015 0.436 . . . . 72.04 111.071 -175.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 51.6 m -116.74 129.67 56.26 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 109.169 -0.678 . . . . 72.51 109.169 178.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 36.4 pt -117.72 149.48 20.04 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 N-CA-C 109.751 -0.463 . . . . 74.43 109.751 179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 56.8 tt0 -144.51 133.21 22.3 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 109.74 -0.467 . . . . 71.31 109.74 177.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 62.5 t -94.77 118.24 40.39 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.177 0 N-CA-C 109.068 -0.716 . . . . 61.43 109.068 -178.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 28.3 m -118.03 126.92 26.94 Favored Pre-proline 0 C--N 1.289 -2.029 0 CA-C-N 115.962 -0.563 . . . . 73.54 110.735 -175.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 30.1 Cg_endo -67.44 112.88 2.72 Favored 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 121.934 1.756 . . . . 61.44 109.018 175.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.636 ' HD3' HG13 ' A' ' 134' ' ' ILE . 58.0 tttm -129.03 -53.97 0.03 OUTLIER Pre-proline 0 C--N 1.297 -1.711 0 N-CA-C 112.424 0.528 . . . . 71.24 112.424 -173.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 34.6 Cg_exo -64.23 -49.01 4.02 Favored 'Trans proline' 0 C--N 1.37 1.71 0 C-N-CA 121.406 1.404 . . . . 74.33 111.533 174.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 165.42 -121.66 1.02 Allowed Glycine 0 N--CA 1.439 -1.157 0 N-CA-C 111.309 -0.716 . . . . 73.21 111.309 179.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -82.1 -81.69 0.89 Allowed Glycine 0 N--CA 1.446 -0.691 0 N-CA-C 110.572 -1.011 . . . . 63.42 110.572 178.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.66 95.88 0.73 Allowed 'Trans proline' 0 N--CA 1.446 -1.271 0 C-N-CA 122.108 1.872 . . . . 65.2 110.886 174.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 134.32 116.83 1.7 Allowed Glycine 0 N--CA 1.416 -2.675 0 N-CA-C 110.903 -0.879 . . . . 72.25 110.903 -178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 20.5 m -137.03 150.75 48.28 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 108.569 -0.9 . . . . 63.4 108.569 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.636 HG13 ' HD3' ' A' ' 127' ' ' LYS . 34.7 mm -103.08 124.6 57.29 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.549 0 C-N-CA 120.239 -0.584 . . . . 63.02 109.998 179.75 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -99.29 118.17 45.5 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.218 0 CA-C-O 121.462 0.649 . . . . 64.13 109.613 178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -93.66 115.75 28.22 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.467 -0.788 . . . . 54.51 110.342 -177.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -97.1 122.56 40.24 Favored 'General case' 0 C--N 1.304 -1.387 0 CA-C-N 115.752 -0.658 . . . . 63.21 109.464 -179.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 72.3 m-70 -115.41 111.41 20.77 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 106.906 -1.516 . . . . 75.05 106.906 176.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.8 mp -107.58 123.43 48.45 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.439 -0.949 . . . . 71.42 108.439 -179.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.449 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 42.5 mt-10 -123.21 126.69 47.43 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.976 -1.12 . . . . 73.13 107.976 -179.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -153.96 166.2 33.74 Favored 'General case' 0 C--N 1.294 -1.827 0 N-CA-C 112.695 0.628 . . . . 73.44 112.695 -171.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -124.92 118.61 26.68 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.7 -0.852 . . . . 74.41 108.7 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.517 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -63.06 140.97 58.93 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 109.726 -0.472 . . . . 71.3 109.726 178.514 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.614 HG12 ' HG3' ' A' ' 116' ' ' LYS . 8.1 mt -77.29 -36.65 24.36 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.575 0 N-CA-C 105.777 -1.934 . . . . 62.55 105.777 172.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.458 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 41.5 t -159.71 156.15 27.21 Favored 'General case' 0 N--CA 1.403 -2.812 0 N-CA-C 104.582 -2.377 . . . . 62.3 104.582 174.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.76 ' HB2' ' HA ' ' A' ' 17' ' ' THR . 79.8 mm-40 -71.98 -47.73 50.05 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-O 120.829 0.347 . . . . 73.3 111.469 -173.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -62.9 -20.4 65.12 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.338 -0.847 . . . . 71.31 110.804 -178.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.458 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 45.5 t -90.92 -15.79 8.34 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 CA-C-N 115.048 -0.978 . . . . 61.23 110.273 -176.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -95.05 154.23 17.27 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 116.056 -0.52 . . . . 72.21 110.986 -177.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -141.05 92.08 8.68 Favored Pre-proline 0 C--N 1.32 -0.712 0 CA-C-N 116.134 -0.485 . . . . 54.32 112.277 178.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -55.19 -25.25 45.3 Favored 'Trans proline' 0 CA--C 1.555 1.56 0 C-N-CA 122.715 2.276 . . . . 71.15 113.235 174.292 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 5.9 pm0 -63.78 -40.66 97.21 Favored 'General case' 0 C--O 1.244 0.79 0 N-CA-C 112.252 0.464 . . . . 72.34 112.252 179.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 69.1 p -71.13 -29.54 65.36 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-O 121.453 0.644 . . . . 63.25 109.79 -177.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 83.0 mt -67.85 -40.42 83.67 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.923 -1.035 . . . . 54.44 109.575 178.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.549 ' O ' HG23 ' A' ' 159' ' ' VAL . 83.2 mt -63.72 -41.26 98.1 Favored 'General case' 0 CA--C 1.507 -0.673 0 CA-C-N 116.12 -0.491 . . . . 43.01 110.707 176.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 42.9 mt-30 -64.71 -38.7 91.88 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 120.907 -0.317 . . . . 73.31 111.212 178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.2 t80 -57.12 -41.72 79.54 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.635 -0.506 . . . . 75.35 109.635 176.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 61.4 m -64.55 -46.25 83.61 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.61 -0.723 . . . . 71.14 109.808 177.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.606 HG12 ' NZ ' ' A' ' 163' ' ' LYS . 94.6 t -59.97 -43.75 93.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 115.766 -0.652 . . . . 73.43 111.785 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.503 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -62.61 -45.03 94.73 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-O 120.791 0.329 . . . . 74.43 111.464 -178.206 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 76.2 t -64.99 -34.34 69.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-N 116.042 -0.526 . . . . 73.31 110.296 178.13 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 64.6 m -52.81 -44.74 66.87 Favored 'General case' 0 C--O 1.217 -0.627 0 N-CA-C 113.208 0.818 . . . . 51.22 113.208 -179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.606 ' NZ ' HG12 ' A' ' 159' ' ' VAL . 4.0 mppt? -64.63 -38.46 91.09 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 119.143 -1.023 . . . . 73.35 111.916 178.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.588 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 12.0 tp10 -64.37 -52.15 59.73 Favored 'General case' 0 C--O 1.209 -1.032 0 C-N-CA 120.45 -0.5 . . . . 74.31 110.256 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -67.76 -42.94 86.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.03 0 O-C-N 123.098 0.249 . . . . 44.31 110.669 -175.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.424 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.0 t70 -60.7 -52.71 63.98 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-O 121.067 0.461 . . . . 75.41 111.018 -179.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -74.59 -29.93 61.5 Favored 'General case' 0 C--N 1.315 -0.922 0 N-CA-C 112.656 0.613 . . . . 74.33 112.656 -177.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.588 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 3.3 t60 -68.18 -35.46 78.07 Favored 'General case' 0 C--O 1.217 -0.645 0 C-N-CA 120.603 -0.439 . . . . 72.42 109.891 -174.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.423 HD21 ' SD ' ' A' ' 42' ' ' MET . 88.2 mt -76.47 -30.88 57.49 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 120.581 -0.448 . . . . 53.25 111.113 176.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.439 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -74.29 -25.66 59.72 Favored 'General case' 0 CA--C 1.513 -0.481 0 CA-C-O 121.076 0.465 . . . . 74.04 110.749 177.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -77.55 105.79 8.92 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 107.624 -1.25 . . . . 73.24 107.624 173.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.5 151.62 42.38 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.592 0.71 . . . . 72.54 112.602 -177.478 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 12.4 tp10 . . . . . 0 C--N 1.289 -2.053 0 CA-C-N 114.878 -1.055 . . . . 62.02 108.804 -176.979 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 88.3 m . . . . . 0 N--CA 1.439 -1.023 0 CA-C-O 121.281 0.563 . . . . 73.35 109.569 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -116.03 174.19 6.17 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.696 -0.684 . . . . 73.02 109.483 -178.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -162.09 131.36 4.44 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 120.701 0.286 . . . . 72.45 110.332 -177.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.5 p -62.06 -29.02 70.01 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-O 121.64 0.733 . . . . 72.4 109.831 177.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 16.8 m -76.39 -5.92 49.39 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.925 -1.034 . . . . 63.22 112.229 -179.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.3 mt 63.23 12.88 6.47 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 123.845 0.858 . . . . 75.43 113.18 -178.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.0 p -73.32 150.46 7.9 Favored 'Isoleucine or valine' 0 C--O 1.258 1.524 0 N-CA-C 109.681 -0.489 . . . . 63.31 109.681 179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.54 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -144.19 125.1 2.37 Favored Glycine 0 N--CA 1.416 -2.67 0 C-N-CA 120.216 -0.992 . . . . 61.44 113.61 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.468 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 47.7 mtpt -130.65 156.28 45.16 Favored 'General case' 0 C--N 1.28 -2.419 0 CA-C-O 120.883 0.373 . . . . 72.13 110.404 174.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 61.8 tp -153.17 133.52 13.55 Favored 'General case' 0 N--CA 1.418 -2.062 0 N-CA-C 107.791 -1.189 . . . . 73.32 107.791 167.559 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -130.56 132.53 45.61 Favored 'General case' 0 C--N 1.285 -2.217 0 N-CA-C 109.029 -0.73 . . . . 72.33 109.029 179.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.7 t -145.57 166.16 26.55 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 108.289 -1.004 . . . . 34.11 108.289 -178.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -136.62 122.44 19.96 Favored 'General case' 0 C--N 1.291 -1.965 0 N-CA-C 109.633 -0.506 . . . . 75.41 109.633 177.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 60.4 t -108.38 141.5 23.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.215 -1.032 . . . . 73.53 108.215 -179.451 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.497 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 2.1 mp0 -94.43 137.51 33.48 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 108.7 -0.852 . . . . 71.14 108.7 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.582 ' O ' ' HA2' ' A' ' 132' ' ' GLY . 33.6 pt -109.0 150.91 11.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 N-CA-C 107.49 -1.3 . . . . 72.42 107.49 172.055 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.679 ' HB2' HD11 ' A' ' 170' ' ' LEU . 88.6 mttt -84.26 -6.4 59.39 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 121.696 0.76 . . . . 74.43 109.649 -177.72 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.34 170.06 10.08 Favored 'General case' 0 N--CA 1.425 -1.688 0 CA-C-N 115.2 -0.909 . . . . 72.43 110.212 -179.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 p -92.1 155.91 17.74 Favored 'General case' 0 N--CA 1.412 -2.331 0 CA-C-N 115.894 -0.594 . . . . 74.45 109.852 178.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.434 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -66.92 -26.99 67.12 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-O 121.429 0.633 . . . . 62.25 110.433 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.0 t70 -67.1 -30.0 69.9 Favored 'General case' 0 N--CA 1.443 -0.804 0 CA-C-N 115.94 -0.573 . . . . 74.15 111.34 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 34.7 mtpt -70.07 -29.61 66.65 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 119.094 -1.042 . . . . 72.22 111.718 177.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.542 ' O ' ' HG2' ' A' ' 42' ' ' MET . 48.2 t80 -65.25 -44.41 88.21 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 106.953 -1.499 . . . . 74.41 106.953 174.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.463 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.4 t-80 -57.43 -39.64 76.66 Favored 'General case' 0 CA--C 1.56 1.331 0 CA-C-N 114.26 -1.336 . . . . 74.5 111.166 174.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.4 m170 -77.08 -32.34 56.64 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.954 1.094 . . . . 63.01 113.954 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.542 ' HG2' ' O ' ' A' ' 39' ' ' PHE . 23.3 ptt? -62.35 -28.51 69.81 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 120.497 -0.481 . . . . 74.43 111.548 -175.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.6 t80 -67.28 -20.1 65.59 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.299 0.571 . . . . 64.42 110.815 -178.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -101.43 14.34 32.26 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 116.011 -0.54 . . . . 72.21 112.429 -176.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -178.67 -49.0 0.07 OUTLIER Glycine 0 C--N 1.332 0.355 0 C-N-CA 118.108 -1.996 . . . . 55.1 114.804 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HB2' ' HB2' ' A' ' 42' ' ' MET . 4.0 mptp? -69.68 141.36 90.16 Favored Pre-proline 0 C--N 1.309 -1.157 0 CA-C-N 116.86 0.33 . . . . 73.41 111.347 -178.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -66.92 165.68 25.25 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 122.117 1.878 . . . . 71.41 110.607 175.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.425 ' HB3' HG11 ' A' ' 75' ' ' VAL . 57.1 t60 -87.46 -9.28 55.03 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-O 121.434 0.635 . . . . 53.54 110.464 -177.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 4.8 t-80 -136.57 151.17 49.08 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 124.484 1.114 . . . . 72.34 108.827 -177.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 15.5 m -53.35 122.89 3.69 Favored 'Isoleucine or valine' 0 C--O 1.242 0.683 0 CA-C-O 121.279 0.561 . . . . 73.44 110.325 172.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 19.6 t -105.3 106.81 17.48 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.89 -0.595 . . . . 61.41 110.61 -173.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.511 ' HE3' ' OG ' ' A' ' 54' ' ' SER . 38.5 ttpt -168.2 147.02 4.5 Favored 'General case' 0 C--O 1.24 0.581 0 N-CA-C 108.195 -1.039 . . . . 65.11 108.195 178.122 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -80.72 82.48 6.71 Favored 'General case' 0 C--O 1.246 0.878 0 CA-C-O 121.571 0.7 . . . . 71.23 111.744 -178.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.511 ' OG ' ' HE3' ' A' ' 52' ' ' LYS . 58.9 m -138.24 135.78 18.74 Favored Pre-proline 0 C--N 1.305 -1.368 0 CA-C-N 115.3 -0.864 . . . . 74.43 109.27 178.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -57.48 149.15 68.11 Favored 'Trans proline' 0 C--O 1.24 0.623 0 C-N-CA 123.134 2.556 . . . . 61.31 112.909 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.01 -35.42 0.12 Allowed Glycine 0 C--N 1.302 -1.359 0 N-CA-C 108.744 -1.742 . . . . 61.14 108.744 -177.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 10.0 p30 -143.63 -177.75 5.56 Favored 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 107.108 -1.441 . . . . 72.4 107.108 176.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.443 HG13 ' HG3' ' A' ' 59' ' ' GLN . 37.1 pt -53.75 -34.75 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 113.392 0.886 . . . . 74.05 113.392 -178.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.443 ' HG3' HG13 ' A' ' 58' ' ' ILE . 95.3 mt-30 -101.93 -35.31 9.04 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.108 0.48 . . . . 74.04 111.16 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.45 -66.16 3.85 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 109.499 -1.44 . . . . 34.54 109.499 -175.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 52' ' ' LYS . 50.7 t -107.8 147.18 31.21 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 106.154 -1.795 . . . . 65.33 106.154 174.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -72.41 98.89 2.33 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.198 0.523 . . . . 55.05 109.616 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 62.4 tp -103.38 132.71 49.41 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-N 115.547 -0.751 . . . . 74.22 109.6 -177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 42.4 t-80 66.93 89.86 0.1 Allowed 'General case' 0 C--O 1.237 0.426 0 CA-C-O 122.0 0.905 . . . . 70.31 110.857 178.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . 0.439 ' H ' ' CD ' ' A' ' 65' ' ' GLU . 0.1 OUTLIER -104.64 145.41 30.36 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-N 114.902 -1.045 . . . . 54.43 110.664 -177.452 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -121.48 -27.3 1.82 Allowed Glycine 0 C--N 1.305 -1.141 0 C-N-CA 120.661 -0.78 . . . . 74.34 112.019 178.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.4 t70 70.77 149.49 0.09 Allowed 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.823 0.849 . . . . 73.25 112.073 -179.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.513 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 40.6 m95 -107.5 15.66 24.6 Favored 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 116.198 -0.455 . . . . 75.12 110.85 -177.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.31 14.56 38.19 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.17 -1.014 . . . . 62.1 110.746 -175.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.8 m 72.52 -68.77 0.21 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.91 1.284 . . . . 64.31 110.739 -175.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 67.6 t -72.47 119.9 20.02 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.119 0 N-CA-C 108.439 -0.948 . . . . 63.42 108.439 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.96 -0.32 48.15 Favored Glycine 0 N--CA 1.435 -1.409 0 C-N-CA 120.222 -0.989 . . . . 73.35 111.088 -176.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.513 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 22.8 t -73.21 154.21 40.35 Favored 'General case' 0 N--CA 1.437 -1.085 0 CA-C-O 121.364 0.602 . . . . 74.53 111.347 -178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 81.6 mt -128.55 116.4 41.42 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.887 0 CA-C-N 114.679 -1.146 . . . . 75.32 108.889 179.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.463 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 22.1 t -122.76 165.1 19.21 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 106.817 -1.549 . . . . 72.14 106.817 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 40.7 m-85 -126.67 144.84 50.79 Favored 'General case' 0 N--CA 1.44 -0.964 0 CA-C-N 118.461 0.573 . . . . 74.44 112.192 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.527 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 8.4 m0 -107.03 151.44 25.33 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.754 -0.657 . . . . 72.42 109.947 176.27 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.501 HD22 ' C ' ' A' ' 77' ' ' TRP . 0.9 OUTLIER -129.28 130.79 46.64 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 108.748 -0.834 . . . . 74.33 108.748 176.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -152.94 162.75 40.93 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.601 -0.889 . . . . 75.14 108.601 -179.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.9 t -105.96 119.28 55.02 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 109.174 -0.676 . . . . 71.15 109.174 -177.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.549 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 18.8 t60 -139.62 126.5 20.83 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 107.257 -1.386 . . . . 74.55 107.257 -179.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 60.42 29.03 18.69 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 124.444 1.097 . . . . 71.2 109.906 -174.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.82 -4.48 65.29 Favored Glycine 0 N--CA 1.435 -1.374 0 CA-C-N 115.809 -0.632 . . . . 34.24 113.816 179.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 36.2 tt0 -99.72 148.97 23.81 Favored 'General case' 0 N--CA 1.443 -0.803 0 N-CA-C 108.97 -0.752 . . . . 73.23 108.97 -179.183 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.14 115.31 21.85 Favored 'General case' 0 N--CA 1.427 -1.625 0 N-CA-C 106.217 -1.771 . . . . 61.12 106.217 174.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.549 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 28.8 mmmt -102.73 142.05 34.52 Favored 'General case' 0 C--N 1.281 -2.387 0 N-CA-C 108.516 -0.92 . . . . 73.53 108.516 -174.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.527 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 56.8 t -115.89 132.39 65.5 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.36 0 N-CA-C 108.288 -1.004 . . . . 74.0 108.288 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.414 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -106.54 136.49 46.21 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.432 -1.321 . . . . 62.51 107.432 -179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 108' ' ' GLU . 53.7 mttp -119.22 120.74 37.94 Favored 'General case' 0 N--CA 1.417 -2.078 0 O-C-N 124.138 0.899 . . . . 72.35 108.767 -171.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 11.6 pt-20 -127.84 167.95 15.85 Favored 'General case' 0 N--CA 1.433 -1.293 0 CA-C-O 121.964 0.888 . . . . 63.05 112.173 -169.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.43 ' HB3' ' O ' ' A' ' 105' ' ' ARG . 10.1 tpt180 -136.79 121.68 18.78 Favored 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 113.961 -1.472 . . . . 55.41 107.147 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.409 ' CG2' HG23 ' A' ' 95' ' ' VAL . 40.1 mt -79.38 122.63 34.99 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.312 0 N-CA-C 108.193 -1.04 . . . . 71.44 108.193 174.298 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -104.02 -27.5 12.09 Favored 'General case' 0 C--N 1.29 -2.001 0 C-N-CA 119.228 -0.989 . . . . 61.03 109.506 179.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -162.43 141.47 9.15 Favored 'General case' 0 C--O 1.242 0.671 0 CA-C-N 116.056 -0.52 . . . . 74.53 110.0 179.575 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.573 HG22 HG12 ' A' ' 102' ' ' ILE . 77.6 t -134.5 123.02 41.43 Favored 'Isoleucine or valine' 0 C--O 1.249 1.037 0 O-C-N 123.652 0.595 . . . . 74.54 110.37 177.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.527 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 61.5 mm-40 -111.96 107.36 56.12 Favored Pre-proline 0 C--N 1.306 -1.293 0 N-CA-C 108.13 -1.063 . . . . 72.54 108.13 173.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -69.32 -38.63 8.48 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 121.972 1.781 . . . . 63.14 111.323 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -80.24 -36.51 34.6 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.144 -0.48 . . . . 74.32 112.238 -178.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 59.6 mttp -87.14 -6.24 58.72 Favored 'General case' 0 C--N 1.322 -0.605 0 C-N-CA 120.691 -0.404 . . . . 72.14 112.026 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.434 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 77.1 m-20 58.94 41.72 20.66 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.643 0.777 . . . . 62.14 110.252 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.527 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 41.6 tp -118.4 136.84 53.53 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.034 -0.53 . . . . 63.12 110.172 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.573 HG12 HG22 ' A' ' 95' ' ' VAL . 0.0 OUTLIER -147.32 128.28 5.73 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.372 0 CA-C-O 121.657 0.741 . . . . 73.55 109.23 176.883 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.435 ' N ' HD13 ' A' ' 102' ' ' ILE . 28.1 m -99.71 119.04 37.5 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.03 -0.986 . . . . 72.25 111.158 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -103.51 138.63 39.95 Favored 'General case' 0 N--CA 1.467 0.413 0 N-CA-C 109.598 -0.519 . . . . 63.1 109.598 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.43 ' O ' ' HB3' ' A' ' 91' ' ' ARG . 2.7 tmt_? -124.44 129.28 50.37 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 106.233 -1.766 . . . . 72.42 106.233 177.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 12.8 p -74.06 134.21 30.05 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.383 0 C-N-CA 119.491 -0.883 . . . . 73.02 110.913 -176.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 20.6 pt -108.63 -27.83 2.86 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 CA-C-N 116.12 -0.491 . . . . 75.02 110.089 176.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.683 ' HG2' ' H ' ' A' ' 110' ' ' ASP . 39.0 tt0 -61.54 135.49 57.67 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.173 -0.921 . . . . 71.02 111.429 176.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -82.21 -4.22 90.29 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 115.791 -0.64 . . . . 52.31 113.252 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.683 ' H ' ' HG2' ' A' ' 108' ' ' GLU . 15.5 t70 -62.48 -48.24 80.47 Favored 'General case' 0 C--O 1.213 -0.862 0 CA-C-N 116.882 0.341 . . . . 72.02 110.94 178.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.469 HD12 HG21 ' A' ' 106' ' ' VAL . 79.6 mt -71.82 -23.7 61.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.879 0.847 . . . . 64.41 109.847 177.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.656 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 10.6 mmt -73.64 -5.36 39.98 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.133 -0.94 . . . . 72.11 111.686 179.542 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -77.05 -23.12 52.07 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 121.319 0.58 . . . . 71.4 109.766 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.485 ' HB3' HG12 ' A' ' 148' ' ' VAL . 1.3 pm0 -122.47 -28.75 4.21 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 112.907 0.706 . . . . 72.05 112.907 177.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.656 ' O ' ' HA ' ' A' ' 112' ' ' MET . 35.2 m-85 -111.29 136.52 50.27 Favored 'General case' 0 N--CA 1.424 -1.771 0 N-CA-C 107.504 -1.295 . . . . 74.5 107.504 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.445 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.7 ptmt -92.24 3.31 55.62 Favored 'General case' 0 C--N 1.285 -2.239 0 CA-C-O 121.773 0.797 . . . . 75.44 110.726 179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.7 t -172.87 139.26 0.85 Allowed 'General case' 0 N--CA 1.438 -1.07 0 CA-C-N 114.273 -1.33 . . . . 51.33 108.038 175.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.557 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -146.27 112.48 5.81 Favored 'General case' 0 C--O 1.244 0.766 0 N-CA-C 109.292 -0.633 . . . . 72.34 109.292 178.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 48.5 tp -121.13 129.12 53.13 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 107.951 -1.129 . . . . 74.1 107.951 -179.715 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.557 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -133.91 122.48 23.2 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.328 0.585 . . . . 63.15 110.295 -179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.8 m -115.3 130.48 56.92 Favored 'General case' 0 C--N 1.276 -2.587 0 CA-C-N 115.971 -0.559 . . . . 62.2 109.509 -178.016 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.3 pt -118.03 147.36 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 N-CA-C 109.776 -0.453 . . . . 65.14 109.776 179.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -144.31 128.62 17.83 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 109.179 -0.674 . . . . 74.02 109.179 176.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 60.1 t -95.25 111.69 26.26 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 N-CA-C 108.892 -0.781 . . . . 70.24 108.892 -179.297 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 59.5 m -116.88 131.24 24.05 Favored Pre-proline 0 C--N 1.277 -2.582 0 CA-C-N 115.564 -0.744 . . . . 73.31 110.22 -175.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.03 86.89 0.73 Allowed 'Trans proline' 0 N--CA 1.443 -1.453 0 C-N-CA 121.907 1.738 . . . . 73.2 109.43 175.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.581 ' HD3' HG13 ' A' ' 134' ' ' ILE . 63.9 tttm -86.44 -55.59 0.37 Allowed Pre-proline 0 C--N 1.296 -1.724 0 CA-C-N 114.549 -1.205 . . . . 72.42 111.928 -175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.542 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 13.0 Cg_exo -73.21 -56.95 0.08 OUTLIER 'Trans proline' 0 C--N 1.367 1.532 0 C-N-CA 121.193 1.262 . . . . 71.14 110.499 175.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 160.98 108.67 0.23 Allowed Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.369 -0.92 . . . . 70.51 112.848 178.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 55.71 -117.2 8.26 Favored Glycine 0 CA--C 1.524 0.634 0 O-C-N 123.998 0.469 . . . . 60.32 114.084 177.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -59.66 111.41 0.95 Allowed 'Trans proline' 0 C--N 1.363 1.319 0 C-N-CA 123.08 2.52 . . . . 75.32 110.766 178.572 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.582 ' HA2' ' O ' ' A' ' 32' ' ' ILE . . . 107.82 68.59 0.66 Allowed Glycine 0 N--CA 1.402 -3.607 0 N-CA-C 109.212 -1.555 . . . . 71.02 109.212 -173.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.8 m -99.66 159.96 14.65 Favored 'General case' 0 N--CA 1.426 -1.674 0 CA-C-O 120.929 0.395 . . . . 72.34 110.616 -179.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.581 HG13 ' HD3' ' A' ' 127' ' ' LYS . 45.8 mm -104.32 130.49 55.01 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.443 -175.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 13.1 t -96.59 117.25 40.63 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.05 0 N-CA-C 107.655 -1.239 . . . . 61.41 107.655 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -89.72 110.91 21.77 Favored 'General case' 0 C--N 1.288 -2.095 0 N-CA-C 108.191 -1.04 . . . . 75.32 108.191 178.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.6 m95 -95.78 122.58 38.71 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 116.106 -0.497 . . . . 65.3 110.664 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 82.9 m-70 -111.26 111.75 23.03 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 107.684 -1.228 . . . . 71.4 107.684 175.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -110.16 122.15 46.96 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.914 -1.143 . . . . 61.23 107.914 176.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -132.21 127.66 36.28 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 108.267 -1.012 . . . . 72.14 108.267 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.4 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 25.4 p90 -152.04 165.97 33.05 Favored 'General case' 0 C--N 1.286 -2.176 0 CA-C-N 115.805 -0.634 . . . . 75.55 112.598 -172.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -121.37 124.84 45.51 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 108.122 -1.066 . . . . 65.32 108.122 -176.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.54 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 0.7 OUTLIER -78.46 134.54 37.33 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 120.75 0.31 . . . . 71.11 111.317 -179.529 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.445 HG12 ' HB3' ' A' ' 116' ' ' LYS . 78.0 mt -76.92 -43.5 32.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 105.511 -2.033 . . . . 65.04 105.511 169.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.9 t -148.91 151.01 33.91 Favored 'General case' 0 N--CA 1.409 -2.508 0 N-CA-C 105.181 -2.155 . . . . 62.41 105.181 175.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -79.45 -50.06 11.36 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-O 120.817 0.342 . . . . 61.34 111.846 -172.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -63.65 -20.57 65.79 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.579 -0.737 . . . . 62.32 111.022 -178.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.485 HG12 ' HB3' ' A' ' 114' ' ' GLU . 21.7 t -83.95 -20.31 8.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 CA-C-N 115.757 -0.656 . . . . 53.44 109.708 -177.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -75.61 169.15 18.66 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.803 -0.635 . . . . 32.42 111.462 -177.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -156.91 78.95 3.77 Favored Pre-proline 0 C--N 1.325 -0.461 0 N-CA-C 113.013 0.746 . . . . 74.31 113.013 -179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.415 ' HA ' HD12 ' A' ' 154' ' ' LEU . 68.6 Cg_exo -55.98 -25.34 53.04 Favored 'Trans proline' 0 C--N 1.363 1.322 0 C-N-CA 123.141 2.56 . . . . 63.22 112.134 175.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 37.8 tt0 -52.47 -47.23 66.63 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 124.131 0.972 . . . . 73.12 111.191 177.092 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.0 p -78.26 -30.42 48.55 Favored 'General case' 0 N--CA 1.436 -1.148 0 CA-C-N 116.261 -0.427 . . . . 74.51 110.521 -175.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.415 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.9 mt -62.93 -41.1 99.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.987 -0.551 . . . . 75.3 110.235 178.682 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 57.8 tp -69.93 -36.14 75.09 Favored 'General case' 0 N--CA 1.404 -2.742 0 CA-C-N 116.03 -0.532 . . . . 54.2 110.134 179.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 152' ' ' GLU . 47.7 mt-30 -68.97 -33.32 73.51 Favored 'General case' 0 C--O 1.22 -0.496 0 C-N-CA 120.798 -0.361 . . . . 75.35 110.621 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -60.96 -37.69 83.26 Favored 'General case' 0 N--CA 1.466 0.357 0 N-CA-C 109.23 -0.655 . . . . 65.11 109.23 176.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 62.7 m -62.1 -41.58 98.35 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-N 115.518 -0.764 . . . . 52.03 109.614 176.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 60.3 t -64.72 -44.59 96.52 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.444 0 CA-C-N 116.18 -0.463 . . . . 52.12 110.379 179.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.448 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 7.3 mm-40 -60.67 -42.91 97.99 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.914 -0.585 . . . . 72.33 110.54 179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.53 -34.72 63.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 CA-C-N 116.311 -0.404 . . . . 73.11 110.412 177.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.439 ' HA ' HG22 ' A' ' 165' ' ' ILE . 58.3 m -57.63 -41.45 81.4 Favored 'General case' 0 C--O 1.212 -0.872 0 N-CA-C 110.235 -0.283 . . . . 61.32 110.235 176.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.7 mttm -60.95 -32.53 72.05 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 116.393 -0.367 . . . . 71.12 111.47 177.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.657 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 10.8 tp10 -75.21 -53.57 8.59 Favored 'General case' 0 C--O 1.195 -1.795 0 C-N-CA 120.606 -0.438 . . . . 53.33 109.851 177.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.439 HG22 ' HA ' ' A' ' 162' ' ' SER . 7.9 tp -69.33 -45.27 79.37 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 N-CA-C 113.277 0.843 . . . . 74.12 113.277 -172.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 18.9 t70 -59.7 -52.37 65.77 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 121.403 0.621 . . . . 63.44 110.255 -178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -73.29 -28.01 61.87 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 115.264 -0.88 . . . . 44.12 112.871 -179.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.657 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.2 t60 -67.07 -39.61 86.88 Favored 'General case' 0 C--N 1.304 -1.396 0 N-CA-C 108.794 -0.817 . . . . 73.4 108.794 177.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.9 mt -77.32 -40.44 44.2 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 116.013 -0.54 . . . . 73.35 111.668 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.679 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -75.58 -40.83 56.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.215 0.531 . . . . 51.33 110.505 179.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 61.8 30.63 18.37 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 125.051 1.341 . . . . 72.14 111.112 -178.248 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -67.27 149.59 50.19 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 114.894 -1.048 . . . . 74.34 110.162 177.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 . . . . . 0 C--N 1.282 -2.369 0 N-CA-C 108.664 -0.865 . . . . 75.31 108.664 -178.232 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.443 -0.779 0 N-CA-C 108.818 -0.808 . . . . 54.32 108.818 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -164.65 168.63 17.87 Favored 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 107.673 -1.232 . . . . 63.11 107.673 178.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -114.34 103.56 11.19 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 109.159 -0.682 . . . . 64.52 109.159 178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 36.7 p -72.68 -43.08 63.56 Favored 'General case' 0 C--N 1.297 -1.705 0 CA-C-O 121.162 0.506 . . . . 65.14 111.106 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 32.3 t -80.32 -22.89 41.03 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 115.421 -0.809 . . . . 71.41 109.645 -178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.466 ' O ' ' HD3' ' A' ' 143' ' ' LYS . 63.1 mt 63.58 -20.93 0.06 Allowed 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 115.799 1.777 . . . . 74.43 115.799 179.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.6 p -77.85 131.99 33.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.818 -0.808 . . . . 75.42 108.818 175.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -139.19 162.15 26.02 Favored Glycine 0 N--CA 1.414 -2.77 0 N-CA-C 111.321 -0.712 . . . . 63.03 111.321 -176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.6 ptmt -148.21 155.5 41.45 Favored 'General case' 0 C--N 1.269 -2.902 0 N-CA-C 109.767 -0.457 . . . . 73.14 109.767 -179.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.559 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -144.71 138.59 27.35 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 107.623 -1.251 . . . . 61.11 107.623 177.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.559 ' N ' HD23 ' A' ' 26' ' ' LEU . 44.5 mt-10 -128.3 136.94 51.68 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 109.8 -0.444 . . . . 72.34 109.8 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.2 t -143.18 143.58 31.84 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 108.816 -0.809 . . . . 74.43 108.816 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.411 ' HB2' ' CG2' ' A' ' 134' ' ' ILE . 6.0 p-10 -108.18 119.83 40.62 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.519 -0.548 . . . . 63.01 109.519 177.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 88.5 t -110.84 128.02 67.51 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 N-CA-C 109.16 -0.681 . . . . 53.42 109.16 179.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.406 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.286 0.2 OUTLIER -93.84 132.6 38.1 Favored 'General case' 0 C--N 1.295 -1.786 0 CA-C-O 122.031 0.92 . . . . 75.24 113.24 178.25 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.48 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.7 pt -112.68 172.11 3.29 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.012 0 CA-C-N 114.094 -1.412 . . . . 75.22 109.204 -179.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.514 ' HB2' HD11 ' A' ' 170' ' ' LEU . 45.4 mttp -93.61 -30.3 15.03 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 108.321 -0.992 . . . . 43.31 108.321 -175.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.65 151.02 47.49 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-N 115.186 -0.915 . . . . 75.22 110.445 177.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.0 t -95.6 144.22 26.23 Favored 'General case' 0 N--CA 1.43 -1.447 0 CA-C-O 120.951 0.405 . . . . 61.32 110.334 178.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -63.28 -29.58 70.88 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.489 -0.778 . . . . 61.22 110.231 178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.457 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.4 t70 -69.27 -45.13 70.44 Favored 'General case' 0 CA--C 1.505 -0.777 0 CA-C-N 115.413 -0.812 . . . . 64.42 110.755 179.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.419 ' HA ' ' CD2' ' A' ' 41' ' ' HIS 0.273 0.0 OUTLIER -69.87 -26.04 64.0 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.963 0.411 . . . . 55.02 111.069 -175.101 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.457 ' HA ' ' CD1' ' A' ' 169' ' ' LEU . 22.1 t80 -54.23 -42.12 69.48 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.233 -0.894 . . . . 74.4 109.182 174.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 32.0 m80 -65.11 -32.59 74.36 Favored 'General case' 0 C--O 1.206 -1.188 0 CA-C-N 116.239 -0.437 . . . . 74.3 110.148 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 12.5 m-70 -68.03 -42.44 80.61 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 116.142 -0.481 . . . . 74.1 109.778 -178.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.3 mmt -74.91 -41.02 60.5 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.829 -0.623 . . . . 75.03 112.385 -177.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -92.42 5.76 49.52 Favored 'General case' 0 C--N 1.31 -1.142 0 N-CA-C 113.376 0.88 . . . . 73.33 113.376 -176.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.68 -42.14 95.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.285 0.564 . . . . 43.22 110.477 177.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 46' ' ' LYS . . . 104.21 -15.16 51.16 Favored Glycine 0 N--CA 1.438 -1.229 0 N-CA-C 111.46 -0.656 . . . . 43.23 111.46 -179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.423 ' HD3' ' O ' ' A' ' 45' ' ' GLY . 74.7 mmtt -135.02 157.24 77.43 Favored Pre-proline 0 C--N 1.307 -1.274 0 N-CA-C 108.289 -1.004 . . . . 63.04 108.289 -179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -62.91 113.84 2.17 Favored 'Trans proline' 0 N--CA 1.46 -0.454 0 C-N-CA 122.079 1.852 . . . . 72.3 108.395 173.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 33.7 t-80 -94.27 141.54 28.44 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.145 -0.622 . . . . 63.52 109.626 -173.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 38.7 t-80 -54.3 112.68 1.03 Allowed 'General case' 0 C--O 1.238 0.466 0 O-C-N 123.767 0.667 . . . . 70.53 109.684 178.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 31.5 m -64.87 -27.93 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 112.517 0.562 . . . . 74.43 112.517 -174.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 17.5 m 66.2 31.35 8.71 Favored 'General case' 0 CA--C 1.54 0.59 0 O-C-N 123.777 0.673 . . . . 64.04 110.838 175.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.3 mtpt 67.18 -168.17 0.2 Allowed 'General case' 0 C--O 1.243 0.747 0 C-N-CA 124.12 0.968 . . . . 74.31 111.55 -177.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 76.56 -46.08 0.51 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.325 1.45 . . . . 42.41 112.232 179.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.8 p -154.39 144.52 15.66 Favored Pre-proline 0 C--N 1.305 -1.362 0 N-CA-C 109.603 -0.518 . . . . 64.52 109.603 179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -74.1 174.51 12.3 Favored 'Trans proline' 0 C--O 1.243 0.76 0 C-N-CA 122.279 1.986 . . . . 75.05 111.3 177.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -122.53 63.44 0.53 Allowed Glycine 0 N--CA 1.433 -1.528 0 N-CA-C 111.259 -0.736 . . . . 53.23 111.259 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -78.53 158.32 28.59 Favored 'General case' 0 C--O 1.246 0.914 0 N-CA-C 109.237 -0.653 . . . . 62.01 109.237 178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.2 mt 76.47 99.81 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.224 -0.252 0 N-CA-C 108.127 -1.064 . . . . 74.22 108.127 -173.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 28.6 pt20 -66.48 129.49 40.03 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 113.314 0.857 . . . . 54.01 113.314 -174.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -111.22 57.45 0.43 Allowed Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 109.532 -1.427 . . . . 51.12 109.532 175.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 73.9 m -86.61 159.71 19.14 Favored 'General case' 0 N--CA 1.434 -1.253 0 CA-C-N 115.416 -0.392 . . . . 73.22 110.781 -177.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -63.54 135.75 57.06 Favored 'General case' 0 C--N 1.314 -0.942 0 C-N-CA 124.394 1.078 . . . . 63.04 113.688 -175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.405 ' N ' HD12 ' A' ' 63' ' ' LEU . 3.2 mp -105.61 -168.85 1.51 Allowed 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 105.261 -2.126 . . . . 62.34 105.261 175.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 15.0 p-80 -88.47 131.99 34.66 Favored 'General case' 0 C--N 1.306 -1.292 0 C-N-CA 118.465 -1.294 . . . . 60.02 107.705 171.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -77.77 159.17 29.22 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-O 120.506 0.194 . . . . 70.51 111.196 -179.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -58.4 119.31 16.71 Favored Glycine 0 N--CA 1.44 -1.092 0 O-C-N 123.905 0.753 . . . . 75.21 111.697 -179.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -68.48 2.26 2.49 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.176 0.806 . . . . 75.1 113.176 -176.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 24.8 m-90 -82.6 -2.12 52.88 Favored 'General case' 0 C--N 1.308 -1.227 0 CA-C-N 115.621 -0.718 . . . . 74.22 109.23 174.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.68 14.78 39.35 Favored Glycine 0 C--N 1.341 0.817 0 C-N-CA 120.35 -0.929 . . . . 50.34 111.456 -177.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 88.1 m 74.79 -64.8 0.37 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.022 0.929 . . . . 70.13 109.337 -173.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.1 t -71.85 128.67 35.11 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.062 0 N-CA-C 107.79 -1.189 . . . . 65.3 107.79 173.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.36 -0.79 60.11 Favored Glycine 0 N--CA 1.432 -1.58 0 C-N-CA 120.482 -0.866 . . . . 70.24 111.368 -175.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 34.5 t -67.7 131.58 45.85 Favored 'General case' 0 C--O 1.248 1.015 0 N-CA-C 108.823 -0.806 . . . . 63.13 108.823 178.024 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 77.4 mt -130.24 116.39 36.2 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.294 0 CA-C-O 121.326 0.584 . . . . 53.14 110.519 -178.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.3 m -131.03 152.13 37.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.739 0 CA-C-N 115.266 -0.879 . . . . 45.2 108.958 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 44.2 m-85 -121.84 128.42 51.63 Favored 'General case' 0 C--N 1.302 -1.471 0 CA-C-O 120.678 0.275 . . . . 73.24 110.845 179.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 54.6 m0 -107.77 124.12 49.56 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.959 -0.564 . . . . 74.24 110.119 179.056 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.477 ' OD1' HG22 ' A' ' 87' ' ' VAL . 33.4 m-80 -103.21 131.29 50.36 Favored 'General case' 0 CA--C 1.487 -1.451 0 CA-C-N 115.126 -0.943 . . . . 72.4 108.577 175.575 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 43.6 p90 -149.33 165.81 30.88 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 108.954 -0.758 . . . . 74.41 108.954 -176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.7 t -106.71 118.89 55.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 N-CA-C 108.7 -0.852 . . . . 64.2 108.7 178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 63.6 t60 -139.55 128.86 24.04 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.125 -1.065 . . . . 62.1 108.125 -178.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 64.34 28.19 13.72 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.872 1.269 . . . . 73.24 109.321 -174.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.54 -7.27 33.33 Favored Glycine 0 CA--C 1.529 0.954 0 CA-C-N 115.828 -0.624 . . . . 71.23 113.037 -178.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -101.08 149.6 23.79 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 109.248 -0.649 . . . . 73.11 109.248 -178.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -81.39 115.92 20.97 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.768 -1.197 . . . . 70.44 107.768 176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -119.65 142.48 48.41 Favored 'General case' 0 C--N 1.291 -1.976 0 CA-C-N 115.992 -0.549 . . . . 73.01 110.373 -177.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.477 HG22 ' OD1' ' A' ' 78' ' ' ASN . 22.1 t -117.35 144.11 26.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.324 0 N-CA-C 109.22 -0.659 . . . . 70.32 109.22 -175.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.11 138.05 45.04 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.529 -0.915 . . . . 51.11 108.529 177.04 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.492 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 8.7 mptt -120.74 131.21 54.39 Favored 'General case' 0 N--CA 1.434 -1.249 0 N-CA-C 108.493 -0.929 . . . . 74.12 108.493 -177.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -154.86 153.45 31.15 Favored 'General case' 0 N--CA 1.43 -1.444 0 CA-C-O 121.398 0.618 . . . . 71.14 111.892 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 60.2 ttt-85 -136.51 136.75 39.64 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 104.913 -2.254 . . . . 74.11 104.913 169.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.448 HD12 HD11 ' A' ' 102' ' ' ILE . 49.2 mm -79.19 121.72 32.96 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 N-CA-C 108.406 -0.961 . . . . 64.13 108.406 178.348 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.434 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 21.6 mm-40 -99.64 -41.61 7.24 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-O 121.237 0.541 . . . . 63.51 110.397 178.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.02 143.04 16.6 Favored 'General case' 0 C--N 1.308 -1.213 0 N-CA-C 108.745 -0.835 . . . . 50.11 108.745 -177.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.2 p -146.03 125.5 5.65 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.182 0 O-C-N 123.752 0.658 . . . . 72.43 110.19 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.424 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 66.2 mm-40 -114.88 112.23 45.01 Favored Pre-proline 0 C--N 1.294 -1.845 0 N-CA-C 108.997 -0.742 . . . . 72.21 108.997 179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.75 -43.33 3.79 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 121.724 1.616 . . . . 51.41 111.777 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.81 -37.36 35.32 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 112.089 0.403 . . . . 73.21 112.089 -177.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.404 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 98.6 mttt -82.4 -14.06 55.79 Favored 'General case' 0 CA--C 1.505 -0.776 0 C-N-CA 120.809 -0.356 . . . . 74.32 110.658 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.683 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 46.2 t30 54.32 66.7 1.16 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 122.294 1.045 . . . . 64.45 111.043 -176.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 56.9 tp -131.15 137.71 49.13 Favored 'General case' 0 C--N 1.308 -1.198 0 CA-C-N 113.978 -1.464 . . . . 74.21 109.323 -177.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.448 HD11 HD12 ' A' ' 92' ' ' ILE . 4.9 tp -147.81 122.51 2.24 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.419 0 CA-C-O 121.471 0.653 . . . . 72.4 111.567 177.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.434 ' HB ' ' HB2' ' A' ' 93' ' ' GLU . 91.6 m -99.95 125.89 46.03 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.112 -0.949 . . . . 73.12 110.951 176.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 80.6 m-85 -105.53 149.25 26.41 Favored 'General case' 0 C--O 1.245 0.826 0 N-CA-C 108.088 -1.079 . . . . 64.22 108.088 176.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.483 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 41.5 ttt180 -133.33 146.62 51.49 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 122.451 0.3 . . . . 72.0 110.68 -178.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 118' ' ' PHE . 7.2 p -77.18 137.35 22.59 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.393 0 N-CA-C 109.235 -0.654 . . . . 72.13 109.235 173.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.556 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.51 -23.79 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.307 -1.251 0 CA-C-O 121.105 0.479 . . . . 71.34 110.709 177.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.509 ' HG3' ' H ' ' A' ' 110' ' ' ASP . 13.7 tp10 -93.64 146.42 23.84 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 115.511 -0.768 . . . . 75.52 110.164 -175.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.402 ' HA2' ' HB2' ' A' ' 112' ' ' MET . . . -63.68 -17.5 60.37 Favored Glycine 0 CA--C 1.525 0.705 0 CA-C-N 115.871 -0.604 . . . . 42.42 113.933 -179.104 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.509 ' H ' ' HG3' ' A' ' 108' ' ' GLU . 23.5 t70 -53.73 -51.69 62.52 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.291 0.636 . . . . 75.35 112.438 -178.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 97.8 mt -78.36 -24.63 46.32 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.387 0.613 . . . . 74.23 111.823 176.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.544 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.1 mmt -70.6 -8.2 49.82 Favored 'General case' 0 N--CA 1.482 1.147 0 CA-C-N 115.632 -0.713 . . . . 73.22 112.606 -174.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -93.89 1.86 56.28 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-O 121.242 0.544 . . . . 73.33 111.389 178.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -117.76 -39.06 3.17 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.435 -0.95 . . . . 70.54 108.435 175.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.544 ' O ' ' HA ' ' A' ' 112' ' ' MET . 26.2 m-85 -128.74 138.34 52.06 Favored 'General case' 0 C--O 1.201 -1.467 0 N-CA-C 106.481 -1.674 . . . . 62.32 106.481 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 18.2 ptmt -91.75 0.87 57.46 Favored 'General case' 0 C--N 1.289 -2.051 0 CA-C-O 122.003 0.906 . . . . 64.41 110.997 -178.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 42.8 t -167.06 136.84 2.93 Favored 'General case' 0 N--CA 1.435 -1.179 0 N-CA-C 106.493 -1.669 . . . . 63.25 106.493 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.543 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.4 t80 -154.8 119.46 4.83 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-O 121.285 0.564 . . . . 74.01 111.273 -175.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 69.5 mt -125.78 146.42 49.79 Favored 'General case' 0 CA--C 1.471 -2.075 0 CA-C-N 115.403 -0.817 . . . . 74.15 110.374 175.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.543 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.39 125.5 16.34 Favored 'General case' 0 C--N 1.264 -3.137 0 CA-C-N 114.651 -1.159 . . . . 74.0 109.926 177.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 74.5 m -124.96 132.11 53.32 Favored 'General case' 0 C--N 1.283 -2.308 0 CA-C-N 116.115 -0.493 . . . . 63.33 110.185 -178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.453 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 40.4 pt -118.45 142.81 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.711 0 CA-C-O 120.96 0.409 . . . . 74.43 110.499 178.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 51.2 tt0 -142.99 133.46 24.86 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 107.652 -1.24 . . . . 74.33 107.652 175.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.683 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 38.9 t -108.57 131.39 59.3 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 CA-C-N 116.34 -0.391 . . . . 71.54 111.114 -172.066 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.404 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 13.8 t -135.93 151.13 73.33 Favored Pre-proline 0 CA--C 1.556 1.194 0 N-CA-C 107.187 -1.412 . . . . 74.14 107.187 179.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.404 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 13.5 Cg_endo -50.49 154.41 6.32 Favored 'Trans proline' 0 N--CA 1.493 1.445 0 C-N-CA 124.245 3.296 . . . . 55.4 114.629 -178.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.599 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 55.5 mtpt -77.84 151.46 79.46 Favored Pre-proline 0 CA--C 1.508 -0.643 0 CA-C-N 115.547 -0.751 . . . . 75.52 110.899 177.213 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.21 100.36 0.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.896 0 C-N-CA 122.381 2.054 . . . . 72.04 110.099 174.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.4 -28.02 3.88 Favored Glycine 0 N--CA 1.429 -1.816 0 N-CA-C 110.835 -0.906 . . . . 45.23 110.835 -177.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 127.88 -89.38 0.33 Allowed Glycine 0 N--CA 1.436 -1.326 0 C-N-CA 120.312 -0.947 . . . . 44.34 113.92 178.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.504 ' O ' ' HD3' ' A' ' 127' ' ' LYS . 9.9 Cg_endo -46.66 114.32 0.88 Allowed 'Trans proline' 0 C--N 1.363 1.324 0 C-N-CA 124.542 3.495 . . . . 71.43 115.232 -173.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 98.16 -172.26 26.51 Favored Glycine 0 N--CA 1.437 -1.288 0 CA-C-N 115.41 -0.814 . . . . 74.3 111.777 178.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.48 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 35.3 p -154.01 156.78 38.02 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 111.842 0.312 . . . . 61.41 111.842 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.599 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.6 mp -98.63 127.14 51.49 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-O 121.089 0.471 . . . . 73.2 109.732 175.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.4 p -93.79 118.34 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.335 0 N-CA-C 107.858 -1.164 . . . . 44.32 107.858 171.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 81.5 m-70 -89.17 111.84 22.71 Favored 'General case' 0 CA--C 1.48 -1.748 0 CA-C-N 116.135 -0.484 . . . . 74.4 109.86 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 64.6 m95 -90.94 121.83 33.1 Favored 'General case' 0 N--CA 1.419 -1.997 0 N-CA-C 108.493 -0.929 . . . . 75.14 108.493 177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.406 ' HA ' ' HG2' ' A' ' 27' ' ' GLU . 72.4 m-70 -117.09 111.02 18.94 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 106.284 -1.747 . . . . 71.1 106.284 177.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.7 mp -110.21 125.82 53.48 Favored 'General case' 0 C--N 1.293 -1.852 0 N-CA-C 108.41 -0.959 . . . . 74.44 108.41 -179.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -126.0 127.07 45.33 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 106.885 -1.524 . . . . 75.22 106.885 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 30.5 p90 -153.01 159.93 42.95 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 114.099 1.148 . . . . 75.35 114.099 -173.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -111.01 114.63 28.07 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 107.798 -1.186 . . . . 74.33 107.798 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 22' ' ' LEU . 1.2 mptm? -66.55 141.96 57.68 Favored 'General case' 0 CA--C 1.505 -0.78 0 N-CA-C 110.199 -0.297 . . . . 74.45 110.199 177.78 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.463 ' HB ' HG11 ' A' ' 148' ' ' VAL . 69.1 mt -76.91 -35.74 24.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.445 0 N-CA-C 105.726 -1.953 . . . . 73.13 105.726 168.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -169.06 175.18 5.88 Favored 'General case' 0 N--CA 1.417 -2.113 0 N-CA-C 105.243 -2.132 . . . . 71.4 105.243 178.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -73.18 -64.05 1.06 Allowed 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 114.537 1.31 . . . . 72.23 114.537 -176.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.432 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 0.0 OUTLIER -64.73 -20.57 66.41 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 123.165 0.586 . . . . 72.23 112.237 -175.005 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.463 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.5 p -78.6 -27.38 14.03 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 C-N-CA 120.38 -0.528 . . . . 73.24 109.762 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.14 148.49 21.97 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 108.556 -0.905 . . . . 61.51 108.556 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.455 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 82.2 m-70 -138.25 89.95 13.86 Favored Pre-proline 0 C--N 1.309 -1.18 0 N-CA-C 112.891 0.7 . . . . 55.25 112.891 -178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.414 ' HA ' HD12 ' A' ' 154' ' ' LEU . 51.3 Cg_exo -56.51 -24.12 51.51 Favored 'Trans proline' 0 N--CA 1.487 1.115 0 C-N-CA 123.03 2.487 . . . . 72.12 111.512 177.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.455 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.1 pt-20 -59.77 -38.33 81.54 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 114.522 -1.217 . . . . 74.33 112.252 177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.3 p -79.32 -29.45 42.37 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.806 -0.813 . . . . 65.2 108.806 -179.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 151' ' ' PRO . 84.7 mt -63.0 -45.51 92.06 Favored 'General case' 0 CA--C 1.508 -0.654 0 CA-C-N 114.815 -1.084 . . . . 61.23 110.161 -179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.534 ' O ' HG23 ' A' ' 159' ' ' VAL . 73.2 mt -58.41 -44.74 89.17 Favored 'General case' 0 C--O 1.216 -0.675 0 O-C-N 123.3 0.375 . . . . 70.34 111.474 176.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 30.6 mm-40 -62.42 -43.5 98.68 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 116.475 -0.329 . . . . 63.14 111.602 178.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.7 t80 -60.29 -36.43 77.86 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 116.123 -0.49 . . . . 63.01 109.986 178.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 70.8 m -67.2 -45.74 75.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.298 -0.41 . . . . 73.21 110.081 177.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.534 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.0 t -60.55 -48.29 89.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.942 -0.572 . . . . 74.02 111.633 -178.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -63.66 -37.28 86.75 Favored 'General case' 0 C--O 1.243 0.761 0 CA-C-O 120.857 0.36 . . . . 73.23 111.942 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.8 t -72.13 -33.4 46.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 CA-C-N 116.195 -0.457 . . . . 73.12 110.534 177.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 67.3 m -54.36 -35.42 62.75 Favored 'General case' 0 CA--C 1.544 0.724 0 N-CA-C 112.141 0.423 . . . . 74.01 112.141 177.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -68.84 -43.15 76.04 Favored 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 120.411 -0.516 . . . . 74.11 109.923 175.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -56.93 -50.19 73.33 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.514 -0.766 . . . . 74.02 111.029 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -68.89 -43.18 82.59 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.954 0 CA-C-N 115.62 -0.718 . . . . 74.12 110.353 -177.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.48 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 38.0 t70 -64.09 -49.05 73.77 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.371 -0.377 . . . . 73.45 110.948 -178.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 19.8 mm-40 -61.07 -31.88 71.54 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 122.848 0.459 . . . . 63.51 111.264 177.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 13.9 t60 -64.21 -46.16 85.11 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 109.7 -0.482 . . . . 75.4 109.7 178.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.457 ' CD1' ' HA ' ' A' ' 39' ' ' PHE . 3.9 mm? -76.62 -28.45 56.1 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 113.548 0.944 . . . . 73.13 113.548 -179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 33' ' ' LYS . 87.6 mt -82.51 -41.29 19.88 Favored 'General case' 0 C--N 1.307 -1.264 0 C-N-CA 120.023 -0.671 . . . . 73.21 110.331 179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 46.33 72.6 0.22 Allowed 'General case' 0 C--O 1.251 1.151 0 C-N-CA 125.102 1.361 . . . . 64.12 113.808 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -134.52 -158.46 0.88 Allowed 'General case' 0 C--N 1.299 -1.598 0 CA-C-N 113.898 -1.501 . . . . 63.13 107.447 178.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 . . . . . 0 C--N 1.298 -1.651 0 O-C-N 123.187 0.304 . . . . 63.24 111.014 178.329 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.541 0.606 0 CA-C-O 121.106 0.479 . . . . 62.22 110.495 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -134.68 173.16 11.98 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 108.738 -0.838 . . . . 55.22 108.738 179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 70.39 -14.98 0.38 Allowed 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 124.856 1.263 . . . . 42.13 113.436 176.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 11.8 p -72.18 -32.08 66.51 Favored 'General case' 0 N--CA 1.43 -1.433 0 C-N-CA 123.118 0.567 . . . . 55.21 111.129 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 21.5 m -84.27 -5.5 59.27 Favored 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.992 -0.549 . . . . 64.44 110.907 178.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 82.5 mt -80.71 19.03 0.87 Allowed 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 121.293 0.568 . . . . 75.32 111.077 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.58 133.72 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.559 0 N-CA-C 108.328 -0.99 . . . . 71.24 108.328 174.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.67 168.1 24.84 Favored Glycine 0 N--CA 1.418 -2.513 0 C-N-CA 121.008 -0.615 . . . . 65.42 112.154 -176.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.449 ' HB3' ' HE2' ' A' ' 25' ' ' LYS . 51.1 mtpt -129.34 157.62 41.39 Favored 'General case' 0 C--N 1.292 -1.932 0 C-N-CA 122.949 0.5 . . . . 75.53 110.954 -178.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.0 tp -151.65 134.91 15.97 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 107.993 -1.114 . . . . 71.32 107.993 166.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -132.49 143.37 49.72 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 110.222 -0.288 . . . . 65.25 110.222 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.6 t -152.17 165.13 35.76 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.923 -1.139 . . . . 61.35 107.923 179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -133.55 128.53 35.46 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 109.093 -0.706 . . . . 71.54 109.093 177.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 67.3 t -114.51 144.0 23.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 N-CA-C 108.463 -0.94 . . . . 74.02 108.463 -179.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.447 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.2 mp0 -95.16 133.59 38.83 Favored 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 108.657 -0.868 . . . . 75.45 108.657 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.594 ' O ' ' HA3' ' A' ' 132' ' ' GLY . 34.9 pt -105.83 152.96 7.41 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.907 0 N-CA-C 106.883 -1.525 . . . . 54.3 106.883 171.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.45 ' HB2' HD11 ' A' ' 170' ' ' LEU . 58.3 mttp -89.61 -8.71 51.97 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.465 0.65 . . . . 74.45 110.003 -175.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.34 160.75 15.33 Favored 'General case' 0 C--N 1.306 -1.325 0 CA-C-N 115.484 -0.78 . . . . 53.14 111.744 -177.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 46.2 t -75.62 148.06 39.06 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.26 -0.882 . . . . 34.53 109.938 178.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -64.5 -24.4 67.6 Favored 'General case' 0 C--O 1.244 0.774 0 CA-C-N 115.841 -0.618 . . . . 63.03 109.939 178.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 15.9 t70 -60.02 -37.28 79.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.501 -0.772 . . . . 64.42 110.187 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.429 ' O ' ' HB3' ' A' ' 41' ' ' HIS . 57.9 mttp -69.81 -35.55 74.92 Favored 'General case' 0 CA--C 1.51 -0.566 0 N-CA-C 112.614 0.598 . . . . 65.13 112.614 178.611 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -68.61 -40.67 80.32 Favored 'General case' 0 C--N 1.315 -0.935 0 N-CA-C 108.531 -0.914 . . . . 65.02 108.531 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.441 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 5.2 t60 -64.51 -33.04 74.96 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 115.135 -0.939 . . . . 73.21 108.51 176.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.429 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 63.1 t-80 -63.43 -35.2 79.65 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 114.838 -1.074 . . . . 74.41 110.631 -177.156 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.19 -23.63 60.44 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.182 0.515 . . . . 72.11 111.508 -176.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -96.44 3.36 52.86 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.156 -0.475 . . . . 63.11 110.788 177.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -115.75 -50.83 2.68 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 116.045 -0.525 . . . . 72.24 110.733 -179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -127.21 -146.37 6.43 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 111.509 -0.636 . . . . 73.33 111.509 -178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.448 ' N ' ' HD2' ' A' ' 46' ' ' LYS . 9.8 mptt -108.21 156.21 38.84 Favored Pre-proline 0 C--N 1.313 -0.988 0 N-CA-C 109.348 -0.612 . . . . 63.22 109.348 -179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -68.44 118.96 6.0 Favored 'Trans proline' 0 C--O 1.241 0.641 0 C-N-CA 122.182 1.921 . . . . 73.44 109.033 173.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -116.37 127.1 54.35 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.819 -0.808 . . . . 72.11 108.819 -176.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 6.1 p-80 -92.07 163.89 13.8 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 112.427 0.528 . . . . 71.01 112.427 -175.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.3 p -67.78 128.12 30.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 CA-C-N 115.285 -0.87 . . . . 52.51 110.309 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.7 t -164.12 -43.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 109.901 -0.407 . . . . 75.51 109.901 -178.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.2 ttpt 70.34 145.69 0.06 Allowed 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.123 0.969 . . . . 64.42 111.115 -178.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 58.99 73.33 0.49 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 122.073 0.939 . . . . 61.35 111.411 -177.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 33.7 m -138.65 164.7 38.01 Favored Pre-proline 0 C--N 1.293 -1.876 0 N-CA-C 106.632 -1.618 . . . . 73.05 106.632 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -62.11 152.62 74.67 Favored 'Trans proline' 0 C--O 1.247 0.928 0 C-N-CA 121.634 1.556 . . . . 74.12 110.967 176.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -88.1 -135.3 4.92 Favored Glycine 0 N--CA 1.437 -1.277 0 C-N-CA 120.965 -0.636 . . . . 54.02 111.968 -179.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 27.7 t-20 -81.09 104.93 11.91 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-O 121.074 0.464 . . . . 74.34 110.805 -178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.3 pt -140.18 174.05 9.14 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.087 0 N-CA-C 108.32 -0.992 . . . . 61.05 108.32 177.456 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 29.4 pt20 -84.28 147.32 27.29 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.907 -0.775 . . . . 61.21 108.907 175.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 113.8 113.38 3.09 Favored Glycine 0 C--N 1.298 -1.552 0 C-N-CA 120.372 -0.918 . . . . 65.52 110.86 -177.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 46.1 t -94.11 153.83 17.92 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 120.903 0.382 . . . . 70.35 110.215 -178.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -100.82 -10.85 20.35 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 120.992 0.425 . . . . 63.54 111.26 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -148.19 92.83 2.08 Favored 'General case' 0 C--N 1.31 -1.152 0 CA-C-O 121.198 0.523 . . . . 73.23 110.512 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -85.51 114.33 22.45 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.555 0.693 . . . . 62.25 111.806 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -93.32 169.85 10.06 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-N 115.174 -0.921 . . . . 75.31 109.365 179.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -85.13 59.89 4.83 Favored Glycine 0 C--N 1.314 -0.658 0 C-N-CA 120.971 -0.633 . . . . 62.05 112.333 -178.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -83.78 158.42 21.73 Favored 'General case' 0 C--N 1.307 -1.244 0 C-N-CA 122.557 0.343 . . . . 62.5 110.504 -178.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 11.2 m95 -98.59 -17.13 18.81 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.814 -0.439 . . . . 75.01 109.814 176.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.26 -10.8 67.52 Favored Glycine 0 C--O 1.243 0.689 0 CA-C-N 115.852 -0.613 . . . . 32.14 113.687 175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.7 p -140.19 170.45 15.82 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 122.915 0.486 . . . . 74.04 111.085 -177.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 44.5 t -66.82 140.57 19.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 N-CA-C 108.283 -1.006 . . . . 75.05 108.283 178.442 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 105.5 -0.42 39.97 Favored Glycine 0 C--N 1.309 -0.954 0 N-CA-C 110.621 -0.992 . . . . 61.2 110.621 -175.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.485 ' HB3' HD12 ' A' ' 92' ' ' ILE . 36.8 t -60.42 146.97 42.59 Favored 'General case' 0 C--O 1.249 1.046 0 C-N-CA 123.967 0.907 . . . . 64.11 110.664 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.5 mt -130.38 116.18 34.94 Favored 'Isoleucine or valine' 0 C--O 1.246 0.895 0 C-N-CA 123.821 0.848 . . . . 61.54 109.444 177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 93.3 t -132.82 140.49 47.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 N-CA-C 109.046 -0.724 . . . . 65.34 109.046 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.403 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 39.3 m-85 -111.27 138.68 47.43 Favored 'General case' 0 N--CA 1.426 -1.675 0 C-N-CA 120.33 -0.548 . . . . 71.4 111.591 -178.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.442 ' CZ3' ' HG2' ' A' ' 90' ' ' GLU . 7.5 m-90 -108.22 134.73 50.65 Favored 'General case' 0 C--N 1.3 -1.574 0 CA-C-N 115.376 -0.829 . . . . 73.54 108.894 176.168 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' A' ' 86' ' ' LYS . 11.8 m120 -121.09 131.83 54.51 Favored 'General case' 0 C--N 1.304 -1.396 0 CA-C-N 116.095 -0.502 . . . . 70.2 109.825 -178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 48.4 p90 -137.42 157.49 46.46 Favored 'General case' 0 C--N 1.295 -1.803 0 N-CA-C 108.284 -1.006 . . . . 73.32 108.284 177.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 47.7 t -108.14 123.96 64.07 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 C-N-CA 120.188 -0.605 . . . . 72.04 112.347 -172.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 31.1 t60 -142.3 131.41 23.26 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 107.145 -1.428 . . . . 73.44 107.145 177.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 51.4 m-20 61.75 28.39 17.46 Favored 'General case' 0 N--CA 1.499 1.985 0 C-N-CA 124.79 1.236 . . . . 71.31 110.552 -175.547 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.56 -1.62 61.01 Favored Glycine 0 N--CA 1.441 -1.01 0 CA-C-N 115.557 -0.747 . . . . 61.43 113.022 -179.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -101.48 153.08 20.02 Favored 'General case' 0 CA--C 1.483 -1.606 0 CA-C-N 117.122 0.461 . . . . 60.02 109.977 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -91.93 120.05 32.25 Favored 'General case' 0 C--N 1.279 -2.486 0 CA-C-N 115.307 -0.86 . . . . 72.43 108.691 175.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 78' ' ' ASN . 4.5 mptp? -94.7 146.47 24.14 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 108.751 -0.833 . . . . 70.3 108.751 178.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.449 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 60.2 t -121.27 142.35 37.84 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-N 116.164 -0.471 . . . . 72.21 110.956 -173.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.0 116.18 31.49 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 106.436 -1.69 . . . . 40.5 106.436 174.662 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.474 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 6.0 mptt -102.47 125.34 49.16 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 108.203 -1.036 . . . . 71.31 108.203 -174.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.442 ' HG2' ' CZ3' ' A' ' 77' ' ' TRP . 0.0 OUTLIER -150.52 153.76 36.39 Favored 'General case' 0 N--CA 1.443 -0.806 0 CA-C-O 120.94 0.4 . . . . 61.42 111.805 -173.305 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 2.7 tmt_? -138.55 123.52 18.95 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 105.018 -2.216 . . . . 63.44 105.018 175.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.485 HD12 ' HB3' ' A' ' 73' ' ' SER . 54.7 mt -66.71 122.03 16.95 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 C-N-CA 119.54 -0.864 . . . . 71.43 109.144 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.4 tp10 -96.6 -41.63 8.44 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 109.327 -0.62 . . . . 73.15 109.327 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.21 147.0 21.95 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 107.952 -1.129 . . . . 72.31 107.952 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -146.91 142.79 20.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 110.266 -0.272 . . . . 70.13 110.266 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.453 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 5.5 tp10 -125.47 105.27 27.66 Favored Pre-proline 0 N--CA 1.432 -1.329 0 N-CA-C 104.739 -2.319 . . . . 74.11 104.739 172.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -66.67 -29.4 43.36 Favored 'Trans proline' 0 CA--C 1.515 -0.466 0 C-N-CA 122.276 1.984 . . . . 73.35 111.38 -179.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.441 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 28.5 t70 -79.45 -34.29 41.71 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.029 -0.987 . . . . 74.11 111.808 -178.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 88.8 mttt -99.27 6.93 46.08 Favored 'General case' 0 C--N 1.311 -1.082 0 N-CA-C 112.777 0.658 . . . . 74.01 112.777 -175.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 57.48 45.25 19.96 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 123.451 0.469 . . . . 70.54 110.27 -178.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.1 136.27 53.69 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.005 -0.543 . . . . 73.13 109.953 -175.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.4 HG23 HG12 ' A' ' 122' ' ' ILE . 5.6 tp -149.38 122.85 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.238 0 CA-C-O 121.523 0.678 . . . . 71.54 111.592 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 91.6 m -101.2 121.02 41.1 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.075 -0.966 . . . . 70.3 110.724 176.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -103.47 130.55 50.86 Favored 'General case' 0 C--N 1.321 -0.664 0 C-N-CA 124.165 0.986 . . . . 75.45 109.906 -179.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.6 ttm180 -109.23 122.74 47.98 Favored 'General case' 0 C--N 1.311 -1.099 0 N-CA-C 107.738 -1.208 . . . . 75.1 107.738 170.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 74.5 t -79.12 123.69 36.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 N-CA-C 107.615 -1.254 . . . . 63.14 107.615 176.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.594 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -106.85 -27.02 3.12 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.327 0 N-CA-C 112.562 0.579 . . . . 74.23 112.562 -174.127 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.419 ' HG2' ' N ' ' A' ' 109' ' ' GLY . 33.1 tt0 -138.56 168.38 19.91 Favored 'General case' 0 C--N 1.298 -1.633 0 N-CA-C 108.855 -0.795 . . . . 61.24 108.855 -172.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.419 ' N ' ' HG2' ' A' ' 108' ' ' GLU . . . 103.98 -179.12 25.02 Favored Glycine 0 N--CA 1.397 -3.965 0 CA-C-O 122.21 0.895 . . . . 71.32 114.346 172.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -57.38 -30.04 64.57 Favored 'General case' 0 C--N 1.288 -2.081 0 C-N-CA 126.863 2.065 . . . . 72.05 112.106 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 93.4 mt -66.82 -29.15 69.01 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 116.503 -0.317 . . . . 74.21 111.601 -178.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.427 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 3.0 mmt -81.22 -11.92 59.28 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.325 0.491 . . . . 75.24 112.325 -178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.91 -2.99 33.33 Favored 'General case' 0 N--CA 1.438 -1.027 0 C-N-CA 119.718 -0.793 . . . . 73.35 110.998 176.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -101.58 -44.08 5.69 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 107.786 -1.191 . . . . 72.13 107.786 174.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.496 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 36.3 m-85 -120.26 139.4 52.75 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.361 -1.348 . . . . 74.31 107.361 -178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.502 ' HB3' HG12 ' A' ' 144' ' ' ILE . 11.5 ptmm? -86.9 3.01 47.28 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-O 121.44 0.638 . . . . 74.44 112.058 -178.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -170.6 141.44 1.89 Allowed 'General case' 0 N--CA 1.431 -1.386 0 N-CA-C 108.127 -1.064 . . . . 64.12 108.127 174.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -156.51 117.18 3.69 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-O 121.283 0.563 . . . . 52.4 109.577 -179.999 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 41.8 tp -132.66 129.07 38.35 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 107.623 -1.251 . . . . 75.35 107.623 -178.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -133.68 131.97 40.14 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 120.219 -0.593 . . . . 75.0 111.515 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.412 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 57.0 m -116.16 131.92 56.8 Favored 'General case' 0 C--N 1.292 -1.912 0 CA-C-N 115.844 -0.616 . . . . 71.01 109.901 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.4 HG12 HG23 ' A' ' 102' ' ' ILE . 34.9 pt -122.8 149.29 26.41 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.253 0 N-CA-C 109.74 -0.467 . . . . 64.1 109.74 177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 62.0 tt0 -144.31 135.08 24.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.894 -0.78 . . . . 75.33 108.894 176.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 66.1 t -94.63 126.12 47.11 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 108.481 -0.933 . . . . 75.02 108.481 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 38.6 m -133.75 142.54 44.09 Favored Pre-proline 0 C--N 1.292 -1.909 0 N-CA-C 109.229 -0.656 . . . . 75.1 109.229 -174.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_exo -48.01 122.42 7.26 Favored 'Trans proline' 0 C--N 1.356 0.961 0 C-N-CA 122.663 2.242 . . . . 64.52 110.182 173.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.66 ' CB ' HG12 ' A' ' 134' ' ' ILE . 0.0 OUTLIER -64.3 141.08 98.09 Favored Pre-proline 0 C--N 1.317 -0.807 0 N-CA-C 112.155 0.428 . . . . 74.1 112.155 -176.098 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 127' ' ' LYS . 18.6 Cg_exo -69.03 -24.33 33.12 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.242 1.962 . . . . 61.51 109.957 175.117 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -169.16 150.63 15.89 Favored Glycine 0 N--CA 1.432 -1.61 0 N-CA-C 108.618 -1.793 . . . . 72.3 108.618 177.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 112.9 -170.02 13.22 Favored Glycine 0 C--N 1.303 -1.261 0 C-N-CA 120.31 -0.948 . . . . 75.13 111.73 179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -96.43 166.74 1.14 Allowed 'Trans proline' 0 CA--C 1.543 0.927 0 C-N-CA 123.022 2.482 . . . . 71.4 113.508 -179.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 32' ' ' ILE . . . 55.67 -103.73 0.25 Allowed Glycine 0 C--N 1.335 0.479 0 CA-C-N 115.352 -0.84 . . . . 73.14 115.006 174.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 18.0 m -155.49 156.57 35.48 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 108.209 -1.034 . . . . 74.04 108.209 -179.277 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.66 HG12 ' CB ' ' A' ' 127' ' ' LYS . 21.5 mm -98.35 133.58 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.088 0 C-N-CA 119.224 -0.99 . . . . 64.34 109.644 176.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.2 p -106.85 118.37 54.47 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.925 0 N-CA-C 109.547 -0.538 . . . . 74.31 109.547 173.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -89.64 112.53 23.8 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.685 -0.689 . . . . 64.34 110.929 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.3 m95 -94.2 125.4 38.81 Favored 'General case' 0 C--N 1.307 -1.268 0 CA-C-N 115.603 -0.726 . . . . 72.23 109.918 179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 69.6 m-70 -120.64 111.9 18.22 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.111 -1.44 . . . . 73.4 107.111 177.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.452 HD22 ' HB3' ' A' ' 154' ' ' LEU . 3.8 mp -113.17 126.25 55.23 Favored 'General case' 0 C--N 1.295 -1.803 0 CA-C-O 120.722 0.296 . . . . 72.11 110.345 -175.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -128.02 127.76 43.76 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.387 -0.968 . . . . 61.31 108.387 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 14.3 p90 -151.28 165.08 35.09 Favored 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 116.206 -0.452 . . . . 74.34 111.848 -172.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' OE1' ' HG3' ' A' ' 116' ' ' LYS . 45.0 tt0 -127.68 124.04 36.97 Favored 'General case' 0 C--N 1.297 -1.703 0 N-CA-C 108.982 -0.747 . . . . 72.3 108.982 -176.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.425 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -74.16 138.28 43.71 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.729 -0.214 . . . . 65.22 111.299 -178.412 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.502 HG12 ' HB3' ' A' ' 116' ' ' LYS . 64.6 mt -72.82 -35.82 50.57 Favored 'Isoleucine or valine' 0 C--O 1.239 0.504 0 N-CA-C 106.871 -1.529 . . . . 75.44 106.871 170.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.527 ' HB3' HG23 ' A' ' 148' ' ' VAL . 35.1 t -166.09 160.56 16.48 Favored 'General case' 0 N--CA 1.408 -2.543 0 N-CA-C 104.629 -2.36 . . . . 74.24 104.629 174.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -75.08 -44.54 46.89 Favored 'General case' 0 C--N 1.293 -1.849 0 CA-C-O 120.776 0.322 . . . . 73.51 111.297 -172.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -61.04 -20.11 62.16 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.777 0.799 . . . . 65.24 110.453 178.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.527 HG23 ' HB3' ' A' ' 145' ' ' SER . 62.1 t -87.42 -33.39 6.73 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 CA-C-N 114.95 -1.023 . . . . 70.02 111.356 -175.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.496 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -95.37 139.59 31.45 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.226 -0.443 . . . . 65.21 111.716 -174.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 22.2 m-70 -133.95 90.53 26.56 Favored Pre-proline 0 C--N 1.318 -0.795 0 CA-C-N 116.438 -0.347 . . . . 62.2 111.509 -179.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -54.06 -14.34 5.96 Favored 'Trans proline' 0 N--CA 1.501 1.943 0 C-N-CA 124.516 3.477 . . . . 64.43 114.007 -178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -52.58 -45.29 66.4 Favored 'General case' 0 C--O 1.244 0.779 0 C-N-CA 124.799 1.24 . . . . 61.22 109.332 178.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 73.0 p -68.36 -30.89 69.94 Favored 'General case' 0 N--CA 1.415 -2.2 0 CA-C-N 112.64 -2.073 . . . . 73.12 111.621 -172.341 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.452 ' HB3' HD22 ' A' ' 139' ' ' LEU . 9.9 mp -66.43 -37.08 84.38 Favored 'General case' 0 C--N 1.309 -1.185 0 N-CA-C 112.512 0.56 . . . . 73.22 112.512 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.44 ' O ' HG23 ' A' ' 159' ' ' VAL . 80.4 mt -62.9 -46.52 87.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.014 0.435 . . . . 73.13 110.383 177.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.46 ' O ' ' HG2' ' A' ' 160' ' ' GLU 0.344 0.0 OUTLIER -72.31 -30.05 64.42 Favored 'General case' 0 N--CA 1.438 -1.05 0 N-CA-C 113.011 0.745 . . . . 64.53 113.011 178.812 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 70.5 t80 -60.15 -37.92 81.59 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.322 -0.621 . . . . 70.01 109.322 173.122 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 76.2 m -62.97 -43.66 98.18 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.98 -0.748 . . . . 62.24 108.98 175.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.469 ' O ' ' HD3' ' A' ' 163' ' ' LYS . 80.5 t -57.04 -47.13 84.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-N 115.386 -0.824 . . . . 72.21 110.355 178.232 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.46 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.2 mm-40 -51.73 -49.8 61.85 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.35 0.66 . . . . 73.3 111.698 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.431 ' O ' HG22 ' A' ' 165' ' ' ILE . 59.0 t -71.48 -35.04 55.24 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.783 -0.644 . . . . 43.35 110.732 -178.622 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 59.6 m -52.8 -50.18 64.14 Favored 'General case' 0 C--O 1.216 -0.707 0 N-CA-C 113.128 0.788 . . . . 60.24 113.128 -178.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.496 ' H ' ' HD3' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -67.44 -37.75 83.47 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 119.82 -0.752 . . . . 62.53 110.863 -178.567 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -58.81 -50.01 75.58 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.269 -0.878 . . . . 73.35 110.239 -176.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.519 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -75.65 -46.24 36.95 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.662 -0.699 . . . . 62.12 111.811 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -55.65 -52.47 63.71 Favored 'General case' 0 N--CA 1.485 1.303 0 C-N-CA 123.729 0.812 . . . . 74.32 112.146 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -69.57 -30.09 67.8 Favored 'General case' 0 CA--C 1.501 -0.928 0 N-CA-C 112.06 0.393 . . . . 71.05 112.06 179.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 23.5 t60 -69.12 -32.37 71.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.425 -0.583 . . . . 72.2 109.425 177.514 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 93.1 mt -76.26 -45.15 34.07 Favored 'General case' 0 CA--C 1.515 -0.402 0 CA-C-N 116.438 -0.346 . . . . 64.31 110.5 177.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.45 HD11 ' HB2' ' A' ' 33' ' ' LYS . 92.1 mt -68.31 -43.03 78.53 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.571 -0.452 . . . . 63.13 110.297 -179.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 38.24 86.93 0.01 OUTLIER 'General case' 0 C--O 1.246 0.908 0 C-N-CA 126.016 1.726 . . . . 55.11 115.056 176.414 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -100.82 137.72 38.83 Favored 'General case' 0 CA--C 1.5 -0.972 0 CA-C-O 121.573 0.702 . . . . 62.01 110.493 178.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 . . . . . 0 C--N 1.273 -2.726 0 CA-C-N 114.955 -1.02 . . . . 73.15 108.625 -177.829 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 49.1 m . . . . . 0 N--CA 1.421 -1.902 0 N-CA-C 108.113 -1.069 . . . . 61.3 108.113 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -94.87 179.45 5.23 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.901 -1.045 . . . . 65.22 110.566 -176.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 64.44 33.21 11.32 Favored 'General case' 0 C--O 1.218 -0.601 0 O-C-N 124.296 0.998 . . . . 70.32 108.767 -176.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.9 m -59.2 -28.34 66.55 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 114.282 -1.326 . . . . 62.31 112.132 -177.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 42.5 t -75.93 -15.46 60.18 Favored 'General case' 0 N--CA 1.44 -0.945 0 C-N-CA 120.96 -0.296 . . . . 65.45 110.457 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 96.2 mt 56.69 15.38 2.14 Favored 'General case' 0 C--N 1.344 0.364 0 C-N-CA 125.472 1.509 . . . . 73.21 113.762 -178.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 90.5 t -93.66 115.31 32.16 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 N-CA-C 108.01 -1.107 . . . . 74.13 108.01 177.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -118.56 143.57 17.59 Favored Glycine 0 C--N 1.269 -3.177 0 N-CA-C 110.501 -1.04 . . . . 35.34 110.501 -177.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.8 ptmt -147.86 152.5 37.72 Favored 'General case' 0 C--N 1.265 -3.1 0 O-C-N 122.862 -0.199 . . . . 55.01 110.656 -178.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.573 HD23 ' N ' ' A' ' 27' ' ' GLU . 5.5 tt -152.71 143.76 23.05 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 106.904 -1.517 . . . . 63.42 106.904 179.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.573 ' N ' HD23 ' A' ' 26' ' ' LEU . 38.8 tt0 -132.37 125.12 30.11 Favored 'General case' 0 C--N 1.291 -1.973 0 CA-C-O 121.091 0.472 . . . . 75.03 109.882 -179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.0 t -130.49 169.45 15.53 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 109.383 -0.599 . . . . 73.5 109.383 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -136.04 125.44 24.96 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.988 -1.116 . . . . 72.15 107.988 178.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 92.7 t -114.55 130.92 68.08 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.914 0 N-CA-C 108.755 -0.831 . . . . 71.42 108.755 179.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -92.33 135.15 34.26 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 108.526 -0.916 . . . . 75.25 108.526 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.549 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -114.87 169.18 5.97 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 CA-C-N 116.539 -0.301 . . . . 72.41 110.782 -178.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -80.31 -38.23 31.09 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 107.547 -1.279 . . . . 74.12 107.547 179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.406 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -69.03 160.98 29.96 Favored 'General case' 0 N--CA 1.436 -1.153 0 CA-C-N 114.121 -1.4 . . . . 72.44 113.288 -176.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 18.0 m -104.18 148.06 26.74 Favored 'General case' 0 N--CA 1.424 -1.731 0 CA-C-N 114.667 -1.151 . . . . 71.03 109.872 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -56.77 -32.95 66.13 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.309 1.043 . . . . 60.53 112.045 -179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.1 -31.42 71.11 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.134 -0.485 . . . . 72.04 111.52 177.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -76.64 -33.18 58.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.611 0.243 . . . . 62.54 110.908 178.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -63.28 -46.25 87.68 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 108.423 -0.955 . . . . 74.2 108.423 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.418 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 6.1 t60 -63.31 -44.35 95.22 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 114.696 -1.138 . . . . 72.22 109.221 177.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 77.3 t60 -63.24 -44.46 95.16 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.167 -0.924 . . . . 71.14 113.053 -178.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.7 ptt? -67.87 -31.84 71.93 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.728 -0.389 . . . . 75.45 111.491 -175.767 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.4 t80 -72.07 -23.44 61.35 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 121.229 0.537 . . . . 72.0 110.139 -179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -89.53 11.51 19.3 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.981 -0.554 . . . . 53.1 111.036 -179.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -163.94 -151.7 6.6 Favored Glycine 0 N--CA 1.438 -1.181 0 N-CA-C 111.587 -0.605 . . . . 71.23 111.587 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.0 155.82 60.42 Favored Pre-proline 0 C--N 1.301 -1.509 0 N-CA-C 108.851 -0.796 . . . . 65.3 108.851 177.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -75.71 145.65 29.33 Favored 'Trans proline' 0 C--O 1.257 1.436 0 N-CA-C 108.621 -1.338 . . . . 73.04 108.621 172.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -66.87 -49.65 64.99 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 108.915 -0.772 . . . . 75.21 108.915 177.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 63.23 -80.18 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.688 0 C-N-CA 124.435 1.094 . . . . 51.32 112.048 176.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -145.64 145.42 20.41 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 C-N-CA 123.149 0.58 . . . . 74.53 110.001 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.3 t -103.06 115.86 31.4 Favored 'General case' 0 N--CA 1.42 -1.926 0 N-CA-C 106.957 -1.497 . . . . 62.42 106.957 176.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.423 ' HE3' ' HB2' ' A' ' 52' ' ' LYS . 49.7 mtmt -121.88 176.37 5.8 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 120.833 0.349 . . . . 74.35 111.005 -176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -94.52 90.96 6.38 Favored 'General case' 0 N--CA 1.43 -1.457 0 N-CA-C 108.728 -0.841 . . . . 30.22 108.728 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.1 t -131.98 104.3 14.06 Favored Pre-proline 0 N--CA 1.426 -1.631 0 N-CA-C 108.003 -1.11 . . . . 72.32 108.003 -177.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -62.4 -36.66 65.33 Favored 'Trans proline' 0 C--N 1.348 0.524 0 C-N-CA 122.988 2.458 . . . . 74.41 112.005 -179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -98.23 -139.14 10.6 Favored Glycine 0 N--CA 1.43 -1.732 0 N-CA-C 110.712 -0.955 . . . . 64.04 110.712 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.9 t30 61.03 28.93 18.66 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-O 121.956 0.884 . . . . 75.51 109.247 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 49.5 mm -73.6 112.33 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 CA-C-N 115.487 -0.779 . . . . 64.43 110.419 -176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 71.77 -62.03 0.47 Allowed 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.583 1.153 . . . . 53.44 113.108 176.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 133.6 104.11 0.85 Allowed Glycine 0 N--CA 1.434 -1.489 0 N-CA-C 110.072 -1.211 . . . . 61.13 110.072 -175.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 55.6 m -73.89 -18.64 60.89 Favored 'General case' 0 C--N 1.304 -1.413 0 CA-C-O 121.223 0.535 . . . . 72.44 111.034 -177.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -89.52 0.25 57.02 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.709 -0.678 . . . . 63.5 112.346 -177.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 3.3 pp -114.59 145.22 42.24 Favored 'General case' 0 C--N 1.317 -0.831 0 C-N-CA 120.413 -0.515 . . . . 74.01 111.253 178.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -146.18 -29.48 0.4 Allowed 'General case' 0 C--N 1.31 -1.117 0 CA-C-N 116.579 -0.282 . . . . 64.23 110.695 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 80.54 118.85 0.05 Allowed 'General case' 0 CA--C 1.508 -0.65 0 C-N-CA 125.592 1.557 . . . . 75.44 109.076 -174.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 91.74 9.08 63.07 Favored Glycine 0 N--CA 1.427 -1.966 0 N-CA-C 109.132 -1.587 . . . . 44.33 109.132 -171.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -99.17 -45.25 5.97 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.328 -0.436 . . . . 72.14 110.643 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 17.6 t-105 -106.39 -5.39 19.03 Favored 'General case' 0 CA--C 1.55 0.971 0 CA-C-O 122.243 1.02 . . . . 73.32 109.173 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.9 -14.29 59.03 Favored Glycine 0 CA--C 1.521 0.416 0 N-CA-C 117.316 1.686 . . . . 72.41 117.316 168.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 52.5 m 60.42 -75.94 0.02 OUTLIER 'General case' 0 CA--C 1.569 1.675 0 CA-C-N 118.402 1.101 . . . . 75.22 111.489 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.6 t -73.09 121.49 23.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 107.094 -1.447 . . . . 71.11 107.094 170.441 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.2 -2.04 61.05 Favored Glycine 0 C--N 1.297 -1.591 0 C-N-CA 119.94 -1.124 . . . . 60.12 110.585 -175.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 48.5 t -64.48 142.66 58.34 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 109.575 -0.528 . . . . 55.14 109.575 178.227 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 78.2 mt -116.0 116.84 53.61 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.358 0 CA-C-N 115.762 -0.654 . . . . 62.41 109.686 177.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.3 m -134.14 147.66 30.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 107.194 -1.41 . . . . 64.01 107.194 179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.62 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 24.5 m-85 -125.93 151.41 47.0 Favored 'General case' 0 C--N 1.308 -1.213 0 O-C-N 123.594 0.559 . . . . 75.02 111.501 -176.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.0 m-90 -107.5 136.43 47.29 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.952 -0.567 . . . . 72.44 110.412 176.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.435 HD22 HG22 ' A' ' 87' ' ' VAL . 26.3 t-20 -117.65 131.67 56.61 Favored 'General case' 0 C--N 1.303 -1.425 0 N-CA-C 107.842 -1.169 . . . . 72.03 107.842 175.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 33.6 p90 -153.17 170.34 20.78 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.313 -0.625 . . . . 74.42 109.313 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.7 t -111.94 128.1 68.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 N-CA-C 108.694 -0.854 . . . . 65.4 108.694 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 71.9 t60 -138.25 115.04 10.68 Favored 'General case' 0 C--N 1.305 -1.357 0 N-CA-C 109.415 -0.587 . . . . 73.55 109.415 -179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.6 m-20 64.21 29.23 13.94 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 125.065 1.346 . . . . 72.44 111.155 -177.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.96 -11.0 73.44 Favored Glycine 0 N--CA 1.443 -0.863 0 CA-C-N 115.372 -0.831 . . . . 55.44 113.517 179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -94.32 146.36 24.09 Favored 'General case' 0 CA--C 1.491 -1.326 0 CA-C-N 117.406 0.603 . . . . 51.12 111.08 178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.27 116.47 22.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 106.529 -1.656 . . . . 51.23 106.529 173.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 4.6 mtpm? -118.23 136.68 53.51 Favored 'General case' 0 N--CA 1.418 -2.059 0 CA-C-O 120.766 0.317 . . . . 70.3 110.259 -175.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.435 HG22 HD22 ' A' ' 78' ' ' ASN . 59.8 t -115.55 140.87 35.02 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.565 0 N-CA-C 108.979 -0.748 . . . . 44.11 108.979 -177.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -106.63 138.4 42.88 Favored 'General case' 0 C--N 1.28 -2.435 0 N-CA-C 106.313 -1.736 . . . . 71.13 106.313 179.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.62 ' HA ' ' CD1' ' A' ' 76' ' ' PHE . 97.1 mttt -125.86 120.49 30.61 Favored 'General case' 0 N--CA 1.429 -1.498 0 CA-C-O 121.257 0.551 . . . . 54.03 111.08 -176.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -152.91 170.91 19.21 Favored 'General case' 0 N--CA 1.415 -2.213 0 CA-C-N 115.376 -0.829 . . . . 72.32 111.865 -174.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 65.3 ttt-85 -133.36 141.41 47.9 Favored 'General case' 0 C--N 1.294 -1.811 0 N-CA-C 107.365 -1.346 . . . . 75.11 107.365 178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 48.2 mm -73.94 122.98 28.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.231 0 N-CA-C 108.827 -0.805 . . . . 73.34 108.827 176.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -97.29 -39.71 9.1 Favored 'General case' 0 C--N 1.309 -1.156 0 C-N-CA 120.582 -0.447 . . . . 73.05 110.094 -178.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.56 140.16 16.95 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 108.701 -0.851 . . . . 74.41 108.701 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.9 124.38 3.57 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.208 0 CA-C-O 121.192 0.52 . . . . 74.21 111.38 -179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 50.8 mm-40 -114.09 107.02 52.56 Favored Pre-proline 0 C--N 1.304 -1.38 0 CA-C-N 115.625 -0.716 . . . . 72.53 109.796 179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -68.36 -36.35 16.08 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 122.461 2.108 . . . . 62.35 111.236 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 17.7 m-20 -80.15 -35.49 36.53 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 112.554 0.576 . . . . 74.53 112.554 -179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -93.65 1.14 56.71 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 112.762 0.653 . . . . 75.23 112.762 -178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.457 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 79.4 m-20 58.01 43.22 21.44 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 123.381 0.672 . . . . 73.12 111.201 178.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.47 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.9 tt -119.02 141.88 48.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-N 116.099 -0.501 . . . . 41.35 110.397 -177.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.9 tt -150.71 122.5 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.59 0.71 . . . . 64.15 111.178 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 58.2 m -98.68 123.1 42.68 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-N 115.168 -0.924 . . . . 64.34 110.9 177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.445 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 85.2 m-85 -103.13 126.44 50.3 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 108.723 -0.843 . . . . 74.45 108.723 178.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.414 ' HG2' ' HG ' ' A' ' 119' ' ' LEU . 1.5 tmt_? -111.06 116.69 31.58 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 106.487 -1.671 . . . . 71.43 106.487 176.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 59.5 t -77.79 124.58 36.41 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 N-CA-C 109.659 -0.497 . . . . 72.04 109.659 -178.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.432 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -99.99 -29.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 C-N-CA 119.762 -0.775 . . . . 74.42 111.481 -176.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -152.36 177.3 10.73 Favored 'General case' 0 CA--C 1.487 -1.461 0 CA-C-O 121.362 0.601 . . . . 64.23 110.824 178.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 113.75 -165.33 12.04 Favored Glycine 0 C--N 1.284 -2.321 0 CA-C-N 114.908 -1.042 . . . . 62.44 114.606 175.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -59.19 -48.45 81.58 Favored 'General case' 0 C--N 1.319 -0.737 0 C-N-CA 125.368 1.467 . . . . 71.25 110.888 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 92.2 mt -62.77 -27.69 69.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.484 -0.78 . . . . 75.42 111.442 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.401 ' HE2' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -73.88 -13.9 60.98 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 121.27 0.557 . . . . 73.54 109.793 -177.18 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -79.34 -17.19 55.02 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.391 -0.368 . . . . 71.1 110.848 177.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -106.66 -43.68 4.65 Favored 'General case' 0 C--N 1.31 -1.129 0 CA-C-O 121.578 0.704 . . . . 74.13 110.344 178.219 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.427 ' CE2' HD11 ' A' ' 154' ' ' LEU . 6.5 m-85 -116.89 135.69 53.53 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.236 -1.394 . . . . 70.53 107.236 -175.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.5 ptmm? -86.69 2.48 48.42 Favored 'General case' 0 C--N 1.293 -1.89 0 CA-C-O 121.445 0.641 . . . . 63.34 111.909 -178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 39.9 t -169.11 139.45 2.27 Favored 'General case' 0 N--CA 1.42 -1.947 0 N-CA-C 106.841 -1.541 . . . . 72.03 106.841 172.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.593 ' CE2' HD22 ' A' ' 120' ' ' LEU . 89.5 t80 -151.85 117.92 5.54 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 110.165 -0.309 . . . . 72.54 110.165 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.414 ' HG ' ' HG2' ' A' ' 105' ' ' ARG . 5.5 mp -127.02 143.35 51.31 Favored 'General case' 0 CA--C 1.492 -1.274 0 CA-C-O 121.145 0.498 . . . . 61.51 110.484 175.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.593 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.7 pt? -142.18 127.24 18.45 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 115.399 -0.819 . . . . 74.24 109.856 178.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.482 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 69.7 m -106.74 131.16 54.19 Favored 'General case' 0 C--N 1.283 -2.296 0 CA-C-N 115.757 -0.656 . . . . 72.2 110.013 178.666 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.7 pt -117.5 134.67 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.822 0 N-CA-C 109.117 -0.697 . . . . 63.23 109.117 174.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.457 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 62.5 tt0 -135.61 124.34 23.86 Favored 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.628 -0.879 . . . . 74.45 108.628 177.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.4 t -96.07 114.83 33.75 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 CA-C-N 115.944 -0.571 . . . . 74.42 110.563 -176.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 6.0 p -114.17 145.13 33.01 Favored Pre-proline 0 C--N 1.297 -1.682 0 CA-C-N 115.701 -0.681 . . . . 74.44 111.449 177.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -51.11 141.05 39.25 Favored 'Trans proline' 0 CA--C 1.54 0.809 0 C-N-CA 123.887 3.058 . . . . 63.03 111.67 175.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 59.6 tptt -63.22 114.08 11.59 Favored Pre-proline 0 CA--C 1.536 0.426 0 N-CA-C 109.147 -0.686 . . . . 74.11 109.147 178.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.25 -22.35 32.43 Favored 'Trans proline' 0 N--CA 1.481 0.755 0 C-N-CA 123.497 2.798 . . . . 74.51 114.168 -176.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -113.04 25.53 11.38 Favored Glycine 0 N--CA 1.436 -1.366 0 C-N-CA 119.968 -1.11 . . . . 73.33 114.183 -177.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.17 -147.71 19.43 Favored Glycine 0 C--O 1.222 -0.599 0 C-N-CA 119.239 -1.458 . . . . 74.12 113.684 177.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -72.9 154.96 53.55 Favored 'Trans proline' 0 C--O 1.244 0.793 0 C-N-CA 122.82 2.347 . . . . 71.14 112.859 -178.702 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 104.09 -177.13 24.05 Favored Glycine 0 N--CA 1.435 -1.381 0 N-CA-C 110.407 -1.077 . . . . 74.31 110.407 -178.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 68.5 m -149.74 156.14 41.33 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 117.4 0.6 . . . . 74.34 111.523 178.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 50.2 mm -111.51 137.37 44.38 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.344 0 N-CA-C 108.372 -0.973 . . . . 64.11 108.372 -178.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 14.8 t -104.43 116.16 47.71 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.576 0 N-CA-C 107.328 -1.36 . . . . 70.3 107.328 176.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 76.4 m-70 -89.53 111.57 22.52 Favored 'General case' 0 C--N 1.289 -2.063 0 N-CA-C 108.902 -0.777 . . . . 72.23 108.902 176.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.4 m95 -97.38 120.8 38.42 Favored 'General case' 0 N--CA 1.425 -1.713 0 N-CA-C 108.21 -1.033 . . . . 73.25 108.21 178.072 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 59.1 t60 -117.88 111.72 19.4 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 107.751 -1.203 . . . . 74.2 107.751 177.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.2 mp -111.79 135.52 52.29 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 110.156 -0.313 . . . . 52.45 110.156 -175.788 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -142.42 128.4 19.56 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 107.689 -1.226 . . . . 74.32 107.689 174.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.478 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 23.8 p90 -146.49 165.72 28.59 Favored 'General case' 0 C--N 1.285 -2.228 0 N-CA-C 113.211 0.819 . . . . 75.14 113.211 -171.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -120.75 117.11 26.62 Favored 'General case' 0 C--N 1.28 -2.422 0 CA-C-N 115.021 -0.991 . . . . 64.24 109.464 -174.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.655 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 1.0 OUTLIER -72.24 146.19 47.44 Favored 'General case' 0 C--N 1.308 -1.233 0 CA-C-N 116.298 -0.41 . . . . 73.14 111.449 179.521 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 71.3 mt -77.82 -37.92 24.3 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.826 0 N-CA-C 106.285 -1.746 . . . . 75.42 106.285 168.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 39.8 t -170.01 162.26 9.04 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 106.001 -1.851 . . . . 74.42 106.001 178.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.655 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 20.1 mm-40 -76.09 -32.52 59.26 Favored 'General case' 0 C--N 1.3 -1.585 0 CA-C-O 121.251 0.548 . . . . 74.2 110.655 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -60.78 -20.18 60.89 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.74 -1.118 . . . . 71.2 110.197 -177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.0 p -109.36 -26.49 3.2 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 CA-C-N 115.454 -0.794 . . . . 72.43 111.843 -175.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.65 135.7 34.97 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 116.284 -0.417 . . . . 53.12 111.907 -175.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -126.36 93.61 42.72 Favored Pre-proline 0 C--N 1.312 -1.034 0 CA-C-N 116.208 -0.451 . . . . 71.24 109.973 176.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.458 ' HA ' HD23 ' A' ' 154' ' ' LEU . 57.8 Cg_exo -55.56 -10.58 3.72 Favored 'Trans proline' 0 N--CA 1.504 2.103 0 C-N-CA 124.314 3.343 . . . . 60.31 114.309 -178.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 16.6 mm-40 -73.08 -41.32 64.23 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.882 0.848 . . . . 55.3 110.422 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 44.1 p -62.61 -30.93 71.71 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 114.238 -1.346 . . . . 51.21 112.401 -172.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.495 HD22 ' H ' ' A' ' 154' ' ' LEU . 1.7 mm? -66.94 -36.55 82.48 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-N 116.57 -0.286 . . . . 65.25 111.073 -177.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 159' ' ' VAL . 86.2 mt -68.37 -36.65 79.5 Favored 'General case' 0 CA--C 1.5 -0.965 0 CA-C-O 120.847 0.356 . . . . 71.54 110.474 177.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 44.7 mt-30 -68.96 -35.13 76.41 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 116.13 -0.486 . . . . 71.42 110.4 178.105 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.3 t80 -62.93 -39.52 94.84 Favored 'General case' 0 C--O 1.224 -0.262 0 N-CA-C 108.85 -0.796 . . . . 63.41 108.85 174.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 67.8 m -61.57 -47.5 85.23 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.853 -0.612 . . . . 75.24 110.174 177.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 155' ' ' LEU . 70.5 t -57.01 -50.91 74.81 Favored 'Isoleucine or valine' 0 C--O 1.243 0.76 0 C-N-CA 122.746 0.419 . . . . 73.13 111.613 -179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -68.6 -32.19 71.9 Favored 'General case' 0 C--O 1.24 0.577 0 CA-C-N 116.195 -0.457 . . . . 50.32 111.607 -173.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.401 ' O ' HG22 ' A' ' 165' ' ' ILE . 96.8 t -77.18 -36.95 25.21 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.948 0 CA-C-N 116.307 -0.406 . . . . 64.33 110.647 176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -59.13 -50.84 72.5 Favored 'General case' 0 C--O 1.222 -0.371 0 N-CA-C 111.828 0.307 . . . . 70.54 111.828 -178.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 19.1 ptpt -64.75 -32.86 74.74 Favored 'General case' 0 C--O 1.215 -0.751 0 CA-C-O 120.739 0.304 . . . . 74.44 110.732 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 12.9 tp10 -68.58 -51.05 46.86 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 121.415 0.626 . . . . 63.21 110.101 -178.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.401 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.6 tp -71.63 -42.68 71.53 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.363 0 CA-C-N 115.646 -0.707 . . . . 64.41 111.565 -175.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.549 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 32.9 t70 -56.77 -46.34 81.53 Favored 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 123.216 0.606 . . . . 72.44 111.685 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 14.1 mm-40 -61.01 -30.54 70.36 Favored 'General case' 0 C--O 1.203 -1.386 0 CA-C-N 116.241 -0.436 . . . . 73.13 110.477 174.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 66.2 t60 -72.86 -32.67 65.6 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 111.964 0.357 . . . . 72.32 111.964 -178.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.82 -44.24 56.32 Favored 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 120.138 -0.625 . . . . 53.13 111.371 179.337 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.406 HD21 ' HA ' ' A' ' 34' ' ' ALA . 90.6 mt -80.72 -39.7 26.6 Favored 'General case' 0 CA--C 1.495 -1.138 0 CA-C-O 121.034 0.445 . . . . 70.4 110.747 -179.065 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 60.61 73.99 0.46 Allowed 'General case' 0 N--CA 1.432 -1.343 0 CA-C-N 114.48 -1.236 . . . . 44.15 111.432 -177.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -132.47 157.2 45.23 Favored 'General case' 0 C--N 1.292 -1.923 0 CA-C-N 113.527 -1.67 . . . . 75.32 108.648 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.298 -1.649 0 N-CA-C 106.41 -1.7 . . . . 70.33 106.41 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.3 m . . . . . 0 CA--C 1.558 1.26 0 N-CA-C 114.337 1.236 . . . . 71.1 114.337 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 29.1 mm-40 -70.95 164.66 25.0 Favored 'General case' 0 C--N 1.312 -1.064 0 N-CA-C 113.045 0.757 . . . . 72.24 113.045 -175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.48 144.53 51.38 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.216 -0.902 . . . . 71.24 111.643 -177.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 19.7 m -66.19 -27.94 68.38 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.484 -0.78 . . . . 73.22 111.581 -178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.457 ' C ' ' H ' ' A' ' 23' ' ' VAL . 28.0 m -65.08 -3.92 4.22 Favored 'General case' 0 CA--C 1.55 0.951 0 N-CA-C 114.459 1.281 . . . . 44.02 114.459 -177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 90.6 mt -70.24 32.94 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 123.345 0.658 . . . . 64.51 112.171 177.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.457 ' H ' ' C ' ' A' ' 21' ' ' SER . 44.2 t -73.93 127.82 35.97 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.68 0 C-N-CA 123.301 0.64 . . . . 51.25 109.862 -179.324 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -116.49 117.8 3.99 Favored Glycine 0 C--N 1.273 -2.965 0 N-CA-C 108.971 -1.652 . . . . 63.24 108.971 176.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 33.9 ttpt -131.27 135.47 47.35 Favored 'General case' 0 N--CA 1.397 -3.116 0 N-CA-C 107.331 -1.359 . . . . 65.35 107.331 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.509 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.4 tt -142.66 143.37 32.31 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.27 -0.641 . . . . 45.11 109.27 -179.564 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.545 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 5.8 tm-20 -130.89 124.0 30.21 Favored 'General case' 0 C--N 1.31 -1.152 0 N-CA-C 107.508 -1.293 . . . . 72.52 107.508 177.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.6 t -136.79 137.06 39.41 Favored 'General case' 0 N--CA 1.418 -2.026 0 N-CA-C 108.48 -0.934 . . . . 55.03 108.48 179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -103.24 117.48 34.61 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-O 121.261 0.553 . . . . 75.43 110.335 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.505 HG11 ' CB ' ' A' ' 162' ' ' SER . 54.8 t -108.51 144.56 16.82 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.086 0 N-CA-C 107.43 -1.322 . . . . 62.12 107.43 177.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 25.7 mt-10 -99.85 134.2 43.1 Favored 'General case' 0 C--N 1.283 -2.301 0 C-N-CA 120.008 -0.677 . . . . 74.25 110.089 -177.357 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.453 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 40.0 pt -105.37 161.66 5.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.852 0 N-CA-C 108.283 -1.006 . . . . 73.41 108.283 174.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -103.44 -18.39 14.83 Favored 'General case' 0 C--N 1.281 -2.384 0 N-CA-C 109.08 -0.711 . . . . 74.43 109.08 -175.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.21 168.05 20.7 Favored 'General case' 0 N--CA 1.435 -1.211 0 CA-C-N 115.282 -0.872 . . . . 61.14 109.544 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.7 m -95.04 138.49 32.69 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 110.035 -0.357 . . . . 73.53 110.035 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.404 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.35 -33.1 58.36 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 123.743 0.817 . . . . 41.31 112.045 -179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.556 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 38.5 t70 -60.15 -29.78 68.87 Favored 'General case' 0 C--O 1.218 -0.572 0 N-CA-C 112.074 0.398 . . . . 70.25 112.074 179.556 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.8 mtpt -68.76 -30.19 68.74 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 119.987 -0.685 . . . . 72.44 111.389 178.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -69.15 -40.96 77.89 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 106.565 -1.643 . . . . 74.2 106.565 176.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.556 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 10.8 t-160 -57.56 -29.09 64.13 Favored 'General case' 0 CA--C 1.554 1.134 0 CA-C-N 113.815 -1.539 . . . . 71.14 111.566 176.082 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 83.6 m-70 -78.17 -29.21 48.46 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.564 0.95 . . . . 72.21 113.564 175.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 16.9 mmt -54.02 -24.06 15.67 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 116.756 2.132 . . . . 75.24 116.756 -169.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.2 t80 -98.6 -18.0 18.34 Favored 'General case' 0 C--N 1.312 -1.049 0 C-N-CA 119.547 -0.861 . . . . 74.41 110.974 -177.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.43 106.06 3.28 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-N 115.599 -0.728 . . . . 52.12 110.411 -177.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -74.82 69.06 1.86 Allowed Glycine 0 C--N 1.296 -1.686 0 CA-C-N 114.529 -1.214 . . . . 53.41 112.094 178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 33.5 mmtp -92.12 150.94 41.27 Favored Pre-proline 0 C--N 1.304 -1.391 0 N-CA-C 109.034 -0.728 . . . . 74.33 109.034 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -49.87 115.29 1.76 Allowed 'Trans proline' 0 C--O 1.246 0.9 0 C-N-CA 123.151 2.567 . . . . 35.14 112.601 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -77.21 104.19 7.57 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 108.517 -0.919 . . . . 62.3 108.517 177.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.3 p-80 -54.53 170.55 0.15 Allowed 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 115.821 1.786 . . . . 74.35 115.821 -175.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 84.1 t 80.43 92.79 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.233 0 C-N-CA 125.025 1.33 . . . . 51.34 108.701 -171.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 45.1 t -130.73 159.48 37.14 Favored 'General case' 0 C--N 1.296 -1.724 0 CA-C-N 114.651 -1.158 . . . . 63.22 109.023 -175.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.4 ttmt -135.75 149.89 49.33 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 109.436 -0.579 . . . . 74.1 109.436 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.29 95.45 0.07 Allowed 'General case' 0 C--O 1.246 0.912 0 CA-C-O 121.253 0.549 . . . . 70.44 110.895 -179.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 50.2 p -169.89 175.2 1.6 Allowed Pre-proline 0 N--CA 1.434 -1.274 0 N-CA-C 107.171 -1.418 . . . . 73.13 107.171 -176.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -58.88 111.87 1.03 Allowed 'Trans proline' 0 C--N 1.359 1.099 0 C-N-CA 122.032 1.822 . . . . 75.2 110.537 174.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.17 61.31 0.45 Allowed Glycine 0 N--CA 1.428 -1.834 0 N-CA-C 110.615 -0.994 . . . . 53.23 110.615 -176.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 20.4 m120 -76.25 139.37 41.11 Favored 'General case' 0 CA--C 1.505 -0.768 0 N-CA-C 109.666 -0.494 . . . . 72.43 109.666 178.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 44.8 mm 69.89 -56.71 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.243 0 C-N-CA 124.901 1.28 . . . . 74.41 111.679 -177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -95.77 93.22 6.96 Favored 'General case' 0 C--N 1.303 -1.447 0 N-CA-C 108.049 -1.093 . . . . 70.0 108.049 174.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -71.99 -80.1 0.39 Allowed Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 111.332 -0.707 . . . . 42.31 111.332 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.8 t -170.82 135.21 1.06 Allowed 'General case' 0 N--CA 1.439 -1.014 0 CA-C-O 121.139 0.495 . . . . 72.14 110.837 178.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -144.71 137.54 26.61 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 107.774 -1.195 . . . . 72.33 107.774 172.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.4 tt -160.3 118.94 2.65 Favored 'General case' 0 C--N 1.291 -1.936 0 N-CA-C 106.332 -1.729 . . . . 74.44 106.332 -177.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.4 t-80 -108.51 -20.15 13.2 Favored 'General case' 0 C--N 1.311 -1.089 0 C-N-CA 120.525 -0.47 . . . . 73.21 111.254 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 46.0 tt0 66.67 109.5 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.947 0.899 . . . . 61.44 112.282 -179.853 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 119.46 -32.05 5.18 Favored Glycine 0 N--CA 1.436 -1.3 0 N-CA-C 110.54 -1.024 . . . . 72.13 110.54 -179.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -84.19 102.29 12.5 Favored 'General case' 0 C--N 1.303 -1.45 0 N-CA-C 108.387 -0.968 . . . . 74.03 108.387 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 91.0 m95 -94.43 -16.17 23.64 Favored 'General case' 0 C--N 1.298 -1.661 0 C-N-CA 120.789 -0.365 . . . . 74.42 110.606 -179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.65 12.59 84.3 Favored Glycine 0 C--N 1.332 0.343 0 CA-C-N 116.182 -0.463 . . . . 74.12 112.224 178.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 39.7 p -134.18 164.12 28.08 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 122.51 0.324 . . . . 73.23 110.341 -177.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 89.8 t -66.6 135.0 29.28 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.183 -1.043 . . . . 73.54 108.183 174.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.53 -0.91 56.91 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 111.268 -0.733 . . . . 72.05 111.268 -175.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 32.7 t -65.58 131.83 47.35 Favored 'General case' 0 N--CA 1.442 -0.875 0 N-CA-C 109.343 -0.614 . . . . 52.24 109.343 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.0 mt -124.87 120.97 60.05 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 CA-C-O 120.979 0.418 . . . . 72.32 110.128 179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.3 158.04 40.37 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.703 -1.591 . . . . 64.01 106.703 -179.048 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 70.0 m-85 -126.41 129.33 48.54 Favored 'General case' 0 C--N 1.304 -1.412 0 C-N-CA 120.098 -0.641 . . . . 61.2 110.897 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -108.62 142.82 38.53 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 107.533 -1.284 . . . . 74.34 107.533 178.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -111.34 131.4 55.2 Favored 'General case' 0 C--N 1.299 -1.625 0 N-CA-C 109.204 -0.665 . . . . 75.35 109.204 179.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.9 p90 -127.41 145.2 50.9 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 109.048 -0.723 . . . . 54.34 109.048 178.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 59.6 t -104.52 117.74 50.63 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 C-N-CA 120.114 -0.634 . . . . 74.14 110.047 -176.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.498 ' O ' ' HE2' ' A' ' 86' ' ' LYS . 71.6 t60 -134.2 125.42 27.8 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 107.621 -1.252 . . . . 71.51 107.621 -178.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 63.63 28.9 15.17 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.808 0.843 . . . . 74.45 110.987 -175.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 83.64 -12.52 51.84 Favored Glycine 0 C--N 1.312 -0.771 0 CA-C-N 115.932 -0.576 . . . . 50.03 113.533 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -97.11 151.74 19.47 Favored 'General case' 0 CA--C 1.488 -1.418 0 CA-C-N 117.286 0.543 . . . . 73.05 110.16 179.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -92.34 116.12 28.69 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-N 115.428 -0.806 . . . . 70.43 108.961 177.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.498 ' HE2' ' O ' ' A' ' 81' ' ' HIS . 4.0 mptp? -97.11 154.88 17.08 Favored 'General case' 0 C--N 1.291 -1.939 0 N-CA-C 108.874 -0.787 . . . . 74.11 108.874 178.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 52.9 t -115.59 140.73 35.79 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 109.296 -0.631 . . . . 62.43 109.296 -178.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.68 120.4 42.13 Favored 'General case' 0 N--CA 1.425 -1.705 0 N-CA-C 108.597 -0.89 . . . . 42.53 108.597 179.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.519 ' HE2' ' H ' ' A' ' 89' ' ' LYS . 0.0 OUTLIER -97.43 123.41 41.26 Favored 'General case' 0 N--CA 1.427 -1.587 0 N-CA-C 108.066 -1.087 . . . . 74.52 108.066 179.75 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.61 150.83 30.74 Favored 'General case' 0 N--CA 1.424 -1.767 0 CA-C-O 121.715 0.769 . . . . 62.22 111.373 -172.34 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 105' ' ' ARG . 28.5 ttt180 -136.93 133.52 35.78 Favored 'General case' 0 C--N 1.291 -1.966 0 CA-C-N 114.201 -1.363 . . . . 75.13 107.931 175.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 49.4 mm -74.95 121.45 26.47 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.25 0 N-CA-C 108.932 -0.766 . . . . 73.45 108.932 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -104.76 -29.6 10.45 Favored 'General case' 0 C--N 1.305 -1.351 0 CA-C-O 121.265 0.555 . . . . 73.24 110.725 178.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -165.82 137.14 3.8 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.171 -1.048 . . . . 61.33 108.171 -179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.4 p -143.94 123.19 7.69 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.613 0 CA-C-O 121.528 0.68 . . . . 74.12 110.987 178.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 41.4 mm-40 -115.72 106.99 49.26 Favored Pre-proline 0 C--N 1.298 -1.663 0 N-CA-C 108.597 -0.89 . . . . 72.54 108.597 177.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_endo -70.02 -29.83 22.01 Favored 'Trans proline' 0 C--N 1.319 -1.0 0 C-N-CA 121.203 1.269 . . . . 73.14 109.237 172.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -70.29 -29.76 66.6 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.415 -1.266 . . . . 75.14 112.678 -179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 55.6 mttp -115.8 5.68 14.18 Favored 'General case' 0 C--N 1.296 -1.741 0 C-N-CA 120.753 -0.379 . . . . 74.43 111.343 -177.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.479 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 86.4 m-20 51.8 44.29 29.43 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.171 0.92 . . . . 65.4 111.261 -176.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 48.3 tp -118.43 136.39 53.8 Favored 'General case' 0 C--N 1.313 -0.999 0 N-CA-C 109.829 -0.434 . . . . 51.23 109.829 -175.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.6 tt -148.79 125.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 CA-C-O 121.76 0.791 . . . . 75.04 111.076 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.5 m -99.18 124.06 43.94 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 115.1 -0.955 . . . . 74.34 111.036 179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 78.2 m-85 -106.76 150.12 26.63 Favored 'General case' 0 C--O 1.241 0.647 0 C-N-CA 124.011 0.925 . . . . 73.35 109.138 178.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.403 ' HD3' ' HD3' ' A' ' 91' ' ' ARG . 52.5 ttt180 -139.94 146.47 39.22 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 122.738 0.415 . . . . 62.15 110.767 -177.482 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.402 HG11 ' HE1' ' A' ' 112' ' ' MET . 7.5 p -72.19 139.42 19.71 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.372 -0.603 . . . . 64.24 109.372 173.563 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -129.72 -30.87 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.49 0 N-CA-C 113.332 0.864 . . . . 72.22 113.332 179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -89.36 -92.99 0.12 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 118.791 -1.163 . . . . 65.53 112.911 -175.382 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -166.82 -21.53 0.02 OUTLIER Glycine 0 C--O 1.219 -0.792 0 C-N-CA 118.296 -1.907 . . . . 75.02 114.969 -178.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -48.56 -49.6 35.83 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 112.888 0.699 . . . . 65.01 112.888 -179.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.493 HD13 ' CD2' ' A' ' 118' ' ' PHE . 87.1 mt -75.04 -23.9 58.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-O 121.133 0.492 . . . . 74.24 111.656 -179.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 7.4 mmt -79.11 -6.76 57.24 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.073 -0.512 . . . . 72.32 112.139 -175.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 33.7 mmtp -79.7 -26.21 40.96 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.458 0.647 . . . . 74.13 109.661 179.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -104.81 -32.81 8.66 Favored 'General case' 0 C--N 1.311 -1.089 0 CA-C-N 114.724 -1.125 . . . . 72.52 110.854 179.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.535 ' O ' ' HA ' ' A' ' 112' ' ' MET . 61.9 m-85 -124.35 149.01 47.1 Favored 'General case' 0 C--O 1.204 -1.305 0 CA-C-N 115.976 -0.556 . . . . 74.21 109.803 -175.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.1 ptmm? -95.02 -7.66 39.03 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-O 121.42 0.628 . . . . 51.54 112.04 -179.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 23.3 t -164.93 145.68 7.49 Favored 'General case' 0 N--CA 1.434 -1.25 0 N-CA-C 106.592 -1.633 . . . . 72.31 106.592 173.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.515 ' CE2' HD22 ' A' ' 120' ' ' LEU . 71.7 t80 -156.39 124.11 5.52 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-O 121.202 0.525 . . . . 73.25 111.709 -174.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 54.1 mt -135.88 148.31 48.56 Favored 'General case' 0 CA--C 1.484 -1.565 0 CA-C-O 121.849 0.833 . . . . 52.21 110.777 176.59 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.515 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -143.28 132.61 23.34 Favored 'General case' 0 C--N 1.265 -3.091 0 CA-C-N 114.794 -1.094 . . . . 75.23 109.771 175.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 31.5 m -129.42 128.15 42.4 Favored 'General case' 0 C--N 1.273 -2.743 0 N-CA-C 108.94 -0.763 . . . . 61.25 108.94 -178.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.2 pt -117.59 149.05 19.99 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.289 0 C-N-CA 120.441 -0.504 . . . . 72.35 110.176 -179.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.479 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 53.8 tt0 -143.06 130.08 20.67 Favored 'General case' 0 N--CA 1.421 -1.919 0 N-CA-C 108.771 -0.826 . . . . 74.44 108.771 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 43.5 t -94.92 117.1 37.94 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 CA-C-O 121.664 0.745 . . . . 61.24 109.915 -176.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.2 m -116.35 140.77 26.94 Favored Pre-proline 0 C--N 1.286 -2.163 0 CA-C-N 115.001 -1.0 . . . . 63.42 108.587 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 80.5 Cg_exo -46.56 148.01 3.88 Favored 'Trans proline' 0 C--N 1.358 1.063 0 C-N-CA 123.309 2.672 . . . . 71.4 112.667 177.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -98.25 125.77 42.25 Favored Pre-proline 0 C--N 1.306 -1.307 0 CA-C-N 116.158 -0.474 . . . . 54.01 111.461 -179.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_exo -64.09 115.21 3.0 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 122.475 2.117 . . . . 72.12 109.501 174.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 140.37 -34.91 1.94 Allowed Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 110.53 -1.028 . . . . 72.32 110.53 -177.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 128.44 -91.01 0.33 Allowed Glycine 0 N--CA 1.436 -1.316 0 C-N-CA 120.381 -0.914 . . . . 62.43 112.977 178.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -70.39 140.17 39.72 Favored 'Trans proline' 0 C--O 1.246 0.897 0 C-N-CA 122.813 2.342 . . . . 74.02 113.106 -177.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 91.79 -177.68 40.4 Favored Glycine 0 N--CA 1.436 -1.356 0 CA-C-N 115.514 -0.766 . . . . 52.21 111.634 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 64.6 m -152.16 163.74 38.75 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.03 -0.73 . . . . 70.24 109.03 178.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.429 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 48.8 mm -110.58 135.17 50.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 N-CA-C 109.272 -0.64 . . . . 74.32 109.272 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -108.76 115.79 50.27 Favored 'Isoleucine or valine' 0 C--N 1.267 -2.994 0 CA-C-O 121.414 0.626 . . . . 73.31 109.35 176.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 89.2 m-70 -92.1 119.42 31.76 Favored 'General case' 0 CA--C 1.482 -1.669 0 CA-C-N 115.708 -0.678 . . . . 60.22 110.24 178.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.545 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 48.5 m95 -96.7 121.02 38.09 Favored 'General case' 0 C--N 1.288 -2.098 0 CA-C-N 115.184 -0.916 . . . . 64.31 109.799 179.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 40.6 t60 -107.78 111.49 23.68 Favored 'General case' 0 N--CA 1.423 -1.789 0 N-CA-C 106.938 -1.504 . . . . 61.43 106.938 173.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.499 HD21 ' SG ' ' A' ' 158' ' ' CYS . 4.3 mp -107.05 130.24 54.69 Favored 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 106.93 -1.508 . . . . 62.23 106.93 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -140.1 124.07 17.55 Favored 'General case' 0 N--CA 1.406 -2.642 0 N-CA-C 105.783 -1.932 . . . . 73.24 105.783 178.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 19.3 p90 -153.13 165.68 34.87 Favored 'General case' 0 C--N 1.271 -2.819 0 CA-C-N 115.795 -0.639 . . . . 60.22 110.403 -171.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -126.19 117.63 23.49 Favored 'General case' 0 C--N 1.281 -2.405 0 N-CA-C 109.523 -0.547 . . . . 73.54 109.523 -176.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.41 ' HG2' ' OE1' ' A' ' 146' ' ' GLU . 1.4 mptm? -64.69 143.57 57.84 Favored 'General case' 0 CA--C 1.504 -0.817 0 CA-C-N 115.857 -0.611 . . . . 74.43 111.444 179.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 41.4 mt -74.83 -46.07 42.0 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.051 0 N-CA-C 106.393 -1.706 . . . . 74.21 106.393 167.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.525 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 69.7 m -158.56 154.09 26.06 Favored 'General case' 0 N--CA 1.413 -2.288 0 N-CA-C 106.448 -1.686 . . . . 72.52 106.448 175.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.41 ' OE1' ' HG2' ' A' ' 143' ' ' LYS . 14.1 mm-40 -59.78 -58.04 10.29 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 113.356 0.873 . . . . 62.14 113.356 -173.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -64.58 -19.56 65.73 Favored 'General case' 0 C--N 1.312 -1.048 0 C-N-CA 123.582 0.753 . . . . 70.4 111.172 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.525 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 61.9 t -82.52 -26.65 8.65 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 CA-C-N 115.072 -0.967 . . . . 75.22 110.287 -178.751 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.06 160.76 20.89 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.793 -0.64 . . . . 52.41 111.248 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 47.6 m-70 -137.74 87.4 17.18 Favored Pre-proline 0 C--N 1.321 -0.652 0 CA-C-N 116.542 -0.299 . . . . 53.3 110.317 -179.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -61.52 -26.36 80.7 Favored 'Trans proline' 0 N--CA 1.48 0.696 0 C-N-CA 122.389 2.059 . . . . 72.14 112.347 176.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -59.43 -47.0 87.13 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-O 121.756 0.789 . . . . 74.13 110.84 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.7 p -70.13 -30.06 67.15 Favored 'General case' 0 N--CA 1.422 -1.838 0 CA-C-N 114.704 -1.135 . . . . 74.01 111.463 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 9.4 mp -63.15 -44.65 94.93 Favored 'General case' 0 CA--C 1.506 -0.745 0 CA-C-N 116.319 -0.401 . . . . 73.54 110.965 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 69.7 mt -67.79 -36.86 81.21 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.408 -0.517 . . . . 73.21 111.392 178.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 84.2 mm-40 -64.1 -39.55 94.28 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 109.518 -0.549 . . . . 62.05 109.518 174.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -62.22 -47.19 85.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.926 -0.579 . . . . 75.32 110.057 177.468 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.499 ' SG ' HD21 ' A' ' 139' ' ' LEU . 77.5 m -63.05 -48.44 78.68 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.739 -0.664 . . . . 64.14 111.859 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.1 p -61.87 -45.5 98.57 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 C-N-CA 120.478 -0.489 . . . . 71.33 111.156 -176.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.461 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 5.6 mm-40 -61.1 -49.39 77.49 Favored 'General case' 0 CA--C 1.506 -0.716 0 N-CA-C 112.172 0.434 . . . . 63.25 112.172 -178.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.4 t -60.73 -33.91 56.9 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.56 179.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.505 ' CB ' HG11 ' A' ' 30' ' ' VAL . 69.5 m -56.35 -41.34 75.96 Favored 'General case' 0 C--O 1.216 -0.683 0 N-CA-C 112.425 0.528 . . . . 43.3 112.425 178.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.66 -42.97 63.77 Favored 'General case' 0 C--O 1.211 -0.953 0 C-N-CA 119.138 -1.025 . . . . 72.23 109.94 176.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 22.1 mm-40 -54.84 -49.37 71.24 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.909 -0.587 . . . . 75.22 112.105 -178.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.408 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -72.73 -39.51 60.14 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 N-CA-C 109.658 -0.497 . . . . 64.52 109.658 -177.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.453 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 26.2 t70 -62.33 -51.61 66.96 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-O 121.189 0.518 . . . . 71.32 111.541 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -66.53 -30.68 71.05 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-N 115.741 -0.663 . . . . 73.21 110.424 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.432 ' O ' ' HG2' ' A' ' 172' ' ' GLU . 69.9 t60 -63.13 -40.95 99.07 Favored 'General case' 0 C--O 1.216 -0.661 0 N-CA-C 109.349 -0.612 . . . . 62.53 109.349 175.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.25 -38.68 78.58 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 121.098 -0.241 . . . . 74.31 110.679 179.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 97.2 mt -63.1 -35.13 79.23 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.222 0.534 . . . . 75.34 110.167 177.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -74.78 -41.32 60.25 Favored 'General case' 0 C--N 1.313 -0.991 0 CA-C-N 115.287 -0.869 . . . . 63.12 112.055 -179.768 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 168' ' ' HIS . 23.5 mm-40 -69.7 170.89 9.99 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-O 121.596 0.712 . . . . 74.11 112.767 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 . . . . . 0 C--N 1.293 -1.867 0 CA-C-N 114.658 -1.156 . . . . 75.32 110.275 -177.769 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 60.5 m . . . . . 0 N--CA 1.416 -2.142 0 N-CA-C 107.31 -1.367 . . . . 62.04 107.31 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.495 ' HB2' ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -101.67 159.22 15.5 Favored 'General case' 0 N--CA 1.43 -1.469 0 N-CA-C 109.951 -0.389 . . . . 42.14 109.951 -178.662 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -84.68 105.04 15.18 Favored 'General case' 0 N--CA 1.424 -1.752 0 N-CA-C 107.258 -1.386 . . . . 65.23 107.258 174.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 48.4 p -60.68 -40.1 90.9 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.307 0.575 . . . . 63.2 111.123 -177.071 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 18.7 m -89.15 -3.6 58.56 Favored 'General case' 0 C--N 1.301 -1.534 0 CA-C-N 115.589 -0.732 . . . . 62.43 110.63 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 83.7 mt 68.85 -23.62 0.14 Allowed 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.931 1.292 . . . . 72.41 113.823 -174.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 93.9 t -79.47 129.72 37.15 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.428 0 N-CA-C 106.918 -1.512 . . . . 64.14 106.918 170.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.16 159.89 25.27 Favored Glycine 0 N--CA 1.415 -2.723 0 C-N-CA 120.372 -0.918 . . . . 72.04 111.93 -178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.443 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.5 mtpt -118.61 155.69 30.52 Favored 'General case' 0 CA--C 1.466 -2.284 0 CA-C-O 121.354 0.597 . . . . 62.11 110.731 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 54.8 tp -144.91 126.12 14.73 Favored 'General case' 0 N--CA 1.407 -2.596 0 N-CA-C 107.226 -1.398 . . . . 71.22 107.226 167.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -135.38 132.79 37.99 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.2 -0.667 . . . . 74.54 109.2 -175.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.34 169.33 21.07 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 109.286 -0.635 . . . . 72.34 109.286 -179.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 30.5 m-20 -127.11 117.74 22.99 Favored 'General case' 0 CA--C 1.503 -0.836 0 N-CA-C 109.21 -0.663 . . . . 61.01 109.21 179.154 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 162' ' ' SER . 82.9 t -107.11 144.55 15.88 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 N-CA-C 107.976 -1.12 . . . . 65.4 107.976 179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.53 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 17.1 mt-10 -105.72 121.55 44.24 Favored 'General case' 0 N--CA 1.417 -2.107 0 N-CA-C 109.037 -0.727 . . . . 74.32 109.037 -177.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 37.1 pt -91.14 149.42 4.08 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 106.006 -1.85 . . . . 62.01 106.006 172.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 66.4 mttm -104.04 20.53 18.05 Favored 'General case' 0 C--N 1.288 -2.107 0 CA-C-O 122.419 1.104 . . . . 62.02 110.646 -174.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.14 158.49 19.57 Favored 'General case' 0 N--CA 1.417 -2.086 0 N-CA-C 106.844 -1.539 . . . . 65.24 106.844 172.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -79.29 146.89 32.72 Favored 'General case' 0 C--N 1.3 -1.562 0 C-N-CA 120.102 -0.639 . . . . 65.21 110.766 -178.396 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.09 -26.52 62.68 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.682 0.793 . . . . 62.12 111.224 179.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -57.95 -36.85 73.13 Favored 'General case' 0 CA--C 1.502 -0.878 0 CA-C-N 115.898 -0.592 . . . . 75.55 109.624 177.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.437 ' NZ ' ' HB3' ' A' ' 38' ' ' LYS . 6.3 mtpm? -71.88 -28.41 63.5 Favored 'General case' 0 N--CA 1.428 -1.55 0 CA-C-N 115.904 -0.589 . . . . 74.21 111.119 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.558 ' O ' ' HG3' ' A' ' 42' ' ' MET . 67.1 t80 -69.19 -34.92 75.66 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 108.452 -0.944 . . . . 72.22 108.452 177.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 67.8 t60 -72.09 -38.7 69.32 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.436 -0.802 . . . . 64.23 109.796 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 41.4 m-70 -75.93 -28.93 58.17 Favored 'General case' 0 C--O 1.208 -1.079 0 N-CA-C 114.347 1.24 . . . . 71.2 114.347 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.558 ' HG3' ' O ' ' A' ' 39' ' ' PHE . 0.0 OUTLIER -53.13 -21.36 4.81 Favored 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 115.059 1.503 . . . . 75.34 115.059 -173.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.471 ' O ' ' HA ' ' A' ' 63' ' ' LEU . 99.0 m-85 -65.92 -31.67 72.73 Favored 'General case' 0 C--O 1.217 -0.652 0 N-CA-C 109.26 -0.644 . . . . 63.03 109.26 177.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -103.91 -47.17 4.27 Favored 'General case' 0 C--N 1.315 -0.91 0 N-CA-C 109.28 -0.637 . . . . 52.41 109.28 176.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 121.56 -119.29 4.02 Favored Glycine 0 N--CA 1.438 -1.191 0 N-CA-C 110.264 -1.135 . . . . 75.45 110.264 -179.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 49' ' ' HIS . 31.1 mmtp -100.73 160.84 25.68 Favored Pre-proline 0 C--N 1.293 -1.873 0 N-CA-C 108.761 -0.829 . . . . 74.14 108.761 175.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -41.61 -44.83 6.38 Favored 'Trans proline' 0 C--N 1.365 1.446 0 C-N-CA 124.155 3.237 . . . . 72.34 112.989 177.046 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.519 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . 39.4 t60 -147.64 -46.86 0.17 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.474 -0.33 . . . . 65.03 110.555 175.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . 0.427 ' HB2' ' HB2' ' A' ' 46' ' ' LYS . 13.0 t60 68.8 114.38 0.04 OUTLIER 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 124.266 1.027 . . . . 75.22 111.38 -177.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.7 m -119.74 148.32 22.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 N-CA-C 109.393 -0.595 . . . . 75.3 109.393 176.374 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.3 t -95.6 112.59 24.28 Favored 'General case' 0 C--N 1.297 -1.704 0 N-CA-C 108.288 -1.004 . . . . 73.12 108.288 177.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 40.5 ttmt 72.52 159.17 0.21 Allowed 'General case' 0 C--N 1.35 0.608 0 C-N-CA 123.976 0.91 . . . . 62.35 109.843 -176.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -81.32 84.69 6.56 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 108.715 -0.846 . . . . 63.2 108.715 176.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -160.87 172.73 5.48 Favored Pre-proline 0 C--N 1.307 -1.244 0 N-CA-C 106.627 -1.619 . . . . 74.42 106.627 -177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -56.31 109.67 0.47 Allowed 'Trans proline' 0 C--N 1.356 0.955 0 C-N-CA 121.839 1.692 . . . . 71.42 110.179 173.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -65.58 -56.58 14.32 Favored Glycine 0 N--CA 1.432 -1.584 0 CA-C-N 115.62 -0.718 . . . . 72.45 112.709 -176.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 49.4 t-20 69.34 -70.44 0.14 Allowed 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 124.08 0.952 . . . . 73.41 109.634 -177.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 63.3 mt -74.61 117.26 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.885 0 N-CA-C 107.561 -1.274 . . . . 73.24 107.561 178.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.476 ' HB3' ' CE1' ' A' ' 48' ' ' HIS . 11.7 pt20 -92.81 152.06 19.66 Favored 'General case' 0 C--N 1.282 -2.345 0 CA-C-N 115.715 -0.675 . . . . 55.24 111.061 -178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -91.15 5.27 81.41 Favored Glycine 0 N--CA 1.433 -1.534 0 N-CA-C 110.979 -0.848 . . . . 72.43 110.979 179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.519 ' SG ' ' HA ' ' A' ' 48' ' ' HIS . 39.6 m -76.78 83.57 3.38 Favored 'General case' 0 N--CA 1.44 -0.961 0 N-CA-C 108.625 -0.88 . . . . 51.43 108.625 177.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -77.54 -32.68 54.07 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 115.287 -0.87 . . . . 62.43 110.956 -177.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.471 ' HA ' ' O ' ' A' ' 43' ' ' PHE . 48.0 tp 62.93 83.84 0.15 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.872 -1.058 . . . . 73.33 108.689 -175.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 t60 -91.01 95.95 10.37 Favored 'General case' 0 C--N 1.302 -1.464 0 CA-C-N 114.687 -1.142 . . . . 74.52 110.185 -172.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -110.39 154.01 24.16 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.501 -0.772 . . . . 71.1 109.278 179.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -68.64 134.85 28.35 Favored Glycine 0 N--CA 1.439 -1.16 0 N-CA-C 109.829 -1.308 . . . . 55.21 109.829 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -62.65 -17.94 61.37 Favored 'General case' 0 C--N 1.31 -1.138 0 N-CA-C 113.936 1.087 . . . . 64.52 113.936 -173.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.544 ' HB2' ' HA ' ' A' ' 73' ' ' SER . 87.6 m95 -102.13 18.11 21.63 Favored 'General case' 0 C--N 1.307 -1.263 0 C-N-CA 120.551 -0.46 . . . . 74.1 110.753 176.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 98.8 13.16 41.28 Favored Glycine 0 C--N 1.329 0.143 0 C-N-CA 120.846 -0.693 . . . . 62.22 112.855 -179.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 54.9 m 72.47 -71.79 0.13 Allowed 'General case' 0 C--N 1.32 -0.698 0 C-N-CA 123.807 0.843 . . . . 54.33 111.817 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.5 t -71.99 120.13 19.78 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 108.806 -0.813 . . . . 64.14 108.806 177.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 92.51 -0.58 71.14 Favored Glycine 0 N--CA 1.434 -1.48 0 N-CA-C 110.935 -0.866 . . . . 72.4 110.935 -176.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.544 ' HA ' ' HB2' ' A' ' 68' ' ' TRP . 10.5 t -84.26 153.1 23.77 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.001 -0.74 . . . . 74.22 109.001 -177.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.524 HG23 ' O ' ' A' ' 90' ' ' GLU . 69.5 mt -124.98 120.1 57.63 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.275 0 CA-C-N 115.777 -0.647 . . . . 61.41 110.87 -177.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 56.8 t -118.08 146.79 22.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 107.692 -1.225 . . . . 65.32 107.692 178.202 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -121.03 151.56 39.64 Favored 'General case' 0 C--N 1.315 -0.906 0 N-CA-C 113.034 0.753 . . . . 71.41 113.034 -177.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 12.1 m0 -118.87 121.31 39.7 Favored 'General case' 0 N--CA 1.437 -1.078 0 N-CA-C 108.209 -1.034 . . . . 74.35 108.209 169.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 2.4 m-20 -109.45 130.41 55.5 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.984 -1.858 . . . . 75.35 105.984 174.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 p90 -162.97 153.75 16.79 Favored 'General case' 0 C--N 1.3 -1.587 0 CA-C-O 121.237 0.541 . . . . 74.32 111.032 -175.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 85.9 t -106.59 118.29 54.0 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.091 0 N-CA-C 108.21 -1.033 . . . . 74.54 108.21 176.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 18.3 t60 -109.9 109.94 20.73 Favored 'General case' 0 C--N 1.296 -1.753 0 N-CA-C 108.351 -0.981 . . . . 75.34 108.351 -177.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 61.2 33.04 19.4 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 113.242 0.83 . . . . 61.33 113.242 178.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.84 -10.03 76.05 Favored Glycine 0 C--N 1.308 -1.001 0 C-N-CA 120.506 -0.854 . . . . 73.25 113.056 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -103.89 131.67 50.89 Favored 'General case' 0 CA--C 1.489 -1.382 0 O-C-N 122.448 -0.443 . . . . 72.52 110.268 175.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.79 126.98 31.9 Favored 'General case' 0 C--N 1.28 -2.428 0 CA-C-N 115.494 -0.776 . . . . 52.5 110.67 -178.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.2 mptp? -122.5 144.11 49.28 Favored 'General case' 0 C--N 1.303 -1.432 0 CA-C-N 115.734 -0.666 . . . . 64.54 110.202 178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.6 t -131.18 132.8 63.14 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 N-CA-C 107.086 -1.45 . . . . 50.03 107.086 177.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 113.65 26.96 Favored 'General case' 0 C--N 1.291 -1.952 0 N-CA-C 108.817 -0.809 . . . . 64.05 108.817 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.567 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 94.9 mttt -114.87 122.85 47.59 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 115.121 -0.945 . . . . 63.13 108.791 179.673 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.524 ' O ' HG23 ' A' ' 74' ' ' ILE . 9.6 pt-20 -147.44 163.83 35.25 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.841 -0.8 . . . . 73.4 108.841 -171.749 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.2 ttt180 -136.29 132.66 36.02 Favored 'General case' 0 C--N 1.283 -2.305 0 N-CA-C 108.153 -1.054 . . . . 74.21 108.153 174.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.486 ' CG2' HG23 ' A' ' 95' ' ' VAL . 63.3 mt -70.98 122.89 23.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 N-CA-C 108.492 -0.929 . . . . 65.24 108.492 174.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.78 -35.23 12.19 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.03 -1.1 . . . . 74.13 108.03 -177.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.8 145.2 17.0 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.22 -0.445 . . . . 70.22 110.566 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.486 HG23 ' CG2' ' A' ' 92' ' ' ILE . 79.3 t -142.58 122.74 10.33 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.007 0 N-CA-C 108.526 -0.916 . . . . 65.23 108.526 175.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.439 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 6.6 mm-40 -113.16 106.5 54.76 Favored Pre-proline 0 C--N 1.293 -1.871 0 N-CA-C 106.636 -1.616 . . . . 71.44 106.636 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -66.18 -33.09 41.22 Favored 'Trans proline' 0 C--N 1.327 -0.57 0 C-N-CA 122.335 2.023 . . . . 43.21 111.539 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -78.89 -36.28 42.33 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 116.167 -0.469 . . . . 75.02 111.201 -177.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 89.7 mttt -91.55 -5.02 54.73 Favored 'General case' 0 C--N 1.306 -1.318 0 CA-C-N 115.918 -0.583 . . . . 74.32 111.755 -176.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 56.42 45.89 21.82 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 123.864 0.728 . . . . 75.51 110.076 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.439 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.5 tp -119.35 141.73 48.77 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.724 -0.671 . . . . 61.32 110.588 -175.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.06 124.37 1.64 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.026 0 CA-C-O 121.693 0.758 . . . . 72.22 111.462 176.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.409 ' CG2' HD21 ' A' ' 119' ' ' LEU . 30.5 m -100.69 122.04 42.66 Favored 'General case' 0 CA--C 1.564 1.484 0 CA-C-N 115.069 -0.969 . . . . 52.33 110.543 -179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -107.55 126.57 52.71 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 122.739 0.415 . . . . 74.44 110.44 179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 70.6 ttt180 -111.95 137.89 49.33 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.638 -0.875 . . . . 65.01 108.638 174.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.49 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.9 p -86.4 131.38 34.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 N-CA-C 107.057 -1.46 . . . . 64.53 107.057 174.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.525 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -107.59 -24.4 4.06 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.269 0 C-N-CA 118.334 -1.347 . . . . 61.32 111.118 -179.519 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.567 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 30.4 tt0 -168.05 175.78 6.47 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 106.388 -1.708 . . . . 62.04 106.388 178.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 118.79 -170.25 13.76 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 119.924 -1.131 . . . . 71.4 113.59 176.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -53.88 -48.32 70.19 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 124.778 1.231 . . . . 74.13 111.678 -177.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 98.0 mt -69.37 -24.52 63.89 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 112.715 0.635 . . . . 74.33 112.715 -177.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -72.48 -15.3 61.8 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-O 121.244 0.545 . . . . 71.01 110.188 -175.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt -90.58 -2.88 57.88 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.281 -0.418 . . . . 63.44 111.804 178.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 53.5 mt-10 -117.32 -34.7 4.24 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 121.762 0.792 . . . . 74.45 109.674 178.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 34.5 m-85 -124.49 132.44 53.48 Favored 'General case' 0 N--CA 1.419 -1.991 0 N-CA-C 106.711 -1.588 . . . . 72.13 106.711 179.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -80.29 -7.56 59.09 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 120.972 0.415 . . . . 74.44 111.46 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.4 t -163.05 130.56 3.61 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 108.061 -1.089 . . . . 75.33 108.061 173.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.495 ' CE2' HD22 ' A' ' 120' ' ' LEU . 92.3 t80 -143.0 115.47 8.55 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.822 -1.177 . . . . 70.43 107.822 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.409 HD21 ' CG2' ' A' ' 103' ' ' THR . 7.7 tt -138.5 129.75 27.21 Favored 'General case' 0 N--CA 1.413 -2.281 0 N-CA-C 109.006 -0.739 . . . . 75.41 109.006 -179.766 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.505 ' H ' HD23 ' A' ' 120' ' ' LEU . 1.6 pt? -131.12 139.35 49.8 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 115.404 -0.816 . . . . 73.33 110.159 -175.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 34.3 m -119.78 135.85 54.69 Favored 'General case' 0 C--N 1.282 -2.33 0 N-CA-C 109.236 -0.653 . . . . 75.31 109.236 179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.7 pt -123.89 145.63 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.001 0 CA-C-O 120.815 0.34 . . . . 72.03 110.295 177.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.5 tt0 -143.2 126.82 16.95 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 109.494 -0.558 . . . . 74.11 109.494 177.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 48.2 t -97.19 130.13 46.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.354 0 N-CA-C 108.812 -0.81 . . . . 74.13 108.812 -178.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 4.5 t -138.88 148.87 59.72 Favored Pre-proline 0 N--CA 1.42 -1.975 0 C-N-CA 119.3 -0.96 . . . . 62.02 109.145 178.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -65.21 104.91 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.453 0 C-N-CA 122.867 2.378 . . . . 65.04 109.602 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.57 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 63.2 tttm -119.2 -57.06 0.04 OUTLIER Pre-proline 0 C--N 1.291 -1.97 0 C-N-CA 120.563 -0.455 . . . . 74.23 111.309 -177.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 11.5 Cg_exo -76.58 -55.16 0.06 OUTLIER 'Trans proline' 0 C--N 1.366 1.481 0 C-N-CA 121.24 1.294 . . . . 73.52 109.829 172.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 119.03 142.13 6.75 Favored Glycine 0 N--CA 1.438 -1.201 0 CA-C-N 116.017 -0.538 . . . . 63.42 112.369 176.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 68.49 -121.24 12.56 Favored Glycine 0 N--CA 1.45 -0.416 0 O-C-N 123.701 0.294 . . . . 74.31 112.736 177.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -78.85 39.48 0.81 Allowed 'Trans proline' 0 N--CA 1.477 0.53 0 C-N-CA 123.524 2.816 . . . . 63.04 111.627 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -163.13 113.67 0.57 Allowed Glycine 0 C--N 1.274 -2.889 0 CA-C-N 114.893 -1.049 . . . . 73.41 111.099 179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 33.1 m -133.86 145.25 49.5 Favored 'General case' 0 C--N 1.298 -1.674 0 N-CA-C 108.307 -0.997 . . . . 65.03 108.307 176.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.534 HG13 ' HD3' ' A' ' 127' ' ' LYS . 43.3 mm -100.64 130.18 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.368 0 C-N-CA 120.086 -0.646 . . . . 64.02 110.932 -176.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -107.82 119.93 58.27 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.949 0 N-CA-C 108.597 -0.89 . . . . 54.44 108.597 175.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 94.3 m-70 -89.93 114.61 26.44 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 115.683 -0.69 . . . . 74.22 109.304 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 54.8 m95 -94.44 120.95 35.46 Favored 'General case' 0 N--CA 1.43 -1.425 0 N-CA-C 109.084 -0.71 . . . . 74.43 109.084 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 64.4 t60 -121.18 110.55 16.32 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 107.726 -1.213 . . . . 73.24 107.726 178.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.1 mp -114.51 132.73 56.2 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 116.148 -0.478 . . . . 74.22 109.721 -176.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.443 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 45.9 mt-10 -133.73 127.72 33.39 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.812 -1.181 . . . . 73.54 107.812 176.002 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -149.81 151.14 33.07 Favored 'General case' 0 C--N 1.299 -1.627 0 N-CA-C 113.421 0.897 . . . . 74.14 113.421 -171.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -105.38 114.68 29.01 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-N 114.104 -1.407 . . . . 61.23 108.934 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.523 ' HG2' ' OE2' ' A' ' 146' ' ' GLU . 2.0 mptm? -70.41 142.52 52.03 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.822 0.344 . . . . 72.44 111.234 176.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 63.5 mt -76.32 -42.47 36.7 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.959 0 N-CA-C 105.693 -1.966 . . . . 74.52 105.693 169.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -163.57 171.92 15.11 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 106.139 -1.8 . . . . 72.22 106.139 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.523 ' OE2' ' HG2' ' A' ' 143' ' ' LYS . 50.4 mm-40 -82.69 -32.36 28.1 Favored 'General case' 0 C--N 1.3 -1.566 0 N-CA-C 112.609 0.596 . . . . 74.44 112.609 -177.709 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -61.04 -19.75 61.74 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.801 -0.636 . . . . 64.24 110.477 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 33.0 m -109.11 2.76 9.41 Favored 'Isoleucine or valine' 0 C--O 1.202 -1.398 0 CA-C-N 115.736 -0.665 . . . . 62.02 112.226 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -91.12 132.3 36.14 Favored 'General case' 0 C--N 1.304 -1.382 0 C-N-CA 120.513 -0.475 . . . . 65.24 111.39 -176.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -126.89 83.72 65.0 Favored Pre-proline 0 C--N 1.322 -0.624 0 N-CA-C 113.357 0.873 . . . . 73.24 113.357 178.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_exo -56.92 -28.74 79.16 Favored 'Trans proline' 0 CA--C 1.554 1.515 0 C-N-CA 122.41 2.074 . . . . 65.11 111.918 172.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -58.05 -46.88 84.64 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 123.675 0.79 . . . . 74.23 110.413 178.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . 0.445 ' HA ' ' HG3' ' A' ' 156' ' ' GLN . 77.7 p -73.19 -30.61 63.66 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 116.477 -0.329 . . . . 75.21 111.192 -177.011 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.409 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.4 mt -62.61 -47.54 83.35 Favored 'General case' 0 C--O 1.236 0.365 0 CA-C-N 116.201 -0.454 . . . . 71.12 110.827 179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.424 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 69.7 mt -64.35 -37.49 87.71 Favored 'General case' 0 CA--C 1.503 -0.85 0 N-CA-C 112.358 0.503 . . . . 54.53 112.358 178.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.635 ' O ' ' HG3' ' A' ' 160' ' ' GLU 0.313 0.0 OUTLIER -72.59 -31.92 65.58 Favored 'General case' 0 C--O 1.2 -1.52 0 C-N-CA 118.391 -1.324 . . . . 73.15 112.004 176.816 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -61.61 -46.44 89.82 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.935 -0.394 . . . . 74.35 109.935 176.282 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.424 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.0 p -65.36 -35.56 81.33 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 112.4 0.519 . . . . 63.44 112.4 -178.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 156' ' ' GLN . 7.6 p -70.99 -36.65 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.101 0 C-N-CA 119.998 -0.681 . . . . 72.01 110.022 -178.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.635 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 45.9 mt-10 -62.18 -48.06 81.75 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 115.71 -0.677 . . . . 62.25 110.364 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 82.8 t -62.7 -37.54 79.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-N 116.015 -0.538 . . . . 45.51 110.598 178.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 30' ' ' VAL . 63.8 m -57.45 -37.86 73.5 Favored 'General case' 0 C--O 1.223 -0.3 0 CA-C-O 120.939 0.4 . . . . 72.31 111.372 177.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -71.61 -42.12 68.08 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.321 -0.4 . . . . 53.01 110.062 179.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.444 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 49.6 mm-40 -57.2 -48.48 78.66 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 115.679 -0.691 . . . . 74.41 110.587 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 7.9 tp -69.57 -44.09 79.94 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.128 0 CA-C-N 115.647 -0.706 . . . . 72.34 111.62 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -53.73 -44.53 69.96 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.582 0.753 . . . . 71.23 109.901 178.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -60.58 -33.09 72.21 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 112.786 0.661 . . . . 74.41 112.786 176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 47.9 m-70 -70.95 -32.45 69.34 Favored 'General case' 0 C--N 1.32 -0.708 0 C-N-CA 120.398 -0.521 . . . . 74.24 110.414 179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 8.9 mp -75.96 -41.55 51.13 Favored 'General case' 0 CA--C 1.504 -0.825 0 CA-C-N 116.068 -0.515 . . . . 54.2 111.853 177.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.15 -43.24 71.28 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 119.26 -0.976 . . . . 62.04 109.311 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 36.18 76.49 0.05 OUTLIER 'General case' 0 C--O 1.235 0.293 0 C-N-CA 125.758 1.623 . . . . 54.55 114.197 179.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -130.39 148.38 52.2 Favored 'General case' 0 C--N 1.298 -1.653 0 CA-C-N 115.267 -0.878 . . . . 51.04 109.06 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 119.054 -0.498 . . . . 74.21 110.27 -173.266 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 40.0 m . . . . . 0 CA--C 1.557 1.233 0 CA-C-O 120.91 0.386 . . . . 61.1 111.726 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -73.92 90.31 1.93 Allowed 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.645 0.736 . . . . 65.41 111.83 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 178.35 25.88 0.0 OUTLIER 'General case' 0 C--N 1.307 -1.246 0 C-N-CA 126.811 2.044 . . . . 65.42 105.849 177.053 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.1 m -57.01 -48.7 77.85 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-N 114.22 -1.355 . . . . 62.31 112.799 -172.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 20.1 m -85.99 -28.89 23.93 Favored 'General case' 0 C--N 1.306 -1.292 0 N-CA-C 111.78 0.289 . . . . 71.11 111.78 -176.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 75.9 mt 65.4 5.04 2.95 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 124.328 1.051 . . . . 64.3 112.365 -172.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.1 t -93.98 119.83 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.423 -1.789 0 N-CA-C 108.487 -0.931 . . . . 71.51 108.487 177.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -103.22 132.4 11.01 Favored Glycine 0 N--CA 1.407 -3.236 0 CA-C-N 115.102 -0.954 . . . . 71.03 110.745 -178.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.533 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -142.31 130.59 22.21 Favored 'General case' 0 C--N 1.272 -2.776 0 CA-C-O 121.291 0.567 . . . . 72.12 110.235 177.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 44.1 tp -134.47 139.81 45.77 Favored 'General case' 0 C--N 1.277 -2.566 0 N-CA-C 108.057 -1.09 . . . . 74.24 108.057 -175.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -130.29 140.16 50.69 Favored 'General case' 0 C--N 1.29 -2.02 0 N-CA-C 109.578 -0.527 . . . . 64.2 109.578 -176.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 13.3 t -150.53 156.47 41.47 Favored 'General case' 0 C--N 1.297 -1.705 0 N-CA-C 108.667 -0.864 . . . . 75.11 108.667 -178.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -124.25 117.7 25.15 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-O 121.488 0.661 . . . . 64.33 109.355 177.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 89.0 t -107.25 136.97 40.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.314 0 CA-C-N 115.128 -0.942 . . . . 74.03 109.184 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.4 mp0 -90.94 142.5 27.7 Favored 'General case' 0 C--N 1.302 -1.497 0 N-CA-C 108.751 -0.833 . . . . 70.41 108.751 -179.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.481 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 30.4 pt -121.19 167.75 14.32 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.096 0 N-CA-C 108.62 -0.881 . . . . 74.23 108.62 173.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 67.2 mttm -101.61 -22.77 14.39 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 108.103 -1.073 . . . . 71.31 108.103 179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.77 158.91 31.32 Favored 'General case' 0 N--CA 1.43 -1.451 0 CA-C-N 114.728 -1.124 . . . . 74.14 110.315 175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.407 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 19.5 m -96.51 137.65 35.26 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 116.146 -0.479 . . . . 73.31 111.042 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.436 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -54.54 -32.79 58.95 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.724 0.81 . . . . 61.12 111.355 178.038 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.49 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 22.8 t70 -55.46 -42.69 74.64 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.158 -0.928 . . . . 73.0 111.929 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 45.9 mtpt -71.2 -30.13 66.02 Favored 'General case' 0 CA--C 1.51 -0.581 0 C-N-CA 120.527 -0.469 . . . . 75.33 111.39 -177.43 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 40.4 t80 -64.13 -43.87 93.94 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 107.685 -1.228 . . . . 73.31 107.685 177.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.565 ' CE1' ' HA ' ' A' ' 98' ' ' ASP . 4.7 t60 -59.64 -48.82 80.18 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 114.518 -1.219 . . . . 75.4 109.812 178.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.49 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 32.8 m-70 -66.13 -44.29 84.68 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 113.51 0.93 . . . . 64.45 113.51 -177.475 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 25.1 ptt? -65.29 -23.91 67.15 Favored 'General case' 0 N--CA 1.469 0.488 0 N-CA-C 113.571 0.952 . . . . 74.22 113.571 -173.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.41 ' C ' ' H ' ' A' ' 45' ' ' GLY . 43.7 t80 -101.36 5.26 42.16 Favored 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 119.128 -1.029 . . . . 72.41 110.888 -177.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -79.6 22.21 0.47 Allowed 'General case' 0 CA--C 1.552 1.029 0 O-C-N 121.447 -0.783 . . . . 74.33 111.013 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.41 ' H ' ' C ' ' A' ' 43' ' ' PHE . . . 160.87 -143.48 8.99 Favored Glycine 0 N--CA 1.42 -2.375 0 N-CA-C 109.214 -1.554 . . . . 75.11 109.214 -178.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.492 ' HD3' ' N ' ' A' ' 46' ' ' LYS . 0.0 OUTLIER -146.56 146.83 28.45 Favored Pre-proline 0 C--N 1.296 -1.753 0 N-CA-C 108.347 -0.983 . . . . 74.03 108.347 178.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.96 172.53 16.18 Favored 'Trans proline' 0 C--O 1.244 0.796 0 C-N-CA 122.185 1.923 . . . . 71.24 111.904 -179.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 51.9 m-70 -82.78 97.3 8.53 Favored 'General case' 0 C--N 1.31 -1.149 0 CA-C-O 121.704 0.764 . . . . 51.31 109.117 177.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -113.29 119.91 39.34 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.94 -1.027 . . . . 75.1 109.563 -174.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.4 m -84.16 140.88 15.49 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 N-CA-C 108.636 -0.876 . . . . 73.32 108.636 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.499 ' OG ' ' HB3' ' A' ' 64' ' ' HIS . 14.6 t -140.94 -176.72 4.78 Favored 'General case' 0 C--N 1.279 -2.457 0 N-CA-C 106.869 -1.53 . . . . 64.55 106.869 -175.758 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.0 ttmt -70.79 123.52 22.14 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 120.058 -0.657 . . . . 73.22 111.502 -177.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -72.84 109.29 6.32 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.698 -1.137 . . . . 61.23 111.327 -175.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 43.0 m -149.34 83.14 6.64 Favored Pre-proline 0 C--N 1.298 -1.65 0 CA-C-N 116.331 -0.395 . . . . 61.03 110.171 176.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_exo -73.48 148.53 42.91 Favored 'Trans proline' 0 C--O 1.252 1.18 0 C-N-CA 122.416 2.077 . . . . 72.34 110.776 178.423 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -94.33 -175.72 38.96 Favored Glycine 0 N--CA 1.428 -1.837 0 N-CA-C 111.181 -0.768 . . . . 73.52 111.181 179.194 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -84.07 103.09 13.01 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 109.783 -0.451 . . . . 63.43 109.783 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 58' ' ' ILE . 42.0 mm 64.44 23.17 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.575 1.934 0 CA-C-O 122.406 1.098 . . . . 65.01 110.606 177.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 24.9 pt20 -165.62 179.66 5.91 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.557 -0.747 . . . . 60.4 109.193 177.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 148.62 -163.85 29.05 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 120.053 -1.07 . . . . 53.12 112.104 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 48.7 t -147.01 152.04 37.94 Favored 'General case' 0 C--N 1.301 -1.514 0 N-CA-C 108.412 -0.959 . . . . 73.51 108.412 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -78.2 -50.68 11.47 Favored 'General case' 0 CA--C 1.509 -0.624 0 N-CA-C 109.206 -0.664 . . . . 74.14 109.206 -179.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.8 mp -88.91 111.18 21.79 Favored 'General case' 0 C--N 1.309 -1.189 0 N-CA-C 108.808 -0.812 . . . . 74.11 108.808 176.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.499 ' HB3' ' OG ' ' A' ' 51' ' ' SER . 15.0 t60 -63.72 -41.0 98.13 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 107.56 -1.274 . . . . 71.44 107.56 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -144.88 148.38 33.86 Favored 'General case' 0 C--O 1.241 0.645 0 C-N-CA 125.366 1.466 . . . . 74.32 107.225 175.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 150.53 -159.58 28.2 Favored Glycine 0 C--N 1.319 -0.406 0 C-N-CA 119.984 -1.103 . . . . 75.54 112.917 179.058 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 7.2 m-20 -80.89 129.73 34.68 Favored 'General case' 0 CA--C 1.494 -1.179 0 C-N-CA 123.284 0.634 . . . . 72.45 109.906 -178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -93.34 -17.11 23.94 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 119.721 -0.792 . . . . 73.41 110.38 179.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 75.39 12.59 83.52 Favored Glycine 0 CA--C 1.523 0.553 0 N-CA-C 115.432 0.933 . . . . 55.05 115.432 170.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 11.1 t -144.7 -177.91 5.74 Favored 'General case' 0 C--N 1.31 -1.121 0 CA-C-N 117.866 0.833 . . . . 51.12 110.397 -177.18 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.414 HG22 HG12 ' A' ' 95' ' ' VAL . 41.2 t -66.5 134.8 29.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 N-CA-C 108.67 -0.863 . . . . 61.31 108.67 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.52 -1.92 69.82 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.261 -0.971 . . . . 74.04 111.958 -179.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.541 ' HB3' HD12 ' A' ' 92' ' ' ILE . 29.5 t -63.03 143.48 57.74 Favored 'General case' 0 C--O 1.246 0.879 0 N-CA-C 109.136 -0.69 . . . . 44.22 109.136 178.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.405 HG23 ' O ' ' A' ' 90' ' ' GLU . 78.6 mt -128.33 116.69 42.97 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.514 0 CA-C-N 115.601 -0.727 . . . . 62.43 109.251 179.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.595 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 40.0 t -117.81 165.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.222 0 N-CA-C 107.406 -1.331 . . . . 75.41 107.406 179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 49.2 m-85 -126.56 133.34 51.11 Favored 'General case' 0 N--CA 1.437 -1.085 0 O-C-N 121.918 -0.489 . . . . 73.53 111.213 -178.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 5.7 m-90 -107.66 129.56 55.0 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.996 -0.742 . . . . 73.14 108.996 177.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 -102.58 131.05 49.58 Favored 'General case' 0 C--N 1.297 -1.707 0 N-CA-C 107.937 -1.134 . . . . 55.14 107.937 176.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 21.9 p90 -150.62 148.48 28.68 Favored 'General case' 0 C--N 1.288 -2.099 0 N-CA-C 109.495 -0.557 . . . . 62.45 109.495 -178.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 83.8 t -106.1 118.54 53.88 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.305 0 N-CA-C 109.016 -0.735 . . . . 72.4 109.016 -178.388 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 73.3 t60 -126.07 117.12 22.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.736 -0.839 . . . . 71.41 108.736 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 64.72 32.1 11.43 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 124.03 0.831 . . . . 71.41 112.121 -179.113 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 90.33 -12.26 68.64 Favored Glycine 0 C--N 1.315 -0.589 0 CA-C-N 115.76 -0.655 . . . . 71.31 114.175 175.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.5 ' HB2' ' NZ ' ' A' ' 86' ' ' LYS . 47.4 mt-10 -100.71 150.47 22.72 Favored 'General case' 0 CA--C 1.475 -1.924 0 CA-C-N 117.415 0.607 . . . . 63.22 109.676 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -89.62 114.82 26.47 Favored 'General case' 0 C--N 1.279 -2.471 0 N-CA-C 108.721 -0.844 . . . . 52.53 108.721 176.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.5 ' NZ ' ' HB2' ' A' ' 84' ' ' GLU . 12.8 mptt -102.68 150.95 22.93 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 115.434 -0.803 . . . . 73.03 109.816 178.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 61.6 t -124.39 135.83 62.51 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.732 0 N-CA-C 107.983 -1.117 . . . . 72.11 107.983 178.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.03 131.33 54.69 Favored 'General case' 0 C--N 1.295 -1.785 0 N-CA-C 108.668 -0.864 . . . . 70.34 108.668 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.457 ' HB3' HD11 ' A' ' 107' ' ' ILE . 65.2 mttm -114.72 127.48 55.77 Favored 'General case' 0 N--CA 1.411 -2.412 0 N-CA-C 106.635 -1.617 . . . . 71.33 106.635 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.595 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 12.1 pt-20 -121.62 162.53 20.51 Favored 'General case' 0 C--N 1.296 -1.727 0 C-N-CA 123.204 0.602 . . . . 72.33 110.716 -170.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 105' ' ' ARG . 19.3 tpt180 -137.96 122.25 18.19 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 107.873 -1.158 . . . . 65.24 107.873 172.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.541 HD12 ' HB3' ' A' ' 73' ' ' SER . 52.2 mt -79.06 122.96 35.37 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.066 0 C-N-CA 119.404 -0.919 . . . . 54.54 108.684 175.232 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -99.4 -41.25 7.5 Favored 'General case' 0 C--N 1.304 -1.372 0 CA-C-O 121.325 0.583 . . . . 51.12 110.392 -176.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.76 136.31 20.44 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.008 -1.108 . . . . 73.42 108.008 179.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.414 HG12 HG22 ' A' ' 71' ' ' VAL . 7.8 p -147.51 129.8 7.19 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 C-N-CA 120.197 -0.601 . . . . 73.34 111.465 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.7 tp10 -121.69 105.76 37.98 Favored Pre-proline 0 N--CA 1.42 -1.942 0 N-CA-C 107.461 -1.311 . . . . 73.55 107.461 176.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_exo -65.81 -28.63 51.1 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 123.045 2.497 . . . . 73.33 111.574 179.287 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . 0.565 ' HA ' ' CE1' ' A' ' 40' ' ' HIS . 21.5 t70 -74.47 -36.22 63.31 Favored 'General case' 0 CA--C 1.507 -0.678 0 C-N-CA 120.413 -0.515 . . . . 73.52 111.848 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.627 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 48.3 mmtm -100.24 1.66 42.05 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.711 -0.677 . . . . 72.34 110.946 -176.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.485 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 82.0 m-20 59.83 45.79 12.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 124.069 0.855 . . . . 73.24 110.108 -178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.575 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 34.2 tp -118.08 135.0 54.47 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.615 -0.72 . . . . 74.33 109.959 -175.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.8 tt -150.3 127.69 2.45 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.266 0 CA-C-O 121.655 0.74 . . . . 75.13 111.917 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 62.2 m -99.18 119.8 38.47 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.915 -1.039 . . . . 74.05 109.735 176.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 99.4 m-85 -103.36 133.35 48.58 Favored 'General case' 0 C--N 1.316 -0.891 0 C-N-CA 123.247 0.619 . . . . 64.11 110.072 179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.516 ' HB3' ' HB3' ' A' ' 91' ' ' ARG . 13.6 ttm180 -108.93 118.37 36.61 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 106.048 -1.834 . . . . 74.33 106.048 170.457 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 58.1 t -80.37 124.34 38.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 N-CA-C 108.365 -0.976 . . . . 71.54 108.365 179.289 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.457 HD11 ' HB3' ' A' ' 89' ' ' LYS . 20.7 pt -99.74 -45.15 11.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 C-N-CA 120.35 -0.54 . . . . 72.41 112.05 -175.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -72.04 -72.08 0.25 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 107.901 -1.148 . . . . 72.44 107.901 175.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.577 ' HA3' ' SD ' ' A' ' 112' ' ' MET . . . 66.02 110.64 0.01 OUTLIER Glycine 0 N--CA 1.429 -1.788 0 N-CA-C 117.345 1.698 . . . . 73.3 117.345 171.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -68.57 -28.43 66.95 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 105.933 -1.877 . . . . 62.53 105.933 167.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.531 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.1 mm? -64.64 -29.6 70.61 Favored 'General case' 0 C--O 1.211 -0.939 0 CA-C-N 112.994 -1.912 . . . . 72.44 110.012 178.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.606 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 0.0 OUTLIER -63.65 -10.39 18.69 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 113.657 0.984 . . . . 65.54 113.657 -178.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -87.4 -20.09 27.17 Favored 'General case' 0 C--N 1.302 -1.467 0 C-N-CA 119.86 -0.736 . . . . 64.25 109.96 179.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -109.28 -33.66 6.78 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.737 -0.665 . . . . 71.25 110.8 178.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.606 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.9 m-85 -121.49 136.41 54.96 Favored 'General case' 0 CA--C 1.491 -1.298 0 N-CA-C 107.388 -1.338 . . . . 74.42 107.388 -177.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 ptmt -80.5 0.29 34.27 Favored 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 112.599 0.592 . . . . 72.35 112.599 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 36.6 t -175.32 145.25 0.75 Allowed 'General case' 0 N--CA 1.441 -0.912 0 C-N-CA 123.994 0.918 . . . . 74.11 108.712 174.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.535 ' CE1' HD12 ' A' ' 154' ' ' LEU . 93.8 t80 -142.78 111.58 6.37 Favored 'General case' 0 C--N 1.31 -1.136 0 N-CA-C 108.784 -0.821 . . . . 74.51 108.784 -179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 37.1 tp -117.37 128.77 55.36 Favored 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.447 -1.316 . . . . 64.23 107.447 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.528 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -133.61 132.54 40.92 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.013 -0.675 . . . . 55.13 110.839 -178.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.423 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 49.9 m -115.96 125.91 53.16 Favored 'General case' 0 N--CA 1.412 -2.36 0 N-CA-C 109.074 -0.713 . . . . 73.21 109.074 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.8 pt -117.26 149.06 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.493 0 N-CA-C 109.199 -0.667 . . . . 75.31 109.199 179.322 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.485 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 61.1 tt0 -143.95 127.13 16.6 Favored 'General case' 0 C--N 1.291 -1.935 0 N-CA-C 109.076 -0.713 . . . . 63.24 109.076 176.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 38.6 t -95.25 111.74 26.35 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 N-CA-C 108.924 -0.769 . . . . 71.21 108.924 -177.349 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 52.6 m -124.82 134.92 26.07 Favored Pre-proline 0 C--N 1.293 -1.87 0 CA-C-N 115.12 -0.945 . . . . 74.2 109.24 -174.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -63.73 154.27 70.4 Favored 'Trans proline' 0 C--O 1.252 1.211 0 C-N-CA 122.596 2.198 . . . . 62.3 111.421 177.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.59 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.6 tttt -147.01 -60.29 0.02 OUTLIER Pre-proline 0 C--N 1.312 -1.039 0 CA-C-O 119.339 -0.362 . . . . 72.11 111.754 -177.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.59 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 61.3 Cg_endo -92.02 6.89 3.31 Favored 'Trans proline' 0 C--N 1.375 1.922 0 C-N-CA 121.4 1.4 . . . . 73.45 110.75 176.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 147.84 -166.83 28.82 Favored Glycine 0 N--CA 1.427 -1.938 0 N-CA-C 109.181 -1.568 . . . . 31.23 109.181 -177.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -77.39 -75.28 0.94 Allowed Glycine 0 CA--C 1.524 0.601 0 N-CA-C 111.597 -0.601 . . . . 51.04 111.597 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.407 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 9.8 Cg_endo -54.43 129.23 33.67 Favored 'Trans proline' 0 C--N 1.359 1.119 0 C-N-CA 123.035 2.49 . . . . 64.24 110.615 174.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 83.31 73.03 1.26 Allowed Glycine 0 N--CA 1.432 -1.597 0 N-CA-C 109.254 -1.539 . . . . 44.42 109.254 -175.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.3 m -98.5 173.7 6.81 Favored 'General case' 0 N--CA 1.428 -1.54 0 CA-C-O 121.026 0.441 . . . . 73.31 111.001 -174.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.505 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.1 mm -108.8 137.34 41.2 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.165 0 N-CA-C 109.459 -0.571 . . . . 65.14 109.459 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 12.2 t -102.89 116.57 46.86 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.477 0 N-CA-C 107.667 -1.234 . . . . 44.23 107.667 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -89.86 110.92 21.82 Favored 'General case' 0 C--N 1.285 -2.198 0 N-CA-C 108.281 -1.007 . . . . 75.24 108.281 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -98.29 123.9 42.63 Favored 'General case' 0 C--N 1.304 -1.373 0 CA-C-N 115.867 -0.606 . . . . 73.25 110.327 -177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.9 m-70 -118.59 112.09 19.42 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 107.046 -1.465 . . . . 63.3 107.046 175.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.437 HD23 ' HB3' ' A' ' 154' ' ' LEU . 3.4 mp -107.89 123.84 49.21 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.388 -0.597 . . . . 65.35 109.388 -176.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -129.24 127.73 41.85 Favored 'General case' 0 C--N 1.301 -1.539 0 N-CA-C 108.642 -0.873 . . . . 74.53 108.642 -178.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.7 p90 -151.22 159.02 44.62 Favored 'General case' 0 C--N 1.298 -1.631 0 N-CA-C 113.054 0.761 . . . . 75.51 113.054 -173.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -110.45 128.77 55.76 Favored 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 115.435 -0.802 . . . . 74.21 108.978 -176.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.478 ' HE3' ' HA3' ' A' ' 24' ' ' GLY . 1.3 mptm? -76.23 133.2 40.18 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.054 0.454 . . . . 70.14 112.151 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 68.1 mt -75.77 -42.81 40.51 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 N-CA-C 107.276 -1.379 . . . . 72.13 107.276 171.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.491 ' HB3' ' CG2' ' A' ' 148' ' ' VAL . 48.4 t -156.19 165.79 35.36 Favored 'General case' 0 N--CA 1.425 -1.704 0 CA-C-N 114.453 -1.249 . . . . 65.51 107.763 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -67.14 -59.63 3.29 Favored 'General case' 0 C--N 1.315 -0.891 0 C-N-CA 122.956 0.502 . . . . 71.31 111.731 -176.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -65.92 -20.75 66.32 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 114.798 -1.092 . . . . 75.33 111.73 -175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.491 ' CG2' ' HB3' ' A' ' 145' ' ' SER . 61.8 t -79.73 -32.01 14.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 CA-C-N 115.104 -0.953 . . . . 75.34 110.581 -176.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.418 ' HB2' ' HG3' ' A' ' 143' ' ' LYS . . . -79.78 135.72 36.56 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-N 115.854 -0.612 . . . . 70.43 110.791 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 62.9 m-70 -137.57 89.91 15.24 Favored Pre-proline 0 C--N 1.315 -0.928 0 N-CA-C 109.656 -0.498 . . . . 73.53 109.656 178.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.557 ' HA ' HD23 ' A' ' 154' ' ' LEU . 44.4 Cg_exo -44.95 -22.75 0.75 Allowed 'Trans proline' 0 N--CA 1.494 1.522 0 C-N-CA 124.679 3.586 . . . . 73.4 115.851 -176.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.433 ' O ' ' HG3' ' A' ' 156' ' ' GLN . 19.1 mm-40 -56.84 -44.1 81.77 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.906 0.86 . . . . 74.22 110.036 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.5 p -59.46 -32.36 70.16 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.297 -1.32 . . . . 61.21 112.628 -173.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.557 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.7 mm? -73.42 -36.34 65.96 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.026 0.441 . . . . 73.22 110.311 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 84.2 mt -72.01 -28.09 63.16 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.084 -0.507 . . . . 74.32 110.425 178.469 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.452 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 46.7 mt-30 -71.7 -43.42 65.97 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.813 -0.63 . . . . 72.14 109.841 175.205 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.5 t80 -59.51 -42.13 91.52 Favored 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 108.74 -0.837 . . . . 73.31 108.74 175.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 39.5 t -58.76 -51.52 69.62 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.083 -0.962 . . . . 71.42 112.381 178.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' A' ' 156' ' ' GLN . 14.4 p -66.39 -38.59 82.11 Favored 'Isoleucine or valine' 0 C--O 1.247 0.96 0 CA-C-O 121.017 0.436 . . . . 73.01 111.967 -175.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.452 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 21.1 mm-40 -68.13 -36.66 80.07 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-N 115.875 -0.602 . . . . 64.3 110.869 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.8 t -75.03 -39.49 44.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 C-N-CA 120.576 -0.45 . . . . 75.43 110.596 177.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 60.3 m -55.68 -44.76 77.61 Favored 'General case' 0 C--N 1.345 0.387 0 CA-C-O 120.762 0.315 . . . . 52.2 111.815 179.427 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.435 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 0.2 OUTLIER -70.38 -35.96 73.83 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.393 -0.367 . . . . 71.24 110.8 -179.15 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -65.57 -51.47 59.57 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.86 -0.609 . . . . 63.44 110.411 -178.0 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -40.51 79.06 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.733 0 CA-C-N 115.674 -0.694 . . . . 73.5 110.656 -175.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.481 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 25.0 t70 -58.47 -52.67 64.64 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 112.631 0.604 . . . . 72.14 112.631 -177.486 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.435 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.5 pt-20 -73.46 -29.8 62.77 Favored 'General case' 0 C--O 1.207 -1.184 0 C-N-CA 119.44 -0.904 . . . . 71.44 111.903 -179.249 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 28.6 t60 -54.0 -37.35 63.93 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 110.452 -0.203 . . . . 55.43 110.452 176.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 82.4 mt -75.18 -30.49 60.69 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 111.9 0.334 . . . . 73.42 111.9 -179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 95.5 mt -83.11 -25.79 31.63 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-O 121.24 0.543 . . . . 75.32 110.691 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -67.83 -19.04 65.02 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.161 -0.927 . . . . 73.34 112.017 -179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -121.77 162.09 21.46 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-O 120.763 0.316 . . . . 72.34 110.593 -179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 . . . . . 0 C--N 1.295 -1.762 0 N-CA-C 107.624 -1.251 . . . . 74.54 107.624 176.206 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.573 1.833 0 CA-C-O 121.581 0.705 . . . . 73.01 112.489 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 44.5 tt0 -71.07 121.02 17.49 Favored 'General case' 0 C--O 1.25 1.094 0 O-C-N 121.358 -0.838 . . . . 74.01 109.222 178.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.05 142.04 18.14 Favored 'General case' 0 N--CA 1.418 -2.044 0 CA-C-N 116.107 -0.497 . . . . 72.34 110.375 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 14.4 p -72.57 -36.87 68.3 Favored 'General case' 0 C--N 1.308 -1.212 0 N-CA-C 112.722 0.638 . . . . 60.45 112.722 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 78.6 p -86.37 -22.35 26.69 Favored 'General case' 0 C--N 1.314 -0.936 0 C-N-CA 120.856 -0.338 . . . . 72.35 111.69 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 80.5 mt 66.88 -4.66 0.75 Allowed 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.568 1.147 . . . . 74.23 113.132 -173.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 78.3 t -74.91 130.91 35.8 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.622 0 N-CA-C 108.311 -0.996 . . . . 73.12 108.311 177.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -138.9 150.64 21.3 Favored Glycine 0 N--CA 1.402 -3.586 0 C-N-CA 120.356 -0.926 . . . . 74.12 111.148 -178.345 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.34 145.19 29.23 Favored 'General case' 0 N--CA 1.402 -2.83 0 N-CA-C 109.179 -0.674 . . . . 72.22 109.179 178.254 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.1 tt -132.47 139.19 47.87 Favored 'General case' 0 C--N 1.274 -2.682 0 N-CA-C 108.029 -1.1 . . . . 72.4 108.029 -175.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.423 ' N ' HD23 ' A' ' 26' ' ' LEU . 31.9 tt0 -133.35 127.62 33.92 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 108.876 -0.787 . . . . 73.3 108.876 179.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.6 t -140.97 161.85 36.87 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.792 -0.818 . . . . 65.22 108.792 -178.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -127.52 132.57 49.91 Favored 'General case' 0 C--N 1.299 -1.609 0 N-CA-C 109.392 -0.595 . . . . 73.22 109.392 179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.517 HG11 ' CB ' ' A' ' 162' ' ' SER . 91.3 t -120.31 137.61 53.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 N-CA-C 108.109 -1.071 . . . . 74.13 108.109 177.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.508 ' HG2' HD12 ' A' ' 134' ' ' ILE . 30.4 mt-10 -94.18 136.94 33.92 Favored 'General case' 0 C--N 1.292 -1.902 0 C-N-CA 119.982 -0.687 . . . . 64.3 109.362 179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 32.2 pt -117.66 158.48 18.39 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 N-CA-C 108.165 -1.05 . . . . 74.11 108.165 175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.515 ' HB2' HD11 ' A' ' 170' ' ' LEU . 41.7 mttp -91.38 -15.48 28.91 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 107.888 -1.153 . . . . 74.11 107.888 -177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.16 149.85 35.57 Favored 'General case' 0 N--CA 1.427 -1.614 0 CA-C-N 114.193 -1.367 . . . . 41.32 111.896 -178.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.474 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 75.5 m -80.55 130.96 35.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.562 -1.199 . . . . 63.43 111.614 -179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.478 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -63.65 -35.69 81.38 Favored 'General case' 0 CA--C 1.502 -0.866 0 N-CA-C 108.345 -0.983 . . . . 73.33 108.345 173.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -57.39 -42.05 81.46 Favored 'General case' 0 CA--C 1.511 -0.554 0 CA-C-N 114.634 -1.166 . . . . 72.45 109.799 175.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.474 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 86.7 tttt -70.04 -38.23 75.77 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 115.628 -0.715 . . . . 73.53 110.535 -178.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -64.34 -40.05 95.1 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 107.181 -1.415 . . . . 62.54 107.181 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -60.97 -30.33 70.19 Favored 'General case' 0 CA--C 1.546 0.817 0 CA-C-N 115.011 -0.995 . . . . 72.14 110.891 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 51.2 m170 -62.58 -29.54 70.67 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-O 120.674 0.274 . . . . 55.44 110.909 176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 66.1 mtt -74.16 -26.63 60.41 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 116.579 -0.282 . . . . 73.52 111.738 -179.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -82.85 -32.21 27.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.562 0.696 . . . . 73.43 109.595 176.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.39 28.49 3.68 Favored 'General case' 0 C--N 1.306 -1.323 0 N-CA-C 108.346 -0.983 . . . . 71.41 108.346 177.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -91.41 48.46 2.88 Favored Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.101 -0.954 . . . . 42.13 114.116 -175.117 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.6 mppt? -112.04 95.89 31.72 Favored Pre-proline 0 C--N 1.306 -1.316 0 N-CA-C 107.716 -1.216 . . . . 75.2 107.716 170.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_exo -69.85 176.79 6.38 Favored 'Trans proline' 0 C--O 1.249 1.025 0 C-N-CA 123.018 2.478 . . . . 74.13 113.21 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -79.96 150.64 30.42 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 108.328 -0.99 . . . . 72.0 108.328 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 12.5 t60 -130.86 109.46 10.58 Favored 'General case' 0 C--N 1.292 -1.902 0 N-CA-C 108.768 -0.827 . . . . 53.15 108.768 -177.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 34.8 m -73.33 149.07 8.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.002 0 CA-C-O 120.818 0.342 . . . . 74.43 111.149 -178.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.452 ' OG ' ' HB2' ' A' ' 54' ' ' SER . 47.8 t -140.96 90.51 2.33 Favored 'General case' 0 N--CA 1.432 -1.368 0 CA-C-O 121.019 0.438 . . . . 73.44 111.377 -177.6 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -84.59 -40.19 17.82 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 107.853 -1.166 . . . . 75.33 107.853 174.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -148.54 85.81 1.52 Allowed 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 107.988 -1.116 . . . . 42.41 107.988 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.452 ' HB2' ' OG ' ' A' ' 51' ' ' SER . 46.9 m -152.58 102.4 2.72 Favored Pre-proline 0 N--CA 1.435 -1.203 0 CA-C-N 116.052 -0.522 . . . . 41.43 112.222 -176.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -72.09 -22.41 22.72 Favored 'Trans proline' 0 CA--C 1.536 0.594 0 C-N-CA 122.124 1.883 . . . . 73.54 109.689 173.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.34 71.88 0.04 OUTLIER Glycine 0 CA--C 1.492 -1.346 0 N-CA-C 108.746 -1.741 . . . . 71.22 108.746 179.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -93.16 92.0 7.56 Favored 'General case' 0 CA--C 1.495 -1.153 0 N-CA-C 113.422 0.897 . . . . 73.43 113.422 -172.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.451 HG22 ' H ' ' A' ' 60' ' ' GLY . 42.6 mm -122.95 123.24 67.62 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.862 0 N-CA-C 106.11 -1.811 . . . . 64.44 106.11 174.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.468 ' HG3' ' SG ' ' A' ' 61' ' ' CYS . 10.9 pt20 -82.66 -5.78 59.03 Favored 'General case' 0 C--N 1.306 -1.315 0 N-CA-C 112.3 0.481 . . . . 73.31 112.3 -177.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.451 ' H ' HG22 ' A' ' 58' ' ' ILE . . . 72.13 74.54 0.75 Allowed Glycine 0 N--CA 1.439 -1.12 0 C-N-CA 121.155 -0.545 . . . . 73.33 112.636 176.558 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.468 ' SG ' ' HG3' ' A' ' 59' ' ' GLN . 61.9 m -104.54 -1.78 26.1 Favored 'General case' 0 C--N 1.301 -1.542 0 CA-C-O 121.711 0.767 . . . . 73.23 109.297 178.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -87.73 135.95 33.16 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 115.202 -0.908 . . . . 72.45 112.156 -176.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 95.8 mt -133.85 -60.29 0.83 Allowed 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 105.901 -1.888 . . . . 70.33 105.901 172.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 67.7 m80 -148.87 115.84 6.04 Favored 'General case' 0 CA--C 1.5 -0.958 0 N-CA-C 107.004 -1.48 . . . . 74.14 107.004 173.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -93.66 -6.07 47.22 Favored 'General case' 0 C--N 1.307 -1.277 0 CA-C-O 121.755 0.788 . . . . 72.5 109.933 -178.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.88 -130.92 3.07 Favored Glycine 0 CA--C 1.479 -2.171 0 N-CA-C 109.013 -1.635 . . . . 60.12 109.013 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -87.17 -171.77 3.65 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 107.863 -1.162 . . . . 72.43 107.863 176.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -77.54 -17.31 58.04 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 112.251 0.463 . . . . 74.3 112.251 -175.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.54 13.93 82.95 Favored Glycine 0 CA--C 1.505 -0.573 0 C-N-CA 120.694 -0.765 . . . . 75.44 112.137 177.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.507 ' HB ' ' OG ' ' A' ' 73' ' ' SER . 37.6 m -126.85 143.09 51.37 Favored 'General case' 0 N--CA 1.426 -1.65 0 CA-C-O 120.849 0.357 . . . . 53.42 110.699 -174.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 71.8 t -70.7 131.38 34.43 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 N-CA-C 109.469 -0.567 . . . . 63.03 109.469 177.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 94.79 -3.7 67.97 Favored Glycine 0 N--CA 1.446 -0.684 0 N-CA-C 112.028 -0.429 . . . . 71.34 112.028 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.507 ' OG ' ' HB ' ' A' ' 70' ' ' THR . 61.3 m -78.19 148.21 34.14 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 121.068 0.461 . . . . 62.43 111.485 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.427 HG23 ' O ' ' A' ' 90' ' ' GLU . 86.9 mt -115.71 126.31 73.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-N 115.737 -0.665 . . . . 75.12 109.475 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.6 p -130.47 157.86 42.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 N-CA-C 108.099 -1.074 . . . . 72.31 108.099 -177.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.4 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 55.1 m-85 -125.92 124.47 40.88 Favored 'General case' 0 CA--C 1.501 -0.941 0 CA-C-O 120.97 0.414 . . . . 72.52 110.378 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -109.64 138.48 45.95 Favored 'General case' 0 N--CA 1.418 -2.068 0 N-CA-C 109.157 -0.682 . . . . 60.23 109.157 -178.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -102.48 132.01 48.8 Favored 'General case' 0 CA--C 1.496 -1.123 0 N-CA-C 108.32 -0.993 . . . . 54.04 108.32 179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.7 ' CE1' ' HG3' ' A' ' 86' ' ' LYS . 32.7 p90 -146.0 156.89 43.8 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 116.319 -0.4 . . . . 63.22 110.184 -177.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.499 ' HA ' ' O ' ' A' ' 84' ' ' GLU . 63.4 t -106.33 118.02 53.19 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.886 0 N-CA-C 107.267 -1.382 . . . . 34.11 107.267 175.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.512 ' HB3' ' HD3' ' A' ' 86' ' ' LYS . 66.9 t60 -139.97 121.2 14.86 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 108.066 -1.087 . . . . 74.43 108.066 -176.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 44.2 m-20 64.16 29.69 13.91 Favored 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 124.186 0.995 . . . . 65.13 110.305 -174.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.54 -7.44 73.03 Favored Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 115.735 -0.666 . . . . 71.42 113.537 177.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.662 ' HB2' ' HD2' ' A' ' 86' ' ' LYS . 43.6 mt-10 -94.91 138.58 32.48 Favored 'General case' 0 CA--C 1.47 -2.11 0 CA-C-N 117.035 0.418 . . . . 74.14 110.241 178.26 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -87.03 113.45 22.79 Favored 'General case' 0 C--N 1.277 -2.546 0 N-CA-C 103.801 -2.666 . . . . 71.51 103.801 169.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.7 ' HG3' ' CE1' ' A' ' 79' ' ' TYR . 12.6 ptmt -137.3 157.24 47.06 Favored 'General case' 0 C--N 1.272 -2.765 0 CA-C-N 116.108 -0.496 . . . . 63.14 111.362 -170.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 43.5 t -115.54 148.38 18.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 CA-C-N 116.137 -0.483 . . . . 65.22 110.177 -173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.79 135.09 51.26 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 107.86 -1.163 . . . . 52.04 107.86 174.358 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.543 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 96.0 mttt -102.82 119.46 38.88 Favored 'General case' 0 N--CA 1.397 -3.098 0 N-CA-C 105.388 -2.078 . . . . 71.51 105.388 175.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.427 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.9 pt-20 -144.98 154.21 42.31 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.376 0.608 . . . . 75.33 111.41 -169.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -122.57 137.5 54.87 Favored 'General case' 0 C--N 1.292 -1.893 0 N-CA-C 107.919 -1.141 . . . . 73.31 107.919 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 50.7 mm -74.15 121.03 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.179 0 N-CA-C 105.295 -2.113 . . . . 73.33 105.295 173.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -95.15 -35.93 11.68 Favored 'General case' 0 C--N 1.296 -1.748 0 C-N-CA 119.85 -0.74 . . . . 60.24 109.408 -175.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.8 140.89 11.13 Favored 'General case' 0 C--N 1.313 -1.004 0 N-CA-C 108.18 -1.044 . . . . 74.14 108.18 179.487 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.416 ' HA ' ' O ' ' A' ' 101' ' ' LEU . 7.1 p -146.5 123.45 3.61 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.196 0 CA-C-O 121.219 0.533 . . . . 73.11 111.369 178.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.454 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 71.4 mm-40 -105.14 107.24 58.44 Favored Pre-proline 0 C--N 1.3 -1.579 0 N-CA-C 107.724 -1.213 . . . . 64.15 107.724 175.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -63.32 -45.59 11.64 Favored 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.08 1.853 . . . . 61.3 111.411 178.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 34.4 t70 -79.88 -36.22 36.88 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.554 0.575 . . . . 61.34 112.554 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 64.3 mttm -86.99 -6.54 58.72 Favored 'General case' 0 CA--C 1.503 -0.842 0 C-N-CA 120.072 -0.651 . . . . 72.42 112.147 -177.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.712 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 26.8 t-20 58.98 75.49 0.4 Allowed 'General case' 0 C--O 1.21 -0.991 0 O-C-N 124.34 1.025 . . . . 65.4 110.069 -176.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.454 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 59.1 tp -140.32 134.96 31.7 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 109.347 -0.612 . . . . 51.24 109.347 179.345 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 13.0 tt -144.65 122.29 5.28 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.894 0.854 . . . . 73.11 110.873 176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.42 HG23 ' OG1' ' A' ' 121' ' ' THR . 26.5 m -101.82 124.75 47.98 Favored 'General case' 0 C--N 1.295 -1.778 0 CA-C-N 114.991 -1.004 . . . . 54.15 110.564 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -103.2 126.85 50.57 Favored 'General case' 0 C--O 1.237 0.432 0 N-CA-C 109.117 -0.697 . . . . 64.34 109.117 179.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -118.14 118.01 30.73 Favored 'General case' 0 C--N 1.3 -1.555 0 N-CA-C 105.382 -2.081 . . . . 75.3 105.382 176.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.555 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.6 p -74.24 130.75 35.8 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.957 0 N-CA-C 107.373 -1.343 . . . . 74.32 107.373 -178.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 17.3 pt -99.37 -40.86 9.17 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.078 0 C-N-CA 119.794 -0.763 . . . . 71.41 111.726 -177.547 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -155.58 154.99 32.54 Favored 'General case' 0 N--CA 1.428 -1.529 0 N-CA-C 104.832 -2.285 . . . . 75.33 104.832 -179.319 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.1 -175.95 21.59 Favored Glycine 0 C--N 1.298 -1.538 0 C-N-CA 120.519 -0.848 . . . . 72.11 111.867 -178.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -54.63 -46.84 73.98 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 123.915 0.886 . . . . 72.51 111.022 -178.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.1 mt -59.56 -23.92 63.29 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.279 -0.873 . . . . 50.2 112.357 -177.371 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 2.4 mmt -81.17 -5.76 58.08 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 112.073 0.398 . . . . 75.32 112.073 -179.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -96.91 -13.31 22.52 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 121.804 0.811 . . . . 63.35 109.288 174.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.483 ' HB2' ' CD2' ' A' ' 115' ' ' TYR . 4.1 mm-40 -97.29 -46.02 6.27 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 107.153 -1.425 . . . . 72.54 107.153 -178.475 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.483 ' CD2' ' HB2' ' A' ' 114' ' ' GLU . 35.8 m-85 -125.66 155.65 40.51 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 107.683 -1.229 . . . . 74.25 107.683 -177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.555 ' HB3' HG12 ' A' ' 144' ' ' ILE . 19.2 ptmt -100.17 3.68 43.92 Favored 'General case' 0 C--N 1.298 -1.648 0 CA-C-O 121.573 0.702 . . . . 73.53 110.736 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.7 t -169.26 123.69 0.82 Allowed 'General case' 0 N--CA 1.431 -1.384 0 N-CA-C 106.851 -1.537 . . . . 64.23 106.851 177.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.568 ' CE2' HD22 ' A' ' 120' ' ' LEU . 87.3 t80 -137.62 111.87 8.55 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 108.241 -1.022 . . . . 70.24 108.241 179.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 42.8 tp -121.6 129.38 52.79 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 108.004 -1.11 . . . . 64.54 108.004 -178.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.568 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -135.32 129.17 33.06 Favored 'General case' 0 C--N 1.293 -1.859 0 C-N-CA 120.484 -0.486 . . . . 45.24 110.037 178.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.42 ' OG1' HG23 ' A' ' 103' ' ' THR . 25.1 m -115.31 131.35 56.96 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 109.834 -0.432 . . . . 60.15 109.834 -179.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.2 pt -118.03 141.46 37.03 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.486 0 CA-C-O 121.145 0.498 . . . . 72.45 109.843 176.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.712 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 57.6 tt0 -142.39 127.67 18.74 Favored 'General case' 0 C--N 1.287 -2.15 0 N-CA-C 107.835 -1.172 . . . . 74.22 107.835 176.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.478 HG12 ' HB2' ' A' ' 36' ' ' ALA . 47.2 t -94.94 117.89 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.869 0 N-CA-C 108.467 -0.938 . . . . 70.11 108.467 -177.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 40.1 m -120.38 126.96 26.54 Favored Pre-proline 0 C--N 1.285 -2.234 0 CA-C-N 114.813 -1.085 . . . . 74.44 108.098 -176.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -53.61 141.5 63.35 Favored 'Trans proline' 0 C--O 1.241 0.658 0 C-N-CA 122.614 2.209 . . . . 72.1 111.689 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.444 ' HG2' ' C ' ' A' ' 132' ' ' GLY . 22.0 ptmt -86.82 167.14 23.37 Favored Pre-proline 0 C--N 1.311 -1.085 0 N-CA-C 109.035 -0.728 . . . . 73.41 109.035 -178.337 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -52.78 112.31 0.87 Allowed 'Trans proline' 0 C--N 1.362 1.256 0 C-N-CA 122.134 1.889 . . . . 75.23 110.248 176.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 136.16 -55.41 0.71 Allowed Glycine 0 N--CA 1.431 -1.675 0 N-CA-C 110.786 -0.926 . . . . 71.51 110.786 -176.173 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 126.53 -64.46 0.58 Allowed Glycine 0 CA--C 1.539 1.57 0 C-N-CA 120.061 -1.066 . . . . 74.21 114.85 178.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 69.9 Cg_exo -54.31 -53.72 5.8 Favored 'Trans proline' 0 C--N 1.367 1.503 0 C-N-CA 123.354 2.702 . . . . 72.11 114.061 -176.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.444 ' C ' ' HG2' ' A' ' 127' ' ' LYS . . . -81.52 165.48 46.41 Favored Glycine 0 N--CA 1.439 -1.147 0 N-CA-C 111.413 -0.675 . . . . 63.14 111.413 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.6 m -143.42 161.49 38.27 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.793 -0.828 . . . . 51.41 112.043 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.508 HD12 ' HG2' ' A' ' 31' ' ' GLU . 39.9 mm -113.37 141.01 30.62 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 107.26 -1.385 . . . . 74.24 107.26 179.22 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.6 p -105.09 116.99 49.97 Favored 'Isoleucine or valine' 0 C--N 1.261 -3.267 0 N-CA-C 108.765 -0.828 . . . . 72.34 108.765 175.067 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -93.06 111.84 23.61 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 115.658 -0.701 . . . . 72.4 110.163 -177.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.5 m95 -95.61 122.49 38.42 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.757 -0.656 . . . . 73.22 110.073 -179.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 65.8 m-70 -119.61 111.78 18.5 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.802 -1.555 . . . . 71.42 106.802 177.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -113.19 127.51 56.2 Favored 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 109.56 -0.534 . . . . 62.21 109.56 -176.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.65 131.38 49.86 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 123.224 0.61 . . . . 71.3 109.381 178.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 23.5 p90 -152.42 144.97 24.15 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 114.557 1.317 . . . . 72.44 114.557 -175.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -102.67 135.37 44.44 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 106.879 -1.526 . . . . 71.2 106.879 175.788 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 59.2 mttp -98.45 142.96 29.42 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 112.354 0.501 . . . . 74.21 112.354 -174.52 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 116' ' ' LYS . 67.6 mt -77.29 -41.5 30.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 107.687 -1.227 . . . . 65.34 107.687 175.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -152.02 172.74 15.81 Favored 'General case' 0 N--CA 1.407 -2.575 0 N-CA-C 106.219 -1.771 . . . . 75.33 106.219 177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -85.81 -55.9 3.74 Favored 'General case' 0 C--N 1.284 -2.261 0 CA-C-O 120.664 0.268 . . . . 73.21 110.397 -175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -63.63 -18.82 64.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.07 0.462 . . . . 54.15 111.761 -177.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 11.5 m -87.47 -9.57 11.01 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.949 0 C-N-CA 120.383 -0.527 . . . . 73.43 110.825 -179.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -93.1 138.71 31.3 Favored 'General case' 0 N--CA 1.439 -1.012 0 N-CA-C 109.018 -0.734 . . . . 72.34 109.018 -179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 8.0 m170 -128.83 86.7 56.76 Favored Pre-proline 0 C--N 1.307 -1.273 0 N-CA-C 110.039 -0.356 . . . . 72.44 110.039 -176.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.65 -16.82 57.02 Favored 'Trans proline' 0 N--CA 1.487 1.14 0 C-N-CA 122.123 1.882 . . . . 72.33 110.356 175.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 11.5 mm-40 -59.66 -46.71 88.22 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 113.867 -1.515 . . . . 73.51 110.072 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.5 p -76.93 -30.16 55.97 Favored 'General case' 0 N--CA 1.43 -1.441 0 CA-C-N 114.856 -1.065 . . . . 64.14 111.576 -173.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 8.1 mp -53.71 -50.37 66.05 Favored 'General case' 0 CA--C 1.503 -0.831 0 N-CA-C 112.679 0.622 . . . . 50.33 112.679 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.652 ' O ' HG23 ' A' ' 159' ' ' VAL . 65.9 mt -63.29 -38.66 92.04 Favored 'General case' 0 C--O 1.214 -0.812 0 C-N-CA 120.043 -0.663 . . . . 54.24 111.635 179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -72.3 -31.54 65.79 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 120.299 -0.56 . . . . 72.52 111.214 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 38.1 t80 -62.65 -49.72 74.02 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 109.12 -0.696 . . . . 62.03 109.12 175.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.461 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 27.2 p -64.85 -33.54 76.25 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 120.202 -0.599 . . . . 75.43 112.106 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 155' ' ' LEU . 83.0 t -62.06 -52.15 63.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.924 0.392 . . . . 74.53 111.479 179.056 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.65 -29.36 63.37 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 112.788 0.662 . . . . 72.1 112.788 -174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.7 t -71.24 -38.59 70.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.57 -0.53 . . . . 55.25 109.57 173.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.517 ' CB ' HG11 ' A' ' 30' ' ' VAL . 66.5 m -64.35 -37.84 88.92 Favored 'General case' 0 CA--C 1.507 -0.679 0 C-N-CA 121.027 -0.269 . . . . 65.11 111.469 -179.344 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 53.2 mtmt -69.88 -39.28 76.4 Favored 'General case' 0 N--CA 1.44 -0.947 0 C-N-CA 120.29 -0.564 . . . . 74.11 111.208 178.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 2.7 tm-20 -59.09 -51.53 69.63 Favored 'General case' 0 C--O 1.21 -0.991 0 N-CA-C 108.698 -0.852 . . . . 74.24 108.698 179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 8.4 tp -68.09 -37.75 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.865 0 CA-C-N 116.131 -0.486 . . . . 53.41 111.947 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.474 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 33.6 t70 -58.52 -52.37 65.95 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-N 116.105 -0.498 . . . . 71.32 110.297 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 12.1 pt-20 -71.63 -28.71 63.96 Favored 'General case' 0 C--O 1.205 -1.262 0 CA-C-N 116.35 -0.386 . . . . 74.2 111.637 178.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.498 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 4.1 t60 -64.62 -45.52 86.5 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 123.592 0.757 . . . . 74.11 109.747 176.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 97.9 mt -76.25 -45.18 34.04 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 116.127 -0.488 . . . . 53.5 111.66 -178.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.515 HD11 ' HB2' ' A' ' 33' ' ' LYS . 85.3 mt -68.99 -41.27 78.09 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.656 -0.868 . . . . 65.25 108.656 178.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 63.63 15.93 9.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 114.048 -1.433 . . . . 64.41 110.863 -178.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -92.27 149.65 21.33 Favored 'General case' 0 N--CA 1.414 -2.253 0 CA-C-N 114.255 -1.339 . . . . 54.05 108.151 178.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 . . . . . 0 C--N 1.277 -2.575 0 CA-C-O 118.078 -0.963 . . . . 74.33 109.35 -175.796 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.451 -0.39 0 CA-C-O 121.234 0.54 . . . . 61.51 109.801 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -80.47 127.54 32.54 Favored 'General case' 0 C--N 1.294 -1.843 0 CA-C-N 115.474 -0.785 . . . . 72.33 112.222 -177.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -151.52 96.45 2.27 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 108.269 -1.011 . . . . 35.45 108.269 174.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 42.2 m -61.57 -48.37 81.26 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.748 -0.66 . . . . 71.24 112.582 -174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 25.6 t -90.86 -5.81 55.05 Favored 'General case' 0 N--CA 1.436 -1.148 0 C-N-CA 120.733 -0.387 . . . . 71.33 110.848 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 88.9 mt 57.27 27.49 13.76 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 123.457 0.703 . . . . 61.32 112.603 -175.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.8 t -86.66 131.94 33.53 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.925 0 CA-C-O 121.436 0.636 . . . . 63.23 110.267 178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -131.84 152.97 20.28 Favored Glycine 0 N--CA 1.42 -2.405 0 N-CA-C 108.828 -1.709 . . . . 72.1 108.828 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.419 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.0 OUTLIER -145.22 145.7 31.41 Favored 'General case' 0 C--N 1.283 -2.312 0 CA-C-N 117.275 0.538 . . . . 71.45 111.669 -178.056 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.4 tp -137.3 139.05 40.64 Favored 'General case' 0 C--N 1.286 -2.169 0 CA-C-N 115.437 -0.802 . . . . 74.13 109.44 -175.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -132.23 136.08 46.75 Favored 'General case' 0 C--N 1.285 -2.222 0 N-CA-C 109.269 -0.641 . . . . 51.51 109.269 178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 11.8 t -145.5 168.53 20.35 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 107.491 -1.3 . . . . 53.25 107.491 179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -134.43 140.65 46.42 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 109.324 -0.621 . . . . 73.14 109.324 178.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.83 145.07 35.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 N-CA-C 107.97 -1.122 . . . . 73.31 107.97 -179.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.523 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.3 mp0 -102.3 127.75 49.15 Favored 'General case' 0 N--CA 1.428 -1.574 0 C-N-CA 119.244 -0.982 . . . . 71.34 109.86 -179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 43.6 pt -99.76 147.37 7.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 N-CA-C 106.828 -1.545 . . . . 73.24 106.828 173.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.639 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 8.6 mptt -96.26 17.46 15.79 Favored 'General case' 0 C--N 1.291 -1.963 0 CA-C-O 121.536 0.684 . . . . 61.02 110.156 -171.502 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -121.62 166.78 13.73 Favored 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.193 -0.912 . . . . 52.22 108.942 177.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.4 m -78.45 142.82 37.24 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 109.864 -0.421 . . . . 54.42 109.864 178.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -58.5 -27.53 64.55 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 123.598 0.759 . . . . 72.32 111.638 -178.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.433 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 3.3 m-20 -60.72 -31.38 70.68 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.644 -0.707 . . . . 72.2 112.396 178.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 41.1 mtpt -68.33 -33.62 74.62 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-O 121.282 0.563 . . . . 73.23 110.336 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 75.8 t80 -67.38 -38.7 85.15 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.438 -0.949 . . . . 65.11 108.438 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 48.1 t60 -63.8 -39.41 94.19 Favored 'General case' 0 C--O 1.237 0.421 0 CA-C-N 115.288 -0.869 . . . . 74.3 110.019 177.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.433 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 38.3 m-70 -59.16 -38.19 79.14 Favored 'General case' 0 C--O 1.206 -1.198 0 CA-C-N 116.399 -0.364 . . . . 71.12 111.277 177.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 81.7 mtp -59.86 -26.55 65.94 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.1 0.778 . . . . 70.24 113.1 -178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -101.59 -31.96 10.59 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 120.167 -0.613 . . . . 72.44 111.25 -179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -81.49 -37.29 28.15 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.113 0.412 . . . . 73.11 112.113 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -164.0 80.54 0.13 Allowed Glycine 0 CA--C 1.496 -1.148 0 N-CA-C 108.697 -1.761 . . . . 75.22 108.697 -179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -45.18 132.52 5.64 Favored Pre-proline 0 CA--C 1.541 0.62 0 N-CA-C 114.026 1.121 . . . . 73.14 114.026 -171.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 96.3 Cg_endo -83.38 3.8 7.49 Favored 'Trans proline' 0 C--O 1.24 0.598 0 C-N-CA 123.565 2.844 . . . . 74.15 110.726 177.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 29.5 t60 -134.8 93.55 3.04 Favored 'General case' 0 N--CA 1.428 -1.558 0 CA-C-N 114.853 -1.067 . . . . 72.1 108.365 -178.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 2.9 p-80 -95.64 150.93 19.81 Favored 'General case' 0 C--N 1.293 -1.891 0 C-N-CA 120.56 -0.456 . . . . 51.13 109.914 179.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.9 m -98.1 96.13 4.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 122.45 1.119 . . . . 70.23 111.511 179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.411 ' HA ' ' SG ' ' A' ' 61' ' ' CYS . 27.0 m -143.99 96.39 2.88 Favored 'General case' 0 C--N 1.293 -1.866 0 CA-C-N 114.438 -1.255 . . . . 72.01 107.759 178.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 37.4 ttpt -134.85 -59.19 0.8 Allowed 'General case' 0 C--N 1.292 -1.897 0 CA-C-N 116.105 -0.498 . . . . 73.23 110.852 -177.056 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 64.66 115.47 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.661 0 O-C-N 124.462 1.101 . . . . 62.11 111.712 -177.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.404 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 21.2 p -62.92 133.71 95.4 Favored Pre-proline 0 C--N 1.302 -1.462 0 CA-C-N 115.398 -0.819 . . . . 74.53 112.237 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 50.5 Cg_exo -57.53 119.8 7.29 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 122.472 2.114 . . . . 72.44 111.27 176.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.27 48.46 1.32 Allowed Glycine 0 N--CA 1.432 -1.612 0 N-CA-C 110.013 -1.235 . . . . 72.41 110.013 -176.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -146.27 160.11 42.44 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 107.15 -1.426 . . . . 55.11 107.15 -177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.6 mt -64.53 -31.22 52.72 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 N-CA-C 108.568 -0.901 . . . . 71.22 108.568 175.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 71.66 96.05 0.07 Allowed 'General case' 0 CA--C 1.503 -0.863 0 C-N-CA 125.423 1.489 . . . . 73.55 112.089 176.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -118.11 -57.71 0.28 Allowed Glycine 0 N--CA 1.419 -2.47 0 N-CA-C 110.45 -1.06 . . . . 53.11 110.45 177.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' A' ' 51' ' ' SER . 28.0 t 60.59 28.65 18.34 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-O 122.584 1.183 . . . . 73.13 108.126 -179.708 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -76.33 -28.76 57.03 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.073 -1.421 . . . . 73.54 110.926 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 86.2 mt -74.21 111.13 9.08 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-N 115.882 -0.599 . . . . 71.14 109.566 177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 31.2 t60 -73.91 123.47 24.31 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 115.893 -0.594 . . . . 71.4 110.273 -178.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -134.33 158.37 43.97 Favored 'General case' 0 N--CA 1.43 -1.427 0 N-CA-C 109.045 -0.724 . . . . 73.33 109.045 -179.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 115.56 -14.12 17.88 Favored Glycine 0 C--N 1.309 -0.952 0 N-CA-C 110.251 -1.14 . . . . 63.43 110.251 -178.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -178.09 151.32 0.65 Allowed 'General case' 0 C--O 1.244 0.783 0 N-CA-C 107.528 -1.286 . . . . 75.44 107.528 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 69.3 m95 -106.06 -16.73 14.54 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.687 -0.486 . . . . 75.42 109.687 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.09 -5.89 81.31 Favored Glycine 0 CA--C 1.521 0.409 0 CA-C-N 115.793 -0.64 . . . . 44.51 113.642 178.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.7 p -115.79 144.35 44.11 Favored 'General case' 0 C--N 1.311 -1.078 0 N-CA-C 111.916 0.339 . . . . 72.3 111.916 -177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -72.21 135.26 28.21 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 N-CA-C 108.157 -1.053 . . . . 75.03 108.157 174.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 99.31 -0.63 57.15 Favored Glycine 0 CA--C 1.494 -1.238 0 C-N-CA 120.309 -0.948 . . . . 72.33 111.532 -177.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 54.9 p -74.58 154.95 38.36 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-O 120.911 0.386 . . . . 61.43 110.628 178.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.466 HG23 ' O ' ' A' ' 90' ' ' GLU . 80.5 mt -115.53 116.06 51.26 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.736 0 CA-C-O 122.137 0.97 . . . . 61.11 112.441 -177.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.2 m -126.76 166.17 23.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 106.085 -1.82 . . . . 75.12 106.085 177.303 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.455 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 56.1 m-85 -125.01 147.98 48.69 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 120.225 -0.59 . . . . 74.45 110.432 -179.415 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 13.0 m0 -106.34 130.27 54.2 Favored 'General case' 0 CA--C 1.483 -1.624 0 CA-C-O 122.072 0.939 . . . . 70.44 110.736 177.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.5 m-80 -102.87 132.88 48.76 Favored 'General case' 0 C--N 1.283 -2.301 0 CA-C-N 113.523 -1.671 . . . . 75.2 109.263 178.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.427 ' CE2' ' HB2' ' A' ' 86' ' ' LYS . 35.9 p90 -143.13 154.34 43.8 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 108.795 -0.817 . . . . 63.44 108.795 178.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 75.7 t -105.88 122.45 59.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 C-N-CA 120.276 -0.57 . . . . 62.14 110.819 -176.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.2 t60 -142.8 129.36 20.22 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.724 -1.213 . . . . 63.54 107.724 178.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 63.94 28.89 14.54 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.69 0.796 . . . . 73.22 109.863 -175.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 78.83 -12.25 23.83 Favored Glycine 0 N--CA 1.438 -1.182 0 CA-C-N 115.32 -0.854 . . . . 70.24 113.582 179.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -95.18 145.97 24.65 Favored 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 117.697 0.748 . . . . 74.13 109.307 -177.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.77 115.29 21.61 Favored 'General case' 0 N--CA 1.423 -1.781 0 N-CA-C 106.646 -1.613 . . . . 65.32 106.646 174.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.427 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 24.7 mmmt -100.81 144.41 29.8 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 106.965 -1.494 . . . . 73.4 106.965 -175.328 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 47.3 t -122.99 133.73 68.19 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 N-CA-C 109.386 -0.598 . . . . 72.3 109.386 -177.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.55 138.32 46.09 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.806 -0.442 . . . . 65.22 109.806 178.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.549 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 58.9 mttp -94.36 126.01 39.35 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.571 -0.9 . . . . 60.4 108.571 176.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.466 ' O ' HG23 ' A' ' 74' ' ' ILE . 10.7 pt-20 -154.09 169.21 24.08 Favored 'General case' 0 N--CA 1.425 -1.706 0 CA-C-N 116.046 -0.524 . . . . 71.03 109.613 -170.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 35.1 ttt180 -136.27 143.92 44.51 Favored 'General case' 0 C--N 1.292 -1.921 0 N-CA-C 107.235 -1.395 . . . . 62.0 107.235 177.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 69.1 mt -76.35 121.53 28.64 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 N-CA-C 106.259 -1.756 . . . . 70.44 106.259 173.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 13.2 tp10 -108.05 -41.61 4.89 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.476 -0.89 . . . . 74.32 110.695 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -148.78 140.93 23.97 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.955 -0.757 . . . . 60.24 108.955 179.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.13 123.7 4.21 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.762 0 CA-C-O 121.094 0.474 . . . . 75.51 110.261 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.473 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 15.6 mm-40 -109.37 112.62 59.1 Favored Pre-proline 0 C--N 1.304 -1.413 0 N-CA-C 108.276 -1.009 . . . . 75.15 108.276 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -65.73 -46.53 4.97 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 122.178 1.919 . . . . 75.42 111.884 177.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -79.59 -36.23 38.42 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.199 0.444 . . . . 74.11 112.199 -175.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 92.6 mttt -85.76 -7.48 58.74 Favored 'General case' 0 CA--C 1.506 -0.745 0 C-N-CA 120.86 -0.336 . . . . 71.05 111.186 -179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.438 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 65.3 t30 51.81 68.42 0.81 Allowed 'General case' 0 C--O 1.243 0.721 0 C-N-CA 124.952 1.301 . . . . 73.32 110.565 -178.084 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.473 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 2.6 tt -132.45 142.24 49.16 Favored 'General case' 0 C--N 1.304 -1.382 0 CA-C-N 114.337 -1.302 . . . . 65.02 110.043 -177.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 5.6 tp -142.03 122.16 11.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.648 0.737 . . . . 72.12 110.126 173.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 90.1 m -98.32 124.12 42.79 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.867 -1.06 . . . . 55.24 110.609 176.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.42 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 77.8 m-85 -103.48 138.78 39.73 Favored 'General case' 0 N--CA 1.437 -1.101 0 N-CA-C 108.54 -0.911 . . . . 71.35 108.54 178.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 12.3 tpt180 -125.37 120.08 30.12 Favored 'General case' 0 C--N 1.289 -2.047 0 CA-C-N 115.79 -0.641 . . . . 53.41 109.715 179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.556 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -77.2 124.86 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.367 0 N-CA-C 107.219 -1.4 . . . . 72.23 107.219 179.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.673 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.9 -26.27 3.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.816 0 C-N-CA 119.891 -0.724 . . . . 65.01 110.584 -178.371 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.549 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 0.4 OUTLIER -162.15 165.6 26.78 Favored 'General case' 0 N--CA 1.427 -1.585 0 N-CA-C 102.582 -3.118 . . . . 72.22 102.582 -178.309 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 138.47 -165.86 25.41 Favored Glycine 0 C--N 1.293 -1.811 0 C-N-CA 118.857 -1.639 . . . . 71.43 113.607 178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -66.31 -48.11 71.4 Favored 'General case' 0 C--N 1.312 -1.055 0 C-N-CA 124.59 1.156 . . . . 70.12 111.466 -177.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.8 mt -72.05 -24.83 61.59 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.489 -0.778 . . . . 72.11 113.081 -174.544 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.438 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 1.9 mmt -66.41 -13.12 60.24 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 113.614 0.968 . . . . 65.23 113.614 -176.037 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 34.4 mmtp -91.27 -15.47 29.11 Favored 'General case' 0 C--N 1.308 -1.234 0 C-N-CA 120.469 -0.492 . . . . 74.54 110.933 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 4.0 mp0 -108.16 -34.43 6.86 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.56 0.695 . . . . 75.4 110.796 177.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -112.51 139.93 47.68 Favored 'General case' 0 C--N 1.298 -1.644 0 N-CA-C 108.104 -1.073 . . . . 73.12 108.104 -179.646 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.494 ' HB3' HG12 ' A' ' 144' ' ' ILE . 20.5 ptmt -90.05 -4.32 57.45 Favored 'General case' 0 C--N 1.306 -1.301 0 C-N-CA 120.412 -0.515 . . . . 64.33 111.615 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 35.1 t -168.83 140.87 2.65 Favored 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 108.198 -1.038 . . . . 74.5 108.198 174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.581 ' CE2' HD22 ' A' ' 120' ' ' LEU . 86.8 t80 -150.44 117.05 5.79 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 107.984 -1.117 . . . . 64.2 107.984 179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 44.3 tp -127.6 129.08 46.65 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 107.166 -1.42 . . . . 73.21 107.166 -178.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.581 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -137.27 137.09 38.65 Favored 'General case' 0 C--N 1.297 -1.716 0 C-N-CA 119.734 -0.786 . . . . 75.31 110.747 -178.337 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.415 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 62.6 m -121.84 134.82 54.89 Favored 'General case' 0 C--N 1.281 -2.408 0 CA-C-N 116.029 -0.532 . . . . 65.04 109.991 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 44.8 pt -117.22 136.73 53.42 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 N-CA-C 109.307 -0.627 . . . . 75.34 109.307 175.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.1 tt0 -133.68 119.23 19.09 Favored 'General case' 0 C--N 1.285 -2.211 0 N-CA-C 107.915 -1.143 . . . . 70.42 107.915 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.438 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 24.7 t -109.8 132.34 58.3 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.187 0 CA-C-N 115.933 -0.576 . . . . 51.12 110.571 -172.648 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 5.5 t -139.2 149.81 62.29 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 108.62 -0.881 . . . . 63.41 108.62 175.527 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -67.17 109.88 1.86 Allowed 'Trans proline' 0 C--O 1.243 0.754 0 C-N-CA 122.795 2.33 . . . . 50.52 110.021 173.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.67 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 63.3 tttm -99.49 -67.45 0.05 OUTLIER Pre-proline 0 C--N 1.308 -1.234 0 C-N-CA 119.483 -0.887 . . . . 74.23 110.556 -178.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.67 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 31.1 Cg_exo -63.69 -39.66 33.56 Favored 'Trans proline' 0 C--N 1.382 2.329 0 CA-C-N 120.818 1.328 . . . . 54.42 110.014 170.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 102.48 135.99 8.99 Favored Glycine 0 N--CA 1.443 -0.892 0 CA-C-N 115.673 -0.694 . . . . 63.32 111.422 179.514 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 81.01 -110.58 3.15 Favored Glycine 0 N--CA 1.442 -0.918 0 N-CA-C 111.363 -0.695 . . . . 45.34 111.363 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 33' ' ' LYS . 97.8 Cg_endo -81.57 29.47 0.54 Allowed 'Trans proline' 0 C--O 1.237 0.459 0 C-N-CA 123.362 2.708 . . . . 72.41 112.205 178.67 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.482 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . -152.0 106.59 0.31 Allowed Glycine 0 C--N 1.286 -2.226 0 CA-C-N 115.48 -0.782 . . . . 63.22 112.973 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 38.9 m -131.54 145.33 51.68 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 108.207 -1.035 . . . . 41.34 108.207 174.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.523 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 31.7 mm -102.51 129.04 54.67 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 CA-C-O 120.822 0.344 . . . . 64.31 111.111 -177.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.3 p -100.56 114.0 38.07 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 N-CA-C 108.596 -0.89 . . . . 75.4 108.596 174.065 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 92.3 m-70 -89.92 111.84 23.02 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 115.486 -0.779 . . . . 63.41 109.06 -179.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 69.4 m95 -92.96 122.44 35.32 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 116.031 -0.531 . . . . 73.23 109.882 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 68.8 m-70 -118.75 110.84 17.73 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 107.24 -1.393 . . . . 73.33 107.24 177.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.5 mp -110.87 123.91 51.05 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.542 -0.54 . . . . 65.15 109.542 -175.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -127.46 127.62 44.37 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.829 -1.175 . . . . 72.53 107.829 178.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 15.9 p90 -153.08 165.65 34.95 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 113.182 0.808 . . . . 63.43 113.182 -172.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.41 129.39 48.66 Favored 'General case' 0 N--CA 1.431 -1.394 0 CA-C-N 115.975 -0.557 . . . . 73.54 110.089 -175.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.524 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.9 OUTLIER -80.65 138.56 36.4 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.503 -0.771 . . . . 64.44 112.165 -177.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.494 HG12 ' HB3' ' A' ' 116' ' ' LYS . 69.7 mt -77.07 -38.3 27.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 105.949 -1.871 . . . . 62.41 105.949 170.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.8 t -154.81 163.17 40.65 Favored 'General case' 0 N--CA 1.409 -2.489 0 CA-C-N 112.938 -1.937 . . . . 73.34 105.806 176.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -73.14 -42.18 63.12 Favored 'General case' 0 C--N 1.288 -2.089 0 CA-C-O 121.667 0.746 . . . . 73.13 109.133 179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.24 -24.03 67.52 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 114.005 -1.452 . . . . 71.33 111.546 -174.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.429 HG11 ' HB ' ' A' ' 144' ' ' ILE . 11.8 p -93.61 -23.45 5.38 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-N 115.609 -0.723 . . . . 74.33 111.053 -174.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.524 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -92.18 127.49 37.67 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 116.053 -0.522 . . . . 75.22 109.806 -178.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -132.31 93.07 26.64 Favored Pre-proline 0 C--N 1.302 -1.482 0 N-CA-C 109.909 -0.404 . . . . 52.42 109.909 -179.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -50.24 -15.94 1.66 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 124.47 3.447 . . . . 54.53 114.286 -178.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -58.0 -43.99 86.94 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.842 0.83 . . . . 64.25 109.068 176.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 70.5 p -66.78 -31.83 72.73 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 114.384 -1.28 . . . . 64.01 110.471 -176.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.422 HD22 ' CE1' ' A' ' 118' ' ' PHE . 69.3 mt -73.14 -41.84 63.49 Favored 'General case' 0 N--CA 1.438 -1.031 0 CA-C-N 115.307 -0.86 . . . . 72.0 109.99 -177.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.6 ' O ' HG23 ' A' ' 159' ' ' VAL . 61.1 mt -62.13 -39.72 93.51 Favored 'General case' 0 CA--C 1.498 -1.051 0 CA-C-N 116.219 -0.446 . . . . 61.42 110.324 175.098 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 45.3 mt-30 -67.52 -40.72 85.09 Favored 'General case' 0 C--N 1.306 -1.302 0 C-N-CA 119.679 -0.809 . . . . 61.5 111.692 176.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 84.0 t80 -58.69 -40.98 85.15 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 122.219 0.207 . . . . 74.3 111.035 178.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -67.62 -31.56 71.68 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 119.292 -0.963 . . . . 62.03 110.664 178.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 155' ' ' LEU . 74.9 t -67.1 -47.08 82.97 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.3 0 N-CA-C 109.034 -0.728 . . . . 71.22 109.034 176.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -51.65 -47.15 63.88 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 123.041 0.536 . . . . 71.44 112.287 176.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 165' ' ' ILE . 66.9 t -67.81 -43.05 86.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 116.238 -0.437 . . . . 75.15 110.311 179.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.476 ' HA ' HG22 ' A' ' 165' ' ' ILE . 66.6 m -57.24 -34.61 68.77 Favored 'General case' 0 C--O 1.213 -0.847 0 CA-C-N 116.437 -0.347 . . . . 73.34 111.195 178.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.578 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 67.2 mttm -58.95 -53.76 54.81 Favored 'General case' 0 CA--C 1.51 -0.565 0 CA-C-O 120.762 0.315 . . . . 74.31 110.645 178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.554 ' O ' ' HB2' ' A' ' 168' ' ' HIS . 15.3 tp10 -66.54 -52.92 40.48 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-N 115.97 -0.559 . . . . 61.24 110.683 -178.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.603 ' O ' HD13 ' A' ' 169' ' ' LEU . 9.8 tp -63.97 -46.17 94.74 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.197 0 N-CA-C 112.628 0.603 . . . . 74.33 112.628 -171.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -64.52 -51.49 62.67 Favored 'General case' 0 C--N 1.29 -1.986 0 CA-C-O 120.957 0.408 . . . . 64.32 111.605 -177.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -68.44 -30.56 69.47 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.153 -0.476 . . . . 74.52 111.298 179.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.554 ' HB2' ' O ' ' A' ' 164' ' ' GLU . 7.5 t60 -62.75 -42.55 99.72 Favored 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 109.569 -0.53 . . . . 72.4 109.569 179.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.603 HD13 ' O ' ' A' ' 165' ' ' ILE . 9.6 mp -65.39 -30.95 71.82 Favored 'General case' 0 C--O 1.213 -0.85 0 CA-C-N 116.047 -0.524 . . . . 75.21 112.381 178.169 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.473 HD11 ' HB2' ' A' ' 33' ' ' LYS . 89.0 mt -84.15 -19.39 34.24 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-O 121.439 0.638 . . . . 73.24 110.828 178.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -80.6 -45.14 17.8 Favored 'General case' 0 C--N 1.306 -1.304 0 CA-C-N 115.07 -0.968 . . . . 60.21 111.615 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -109.1 168.56 9.28 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 112.495 0.554 . . . . 72.11 112.495 -176.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 . . . . . 0 C--N 1.301 -1.534 0 CA-C-N 115.438 -0.801 . . . . 74.21 109.7 -177.709 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 N--CA 1.443 -0.791 0 N-CA-C 111.403 0.149 . . . . 71.14 111.403 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 68.22 145.89 0.05 OUTLIER 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.076 0.951 . . . . 71.11 111.352 -175.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -159.89 138.59 10.6 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.231 -0.655 . . . . 73.14 109.231 -178.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 28.8 p -60.79 -28.37 68.7 Favored 'General case' 0 C--N 1.31 -1.114 0 C-N-CA 122.882 0.473 . . . . 44.15 111.895 -179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 23.9 m -72.74 -4.7 33.0 Favored 'General case' 0 N--CA 1.443 -0.787 0 N-CA-C 113.086 0.773 . . . . 74.05 113.086 -179.178 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 94.4 mt -70.93 -4.43 24.52 Favored 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.027 0.442 . . . . 53.22 110.932 176.345 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.6 p -65.51 136.18 27.12 Favored 'Isoleucine or valine' 0 C--O 1.246 0.891 0 N-CA-C 108.473 -0.936 . . . . 72.51 108.473 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -142.43 143.73 13.13 Favored Glycine 0 N--CA 1.418 -2.518 0 C-N-CA 120.162 -1.018 . . . . 52.1 112.142 -177.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.1 ptmm? -145.89 155.03 42.6 Favored 'General case' 0 C--N 1.267 -2.979 0 O-C-N 122.196 -0.59 . . . . 64.34 109.847 177.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 49.7 tp -148.4 141.0 24.44 Favored 'General case' 0 N--CA 1.413 -2.313 0 N-CA-C 108.182 -1.044 . . . . 53.15 108.182 178.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -132.2 144.23 50.5 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 109.62 -0.511 . . . . 72.22 109.62 -178.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 12.9 t -152.02 165.68 33.91 Favored 'General case' 0 C--N 1.283 -2.325 0 N-CA-C 107.038 -1.467 . . . . 65.0 107.038 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -136.05 130.44 33.48 Favored 'General case' 0 C--N 1.275 -2.652 0 N-CA-C 108.278 -1.008 . . . . 73.02 108.278 176.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 99.0 t -113.42 144.32 21.3 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.0 0 N-CA-C 108.269 -1.012 . . . . 42.21 108.269 -177.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.483 ' HG3' ' CD1' ' A' ' 134' ' ' ILE . 1.5 mp0 -97.23 130.83 44.4 Favored 'General case' 0 N--CA 1.414 -2.227 0 N-CA-C 108.559 -0.904 . . . . 74.4 108.559 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 31.8 pt -105.87 148.77 9.92 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.133 0 N-CA-C 107.575 -1.268 . . . . 73.44 107.575 174.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.532 ' HG3' HD11 ' A' ' 170' ' ' LEU . 60.9 pttt -89.89 7.25 38.22 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.929 0.871 . . . . 74.43 109.962 -177.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.501 ' HA ' HD21 ' A' ' 170' ' ' LEU . . . -93.18 170.74 9.4 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.654 -1.157 . . . . 71.4 109.773 177.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 38' ' ' LYS . 32.3 t -89.3 134.72 33.94 Favored 'General case' 0 N--CA 1.437 -1.108 0 CA-C-N 116.209 -0.451 . . . . 63.13 110.522 -177.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -69.23 -32.93 72.5 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.785 -0.82 . . . . 65.43 108.785 173.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -68.22 -38.44 81.89 Favored 'General case' 0 CA--C 1.493 -1.25 0 CA-C-N 115.04 -0.982 . . . . 74.42 109.452 178.097 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.56 ' CB ' ' HB3' ' A' ' 35' ' ' SER . 85.5 tttt -69.76 -30.11 67.61 Favored 'General case' 0 N--CA 1.438 -1.039 0 CA-C-N 116.058 -0.519 . . . . 72.5 110.094 178.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 83.2 t80 -66.76 -42.12 86.66 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.056 -0.72 . . . . 44.42 109.056 176.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.1 t-80 -67.21 -32.88 74.24 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-O 121.958 0.885 . . . . 72.44 109.121 176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.529 ' HB3' ' O ' ' A' ' 38' ' ' LYS . 65.7 t-80 -64.14 -30.44 71.5 Favored 'General case' 0 C--N 1.316 -0.886 0 C-N-CA 125.565 1.546 . . . . 74.21 110.257 179.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.468 ' HG2' ' O ' ' A' ' 38' ' ' LYS . 93.8 mmm -59.74 -24.35 63.96 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.486 0.715 . . . . 71.14 112.684 -177.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 88.2 t80 -75.34 -28.63 59.68 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.969 0.414 . . . . 72.25 110.868 -179.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -96.47 97.55 9.52 Favored 'General case' 0 C--N 1.307 -1.266 0 N-CA-C 109.458 -0.571 . . . . 54.21 109.458 -179.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 137.85 -170.76 23.6 Favored Glycine 0 N--CA 1.43 -1.718 0 N-CA-C 110.888 -0.885 . . . . 45.55 110.888 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -106.62 150.98 40.28 Favored Pre-proline 0 C--N 1.303 -1.436 0 N-CA-C 110.238 -0.282 . . . . 73.44 110.238 179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.11 163.14 14.9 Favored 'Trans proline' 0 C--N 1.352 0.728 0 C-N-CA 123.056 2.504 . . . . 73.41 112.596 179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -77.44 109.77 11.65 Favored 'General case' 0 CA--C 1.495 -1.157 0 CA-C-N 116.064 -0.516 . . . . 73.01 111.63 -179.557 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 11.5 t60 -65.57 128.36 35.6 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 114.675 -1.148 . . . . 55.44 108.026 179.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 7.6 p -113.28 134.59 55.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.893 0 N-CA-C 109.162 -0.681 . . . . 72.5 109.162 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 t -89.04 104.49 17.03 Favored 'General case' 0 N--CA 1.421 -1.882 0 CA-C-O 121.706 0.765 . . . . 75.43 109.531 -178.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -129.24 149.49 51.01 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.909 -1.041 . . . . 73.43 108.391 179.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.92 -67.12 0.71 Allowed 'General case' 0 C--N 1.302 -1.464 0 N-CA-C 107.549 -1.278 . . . . 62.23 107.549 174.332 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.403 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 79.6 p 56.61 145.69 0.05 OUTLIER Pre-proline 0 N--CA 1.481 1.082 0 C-N-CA 126.011 1.724 . . . . 71.33 114.344 178.441 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 12.6 Cg_exo -71.38 100.75 1.05 Allowed 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 121.609 1.539 . . . . 73.1 109.459 173.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -99.67 164.82 19.92 Favored Glycine 0 N--CA 1.433 -1.558 0 C-N-CA 120.516 -0.849 . . . . 43.4 112.158 -177.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -85.6 100.37 11.91 Favored 'General case' 0 C--N 1.303 -1.451 0 CA-C-O 121.41 0.624 . . . . 74.23 109.872 178.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 69.2 mt 70.96 98.01 0.05 OUTLIER 'Isoleucine or valine' 0 C--O 1.244 0.772 0 CA-C-N 114.72 -1.127 . . . . 73.23 109.35 -173.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -53.66 121.37 7.69 Favored 'General case' 0 C--O 1.239 0.529 0 CA-C-N 115.111 -0.95 . . . . 73.22 112.06 -176.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 150.24 -102.13 0.23 Allowed Glycine 0 N--CA 1.427 -1.914 0 N-CA-C 108.728 -1.749 . . . . 63.3 108.728 -177.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 52.6 t -154.34 136.48 14.76 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.722 -0.473 . . . . 75.2 109.722 176.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -147.3 147.47 30.4 Favored 'General case' 0 C--N 1.294 -1.847 0 N-CA-C 106.128 -1.804 . . . . 60.4 106.128 175.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -78.53 69.48 4.73 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.478 0.656 . . . . 71.54 110.251 -179.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 53.1 t-80 -98.03 101.93 13.54 Favored 'General case' 0 C--N 1.31 -1.14 0 N-CA-C 108.142 -1.058 . . . . 70.22 108.142 -178.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -108.23 144.78 35.22 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-N 116.108 -0.496 . . . . 75.35 111.19 -173.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -101.42 19.5 50.62 Favored Glycine 0 C--N 1.308 -0.978 0 N-CA-C 109.223 -1.551 . . . . 54.35 109.223 175.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -91.77 128.8 37.74 Favored 'General case' 0 C--O 1.247 0.93 0 CA-C-N 114.455 -0.873 . . . . 74.4 109.163 -178.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.46 ' HB2' ' OG ' ' A' ' 73' ' ' SER . 48.6 m95 -107.44 10.07 29.56 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 116.22 -0.445 . . . . 72.13 111.082 -178.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.02 13.68 51.92 Favored Glycine 0 N--CA 1.445 -0.708 0 C-N-CA 119.476 -1.345 . . . . 74.34 111.195 -175.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.1 m 76.48 -68.21 0.19 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.495 1.118 . . . . 60.55 111.34 -178.403 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 59.2 t -71.37 122.86 24.36 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 N-CA-C 109.461 -0.57 . . . . 61.4 109.461 179.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.425 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 97.78 -0.57 59.39 Favored Glycine 0 N--CA 1.442 -0.964 0 C-N-CA 120.077 -1.059 . . . . 62.22 112.557 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.46 ' OG ' ' HB2' ' A' ' 68' ' ' TRP . 26.0 m -71.74 143.25 49.67 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 120.918 0.39 . . . . 61.51 111.962 -178.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 83.8 mt -129.28 116.05 38.11 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.31 0 N-CA-C 107.977 -1.12 . . . . 71.02 107.977 174.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 52.0 t -134.58 151.64 32.02 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 106.71 -1.589 . . . . 75.44 106.71 179.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 -115.32 143.76 44.78 Favored 'General case' 0 C--N 1.298 -1.657 0 C-N-CA 119.488 -0.885 . . . . 64.33 111.581 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.525 ' HB2' ' HB3' ' A' ' 88' ' ' ALA . 6.4 m0 -106.54 137.68 44.09 Favored 'General case' 0 CA--C 1.443 -3.138 0 N-CA-C 107.779 -1.193 . . . . 72.24 107.779 -178.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 -119.85 129.73 54.55 Favored 'General case' 1 C--N 1.239 -4.235 0 CA-C-N 113.799 -1.546 . . . . 62.53 108.226 175.282 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -155.95 169.11 25.19 Favored 'General case' 0 C--N 1.291 -1.956 0 N-CA-C 108.047 -1.094 . . . . 63.2 108.047 -179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 61.5 t -114.11 128.59 71.01 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.996 0 C-N-CA 120.157 -0.617 . . . . 53.22 110.838 -176.434 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.408 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 72.4 t60 -140.59 130.51 24.58 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.383 -0.969 . . . . 73.54 108.383 175.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 29.0 t70 64.29 28.49 13.84 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 122.542 1.163 . . . . 65.42 108.944 178.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.6 -12.05 29.77 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 114.847 -1.069 . . . . 42.2 112.934 -178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -97.63 142.39 29.5 Favored 'General case' 0 N--CA 1.44 -0.94 0 CA-C-O 121.028 0.442 . . . . 74.33 110.121 -178.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.63 116.66 17.51 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 108.203 -1.036 . . . . 64.5 108.203 176.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.408 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 75.5 mmtt -99.58 152.83 19.59 Favored 'General case' 0 C--N 1.295 -1.798 0 N-CA-C 108.446 -0.946 . . . . 73.11 108.446 -178.22 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.477 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 64.6 t -123.96 136.71 59.42 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 N-CA-C 109.919 -0.4 . . . . 74.52 109.919 -178.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.525 ' HB3' ' HB2' ' A' ' 77' ' ' TRP . . . -107.39 138.47 43.53 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 108.187 -1.042 . . . . 71.33 108.187 177.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.548 ' HD3' ' HB3' ' A' ' 108' ' ' GLU . 8.2 ptpt -124.55 123.42 40.05 Favored 'General case' 0 C--N 1.288 -2.103 0 C-N-CA 125.001 1.321 . . . . 75.51 109.676 -169.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -145.99 151.65 38.11 Favored 'General case' 0 N--CA 1.439 -0.985 0 CA-C-O 121.362 0.601 . . . . 61.22 111.202 -170.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.468 ' HD2' ' OE2' ' A' ' 93' ' ' GLU . 2.0 tmt_? -137.99 123.0 19.06 Favored 'General case' 0 C--N 1.289 -2.033 0 N-CA-C 103.934 -2.617 . . . . 73.45 103.934 167.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 56.6 mt -76.34 121.9 29.42 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.115 0 C-N-CA 120.11 -0.636 . . . . 71.04 111.158 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.468 ' OE2' ' HD2' ' A' ' 91' ' ' ARG . 15.0 mm-40 -95.75 -41.96 8.6 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.206 -0.906 . . . . 63.33 111.109 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -158.37 152.34 23.83 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.775 -0.648 . . . . 54.41 109.762 -175.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.6 p -147.09 136.77 16.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 O-C-N 123.586 0.554 . . . . 65.45 110.521 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.573 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 34.8 mm-40 -115.21 106.8 50.64 Favored Pre-proline 0 C--N 1.311 -1.096 0 N-CA-C 108.357 -0.979 . . . . 62.41 108.357 173.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -68.44 -29.99 30.25 Favored 'Trans proline' 0 C--N 1.327 -0.603 0 C-N-CA 122.033 1.822 . . . . 63.1 110.585 174.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -79.73 -36.81 36.83 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.434 -0.803 . . . . 73.41 112.95 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.5 mttp -103.71 2.67 33.35 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 112.4 0.519 . . . . 72.23 112.4 -174.71 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 75.0 m-20 57.55 50.62 10.78 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 124.061 0.851 . . . . 74.34 111.205 -178.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.573 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 49.6 tp -118.5 142.07 47.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 110.16 -0.311 . . . . 71.5 110.16 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 6.5 tp -148.73 122.76 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 CA-C-O 121.451 0.643 . . . . 72.41 110.458 176.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 29.0 m -100.5 121.82 42.19 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.328 -0.851 . . . . 71.43 111.033 -179.156 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -108.74 130.88 55.37 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 123.39 0.676 . . . . 63.14 110.163 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 14.2 ttm180 -108.86 135.48 49.99 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.609 -0.886 . . . . 70.51 108.609 171.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.526 HG11 ' HB2' ' A' ' 111' ' ' LEU . 77.7 t -85.36 124.68 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.258 0 C-N-CA 119.968 -0.693 . . . . 63.41 110.216 175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.74 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -104.18 -34.42 3.29 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.219 0 CA-C-N 115.282 -0.872 . . . . 73.24 112.642 -176.099 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.548 ' HB3' ' HD3' ' A' ' 89' ' ' LYS . 5.0 tm-20 -79.84 145.83 32.56 Favored 'General case' 0 CA--C 1.553 1.088 0 CA-C-O 121.24 0.543 . . . . 73.43 109.94 -172.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . -56.53 -29.4 57.45 Favored Glycine 0 CA--C 1.533 1.213 0 N-CA-C 118.868 2.307 . . . . 73.54 118.868 -171.388 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 27.5 m-20 -52.22 -49.47 63.87 Favored 'General case' 0 N--CA 1.515 2.776 0 CA-C-N 120.402 2.101 . . . . 75.11 114.244 -174.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.526 ' HB2' HG11 ' A' ' 106' ' ' VAL . 95.7 mt -76.06 -24.01 55.1 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.456 0.646 . . . . 54.13 111.106 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 3.7 mmt -76.5 -6.62 52.61 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.428 -0.805 . . . . 74.02 110.988 -179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 75.0 mmtt -84.76 -18.88 33.69 Favored 'General case' 0 C--N 1.315 -0.905 0 N-CA-C 108.743 -0.836 . . . . 73.02 108.743 176.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -102.19 -37.89 7.93 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 115.12 -0.945 . . . . 75.3 108.632 -176.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.42 ' CE1' ' HB1' ' A' ' 149' ' ' ALA . 66.6 m-85 -127.22 151.54 48.57 Favored 'General case' 0 CA--C 1.495 -1.146 0 N-CA-C 108.919 -0.771 . . . . 71.03 108.919 -177.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.596 ' CG ' HG12 ' A' ' 144' ' ' ILE . 28.0 mtpp -81.91 -23.73 36.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 109.062 -0.718 . . . . 75.14 109.062 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.3 t -154.62 137.69 15.56 Favored 'General case' 0 N--CA 1.426 -1.658 0 N-CA-C 107.563 -1.273 . . . . 71.42 107.563 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.404 ' CE1' HD22 ' A' ' 154' ' ' LEU . 89.0 t80 -149.26 117.28 6.33 Favored 'General case' 0 C--O 1.245 0.86 0 CA-C-O 120.998 0.428 . . . . 74.42 110.641 -179.317 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.4 mp -129.19 153.58 47.59 Favored 'General case' 0 N--CA 1.432 -1.373 0 N-CA-C 109.278 -0.638 . . . . 52.32 109.278 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -141.19 137.14 32.44 Favored 'General case' 0 C--N 1.286 -2.153 0 CA-C-N 115.933 -0.576 . . . . 71.12 109.456 179.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 27.5 m -127.42 131.79 50.2 Favored 'General case' 0 C--N 1.278 -2.534 0 N-CA-C 109.072 -0.714 . . . . 71.13 109.072 -177.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.44 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 36.7 pt -121.33 145.49 27.8 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.992 0 C-N-CA 120.697 -0.401 . . . . 41.12 110.635 -179.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.413 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 34.7 tt0 -139.63 126.04 20.27 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 108.581 -0.896 . . . . 62.11 108.581 177.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 47.7 t -100.27 121.61 51.21 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.847 0 CA-C-N 116.244 -0.434 . . . . 55.41 111.426 -174.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.492 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.4 t -139.12 154.04 71.96 Favored Pre-proline 0 CA--C 1.56 1.362 0 N-CA-C 108.254 -1.017 . . . . 72.15 108.254 178.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.492 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 60.2 Cg_endo -66.72 165.01 27.03 Favored 'Trans proline' 0 C--O 1.246 0.922 0 C-N-CA 123.126 2.55 . . . . 52.41 113.091 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.656 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 86.2 tttt -164.48 -67.13 0.01 OUTLIER Pre-proline 0 CA--C 1.556 1.199 0 CA-C-N 115.284 -0.871 . . . . 63.04 109.358 176.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.656 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 32.5 Cg_exo -65.87 -55.43 0.41 Allowed 'Trans proline' 0 C--N 1.386 2.53 0 CA-C-N 120.647 1.267 . . . . 72.41 110.812 170.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 121.36 110.86 2.17 Favored Glycine 0 CA--C 1.507 -0.451 0 C-N-CA 120.316 -0.945 . . . . 71.23 112.915 176.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 80.78 -114.51 3.84 Favored Glycine 0 CA--C 1.499 -0.915 0 N-CA-C 110.328 -1.109 . . . . 35.04 110.328 -178.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -68.09 91.13 0.38 Allowed 'Trans proline' 0 N--CA 1.445 -1.339 0 C-N-CA 121.891 1.727 . . . . 75.34 109.272 171.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.526 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 136.02 92.5 0.36 Allowed Glycine 0 N--CA 1.405 -3.402 0 N-CA-C 109.741 -1.344 . . . . 75.25 109.741 -176.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 50.0 m -130.1 151.97 50.06 Favored 'General case' 0 C--N 1.289 -2.03 0 N-CA-C 107.976 -1.12 . . . . 51.55 107.976 177.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.483 ' CD1' ' HG3' ' A' ' 31' ' ' GLU . 46.2 mm -102.88 127.69 56.43 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 CA-C-O 121.259 0.552 . . . . 62.03 111.305 -175.616 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.4 p -103.93 115.01 45.09 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.57 0 N-CA-C 108.351 -0.981 . . . . 75.11 108.351 173.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.44 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 87.0 m-70 -89.04 116.16 27.12 Favored 'General case' 0 C--N 1.3 -1.563 0 CA-C-N 115.509 -0.769 . . . . 54.33 109.502 -177.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 56.1 m95 -98.29 122.13 41.07 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.838 -0.619 . . . . 74.31 109.967 179.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 54.9 t60 -114.99 111.29 20.91 Favored 'General case' 0 C--N 1.29 -2.016 0 N-CA-C 107.572 -1.27 . . . . 71.22 107.572 174.471 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.429 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.8 mp -107.26 128.66 54.63 Favored 'General case' 0 C--N 1.294 -1.814 0 N-CA-C 107.127 -1.434 . . . . 75.11 107.127 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -134.36 127.07 30.93 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.14 -1.43 . . . . 72.33 107.14 -178.32 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 37.4 p90 -153.78 167.7 28.76 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 113.34 0.867 . . . . 72.33 113.34 -170.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -122.47 121.25 36.15 Favored 'General case' 0 C--N 1.293 -1.889 0 CA-C-N 115.975 -0.557 . . . . 74.01 110.181 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -66.42 140.71 58.06 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 109.601 -0.518 . . . . 63.22 109.601 176.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.596 HG12 ' CG ' ' A' ' 116' ' ' LYS . 9.0 mt -78.1 -33.38 18.01 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 N-CA-C 105.763 -1.939 . . . . 74.53 105.763 171.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.3 t -165.73 160.74 17.54 Favored 'General case' 0 N--CA 1.4 -2.959 0 N-CA-C 103.386 -2.82 . . . . 71.22 103.386 178.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -65.73 -57.9 6.94 Favored 'General case' 0 C--N 1.296 -1.74 0 N-CA-C 113.451 0.908 . . . . 65.22 113.451 -176.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -62.79 -19.5 64.1 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.426 -0.806 . . . . 75.15 112.871 -174.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.421 HG11 ' HB ' ' A' ' 144' ' ' ILE . 10.9 p -84.95 -16.96 10.11 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.118 0 C-N-CA 119.743 -0.783 . . . . 71.34 110.174 -179.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.42 ' HB1' ' CE1' ' A' ' 115' ' ' TYR . . . -89.55 156.43 18.62 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-N 115.717 -0.674 . . . . 73.23 109.844 -178.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 54.4 m-70 -143.87 87.86 7.91 Favored Pre-proline 0 C--N 1.323 -0.579 0 N-CA-C 110.36 -0.237 . . . . 62.42 110.36 -178.631 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_exo -59.83 -21.61 64.67 Favored 'Trans proline' 0 N--CA 1.486 1.078 0 C-N-CA 122.549 2.166 . . . . 73.52 112.276 177.599 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -61.33 -47.27 86.69 Favored 'General case' 0 C--N 1.32 -0.71 0 C-N-CA 124.11 0.964 . . . . 62.44 110.422 -178.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 81.1 p -74.17 -29.52 61.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.007 -0.997 . . . . 72.23 110.655 -174.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.404 HD22 ' CE1' ' A' ' 118' ' ' PHE . 80.9 mt -60.62 -44.06 96.76 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.509 -0.768 . . . . 74.0 110.273 177.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.571 ' O ' HG23 ' A' ' 159' ' ' VAL . 82.7 mt -64.23 -40.79 96.77 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 116.236 -0.438 . . . . 71.43 110.759 178.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 13.9 mm100 -59.45 -43.92 93.07 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.675 -0.491 . . . . 51.51 109.675 177.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 77.0 t80 -58.94 -42.81 90.67 Favored 'General case' 0 C--N 1.343 0.289 0 CA-C-N 115.747 -0.661 . . . . 74.4 109.643 177.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.429 ' SG ' HD21 ' A' ' 139' ' ' LEU . 74.0 m -61.8 -46.79 87.99 Favored 'General case' 0 N--CA 1.449 -0.512 0 CA-C-N 115.841 -0.618 . . . . 72.34 110.689 178.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 155' ' ' LEU . 44.7 t -61.01 -45.27 98.89 Favored 'Isoleucine or valine' 0 C--O 1.244 0.814 0 CA-C-O 120.957 0.408 . . . . 71.1 110.807 -178.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 38.0 mm-40 -65.41 -36.0 82.62 Favored 'General case' 0 CA--C 1.512 -0.488 0 N-CA-C 112.334 0.494 . . . . 54.14 112.334 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.5 t -74.44 -34.97 37.61 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.128 0 C-N-CA 120.521 -0.471 . . . . 63.22 110.098 176.516 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 69.9 m -57.36 -46.87 82.89 Favored 'General case' 0 C--O 1.217 -0.613 0 CA-C-N 116.35 -0.386 . . . . 61.31 111.562 178.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 17.1 ptpt -66.05 -31.53 72.47 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 111.953 0.353 . . . . 74.33 111.953 179.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -70.43 -51.46 29.23 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.795 0.331 . . . . 72.5 111.568 178.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.429 ' O ' HD13 ' A' ' 165' ' ' ILE . 0.0 OUTLIER -66.03 -36.0 76.42 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 N-CA-C 109.233 -0.654 . . . . 65.42 109.233 -177.236 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.423 ' OD1' ' HG2' ' A' ' 33' ' ' LYS . 18.7 t70 -58.94 -51.63 69.24 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-N 115.277 -0.874 . . . . 64.14 110.486 176.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.48 ' OE2' ' HA ' ' A' ' 171' ' ' ALA . 1.3 tm-20 -68.85 -33.91 74.6 Favored 'General case' 0 C--O 1.201 -1.486 0 CA-C-N 115.55 -0.75 . . . . 72.14 109.279 -179.159 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 16.2 t60 -61.63 -36.94 82.21 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 122.162 -0.336 . . . . 74.32 110.996 -179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 85.8 mt -77.41 -41.31 40.43 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.315 0.487 . . . . 72.4 112.315 -178.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.532 HD11 ' HG3' ' A' ' 33' ' ' LYS . 92.2 mt -83.73 -40.91 18.24 Favored 'General case' 0 C--N 1.305 -1.345 0 C-N-CA 120.565 -0.454 . . . . 74.12 111.637 -178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . 0.48 ' HA ' ' OE2' ' A' ' 167' ' ' GLU . . . 52.8 78.26 0.14 Allowed 'General case' 0 C--O 1.251 1.181 0 C-N-CA 124.906 1.282 . . . . 75.25 111.013 -177.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -92.07 160.56 15.16 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.003 -0.999 . . . . 74.21 112.563 -173.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.6 tt0 . . . . . 0 N--CA 1.432 -1.34 0 N-CA-C 107.707 -1.22 . . . . 74.4 107.707 -179.175 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.1 m . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 121.259 0.552 . . . . 75.04 111.096 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -142.69 159.89 41.37 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.668 -0.696 . . . . 74.22 109.334 171.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -156.65 99.49 1.87 Allowed 'General case' 0 C--N 1.305 -1.342 0 CA-C-O 121.036 0.446 . . . . 41.01 109.817 -176.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 23.6 m -71.21 -26.65 63.03 Favored 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.587 -0.733 . . . . 72.52 111.455 -177.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 14.8 m -66.72 -12.68 59.53 Favored 'General case' 0 CA--C 1.551 0.984 0 CA-C-N 116.249 -0.432 . . . . 71.3 110.594 177.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 72.7 mt 62.88 -34.43 0.12 Allowed 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 126.169 1.788 . . . . 71.32 115.201 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 10.3 p -81.11 140.78 16.1 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.021 0 N-CA-C 108.647 -0.871 . . . . 63.2 108.647 175.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HE3' ' A' ' 143' ' ' LYS . . . -146.4 167.1 28.05 Favored Glycine 0 N--CA 1.432 -1.577 0 C-N-CA 119.963 -1.113 . . . . 73.4 112.887 -178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.471 ' HG2' ' HG2' ' A' ' 140' ' ' GLU . 48.1 mtpt -134.44 158.87 42.78 Favored 'General case' 0 CA--C 1.477 -1.853 0 C-N-CA 123.733 0.813 . . . . 70.24 112.072 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 60.7 tp -143.19 126.17 16.29 Favored 'General case' 0 N--CA 1.418 -2.03 0 CA-C-N 114.873 -1.058 . . . . 72.25 108.16 165.662 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.497 ' HA ' ' O ' ' A' ' 137' ' ' TRP . 25.5 tt0 -134.32 126.44 29.7 Favored 'General case' 0 C--N 1.284 -2.276 0 N-CA-C 108.45 -0.945 . . . . 74.41 108.45 -178.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 15.1 t -149.69 164.05 36.27 Favored 'General case' 0 C--N 1.315 -0.901 0 C-N-CA 120.805 -0.358 . . . . 71.32 110.77 -175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.01 117.68 33.35 Favored 'General case' 0 CA--C 1.497 -1.08 0 N-CA-C 109.324 -0.621 . . . . 74.2 109.324 177.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.487 HG11 ' CB ' ' A' ' 162' ' ' SER . 60.1 t -108.97 136.93 43.34 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.107 0 N-CA-C 107.358 -1.349 . . . . 75.44 107.358 174.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.545 ' HG2' HD12 ' A' ' 134' ' ' ILE . 20.4 mt-10 -98.39 137.21 37.43 Favored 'General case' 0 C--N 1.28 -2.414 0 C-N-CA 119.644 -0.822 . . . . 70.2 109.486 -177.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 29.7 pt -115.49 172.97 3.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 N-CA-C 108.779 -0.823 . . . . 71.31 108.779 179.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.428 ' HB2' HD11 ' A' ' 170' ' ' LEU . 96.9 mttt -99.4 -29.19 12.9 Favored 'General case' 0 C--N 1.298 -1.648 0 N-CA-C 109.699 -0.482 . . . . 75.45 109.699 -178.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -77.33 167.06 22.33 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.914 -0.585 . . . . 62.24 110.545 177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.1 p -106.59 157.5 17.64 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 121.049 0.452 . . . . 74.15 111.017 179.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.92 -28.13 69.31 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 115.297 -0.865 . . . . 73.24 109.982 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -59.74 -51.46 69.68 Favored 'General case' 0 N--CA 1.442 -0.87 0 CA-C-N 114.365 -1.289 . . . . 74.51 110.326 178.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.455 ' HE3' ' HB2' ' A' ' 38' ' ' LYS . 22.0 ptmt -75.83 -25.85 56.67 Favored 'General case' 0 CA--C 1.498 -1.03 0 C-N-CA 119.96 -0.696 . . . . 54.25 112.689 -177.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 79.4 t80 -52.85 -33.97 52.08 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 115.621 -0.718 . . . . 54.52 109.668 175.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 33.7 m170 -64.73 -50.81 65.44 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-N 116.049 -0.523 . . . . 75.32 109.948 178.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 23.6 m-70 -62.24 -32.35 73.02 Favored 'General case' 0 C--O 1.217 -0.657 0 CA-C-N 115.268 -0.878 . . . . 74.3 111.229 -174.12 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.418 ' HA ' ' CE ' ' A' ' 42' ' ' MET . 3.0 mmt -71.67 -35.02 70.18 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 112.938 0.718 . . . . 74.13 112.938 -176.551 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -108.35 -32.89 7.27 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 119.311 -0.956 . . . . 64.32 113.542 -176.613 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -177.67 95.49 0.04 OUTLIER 'General case' 0 C--O 1.24 0.6 0 CA-C-O 120.882 0.372 . . . . 70.44 110.582 -178.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -115.32 -145.77 8.7 Favored Glycine 0 C--N 1.297 -1.609 0 N-CA-C 110.192 -1.163 . . . . 72.13 110.192 178.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.55 ' HD3' ' H ' ' A' ' 46' ' ' LYS . 0.1 OUTLIER -79.13 152.03 76.23 Favored Pre-proline 0 C--N 1.304 -1.382 0 N-CA-C 109.029 -0.73 . . . . 72.44 109.029 176.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_exo -42.28 -42.94 7.75 Favored 'Trans proline' 0 C--N 1.365 1.413 0 C-N-CA 124.381 3.388 . . . . 72.55 114.451 -179.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.451 ' O ' ' HE3' ' A' ' 46' ' ' LYS . 53.0 t-80 -78.84 93.91 5.08 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-O 121.34 0.59 . . . . 74.32 109.552 177.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 19.6 t60 -98.64 129.48 45.14 Favored 'General case' 0 C--N 1.289 -2.033 0 CA-C-N 115.187 -0.915 . . . . 54.42 108.745 179.043 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 62.3 t -82.42 102.43 8.35 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 107.45 -1.315 . . . . 71.5 107.45 174.034 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 39.2 m -82.65 -177.25 6.64 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 115.591 -0.731 . . . . 72.53 110.744 -176.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -67.61 150.27 48.99 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 116.672 -0.24 . . . . 75.13 110.746 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -69.37 -31.42 69.81 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.622 -0.881 . . . . 70.22 108.622 175.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 11.3 m -62.6 137.61 96.48 Favored Pre-proline 0 N--CA 1.434 -1.227 0 CA-C-N 114.455 -1.248 . . . . 51.23 108.841 175.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -55.02 -29.36 64.57 Favored 'Trans proline' 0 C--N 1.358 1.037 0 C-N-CA 123.021 2.481 . . . . 61.14 112.234 178.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.37 50.55 2.18 Favored Glycine 0 N--CA 1.428 -1.869 0 C-N-CA 120.656 -0.783 . . . . 73.35 111.33 177.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -79.63 82.62 5.72 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.321 0.581 . . . . 72.2 110.377 179.539 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.402 ' HB ' ' SG ' ' A' ' 61' ' ' CYS . 46.7 mm -128.25 127.69 67.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.61 0 N-CA-C 107.931 -1.137 . . . . 70.43 107.931 178.862 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -69.19 106.22 2.77 Favored 'General case' 0 C--N 1.312 -1.034 0 N-CA-C 109.685 -0.487 . . . . 62.15 109.685 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.26 71.34 1.23 Allowed Glycine 0 N--CA 1.427 -1.908 0 C-N-CA 120.683 -0.77 . . . . 63.33 111.648 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.402 ' SG ' ' HB ' ' A' ' 58' ' ' ILE . 80.6 m -89.22 97.37 11.16 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 108.351 -0.981 . . . . 50.01 108.351 176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.8 m-20 -85.47 81.57 8.65 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-O 121.508 0.671 . . . . 74.13 109.447 -178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 65.6 tp -107.27 -63.45 1.29 Allowed 'General case' 0 C--N 1.305 -1.341 0 CA-C-N 115.206 -0.906 . . . . 72.4 109.811 -178.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 58.1 t-80 -84.21 -37.08 22.27 Favored 'General case' 0 C--N 1.315 -0.895 0 N-CA-C 109.167 -0.679 . . . . 75.42 109.167 -179.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 9.9 mm-40 -84.21 -17.19 40.67 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.571 -0.74 . . . . 63.24 110.531 -178.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -89.46 64.29 3.23 Favored Glycine 0 N--CA 1.439 -1.122 0 N-CA-C 111.274 -0.73 . . . . 72.04 111.274 -179.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -134.32 117.43 16.38 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-O 121.466 0.65 . . . . 71.31 112.006 -178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 21.7 m-90 -104.42 14.72 29.6 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.907 -1.042 . . . . 63.55 109.329 176.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 87.82 12.35 66.54 Favored Glycine 0 N--CA 1.443 -0.871 0 C-N-CA 120.764 -0.732 . . . . 71.41 111.286 -178.509 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 32.3 m 71.86 -74.37 0.09 Allowed 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.383 1.073 . . . . 72.34 110.091 -177.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.0 t -73.01 125.35 31.73 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.01 0 N-CA-C 109.054 -0.721 . . . . 75.13 109.054 176.581 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.91 -0.56 55.12 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.234 -0.984 . . . . 65.13 111.345 -177.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB3' HD12 ' A' ' 92' ' ' ILE . 33.1 t -63.76 131.88 49.24 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 109.955 -0.387 . . . . 75.42 109.955 179.078 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.8 mt -127.47 115.85 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.578 0 CA-C-N 115.697 -0.683 . . . . 62.22 109.409 178.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.0 m -135.52 160.65 39.82 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.027 0 N-CA-C 107.025 -1.472 . . . . 51.01 107.025 179.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.429 ' HD1' ' HA ' ' A' ' 89' ' ' LYS . 25.3 m-85 -121.01 121.61 38.32 Favored 'General case' 0 CA--C 1.481 -1.7 0 N-CA-C 108.468 -0.938 . . . . 70.14 108.468 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 34.8 t-105 -109.66 137.08 48.0 Favored 'General case' 0 N--CA 1.399 -3.0 0 CA-C-N 116.02 -0.536 . . . . 62.31 109.854 -175.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.452 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.8 OUTLIER -105.11 131.72 52.25 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-N 115.488 -0.778 . . . . 71.52 109.987 179.709 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.7 p90 -137.6 156.14 48.4 Favored 'General case' 0 C--N 1.285 -2.221 0 N-CA-C 107.637 -1.246 . . . . 74.34 107.637 177.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 55.4 t -105.68 128.0 60.16 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.158 0 N-CA-C 109.438 -0.578 . . . . 64.24 109.438 -177.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 85.1 t60 -136.05 114.15 11.4 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.757 -0.831 . . . . 73.24 108.757 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 62.18 28.85 17.31 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.687 1.195 . . . . 71.02 111.777 -178.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 91.07 -8.47 79.62 Favored Glycine 0 N--CA 1.43 -1.758 0 C-N-CA 120.181 -1.009 . . . . 72.13 114.454 177.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' HB2' ' HE2' ' A' ' 86' ' ' LYS . 6.5 mp0 -95.44 150.15 20.61 Favored 'General case' 0 CA--C 1.496 -1.112 0 C-N-CA 118.492 -1.283 . . . . 71.13 109.409 175.236 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.67 116.26 23.84 Favored 'General case' 0 N--CA 1.426 -1.672 0 N-CA-C 107.038 -1.467 . . . . 63.44 107.038 174.212 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.459 ' HE2' ' HB2' ' A' ' 84' ' ' GLU . 74.7 mmtt -105.69 142.56 35.21 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 107.299 -1.371 . . . . 74.31 107.299 -176.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.2 p -134.86 131.16 53.11 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.929 0 CA-C-O 121.329 0.585 . . . . 60.21 109.473 178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.77 138.72 45.73 Favored 'General case' 0 C--N 1.292 -1.906 0 CA-C-N 115.441 -0.8 . . . . 74.33 109.529 -177.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.429 ' HA ' ' HD1' ' A' ' 76' ' ' PHE . 7.7 mptt -104.4 120.24 40.77 Favored 'General case' 0 N--CA 1.39 -3.437 0 N-CA-C 105.748 -1.945 . . . . 73.13 105.748 175.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -134.53 157.91 45.33 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-O 121.427 0.632 . . . . 73.31 111.899 -168.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -137.45 127.5 25.92 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 114.707 -1.133 . . . . 73.32 109.649 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.418 HD12 ' HB3' ' A' ' 73' ' ' SER . 56.4 mt -77.85 122.84 33.52 Favored 'Isoleucine or valine' 0 C--O 1.239 0.509 0 N-CA-C 109.6 -0.519 . . . . 61.25 109.6 176.314 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 15.0 mm-40 -99.92 -40.51 7.64 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 113.721 1.008 . . . . 73.53 113.721 -175.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . 0.408 ' O ' ' HA ' ' A' ' 102' ' ' ILE . . . -154.26 142.62 20.56 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 109.3 -0.63 . . . . 53.12 109.3 -178.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.37 123.7 3.91 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 123.816 0.697 . . . . 62.52 110.283 177.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.446 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 8.7 mm-40 -108.58 108.55 61.02 Favored Pre-proline 0 C--N 1.299 -1.629 0 CA-C-N 115.172 -0.922 . . . . 65.32 109.064 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_exo -60.88 -46.05 17.83 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 122.42 2.08 . . . . 73.44 111.282 177.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -79.63 -34.78 40.26 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.067 -0.515 . . . . 64.54 112.371 -177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.403 ' HB2' ' CB ' ' A' ' 96' ' ' GLU . 47.4 mmtm -90.73 0.01 57.56 Favored 'General case' 0 C--N 1.31 -1.131 0 C-N-CA 119.808 -0.757 . . . . 74.3 112.362 -176.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 63.4 m-20 57.55 38.31 27.89 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 123.465 0.706 . . . . 71.21 110.917 177.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.464 HD11 ' CG2' ' A' ' 121' ' ' THR . 45.3 tp -118.11 140.18 50.15 Favored 'General case' 0 C--N 1.31 -1.148 0 CA-C-N 116.831 -0.168 . . . . 73.04 110.583 -172.254 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.408 ' HA ' ' O ' ' A' ' 94' ' ' ALA . 13.8 tt -150.34 124.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.924 0 CA-C-O 121.717 0.77 . . . . 75.22 111.941 176.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 30.8 m -99.69 129.66 45.84 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 114.905 -1.043 . . . . 72.32 111.333 179.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.449 ' HB2' ' HB2' ' A' ' 120' ' ' LEU . 88.8 m-85 -113.53 137.43 51.57 Favored 'General case' 0 C--N 1.352 0.685 0 N-CA-C 107.961 -1.126 . . . . 72.01 107.961 177.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 24.0 ttm180 -109.71 138.68 45.72 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 107.514 -1.291 . . . . 62.32 107.514 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.509 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 11.3 p -84.94 127.61 39.73 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.722 0 N-CA-C 106.715 -1.587 . . . . 72.2 106.715 173.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.415 HD11 ' HB3' ' A' ' 89' ' ' LYS . 28.2 pt -101.36 -35.31 4.2 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.135 0 C-N-CA 119.819 -0.753 . . . . 44.14 110.328 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -156.88 154.86 30.47 Favored 'General case' 0 N--CA 1.438 -1.058 0 N-CA-C 104.792 -2.299 . . . . 63.45 104.792 177.487 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 150.65 167.63 14.71 Favored Glycine 0 N--CA 1.424 -2.146 0 C-N-CA 120.318 -0.944 . . . . 43.03 112.288 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.61 -35.57 42.23 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 124.651 1.18 . . . . 73.31 111.877 179.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.42 ' H ' HD22 ' A' ' 111' ' ' LEU . 2.6 mm? -62.1 -24.9 67.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.93 -0.577 . . . . 75.23 112.006 -178.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.483 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 2.8 mmt -71.45 -9.01 57.51 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 120.883 0.373 . . . . 75.1 111.011 -178.748 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -87.64 -10.35 51.64 Favored 'General case' 0 C--O 1.239 0.55 0 CA-C-O 121.157 0.503 . . . . 61.11 110.566 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -120.21 -35.63 3.41 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-O 121.526 0.679 . . . . 74.11 109.691 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.483 ' O ' ' HA ' ' A' ' 112' ' ' MET . 19.4 m-85 -121.52 131.87 54.38 Favored 'General case' 0 N--CA 1.438 -1.075 0 N-CA-C 107.165 -1.42 . . . . 74.44 107.165 -177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.411 ' HB3' HG12 ' A' ' 144' ' ' ILE . 21.0 ptmt -88.73 3.01 52.38 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-O 121.495 0.664 . . . . 55.52 111.105 -177.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 43.6 t -169.51 140.97 2.32 Favored 'General case' 0 N--CA 1.428 -1.572 0 N-CA-C 107.034 -1.469 . . . . 62.42 107.034 177.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.509 ' HB3' ' CG1' ' A' ' 106' ' ' VAL . 7.0 t80 -155.93 115.87 3.66 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 123.7 0.625 . . . . 71.34 109.459 -175.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 34.4 tp -119.44 130.31 55.2 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.676 -0.861 . . . . 65.21 108.676 -179.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' HB2' ' A' ' 104' ' ' PHE . 2.7 mp -114.11 133.88 55.26 Favored 'General case' 0 CA--C 1.477 -1.842 0 N-CA-C 109.4 -0.593 . . . . 71.5 109.4 -177.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.464 ' CG2' HD11 ' A' ' 101' ' ' LEU . 25.3 m -131.22 123.51 28.6 Favored 'General case' 0 C--N 1.266 -3.056 0 N-CA-C 109.059 -0.719 . . . . 62.33 109.059 170.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 39.1 pt -117.77 148.54 20.5 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 C-N-CA 120.169 -0.612 . . . . 62.13 109.475 178.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 55.0 tt0 -144.14 126.14 15.41 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 108.839 -0.8 . . . . 74.31 108.839 178.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 39.8 t -95.48 118.08 40.9 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 108.591 -0.892 . . . . 75.31 108.591 -178.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 19.9 p -113.35 152.37 45.16 Favored Pre-proline 0 C--N 1.29 -2.018 0 N-CA-C 114.094 1.146 . . . . 73.55 114.094 -177.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.27 42.56 0.31 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 125.119 3.88 . . . . 63.51 111.123 172.135 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.55 ' HB3' ' HD3' ' A' ' 128' ' ' PRO . 88.0 tttt -53.43 -53.66 54.04 Favored Pre-proline 0 CA--C 1.564 1.494 0 C-N-CA 124.329 1.052 . . . . 75.12 112.156 -177.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.55 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 4.0 Cg_exo -83.54 -12.44 8.92 Favored 'Trans proline' 0 C--N 1.368 1.594 0 C-N-CA 121.979 1.786 . . . . 71.44 111.944 174.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 137.85 -150.54 20.91 Favored Glycine 0 N--CA 1.44 -1.067 0 N-CA-C 110.961 -0.856 . . . . 72.54 110.961 179.758 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -73.94 -72.07 1.04 Allowed Glycine 0 C--O 1.239 0.424 0 N-CA-C 109.964 -1.254 . . . . 62.21 109.964 176.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.19 113.23 2.78 Favored 'Trans proline' 0 C--O 1.25 1.076 0 C-N-CA 122.319 2.012 . . . . 75.23 109.04 171.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.434 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 106.5 114.64 3.93 Favored Glycine 0 N--CA 1.425 -2.081 0 N-CA-C 109.54 -1.424 . . . . 53.23 109.54 -173.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 51.1 m -139.53 145.59 38.88 Favored 'General case' 0 C--N 1.293 -1.869 0 N-CA-C 109.787 -0.449 . . . . 70.22 109.787 -178.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.545 HD12 ' HG2' ' A' ' 31' ' ' GLU . 42.1 mm -118.4 142.32 33.69 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.009 0 N-CA-C 107.89 -1.152 . . . . 34.34 107.89 -178.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.0 p -104.88 124.21 59.4 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.127 0 CA-C-O 121.562 0.696 . . . . 61.51 110.987 -179.268 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 70.9 m-70 -93.14 122.85 35.93 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.518 -0.919 . . . . 54.32 108.518 177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.497 ' O ' ' HA ' ' A' ' 27' ' ' GLU . 44.5 m95 -99.85 121.79 41.83 Favored 'General case' 0 C--N 1.286 -2.169 0 N-CA-C 109.173 -0.677 . . . . 74.3 109.173 177.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 57.2 t60 -115.92 110.77 19.45 Favored 'General case' 0 C--N 1.29 -1.997 0 N-CA-C 107.313 -1.366 . . . . 75.14 107.313 176.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.477 HD11 ' HB3' ' A' ' 137' ' ' TRP . 4.2 mp -116.46 134.5 54.79 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 109.743 -0.466 . . . . 64.11 109.743 -176.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.471 ' HG2' ' HG2' ' A' ' 25' ' ' LYS . 43.0 mt-10 -131.13 128.43 40.1 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.825 -0.806 . . . . 74.41 108.825 175.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 16.2 p90 -147.0 156.57 43.15 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.391 0.615 . . . . 74.22 112.595 -173.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 10.8 tp10 -104.77 122.11 45.04 Favored 'General case' 0 C--N 1.304 -1.376 0 CA-C-N 114.972 -1.013 . . . . 63.45 109.155 -176.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.629 ' HG3' ' CB ' ' A' ' 149' ' ' ALA . 0.7 OUTLIER -73.3 127.67 33.3 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 116.5 -0.318 . . . . 64.45 111.169 178.713 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.411 HG12 ' HB3' ' A' ' 116' ' ' LYS . 61.0 mt -67.79 -44.68 85.43 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.677 0 N-CA-C 107.193 -1.41 . . . . 65.44 107.193 170.817 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.5 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 49.2 m -151.38 164.46 36.65 Favored 'General case' 0 N--CA 1.41 -2.454 0 N-CA-C 107.166 -1.42 . . . . 61.21 107.166 177.364 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -66.89 -61.34 2.0 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 123.644 0.59 . . . . 64.3 111.706 -173.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -68.7 -19.43 64.37 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.633 -0.712 . . . . 65.4 111.262 -176.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.5 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 95.9 t -78.07 -25.31 14.18 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 CA-C-N 115.385 -0.825 . . . . 63.43 111.253 -176.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.629 ' CB ' ' HG3' ' A' ' 143' ' ' LYS . . . -94.71 135.41 36.21 Favored 'General case' 0 C--N 1.303 -1.441 0 CA-C-N 116.476 -0.329 . . . . 72.51 110.271 -178.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.439 ' HB3' ' CD ' ' A' ' 152' ' ' GLU . 43.1 m-70 -138.62 97.06 9.33 Favored Pre-proline 0 C--N 1.309 -1.16 0 N-CA-C 112.275 0.472 . . . . 72.15 112.275 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.612 ' HA ' HD23 ' A' ' 154' ' ' LEU . 14.1 Cg_exo -40.08 -33.65 0.83 Allowed 'Trans proline' 0 N--CA 1.49 1.27 0 C-N-CA 124.722 3.615 . . . . 75.23 114.567 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.517 ' O ' ' HG2' ' A' ' 156' ' ' GLN . 5.6 pm0 -55.43 -34.81 64.78 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 113.416 0.895 . . . . 71.32 113.416 177.065 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.3 p -68.82 -29.88 68.31 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-O 121.058 0.456 . . . . 62.24 110.332 -176.683 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.612 HD23 ' HA ' ' A' ' 151' ' ' PRO . 2.2 mm? -72.62 -36.74 68.14 Favored 'General case' 0 C--O 1.203 -1.356 0 N-CA-C 108.93 -0.767 . . . . 75.45 108.93 177.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . . . . . . . . . 81.1 mt -60.45 -35.56 76.13 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 120.886 0.374 . . . . 74.52 110.167 175.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.517 ' HG2' ' O ' ' A' ' 152' ' ' GLU . 27.3 mm-40 -67.11 -35.75 80.43 Favored 'General case' 0 C--O 1.211 -0.922 0 CA-C-N 115.759 -0.655 . . . . 74.41 109.593 177.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 85.2 t80 -71.8 -49.37 39.35 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 109.406 -0.59 . . . . 71.24 109.406 177.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.405 ' SG ' HD21 ' A' ' 139' ' ' LEU . 78.7 m -56.72 -48.04 78.65 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.635 -0.712 . . . . 62.45 112.326 -179.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 13.1 p -59.53 -43.37 90.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.548 0 CA-C-O 121.051 0.453 . . . . 60.44 112.015 -176.177 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.445 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 6.7 mm-40 -67.62 -44.91 76.88 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 115.8 -0.636 . . . . 74.33 110.392 -178.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.6 t -66.08 -34.99 73.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.746 -0.661 . . . . 23.33 110.381 179.242 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 30' ' ' VAL . 58.9 m -60.83 -43.75 97.84 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 120.475 0.179 . . . . 75.44 110.941 177.729 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.495 ' O ' ' HG2' ' A' ' 167' ' ' GLU . 67.4 mttm -62.7 -47.62 82.83 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 109.521 -0.548 . . . . 72.23 109.521 177.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -59.3 -51.45 69.9 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-N 114.929 -1.032 . . . . 73.22 111.887 -178.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.528 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 0.1 OUTLIER -69.31 -37.53 75.89 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.833 0 N-CA-C 110.06 -0.348 . . . . 74.43 110.06 -174.964 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -64.88 -48.82 72.89 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-O 120.748 0.308 . . . . 73.42 111.785 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.495 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.5 pt-20 -67.07 -29.59 69.41 Favored 'General case' 0 C--O 1.212 -0.918 0 CA-C-N 116.787 -0.188 . . . . 70.53 110.565 177.571 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 15.8 t60 -63.26 -35.55 80.71 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 108.793 -0.817 . . . . 74.43 108.793 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.528 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 86.0 mt -77.1 -45.85 25.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.077 -0.51 . . . . 73.24 111.27 177.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.428 HD11 ' HB2' ' A' ' 33' ' ' LYS . 86.9 mt -69.64 -43.2 73.12 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 120.678 0.275 . . . . 71.23 110.434 -177.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 54.6 23.08 4.39 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 124.861 1.264 . . . . 40.33 112.401 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -86.68 149.95 24.53 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-O 121.373 0.606 . . . . 75.42 111.848 -177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 . . . . . 0 C--N 1.296 -1.737 0 N-CA-C 107.163 -1.421 . . . . 64.51 107.163 175.835 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 6.3 t . . . . . 0 N--CA 1.395 -3.224 0 CA-C-O 121.448 0.642 . . . . 74.32 110.486 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 175.47 159.16 0.23 Allowed 'General case' 0 C--N 1.288 -2.092 0 C-N-CA 126.085 1.754 . . . . 71.54 109.061 176.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -158.39 109.84 2.2 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 108.826 -0.805 . . . . 34.45 108.826 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 22.1 p -64.81 -42.77 94.74 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 112.747 0.647 . . . . 71.24 112.747 -176.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 56.0 p -89.32 -39.04 13.73 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 112.728 0.64 . . . . 61.13 112.728 -176.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 82.6 mt 62.57 15.29 7.81 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.528 0.731 . . . . 62.11 112.307 -172.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.0 t -92.68 134.15 31.63 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 107.479 -1.304 . . . . 63.21 107.479 175.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -127.1 147.31 16.87 Favored Glycine 0 N--CA 1.423 -2.182 0 C-N-CA 120.765 -0.731 . . . . 43.53 111.61 -178.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 27.0 mtmm -132.58 157.92 43.5 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 107.459 -1.311 . . . . 60.15 107.459 178.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 63.1 tp -150.49 134.24 16.67 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 107.909 -1.145 . . . . 71.33 107.909 167.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -132.99 138.36 46.82 Favored 'General case' 0 C--N 1.283 -2.286 0 N-CA-C 109.059 -0.719 . . . . 72.32 109.059 178.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.7 t -151.75 145.02 24.69 Favored 'General case' 0 N--CA 1.418 -2.027 0 N-CA-C 108.67 -0.863 . . . . 75.24 108.67 -179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -109.94 131.25 55.23 Favored 'General case' 0 C--N 1.285 -2.203 0 N-CA-C 108.679 -0.86 . . . . 72.44 108.679 176.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 81.7 t -115.1 133.55 60.95 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.346 0 N-CA-C 107.815 -1.179 . . . . 72.35 107.815 177.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.533 ' HG2' HD12 ' A' ' 134' ' ' ILE . 22.6 mt-10 -99.82 121.52 41.41 Favored 'General case' 0 C--N 1.278 -2.538 0 N-CA-C 108.548 -0.908 . . . . 74.3 108.548 -176.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.557 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 28.0 pt -110.34 175.59 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.335 0 CA-C-O 120.849 0.357 . . . . 74.14 111.664 -174.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -99.86 -28.27 13.2 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 108.912 -0.773 . . . . 74.25 108.912 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -67.24 153.32 43.96 Favored 'General case' 0 N--CA 1.429 -1.517 0 CA-C-N 115.045 -0.98 . . . . 73.12 110.751 177.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.458 ' OG ' ' HA ' ' A' ' 131' ' ' PRO . 66.6 m -96.89 147.54 23.86 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.616 -0.72 . . . . 73.35 111.92 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.56 ' HB1' ' ND2' ' A' ' 100' ' ' ASN . . . -61.95 -35.8 79.54 Favored 'General case' 0 N--CA 1.441 -0.922 0 CA-C-N 115.028 -0.987 . . . . 64.35 109.503 177.362 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.404 ' O ' ' HB3' ' A' ' 40' ' ' HIS . 28.0 t70 -57.67 -38.5 75.24 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 114.809 -1.087 . . . . 62.35 111.022 176.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -70.89 -36.98 72.97 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.926 -0.579 . . . . 65.21 111.063 -179.585 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -61.13 -37.68 83.68 Favored 'General case' 0 CA--C 1.546 0.807 0 N-CA-C 108.076 -1.083 . . . . 75.25 108.076 177.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.404 ' HB3' ' O ' ' A' ' 37' ' ' ASP . 13.6 t-80 -65.05 -35.3 80.73 Favored 'General case' 0 CA--C 1.544 0.72 0 CA-C-N 114.491 -1.232 . . . . 72.44 111.812 178.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.457 ' HB2' ' OXT' ' A' ' 173' ' ' GLU . 87.0 m-70 -76.72 -50.64 13.14 Favored 'General case' 0 N--CA 1.472 0.641 0 N-CA-C 111.987 0.366 . . . . 64.43 111.987 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.49 -29.63 67.97 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 114.251 1.204 . . . . 73.22 114.251 -172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -87.52 -31.12 20.1 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.09 -0.644 . . . . 71.45 110.229 -179.608 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.57 -43.6 31.22 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-N 116.209 -0.45 . . . . 42.45 111.043 -177.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -85.96 160.2 33.54 Favored Glycine 0 N--CA 1.441 -0.975 0 N-CA-C 110.877 -0.889 . . . . 43.12 110.877 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -112.0 100.06 47.76 Favored Pre-proline 0 C--N 1.312 -1.034 0 N-CA-C 112.641 0.608 . . . . 71.4 112.641 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.58 150.05 24.38 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 C-N-CA 122.19 1.927 . . . . 71.14 108.189 171.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 27.1 t60 -68.43 -32.15 71.98 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 119.958 -0.697 . . . . 70.23 109.457 -177.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 29.2 m80 -145.96 161.52 39.87 Favored 'General case' 0 CA--C 1.481 -1.679 0 N-CA-C 108.235 -1.024 . . . . 70.42 108.235 172.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' HB ' ' CE1' ' A' ' 168' ' ' HIS . 34.6 m -70.52 162.88 3.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.644 0 O-C-N 123.53 0.519 . . . . 60.41 110.065 177.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . 0.585 ' HB3' ' HB3' ' A' ' 172' ' ' GLU . 26.7 p -59.58 144.93 46.19 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 112.838 0.681 . . . . 65.24 112.838 -179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt 63.47 -80.83 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 C-N-CA 125.079 1.352 . . . . 65.21 110.962 -178.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 61.79 -64.37 0.08 Allowed 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 125.445 1.498 . . . . 32.3 112.107 -178.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.4 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 15.4 m -88.14 151.01 48.51 Favored Pre-proline 0 N--CA 1.413 -2.315 0 C-N-CA 123.939 0.895 . . . . 74.23 109.398 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 54' ' ' SER . 5.6 Cg_exo -79.01 -149.18 0.04 OUTLIER 'Trans proline' 0 C--O 1.246 0.878 0 C-N-CA 122.235 1.956 . . . . 74.35 107.731 169.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -80.22 51.09 4.09 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 120.035 -1.078 . . . . 61.44 110.723 175.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 -143.47 147.26 34.28 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 106.736 -1.579 . . . . 74.33 106.736 -175.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 70.3 mt -84.76 113.71 23.84 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 CA-C-O 121.317 0.58 . . . . 73.54 111.322 -178.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -117.37 159.95 21.93 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 115.551 -0.75 . . . . 71.43 109.845 176.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -147.23 -165.48 11.81 Favored Glycine 0 N--CA 1.421 -2.362 0 N-CA-C 109.634 -1.387 . . . . 54.24 109.634 178.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 69.9 m 69.42 162.22 0.22 Allowed 'General case' 0 C--N 1.322 -0.627 0 C-N-CA 123.788 0.835 . . . . 64.23 111.638 179.209 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -113.74 155.44 25.61 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 122.187 -0.321 . . . . 55.25 110.181 -177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -85.3 102.34 13.3 Favored 'General case' 0 C--N 1.313 -0.988 0 N-CA-C 108.576 -0.898 . . . . 63.31 108.576 178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 48.8 t-80 -89.45 -15.49 33.0 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 116.051 -0.522 . . . . 75.33 110.637 -177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -75.5 90.73 2.75 Favored 'General case' 0 C--O 1.24 0.583 0 CA-C-O 121.249 0.547 . . . . 74.52 110.107 176.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 97.06 -161.46 21.7 Favored Glycine 0 N--CA 1.414 -2.776 0 CA-C-N 115.046 -0.979 . . . . 61.32 110.918 -178.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 26.1 t70 62.36 93.17 0.05 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 122.337 1.065 . . . . 64.43 112.022 -179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 62.6 m95 -104.52 -16.25 15.11 Favored 'General case' 0 C--N 1.297 -1.674 0 CA-C-N 114.579 -1.191 . . . . 61.2 109.44 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.36 -12.51 32.36 Favored Glycine 0 CA--C 1.52 0.385 0 CA-C-N 115.764 -0.653 . . . . 74.32 114.338 176.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 23.2 p -119.3 179.51 4.17 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 123.06 0.544 . . . . 72.44 110.91 -176.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.496 HG23 HG22 ' A' ' 92' ' ' ILE . 11.8 p -65.14 140.55 19.53 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.856 0 N-CA-C 109.104 -0.702 . . . . 65.14 109.104 175.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 95.84 -6.37 67.08 Favored Glycine 0 N--CA 1.438 -1.17 0 N-CA-C 110.718 -0.953 . . . . 63.23 110.718 -176.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.477 ' HB3' HD12 ' A' ' 92' ' ' ILE . 32.7 t -64.92 140.21 58.84 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-O 121.282 0.563 . . . . 72.22 110.803 -179.487 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 79.3 mt -116.3 123.71 71.74 Favored 'Isoleucine or valine' 0 N--CA 1.416 -2.16 0 N-CA-C 107.686 -1.228 . . . . 74.3 107.686 176.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 40.5 t -127.07 154.82 37.67 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.722 -1.214 . . . . 72.31 107.722 -177.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -126.05 122.27 35.34 Favored 'General case' 0 CA--C 1.491 -1.306 0 N-CA-C 109.604 -0.517 . . . . 62.3 109.604 178.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 38.0 t-105 -119.54 144.29 47.13 Favored 'General case' 0 N--CA 1.408 -2.565 0 N-CA-C 108.4 -0.963 . . . . 75.23 108.4 -179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.404 ' ND2' HG22 ' A' ' 87' ' ' VAL . 15.8 m120 -110.21 133.06 53.61 Favored 'General case' 0 C--N 1.311 -1.079 0 N-CA-C 108.775 -0.824 . . . . 74.33 108.775 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 46.5 p90 -139.95 157.2 46.06 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 108.38 -0.97 . . . . 73.22 108.38 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 60.1 t -105.98 117.83 52.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.608 0 C-N-CA 120.037 -0.665 . . . . 75.33 109.79 -178.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 79.5 t60 -140.09 131.1 26.22 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 107.856 -1.164 . . . . 72.14 107.856 -179.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 64.66 27.15 13.21 Favored 'General case' 0 N--CA 1.487 1.415 0 C-N-CA 125.314 1.446 . . . . 71.13 109.601 -174.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.5 -11.21 40.03 Favored Glycine 0 CA--C 1.53 0.992 0 CA-C-N 115.916 -0.584 . . . . 62.51 113.094 -178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.435 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 2.6 mp0 -95.58 144.19 26.24 Favored 'General case' 0 CA--C 1.485 -1.547 0 CA-C-N 117.285 0.543 . . . . 54.4 110.737 177.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.46 115.1 22.99 Favored 'General case' 0 N--CA 1.417 -2.111 0 N-CA-C 106.077 -1.823 . . . . 72.22 106.077 173.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.435 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.2 mttt -112.68 157.41 21.29 Favored 'General case' 0 C--N 1.281 -2.394 0 CA-C-N 115.781 -0.645 . . . . 75.33 109.9 -174.733 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.404 HG22 ' ND2' ' A' ' 78' ' ' ASN . 46.4 t -114.77 141.72 30.27 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 N-CA-C 109.131 -0.692 . . . . 73.03 109.131 -175.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.33 116.2 31.41 Favored 'General case' 0 N--CA 1.421 -1.886 0 N-CA-C 107.965 -1.124 . . . . 62.32 107.965 176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.483 ' HB3' HD11 ' A' ' 107' ' ' ILE . 93.9 mttt -102.25 119.82 39.44 Favored 'General case' 0 N--CA 1.404 -2.763 0 N-CA-C 107.553 -1.277 . . . . 70.34 107.553 176.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -139.72 162.05 36.07 Favored 'General case' 0 C--N 1.298 -1.666 0 CA-C-N 115.148 -0.933 . . . . 74.02 111.201 -169.188 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 57.6 ttt-85 -136.49 136.54 39.51 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.643 -0.873 . . . . 71.53 108.643 175.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.496 HG22 HG23 ' A' ' 71' ' ' VAL . 42.2 mt -72.97 122.93 26.73 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.946 0 N-CA-C 108.868 -0.79 . . . . 75.51 108.868 174.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -98.4 -39.14 8.93 Favored 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 109.374 -0.602 . . . . 50.13 109.374 -178.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -156.61 143.68 18.81 Favored 'General case' 0 CA--C 1.509 -0.598 0 N-CA-C 108.266 -1.013 . . . . 72.43 108.266 179.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.4 p -146.31 135.07 16.44 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.008 0 CA-C-O 121.38 0.61 . . . . 73.5 111.519 -179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 101' ' ' LEU . 10.2 tp10 -130.94 106.08 15.19 Favored Pre-proline 0 N--CA 1.43 -1.429 0 N-CA-C 108.212 -1.032 . . . . 71.43 108.212 175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -68.08 -28.74 34.44 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.163 1.909 . . . . 70.44 111.908 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -75.21 -34.83 61.53 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.263 0.554 . . . . 71.13 111.468 -175.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.584 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 75.8 mmtt -99.34 2.06 44.99 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.709 -0.678 . . . . 74.53 110.829 -178.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.56 ' ND2' ' HB1' ' A' ' 36' ' ' ALA . 62.7 m-20 59.2 46.0 13.57 Favored 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 123.221 0.608 . . . . 60.2 109.581 179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.596 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 51.9 tp -118.41 136.26 53.87 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-N 115.393 -0.822 . . . . 74.14 110.144 -173.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.414 HG23 HG12 ' A' ' 122' ' ' ILE . 5.3 tp -147.38 122.87 2.56 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 CA-C-O 121.712 0.768 . . . . 45.32 110.811 177.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 27.6 m -99.94 119.77 38.75 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 115.061 -0.972 . . . . 65.52 110.089 178.358 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -103.17 140.49 37.28 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 109.264 -0.643 . . . . 73.12 109.264 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -126.24 119.95 28.76 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.012 -1.477 . . . . 75.23 107.012 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.536 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 7.7 p -72.57 139.17 20.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 N-CA-C 109.455 -0.572 . . . . 65.34 109.455 -177.377 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.483 HD11 ' HB3' ' A' ' 89' ' ' LYS . 24.6 pt -109.5 -41.99 5.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 112.371 0.508 . . . . 73.31 112.371 -179.506 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -152.02 147.72 26.85 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 110.31 -0.256 . . . . 63.13 110.31 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 140.24 -165.39 26.03 Favored Glycine 0 N--CA 1.435 -1.377 0 N-CA-C 111.415 -0.674 . . . . 64.12 111.415 178.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -60.82 -38.46 85.51 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 123.6 0.76 . . . . 75.54 111.726 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 79.6 mt -63.01 -36.04 82.23 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.007 -0.542 . . . . 63.52 112.201 -174.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.1 mmt -73.71 -6.63 48.05 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.835 0.35 . . . . 70.54 111.443 -178.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 30.3 mmmt -86.12 -9.44 56.66 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 112.031 0.382 . . . . 74.11 112.031 -177.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.589 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 5.2 tp10 -133.63 -32.07 1.16 Allowed 'General case' 0 CA--C 1.497 -1.072 0 CA-C-O 122.184 0.992 . . . . 55.14 109.945 175.194 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -103.92 120.48 41.12 Favored 'General case' 0 N--CA 1.385 -3.719 0 N-CA-C 105.653 -1.981 . . . . 71.13 105.653 179.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 20.2 ptmt -77.02 -8.33 57.23 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.737 0.779 . . . . 63.22 110.236 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 38.4 t -160.78 133.4 6.25 Favored 'General case' 0 N--CA 1.412 -2.333 0 CA-C-N 114.447 -1.251 . . . . 65.43 107.98 175.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.3 t80 -140.19 108.08 5.69 Favored 'General case' 0 C--N 1.311 -1.108 0 N-CA-C 108.498 -0.927 . . . . 74.13 108.498 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.1 tp -116.33 129.28 56.18 Favored 'General case' 0 N--CA 1.421 -1.906 0 N-CA-C 107.993 -1.114 . . . . 71.31 107.993 -178.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.9 pt? -132.24 132.74 43.37 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 120.493 -0.483 . . . . 63.15 109.722 179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 23.7 m -120.92 131.36 54.32 Favored 'General case' 0 C--N 1.275 -2.644 0 N-CA-C 109.401 -0.592 . . . . 64.44 109.401 -178.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.414 HG12 HG23 ' A' ' 102' ' ' ILE . 35.7 pt -120.47 146.41 25.38 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.302 0 N-CA-C 109.131 -0.692 . . . . 60.32 109.131 177.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 60.5 tt0 -143.99 128.4 17.92 Favored 'General case' 0 C--N 1.29 -1.994 0 N-CA-C 108.639 -0.874 . . . . 71.11 108.639 177.061 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 46.2 t -95.49 113.04 29.0 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.33 0 N-CA-C 108.613 -0.884 . . . . 64.03 108.613 -178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 27.5 m -114.18 131.82 23.04 Favored Pre-proline 0 C--N 1.283 -2.322 0 CA-C-N 115.31 -0.859 . . . . 72.34 110.392 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -72.15 86.18 0.97 Allowed 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 121.984 1.789 . . . . 73.32 109.652 174.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.609 ' HD3' HG13 ' A' ' 134' ' ' ILE . 88.1 tttt -89.32 -54.22 0.32 Allowed Pre-proline 0 C--N 1.306 -1.287 0 CA-C-N 114.731 -1.122 . . . . 74.4 112.842 -175.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.497 ' HD3' HG12 ' A' ' 134' ' ' ILE . 3.4 Cg_exo -79.96 -24.55 5.77 Favored 'Trans proline' 0 C--N 1.37 1.684 0 C-N-CA 121.334 1.356 . . . . 74.15 110.633 177.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 159.71 -149.75 19.63 Favored Glycine 0 N--CA 1.419 -2.475 0 N-CA-C 109.422 -1.471 . . . . 70.42 109.422 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -76.5 -77.04 0.79 Allowed Glycine 0 C--N 1.309 -0.939 0 C-N-CA 121.261 -0.495 . . . . 55.42 112.411 179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . 0.458 ' HA ' ' OG ' ' A' ' 35' ' ' SER . 18.4 Cg_endo -60.83 129.68 29.99 Favored 'Trans proline' 0 C--O 1.239 0.57 0 C-N-CA 122.759 2.306 . . . . 73.44 110.825 176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 75.72 84.42 0.39 Allowed Glycine 0 N--CA 1.436 -1.327 0 N-CA-C 111.121 -0.791 . . . . 72.32 111.121 -176.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 49.7 m -99.38 174.43 6.28 Favored 'General case' 0 C--N 1.303 -1.421 0 CA-C-O 121.082 0.467 . . . . 65.44 111.22 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.609 HG13 ' HD3' ' A' ' 127' ' ' LYS . 44.3 mm -114.72 130.75 68.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.161 0 N-CA-C 109.355 -0.609 . . . . 75.33 109.355 -177.468 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 8.3 p -105.29 122.56 58.73 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.445 0 CA-C-O 121.486 0.66 . . . . 65.41 110.538 179.283 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 90.0 m-70 -94.02 113.06 24.97 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-N 114.942 -1.026 . . . . 60.55 109.351 -179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 44.3 m95 -99.09 121.51 41.09 Favored 'General case' 0 CA--C 1.495 -1.136 0 N-CA-C 108.739 -0.837 . . . . 72.34 108.739 176.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 53.2 t60 -123.96 111.73 16.37 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.811 -1.181 . . . . 70.1 107.811 177.652 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 2.7 mp -110.8 132.46 54.18 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 115.826 -0.625 . . . . 55.43 109.64 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -132.4 128.59 37.89 Favored 'General case' 0 C--N 1.308 -1.234 0 N-CA-C 108.468 -0.938 . . . . 71.41 108.468 176.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.0 p90 -146.12 156.9 43.76 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.956 0.725 . . . . 72.04 112.956 -174.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -110.76 121.2 44.75 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-N 114.941 -1.027 . . . . 63.33 108.648 -175.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.593 ' HB3' ' O ' ' A' ' 145' ' ' SER . 35.4 mmtp -81.64 132.91 35.31 Favored 'General case' 0 C--O 1.245 0.835 0 N-CA-C 110.319 -0.252 . . . . 72.35 110.319 -178.35 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.439 ' HB ' ' OE1' ' A' ' 114' ' ' GLU . 98.4 mt -77.63 -47.2 26.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.789 -1.56 . . . . 74.21 106.789 171.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.593 ' O ' ' HB3' ' A' ' 143' ' ' LYS . 28.5 t -137.98 -156.77 0.72 Allowed 'General case' 0 N--CA 1.413 -2.309 0 CA-C-N 114.094 -1.412 . . . . 61.35 107.194 177.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -126.7 -29.3 2.89 Favored 'General case' 0 C--N 1.294 -1.806 0 CA-C-O 121.549 0.69 . . . . 72.35 109.344 -179.738 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -64.26 -23.76 67.42 Favored 'General case' 0 C--N 1.317 -0.824 0 CA-C-N 114.446 -1.252 . . . . 61.01 110.689 -173.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.585 ' HB ' ' CD ' ' A' ' 114' ' ' GLU . 17.1 t -106.49 -21.25 5.56 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.291 0 CA-C-N 115.581 -0.736 . . . . 61.21 109.523 -173.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.589 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -58.62 133.65 56.07 Favored 'General case' 0 CA--C 1.494 -1.212 0 CA-C-N 115.345 -0.843 . . . . 62.2 111.419 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -152.77 85.44 4.39 Favored Pre-proline 0 C--N 1.286 -2.177 0 CA-C-N 115.03 -0.986 . . . . 75.43 112.243 -175.185 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -64.79 -11.71 30.58 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 123.205 2.603 . . . . 74.35 110.468 175.131 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.401 ' HG2' ' H ' ' A' ' 152' ' ' GLU . 6.8 mm-40 -53.07 -46.36 68.54 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.418 1.487 . . . . 72.23 108.887 175.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.9 p -81.76 -30.21 32.47 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-N 114.991 -1.004 . . . . 62.14 110.853 -175.198 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.474 HD22 ' CE1' ' A' ' 118' ' ' PHE . 82.6 mt -63.95 -45.22 90.15 Favored 'General case' 0 CA--C 1.509 -0.619 0 CA-C-N 115.667 -0.697 . . . . 74.35 111.057 -178.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 158' ' ' CYS . 54.9 tp -70.19 -33.57 71.88 Favored 'General case' 0 N--CA 1.4 -2.94 0 CA-C-N 115.994 -0.548 . . . . 44.55 110.365 -179.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 15.1 mm100 -70.26 -39.24 75.08 Favored 'General case' 0 C--O 1.215 -0.725 0 C-N-CA 120.499 -0.48 . . . . 71.1 110.669 176.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 78.1 t80 -56.94 -41.27 77.94 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.963 -0.754 . . . . 50.01 108.963 176.409 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 27.8 t -56.6 -50.66 71.32 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-N 114.997 -1.001 . . . . 75.14 110.989 175.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 155' ' ' LEU . 66.3 t -61.37 -44.01 97.71 Favored 'Isoleucine or valine' 0 C--O 1.241 0.637 0 CA-C-N 116.534 -0.303 . . . . 63.24 111.5 -179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 5.3 mm-40 -62.23 -46.57 88.26 Favored 'General case' 0 C--O 1.239 0.524 0 CA-C-O 121.371 0.605 . . . . 72.54 110.101 -177.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 165' ' ' ILE . 87.9 t -68.19 -35.14 70.14 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.678 -0.692 . . . . 64.52 110.64 179.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.6 m -59.91 -42.93 94.98 Favored 'General case' 0 C--O 1.22 -0.482 0 CA-C-O 120.476 0.179 . . . . 71.01 110.941 177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -61.49 -46.6 89.34 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.357 0.599 . . . . 64.03 109.624 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -61.51 -52.01 66.26 Favored 'General case' 0 N--CA 1.441 -0.915 0 CA-C-N 114.834 -1.075 . . . . 72.2 110.942 -177.114 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.458 HG22 ' O ' ' A' ' 161' ' ' VAL . 8.5 tp -70.99 -43.18 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.821 0 N-CA-C 112.605 0.594 . . . . 74.15 112.605 -173.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.557 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 33.0 t70 -59.71 -51.57 69.2 Favored 'General case' 0 C--N 1.308 -1.238 0 CA-C-N 116.217 -0.447 . . . . 63.1 111.644 -177.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -68.74 -31.41 70.45 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.396 -0.365 . . . . 62.01 111.235 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.467 ' CE1' ' HB ' ' A' ' 50' ' ' VAL . 30.4 t60 -66.1 -45.2 82.02 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.961 -0.563 . . . . 74.25 110.674 179.64 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 95.3 mt -66.13 -32.9 74.62 Favored 'General case' 0 C--O 1.215 -0.735 0 CA-C-O 120.632 0.253 . . . . 55.43 111.612 -178.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 96.0 mt -67.4 -20.21 65.5 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.283 0.563 . . . . 73.41 110.996 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -88.62 -20.8 24.48 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 112.792 0.664 . . . . 74.24 112.792 -177.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . 0.585 ' HB3' ' HB3' ' A' ' 51' ' ' SER . 7.5 pt-20 -118.76 -177.31 3.28 Favored 'General case' 0 N--CA 1.469 0.516 0 N-CA-C 113.221 0.822 . . . . 64.13 113.221 179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . 0.457 ' OXT' ' HB2' ' A' ' 41' ' ' HIS . 10.1 pt-20 . . . . . 0 C--O 1.263 1.775 0 C-N-CA 124.661 1.184 . . . . 73.23 114.123 -176.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 29.9 m . . . . . 0 N--CA 1.433 -1.302 0 N-CA-C 106.172 -1.788 . . . . 61.4 106.172 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -54.61 143.62 24.14 Favored 'General case' 0 C--O 1.248 0.992 0 CA-C-O 121.628 0.728 . . . . 75.42 111.673 176.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -86.46 94.63 9.46 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 115.347 -0.842 . . . . 73.2 112.024 -174.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 20.5 p -72.65 -39.31 67.27 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.443 -0.799 . . . . 75.11 110.792 177.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 33.5 t -85.5 -10.81 55.55 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.557 -0.747 . . . . 71.41 110.532 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 87.7 mt 62.47 -40.47 0.16 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 114.796 1.406 . . . . 51.4 114.796 -176.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 ' HA ' ' HA ' ' A' ' 142' ' ' GLU . 12.4 p -67.85 133.7 31.25 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 108.976 -0.75 . . . . 73.54 108.976 176.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -137.26 164.11 25.35 Favored Glycine 0 N--CA 1.411 -2.989 0 C-N-CA 120.902 -0.666 . . . . 55.23 111.876 -176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 49.0 mtpt -133.08 157.68 44.67 Favored 'General case' 0 C--N 1.27 -2.856 0 C-N-CA 123.635 0.774 . . . . 52.04 110.216 -179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.426 HD21 HD22 ' A' ' 155' ' ' LEU . 61.4 tp -147.13 129.28 15.58 Favored 'General case' 0 N--CA 1.41 -2.426 0 CA-C-N 115.201 -0.908 . . . . 63.32 108.564 168.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -133.81 127.46 32.71 Favored 'General case' 0 C--N 1.277 -2.563 0 N-CA-C 109.396 -0.594 . . . . 55.34 109.396 179.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.3 t -142.27 137.74 30.88 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 109.02 -0.733 . . . . 75.11 109.02 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -104.01 119.82 39.75 Favored 'General case' 0 C--N 1.302 -1.481 0 CA-C-O 121.001 0.429 . . . . 75.23 109.864 178.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG11 ' CB ' ' A' ' 162' ' ' SER . 68.9 t -109.05 137.63 40.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 N-CA-C 108.799 -0.815 . . . . 74.31 108.799 178.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -92.16 140.85 29.22 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 120.061 -0.656 . . . . 74.21 109.455 -176.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 23.1 pt -128.02 148.52 32.58 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.643 0 CA-C-O 121.235 0.54 . . . . 75.22 110.004 176.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 93.7 mttt -80.32 -10.25 59.75 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-N 115.731 -0.668 . . . . 74.42 109.307 -178.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -65.16 160.03 22.2 Favored 'General case' 0 N--CA 1.428 -1.544 0 CA-C-N 114.657 -1.156 . . . . 54.32 111.409 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.0 m -99.45 135.62 40.6 Favored 'General case' 0 C--N 1.29 -2.011 0 N-CA-C 107.462 -1.31 . . . . 63.23 107.462 177.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -59.19 -34.29 71.96 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.679 0.276 . . . . 72.14 111.431 -177.527 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -68.99 -39.36 79.41 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 121.073 -0.251 . . . . 71.13 111.204 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.525 ' HE3' ' O ' ' A' ' 169' ' ' LEU . 29.7 mtpp -65.49 -30.47 71.25 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.232 0.539 . . . . 74.54 110.813 178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -71.2 -41.74 69.89 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 108.626 -0.879 . . . . 45.13 108.626 175.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -58.45 -36.02 73.02 Favored 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.456 1.102 . . . . 61.0 110.577 177.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 11.6 m170 -66.2 -35.51 80.64 Favored 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 113.831 1.049 . . . . 74.31 113.831 -177.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 26.7 ptt? -73.38 -26.06 60.83 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 118.808 -1.157 . . . . 74.3 112.443 -175.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 94.8 m-85 -86.66 -31.73 20.91 Favored 'General case' 0 C--N 1.322 -0.598 0 C-N-CA 120.146 -0.622 . . . . 63.43 110.813 176.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -98.56 75.76 2.2 Favored 'General case' 0 N--CA 1.438 -1.048 0 CA-C-O 121.494 0.664 . . . . 72.42 109.912 177.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . 178.74 -159.45 24.55 Favored Glycine 0 N--CA 1.431 -1.639 0 N-CA-C 109.846 -1.301 . . . . 62.22 109.846 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 47' ' ' PRO . 0.4 OUTLIER -102.84 134.15 20.0 Favored Pre-proline 0 C--N 1.305 -1.358 0 CA-C-N 117.175 0.487 . . . . 74.31 110.379 -179.308 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 18.1 Cg_exo -68.66 -20.73 40.17 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.616 2.211 . . . . 65.14 111.353 177.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 68.7 m-70 -102.18 144.29 30.92 Favored 'General case' 0 C--O 1.239 0.548 0 N-CA-C 109.051 -0.722 . . . . 72.3 109.051 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 75.1 m80 -116.12 146.34 42.32 Favored 'General case' 0 CA--C 1.483 -1.621 0 N-CA-C 112.198 0.444 . . . . 62.31 112.198 -177.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 25.0 t 64.01 82.45 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.036 0 O-C-N 125.209 1.568 . . . . 74.21 110.083 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 25.1 m -79.64 -19.93 47.97 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 114.799 -1.091 . . . . 71.51 110.79 -177.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -147.31 -66.68 0.26 Allowed 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 108.493 -0.929 . . . . 73.25 108.493 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -147.84 169.8 19.01 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.825 -0.625 . . . . 73.12 110.575 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 68.4 m -161.69 172.68 5.36 Favored Pre-proline 0 C--N 1.304 -1.387 0 N-CA-C 106.518 -1.66 . . . . 72.45 106.518 179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_exo -53.99 119.04 5.64 Favored 'Trans proline' 0 C--N 1.366 1.452 0 C-N-CA 122.238 1.959 . . . . 74.44 110.976 176.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.25 -49.16 2.96 Favored Glycine 0 C--O 1.225 -0.411 0 N-CA-C 110.095 -1.202 . . . . 74.21 110.095 -175.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 61.0 t30 69.76 85.89 0.13 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 125.665 1.586 . . . . 63.2 113.049 176.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 68.3 mt -133.92 106.52 8.78 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 N-CA-C 107.035 -1.468 . . . . 71.33 107.035 174.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 75.3 mt-30 -76.06 -31.01 58.6 Favored 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 115.751 -0.659 . . . . 63.0 110.011 -177.19 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.49 -53.11 4.55 Favored Glycine 0 N--CA 1.441 -0.977 0 N-CA-C 110.734 -0.946 . . . . 63.44 110.734 179.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.8 t 67.38 86.17 0.13 Allowed 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 124.926 1.29 . . . . 75.43 110.876 178.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -111.19 -63.64 1.38 Allowed 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 115.255 -0.884 . . . . 62.21 109.002 179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 56.9 tp 52.83 73.18 0.37 Allowed 'General case' 0 CA--C 1.536 0.442 0 O-C-N 124.526 1.142 . . . . 75.22 111.658 178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 m80 -129.28 166.34 19.64 Favored 'General case' 0 C--N 1.314 -0.952 0 N-CA-C 108.184 -1.043 . . . . 73.14 108.184 179.003 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.97 92.0 7.26 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-O 121.799 0.809 . . . . 71.03 112.202 -178.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -99.53 -110.35 3.11 Favored Glycine 0 N--CA 1.429 -1.828 0 N-CA-C 108.763 -1.735 . . . . 74.32 108.763 175.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -90.88 134.8 34.18 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 109.6 -0.519 . . . . 73.41 109.6 175.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . . . . . . . . . 31.3 m95 -74.52 -13.87 60.74 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 115.997 -0.547 . . . . 74.25 111.842 -177.442 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.71 12.53 82.72 Favored Glycine 0 CA--C 1.507 -0.441 0 C-N-CA 120.916 -0.659 . . . . 73.11 112.887 177.895 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.503 ' O ' ' HB2' ' A' ' 73' ' ' SER . 57.6 m -156.66 142.76 18.07 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 108.161 -1.052 . . . . 73.15 108.161 179.841 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.469 HG23 HG22 ' A' ' 92' ' ' ILE . 11.4 p -50.82 141.35 4.06 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.984 0 C-N-CA 123.732 0.813 . . . . 75.11 110.696 178.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.05 -4.99 52.72 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 108.43 -1.868 . . . . 53.55 108.43 -172.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.518 ' HB3' HD12 ' A' ' 92' ' ' ILE . 46.7 t -64.65 141.59 58.72 Favored 'General case' 0 N--CA 1.432 -1.346 0 C-N-CA 125.308 1.443 . . . . 61.34 110.519 178.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -120.19 115.07 46.14 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.997 0 N-CA-C 108.974 -0.75 . . . . 53.42 108.974 175.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.07 140.37 38.45 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.285 0 N-CA-C 106.769 -1.567 . . . . 74.54 106.769 179.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.585 ' HA ' ' OE2' ' A' ' 90' ' ' GLU . 40.6 m-85 -106.44 150.72 25.78 Favored 'General case' 0 C--N 1.307 -1.268 0 C-N-CA 120.259 -0.577 . . . . 72.03 112.158 -176.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 23.2 t-105 -107.3 129.96 54.83 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.351 -0.841 . . . . 65.33 110.001 -178.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -102.64 131.82 49.16 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.549 -0.908 . . . . 73.11 108.549 176.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.7 p90 -137.9 144.67 41.43 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 120.894 0.378 . . . . 75.34 110.362 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 57.3 t -107.21 118.05 54.2 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 N-CA-C 108.439 -0.948 . . . . 70.51 108.439 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 83.6 t60 -130.93 121.54 25.34 Favored 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 109.056 -0.72 . . . . 71.24 109.056 -178.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 28.1 m-20 64.25 30.61 13.46 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.131 0.973 . . . . 62.34 110.143 -176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 79.98 -4.31 66.77 Favored Glycine 0 N--CA 1.44 -1.096 0 CA-C-N 114.908 -1.042 . . . . 71.2 112.932 179.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -95.82 133.01 40.47 Favored 'General case' 0 N--CA 1.424 -1.727 0 N-CA-C 109.011 -0.737 . . . . 72.21 109.011 -178.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -82.76 115.98 21.91 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-N 115.163 -0.926 . . . . 71.11 109.026 -178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.86 158.17 32.49 Favored 'General case' 0 C--N 1.291 -1.955 0 CA-C-N 115.673 -0.694 . . . . 73.31 110.374 -176.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 85.5 t -125.91 144.41 36.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 N-CA-C 108.725 -0.843 . . . . 74.32 108.725 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.07 140.77 40.76 Favored 'General case' 0 C--N 1.284 -2.277 0 N-CA-C 106.733 -1.58 . . . . 53.34 106.733 178.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.52 ' HD3' ' HG2' ' A' ' 108' ' ' GLU . 7.7 mptt -117.47 121.79 41.99 Favored 'General case' 0 N--CA 1.428 -1.557 0 N-CA-C 108.237 -1.023 . . . . 60.22 108.237 -177.026 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.585 ' OE2' ' HA ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -154.1 168.79 25.3 Favored 'General case' 0 N--CA 1.416 -2.156 0 CA-C-O 121.751 0.786 . . . . 64.24 111.559 -172.546 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 17.6 ttt180 -136.86 143.77 43.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-N 114.524 -1.216 . . . . 73.03 109.069 176.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.518 HD12 ' HB3' ' A' ' 73' ' ' SER . 44.4 mt -79.24 121.76 33.09 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.412 0 N-CA-C 109.907 -0.405 . . . . 71.23 109.907 175.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -102.59 -36.74 8.24 Favored 'General case' 0 CA--C 1.497 -1.062 0 CA-C-N 115.503 -0.771 . . . . 74.34 110.928 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -152.75 138.53 17.95 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.446 -0.946 . . . . 45.3 108.446 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.439 HG12 ' HB ' ' A' ' 71' ' ' VAL . 7.4 p -146.05 126.48 6.53 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.942 0 CA-C-O 121.313 0.578 . . . . 74.4 109.893 178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.656 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 9.0 tp10 -117.7 105.9 47.04 Favored Pre-proline 0 N--CA 1.418 -2.073 0 N-CA-C 107.157 -1.423 . . . . 74.42 107.157 179.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -62.44 -30.08 79.77 Favored 'Trans proline' 0 C--O 1.214 -0.696 0 C-N-CA 122.563 2.176 . . . . 73.11 111.744 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -78.81 -35.64 43.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.093 -0.503 . . . . 71.21 112.048 -176.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.727 ' HB3' HE21 ' A' ' 123' ' ' GLN . 63.5 mttp -90.36 -5.88 55.68 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-N 116.354 -0.384 . . . . 74.32 111.812 -177.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 4.5 m-20 61.66 42.68 10.66 Favored 'General case' 0 N--CA 1.471 0.603 0 O-C-N 124.098 0.874 . . . . 75.42 109.274 -175.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.417 HD23 ' C ' ' A' ' 101' ' ' LEU . 2.4 tt -118.39 141.51 48.47 Favored 'General case' 0 CA--C 1.493 -1.219 0 CA-C-N 114.862 -1.063 . . . . 65.31 111.297 -176.11 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 11.6 tt -150.1 123.58 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.427 -1.613 0 CA-C-N 115.285 -0.871 . . . . 73.31 110.715 175.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 85.6 m -97.79 121.2 39.42 Favored 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 115.164 -0.926 . . . . 73.33 111.126 178.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 93.4 m-85 -103.61 131.14 51.02 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 124.41 1.084 . . . . 73.42 109.497 179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.467 ' O ' ' HA ' ' A' ' 90' ' ' GLU . 64.7 ttt180 -112.11 127.0 55.79 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 109.585 -0.524 . . . . 71.21 109.585 174.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.472 HG11 ' HB2' ' A' ' 111' ' ' LEU . 73.1 t -79.67 124.81 38.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.057 0 N-CA-C 108.989 -0.745 . . . . 75.3 108.989 174.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.656 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -112.36 -18.98 7.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 N-CA-C 113.365 0.876 . . . . 75.1 113.365 -171.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.52 ' HG2' ' HD3' ' A' ' 89' ' ' LYS 0.411 0.0 OUTLIER -54.72 -80.72 0.02 OUTLIER 'General case' 0 CA--C 1.559 1.29 0 N-CA-C 119.59 3.181 . . . . 70.43 119.59 -172.316 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.51 ' O ' ' HG2' ' A' ' 113' ' ' LYS . . . 156.04 -39.4 0.59 Allowed Glycine 0 C--N 1.306 -1.121 0 C-N-CA 120.941 -0.647 . . . . 75.43 112.054 -175.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.463 ' HB3' ' OE1' ' A' ' 108' ' ' GLU . 26.7 t70 -68.3 -44.55 75.19 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 123.524 0.73 . . . . 75.05 111.855 -178.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.472 ' HB2' HG11 ' A' ' 106' ' ' VAL . 77.2 mt -74.2 -25.23 59.56 Favored 'General case' 0 N--CA 1.479 1.019 0 CA-C-O 121.911 0.862 . . . . 55.5 109.389 174.33 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.512 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 0.8 OUTLIER -71.5 -6.08 37.85 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.71 -1.132 . . . . 62.52 110.56 177.204 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 109' ' ' GLY . 74.7 mmtt -87.58 -8.9 55.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.245 0.545 . . . . 64.33 110.522 176.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -106.32 -30.91 8.86 Favored 'General case' 0 C--N 1.31 -1.123 0 CA-C-O 121.546 0.688 . . . . 74.52 109.509 176.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 59.3 m-85 -130.8 138.54 49.95 Favored 'General case' 0 C--O 1.208 -1.131 0 CA-C-N 115.335 -0.848 . . . . 64.24 108.901 -178.277 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.605 ' CG ' HG12 ' A' ' 144' ' ' ILE . 48.3 mtpt -76.63 -15.98 59.68 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 122.006 0.908 . . . . 65.32 108.619 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 40.5 t -162.07 139.55 8.54 Favored 'General case' 0 N--CA 1.419 -2.007 0 N-CA-C 106.449 -1.686 . . . . 73.21 106.449 177.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -145.15 112.46 6.12 Favored 'General case' 0 C--N 1.307 -1.241 0 N-CA-C 109.51 -0.552 . . . . 64.42 109.51 -178.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.5 tp -127.81 137.25 52.32 Favored 'General case' 0 N--CA 1.426 -1.649 0 N-CA-C 108.306 -0.998 . . . . 72.13 108.306 -177.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -138.77 137.23 36.51 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-O 121.013 0.435 . . . . 74.21 110.497 178.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 65.5 m -123.04 136.16 54.72 Favored 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 109.488 -0.56 . . . . 65.24 109.488 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 42.3 pt -117.09 140.98 37.49 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.232 0 N-CA-C 109.114 -0.699 . . . . 62.24 109.114 176.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.727 HE21 ' HB3' ' A' ' 99' ' ' LYS . 57.5 tt0 -140.63 121.3 14.3 Favored 'General case' 0 N--CA 1.423 -1.78 0 N-CA-C 109.478 -0.564 . . . . 75.55 109.478 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 97.5 t -98.43 112.39 30.4 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 CA-C-N 115.778 -0.646 . . . . 64.21 111.22 -176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.467 ' OG1' ' HD2' ' A' ' 126' ' ' PRO . 5.3 t -139.33 153.55 71.04 Favored Pre-proline 0 C--N 1.297 -1.693 0 N-CA-C 107.28 -1.378 . . . . 64.45 107.28 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.467 ' HD2' ' OG1' ' A' ' 125' ' ' THR . 37.7 Cg_endo -61.44 159.8 30.13 Favored 'Trans proline' 0 N--CA 1.486 1.047 0 C-N-CA 123.403 2.735 . . . . 74.22 113.501 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.579 ' CD ' HG13 ' A' ' 134' ' ' ILE . 87.4 tttt -142.77 -51.37 0.02 OUTLIER Pre-proline 0 CA--C 1.552 1.029 0 CA-C-N 115.775 -0.648 . . . . 73.31 111.458 178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.499 ' HD3' ' HB3' ' A' ' 127' ' ' LYS . 48.5 Cg_exo -61.13 -35.98 83.55 Favored 'Trans proline' 0 C--N 1.39 2.725 0 C-N-CA 121.614 1.543 . . . . 73.13 111.282 175.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 162.92 -112.28 0.51 Allowed Glycine 0 N--CA 1.43 -1.743 0 N-CA-C 110.855 -0.898 . . . . 73.22 110.855 178.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -71.47 -77.52 0.52 Allowed Glycine 0 C--N 1.312 -0.757 0 N-CA-C 110.996 -0.842 . . . . 63.44 110.996 178.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -77.51 164.61 28.31 Favored 'Trans proline' 0 N--CA 1.451 -1.008 0 C-N-CA 122.328 2.019 . . . . 74.25 110.696 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . 0.431 ' O ' ' HD2' ' A' ' 128' ' ' PRO . . . 88.82 103.24 1.0 Allowed Glycine 0 N--CA 1.43 -1.736 0 N-CA-C 110.762 -0.935 . . . . 73.04 110.762 -178.444 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.406 ' HA ' ' HA ' ' A' ' 126' ' ' PRO . 61.7 p -112.68 154.3 26.32 Favored 'General case' 0 N--CA 1.416 -2.148 0 CA-C-O 121.421 0.629 . . . . 53.25 110.913 -178.235 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.579 HG13 ' CD ' ' A' ' 127' ' ' LYS . 49.6 mm -119.48 135.41 59.92 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.086 0 N-CA-C 108.338 -0.986 . . . . 71.24 108.338 -179.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.437 HG13 ' HB ' ' A' ' 30' ' ' VAL . 7.4 p -94.75 113.03 28.38 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.897 0 N-CA-C 108.639 -0.874 . . . . 74.13 108.639 176.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 26.9 m-70 -89.31 111.78 22.7 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 115.156 -0.929 . . . . 75.13 108.83 -179.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 51.9 m95 -93.45 121.12 34.52 Favored 'General case' 0 N--CA 1.423 -1.819 0 N-CA-C 108.559 -0.904 . . . . 74.33 108.559 177.379 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -120.62 110.29 16.25 Favored 'General case' 0 N--CA 1.399 -2.99 0 N-CA-C 106.859 -1.534 . . . . 75.45 106.859 177.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.3 mp -114.53 135.76 53.77 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.517 -0.919 . . . . 75.13 108.517 -177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -142.68 129.58 20.6 Favored 'General case' 0 C--N 1.283 -2.31 0 N-CA-C 107.194 -1.41 . . . . 65.23 107.194 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -152.27 166.05 33.01 Favored 'General case' 0 C--N 1.279 -2.496 0 CA-C-N 115.746 -0.661 . . . . 73.12 110.914 -170.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.452 ' HA ' ' HA ' ' A' ' 23' ' ' VAL . 40.1 tt0 -112.81 117.37 31.97 Favored 'General case' 0 C--N 1.284 -2.251 0 N-CA-C 109.11 -0.7 . . . . 65.42 109.11 178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -73.71 132.38 42.61 Favored 'General case' 0 N--CA 1.437 -1.099 0 N-CA-C 108.766 -0.828 . . . . 55.23 108.766 -179.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.605 HG12 ' CG ' ' A' ' 116' ' ' LYS . 7.9 mt -69.13 -38.3 77.86 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.846 0 N-CA-C 107.653 -1.24 . . . . 60.13 107.653 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 23.0 t -158.13 162.01 37.96 Favored 'General case' 0 N--CA 1.398 -3.071 0 N-CA-C 106.394 -1.706 . . . . 75.2 106.394 174.317 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.536 ' CD ' ' H ' ' A' ' 146' ' ' GLU . 1.2 mp0 -51.98 -68.77 0.14 Allowed 'General case' 0 C--N 1.299 -1.626 0 C-N-CA 125.689 1.596 . . . . 53.02 113.124 -171.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -76.58 -16.83 59.49 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 123.863 0.865 . . . . 73.54 112.032 -175.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 62.0 t -75.23 -23.9 17.32 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.291 0 N-CA-C 108.549 -0.908 . . . . 61.32 108.549 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -92.56 145.62 24.3 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.559 -0.904 . . . . 41.13 108.559 175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 88.1 m-70 -131.7 88.21 43.26 Favored Pre-proline 0 C--N 1.313 -0.985 0 N-CA-C 113.062 0.764 . . . . 74.41 113.062 -177.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_exo -60.13 -32.92 95.29 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.353 2.702 . . . . 73.32 113.187 -179.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -65.49 -37.71 87.62 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-O 121.227 0.537 . . . . 74.13 112.426 -176.165 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 82.5 p -66.75 -28.68 68.6 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-N 115.564 -0.744 . . . . 63.11 111.049 -178.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 84.5 mt -65.72 -35.44 80.75 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.314 -0.857 . . . . 60.44 110.213 -179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.545 ' O ' HG23 ' A' ' 159' ' ' VAL . 3.8 mm? -60.31 -45.19 94.28 Favored 'General case' 0 CA--C 1.488 -1.437 0 CA-C-O 121.257 0.551 . . . . 42.1 109.764 176.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.516 ' O ' ' HG2' ' A' ' 160' ' ' GLU . 39.9 mt-30 -62.51 -41.13 98.64 Favored 'General case' 0 C--N 1.295 -1.769 0 CA-C-N 115.3 -0.864 . . . . 64.51 112.682 179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 53.0 t80 -60.75 -44.26 96.93 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 109.073 -0.714 . . . . 60.05 109.073 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.539 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 14.2 t -53.59 -48.58 69.1 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 114.636 -1.166 . . . . 61.13 111.46 176.08 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.545 HG23 ' O ' ' A' ' 155' ' ' LEU . 80.6 t -59.0 -48.25 87.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 116.418 -0.355 . . . . 74.42 111.237 179.583 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.516 ' HG2' ' O ' ' A' ' 156' ' ' GLN . 60.1 mm-40 -58.03 -43.41 86.74 Favored 'General case' 0 C--O 1.244 0.787 0 CA-C-O 121.047 0.451 . . . . 75.44 111.3 -175.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.8 t -69.32 -46.75 76.34 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.282 0 CA-C-N 115.604 -0.725 . . . . 65.52 110.46 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.537 ' CB ' HG11 ' A' ' 30' ' ' VAL . 59.0 m -59.24 -49.98 75.76 Favored 'General case' 0 C--O 1.22 -0.473 0 N-CA-C 113.168 0.803 . . . . 51.24 113.168 -174.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.52 ' HG2' ' O ' ' A' ' 159' ' ' VAL . 21.9 pttp -65.76 -32.11 73.47 Favored 'General case' 0 C--N 1.316 -0.885 0 N-CA-C 112.763 0.653 . . . . 74.24 112.763 -178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -75.48 -46.97 29.25 Favored 'General case' 0 N--CA 1.443 -0.818 0 C-N-CA 120.457 -0.497 . . . . 65.32 110.848 179.677 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 9.4 tp -64.68 -34.68 71.55 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 CA-C-N 115.375 -0.83 . . . . 65.32 110.039 -175.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.411 ' O ' ' HG ' ' A' ' 170' ' ' LEU . 13.6 t70 -51.31 -51.32 55.37 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 125.258 1.423 . . . . 74.12 110.435 176.184 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -71.53 -32.15 67.83 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.795 -0.639 . . . . 72.4 111.566 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 20.1 t60 -62.65 -45.68 91.71 Favored 'General case' 0 C--O 1.215 -0.763 0 CA-C-N 116.343 -0.39 . . . . 73.04 110.505 -179.407 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.525 ' O ' ' HE3' ' A' ' 38' ' ' LYS . 3.6 mm? -73.65 -23.03 59.8 Favored 'General case' 0 C--O 1.207 -1.155 0 N-CA-C 113.68 0.993 . . . . 72.32 113.68 -179.768 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 91.7 mt -68.95 -21.87 64.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.649 0.737 . . . . 72.23 110.636 175.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -99.93 -165.4 1.22 Allowed 'General case' 0 C--N 1.291 -1.937 0 N-CA-C 107.508 -1.293 . . . . 71.13 107.508 174.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 52.66 -169.84 0.04 OUTLIER 'General case' 0 CA--C 1.554 1.114 0 N-CA-C 114.054 1.131 . . . . 73.33 114.054 -179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 44.4 mt-10 . . . . . 0 C--N 1.312 -1.039 0 CA-C-O 118.855 -0.593 . . . . 72.42 110.357 -178.513 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 10.3 t . . . . . 0 N--CA 1.425 -1.697 0 N-CA-C 107.42 -1.326 . . . . 52.05 107.42 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -75.93 164.87 25.75 Favored 'General case' 0 C--N 1.308 -1.225 0 CA-C-O 120.993 0.425 . . . . 74.33 111.511 -176.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' HB3' ' HG2' ' A' ' 146' ' ' GLU . . . -120.21 35.24 4.92 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.83 -0.433 . . . . 72.32 109.83 -178.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 37.7 t -54.95 -45.04 74.84 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.423 0.689 . . . . 72.32 111.788 -179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 27.3 t -89.55 -7.4 54.97 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.866 -0.42 . . . . 74.42 109.866 -178.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 81.7 mt 65.43 -64.13 0.19 Allowed 'General case' 0 C--O 1.239 0.52 0 C-N-CA 125.647 1.579 . . . . 75.33 111.925 -176.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.565 ' O ' ' HA ' ' A' ' 142' ' ' GLU . 61.5 t 48.59 -84.43 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 C-N-CA 126.701 2.001 . . . . 51.3 114.981 -176.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.603 ' HA3' ' O ' ' A' ' 141' ' ' TYR . . . 97.02 82.96 1.66 Allowed Glycine 0 N--CA 1.418 -2.523 0 CA-C-O 121.915 0.731 . . . . 51.43 113.755 -173.245 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.405 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 27.2 mtpp -147.75 141.24 25.4 Favored 'General case' 0 C--N 1.266 -3.064 0 O-C-N 122.347 -0.502 . . . . 63.34 109.745 175.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 58.6 tp -155.88 149.08 24.55 Favored 'General case' 0 N--CA 1.43 -1.437 0 C-N-CA 119.246 -0.982 . . . . 73.12 110.5 169.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' HG3' ' O ' ' A' ' 137' ' ' TRP . 34.2 tt0 -132.68 135.61 45.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 N-CA-C 109.089 -0.708 . . . . 62.34 109.089 170.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.4 t -138.25 143.09 39.92 Favored 'General case' 0 C--N 1.296 -1.739 0 N-CA-C 109.087 -0.709 . . . . 62.43 109.087 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -108.12 122.86 47.77 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 109.564 -0.532 . . . . 64.42 109.564 178.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.433 HG11 ' CB ' ' A' ' 162' ' ' SER . 92.9 t -110.55 126.41 67.86 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.01 0 N-CA-C 108.793 -0.818 . . . . 65.13 108.793 177.283 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.403 ' HB3' ' CD1' ' A' ' 134' ' ' ILE 0.284 0.3 OUTLIER -94.54 125.62 39.3 Favored 'General case' 0 N--CA 1.42 -1.951 0 CA-C-O 122.414 1.102 . . . . 61.43 112.307 177.934 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.42 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 26.0 pt -117.16 168.58 8.6 Favored 'Isoleucine or valine' 0 C--N 1.267 -3.009 0 CA-C-N 114.043 -1.435 . . . . 65.42 107.989 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.466 ' HB2' HD11 ' A' ' 170' ' ' LEU . 66.8 mttm -99.5 -16.14 18.42 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 109.043 -0.725 . . . . 71.22 109.043 -178.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -70.33 133.65 47.16 Favored 'General case' 0 N--CA 1.43 -1.468 0 CA-C-N 115.181 -0.918 . . . . 71.43 109.661 175.286 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.585 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 23.2 t -75.9 139.96 41.91 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-N 115.956 -0.565 . . . . 75.32 110.172 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.402 ' HB2' HG12 ' A' ' 124' ' ' VAL . . . -61.35 -36.05 79.13 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-O 121.383 0.611 . . . . 74.14 109.776 175.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.544 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 20.8 t70 -67.06 -44.46 80.06 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.951 -1.022 . . . . 70.11 109.181 176.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.585 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 86.7 tttt -62.47 -30.0 70.94 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.27 -0.877 . . . . 64.02 111.43 -178.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 5.6 t80 -56.18 -48.51 76.22 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 108.236 -1.024 . . . . 72.11 108.236 176.212 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 12.5 t-80 -60.53 -32.04 71.09 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.039 -0.982 . . . . 74.05 111.222 178.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.544 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 22.5 m-70 -76.14 -37.79 57.57 Favored 'General case' 0 C--O 1.202 -1.428 0 C-N-CA 120.905 -0.318 . . . . 74.32 110.977 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 21.4 mmt -74.42 -23.78 59.0 Favored 'General case' 0 C--N 1.316 -0.858 0 N-CA-C 112.49 0.552 . . . . 72.52 112.49 179.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 80.0 t80 -83.4 -31.96 26.39 Favored 'General case' 0 C--N 1.311 -1.077 0 C-N-CA 120.739 -0.384 . . . . 75.33 110.623 179.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -97.67 -67.64 0.84 Allowed 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 120.812 0.339 . . . . 72.13 111.276 -178.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -90.55 75.23 1.69 Allowed Glycine 0 CA--C 1.499 -0.922 0 N-CA-C 110.789 -0.924 . . . . 64.12 110.789 -178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -66.36 139.98 96.51 Favored Pre-proline 0 C--N 1.297 -1.677 0 C-N-CA 123.361 0.664 . . . . 64.33 110.49 -177.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -74.79 -173.95 1.72 Allowed 'Trans proline' 0 C--O 1.239 0.537 0 C-N-CA 122.286 1.991 . . . . 73.22 111.397 179.239 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 30.6 t-80 -72.56 -32.44 66.05 Favored 'General case' 0 C--N 1.314 -0.976 0 N-CA-C 108.457 -0.942 . . . . 63.42 108.457 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 5.8 t60 65.07 105.78 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.618 0 C-N-CA 124.642 1.177 . . . . 72.32 111.246 173.502 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 35.2 m -60.89 137.6 23.02 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 CA-C-N 116.096 -0.502 . . . . 51.31 109.758 178.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.8 t -74.23 97.59 3.0 Favored 'General case' 0 N--CA 1.419 -1.983 0 CA-C-O 121.421 0.629 . . . . 53.25 109.608 -177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.9 mtpt -83.39 -62.13 1.67 Allowed 'General case' 0 N--CA 1.432 -1.328 0 CA-C-N 115.045 -0.98 . . . . 73.24 108.805 179.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -179.14 103.56 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 125.105 1.362 . . . . 71.45 108.202 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 37.2 p -118.72 111.48 37.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 CA-C-O 120.667 0.27 . . . . 64.01 110.967 179.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -73.16 -15.8 25.5 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 122.58 2.186 . . . . 60.21 112.531 179.048 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.555 ' C ' ' HB3' ' A' ' 62' ' ' ASP . . . 83.84 -54.88 4.99 Favored Glycine 0 C--O 1.238 0.35 0 C-N-CA 121.368 -0.444 . . . . 61.42 112.957 174.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.426 HD22 ' HA ' ' A' ' 61' ' ' CYS . 16.8 m120 -141.48 120.55 12.88 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.745 -0.835 . . . . 52.13 108.745 179.333 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.511 HG13 ' H ' ' A' ' 59' ' ' GLN . 27.2 pt -107.92 -60.29 2.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.61 -0.436 . . . . 73.34 111.384 177.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.511 ' H ' HG13 ' A' ' 58' ' ' ILE . 54.9 mt-30 -145.03 93.3 2.37 Favored 'General case' 0 C--N 1.308 -1.198 0 N-CA-C 107.211 -1.403 . . . . 75.41 107.211 177.658 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 99.66 -55.96 0.89 Allowed Glycine 0 N--CA 1.428 -1.87 0 N-CA-C 108.773 -1.731 . . . . 42.11 108.773 -175.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . 0.426 ' HA ' HD22 ' A' ' 57' ' ' ASN . 34.5 t -169.66 -169.29 0.89 Allowed 'General case' 0 N--CA 1.441 -0.875 0 N-CA-C 107.19 -1.411 . . . . 74.14 107.19 177.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.555 ' HB3' ' C ' ' A' ' 56' ' ' GLY . 11.7 t70 -156.01 -48.21 0.08 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 124.262 1.025 . . . . 51.34 109.233 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -77.26 110.68 12.17 Favored 'General case' 0 N--CA 1.446 -0.648 0 N-CA-C 105.998 -1.853 . . . . 74.14 105.998 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 39.4 m80 -75.94 107.01 7.85 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 112.595 0.591 . . . . 74.32 112.595 -172.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.58 -26.25 10.97 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 115.754 -0.657 . . . . 75.24 110.133 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 98.42 37.62 4.23 Favored Glycine 0 N--CA 1.435 -1.415 0 N-CA-C 110.27 -1.132 . . . . 62.1 110.27 -176.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -53.39 -35.12 60.0 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.416 1.086 . . . . 70.31 112.678 -178.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.496 ' CB ' ' HA ' ' A' ' 73' ' ' SER . 26.6 m-90 -92.01 14.25 16.39 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-N 115.664 -0.698 . . . . 73.4 112.149 -176.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.22 12.51 73.32 Favored Glycine 0 C--O 1.246 0.867 0 C-N-CA 120.225 -0.988 . . . . 65.03 111.739 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 86.3 m 72.59 -72.72 0.11 Allowed 'General case' 0 CA--C 1.553 1.092 0 C-N-CA 124.04 0.936 . . . . 74.15 110.607 -177.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.5 t -72.73 125.89 32.36 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.383 -0.969 . . . . 74.12 108.383 175.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 100.56 -0.29 55.54 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.034 -1.079 . . . . 64.11 111.395 -177.17 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.496 ' HA ' ' CB ' ' A' ' 68' ' ' TRP . 40.0 t -64.31 136.84 57.54 Favored 'General case' 0 C--O 1.247 0.923 0 CA-C-O 121.128 0.49 . . . . 73.42 112.178 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 84.0 mt -130.09 114.09 28.39 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.426 0 CA-C-N 115.167 -0.924 . . . . 74.53 108.829 175.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.459 ' O ' ' HG2' ' A' ' 90' ' ' GLU . 12.5 p -139.47 159.02 28.26 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 N-CA-C 105.991 -1.855 . . . . 63.23 105.991 177.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.436 ' CD1' ' HG2' ' A' ' 89' ' ' LYS . 10.7 m-85 -120.48 146.48 46.22 Favored 'General case' 0 C--N 1.306 -1.291 0 C-N-CA 118.911 -1.115 . . . . 72.43 110.109 -177.189 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.8 p90 -125.09 154.39 41.45 Favored 'General case' 0 N--CA 1.433 -1.291 0 N-CA-C 108.866 -0.79 . . . . 75.24 108.866 176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -110.58 132.02 54.55 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 109.145 -0.687 . . . . 65.33 109.145 -179.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.415 ' CE1' ' HB2' ' A' ' 88' ' ' ALA . 13.2 p90 -141.23 157.59 45.03 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 109.383 -0.599 . . . . 74.33 109.383 -178.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 92.4 t -106.79 118.74 55.11 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.362 0 N-CA-C 109.015 -0.735 . . . . 73.52 109.015 -179.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 32.5 t60 -128.16 127.27 42.66 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.703 -0.851 . . . . 42.33 108.703 -177.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.0 t70 63.48 29.3 15.44 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 124.744 1.218 . . . . 64.52 108.833 -178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 77.21 1.03 73.08 Favored Glycine 0 CA--C 1.523 0.565 0 CA-C-N 115.302 -0.863 . . . . 75.14 112.087 -178.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -102.97 153.99 19.68 Favored 'General case' 0 CA--C 1.495 -1.149 0 CA-C-O 121.599 0.714 . . . . 71.21 112.274 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -84.0 116.45 22.83 Favored 'General case' 0 C--N 1.285 -2.231 0 CA-C-N 114.536 -1.211 . . . . 65.12 110.014 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 5.4 mptp? -117.53 144.45 45.08 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-N 115.985 -0.552 . . . . 72.44 111.37 179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 48.9 t -115.77 131.37 68.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 106.448 -1.686 . . . . 72.25 106.448 174.062 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . . . -108.68 116.52 32.13 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 109.256 -0.646 . . . . 52.22 109.256 -178.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.502 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 97.3 mttt -103.9 124.19 48.51 Favored 'General case' 0 N--CA 1.407 -2.594 0 CA-C-N 115.223 -0.899 . . . . 61.45 109.01 178.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HG2' ' O ' ' A' ' 75' ' ' VAL . 10.9 pt-20 -128.71 160.39 32.66 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 123.018 0.527 . . . . 62.11 110.811 -168.727 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 55.5 ttt-85 -136.14 128.38 29.99 Favored 'General case' 0 C--N 1.291 -1.954 0 N-CA-C 107.017 -1.475 . . . . 62.41 107.017 170.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.462 HD12 ' HB3' ' A' ' 73' ' ' SER . 45.4 mt -79.23 123.0 35.59 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 C-N-CA 120.067 -0.653 . . . . 72.43 109.82 176.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . 0.446 ' HB2' ' HB ' ' A' ' 103' ' ' THR . 49.7 mm-40 -91.53 -41.36 10.85 Favored 'General case' 0 C--N 1.308 -1.211 0 CA-C-N 115.662 -0.699 . . . . 74.33 109.33 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -159.23 141.21 13.53 Favored 'General case' 0 N--CA 1.433 -1.299 0 CA-C-N 114.998 -1.001 . . . . 73.31 108.428 -178.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.83 123.73 3.36 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.193 0.52 . . . . 73.35 110.144 178.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 28.9 mm-40 -106.56 108.9 62.66 Favored Pre-proline 0 C--N 1.292 -1.896 0 CA-C-N 115.424 -0.807 . . . . 74.23 109.45 179.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -64.65 -45.96 7.82 Favored 'Trans proline' 0 N--CA 1.448 -1.201 0 C-N-CA 121.997 1.798 . . . . 74.31 111.463 176.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -79.65 -36.47 37.77 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.772 0.656 . . . . 75.21 112.772 -176.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 96' ' ' GLU . 96.5 mttt -86.01 -10.82 54.39 Favored 'General case' 0 CA--C 1.505 -0.756 0 CA-C-O 121.124 0.488 . . . . 64.44 111.117 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.576 ' O ' ' HG3' ' A' ' 123' ' ' GLN . 51.0 t30 53.81 69.09 0.75 Allowed 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 114.838 -1.073 . . . . 53.5 111.116 -177.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.482 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 57.0 tp -135.21 142.12 45.96 Favored 'General case' 0 C--N 1.307 -1.263 0 CA-C-N 114.351 -1.295 . . . . 74.24 108.544 -178.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.524 HG23 HG12 ' A' ' 122' ' ' ILE . 4.6 tp -150.27 122.36 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-O 121.619 0.723 . . . . 64.03 111.692 178.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 121' ' ' THR . 85.9 m -100.28 118.79 37.3 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.976 -1.011 . . . . 73.24 110.303 176.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -104.07 127.9 51.67 Favored 'General case' 0 N--CA 1.467 0.421 0 C-N-CA 123.205 0.602 . . . . 74.34 110.355 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -110.02 137.52 47.67 Favored 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 107.277 -1.379 . . . . 55.25 107.277 171.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.503 ' CG1' ' HB3' ' A' ' 118' ' ' PHE . 9.3 p -87.67 130.94 36.58 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 N-CA-C 106.988 -1.486 . . . . 71.44 106.988 174.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.44 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -103.41 -25.23 3.78 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.065 0 C-N-CA 117.536 -1.666 . . . . 72.4 110.383 177.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.502 ' HB3' ' HD2' ' A' ' 89' ' ' LYS . 40.2 tt0 -156.29 141.79 17.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.02 -0.991 . . . . 74.32 108.875 173.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 170.74 169.43 33.79 Favored Glycine 0 CA--C 1.504 -0.629 0 N-CA-C 110.565 -1.014 . . . . 72.14 110.565 179.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -68.11 -27.24 66.3 Favored 'General case' 0 N--CA 1.477 0.919 0 CA-C-N 117.855 0.827 . . . . 72.35 110.465 -177.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 90.7 mt -58.61 -24.96 62.12 Favored 'General case' 0 C--O 1.215 -0.734 0 CA-C-N 115.661 -0.7 . . . . 62.13 111.634 179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.473 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 5.0 mmt -72.37 -7.03 47.51 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-O 120.875 0.369 . . . . 74.23 111.643 -179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 35.0 mmtp -90.2 -12.11 39.06 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.011 0.434 . . . . 62.24 110.218 178.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -119.89 -33.69 3.92 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 121.757 0.789 . . . . 74.52 109.913 -177.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.473 ' O ' ' HA ' ' A' ' 112' ' ' MET . 20.8 m-85 -121.92 133.94 54.85 Favored 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.267 -1.753 . . . . 75.11 106.267 179.264 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -82.65 -10.26 59.01 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 112.594 0.591 . . . . 63.53 112.594 -177.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 47.2 t -155.16 145.11 21.6 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 107.0 -1.481 . . . . 73.13 107.0 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.547 ' CE2' HD22 ' A' ' 120' ' ' LEU . 83.9 t80 -147.97 111.79 5.09 Favored 'General case' 0 N--CA 1.437 -1.103 0 N-CA-C 109.085 -0.709 . . . . 73.01 109.085 179.482 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 56.5 tp -130.14 133.67 46.78 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 107.578 -1.267 . . . . 74.21 107.578 -179.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.547 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.6 pt? -142.49 123.77 14.7 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 120.238 -0.585 . . . . 72.22 111.721 -179.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . 0.462 ' HA ' ' HA ' ' A' ' 103' ' ' THR . 90.5 m -109.04 124.58 50.98 Favored 'General case' 0 C--N 1.292 -1.911 0 N-CA-C 109.042 -0.725 . . . . 71.53 109.042 177.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 102' ' ' ILE . 25.3 pt -117.77 144.91 24.5 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 C-N-CA 120.281 -0.568 . . . . 74.2 109.701 -179.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.576 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 52.6 tt0 -142.23 135.08 28.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 107.932 -1.136 . . . . 73.51 107.932 176.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.57 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 15.0 t -103.4 132.28 50.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 CA-C-N 116.258 -0.428 . . . . 72.55 110.032 -173.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 12.9 t -130.46 149.69 74.16 Favored Pre-proline 0 CA--C 1.558 1.254 0 N-CA-C 107.413 -1.328 . . . . 74.51 107.413 178.392 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -55.91 159.04 12.66 Favored 'Trans proline' 0 N--CA 1.503 2.04 0 C-N-CA 123.869 3.046 . . . . 73.33 113.832 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.552 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 58.0 mtpt -82.85 142.48 45.15 Favored Pre-proline 0 N--CA 1.462 0.133 0 N-CA-C 109.963 -0.384 . . . . 73.23 109.963 176.93 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 127' ' ' LYS . 31.6 Cg_exo -61.62 -46.69 13.37 Favored 'Trans proline' 0 CA--C 1.533 0.472 0 C-N-CA 123.07 2.513 . . . . 62.14 112.747 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.82 84.44 0.3 Allowed Glycine 0 N--CA 1.435 -1.421 0 C-N-CA 120.568 -0.825 . . . . 64.33 111.78 -178.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 139.12 146.44 4.93 Favored Glycine 0 N--CA 1.435 -1.385 0 C-N-CA 120.993 -0.622 . . . . 52.44 111.982 178.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.28 118.93 5.92 Favored 'Trans proline' 0 C--O 1.24 0.603 0 C-N-CA 122.998 2.465 . . . . 72.21 111.845 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 152.71 -164.3 30.68 Favored Glycine 0 N--CA 1.431 -1.671 0 N-CA-C 109.954 -1.258 . . . . 74.1 109.954 -179.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.484 ' N ' ' HG3' ' A' ' 127' ' ' LYS . 70.9 m -151.51 152.74 33.38 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 117.603 0.702 . . . . 73.53 112.762 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.552 ' CD1' ' HG2' ' A' ' 127' ' ' LYS . 1.5 mp -100.9 123.47 53.92 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 108.649 -0.871 . . . . 53.25 108.649 173.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.445 ' HA ' ' HA ' ' A' ' 124' ' ' VAL . 4.1 p -98.01 124.37 51.01 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.598 0 N-CA-C 109.167 -0.679 . . . . 75.21 109.167 174.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.4 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 48.6 m-70 -89.26 111.57 22.42 Favored 'General case' 0 CA--C 1.468 -2.207 0 N-CA-C 108.971 -0.752 . . . . 71.23 108.971 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.517 ' HA ' HG22 ' A' ' 122' ' ' ILE . 60.3 m95 -91.88 119.42 31.64 Favored 'General case' 0 N--CA 1.401 -2.895 0 N-CA-C 107.602 -1.258 . . . . 74.2 107.602 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -115.39 110.33 19.18 Favored 'General case' 0 C--N 1.284 -2.243 0 N-CA-C 106.966 -1.494 . . . . 73.12 106.966 179.427 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.0 mp -112.01 135.43 52.65 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-N 115.805 -0.634 . . . . 72.33 110.076 -174.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -131.6 127.61 37.45 Favored 'General case' 0 C--N 1.288 -2.084 0 N-CA-C 108.457 -0.942 . . . . 72.4 108.457 176.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.603 ' O ' ' HA3' ' A' ' 24' ' ' GLY . 17.0 p90 -151.49 169.4 22.16 Favored 'General case' 0 C--O 1.166 -3.322 0 CA-C-N 114.977 -1.011 . . . . 71.43 109.247 -174.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 23' ' ' VAL . 12.1 tp10 -130.12 129.59 43.73 Favored 'General case' 0 C--N 1.267 -3.0 0 N-CA-C 107.501 -1.296 . . . . 74.0 107.501 177.175 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.51 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.9 OUTLIER -74.01 135.7 43.12 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.845 0.355 . . . . 75.23 110.695 179.776 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . . . . . . . . . 66.1 mt -75.81 -39.04 37.96 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 N-CA-C 108.119 -1.067 . . . . 55.41 108.119 174.726 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.1 t -154.74 158.76 40.03 Favored 'General case' 0 N--CA 1.419 -2.006 0 N-CA-C 105.852 -1.907 . . . . 72.42 105.852 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.407 ' HG2' ' HB3' ' A' ' 19' ' ' ALA . 42.0 mt-10 -62.47 -63.71 1.15 Allowed 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.213 0.53 . . . . 75.31 111.254 -178.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -61.28 -21.18 63.69 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 114.649 -1.16 . . . . 63.11 112.997 -174.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . . . . . . . . . 15.6 m -80.91 -25.59 10.83 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.853 0 C-N-CA 119.548 -0.861 . . . . 62.31 111.953 -176.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -89.13 148.67 23.54 Favored 'General case' 0 N--CA 1.438 -1.068 0 CA-C-O 120.954 0.407 . . . . 50.44 110.984 -177.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 152' ' ' GLU . 34.8 m-70 -133.78 87.37 36.03 Favored Pre-proline 0 C--N 1.31 -1.147 0 CA-C-N 115.915 -0.584 . . . . 72.22 111.021 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.543 ' HA ' HD23 ' A' ' 154' ' ' LEU . 82.2 Cg_exo -47.43 -27.26 6.99 Favored 'Trans proline' 0 CA--C 1.553 1.453 0 C-N-CA 123.713 2.942 . . . . 73.02 113.954 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 150' ' ' HIS . 12.7 pt-20 -54.32 -38.95 66.56 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 123.859 0.864 . . . . 71.54 112.294 176.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 76.8 p -64.9 -32.38 74.06 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-N 115.708 -0.678 . . . . 71.12 111.43 -173.904 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.543 HD23 ' HA ' ' A' ' 151' ' ' PRO . 1.8 mm? -74.05 -38.73 63.9 Favored 'General case' 0 N--CA 1.439 -1.01 0 CA-C-N 116.081 -0.509 . . . . 60.13 110.787 -176.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 159' ' ' VAL . 78.9 mt -64.97 -39.93 94.22 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-N 116.02 -0.536 . . . . 73.31 110.164 178.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . 0.525 ' O ' ' HG3' ' A' ' 160' ' ' GLU . 42.5 mt-30 -72.89 -37.59 67.24 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 119.741 -0.784 . . . . 61.11 111.592 177.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 91.0 t80 -57.64 -44.37 85.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 122.915 0.486 . . . . 73.54 110.369 178.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.426 ' HB2' ' CE2' ' A' ' 137' ' ' TRP . 31.2 p -64.85 -34.31 78.06 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 120.302 -0.559 . . . . 73.43 110.801 -179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 155' ' ' LEU . 99.0 t -63.8 -50.78 76.22 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.16 0 N-CA-C 109.65 -0.5 . . . . 72.21 109.65 178.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 156' ' ' GLN . 46.9 mt-10 -59.02 -35.26 72.98 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.667 -0.697 . . . . 62.32 111.997 -176.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 60.1 t -77.39 -39.47 27.94 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 116.523 -0.308 . . . . 75.52 110.434 177.123 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.433 ' CB ' HG11 ' A' ' 30' ' ' VAL . 70.6 m -60.85 -33.82 73.63 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 116.337 -0.392 . . . . 62.34 111.419 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.595 ' HG3' ' O ' ' A' ' 159' ' ' VAL . 96.6 mttt -57.64 -54.64 44.58 Favored 'General case' 0 CA--C 1.51 -0.562 0 CA-C-N 115.848 -0.614 . . . . 75.32 109.496 179.111 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -61.39 -51.04 70.43 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-N 113.844 -1.525 . . . . 72.53 111.143 -173.097 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.422 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -67.37 -43.28 87.89 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 CA-C-N 115.8 -0.636 . . . . 51.53 111.821 -175.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.42 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 21.8 t70 -59.2 -49.41 77.96 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.967 -0.56 . . . . 71.21 111.235 179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . 0.568 ' HG2' ' O ' ' A' ' 163' ' ' LYS . 11.9 pt-20 -68.58 -30.13 68.82 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 116.496 -0.32 . . . . 42.23 111.807 179.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.9 t60 -70.06 -36.57 75.06 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 110.046 -0.354 . . . . 75.5 110.046 177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 90.0 mt -77.49 -35.59 53.51 Favored 'General case' 0 N--CA 1.464 0.252 0 N-CA-C 112.123 0.416 . . . . 72.42 112.123 179.261 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 33' ' ' LYS . 96.3 mt -81.17 -41.55 22.2 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 120.84 0.352 . . . . 73.54 110.273 179.007 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 59.68 15.27 4.59 Favored 'General case' 0 C--N 1.318 -0.776 0 C-N-CA 124.892 1.277 . . . . 63.21 114.441 176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 62.09 166.72 0.11 Allowed 'General case' 0 CA--C 1.543 0.678 0 C-N-CA 124.787 1.235 . . . . 64.42 114.223 175.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 . . . . . 0 C--N 1.312 -1.027 0 CA-C-N 114.968 -1.014 . . . . 64.12 108.485 174.211 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 43.0 m . . . . . 0 CA--C 1.552 1.024 0 N-CA-C 114.708 1.373 . . . . 61.03 114.708 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 47.3 mm-40 -143.96 177.34 8.62 Favored 'General case' 0 C--N 1.303 -1.416 0 N-CA-C 105.845 -1.909 . . . . 61.34 105.845 171.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.2 145.44 46.27 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 109.062 -0.718 . . . . 74.43 109.062 176.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 49.1 m -62.52 -28.8 70.1 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.139 0.495 . . . . 72.31 111.083 179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 35.7 p -88.91 -5.26 58.12 Favored 'General case' 0 N--CA 1.433 -1.276 0 CA-C-N 116.214 -0.448 . . . . 72.32 110.879 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.495 ' HB3' ' HB2' ' A' ' 143' ' ' LYS . 91.4 mt 60.33 20.98 10.5 Favored 'General case' 0 C--N 1.346 0.443 0 C-N-CA 124.054 0.942 . . . . 75.54 112.777 -175.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 72.3 t -89.04 120.26 37.44 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.306 0 N-CA-C 108.641 -0.874 . . . . 74.31 108.641 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -124.63 154.15 17.96 Favored Glycine 0 C--N 1.279 -2.617 0 N-CA-C 110.79 -0.924 . . . . 21.4 110.79 -177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.43 ' O ' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -148.02 148.23 30.48 Favored 'General case' 0 C--N 1.276 -2.602 0 N-CA-C 109.929 -0.397 . . . . 73.31 109.929 179.683 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.0 tt -141.08 142.95 34.1 Favored 'General case' 0 C--N 1.285 -2.21 0 N-CA-C 108.089 -1.078 . . . . 61.41 108.089 -177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.557 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.6 tt0 -127.12 140.09 52.51 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 109.142 -0.688 . . . . 73.21 109.142 -179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 14.8 t -152.09 161.99 41.79 Favored 'General case' 0 N--CA 1.43 -1.442 0 N-CA-C 108.857 -0.794 . . . . 73.54 108.857 179.016 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.491 ' HB2' HG23 ' A' ' 134' ' ' ILE . 4.9 p-10 -130.6 132.06 45.3 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.623 -0.51 . . . . 75.14 109.623 177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 162' ' ' SER . 71.9 t -117.71 131.95 68.95 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 109.242 -0.651 . . . . 74.22 109.242 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . 0.271 0.0 OUTLIER -88.83 132.47 34.64 Favored 'General case' 0 N--CA 1.425 -1.702 0 CA-C-O 122.186 0.993 . . . . 74.34 112.815 178.745 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.443 HD12 ' HB3' ' A' ' 34' ' ' ALA . 15.9 pt -124.7 151.31 30.03 Favored 'Isoleucine or valine' 0 C--N 1.278 -2.506 0 CA-C-N 114.453 -1.249 . . . . 72.25 109.824 -177.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -77.08 -18.18 58.19 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.779 -0.823 . . . . 61.24 108.779 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.443 ' HB3' HD12 ' A' ' 32' ' ' ILE . . . -56.64 146.49 25.27 Favored 'General case' 0 N--CA 1.434 -1.237 0 CA-C-N 113.845 -1.525 . . . . 45.13 112.0 -179.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.467 ' HB2' ' HB2' ' A' ' 38' ' ' LYS . 50.1 m -90.4 130.19 36.51 Favored 'General case' 0 N--CA 1.43 -1.457 0 CA-C-N 115.366 -0.834 . . . . 64.43 109.517 179.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.2 -40.46 90.4 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.018 0.437 . . . . 54.0 111.037 -177.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.444 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 12.3 m-20 -68.42 -36.33 78.94 Favored 'General case' 0 CA--C 1.497 -1.074 0 CA-C-N 116.01 -0.541 . . . . 72.41 110.226 179.026 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.467 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 63.9 tttm -61.34 -39.42 90.5 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.767 -0.651 . . . . 73.13 110.148 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.437 ' HA ' HD11 ' A' ' 169' ' ' LEU . 12.4 t80 -62.25 -46.09 90.39 Favored 'General case' 0 C--O 1.222 -0.369 0 N-CA-C 108.533 -0.914 . . . . 74.24 108.533 178.81 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 5.6 t60 -57.88 -39.71 78.48 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 115.421 -0.809 . . . . 64.32 110.112 -179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.444 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 21.1 m-70 -70.25 -50.78 36.25 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 112.47 0.545 . . . . 75.5 112.47 179.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.532 ' SD ' HD13 ' A' ' 169' ' ' LEU . 24.7 ptm -74.57 -22.9 58.75 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.376 0.88 . . . . 62.11 113.376 -177.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -76.41 -24.47 54.03 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.328 0.585 . . . . 71.24 109.66 176.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.11 -16.32 47.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.575 0.702 . . . . 45.03 109.696 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -116.38 73.01 0.27 Allowed Glycine 0 N--CA 1.432 -1.631 0 N-CA-C 109.579 -1.408 . . . . 75.44 109.579 176.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.526 ' HE2' ' OG1' ' A' ' 70' ' ' THR . 58.8 mttp -68.46 143.85 95.83 Favored Pre-proline 0 C--N 1.309 -1.193 0 CA-C-N 115.418 -0.391 . . . . 64.04 110.763 -176.203 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.91 117.1 3.63 Favored 'Trans proline' 0 C--O 1.243 0.771 0 C-N-CA 122.734 2.29 . . . . 54.03 111.454 179.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 20.9 t60 -91.15 81.42 5.56 Favored 'General case' 0 N--CA 1.426 -1.673 0 N-CA-C 109.448 -0.575 . . . . 74.14 109.448 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 23.7 t-160 55.48 89.14 0.04 OUTLIER 'General case' 0 C--O 1.237 0.427 0 C-N-CA 124.82 1.248 . . . . 73.1 112.071 -179.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 29.5 m -127.11 156.8 38.72 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.391 0 CA-C-N 115.91 -0.586 . . . . 70.21 110.016 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.7 t -160.6 93.96 1.03 Allowed 'General case' 0 N--CA 1.43 -1.453 0 N-CA-C 109.306 -0.627 . . . . 65.15 109.306 178.487 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -178.73 -68.23 0.01 OUTLIER 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 124.178 0.991 . . . . 73.22 108.485 177.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -85.98 92.94 8.83 Favored 'General case' 0 N--CA 1.44 -0.95 0 CA-C-N 115.441 -0.799 . . . . 74.02 109.956 -178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 p -177.47 163.42 1.4 Allowed Pre-proline 0 C--N 1.311 -1.101 0 N-CA-C 108.01 -1.107 . . . . 71.23 108.01 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.62 135.94 71.75 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.16 1.906 . . . . 62.3 110.012 174.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -78.9 65.4 3.53 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.127 -0.559 . . . . 52.15 113.614 -175.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -126.8 99.39 5.74 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 108.373 -0.973 . . . . 64.45 108.373 175.419 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 64.4 mt -95.78 120.45 45.19 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.854 0 CA-C-N 115.732 -0.667 . . . . 71.05 109.649 -177.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -82.46 133.76 35.21 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.998 -0.546 . . . . 73.24 110.068 177.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -98.92 167.47 21.83 Favored Glycine 0 N--CA 1.434 -1.5 0 C-N-CA 120.532 -0.842 . . . . 74.41 111.27 -178.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 42.2 t 71.07 -66.67 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 124.038 0.935 . . . . 74.21 112.501 179.025 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -124.85 100.41 6.6 Favored 'General case' 0 C--N 1.309 -1.189 0 CA-C-O 121.006 0.431 . . . . 72.04 110.185 -176.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 5.2 tt -111.51 99.67 8.39 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 105.763 -1.94 . . . . 50.02 105.763 175.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 9.0 t60 -91.06 131.79 36.42 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.505 -0.924 . . . . 70.22 108.505 -177.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -146.68 -90.51 0.09 Allowed 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 109.63 -0.507 . . . . 73.02 109.63 176.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 44.26 -136.66 5.5 Favored Glycine 0 C--N 1.355 1.598 0 O-C-N 124.008 0.817 . . . . 72.45 112.411 -178.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -104.95 110.17 22.46 Favored 'General case' 0 C--N 1.298 -1.639 0 N-CA-C 105.867 -1.901 . . . . 73.23 105.867 171.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.598 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 1.2 t90 -88.32 -17.24 31.07 Favored 'General case' 0 C--N 1.313 -0.983 0 N-CA-C 109.599 -0.519 . . . . 72.0 109.599 -172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 97.0 4.81 58.61 Favored Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 121.16 -0.543 . . . . 74.32 112.922 177.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.526 ' OG1' ' HE2' ' A' ' 46' ' ' LYS . 50.7 m 67.68 -76.93 0.05 OUTLIER 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.859 0.863 . . . . 72.43 110.856 -176.174 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.558 ' HA ' ' CG2' ' A' ' 92' ' ' ILE . 6.7 p -72.27 125.83 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.41 0 CA-C-O 121.435 0.636 . . . . 71.45 109.989 177.43 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.419 ' HA2' ' CZ ' ' A' ' 91' ' ' ARG . . . 103.26 -4.17 48.01 Favored Glycine 0 N--CA 1.427 -1.96 0 N-CA-C 110.83 -0.908 . . . . 75.31 110.83 -175.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.598 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 32.1 t -69.42 148.35 49.72 Favored 'General case' 0 C--O 1.251 1.162 0 N-CA-C 109.883 -0.414 . . . . 60.34 109.883 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 85.6 mt -130.23 116.83 37.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 CA-C-N 115.311 -0.859 . . . . 71.13 109.111 -177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 45.5 t -125.28 149.13 29.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.713 0 N-CA-C 108.401 -0.963 . . . . 65.34 108.401 -178.479 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 41.0 m-85 -126.2 130.3 50.69 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 121.069 0.461 . . . . 74.43 111.361 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . 0.45 ' O ' ' HA ' ' A' ' 87' ' ' VAL . 44.7 m0 -107.79 121.14 44.11 Favored 'General case' 0 C--N 1.309 -1.158 0 N-CA-C 108.548 -0.908 . . . . 75.14 108.548 176.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -108.8 131.31 55.1 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 108.749 -0.834 . . . . 73.52 108.749 -178.41 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 32.4 p90 -156.18 163.94 38.99 Favored 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 109.6 -0.518 . . . . 71.24 109.6 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 58.2 t -106.32 119.65 56.09 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 109.12 -0.696 . . . . 72.01 109.12 179.383 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 65.9 t60 -140.64 130.88 24.99 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.29 -1.004 . . . . 72.5 108.29 -178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 45.6 m-20 64.3 27.78 13.78 Favored 'General case' 0 N--CA 1.488 1.462 0 C-N-CA 125.227 1.411 . . . . 72.34 109.09 -175.305 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 80.85 -13.28 31.41 Favored Glycine 0 CA--C 1.523 0.559 0 CA-C-N 115.551 -0.75 . . . . 41.15 113.522 -178.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.414 ' HB2' ' HE3' ' A' ' 86' ' ' LYS . 1.7 mp0 -95.15 149.24 21.51 Favored 'General case' 0 CA--C 1.491 -1.309 0 CA-C-O 120.965 0.412 . . . . 75.54 111.097 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -80.95 115.77 20.59 Favored 'General case' 0 N--CA 1.419 -1.98 0 N-CA-C 106.605 -1.628 . . . . 60.42 106.605 173.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.414 ' HE3' ' HB2' ' A' ' 84' ' ' GLU . 99.4 mttt -119.16 146.44 45.16 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 116.225 -0.443 . . . . 73.44 109.816 -176.664 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 77' ' ' TRP . 30.9 t -125.93 152.16 32.82 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 N-CA-C 109.06 -0.719 . . . . 53.41 109.06 -175.049 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.83 113.86 27.38 Favored 'General case' 0 C--N 1.288 -2.096 0 N-CA-C 106.827 -1.546 . . . . 64.31 106.827 174.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.728 ' HD2' ' HA ' ' A' ' 108' ' ' GLU . 57.5 mttp -108.83 128.63 55.06 Favored 'General case' 0 N--CA 1.432 -1.339 0 CA-C-N 115.409 -0.814 . . . . 64.5 109.564 -176.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -154.04 153.95 32.82 Favored 'General case' 0 N--CA 1.433 -1.311 0 CA-C-O 121.18 0.514 . . . . 62.42 110.592 -168.611 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.419 ' CZ ' ' HA2' ' A' ' 72' ' ' GLY . 2.9 tmt_? -136.81 123.34 20.89 Favored 'General case' 0 C--N 1.289 -2.027 0 N-CA-C 105.624 -1.991 . . . . 64.24 105.624 177.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.558 ' CG2' ' HA ' ' A' ' 71' ' ' VAL . 48.2 mt -65.17 122.73 16.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 C-N-CA 120.064 -0.654 . . . . 73.33 110.395 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -103.59 -41.61 5.91 Favored 'General case' 0 C--N 1.307 -1.264 0 CA-C-O 120.978 0.418 . . . . 74.31 110.648 -176.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -147.43 145.86 29.36 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.706 -0.85 . . . . 73.41 108.706 -179.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.7 p -147.28 138.9 18.42 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 C-N-CA 121.061 -0.256 . . . . 74.04 110.764 -178.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.628 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 8.0 tp10 -130.11 105.96 16.46 Favored Pre-proline 0 N--CA 1.432 -1.364 0 N-CA-C 107.316 -1.365 . . . . 74.33 107.316 173.733 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -65.75 -29.54 50.87 Favored 'Trans proline' 0 N--CA 1.459 -0.544 0 C-N-CA 122.529 2.153 . . . . 73.03 111.295 178.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -76.47 -34.07 58.68 Favored 'General case' 0 C--O 1.213 -0.819 0 CA-C-N 115.885 -0.598 . . . . 74.24 111.419 -177.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.628 ' HG3' ' HG2' ' A' ' 96' ' ' GLU . 62.1 mttp -96.08 -3.7 44.24 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 116.451 -0.341 . . . . 63.32 111.472 -177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.491 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 4.0 t30 56.27 51.75 11.18 Favored 'General case' 0 C--O 1.246 0.883 0 N-CA-C 107.28 -1.378 . . . . 74.42 107.28 -175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.587 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 47.1 tp -118.88 141.42 48.67 Favored 'General case' 0 CA--C 1.508 -0.666 0 CA-C-N 114.079 -1.419 . . . . 75.24 110.057 -174.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 7.1 tp -147.33 125.37 3.65 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.431 0 CA-C-O 121.755 0.788 . . . . 74.42 111.117 178.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 35.7 m -104.29 121.91 44.32 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.421 -0.809 . . . . 73.43 109.898 177.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 81.0 m-85 -105.43 136.65 44.59 Favored 'General case' 0 C--N 1.309 -1.168 0 N-CA-C 109.31 -0.626 . . . . 73.13 109.31 179.026 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 71.5 ttt180 -109.23 120.11 41.52 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 106.268 -1.753 . . . . 73.12 106.268 171.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.517 HG11 HD12 ' A' ' 111' ' ' LEU . 67.0 t -81.4 122.78 36.99 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.03 0 C-N-CA 119.378 -0.929 . . . . 64.44 109.722 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.631 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -94.52 -48.45 13.0 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.473 0 N-CA-C 108.934 -0.765 . . . . 73.45 108.934 179.228 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.728 ' HA ' ' HD2' ' A' ' 89' ' ' LYS . 11.2 tp10 40.07 -80.85 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.998 0 N-CA-C 117.411 2.374 . . . . 73.43 117.411 171.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 116.72 -51.69 0.72 Allowed Glycine 0 N--CA 1.433 -1.551 0 N-CA-C 109.824 -1.31 . . . . 54.51 109.824 -173.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . 0.473 ' N ' ' HG3' ' A' ' 108' ' ' GLU . 30.6 t70 -68.07 -48.21 66.18 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-O 121.056 0.455 . . . . 74.33 111.399 178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.517 HD12 HG11 ' A' ' 106' ' ' VAL . 99.1 mt -66.82 -24.96 66.23 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.495 0.664 . . . . 72.33 110.056 176.016 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.678 ' HA ' ' O ' ' A' ' 115' ' ' TYR . 21.5 mmt -73.32 -5.51 40.08 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.52 -0.764 . . . . 70.3 111.87 177.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -72.22 -22.58 61.23 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 120.79 0.328 . . . . 73.44 110.792 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.579 ' HG2' ' N ' ' A' ' 149' ' ' ALA . 6.9 tp10 -124.56 -36.07 2.66 Favored 'General case' 0 CA--C 1.483 -1.619 0 CA-C-O 121.666 0.746 . . . . 70.42 110.459 175.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.678 ' O ' ' HA ' ' A' ' 112' ' ' MET . 21.5 m-85 -99.79 122.08 42.23 Favored 'General case' 0 N--CA 1.393 -3.296 0 C-N-CA 117.586 -1.646 . . . . 71.25 106.667 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HB3' HG12 ' A' ' 144' ' ' ILE . 18.4 ptmt -80.57 -7.28 59.18 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-O 121.766 0.793 . . . . 72.42 110.399 179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 48.2 t -163.9 138.36 5.83 Favored 'General case' 0 N--CA 1.411 -2.386 0 CA-C-N 114.351 -1.295 . . . . 53.12 108.781 175.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -143.57 107.27 4.63 Favored 'General case' 0 C--N 1.308 -1.235 0 N-CA-C 107.739 -1.208 . . . . 71.21 107.739 176.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.51 129.81 56.4 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 107.925 -1.139 . . . . 72.41 107.925 -177.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' A' ' 138' ' ' HIS . 1.9 pt? -133.3 129.52 37.68 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 120.229 -0.588 . . . . 73.2 110.367 179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 28.5 m -115.8 129.59 56.5 Favored 'General case' 0 C--N 1.282 -2.332 0 N-CA-C 109.428 -0.582 . . . . 73.22 109.428 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 136' ' ' HIS . 37.1 pt -121.3 144.86 28.99 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.543 0 N-CA-C 109.671 -0.492 . . . . 74.41 109.671 178.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.571 ' NE2' ' HB3' ' A' ' 99' ' ' LYS . 60.7 tt0 -140.26 134.32 30.89 Favored 'General case' 0 C--N 1.291 -1.97 0 N-CA-C 107.427 -1.323 . . . . 75.04 107.427 175.793 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.491 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.5 t -95.39 119.41 43.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.09 0.472 . . . . 65.31 110.005 -176.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 15.2 m -120.18 133.6 23.98 Favored Pre-proline 0 C--N 1.299 -1.63 0 N-CA-C 108.18 -1.045 . . . . 75.32 108.18 -176.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -57.0 151.88 47.2 Favored 'Trans proline' 0 CA--C 1.54 0.811 0 C-N-CA 122.584 2.189 . . . . 73.01 112.287 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.469 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 51.6 mtpt -78.14 142.01 63.31 Favored Pre-proline 0 C--N 1.321 -0.633 0 N-CA-C 110.158 -0.312 . . . . 72.4 110.158 -179.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -73.47 100.92 1.3 Allowed 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 122.209 1.939 . . . . 70.4 111.17 177.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 67.06 52.91 29.42 Favored Glycine 0 N--CA 1.437 -1.257 0 N-CA-C 111.325 -0.71 . . . . 75.43 111.325 -178.443 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -166.51 137.31 4.58 Favored Glycine 0 N--CA 1.432 -1.589 0 C-N-CA 120.636 -0.792 . . . . 51.53 111.871 -179.248 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.28 113.13 3.51 Favored 'Trans proline' 0 N--CA 1.455 -0.79 0 C-N-CA 122.546 2.164 . . . . 53.51 111.332 178.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 133.48 -159.98 23.82 Favored Glycine 0 N--CA 1.432 -1.591 0 N-CA-C 110.469 -1.053 . . . . 65.15 110.469 -179.119 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 29.3 p -150.34 163.98 36.96 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 117.274 0.537 . . . . 74.41 112.137 -178.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.491 HG23 ' HB2' ' A' ' 29' ' ' ASP . 1.4 mp -109.72 130.34 63.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 N-CA-C 108.925 -0.768 . . . . 61.53 108.925 173.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 4.0 p -96.08 118.38 42.27 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 N-CA-C 108.387 -0.968 . . . . 62.24 108.387 173.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.469 ' O ' ' HA ' ' A' ' 122' ' ' ILE . 91.6 m-70 -89.51 111.85 22.87 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.957 -0.565 . . . . 74.44 109.818 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -94.71 122.91 37.8 Favored 'General case' 0 C--N 1.305 -1.368 0 CA-C-N 115.797 -0.638 . . . . 63.54 110.252 -179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' LEU . 70.6 m-70 -116.51 111.81 20.49 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.863 -1.532 . . . . 74.24 106.863 175.555 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 3.9 mp -107.68 124.56 50.18 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 108.829 -0.804 . . . . 63.32 108.829 -177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -129.23 127.83 42.06 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 108.888 -0.782 . . . . 65.53 108.888 178.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -152.44 165.27 35.58 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 113.16 0.8 . . . . 63.32 113.16 -173.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -134.43 123.89 24.77 Favored 'General case' 0 C--N 1.3 -1.568 0 CA-C-N 116.063 -0.517 . . . . 54.13 110.557 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.495 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -77.64 138.01 38.86 Favored 'General case' 0 C--O 1.242 0.696 0 CA-C-O 121.381 0.61 . . . . 73.42 111.895 -179.592 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 114' ' ' GLU . 95.8 mt -77.5 -46.47 27.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-N 115.187 -0.915 . . . . 72.13 108.631 174.508 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.502 ' O ' ' HB2' ' A' ' 146' ' ' GLU . 46.7 t -120.96 -78.13 0.59 Allowed 'General case' 0 N--CA 1.422 -1.865 0 CA-C-N 115.292 -0.867 . . . . 72.24 111.126 -179.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 145' ' ' SER 0.259 33.7 tt0 156.45 -51.37 0.0 OUTLIER 'General case' 0 C--N 1.359 1.015 0 C-N-CA 124.758 1.223 . . . . 63.11 107.953 -174.799 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -60.98 -30.53 70.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 112.858 -1.974 . . . . 73.52 112.602 -171.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' HB ' ' HB2' ' A' ' 114' ' ' GLU . 41.6 t -93.89 -6.11 10.42 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.482 0 CA-C-O 121.481 0.657 . . . . 75.5 110.273 -173.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.579 ' N ' ' HG2' ' A' ' 114' ' ' GLU . . . -77.76 136.48 38.14 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 112.594 0.59 . . . . 71.44 112.594 -175.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 71.9 m-70 -145.4 89.46 6.32 Favored Pre-proline 0 C--N 1.311 -1.092 0 CA-C-N 115.46 -0.791 . . . . 65.35 110.889 179.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.4 ' HA ' HD12 ' A' ' 154' ' ' LEU . 61.6 Cg_exo -58.39 -19.18 42.16 Favored 'Trans proline' 0 N--CA 1.485 1.02 0 C-N-CA 122.538 2.159 . . . . 74.52 112.038 174.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -53.62 -47.85 69.86 Favored 'General case' 0 CA--C 1.502 -0.901 0 C-N-CA 124.365 1.066 . . . . 72.55 110.299 179.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 71.1 p -80.77 -30.73 36.01 Favored 'General case' 0 N--CA 1.413 -2.307 0 CA-C-N 113.495 -1.684 . . . . 51.44 110.142 -172.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 151' ' ' PRO . 87.3 mt -63.41 -42.06 98.74 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.831 -0.622 . . . . 71.41 109.569 176.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.584 ' O ' HG23 ' A' ' 159' ' ' VAL . 72.8 mt -69.95 -34.76 73.85 Favored 'General case' 0 N--CA 1.438 -1.057 0 CA-C-N 115.941 -0.572 . . . . 73.51 111.834 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -71.62 -31.59 67.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 119.789 -0.764 . . . . 63.4 110.813 176.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -57.27 -43.94 83.52 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 107.847 -1.168 . . . . 74.53 107.847 172.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.492 ' HB3' ' O ' ' A' ' 155' ' ' LEU . 11.6 t -60.65 -50.45 73.45 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 114.81 -1.087 . . . . 74.42 110.998 174.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 155' ' ' LEU . 93.3 t -55.84 -50.54 67.87 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 C-N-CA 123.404 0.682 . . . . 75.15 112.566 -178.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -68.43 -33.92 75.07 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-O 120.89 0.376 . . . . 72.02 111.882 -175.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 75.7 t -69.52 -41.61 80.53 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 CA-C-N 116.126 -0.488 . . . . 71.41 109.744 175.759 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 30' ' ' VAL . 59.5 m -59.53 -39.8 85.1 Favored 'General case' 0 C--O 1.22 -0.456 0 O-C-N 123.299 0.375 . . . . 61.22 111.615 -179.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -62.27 -39.37 92.71 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.104 -0.498 . . . . 73.34 111.474 179.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -76.13 -48.75 19.46 Favored 'General case' 0 CA--C 1.51 -0.595 0 C-N-CA 120.671 -0.412 . . . . 70.35 111.098 -176.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.415 HG22 ' HA ' ' A' ' 162' ' ' SER . 0.0 OUTLIER -60.75 -35.75 66.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 115.8 -0.637 . . . . 71.24 109.482 -176.891 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -54.35 -51.79 63.65 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-N 115.602 -0.726 . . . . 74.1 110.238 175.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -75.11 -31.68 61.2 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.516 -0.765 . . . . 74.22 112.569 -178.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 51.5 t60 -58.43 -36.76 74.12 Favored 'General case' 0 C--O 1.212 -0.874 0 C-N-CA 122.506 0.322 . . . . 63.33 111.42 -176.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.532 HD13 ' SD ' ' A' ' 42' ' ' MET . 3.6 mm? -76.61 -29.06 56.38 Favored 'General case' 0 C--N 1.31 -1.132 0 C-N-CA 121.063 -0.255 . . . . 74.22 111.623 176.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 70.4 mt -77.53 -21.56 52.44 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.126 -0.63 . . . . 50.02 110.203 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -85.07 108.12 17.5 Favored 'General case' 0 N--CA 1.43 -1.43 0 N-CA-C 108.174 -1.046 . . . . 61.11 108.174 173.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -87.49 155.84 19.82 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.719 -0.792 . . . . 70.11 110.96 -179.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 . . . . . 0 C--N 1.3 -1.579 0 CA-C-N 115.318 -0.855 . . . . 73.05 109.897 -178.87 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 8.8 m . . . . . 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 63.02 109.765 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -85.79 -5.62 59.22 Favored 'General case' 0 CA--C 1.51 -0.569 0 CA-C-N 115.168 -0.923 . . . . 75.54 109.689 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -128.9 105.13 8.01 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.645 -1.161 . . . . 52.51 108.363 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 39.1 m -66.08 -28.7 69.03 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.989 -0.551 . . . . 43.12 111.802 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.417 ' HB2' HG12 ' A' ' 23' ' ' VAL . 50.4 m -87.79 -3.94 58.91 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 116.517 -0.31 . . . . 60.12 111.714 179.075 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 84.5 mt 62.81 18.55 10.81 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.638 0.775 . . . . 53.22 112.737 -177.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG12 ' HB2' ' A' ' 21' ' ' SER . 12.9 p -101.81 134.23 42.92 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.188 0 N-CA-C 108.082 -1.081 . . . . 61.24 108.082 176.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -146.38 161.19 28.33 Favored Glycine 0 N--CA 1.414 -2.818 0 C-N-CA 120.129 -1.034 . . . . 63.22 111.108 -178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.6 ptmm? -147.27 155.46 42.07 Favored 'General case' 0 C--N 1.272 -2.783 0 N-CA-C 109.883 -0.414 . . . . 72.43 109.883 179.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.404 HD23 ' N ' ' A' ' 27' ' ' GLU . 6.2 tt -137.96 137.32 37.84 Favored 'General case' 0 C--N 1.281 -2.411 0 N-CA-C 107.177 -1.416 . . . . 63.34 107.177 178.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.404 ' N ' HD23 ' A' ' 26' ' ' LEU . 35.9 tt0 -132.01 129.62 40.34 Favored 'General case' 0 C--N 1.275 -2.647 0 N-CA-C 108.303 -0.999 . . . . 74.53 108.303 -179.076 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 9.1 t -143.22 147.0 34.16 Favored 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 121.167 0.508 . . . . 72.52 109.858 -177.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -99.93 142.37 31.5 Favored 'General case' 0 C--N 1.289 -2.064 0 N-CA-C 108.025 -1.102 . . . . 62.14 108.025 172.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 86.9 t -127.48 125.2 65.22 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.883 0 N-CA-C 108.314 -0.995 . . . . 73.51 108.314 174.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.29 137.08 32.64 Favored 'General case' 0 N--CA 1.413 -2.312 0 CA-C-O 121.822 0.82 . . . . 72.3 112.519 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.493 ' HB ' ' OD1' ' A' ' 166' ' ' ASP . 37.6 pt -128.08 177.23 6.27 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.327 0 CA-C-N 114.49 -1.232 . . . . 62.2 108.129 -179.554 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . 0.454 ' HD2' ' N ' ' A' ' 33' ' ' LYS . 10.1 mptt -93.69 -145.73 0.24 Allowed 'General case' 0 C--N 1.28 -2.456 0 N-CA-C 105.813 -1.921 . . . . 73.43 105.813 176.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . 64.6 -162.05 0.27 Allowed 'General case' 0 C--O 1.219 -0.548 0 CA-C-O 121.225 0.536 . . . . 74.42 111.977 174.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.612 ' HB3' ' HB2' ' A' ' 38' ' ' LYS . 39.5 t -131.36 148.84 52.71 Favored 'General case' 0 C--N 1.287 -2.123 0 N-CA-C 107.731 -1.211 . . . . 72.54 107.731 178.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -66.19 -29.55 69.84 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 108.97 -0.752 . . . . 71.34 108.97 176.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -74.11 -40.61 62.57 Favored 'General case' 0 CA--C 1.507 -0.686 0 CA-C-N 115.391 -0.822 . . . . 75.22 109.581 176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.612 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 85.0 tttt -64.44 -29.21 70.27 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.438 -0.801 . . . . 73.15 110.263 -178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . 0.404 ' HA ' HD22 ' A' ' 169' ' ' LEU . 86.1 t80 -53.98 -46.1 71.58 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.92 -0.582 . . . . 73.33 110.699 175.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . . . . . . . . . 49.3 m-70 -56.01 -46.48 78.76 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-O 121.422 0.629 . . . . 64.12 110.507 -179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -76.26 -43.37 42.11 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.355 -0.839 . . . . 74.51 111.984 -174.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 94.4 mmm -74.53 -31.87 62.29 Favored 'General case' 0 C--N 1.311 -1.07 0 N-CA-C 113.713 1.005 . . . . 74.34 113.713 -175.898 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 81.5 t80 -77.8 -32.12 52.18 Favored 'General case' 0 C--N 1.318 -0.768 0 C-N-CA 120.033 -0.667 . . . . 74.23 110.612 -178.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -87.32 -27.72 22.68 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.219 0.533 . . . . 43.25 110.708 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . . . . . . . . . . . -86.02 21.15 17.01 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.618 -0.719 . . . . 74.41 113.428 -176.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.454 ' C ' ' HD3' ' A' ' 46' ' ' LYS . 6.6 tmtm? -83.67 121.16 76.18 Favored Pre-proline 0 N--CA 1.427 -1.588 0 N-CA-C 107.581 -1.266 . . . . 74.41 107.581 177.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_exo -68.89 104.33 1.16 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 C-N-CA 122.147 1.898 . . . . 64.35 110.069 176.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.5 p-80 -86.44 120.97 28.34 Favored 'General case' 0 C--N 1.303 -1.428 0 CA-C-O 121.075 0.464 . . . . 72.43 110.793 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 28.0 t60 -160.08 -44.59 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.574 -0.739 . . . . 71.41 110.796 -178.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 61.2 t 69.61 87.18 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 N-CA-C 107.982 -1.118 . . . . 75.21 107.982 -171.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 18.5 p -67.25 -68.31 0.39 Allowed 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 114.691 -1.14 . . . . 64.1 113.162 -174.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.472 ' HE2' ' O ' ' A' ' 54' ' ' SER . 57.7 mtpt 65.68 172.86 0.22 Allowed 'General case' 0 C--O 1.242 0.664 0 C-N-CA 123.665 0.786 . . . . 74.12 112.166 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -78.48 -32.43 48.31 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 108.337 -0.986 . . . . 43.41 108.337 175.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.472 ' O ' ' HE2' ' A' ' 52' ' ' LYS . 45.7 p -139.27 129.87 14.65 Favored Pre-proline 0 N--CA 1.425 -1.703 0 N-CA-C 107.317 -1.364 . . . . 61.3 107.317 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -48.93 -54.32 5.61 Favored 'Trans proline' 0 N--CA 1.484 0.952 0 C-N-CA 123.397 2.731 . . . . 62.54 113.385 -176.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -176.61 84.25 0.07 OUTLIER Glycine 0 CA--C 1.484 -1.878 0 N-CA-C 109.746 -1.341 . . . . 64.32 109.746 -179.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -92.35 87.94 6.22 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.114 0.483 . . . . 73.33 112.272 -176.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.68 -174.48 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 C-N-CA 125.222 1.409 . . . . 72.21 108.289 175.083 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 49.6 mt-30 -55.88 -56.81 16.15 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 121.094 0.473 . . . . 62.11 111.303 179.355 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 155.5 82.97 0.04 OUTLIER Glycine 0 N--CA 1.429 -1.784 0 C-N-CA 120.39 -0.91 . . . . 71.31 111.674 -179.071 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 51.4 t -143.5 118.4 9.97 Favored 'General case' 0 C--N 1.292 -1.93 0 N-CA-C 107.834 -1.173 . . . . 72.21 107.834 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -136.13 104.59 5.72 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.76 0.791 . . . . 73.01 111.453 -179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.402 HD23 ' N ' ' A' ' 64' ' ' HIS . 5.1 tt -87.97 131.38 34.64 Favored 'General case' 0 C--N 1.311 -1.08 0 N-CA-C 105.416 -2.068 . . . . 60.32 105.416 175.015 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.402 ' N ' HD23 ' A' ' 63' ' ' LEU . 33.9 m-70 -83.9 94.06 8.16 Favored 'General case' 0 C--N 1.299 -1.599 0 CA-C-O 122.023 0.916 . . . . 53.24 113.017 -174.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -98.34 102.56 14.34 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 113.64 -1.618 . . . . 74.53 107.772 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -169.57 166.1 39.39 Favored Glycine 0 CA--C 1.484 -1.852 0 N-CA-C 110.61 -0.996 . . . . 63.31 110.61 -178.24 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -70.35 134.94 48.39 Favored 'General case' 0 C--N 1.303 -1.443 0 CA-C-O 120.8 0.333 . . . . 63.04 111.319 -178.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.455 ' CG ' ' HA ' ' A' ' 73' ' ' SER . 20.7 m0 -87.48 -16.01 35.97 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.606 -0.725 . . . . 64.33 110.52 -178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.08 12.24 81.26 Favored Glycine 0 C--O 1.236 0.243 0 C-N-CA 121.307 -0.473 . . . . 43.52 113.438 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.0 t -157.01 179.73 9.01 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 109.731 -0.47 . . . . 74.55 109.731 -177.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.7 t -64.89 134.55 29.31 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 N-CA-C 108.671 -0.862 . . . . 73.03 108.671 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.48 -2.98 49.95 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.825 -0.91 . . . . 63.11 110.825 -176.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.455 ' HA ' ' CG ' ' A' ' 68' ' ' TRP . 33.8 t -63.15 136.89 58.03 Favored 'General case' 0 C--O 1.242 0.661 0 C-N-CA 123.227 0.611 . . . . 70.2 110.882 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . . . . . . . . . 80.0 mt -129.92 114.57 30.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 CA-C-O 121.423 0.63 . . . . 73.51 109.543 176.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 7.2 p -139.29 151.0 22.78 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 107.462 -1.311 . . . . 75.25 107.462 -179.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -122.13 143.17 49.71 Favored 'General case' 0 C--N 1.308 -1.223 0 C-N-CA 120.058 -0.657 . . . . 72.22 111.695 -175.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 1.2 p90 -118.16 154.26 32.45 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 109.844 -0.428 . . . . 71.14 109.844 173.095 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.8 m-20 -109.82 134.61 51.84 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.771 -0.825 . . . . 72.35 108.771 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -128.39 145.15 51.17 Favored 'General case' 0 C--N 1.292 -1.906 0 N-CA-C 108.012 -1.107 . . . . 63.21 108.012 176.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 53.9 t -105.85 124.89 61.27 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.823 0 C-N-CA 120.057 -0.657 . . . . 73.53 110.512 -173.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 30.5 t60 -139.65 126.76 21.1 Favored 'General case' 0 C--N 1.309 -1.186 0 N-CA-C 107.559 -1.274 . . . . 73.11 107.559 -178.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 56.5 m-20 61.63 28.04 17.32 Favored 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 125.149 1.379 . . . . 74.33 110.201 -175.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 81.91 -6.03 68.22 Favored Glycine 0 N--CA 1.438 -1.194 0 CA-C-N 115.836 -0.62 . . . . 73.43 112.986 -179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -95.53 143.77 26.57 Favored 'General case' 0 CA--C 1.501 -0.931 0 N-CA-C 109.22 -0.659 . . . . 73.11 109.22 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -83.83 114.68 21.81 Favored 'General case' 0 N--CA 1.422 -1.835 0 N-CA-C 107.006 -1.479 . . . . 73.01 107.006 175.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . . . . . . . . . 23.8 mmmt -103.49 144.17 31.75 Favored 'General case' 0 C--N 1.285 -2.227 0 N-CA-C 105.724 -1.954 . . . . 74.23 105.724 -176.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.429 ' HB ' ' HE3' ' A' ' 89' ' ' LYS . 22.3 t -115.93 144.3 23.88 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.724 0 C-N-CA 119.939 -0.704 . . . . 73.41 109.353 -176.208 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -108.92 128.03 54.57 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.52 -0.548 . . . . 64.51 109.52 178.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.466 ' HD2' ' N ' ' A' ' 89' ' ' LYS . 0.2 OUTLIER -105.17 121.87 44.73 Favored 'General case' 0 C--N 1.311 -1.091 0 N-CA-C 109.181 -0.674 . . . . 73.0 109.181 179.445 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -145.27 160.12 41.98 Favored 'General case' 0 N--CA 1.437 -1.105 0 CA-C-N 115.703 -0.68 . . . . 71.22 110.406 -170.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . . . . . . . . . 27.0 ttm180 -136.65 139.37 41.99 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.43 -1.322 . . . . 74.21 107.43 170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 42.6 mm -79.08 122.4 34.22 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.124 0 CA-C-O 120.743 0.306 . . . . 60.02 110.756 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.3 mm-40 -99.06 -31.39 11.8 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.79 -0.641 . . . . 71.3 110.402 178.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -160.43 141.55 12.1 Favored 'General case' 0 CA--C 1.507 -0.685 0 N-CA-C 108.176 -1.046 . . . . 35.13 108.176 179.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 7.8 p -146.19 123.87 4.25 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.413 0.625 . . . . 75.44 112.384 -178.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.496 ' HB2' ' HB3' ' A' ' 101' ' ' LEU . 23.1 mm-40 -114.78 106.32 52.12 Favored Pre-proline 0 C--N 1.312 -1.027 0 N-CA-C 108.502 -0.925 . . . . 75.01 108.502 176.339 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_exo -69.45 -37.05 10.46 Favored 'Trans proline' 0 C--N 1.327 -0.594 0 C-N-CA 122.16 1.907 . . . . 65.3 110.585 177.73 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -79.34 -34.97 41.72 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.576 -0.738 . . . . 74.3 112.596 -177.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -91.8 -1.72 57.24 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 112.91 0.708 . . . . 62.34 112.91 -178.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.587 ' O ' ' HA ' ' A' ' 123' ' ' GLN . 90.0 m-20 58.4 38.6 25.73 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 122.445 0.298 . . . . 73.22 110.896 -176.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.496 ' HB3' ' HB2' ' A' ' 96' ' ' GLU . 42.0 tp -118.01 134.32 55.08 Favored 'General case' 0 CA--C 1.495 -1.142 0 N-CA-C 108.777 -0.823 . . . . 62.05 108.777 -177.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.2 tt -151.12 124.25 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.674 0 CA-C-O 121.549 0.69 . . . . 74.24 111.693 179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 70.4 m -98.97 120.17 38.97 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.221 -0.9 . . . . 71.21 111.236 178.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . 0.422 ' HB2' ' CD2' ' A' ' 120' ' ' LEU . 88.3 m-85 -105.48 145.56 30.71 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.018 0.927 . . . . 73.45 109.561 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 56.8 ttt180 -122.86 137.51 54.92 Favored 'General case' 0 C--N 1.299 -1.605 0 N-CA-C 108.459 -0.941 . . . . 74.04 108.459 174.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 111' ' ' LEU . 7.8 p -82.4 139.01 18.47 Favored 'Isoleucine or valine' 0 C--O 1.243 0.734 0 N-CA-C 107.596 -1.261 . . . . 75.44 107.596 175.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.495 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -125.97 -23.02 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.799 0 C-N-CA 118.674 -1.21 . . . . 60.42 114.056 -175.857 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -86.54 -92.85 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 115.74 1.755 . . . . 73.02 115.74 -172.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.547 ' O ' ' HG3' ' A' ' 113' ' ' LYS . . . -143.4 -53.72 0.03 OUTLIER Glycine 0 C--O 1.207 -1.586 0 C-N-CA 117.202 -2.428 . . . . 33.41 117.81 -170.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -49.03 -51.0 33.46 Favored 'General case' 0 N--CA 1.503 2.194 0 CA-C-N 118.452 1.126 . . . . 72.34 114.029 -171.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.497 ' HB2' HG21 ' A' ' 106' ' ' VAL . 89.0 mt -76.76 -24.48 52.96 Favored 'General case' 0 C--N 1.308 -1.229 0 CA-C-O 121.173 0.511 . . . . 74.22 111.805 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . . . . . . . . . 1.2 mmt -73.58 -17.5 61.18 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 116.037 -0.529 . . . . 64.32 110.548 -178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 109' ' ' GLY . 96.7 mttt -73.51 -28.61 62.0 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.32 0.581 . . . . 73.54 110.306 178.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.468 ' HB3' ' HA ' ' A' ' 149' ' ' ALA . 56.6 mt-10 -101.53 -45.34 5.32 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.074 -0.966 . . . . 73.35 111.523 -177.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . 0.476 ' CE2' HD21 ' A' ' 154' ' ' LEU . 11.2 m-85 -115.9 146.77 41.77 Favored 'General case' 0 N--CA 1.425 -1.68 0 N-CA-C 107.826 -1.175 . . . . 73.44 107.826 -176.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.492 ' HB3' HG12 ' A' ' 144' ' ' ILE . 17.4 ptmt -87.92 -6.76 57.89 Favored 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.024 0.44 . . . . 74.22 111.066 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . 0.43 ' OG ' ' HB3' ' A' ' 142' ' ' GLU . 96.7 p -163.3 136.96 5.81 Favored 'General case' 0 N--CA 1.426 -1.664 0 N-CA-C 108.427 -0.953 . . . . 63.33 108.427 173.022 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.604 ' CE2' HD22 ' A' ' 120' ' ' LEU . 73.8 t80 -140.14 116.24 10.46 Favored 'General case' 0 C--N 1.31 -1.144 0 CA-C-O 121.3 0.571 . . . . 72.12 109.617 177.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 35.4 tp -123.96 129.88 51.68 Favored 'General case' 0 N--CA 1.422 -1.828 0 N-CA-C 107.992 -1.114 . . . . 73.02 107.992 -177.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.604 HD22 ' CE2' ' A' ' 118' ' ' PHE . 2.0 pt? -135.5 137.32 42.01 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 120.324 -0.55 . . . . 74.11 110.347 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 42.3 m -125.71 130.69 52.02 Favored 'General case' 0 C--N 1.283 -2.318 0 CA-C-N 116.329 -0.396 . . . . 60.15 110.158 -178.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 40.9 pt -118.05 147.9 21.21 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.098 0 N-CA-C 109.963 -0.384 . . . . 75.01 109.963 178.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.587 ' HA ' ' O ' ' A' ' 100' ' ' ASN . 60.7 tt0 -144.36 129.97 19.07 Favored 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 108.462 -0.94 . . . . 54.02 108.462 175.115 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . . . . . . . . . 61.9 t -94.31 111.4 25.22 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.082 0 N-CA-C 109.496 -0.557 . . . . 35.45 109.496 -177.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 57.2 m -115.39 130.63 24.13 Favored Pre-proline 0 N--CA 1.429 -1.525 0 CA-C-N 115.162 -0.926 . . . . 74.01 109.185 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -63.92 141.04 76.02 Favored 'Trans proline' 0 C--O 1.237 0.458 0 C-N-CA 122.473 2.116 . . . . 74.42 111.956 -178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.461 ' HB3' HD13 ' A' ' 134' ' ' ILE . 22.4 ptmt -94.04 163.34 23.94 Favored Pre-proline 0 C--N 1.306 -1.297 0 N-CA-C 109.198 -0.667 . . . . 70.23 109.198 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_exo -59.79 110.41 0.74 Allowed 'Trans proline' 0 C--O 1.25 1.123 0 C-N-CA 122.405 2.07 . . . . 41.11 111.299 177.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 143.92 -158.37 27.37 Favored Glycine 0 N--CA 1.431 -1.653 0 N-CA-C 110.038 -1.225 . . . . 70.13 110.038 -177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . -99.58 -76.58 1.25 Allowed Glycine 0 C--N 1.302 -1.323 0 C-N-CA 120.527 -0.844 . . . . 53.25 111.445 178.931 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -84.59 153.15 11.84 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 122.406 2.071 . . . . 74.54 110.948 176.121 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 107.55 148.62 14.51 Favored Glycine 0 N--CA 1.419 -2.478 0 N-CA-C 111.275 -0.73 . . . . 74.52 111.275 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 67.6 m -153.72 159.43 41.98 Favored 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 110.078 -0.342 . . . . 64.03 110.078 178.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.461 HD13 ' HB3' ' A' ' 127' ' ' LYS . 1.6 mp -111.82 123.74 67.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 122.954 0.502 . . . . 61.11 109.763 175.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 6.7 p -93.79 121.06 44.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -1.975 0 N-CA-C 108.508 -0.923 . . . . 73.43 108.508 174.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 62.1 m-70 -89.75 111.46 22.46 Favored 'General case' 0 C--N 1.304 -1.389 0 CA-C-N 115.661 -0.7 . . . . 73.32 109.754 -179.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.404 ' HH2' ' HB ' ' A' ' 161' ' ' VAL . 61.2 m95 -93.96 122.35 36.38 Favored 'General case' 0 C--N 1.305 -1.328 0 CA-C-N 115.95 -0.568 . . . . 74.24 109.716 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -115.11 112.23 22.25 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 106.143 -1.799 . . . . 73.44 106.143 176.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.516 HD21 ' SG ' ' A' ' 158' ' ' CYS . 3.5 mp -113.22 122.29 47.02 Favored 'General case' 0 C--N 1.293 -1.85 0 N-CA-C 108.807 -0.812 . . . . 72.11 108.807 -179.709 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 4.5 mp0 -119.7 128.86 54.2 Favored 'General case' 0 C--N 1.297 -1.686 0 N-CA-C 107.827 -1.175 . . . . 71.23 107.827 177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.415 ' HB3' ' HD1' ' A' ' 118' ' ' PHE . 16.0 p90 -152.62 154.23 34.93 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 114.197 1.184 . . . . 73.14 114.197 -174.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . 0.43 ' HB3' ' OG ' ' A' ' 117' ' ' SER . 34.6 tt0 -117.19 118.94 33.7 Favored 'General case' 0 C--N 1.285 -2.213 0 CA-C-N 114.607 -1.179 . . . . 74.22 109.234 -175.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -74.1 140.19 45.11 Favored 'General case' 0 CA--C 1.502 -0.897 0 CA-C-N 116.032 -0.531 . . . . 74.23 110.85 -177.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.492 HG12 ' HB3' ' A' ' 116' ' ' LYS . 65.1 mt -75.22 -47.07 37.13 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 107.614 -1.254 . . . . 62.44 107.614 172.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.467 ' HB2' ' CG2' ' A' ' 148' ' ' VAL . 54.3 m -160.84 161.19 31.83 Favored 'General case' 0 N--CA 1.422 -1.827 0 N-CA-C 107.286 -1.375 . . . . 72.22 107.286 179.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -66.09 -56.06 13.4 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 123.005 0.522 . . . . 75.14 111.886 -176.389 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.497 ' CD ' ' H ' ' A' ' 147' ' ' GLU . 1.8 mp0 -60.66 -20.25 60.38 Favored 'General case' 0 N--CA 1.477 0.892 0 CA-C-O 121.725 0.774 . . . . 63.42 110.138 -177.216 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.467 ' CG2' ' HB2' ' A' ' 145' ' ' SER . 48.1 t -92.2 -35.84 7.22 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.719 0 CA-C-N 115.03 -0.986 . . . . 64.31 112.203 -172.711 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.468 ' HA ' ' HB3' ' A' ' 114' ' ' GLU . . . -92.46 134.23 35.15 Favored 'General case' 0 C--N 1.315 -0.918 0 C-N-CA 120.548 -0.461 . . . . 75.11 111.963 -176.13 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -125.01 88.52 53.99 Favored Pre-proline 0 C--O 1.213 -0.847 0 N-CA-C 109.606 -0.516 . . . . 64.42 109.606 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -55.24 -11.14 3.77 Favored 'Trans proline' 0 N--CA 1.511 2.529 0 C-N-CA 123.405 2.736 . . . . 75.42 113.87 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -52.52 -45.91 66.49 Favored 'General case' 0 C--O 1.241 0.649 0 C-N-CA 125.327 1.451 . . . . 72.22 109.796 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 68.0 p -71.68 -34.68 69.89 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 112.943 -1.935 . . . . 61.43 112.48 -170.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . 0.477 HD22 ' CE1' ' A' ' 118' ' ' PHE . 86.6 mt -63.64 -44.53 93.57 Favored 'General case' 0 CA--C 1.504 -0.814 0 C-N-CA 122.866 0.466 . . . . 53.23 112.159 -177.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.475 ' O ' HG23 ' A' ' 159' ' ' VAL . 53.8 tp -69.48 -29.6 67.29 Favored 'General case' 0 N--CA 1.401 -2.925 0 CA-C-O 120.9 0.381 . . . . 72.34 110.436 -177.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 29.0 mm-40 -72.44 -38.04 68.41 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.751 -0.462 . . . . 51.41 109.751 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -58.94 -40.59 85.11 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 115.629 -0.714 . . . . 70.44 109.271 176.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.516 ' SG ' HD21 ' A' ' 139' ' ' LEU . 66.0 m -60.5 -45.35 94.08 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.625 -0.716 . . . . 20.24 110.608 178.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 155' ' ' LEU . 59.1 t -61.79 -46.32 96.78 Favored 'Isoleucine or valine' 0 C--O 1.246 0.888 0 CA-C-N 116.397 -0.365 . . . . 72.4 110.945 -179.149 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 164' ' ' GLU . 18.7 mm-40 -64.79 -36.2 83.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.02 -0.536 . . . . 73.2 111.942 -177.764 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HB ' ' HH2' ' A' ' 137' ' ' TRP . 86.5 t -74.71 -37.56 43.13 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.312 0 CA-C-N 116.408 -0.36 . . . . 75.32 110.477 176.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 66.5 m -58.2 -43.37 87.55 Favored 'General case' 0 C--O 1.22 -0.458 0 CA-C-O 120.586 0.231 . . . . 51.15 111.22 178.687 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -68.43 -36.15 78.65 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 120.51 -0.476 . . . . 75.34 111.933 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' A' ' 160' ' ' GLU . 43.2 mm-40 -60.24 -50.6 73.02 Favored 'General case' 0 CA--C 1.495 -1.137 0 CA-C-O 120.794 0.33 . . . . 65.42 111.384 178.392 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.585 ' O ' ' HG ' ' A' ' 169' ' ' LEU . 7.5 tp -70.62 -44.15 76.97 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.416 0 CA-C-N 115.716 -0.674 . . . . 73.32 111.41 -176.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.493 ' OD1' ' HB ' ' A' ' 32' ' ' ILE . 15.6 t70 -57.29 -51.8 67.9 Favored 'General case' 0 C--N 1.306 -1.295 0 CA-C-N 115.839 -0.619 . . . . 71.42 111.0 178.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -64.89 -30.35 71.35 Favored 'General case' 0 C--O 1.21 -1.004 0 CA-C-N 116.218 -0.446 . . . . 64.45 111.43 178.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 19.4 t60 -67.38 -36.44 81.33 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 109.997 -0.372 . . . . 62.41 109.997 177.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 165' ' ' ILE . 84.0 mt -76.22 -30.78 58.08 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.24 -0.436 . . . . 65.53 111.33 -177.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.21 -19.15 37.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.502 0.667 . . . . 73.54 110.372 178.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . -79.69 -162.82 0.45 Allowed 'General case' 0 C--N 1.308 -1.232 0 CA-C-N 114.99 -1.004 . . . . 23.43 110.507 177.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -122.58 179.33 4.64 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.411 -0.813 . . . . 74.25 110.016 -177.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 C--O 1.255 1.387 0 CA-C-N 116.133 -0.485 . . . . 73.25 110.851 177.66 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.5 p . . . . . 0 N--CA 1.443 -0.803 0 CA-C-O 121.43 0.633 . . . . 54.41 109.478 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -106.82 -14.92 14.86 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.636 -0.711 . . . . 74.4 112.208 -173.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -143.52 21.68 1.84 Allowed 'General case' 0 C--N 1.284 -2.275 0 CA-C-N 115.045 -0.979 . . . . 71.34 109.44 -179.576 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 34.7 t -72.48 -27.85 62.54 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.607 -0.724 . . . . 73.34 109.515 -179.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 39.5 m -79.58 -22.99 43.06 Favored 'General case' 0 N--CA 1.43 -1.453 0 CA-C-N 115.829 -0.623 . . . . 61.12 111.311 179.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . . . . . . . . . 92.7 mt 58.16 17.62 4.69 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.838 0.855 . . . . 74.4 112.612 -176.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.6 t -78.91 123.66 36.19 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.26 0 N-CA-C 108.439 -0.949 . . . . 64.54 108.439 178.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -112.06 130.28 9.54 Favored Glycine 0 N--CA 1.4 -3.752 0 C-N-CA 120.08 -1.057 . . . . 41.55 113.302 -175.557 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.457 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 39.6 mtpt -142.05 155.8 45.4 Favored 'General case' 0 CA--C 1.455 -2.708 0 CA-C-O 121.404 0.621 . . . . 75.14 110.568 173.451 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 6.6 tt -148.66 127.65 12.74 Favored 'General case' 0 C--N 1.262 -3.196 0 N-CA-C 106.615 -1.624 . . . . 63.31 106.615 167.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -133.87 123.46 24.78 Favored 'General case' 0 C--N 1.269 -2.905 0 N-CA-C 109.446 -0.576 . . . . 64.15 109.446 -176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 10.0 t -144.7 145.31 31.66 Favored 'General case' 0 C--N 1.293 -1.875 0 N-CA-C 108.934 -0.765 . . . . 52.11 108.934 -177.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -109.47 135.94 49.67 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.458 -0.942 . . . . 74.13 108.458 176.691 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.486 HG11 ' CB ' ' A' ' 162' ' ' SER . 58.4 t -124.21 142.94 39.28 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.771 0 N-CA-C 108.265 -1.013 . . . . 34.33 108.265 -177.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG2' ' CD1' ' A' ' 134' ' ' ILE . 23.2 mt-10 -90.83 142.37 27.83 Favored 'General case' 0 C--N 1.296 -1.734 0 C-N-CA 120.317 -0.553 . . . . 72.23 109.624 -176.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.439 ' HA ' ' OD1' ' A' ' 166' ' ' ASP . 24.5 pt -123.1 147.24 27.45 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.599 0 CA-C-O 121.551 0.691 . . . . 74.33 111.568 174.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' LYS . . . . . . . . . . . . . 91.8 mttt -73.08 -6.88 48.58 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 114.442 -1.254 . . . . 72.52 111.093 -178.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -105.69 164.62 11.77 Favored 'General case' 0 C--N 1.304 -1.392 0 CA-C-N 116.08 -0.509 . . . . 72.01 111.459 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.7 m -97.47 149.29 22.32 Favored 'General case' 0 N--CA 1.433 -1.294 0 CA-C-N 115.687 -0.688 . . . . 74.3 109.51 177.662 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -61.09 -26.51 67.71 Favored 'General case' 0 C--O 1.244 0.775 0 C-N-CA 123.513 0.725 . . . . 75.34 111.414 -178.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.488 ' O ' ' HD2' ' A' ' 41' ' ' HIS . 5.2 m-20 -53.94 -45.37 71.23 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 115.251 -0.886 . . . . 74.31 111.412 178.228 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.457 ' O ' ' HG3' ' A' ' 42' ' ' MET . 53.9 mtpt -66.94 -35.42 79.93 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 112.703 0.631 . . . . 74.11 112.703 -175.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -64.57 -44.19 91.48 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 107.639 -1.245 . . . . 73.13 107.639 178.019 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' HIS . . . . . 0.409 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 23.8 t-80 -58.09 -39.71 79.3 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 114.811 -1.086 . . . . 72.32 110.638 -179.709 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' HIS . . . . . 0.488 ' HD2' ' O ' ' A' ' 37' ' ' ASP . 54.2 m-70 -77.15 -53.11 8.17 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.679 0.622 . . . . 73.14 112.679 178.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . 0.457 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 3.4 ppp? -72.03 -23.93 61.46 Favored 'General case' 0 N--CA 1.473 0.681 0 N-CA-C 114.081 1.141 . . . . 54.22 114.081 -170.19 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.449 ' CZ ' HG21 ' A' ' 95' ' ' VAL . 80.2 t80 -69.25 -31.48 70.05 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 120.486 -0.485 . . . . 74.22 109.949 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -80.51 -34.1 35.92 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.809 -0.632 . . . . 75.32 109.928 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 42' ' ' MET . . . 167.63 173.04 35.38 Favored Glycine 0 N--CA 1.429 -1.789 0 N-CA-C 110.607 -0.997 . . . . 50.33 110.607 179.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -76.05 122.57 87.15 Favored Pre-proline 0 C--N 1.306 -1.317 0 CA-C-N 116.915 0.357 . . . . 64.24 110.188 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PRO . . . . . 0.45 ' HG3' ' HB3' ' A' ' 41' ' ' HIS . 17.1 Cg_exo -68.09 -63.53 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 121.751 1.634 . . . . 54.4 110.348 177.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 18.2 p-80 -168.49 179.92 4.16 Favored 'General case' 0 N--CA 1.439 -0.997 0 N-CA-C 108.377 -0.971 . . . . 73.11 108.377 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' HIS . . . . . . . . . . . . . 39.6 m80 -136.93 141.61 42.67 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 123.407 0.442 . . . . 73.4 111.177 178.079 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.8 m -111.9 131.27 63.76 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 CA-C-N 115.553 -0.748 . . . . 75.35 110.091 -178.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 36.9 t -105.79 94.32 5.13 Favored 'General case' 0 N--CA 1.421 -1.876 0 C-N-CA 119.889 -0.725 . . . . 74.1 112.122 -175.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 54.7 mtpt -130.31 125.32 34.42 Favored 'General case' 0 CA--C 1.496 -1.099 0 N-CA-C 107.175 -1.417 . . . . 63.52 107.175 171.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' A' ' 55' ' ' PRO . . . 57.95 -160.34 0.25 Allowed 'General case' 0 C--O 1.242 0.667 0 N-CA-C 108.239 -1.023 . . . . 73.44 108.239 -172.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 23.2 t -98.63 104.79 26.39 Favored Pre-proline 0 C--N 1.303 -1.445 0 N-CA-C 108.301 -1.0 . . . . 64.53 108.301 175.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.455 ' HD3' ' O ' ' A' ' 53' ' ' ALA . 8.0 Cg_exo -72.28 132.94 20.16 Favored 'Trans proline' 0 C--O 1.246 0.893 0 C-N-CA 122.515 2.143 . . . . 71.13 111.681 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -66.18 126.78 29.02 Favored Glycine 0 N--CA 1.437 -1.253 0 CA-C-N 115.39 -0.823 . . . . 73.31 112.853 -179.409 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -91.71 102.48 15.1 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 109.107 -0.701 . . . . 75.31 109.107 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 31.4 pt -87.8 172.42 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.417 -2.115 0 CA-C-N 115.419 -0.809 . . . . 55.51 111.06 -178.097 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . . . . . . . . . 72.9 mm-40 -110.81 151.06 28.26 Favored 'General case' 0 C--N 1.281 -2.386 0 CA-C-N 114.908 -1.042 . . . . 74.02 109.707 -175.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 101.53 -4.7 54.28 Favored Glycine 0 C--N 1.309 -0.949 0 C-N-CA 120.585 -0.817 . . . . 44.3 113.128 176.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 77.8 m -94.03 -21.08 19.38 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.298 0.571 . . . . 64.11 109.581 177.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -102.06 149.18 24.52 Favored 'General case' 0 C--N 1.313 -1.01 0 N-CA-C 107.797 -1.186 . . . . 73.54 107.797 176.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -91.69 118.22 30.45 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 112.577 0.584 . . . . 70.43 112.577 -174.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -78.97 -30.52 44.52 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.503 -0.771 . . . . 75.22 109.833 176.152 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -166.61 164.61 16.91 Favored 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 108.825 -0.805 . . . . 62.44 108.825 -175.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . 153.63 -118.35 0.86 Allowed Glycine 0 N--CA 1.428 -1.85 0 N-CA-C 110.996 -0.842 . . . . 75.33 110.996 -179.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASP . . . . . . . . . . . . . 33.3 t70 67.41 15.22 9.85 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.955 0.902 . . . . 73.15 111.405 178.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' TRP . . . . . 0.447 ' CD1' ' HA ' ' A' ' 73' ' ' SER . 92.1 m95 -85.33 -0.45 54.81 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.01 -0.541 . . . . 65.41 111.24 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 95.43 13.88 49.81 Favored Glycine 0 C--N 1.311 -0.821 0 C-N-CA 119.212 -1.47 . . . . 65.41 109.873 -175.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 55.2 m 75.77 -60.18 0.5 Allowed 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 124.547 1.139 . . . . 74.45 110.889 -177.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 43.7 t -71.67 120.7 20.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 N-CA-C 108.2 -1.037 . . . . 73.13 108.2 176.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 102.02 -0.4 51.44 Favored Glycine 0 N--CA 1.437 -1.241 0 C-N-CA 120.393 -0.908 . . . . 74.44 112.144 -178.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HA ' ' CD1' ' A' ' 68' ' ' TRP . 19.5 t -68.97 148.41 50.18 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 122.631 0.372 . . . . 74.54 110.373 -178.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ILE . . . . . 0.429 HG23 ' O ' ' A' ' 90' ' ' GLU . 87.2 mt -131.09 122.65 52.06 Favored 'Isoleucine or valine' 0 C--O 1.242 0.679 0 C-N-CA 122.775 0.43 . . . . 73.32 110.717 179.324 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.5 p -138.54 151.11 24.14 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 N-CA-C 108.886 -0.783 . . . . 75.24 108.886 176.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.441 ' CD1' ' HA ' ' A' ' 89' ' ' LYS . 21.0 m-85 -113.48 137.31 51.73 Favored 'General case' 0 C--N 1.311 -1.074 0 C-N-CA 120.113 -0.635 . . . . 72.35 110.557 -179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TRP . . . . . . . . . . . . . 6.1 m0 -108.01 135.39 49.46 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-N 116.357 -0.383 . . . . 75.33 110.576 -176.281 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -108.85 135.27 50.34 Favored 'General case' 0 C--N 1.313 -1.016 0 N-CA-C 107.935 -1.135 . . . . 72.31 107.935 173.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.405 ' O ' ' HA ' ' A' ' 85' ' ' ALA . 38.6 p90 -159.27 164.53 34.86 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 108.667 -0.864 . . . . 73.31 108.667 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 56.3 t -105.89 120.88 57.5 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.109 0 CA-C-O 121.41 0.624 . . . . 73.43 109.972 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.403 ' HB3' ' HG3' ' A' ' 86' ' ' LYS . 29.8 t60 -137.34 119.91 16.05 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 107.498 -1.297 . . . . 74.4 107.498 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 64.25 30.45 13.51 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.378 0.609 . . . . 74.33 111.53 -177.238 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.87 -0.66 89.13 Favored Glycine 0 N--CA 1.439 -1.109 0 CA-C-N 115.355 -0.839 . . . . 54.41 114.229 176.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 33.6 tt0 -118.42 146.91 44.08 Favored 'General case' 0 N--CA 1.431 -1.377 0 CA-C-N 117.905 0.852 . . . . 54.14 109.574 179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.405 ' HA ' ' O ' ' A' ' 79' ' ' TYR . . . -79.44 115.96 19.39 Favored 'General case' 0 N--CA 1.424 -1.728 0 N-CA-C 106.613 -1.625 . . . . 74.0 106.613 173.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LYS . . . . . 0.403 ' HG3' ' HB3' ' A' ' 81' ' ' HIS . 27.8 mmmt -105.17 155.65 18.83 Favored 'General case' 0 C--N 1.283 -2.289 0 N-CA-C 107.851 -1.166 . . . . 65.31 107.851 -175.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 59.2 t -115.79 132.05 66.4 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.879 0 N-CA-C 108.538 -0.912 . . . . 62.14 108.538 178.114 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -109.48 128.18 54.98 Favored 'General case' 0 C--N 1.3 -1.587 0 N-CA-C 108.39 -0.967 . . . . 41.25 108.39 177.634 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.592 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 88.1 mttt -111.96 129.47 56.17 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 115.453 -0.794 . . . . 73.23 109.072 -177.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.429 ' O ' HG23 ' A' ' 74' ' ' ILE . 0.0 OUTLIER -149.6 167.7 25.61 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-O 121.129 0.49 . . . . 70.54 111.711 -170.812 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 91' ' ' ARG . 33.8 ttt180 -138.15 145.18 41.25 Favored 'General case' 0 N--CA 1.421 -1.878 0 N-CA-C 107.089 -1.449 . . . . 72.21 107.089 171.437 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 58.7 mt -79.16 121.65 32.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 107.321 -1.363 . . . . 44.42 107.321 171.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -96.66 -41.96 8.26 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 120.493 -0.483 . . . . 71.24 110.001 -177.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ALA . . . . . . . . . . . . . . . -155.83 140.81 17.3 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.785 -0.82 . . . . 53.53 108.785 -179.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.449 HG21 ' CZ ' ' A' ' 43' ' ' PHE . 7.2 p -146.69 125.35 4.43 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 CA-C-O 121.034 0.445 . . . . 63.23 110.724 178.395 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.69 ' HG3' ' H ' ' A' ' 99' ' ' LYS . 9.5 tp10 -117.54 104.97 48.97 Favored Pre-proline 0 C--N 1.297 -1.679 0 N-CA-C 107.49 -1.3 . . . . 75.23 107.49 175.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.409 ' O ' ' HD2' ' A' ' 40' ' ' HIS . 24.4 Cg_exo -66.98 -28.45 41.82 Favored 'Trans proline' 0 N--CA 1.453 -0.879 0 C-N-CA 122.634 2.222 . . . . 65.13 111.499 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -73.33 -34.33 65.61 Favored 'General case' 0 CA--C 1.511 -0.534 0 CA-C-O 121.272 0.558 . . . . 65.0 111.155 -173.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.69 ' H ' ' HG3' ' A' ' 96' ' ' GLU . 35.5 mmtp -99.41 -0.1 41.61 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 115.609 -0.723 . . . . 73.42 110.357 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . 0.449 ' ND2' ' HB ' ' A' ' 124' ' ' VAL . 51.7 t-20 56.82 65.27 1.44 Allowed 'General case' 0 N--CA 1.466 0.364 0 O-C-N 124.211 0.944 . . . . 65.52 108.807 -177.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LEU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 96' ' ' GLU . 38.7 tp -133.44 139.46 46.73 Favored 'General case' 0 C--N 1.31 -1.119 0 CA-C-N 114.801 -1.09 . . . . 60.34 110.037 -174.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 12.0 tt -150.01 126.71 2.22 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.205 0 CA-C-O 121.357 0.599 . . . . 65.14 111.558 175.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.5 m -99.15 123.35 43.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 115.441 -0.799 . . . . 75.41 111.079 178.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -102.48 128.01 49.28 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 107.19 -1.411 . . . . 53.51 107.19 176.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 2.0 tmt_? -120.15 118.47 30.63 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 107.189 -1.411 . . . . 61.43 107.189 179.472 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 87.8 t -78.74 123.46 35.69 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 N-CA-C 108.165 -1.05 . . . . 64.22 108.165 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.519 HD13 ' H ' ' A' ' 107' ' ' ILE . 0.2 OUTLIER -98.41 -26.41 3.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.928 0 C-N-CA 120.34 -0.544 . . . . 73.52 111.496 -176.242 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 89' ' ' LYS . 35.9 tt0 -152.85 153.74 33.7 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.407 -1.331 . . . . 74.11 107.407 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 143.65 177.92 18.99 Favored Glycine 0 N--CA 1.423 -2.226 0 C-N-CA 119.792 -1.194 . . . . 64.15 111.647 179.793 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -68.22 -29.55 68.41 Favored 'General case' 0 C--N 1.301 -1.528 0 CA-C-O 121.267 0.556 . . . . 52.5 111.001 -177.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.9 mp -72.53 -24.41 61.14 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-O 121.383 0.611 . . . . 71.12 109.939 178.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' MET . . . . . 0.565 ' HE3' ' HA ' ' A' ' 112' ' ' MET . 0.1 OUTLIER -73.4 -16.73 61.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.72 -0.673 . . . . 73.4 110.596 -176.235 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.05 -10.81 37.77 Favored 'General case' 0 N--CA 1.444 -0.737 0 C-N-CA 119.751 -0.78 . . . . 65.32 111.832 176.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -88.98 -54.18 4.25 Favored 'General case' 0 CA--C 1.483 -1.6 0 CA-C-O 122.44 1.114 . . . . 63.24 108.36 177.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -110.97 133.85 53.06 Favored 'General case' 0 N--CA 1.397 -3.115 0 N-CA-C 105.878 -1.897 . . . . 74.25 105.878 -177.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -72.9 -6.32 44.35 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.355 0.598 . . . . 72.31 111.607 -179.135 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' SER . . . . . . . . . . . . . 41.1 t -164.18 135.64 4.56 Favored 'General case' 0 N--CA 1.426 -1.65 0 N-CA-C 106.939 -1.504 . . . . 73.41 106.939 175.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' PHE . . . . . 0.534 ' CE2' HD22 ' A' ' 120' ' ' LEU . 91.7 t80 -141.93 120.95 12.86 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 121.154 0.502 . . . . 73.13 111.205 -177.223 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 49.3 mt -122.98 145.23 48.67 Favored 'General case' 0 CA--C 1.475 -1.907 0 CA-C-N 114.947 -1.024 . . . . 71.5 110.745 177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.534 HD22 ' CE2' ' A' ' 118' ' ' PHE . 1.8 pt? -142.34 118.8 10.93 Favored 'General case' 0 C--N 1.261 -3.272 0 CA-C-N 114.524 -1.216 . . . . 75.13 109.03 173.564 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' THR . . . . . . . . . . . . . 29.4 m -118.21 131.08 56.4 Favored 'General case' 0 N--CA 1.409 -2.514 0 N-CA-C 109.31 -0.626 . . . . 71.42 109.31 -176.741 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . . . . . . . . . 37.9 pt -117.17 144.17 25.66 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.733 0 C-N-CA 120.561 -0.456 . . . . 71.24 109.956 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . 0.423 ' HG3' ' O ' ' A' ' 100' ' ' ASN . 55.1 tt0 -138.65 123.88 19.21 Favored 'General case' 0 C--N 1.29 -2.015 0 N-CA-C 107.74 -1.207 . . . . 63.34 107.74 176.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' VAL . . . . . 0.449 ' HB ' ' ND2' ' A' ' 100' ' ' ASN . 57.9 t -95.07 115.86 35.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-O 121.458 0.647 . . . . 75.53 109.614 -175.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 61.3 m -127.42 138.24 32.38 Favored Pre-proline 0 C--N 1.292 -1.928 0 CA-C-N 115.032 -0.985 . . . . 65.31 108.427 -174.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 82.5 Cg_exo -45.06 146.79 2.39 Favored 'Trans proline' 0 CA--C 1.547 1.159 0 C-N-CA 123.634 2.89 . . . . 73.14 113.983 179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . 0.42 ' HG3' ' CA ' ' A' ' 133' ' ' SER . 7.1 mtpm? -72.06 148.58 91.76 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.823 -0.626 . . . . 71.34 109.798 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -57.29 110.1 0.56 Allowed 'Trans proline' 0 C--O 1.244 0.811 0 C-N-CA 122.484 2.123 . . . . 64.31 110.449 176.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 130.94 -53.65 0.8 Allowed Glycine 0 N--CA 1.425 -2.037 0 N-CA-C 110.025 -1.23 . . . . 65.11 110.025 -176.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLY . . . . . . . . . . . . . . . 150.99 -79.59 0.2 Allowed Glycine 0 N--CA 1.438 -1.195 0 C-N-CA 120.728 -0.748 . . . . 55.01 113.102 178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' PRO . . . . . . . . . . . . . 9.6 Cg_endo -52.53 125.31 17.41 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 124.134 3.223 . . . . 73.42 114.078 -177.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 86.95 175.67 49.24 Favored Glycine 0 N--CA 1.441 -1.03 0 CA-C-N 115.548 -0.751 . . . . 52.31 112.462 178.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.42 ' CA ' ' HG3' ' A' ' 127' ' ' LYS . 36.5 p -137.79 159.68 41.33 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-O 121.318 0.58 . . . . 61.42 112.144 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.528 ' CD1' ' HG2' ' A' ' 31' ' ' GLU . 4.5 tp -111.02 147.52 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.411 -2.419 0 N-CA-C 104.981 -2.229 . . . . 74.52 104.981 -179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 7.1 p -109.26 118.88 57.62 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.759 0 O-C-N 121.658 -0.651 . . . . 42.41 109.38 174.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -89.87 111.41 22.44 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 115.86 -0.609 . . . . 74.25 109.513 179.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . . . . . . . . . 55.3 m95 -94.33 122.22 36.66 Favored 'General case' 0 CA--C 1.497 -1.094 0 N-CA-C 109.447 -0.575 . . . . 54.13 109.447 178.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -116.74 111.46 19.8 Favored 'General case' 0 C--N 1.29 -2.008 0 N-CA-C 106.558 -1.645 . . . . 63.42 106.558 175.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . . . . . . . . . 4.2 mp -107.06 122.53 46.65 Favored 'General case' 0 C--N 1.273 -2.726 0 N-CA-C 106.619 -1.623 . . . . 72.35 106.619 177.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -128.69 127.1 41.46 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 107.799 -1.186 . . . . 73.13 107.799 -177.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TYR . . . . . 0.426 ' OH ' ' HB3' ' A' ' 151' ' ' PRO . 18.1 p90 -152.04 165.7 33.88 Favored 'General case' 0 C--N 1.286 -2.173 0 N-CA-C 113.079 0.77 . . . . 73.24 113.079 -172.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -117.45 120.76 39.13 Favored 'General case' 0 C--N 1.3 -1.576 0 N-CA-C 108.964 -0.754 . . . . 62.32 108.964 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 1.1 mptm? -77.52 137.03 38.39 Favored 'General case' 0 CA--C 1.507 -0.707 0 C-N-CA 120.724 -0.39 . . . . 71.23 111.395 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ILE . . . . . 0.41 ' HB ' HG11 ' A' ' 148' ' ' VAL . 61.6 mt -77.58 -37.1 24.05 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.164 0 N-CA-C 106.494 -1.669 . . . . 71.31 106.494 170.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.2 t -167.45 174.27 8.07 Favored 'General case' 0 N--CA 1.431 -1.412 0 N-CA-C 104.884 -2.265 . . . . 72.34 104.884 178.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -84.37 -49.93 8.27 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.592 0.71 . . . . 73.44 110.136 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -60.1 -20.17 56.94 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 114.079 -1.418 . . . . 71.31 112.436 -175.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.41 HG11 ' HB ' ' A' ' 144' ' ' ILE . 13.7 p -88.55 -24.93 5.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 121.309 0.576 . . . . 65.01 110.192 -179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -98.01 160.84 14.05 Favored 'General case' 0 C--N 1.311 -1.095 0 CA-C-N 115.945 -0.57 . . . . 63.33 111.751 -174.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' HIS . . . . . . . . . . . . . 19.0 p80 -143.35 82.0 11.99 Favored Pre-proline 0 C--N 1.313 -1.001 0 CA-C-N 115.61 -0.723 . . . . 70.32 112.202 174.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' PRO . . . . . 0.426 ' HB3' ' OH ' ' A' ' 141' ' ' TYR . 21.0 Cg_exo -69.02 -3.48 11.61 Favored 'Trans proline' 0 N--CA 1.498 1.778 0 C-N-CA 123.59 2.86 . . . . 73.44 113.161 -179.15 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -70.43 -45.53 65.69 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-O 121.841 0.829 . . . . 75.01 110.809 179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' THR . . . . . . . . . . . . . 67.1 p -65.7 -27.58 68.44 Favored 'General case' 0 C--N 1.294 -1.837 0 CA-C-N 114.547 -1.206 . . . . 71.41 112.1 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 90.4 mt -52.56 -37.66 58.29 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 123.48 0.712 . . . . 71.13 111.556 178.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' LEU . . . . . 0.602 ' HA ' ' SG ' ' A' ' 158' ' ' CYS . 63.1 mt -64.36 -35.15 79.95 Favored 'General case' 0 CA--C 1.509 -0.608 0 C-N-CA 120.979 -0.288 . . . . 71.35 111.452 178.1 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLN . . . . . . . . . . . . . 15.2 mm100 -68.47 -37.98 80.64 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 115.984 -0.553 . . . . 74.42 109.805 177.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -67.45 -45.99 74.39 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.211 -0.45 . . . . 72.33 110.491 178.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . 0.602 ' SG ' ' HA ' ' A' ' 155' ' ' LEU . 28.6 p -67.35 -37.09 82.7 Favored 'General case' 0 C--N 1.32 -0.677 0 C-N-CA 120.323 -0.551 . . . . 51.02 112.392 -177.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' VAL . . . . . . . . . . . . . 10.4 p -66.83 -42.98 89.94 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 111.976 0.361 . . . . 64.23 111.976 -175.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -68.62 -37.97 80.17 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.4 -0.364 . . . . 61.24 111.44 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.0 t -69.39 -34.36 61.97 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 CA-C-N 116.365 -0.38 . . . . 62.33 110.183 177.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.56 ' O ' HG22 ' A' ' 165' ' ' ILE . 69.4 m -61.66 -48.25 81.66 Favored 'General case' 0 C--O 1.22 -0.495 0 N-CA-C 111.669 0.248 . . . . 60.13 111.669 177.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 67.1 mttm -60.2 -35.86 76.35 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.397 0.618 . . . . 72.01 110.171 179.848 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -68.2 -42.21 80.24 Favored 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 114.782 -1.099 . . . . 73.53 109.468 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.56 HG22 ' O ' ' A' ' 162' ' ' SER . 0.4 OUTLIER -68.07 -34.62 67.82 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 115.78 -0.646 . . . . 75.02 109.981 -176.107 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASP . . . . . 0.439 ' OD1' ' HA ' ' A' ' 32' ' ' ILE . 8.8 m-20 -52.38 -52.7 52.15 Favored 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.887 0.851 . . . . 74.43 109.099 175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -72.66 -30.7 64.49 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.068 -1.424 . . . . 72.1 111.548 -176.44 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . . . . . . . . . 48.2 t60 -61.57 -41.27 97.16 Favored 'General case' 0 C--N 1.311 -1.066 0 N-CA-C 109.361 -0.607 . . . . 62.4 109.361 177.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 70.3 mt -78.5 -44.24 24.94 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 112.734 0.642 . . . . 75.32 112.734 178.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LEU . . . . . 0.439 ' HG ' ' O ' ' A' ' 166' ' ' ASP . 95.9 mt -65.47 -43.98 88.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 C-N-CA 119.929 -0.708 . . . . 61.15 110.116 -178.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ALA . . . . . . . . . . . . . . . 50.69 -74.72 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 126.255 1.822 . . . . 74.22 114.538 177.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -83.35 171.35 13.61 Favored 'General case' 0 N--CA 1.428 -1.527 0 N-CA-C 108.977 -0.749 . . . . 75.45 108.977 -179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.284 -2.243 0 N-CA-C 106.747 -1.575 . . . . 72.52 106.747 -177.248 . . . . . . . . 1 1 . 1 stop_ save_